Citrus Sinensis ID: 007788
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 589 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.814 | 0.755 | 0.306 | 2e-63 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.758 | 0.728 | 0.303 | 3e-60 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.814 | 0.759 | 0.295 | 7e-58 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.767 | 0.708 | 0.292 | 2e-54 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.757 | 0.703 | 0.291 | 1e-53 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.772 | 0.702 | 0.284 | 4e-53 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.833 | 0.830 | 0.297 | 1e-51 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.782 | 0.369 | 0.271 | 3e-51 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.882 | 0.739 | 0.277 | 3e-50 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.813 | 0.458 | 0.295 | 2e-48 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 244 bits (623), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 170/555 (30%), Positives = 276/555 (49%), Gaps = 75/555 (13%)
Query: 42 FVV-LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100
FV+ L+ L+G + + IG+L +L + LQ+N + G IP +G L KLK LDLS N+
Sbjct: 82 FVIRLEAPSQNLSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNF 141
Query: 101 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG----GFQFQNNPGLCGDGIASLR 156
G IP +L+ + L +L V NN+L+G +PS+L + + N G +A +
Sbjct: 142 TGQIPFTLSYSKNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLA--K 199
Query: 157 ACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNS-SKFPQIAVLAAV- 214
V N+QI P N T P +P + +Q++ S+ +K +IAV+ V
Sbjct: 200 TFNVMGNSQICPTGT-EKDCNGTQP----KPMSITLNSSQNKSSDGGTKNRKIAVVFGVS 254
Query: 215 -TSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEY 273
T V +++ G G L+++R R +KQ L D N E
Sbjct: 255 LTCVCLLIIGFGFLLWWRRRHNKQ-----------------VLFFDINEQNKE-----EM 292
Query: 274 CHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG 333
C G N R N +E++SAT FS NL+GKG F +VYKG L DG
Sbjct: 293 CLG------------------NLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDG 334
Query: 334 TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393
+++A++ + + E +F L +++ H N++RL GFC + E L+Y + G
Sbjct: 335 SIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSS--ERLLVYPYMSNG 392
Query: 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453
++ L + VLDW TR I +G +G+ YLH E P I+HR++ +L+D
Sbjct: 393 SVASRLKAKP----VLDWGTRKRIALGAGRGLLYLH--EQCDPKIIHRDVKAANILLDDY 446
Query: 454 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
F ++ D GL KLL + +G++APEY++TG+ +E++D+F FG+++L+++T
Sbjct: 447 FEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 506
Query: 514 GSLVL----TSSMRLA--------AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHE 561
G L ++ R A + E +D++LK + E ++ ++AL+CT
Sbjct: 507 GLRALEFGKAANQRGAILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQY 566
Query: 562 DPENRPTMEAVIEEL 576
P +RP M V+ L
Sbjct: 567 LPIHRPKMSEVVRML 581
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (594), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 164/540 (30%), Positives = 254/540 (47%), Gaps = 93/540 (17%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
NQLTG IP+++G L L L L NR +G IP SLG L L L LS N L G +P +A
Sbjct: 113 NQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLVA 172
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPV 169
+ L FLD+ N LSG P+ + ++ N LCG AS C+
Sbjct: 173 GLSGLSFLDLSFNNLSGPTPNISAK---DYRIVGNAFLCGP--ASQELCS---------- 217
Query: 170 KPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIF 229
D TP+ +G E N S F V+A + S+ + +F
Sbjct: 218 --------DATPV--RNATGLSEKDNSKHHSLVLSFAFGIVVAFIISL--------MFLF 259
Query: 230 FRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGF 289
F H+ ++ + D++ F
Sbjct: 260 FWVLWHRSRLSRSHVQQDYE---------------------------------------F 280
Query: 290 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE 349
HL R + E+++AT FS N+LG+G F VYKG L +GT+VA++ + +
Sbjct: 281 EIGHLK--RFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLK-DPIYTG 337
Query: 350 EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 409
E +F + ++ H N++RL GFC + E L+Y + P G ++ L G L
Sbjct: 338 EVQFQTEVEMIGLAVHRNLLRLFGFCMTPE--ERMLVYPYMPNGSVADRLRDNYGEKPSL 395
Query: 410 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469
DW+ R+SI +G A+G+ YLH E P I+HR++ +L+D+ F ++ D GL KLL
Sbjct: 396 DWNRRISIALGAARGLVYLH--EQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQ 453
Query: 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-------------SL 516
+G++APEY++TG+ +E++D+F FGV+IL+++TG +
Sbjct: 454 RDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGM 513
Query: 517 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+L+ L AE F +DR+LKG+F + ++ ++AL+CT P RP M V++ L
Sbjct: 514 ILSWVRTLKAEK-RFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVL 572
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (574), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 162/548 (29%), Positives = 264/548 (48%), Gaps = 68/548 (12%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L L+G + +IG+L L + LQ+N + G IP+++G L KL+ LDLS NS G I
Sbjct: 79 LDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEI 138
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLNG----GFQFQNNPGLCGDGIASLRACTV 160
P SL L +L + NN+L G P +L ++ G + N G S R V
Sbjct: 139 PASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--VSARTFKV 196
Query: 161 YDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVI 220
N I K + S P+ + + + ++S + +A A+ ++ +
Sbjct: 197 IGNALICGPKAVSNCSAVPEPLTLPQ-----DGPDESGTRTNGHHVALAFAASFSAAFFV 251
Query: 221 LAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPL 280
+G+ +++RYRR+KQ + +E D P VSL
Sbjct: 252 FFTSGMFLWWRYRRNKQIFFDVNEQYD-------------------PEVSLG-------- 284
Query: 281 GDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS 340
HL R +E+ SAT F+ N+LG+G + VYKG L DGTLVA++
Sbjct: 285 ------------HLK--RYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKR 330
Query: 341 INVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 400
+ + E +F + ++ H N++RLRGFC S E L+Y + P G ++ L
Sbjct: 331 LKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSS--NQERILVYPYMPNGSVASRLK 388
Query: 401 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460
LDWS R I +G A+G+ YLH E P I+HR++ +L+D+ F ++ D
Sbjct: 389 DNIRGEPALDWSRRKKIAVGTARGLVYLH--EQCDPKIIHRDVKAANILLDEDFEAVVGD 446
Query: 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL---- 516
GL KLL +G++APEY++TG+ +E++D+F FG+++L+++TG
Sbjct: 447 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDF 506
Query: 517 --------VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
V+ ++ + + ID++L KF E ++ ++AL+CT +P +RP
Sbjct: 507 GRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPK 566
Query: 569 MEAVIEEL 576
M V++ L
Sbjct: 567 MSEVMKML 574
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 159/544 (29%), Positives = 252/544 (46%), Gaps = 92/544 (16%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N + G IPA+IG L L L L N +G IP S+G L L+ L L+ NSL G P SL+
Sbjct: 115 NNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLS 174
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPV 169
N +L FLD+ N LSG VP + F NP +C G
Sbjct: 175 NMTQLAFLDLSYNNLSGPVPRFAAKT---FSIVGNPLICPTG-----------------T 214
Query: 170 KPFGSHSNDTTPIDIS---EPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGI 226
+P N TT I +S +G + S+ + IAV ++V +V++I G+
Sbjct: 215 EP---DCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMA----IAVGSSVGTVSLIFIAVGL 267
Query: 227 LIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNG 286
+++R R ++ + KD N + L +L
Sbjct: 268 FLWWRQRHNQNTFFD---------------VKDGNHHEEVSLGNLR-------------- 298
Query: 287 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC 346
R E++ AT FS NLLGKG + +VYKG L D T+VA++ +
Sbjct: 299 -----------RFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGA 347
Query: 347 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 406
E +F + +++ H N++RL GFC ++ E L+Y + G ++ + +
Sbjct: 348 LGGEIQFQTEVEMISLAVHRNLLRLYGFCITQT--EKLLVYPYMSNGSVASRMKAKP--- 402
Query: 407 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466
VLDWS R I IG A+G+ YLH E P I+HR++ +L+D ++ D GL KL
Sbjct: 403 -VLDWSIRKRIAIGAARGLVYLH--EQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKL 459
Query: 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL---------- 516
L +G++APEY++TG+ +E++D+F FG+++L+++TG
Sbjct: 460 LDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQ 519
Query: 517 --VLTSSMRLAAESATFENFIDRNL--KGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 572
V+ ++ + E +D+ L K + E E ++ ++AL+CT P +RP M V
Sbjct: 520 KGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEV 579
Query: 573 IEEL 576
+ L
Sbjct: 580 VRML 583
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 158/542 (29%), Positives = 255/542 (47%), Gaps = 96/542 (17%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N ++G IP +I SL L L L +NR +G IP S+ L L+ L L+ NSL G P SL+
Sbjct: 108 NNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLS 167
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPV 169
L FLD+ N L G VP R F NP +C + + + C+
Sbjct: 168 QIPHLSFLDLSYNNLRGPVPKFPART---FNVAGNPLICKNSLPEI--CS---------- 212
Query: 170 KPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVT---SVTVILAGTGI 226
GS S + + SG + + +AV V+ +V+VIL+
Sbjct: 213 ---GSISASPLSVSLRSSSGRRTNI-------------LAVALGVSLGFAVSVILS---- 252
Query: 227 LIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNG 286
L F YR+ +++ LT+ + +S + G LG+
Sbjct: 253 LGFIWYRKKQRR---------------LTMLR----------ISDKQEEGLLGLGN---- 283
Query: 287 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC 346
L SF E+ AT FS ++LG G F +VY+G DGT+VA++ + +
Sbjct: 284 -------LRSF--TFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNG 334
Query: 347 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 406
S ++F L +++ H N++RL G+C S E L+Y + G ++ L +
Sbjct: 335 TSGNSQFRTELEMISLAVHRNLLRLIGYCASSS--ERLLVYPYMSNGSVASRLKAKPA-- 390
Query: 407 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466
LDW+TR I IG A+G+ YLH E P I+HR++ +L+D+ F ++ D GL KL
Sbjct: 391 --LDWNTRKKIAIGAARGLFYLH--EQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKL 446
Query: 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 526
L + +G++APEY++TG+ +E++D+F FG+++L+++TG L ++
Sbjct: 447 LNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQ 506
Query: 527 ESATF------------ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ A E +DR L + E ++ ++AL+CT P +RP M V++
Sbjct: 507 KGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQ 566
Query: 575 EL 576
L
Sbjct: 567 ML 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (533), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 156/548 (28%), Positives = 261/548 (47%), Gaps = 93/548 (16%)
Query: 52 LTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN 111
L+G + IG+L +L ++LQ+N ++G IP LG L KL+ LDLS N G IP S+
Sbjct: 89 LSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQL 148
Query: 112 AELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKP 171
+ L +L + NN+LSG P++L + I L + N PV
Sbjct: 149 SSLQYLRLNNNSLSGPFPASLSQ-----------------IPHLSFLDLSYNNLSGPVPK 191
Query: 172 FGSHSNDTTPIDISEPSGFKEHCNQS------------QCSNSSKFPQIAVLAAVTSVTV 219
F + + + + S E C+ S S IA+ ++ SV +
Sbjct: 192 FPARTFNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRRSNRLAIALSVSLGSVVI 251
Query: 220 ILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDP 279
++ G ++R ++ + I N ++ +
Sbjct: 252 LVLALGSFCWYRKKQRRLLILNLNDKQE-------------------------------- 279
Query: 280 LGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIR 339
+ L G G +L SF E+ T FS N+LG G F +VY+G L DGT+VA++
Sbjct: 280 --EGLQGLG----NLRSF--TFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVK 331
Query: 340 SINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL 399
+ + S +++F L +++ H+N++RL G+C + GE L+Y + P G ++ L
Sbjct: 332 RLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCAT--SGERLLVYPYMPNGSVASKL 389
Query: 400 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459
S LDW+ R I IG A+G+ YLH E P I+HR++ +L+D+ F ++
Sbjct: 390 K----SKPALDWNMRKRIAIGAARGLLYLH--EQCDPKIIHRDVKAANILLDECFEAVVG 443
Query: 460 DCGLHKLL--ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 517
D GL KLL AD V + ++ +G++APEY++TG+ +E++D+F FG+++L+++TG
Sbjct: 444 DFGLAKLLNHADSHVTTAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRA 501
Query: 518 LT------------SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPEN 565
L +R E E +DR L + + E ++ ++AL+CT P +
Sbjct: 502 LEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAH 561
Query: 566 RPTMEAVI 573
RP M V+
Sbjct: 562 RPKMSEVV 569
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 167/562 (29%), Positives = 264/562 (46%), Gaps = 71/562 (12%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ L L +++ G +P IG L L +L L +N L G IP +LGN L+ + L N G
Sbjct: 77 ITLNLTYHKIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTG 136
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLN--GGFQFQNN---PGLCGDGIASLRA 157
IP + + L LD+ +NTLSG +P++L +L F NN + DG+ S
Sbjct: 137 PIPAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLS--- 193
Query: 158 CTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSV 217
N+ I + G H + D PS + Q+Q NS K +++A +V
Sbjct: 194 -GFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQ-SGQNQKKNSGKL----LISASATV 247
Query: 218 TVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGW 277
+L ++ F+ +K K+G S LAKD G + +V HG
Sbjct: 248 GALLL-VALMCFWGCFLYK-KLGKVEIKS---------LAKDVG--GGASIVMF---HGD 291
Query: 278 DPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVA 337
P +++ + +E +++G G F +VYK + DG + A
Sbjct: 292 LPYSS-------------------KDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFA 332
Query: 338 IRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSK 397
++ I + + + F + L +L S++H ++ LRG+C S L+YD+ P G L +
Sbjct: 333 LKRI-LKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK--LLLYDYLPGGSLDE 389
Query: 398 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457
L E G LDW +RV+IIIG AKG+ YLH P I+HR++ +L+D
Sbjct: 390 AL-HERGEQ--LDWDSRVNIIIGAAKGLSYLHHD--CSPRIIHRDIKSSNILLDGNLEAR 444
Query: 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-- 515
++D GL KLL D+ + GYLAPEY+ +GR TE++D+++FGV++L++L+G
Sbjct: 445 VSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 504
Query: 516 ---------LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR 566
L + ++ + +D N +G ES A L +A C PE R
Sbjct: 505 TDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALL-SIATQCVSPSPEER 563
Query: 567 PTMEAVIE--ELTVAAPVMATF 586
PTM V++ E V P + F
Sbjct: 564 PTMHRVVQLLESEVMTPCPSEF 585
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (517), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 152/559 (27%), Positives = 246/559 (44%), Gaps = 98/559 (17%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSL-SVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L+L N LTG IP +IG L+ L S L L +N G IP ++G L KL+ LDLS N L G
Sbjct: 748 LRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGE 807
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
+P S+ + L +L+V N L G + R F N GLCG ++
Sbjct: 808 VPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPAD-SFLGNTGLCGSPLS---------- 856
Query: 164 TQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSK---FPQIAVLAAVTSVTVI 220
CN+ + +N + + +++A++++T I
Sbjct: 857 -----------------------------RCNRVRSNNKQQGLSARSVVIISAISALTAI 887
Query: 221 LAGTGILIFFRYRRHK--QKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWD 278
++ F +RH +K+G+ S + S+ K RNGAS
Sbjct: 888 GLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGAS------------ 935
Query: 279 PLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAI 338
+ E++ AT SE ++G G VYK L +G VA+
Sbjct: 936 -----------------KSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAV 978
Query: 339 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 398
+ I F + + L +RH ++++L G+C S+ G LIY++ G + +
Sbjct: 979 KKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDW 1038
Query: 399 LDQE----EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454
L ++ E +LDW R+ I +G+A+G+ YLH V P IVHR++ VL+D
Sbjct: 1039 LHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCV--PPIVHRDIKSSNVLLDSNM 1096
Query: 455 NPLIADCGLHKLLA---DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 511
+ D GL K+L D S + + GY+APEY + + TE+SD+++ G+++++I
Sbjct: 1097 EAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEI 1156
Query: 512 LTGSLVLTS------------SMRLAAESATFENFIDRNLKG--KFSESEAAKLGKMALV 557
+TG + S L + + ID LK F E A ++ ++AL
Sbjct: 1157 VTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQ 1216
Query: 558 CTHEDPENRPTMEAVIEEL 576
CT P+ RP+ + L
Sbjct: 1217 CTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (508), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 155/558 (27%), Positives = 262/558 (46%), Gaps = 38/558 (6%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L N L+GN+P I ++ SLS + + N L I D + L LDLS N+ G +
Sbjct: 124 LNLARNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDL 183
Query: 105 PESLANNAELLFLDVQNNTLSGIVPS----ALKRLNGGFQFQNNPGLCGDGIASLRACTV 160
P SL+ + L L VQNN L+G + LK LN N G ++S++ +
Sbjct: 184 PSSLSTVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFN--GSIPKELSSIQTL-I 240
Query: 161 YDNTQIN--PVKPFGSHSNDTTPIDISEPSGFKEH--CNQSQCSNSSKFPQIAVLAAVTS 216
YD + P P P PSG K+ ++ + S+S K V+ +
Sbjct: 241 YDGNSFDNVPASP-----QPERPGKKETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGIVF 295
Query: 217 VTVILAG-TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNR-NGASPLVSLEYC 274
++ +AG ++++ + K+K+ ++ +S L T R + + L+
Sbjct: 296 GSLFVAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGTPEVQEQRVKSVASVADLKSS 355
Query: 275 HGWDPLGDYLNGTGF---SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR 331
D + G R + + + + ++ AT FS+ N++G+G+ VY+
Sbjct: 356 PAEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFP 415
Query: 332 DGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390
+G ++AI+ I N EE F++ + ++ LRH NI+ L G+C G+ L+Y++
Sbjct: 416 NGKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTE--HGQRLLVYEYV 473
Query: 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450
G L L + S L W+ RV + +G AK + YLH EV P+IVHRN +L+
Sbjct: 474 GNGNLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLH--EVCLPSIVHRNFKSANILL 531
Query: 451 DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQ 510
D++ NP ++D GL L + + + GY APE+ +G +T +SD++ FGV++L+
Sbjct: 532 DEELNPHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLE 591
Query: 511 ILTGSLVLTSSMRLAAES------------ATFENFIDRNLKGKFSESEAAKLGKMALVC 558
+LTG L SS A +S +D +L G + ++ + +C
Sbjct: 592 LLTGRKPLDSSRTRAEQSLVRWATPQLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALC 651
Query: 559 THEDPENRPTMEAVIEEL 576
+PE RP M V+++L
Sbjct: 652 IQPEPEFRPPMSEVVQQL 669
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 165/559 (29%), Positives = 256/559 (45%), Gaps = 80/559 (14%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
LQL N+L+G IP+ I L +L L L NR + IP +L NL +L ++LS N L TI
Sbjct: 531 LQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTI 590
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLNG----GFQFQNNPGLCGDGIASLRACTV 160
PE L ++L LD+ N L G + S + L N G + A T
Sbjct: 591 PEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTH 650
Query: 161 YDNTQINPVKPFGSHSN-DTTPIDISEPSGFKEHC---NQSQ----CS-NSSKFPQ---- 207
D + N P ++ P D E G K+ C N +Q CS SSK
Sbjct: 651 VDVSHNNLQGPIPDNAAFRNAPPDAFE--GNKDLCGSVNTTQGLKPCSITSSKKSHKDRN 708
Query: 208 --IAVLAAVTSVTVILA-GTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNG 264
I +L + +IL+ GI I FR R + + SES LS F+ +G
Sbjct: 709 LIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSI-------FSFDG 761
Query: 265 ASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSS 324
++ +E+ AT F L+G G
Sbjct: 762 ---------------------------------KVRYQEIIKATGEFDPKYLIGTGGHGK 788
Query: 325 VYKGTLRDGTLVAIRSINVT-----SCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG 379
VYK L + ++A++ +N T S S + EF+ + LT +RH N+++L GFC R
Sbjct: 789 VYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRR 847
Query: 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 439
FL+Y++ +G L K L+ ++ + LDW R++++ G+A + Y+H PAIV
Sbjct: 848 N--TFLVYEYMERGSLRKVLENDDEAKK-LDWGKRINVVKGVAHALSYMHHDR--SPAIV 902
Query: 440 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERS 499
HR++S +L+ + + I+D G KLL D + + GY+APE + TE+
Sbjct: 903 HRDISSGNILLGEDYEAKISDFGTAKLLKPD-SSNWSAVAGTYGYVAPELAYAMKVTEKC 961
Query: 500 DIFAFGVIILQIL----TGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SEAAKLGK 553
D+++FGV+ L+++ G LV T S + + ++ D L E E ++ K
Sbjct: 962 DVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILK 1021
Query: 554 MALVCTHEDPENRPTMEAV 572
+AL+C H DP+ RPTM ++
Sbjct: 1022 VALLCLHSDPQARPTMLSI 1040
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 589 | ||||||
| 255537079 | 693 | leucine rich repeat receptor kinase, put | 0.901 | 0.766 | 0.690 | 0.0 | |
| 224125098 | 682 | predicted protein [Populus trichocarpa] | 0.906 | 0.782 | 0.686 | 0.0 | |
| 224071591 | 646 | predicted protein [Populus trichocarpa] | 0.896 | 0.817 | 0.672 | 0.0 | |
| 296082849 | 680 | unnamed protein product [Vitis vinifera] | 0.904 | 0.783 | 0.658 | 0.0 | |
| 359474325 | 813 | PREDICTED: probable LRR receptor-like se | 0.901 | 0.653 | 0.655 | 0.0 | |
| 296084139 | 659 | unnamed protein product [Vitis vinifera] | 0.901 | 0.805 | 0.626 | 0.0 | |
| 225455531 | 681 | PREDICTED: leucine-rich repeat receptor- | 0.901 | 0.779 | 0.626 | 0.0 | |
| 297803850 | 687 | hypothetical protein ARALYDRAFT_492596 [ | 0.896 | 0.768 | 0.616 | 0.0 | |
| 449460425 | 683 | PREDICTED: LRR receptor-like serine/thre | 0.899 | 0.775 | 0.617 | 0.0 | |
| 15235780 | 688 | leucine-rich repeat protein kinase-like | 0.896 | 0.767 | 0.610 | 0.0 |
| >gi|255537079|ref|XP_002509606.1| leucine rich repeat receptor kinase, putative [Ricinus communis] gi|223549505|gb|EEF50993.1| leucine rich repeat receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/533 (69%), Positives = 437/533 (81%), Gaps = 2/533 (0%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL+LCCNQLTG+IP ++ SLK L+V+ LQ+NRL IP LGNLG L+RLDL FN+L G
Sbjct: 160 VLELCCNQLTGSIPREMDSLKRLTVVALQYNRLTDQIPAGLGNLGMLRRLDLGFNNLSGP 219
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP +LAN +L LDV+NN+LSG+VPSAL++LNGGFQF+NN GLCG G LRACT +DN
Sbjct: 220 IPITLANAPQLQVLDVRNNSLSGMVPSALQKLNGGFQFENNKGLCGAGFPELRACTAFDN 279
Query: 164 TQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAG 223
IN V+P GS +N TT +I + + C+Q++CSNSSKFPQ+A+++ VT+ T+IL G
Sbjct: 280 MNINQVEPSGSITNTTTSKNIPVSAILQAPCDQTKCSNSSKFPQVAIISGVTTATIILIG 339
Query: 224 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 283
LI F YRR KQKIGN SESS+ +LSTD AK+F+R GASPLVSLEY +GWDP
Sbjct: 340 VAFLIIFFYRRQKQKIGNISESSEGRLSTDK--AKEFHRAGASPLVSLEYSNGWDPFRGC 397
Query: 284 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINV 343
NG G S LN+FR NLEEVESATQCFSEVNLLGK +FSSVYKG LR G+LVA+RSIN+
Sbjct: 398 RNGVGISEPSLNNFRFNLEEVESATQCFSEVNLLGKSSFSSVYKGILRGGSLVAVRSINI 457
Query: 344 TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE 403
TSCKSEE EFVKGL LLTSLRH+N++RLRGFCCS+GRGECFLIYDFAP G LS+YLD E+
Sbjct: 458 TSCKSEEDEFVKGLNLLTSLRHDNLVRLRGFCCSKGRGECFLIYDFAPMGNLSRYLDLED 517
Query: 404 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
GSS++L+WSTRVSII GIAKGI YLH EVNKPAI+HR +S+EKVL+DQ+F PL+AD GL
Sbjct: 518 GSSHILEWSTRVSIINGIAKGIEYLHRREVNKPAIIHRRVSIEKVLLDQEFKPLMADSGL 577
Query: 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523
HKLLADDIVFS LKTSAAMGYLAPEYVTTG FTE+SDI+AFGVIILQIL+G +L++ MR
Sbjct: 578 HKLLADDIVFSGLKTSAAMGYLAPEYVTTGHFTEKSDIYAFGVIILQILSGQHMLSNLMR 637
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
LAA S+ +E+FID NLKG FSESEAA L K+AL CT E PE RPTMEAVI+E+
Sbjct: 638 LAAASSRYEDFIDTNLKGNFSESEAAMLSKIALDCTQELPEQRPTMEAVIQEM 690
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125098|ref|XP_002329893.1| predicted protein [Populus trichocarpa] gi|222871130|gb|EEF08261.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/536 (68%), Positives = 430/536 (80%), Gaps = 2/536 (0%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL+LCCNQL G IP ++GSLK LSVL LQ+NRL G IP SLG LG LKRLD+SFN L GT
Sbjct: 145 VLELCCNQLAGYIPTEMGSLKRLSVLALQYNRLVGQIPASLGTLGMLKRLDMSFNYLSGT 204
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP+ +AN L LDV+NN+LSG VP ALKRLNGGFQF+NN GLCG G LRAC+ +DN
Sbjct: 205 IPQGIANIPRLEVLDVRNNSLSGTVPFALKRLNGGFQFENNQGLCGTGFHPLRACSAFDN 264
Query: 164 TQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAG 223
IN V G +N++ + + + HCNQ+ CSNSSK PQ A++A V VT+ L G
Sbjct: 265 MNINQVGSLGPIANNSAKKVTPQSAILQAHCNQTHCSNSSKLPQAAIVAGVIIVTITLMG 324
Query: 224 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 283
G LI F YRR KQKIGNTS+SSD +LSTD AK+F+R GASPL SLEY +GWDPLGD
Sbjct: 325 AGFLIIFCYRRKKQKIGNTSDSSDGRLSTDQ--AKEFHRAGASPLASLEYSNGWDPLGDS 382
Query: 284 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINV 343
NG FS EHLN+FR NLEE+ESATQCFSEVN+LGK +FS+VYKG LRDG++VAI+SINV
Sbjct: 383 RNGIEFSVEHLNNFRFNLEEIESATQCFSEVNVLGKSSFSTVYKGVLRDGSIVAIKSINV 442
Query: 344 TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE 403
TSCK EEAEFVKGL LLTSLRH+N+ RLRGFCCSRGRGECFLIYDFAPKG LS+YLD E+
Sbjct: 443 TSCKPEEAEFVKGLNLLTSLRHDNLTRLRGFCCSRGRGECFLIYDFAPKGDLSRYLDLED 502
Query: 404 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
GS+ VLDWSTRVSII GIAKGI YLHS E KPAI+HR +SVEKVL+DQQ NPLIAD GL
Sbjct: 503 GSNQVLDWSTRVSIINGIAKGIRYLHSIEEKKPAIIHRRISVEKVLLDQQVNPLIADSGL 562
Query: 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523
KLLADDIVFS +K SAAMGYLAPEYVTTG FTE+SDI++FGVIILQIL+G +L++SMR
Sbjct: 563 AKLLADDIVFSTIKISAAMGYLAPEYVTTGLFTEKSDIYSFGVIILQILSGKQLLSNSMR 622
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579
LAA + +FID +L+G FSESEAAKL K+AL CT + P+ RPTM+ VI+EL ++
Sbjct: 623 LAAACCRYNDFIDTSLRGNFSESEAAKLAKIALACTDDLPDQRPTMKEVIQELNLS 678
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224071591|ref|XP_002303531.1| predicted protein [Populus trichocarpa] gi|222840963|gb|EEE78510.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/538 (67%), Positives = 427/538 (79%), Gaps = 10/538 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL+LCCNQL+GNIP ++GSLK LSVL LQ+NRL IP SLG LG LK L +SFN L G+
Sbjct: 113 VLELCCNQLSGNIPPEMGSLKRLSVLALQYNRLTDQIPASLGTLGMLKMLYMSFNHLSGS 172
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRAC-TVYD 162
IP+ +AN ++ LDV+NN+LSGIVPSALKRLNGGFQF+NNPGLCG G LRAC V+D
Sbjct: 173 IPQGIANIPQMEVLDVRNNSLSGIVPSALKRLNGGFQFENNPGLCGTGFPLLRACNAVFD 232
Query: 163 NTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILA 222
IN V P G +N+T I + + HCN + CSNSSK PQ A++A V +VTV L
Sbjct: 233 ---INQVGPLGPIANNTAQKVIPQSEILQAHCNLTHCSNSSKLPQAAIVAGVITVTVTLM 289
Query: 223 GTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGD 282
G G LI F YRR KQKIGNTS S+ +LST AK+F+R GASPLVSLEY +GWDPLGD
Sbjct: 290 GAGFLIIFLYRRKKQKIGNTSAFSEGRLSTHQ--AKEFHRAGASPLVSLEYSNGWDPLGD 347
Query: 283 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSIN 342
NG S EHLN+FR NLEE+ESAT+CFSEVN+LGK +FS+VYKG LRDG+LVAIRSIN
Sbjct: 348 SRNGIEISGEHLNNFRFNLEEIESATRCFSEVNVLGKSSFSTVYKGILRDGSLVAIRSIN 407
Query: 343 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 402
+TSCK EEAEFVKGL LLTSLRH N+ RLRGFCCSRGRGECFLIYDFAP+G LS+YLD E
Sbjct: 408 LTSCKPEEAEFVKGLDLLTSLRHNNLTRLRGFCCSRGRGECFLIYDFAPRGDLSRYLDLE 467
Query: 403 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462
+GS+ VLDWS RV II GIAKGI YLHSSE NKP ++HR +SVEKVL+DQQFNPLIAD G
Sbjct: 468 DGSNQVLDWSARVYIINGIAKGIRYLHSSEENKPVMIHRRISVEKVLLDQQFNPLIADSG 527
Query: 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS-S 521
L KLLADD+VFS +K SAAMGYL+PEYVTTG FTE+SDI+AFGVIILQIL+G +L S S
Sbjct: 528 LAKLLADDVVFSTIKISAAMGYLSPEYVTTGLFTEKSDIYAFGVIILQILSGKQMLYSKS 587
Query: 522 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579
MRLAA +++F+D +L+G FSESEAAKL K+AL P++RPTM+ VI+EL ++
Sbjct: 588 MRLAAACCMYDDFVDTSLQGNFSESEAAKLAKIALT---RLPDHRPTMKEVIQELNLS 642
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082849|emb|CBI22150.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/536 (65%), Positives = 422/536 (78%), Gaps = 3/536 (0%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VLQLC NQLTG IP++IG LK LSV++LQ N L G IP SLGNLG L+ L+LSFN L GT
Sbjct: 147 VLQLCSNQLTGAIPSEIGFLKKLSVVSLQKNNLTGKIPPSLGNLGMLRMLNLSFNRLSGT 206
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN-PGLCGDGIASLRACTVYD 162
IP +LA L FLDV+NN+L GIVPS LK+L GFQ NN GLCG G +SLR C+ +D
Sbjct: 207 IPANLAQAPALEFLDVRNNSLWGIVPSGLKKLKEGFQHANNSAGLCGVGFSSLRVCSYWD 266
Query: 163 NTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILA 222
IN + F + + D TP S F+ HCNQ+ C N SKFP+I +++ VT+VTV L+
Sbjct: 267 GMNINQSETFPATNTDFTPTIYPVSSNFRPHCNQTHCPNVSKFPRIVLVSGVTTVTVTLS 326
Query: 223 GTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGD 282
G+L F YRR KQKIG++ ++S+ QLSTD ++ D +R ASPLVSLEY GWDPL D
Sbjct: 327 AVGLLTFLCYRRRKQKIGSSFDTSECQLSTDRSI--DCHRKIASPLVSLEYSTGWDPLAD 384
Query: 283 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSIN 342
NG FS+E + R NL+E+ESATQ FSEVNLLGK F SVYKG LRDG+LVAIRSI+
Sbjct: 385 GRNGNVFSQEFCQNPRFNLDEIESATQYFSEVNLLGKSKFWSVYKGILRDGSLVAIRSIS 444
Query: 343 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 402
TSCKSEEA+F+KGL LL+SLRHEN++RLRGFCCS+GRGEC+LI+DF P G LS+YLD E
Sbjct: 445 ATSCKSEEADFLKGLNLLSSLRHENLVRLRGFCCSKGRGECYLIHDFVPNGSLSRYLDLE 504
Query: 403 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462
EGSS VL+WSTRVSII GIAKGIGYLHSSE NKP++VHR++S +KVLIDQ+FNPLI+D G
Sbjct: 505 EGSSQVLNWSTRVSIIHGIAKGIGYLHSSEENKPSLVHRSISADKVLIDQRFNPLISDSG 564
Query: 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM 522
L KLLADDIVFS LKTSAA+GYLAPEY+TTG FTE+SDI+AFGVIILQIL+G LT+SM
Sbjct: 565 LPKLLADDIVFSALKTSAALGYLAPEYITTGSFTEKSDIYAFGVIILQILSGKQQLTNSM 624
Query: 523 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578
RLAAES F +F+D NLKG+FSESEAAKL K+ L CTHE P+NRP ME VI+EL+
Sbjct: 625 RLAAESCRFADFVDTNLKGEFSESEAAKLAKIGLACTHELPDNRPIMETVIQELST 680
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474325|ref|XP_002266682.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 678 bits (1750), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/534 (65%), Positives = 420/534 (78%), Gaps = 3/534 (0%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VLQLC NQLTG IP++IG LK LSV++LQ N L G IP SLGNLG L+ L+LSFN L GT
Sbjct: 147 VLQLCSNQLTGAIPSEIGFLKKLSVVSLQKNNLTGKIPPSLGNLGMLRMLNLSFNRLSGT 206
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN-PGLCGDGIASLRACTVYD 162
IP +LA L FLDV+NN+L GIVPS LK+L GFQ NN GLCG G +SLR C+ +D
Sbjct: 207 IPANLAQAPALEFLDVRNNSLWGIVPSGLKKLKEGFQHANNSAGLCGVGFSSLRVCSYWD 266
Query: 163 NTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILA 222
IN + F + + D TP S F+ HCNQ+ C N SKFP+I +++ VT+VTV L+
Sbjct: 267 GMNINQSETFPATNTDFTPTIYPVSSNFRPHCNQTHCPNVSKFPRIVLVSGVTTVTVTLS 326
Query: 223 GTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGD 282
G+L F YRR KQKIG++ ++S+ QLSTD ++ D +R ASPLVSLEY GWDPL D
Sbjct: 327 AVGLLTFLCYRRRKQKIGSSFDTSECQLSTDRSI--DCHRKIASPLVSLEYSTGWDPLAD 384
Query: 283 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSIN 342
NG FS+E + R NL+E+ESATQ FSEVNLLGK F SVYKG LRDG+LVAIRSI+
Sbjct: 385 GRNGNVFSQEFCQNPRFNLDEIESATQYFSEVNLLGKSKFWSVYKGILRDGSLVAIRSIS 444
Query: 343 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 402
TSCKSEEA+F+KGL LL+SLRHEN++RLRGFCCS+GRGEC+LI+DF P G LS+YLD E
Sbjct: 445 ATSCKSEEADFLKGLNLLSSLRHENLVRLRGFCCSKGRGECYLIHDFVPNGSLSRYLDLE 504
Query: 403 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462
EGSS VL+WSTRVSII GIAKGIGYLHSSE NKP++VHR++S +KVLIDQ+FNPLI+D G
Sbjct: 505 EGSSQVLNWSTRVSIIHGIAKGIGYLHSSEENKPSLVHRSISADKVLIDQRFNPLISDSG 564
Query: 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM 522
L KLLADDIVFS LKTSAA+GYLAPEY+TTG FTE+SDI+AFGVIILQIL+G LT+SM
Sbjct: 565 LPKLLADDIVFSALKTSAALGYLAPEYITTGSFTEKSDIYAFGVIILQILSGKQQLTNSM 624
Query: 523 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
RLAAES F +F+D NLKG+FSESEAAKL K+ L CTHE P+NRP ME +++L
Sbjct: 625 RLAAESCRFADFVDTNLKGEFSESEAAKLAKIGLACTHELPDNRPIMETTLKKL 678
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084139|emb|CBI24527.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/533 (62%), Positives = 407/533 (76%), Gaps = 2/533 (0%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VLQLC NQLTG+IP Q+GSLK LSVL LQ N+L G IP SLG+LG L RLDLSFN LFG+
Sbjct: 122 VLQLCYNQLTGSIPTQLGSLKKLSVLALQSNQLTGAIPASLGDLGMLVRLDLSFNRLFGS 181
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP LA+ L LD++NNTLSG +P ALKRLNGGFQ++NN LCGDG + L+ C D
Sbjct: 182 IPRRLADVVSLEVLDIRNNTLSGKIPPALKRLNGGFQYKNNARLCGDGFSYLKVCNSLDL 241
Query: 164 TQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAG 223
T + +P+G+ SN + DI E + + HC+++ CSN SK V+ + VT+ L+
Sbjct: 242 TNQSRPEPYGAGSNTQSTGDIPETANVQLHCDKAHCSNPSKSSHAPVVVGMVVVTIALSA 301
Query: 224 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 283
GIL F +YRR KQK+G++ + SD +LSTD K+ R SPLVSLEY +GWDPL D
Sbjct: 302 IGILSFAQYRRRKQKLGSSFDISDSRLSTDQ--GKEVYRKNGSPLVSLEYSNGWDPLADG 359
Query: 284 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINV 343
N GF +E SFR NLEEVESATQ FSEVNLLGK NFS++YKG LRDG+LVAI+SIN
Sbjct: 360 RNYGGFPQEVFQSFRFNLEEVESATQHFSEVNLLGKSNFSAIYKGILRDGSLVAIKSINK 419
Query: 344 TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE 403
TSCKSE+AEF+KGL +LTSLRHEN++RLRG CCS+GRGECFLIYDF P G L YLD ++
Sbjct: 420 TSCKSEDAEFLKGLNILTSLRHENLVRLRGLCCSKGRGECFLIYDFIPNGNLLSYLDLKD 479
Query: 404 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
G S VL+WSTRVS+I GIAKGI YLH ++NKPA+VH+N+S EKVLIDQ+ NPL++D GL
Sbjct: 480 GDSKVLEWSTRVSMISGIAKGIEYLHGYKLNKPALVHQNISAEKVLIDQRLNPLLSDSGL 539
Query: 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523
HKLL DDIVFS LK SAAMGYLAPEY TTGRFTE+SD++AFGV++ QIL+G TSS+
Sbjct: 540 HKLLTDDIVFSALKASAAMGYLAPEYTTTGRFTEKSDLYAFGVLVFQILSGKRKFTSSIH 599
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L AE+ F++FID NL G+FSE EAAKL ++AL+CTHE P RP+ME VI EL
Sbjct: 600 LGAETCRFQDFIDANLHGRFSEYEAAKLARIALMCTHESPIERPSMETVIHEL 652
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455531|ref|XP_002267632.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/533 (62%), Positives = 407/533 (76%), Gaps = 2/533 (0%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VLQLC NQLTG+IP Q+GSLK LSVL LQ N+L G IP SLG+LG L RLDLSFN LFG+
Sbjct: 144 VLQLCYNQLTGSIPTQLGSLKKLSVLALQSNQLTGAIPASLGDLGMLVRLDLSFNRLFGS 203
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP LA+ L LD++NNTLSG +P ALKRLNGGFQ++NN LCGDG + L+ C D
Sbjct: 204 IPRRLADVVSLEVLDIRNNTLSGKIPPALKRLNGGFQYKNNARLCGDGFSYLKVCNSLDL 263
Query: 164 TQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAG 223
T + +P+G+ SN + DI E + + HC+++ CSN SK V+ + VT+ L+
Sbjct: 264 TNQSRPEPYGAGSNTQSTGDIPETANVQLHCDKAHCSNPSKSSHAPVVVGMVVVTIALSA 323
Query: 224 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 283
GIL F +YRR KQK+G++ + SD +LSTD K+ R SPLVSLEY +GWDPL D
Sbjct: 324 IGILSFAQYRRRKQKLGSSFDISDSRLSTDQ--GKEVYRKNGSPLVSLEYSNGWDPLADG 381
Query: 284 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINV 343
N GF +E SFR NLEEVESATQ FSEVNLLGK NFS++YKG LRDG+LVAI+SIN
Sbjct: 382 RNYGGFPQEVFQSFRFNLEEVESATQHFSEVNLLGKSNFSAIYKGILRDGSLVAIKSINK 441
Query: 344 TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE 403
TSCKSE+AEF+KGL +LTSLRHEN++RLRG CCS+GRGECFLIYDF P G L YLD ++
Sbjct: 442 TSCKSEDAEFLKGLNILTSLRHENLVRLRGLCCSKGRGECFLIYDFIPNGNLLSYLDLKD 501
Query: 404 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
G S VL+WSTRVS+I GIAKGI YLH ++NKPA+VH+N+S EKVLIDQ+ NPL++D GL
Sbjct: 502 GDSKVLEWSTRVSMISGIAKGIEYLHGYKLNKPALVHQNISAEKVLIDQRLNPLLSDSGL 561
Query: 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523
HKLL DDIVFS LK SAAMGYLAPEY TTGRFTE+SD++AFGV++ QIL+G TSS+
Sbjct: 562 HKLLTDDIVFSALKASAAMGYLAPEYTTTGRFTEKSDLYAFGVLVFQILSGKRKFTSSIH 621
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L AE+ F++FID NL G+FSE EAAKL ++AL+CTHE P RP+ME VI EL
Sbjct: 622 LGAETCRFQDFIDANLHGRFSEYEAAKLARIALMCTHESPIERPSMETVIHEL 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803850|ref|XP_002869809.1| hypothetical protein ARALYDRAFT_492596 [Arabidopsis lyrata subsp. lyrata] gi|297315645|gb|EFH46068.1| hypothetical protein ARALYDRAFT_492596 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/543 (61%), Positives = 416/543 (76%), Gaps = 15/543 (2%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
V+ LCCN LTG IP IG+LK L+VL+LQHN+L G +P SLGNL L R+DLSFN+L G
Sbjct: 144 VMDLCCNSLTGKIPKNIGTLKKLNVLSLQHNQLTGEVPWSLGNLSMLSRIDLSFNNLLGL 203
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP++LAN +L LD++NNTLSG VPS LK+LNG FQF+NN GLCG SLRAC+ +DN
Sbjct: 204 IPKTLANIPQLETLDLRNNTLSGFVPSGLKKLNGSFQFENNTGLCGMDFPSLRACSAFDN 263
Query: 164 TQINPVK-PFGSHSNDTTPI-DISEPSGFKEHCNQSQCS-NSSKFPQIAVLAAVTSVTVI 220
I K P G D + + +ISE ++HCN++QC +SSK PQ+A++++V +VT+
Sbjct: 264 ANIEQFKQPPGEIDTDKSALHNISESVYLQKHCNKTQCKKSSSKLPQVALISSVITVTIT 323
Query: 221 LAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPL 280
L G GIL FFRYRR KQKI NT E S+ +LSTDL KDF ASPLVSL Y WDPL
Sbjct: 324 LLGAGILTFFRYRRRKQKISNTPEFSEGRLSTDL--QKDFR---ASPLVSLAYTKEWDPL 378
Query: 281 GDYLNGTGFSRE-HL----NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTL 335
GD NG FS+E HL +SFR NLE++ESATQCFSE NLL + +F+SV+KG LRDG+
Sbjct: 379 GDSRNGAEFSQEPHLFVVNSSFRFNLEDIESATQCFSEANLLSRNSFTSVFKGVLRDGSP 438
Query: 336 VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL 395
VAIRSIN++SCK+EE EF+ GL LL+SL HEN+++LRGFCCSRGRGECFLIYDFA KGKL
Sbjct: 439 VAIRSINISSCKNEEVEFMNGLKLLSSLSHENLMKLRGFCCSRGRGECFLIYDFASKGKL 498
Query: 396 SKYLD-QEEGSSNVLDWSTRVSIIIGIAKGIGYLH-SSEVNKPAIVHRNLSVEKVLIDQQ 453
S +LD QE ++ VLDW R+SII GIAKGI YLH S + KP IVHRN+SVEK+L+D+Q
Sbjct: 499 SNFLDIQEHETNQVLDWPARISIIKGIAKGIAYLHGSDQQKKPTIVHRNISVEKILLDEQ 558
Query: 454 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
FNPLIAD GLH LLADD+VFS LKTSAAMGYLAPEYVTTG+FTE++DIFAFGVIILQIL+
Sbjct: 559 FNPLIADSGLHNLLADDMVFSALKTSAAMGYLAPEYVTTGKFTEKTDIFAFGVIILQILS 618
Query: 514 GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 573
G L+LTSS+R+AAE+ FID L+ +F + EA + ++ + CT E P NRP +E ++
Sbjct: 619 GKLMLTSSLRIAAENGEHSGFIDEYLREEFDKPEAIAMARIGISCTQEIPNNRPNIETLL 678
Query: 574 EEL 576
E++
Sbjct: 679 EDI 681
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460425|ref|XP_004147946.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus] gi|449494315|ref|XP_004159511.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/538 (61%), Positives = 409/538 (76%), Gaps = 8/538 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VLQ+CCNQL+G IP QIGSL+ L+VL LQHNRL+G IP SLG+L LKRL LSFN+ G
Sbjct: 146 VLQICCNQLSGKIPTQIGSLRKLTVLALQHNRLSGEIPTSLGSLEMLKRLYLSFNNFSGR 205
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP +LA +L +DV+NN+ G VPS L++LN GFQ +NNPGLCG G ++R CTV+DN
Sbjct: 206 IPFNLATIPQLEVVDVRNNSFFGHVPSGLRKLNEGFQGENNPGLCGVGFVTVRKCTVFDN 265
Query: 164 TQI--NPVKPFGSHSNDTTPIDISEPSG---FKEHCNQSQCSNSSKFPQIAVLAAVTSVT 218
I + +PF S N+T + P + +CNQ CS S++ P+IAV++AV V+
Sbjct: 266 ENIKGDGFQPFLSEPNNTATTQKNIPQSADFYNANCNQLHCSKSTRVPKIAVVSAVLIVS 325
Query: 219 VILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWD 278
VIL + IL F YRR KQKIGN+S S D +LSTD A++ ASPLV LEY HGWD
Sbjct: 326 VILMVSMILTVFWYRRRKQKIGNSSLSCDDRLSTDQ--ARELYSKSASPLVCLEYSHGWD 383
Query: 279 PLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAI 338
L D + G G S ++L F N+EEVESATQ FSE NLLG+ +FS VYKG L+DG+ VAI
Sbjct: 384 SLADGIKGLGLS-QYLGKFIFNVEEVESATQYFSEANLLGRSSFSMVYKGVLKDGSCVAI 442
Query: 339 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 398
RSIN+TSCKSEEAEF++GL LL+SLRHEN++ LRGFCCSRGRGE FL+YDF +G LS+Y
Sbjct: 443 RSINMTSCKSEEAEFLRGLNLLSSLRHENLVTLRGFCCSRGRGEFFLVYDFVSRGSLSQY 502
Query: 399 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458
LD E+GSS+VL+WS RVSII GIAKGI YLH E NKPA+VH+++S+EK+LID QFN LI
Sbjct: 503 LDVEDGSSHVLEWSKRVSIINGIAKGIAYLHHEEANKPAMVHKSISIEKILIDHQFNALI 562
Query: 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL 518
+D GL KLLADDI+FS LK+SAAMGYLAPEY+T GRFTE+SDI+AFGVII QIL+G+ L
Sbjct: 563 SDSGLSKLLADDIIFSSLKSSAAMGYLAPEYITIGRFTEKSDIYAFGVIIFQILSGTRRL 622
Query: 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+S+ L AE FE+FIDRNLKG FSES+A KL +AL CT+E P NRPT+E +IEEL
Sbjct: 623 ANSLLLQAEVCKFEDFIDRNLKGNFSESQATKLANLALSCTNELPINRPTIEDLIEEL 680
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15235780|ref|NP_194004.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|2827550|emb|CAA16558.1| leucine rich repeat receptor kinase-like protein [Arabidopsis thaliana] gi|7269119|emb|CAB79228.1| leucine rich repeat receptor kinase-like protein [Arabidopsis thaliana] gi|38564276|gb|AAR23717.1| At4g22730 [Arabidopsis thaliana] gi|51971929|dbj|BAD44629.1| leucine rich repeat receptor kinase-like protein [Arabidopsis thaliana] gi|224589626|gb|ACN59346.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332659245|gb|AEE84645.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/544 (61%), Positives = 411/544 (75%), Gaps = 16/544 (2%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
V+ LCCN LTG IP IGSLK L+VL+LQHN+L G +P +LGNL L RLDLSFN+L G
Sbjct: 144 VMDLCCNSLTGKIPKNIGSLKKLNVLSLQHNKLTGEVPWTLGNLSMLSRLDLSFNNLLGL 203
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP++LAN +L LD++NNTLSG VP LK+LNG FQF+NN GLCG SLRAC+ +DN
Sbjct: 204 IPKTLANIPQLDTLDLRNNTLSGFVPPGLKKLNGSFQFENNTGLCGIDFPSLRACSAFDN 263
Query: 164 TQ-INPVK-PFGSHSNDTTPI-DISEPSGFKEHCNQSQCS-NSSKFPQIAVLAAVTSVTV 219
I K P G D + + +I E ++HCNQ+ C +SSK PQ+A++++V +VT+
Sbjct: 264 ANNIEQFKQPPGEIDTDKSALHNIPESVYLQKHCNQTHCKKSSSKLPQVALISSVITVTI 323
Query: 220 ILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDP 279
L G GIL FFRYRR KQKI NT E S+ +LSTD K+F ASPLVSL Y WDP
Sbjct: 324 TLIGAGILTFFRYRRRKQKISNTPEFSEGRLSTDQ--QKEFR---ASPLVSLAYTKEWDP 378
Query: 280 LGDYLNGTGFSRE-HL----NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGT 334
LGD NG FS+E HL +SFR NLE++ESATQCFSE NLL + +F+SV+KG LRDG+
Sbjct: 379 LGDSRNGAEFSQEPHLFVVNSSFRFNLEDIESATQCFSEANLLSRNSFTSVFKGVLRDGS 438
Query: 335 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394
VAIRSIN++SCK+EE EF+ GL LL+SL HEN+++LRGFCCSRGRGECFLIYDFA KGK
Sbjct: 439 PVAIRSINISSCKNEEVEFMNGLKLLSSLSHENLVKLRGFCCSRGRGECFLIYDFASKGK 498
Query: 395 LSKYLDQEEGSSN-VLDWSTRVSIIIGIAKGIGYLH-SSEVNKPAIVHRNLSVEKVLIDQ 452
LS +LD +E +N VL WS R+SII GIAKGI YLH S + KP IVHRN+SVEK+L+D+
Sbjct: 499 LSNFLDLQERETNLVLAWSARISIIKGIAKGIAYLHGSDQQKKPTIVHRNISVEKILLDE 558
Query: 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 512
QFNPLIAD GLH LLADD+VFS LKTSAAMGYLAPEYVTTG+FTE++DIFAFGVIILQIL
Sbjct: 559 QFNPLIADSGLHNLLADDMVFSALKTSAAMGYLAPEYVTTGKFTEKTDIFAFGVIILQIL 618
Query: 513 TGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 572
+G L+LTSS+R AAE+ FID +L+ +F + EA + ++ + CT E P NRP +E +
Sbjct: 619 SGKLMLTSSLRNAAENGEHNGFIDEDLREEFDKPEATAMARIGISCTQEIPNNRPNIETL 678
Query: 573 IEEL 576
+E +
Sbjct: 679 LENI 682
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 589 | ||||||
| TAIR|locus:2132634 | 688 | AT4G22730 [Arabidopsis thalian | 0.896 | 0.767 | 0.610 | 1.5e-170 | |
| TAIR|locus:2153097 | 680 | AT5G51560 [Arabidopsis thalian | 0.894 | 0.775 | 0.549 | 4e-154 | |
| TAIR|locus:2050877 | 691 | AT2G45340 [Arabidopsis thalian | 0.901 | 0.768 | 0.537 | 4.8e-149 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.468 | 0.436 | 0.335 | 9.9e-64 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.475 | 0.448 | 0.315 | 3.7e-62 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.475 | 0.445 | 0.315 | 6.1e-62 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.471 | 0.452 | 0.346 | 1.8e-60 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.475 | 0.451 | 0.325 | 2.3e-60 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.465 | 0.446 | 0.341 | 2.9e-60 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.475 | 0.465 | 0.325 | 6.1e-58 |
| TAIR|locus:2132634 AT4G22730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1658 (588.7 bits), Expect = 1.5e-170, P = 1.5e-170
Identities = 332/544 (61%), Positives = 411/544 (75%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
V+ LCCN LTG IP IGSLK L+VL+LQHN+L G +P +LGNL L RLDLSFN+L G
Sbjct: 144 VMDLCCNSLTGKIPKNIGSLKKLNVLSLQHNKLTGEVPWTLGNLSMLSRLDLSFNNLLGL 203
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
IP++LAN +L LD++NNTLSG VP LK+LNG FQF+NN GLCG SLRAC+ +DN
Sbjct: 204 IPKTLANIPQLDTLDLRNNTLSGFVPPGLKKLNGSFQFENNTGLCGIDFPSLRACSAFDN 263
Query: 164 TQ-INPVK-PFGSHSNDTTPI-DISEPSGFKEHCNQSQCS-NSSKFPQIAVLAAVTSVTV 219
I K P G D + + +I E ++HCNQ+ C +SSK PQ+A++++V +VT+
Sbjct: 264 ANNIEQFKQPPGEIDTDKSALHNIPESVYLQKHCNQTHCKKSSSKLPQVALISSVITVTI 323
Query: 220 ILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDP 279
L G GIL FFRYRR KQKI NT E S+ +LSTD K+F ASPLVSL Y WDP
Sbjct: 324 TLIGAGILTFFRYRRRKQKISNTPEFSEGRLSTDQQ--KEFR---ASPLVSLAYTKEWDP 378
Query: 280 LGDYLNGTGFSRE-HL----NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGT 334
LGD NG FS+E HL +SFR NLE++ESATQCFSE NLL + +F+SV+KG LRDG+
Sbjct: 379 LGDSRNGAEFSQEPHLFVVNSSFRFNLEDIESATQCFSEANLLSRNSFTSVFKGVLRDGS 438
Query: 335 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394
VAIRSIN++SCK+EE EF+ GL LL+SL HEN+++LRGFCCSRGRGECFLIYDFA KGK
Sbjct: 439 PVAIRSINISSCKNEEVEFMNGLKLLSSLSHENLVKLRGFCCSRGRGECFLIYDFASKGK 498
Query: 395 LSKYLDQEEGSSN-VLDWSTRVSIIIGIAKGIGYLHSSEVNK-PAIVHRNLSVEKVLIDQ 452
LS +LD +E +N VL WS R+SII GIAKGI YLH S+ K P IVHRN+SVEK+L+D+
Sbjct: 499 LSNFLDLQERETNLVLAWSARISIIKGIAKGIAYLHGSDQQKKPTIVHRNISVEKILLDE 558
Query: 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 512
QFNPLIAD GLH LLADD+VFS LKTSAAMGYLAPEYVTTG+FTE++DIFAFGVIILQIL
Sbjct: 559 QFNPLIADSGLHNLLADDMVFSALKTSAAMGYLAPEYVTTGKFTEKTDIFAFGVIILQIL 618
Query: 513 TGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 572
+G L+LTSS+R AAE+ FID +L+ +F + EA + ++ + CT E P NRP +E +
Sbjct: 619 SGKLMLTSSLRNAAENGEHNGFIDEDLREEFDKPEATAMARIGISCTQEIPNNRPNIETL 678
Query: 573 IEEL 576
+E +
Sbjct: 679 LENI 682
|
|
| TAIR|locus:2153097 AT5G51560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1503 (534.1 bits), Expect = 4.0e-154, P = 4.0e-154
Identities = 293/533 (54%), Positives = 384/533 (72%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VLQLC N LTG+IP ++ SL+ LSVL LQ N+L G IP SLG+L L+RLDLS+N LFG+
Sbjct: 147 VLQLCYNNLTGSIPRELSSLRKLSVLALQSNKLTGAIPASLGDLSALERLDLSYNHLFGS 206
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
+P LA+ L LD++NN+L+G VP LKRLN GF F+NN GLCG + L++C +
Sbjct: 207 VPGKLASPPLLRVLDIRNNSLTGNVPPVLKRLNEGFSFENNLGLCGAEFSPLKSC---NG 263
Query: 164 TQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAG 223
T KP+G+ DI E + + CN + C+ K Q A+L + T+ L+
Sbjct: 264 TAPEEPKPYGATVFGFPSRDIPESANLRSPCNGTNCNTPPKSHQGAILIGLVVSTIALSA 323
Query: 224 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 283
IL+F YRR KQK+ T E SD +L+T + F +N SPL SLEY +GWDPL D
Sbjct: 324 ISILLFTHYRRRKQKLSTTYEMSDNRLNT---VGGGFRKNNGSPLASLEYTNGWDPLSDN 380
Query: 284 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINV 343
N + F++E + SFR NLEEVE+ATQ FSEVNLLG+ NFS+ YKG LRDG+ VAI+ +
Sbjct: 381 RNLSVFAQEVIQSFRFNLEEVETATQYFSEVNLLGRSNFSATYKGILRDGSAVAIKRFSK 440
Query: 344 TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE 403
TSCKSEE EF+KGL +L SL+HEN+ +LRGFCCSRGRGECFLIYDFAP G L YLD ++
Sbjct: 441 TSCKSEEPEFLKGLNMLASLKHENLSKLRGFCCSRGRGECFLIYDFAPNGNLLSYLDLKD 500
Query: 404 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
G ++VLDWSTRVSI GIAKGI YLHS + +KPA+VH+N+S EKVLIDQ+++PL+++ GL
Sbjct: 501 GDAHVLDWSTRVSIAKGIAKGIAYLHSYKGSKPALVHQNISAEKVLIDQRYSPLLSNSGL 560
Query: 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523
H LL +DIVFS LK SAAMGYLAPEY TTGRFTE++D++AFG+++ QI++G + ++
Sbjct: 561 HTLLTNDIVFSALKDSAAMGYLAPEYTTTGRFTEKTDVYAFGILVFQIISGKQKVRHLVK 620
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L E+ F ++ID NL+G+F E EA KL ++A +CTHE P RP++EAV+ EL
Sbjct: 621 LGTEACRFNDYIDPNLQGRFFEYEATKLARIAWLCTHESPIERPSVEAVVHEL 673
|
|
| TAIR|locus:2050877 AT2G45340 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1455 (517.2 bits), Expect = 4.8e-149, P = 4.8e-149
Identities = 292/543 (53%), Positives = 382/543 (70%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
V+QLC N+L+G+IP Q GSLK ++VL LQ+N+L+G IP SLG++ L RLDLSFN+LFG
Sbjct: 144 VIQLCYNKLSGSIPTQFGSLKKITVLALQYNQLSGAIPASLGDIDTLTRLDLSFNNLFGP 203
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 163
+P LA L LD++NN+ SG VPSALKRLN GFQ+ NN GLCGDG L+ACT +
Sbjct: 204 VPVKLAGAPLLEVLDIRNNSFSGFVPSALKRLNNGFQYSNNHGLCGDGFTDLKACTGLNG 263
Query: 164 TQINPVKPFGSHSNDTTPIDISEPSGF--KEHC--NQSQCSNSS-KFPQIAVLAAVTSVT 218
NP +P ++ + T +D+ S + +C N CS+ S K + ++ +
Sbjct: 264 P--NPNRPDPTNPTNFTTVDVKPESADLQRSNCSNNNGGCSSKSLKSSPLGIVMGLIGSI 321
Query: 219 VILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWD 278
+ +A G F YRR KQKIG++ ++ D ++ST+ + R +SPL+SLEY GWD
Sbjct: 322 LAVAIFGGSTFTWYRRRKQKIGSSLDAMDGRISTEYNFKEVSRRKSSSPLISLEYASGWD 381
Query: 279 PLG---DYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTL 335
PLG N + S+E SF NLEE+E ATQ FSE+NLLGK N SSVYKG LRDG++
Sbjct: 382 PLGRGQSSNNNSALSQEVFESFMFNLEEIERATQSFSEINLLGKSNVSSVYKGILRDGSV 441
Query: 336 VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL 395
AI+ I +SCKS+E+EF+KGL +LT L+HEN+ RLRGFCCS+GRGECFLIY+F P G L
Sbjct: 442 AAIKCIAKSSCKSDESEFLKGLKMLTLLKHENLARLRGFCCSKGRGECFLIYEFVPNGNL 501
Query: 396 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455
+YLD ++ + VL+W+TRVSII GIA+GI YLH NKPAIVH+NLS EK+LID +N
Sbjct: 502 LQYLDVKDETGEVLEWATRVSIINGIARGIVYLHGENGNKPAIVHQNLSAEKILIDHWYN 561
Query: 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 515
P +AD GLHKL DDIVFS LK SAAMGYLAPEY+TTGRFT++SD++AFG+I+LQIL+G
Sbjct: 562 PSLADSGLHKLFTDDIVFSKLKASAAMGYLAPEYITTGRFTDKSDVYAFGMILLQILSGK 621
Query: 516 LVLTSSMRL-AAESATF-ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 573
++ M L A ES E+F+D NL+ F E EAA+L ++ L+CTHE RP+ME VI
Sbjct: 622 SKISHLMILQAVESGRLNEDFMDPNLRKNFPEVEAAQLARLGLLCTHESSNQRPSMEDVI 681
Query: 574 EEL 576
+EL
Sbjct: 682 QEL 684
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 460 (167.0 bits), Expect = 9.9e-64, Sum P(2) = 9.9e-64
Identities = 100/298 (33%), Positives = 166/298 (55%)
Query: 293 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE 352
HL R +E+ SAT F+ N+LG+G + VYKG L DGTLVA++ + + E +
Sbjct: 285 HLK--RYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQ 342
Query: 353 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 412
F + ++ H N++RLRGFC S E L+Y + P G ++ L LDWS
Sbjct: 343 FQTEVETISLALHRNLLRLRGFCSSNQ--ERILVYPYMPNGSVASRLKDNIRGEPALDWS 400
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADD 470
R I +G A+G+ YLH E P I+HR++ +L+D+ F ++ D GL KLL D
Sbjct: 401 RRKKIAVGTARGLVYLH--EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 458
Query: 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL------------VL 518
V + ++ +G++APEY++TG+ +E++D+F FG+++L+++TG V+
Sbjct: 459 HVTTAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVM 516
Query: 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + + ID++L KF E ++ ++AL+CT +P +RP M V++ L
Sbjct: 517 LDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKML 574
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 3.7e-62, Sum P(2) = 3.7e-62
Identities = 94/298 (31%), Positives = 161/298 (54%)
Query: 293 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 351
HL R +L E++ A+ FS N+LG+G F VYKG L DGTLVA++ + E
Sbjct: 283 HLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGEL 342
Query: 352 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 411
+F + +++ H N++RLRGFC + E L+Y + G ++ L + S LDW
Sbjct: 343 QFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPPSQPPLDW 400
Query: 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471
TR I +G A+G+ YLH P I+HR++ +L+D++F ++ D GL KL+
Sbjct: 401 PTRKRIALGSARGLSYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 458
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 518
+G++APEY++TG+ +E++D+F +G+++L+++TG ++L
Sbjct: 459 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 518
Query: 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + E +D +L+ + E E ++ ++AL+CT P RP M V+ L
Sbjct: 519 LDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRML 576
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 446 (162.1 bits), Expect = 6.1e-62, Sum P(2) = 6.1e-62
Identities = 94/298 (31%), Positives = 162/298 (54%)
Query: 293 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 351
HL R +L E++ AT FS N+LG+G F VYKG L DGTLVA++ + E
Sbjct: 286 HLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGEL 345
Query: 352 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 411
+F + +++ H N++RLRGFC + E L+Y + G ++ L + S L W
Sbjct: 346 QFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPPSQLPLAW 403
Query: 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471
S R I +G A+G+ YLH P I+HR++ +L+D++F ++ D GL +L+
Sbjct: 404 SIRQQIALGSARGLSYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKD 461
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 518
+G++APEY++TG+ +E++D+F +G+++L+++TG ++L
Sbjct: 462 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 521
Query: 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + E +D +L+ ++E+E +L ++AL+CT P RP M V+ L
Sbjct: 522 LDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRML 579
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 461 (167.3 bits), Expect = 1.8e-60, Sum P(2) = 1.8e-60
Identities = 105/303 (34%), Positives = 173/303 (57%)
Query: 289 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS 348
F HL F + E+++AT FS N+LG+G F VYKG L +GT+VA++ + +
Sbjct: 280 FEIGHLKRF--SFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLK-DPIYT 336
Query: 349 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV 408
E +F + ++ H N++RL GFC + E L+Y + P G ++ L G
Sbjct: 337 GEVQFQTEVEMIGLAVHRNLLRLFGFCMTPE--ERMLVYPYMPNGSVADRLRDNYGEKPS 394
Query: 409 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL- 467
LDW+ R+SI +G A+G+ YLH + N P I+HR++ +L+D+ F ++ D GL KLL
Sbjct: 395 LDWNRRISIALGAARGLVYLHE-QCN-PKIIHRDVKAANILLDESFEAIVGDFGLAKLLD 452
Query: 468 -ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG------------ 514
D V + ++ +G++APEY++TG+ +E++D+F FGV+IL+++TG
Sbjct: 453 QRDSHVTTAVR--GTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVR 510
Query: 515 -SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 573
++L+ L AE F +DR+LKG+F + ++ ++AL+CT P RP M V+
Sbjct: 511 KGMILSWVRTLKAEKR-FAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVL 569
Query: 574 EEL 576
+ L
Sbjct: 570 KVL 572
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 2.3e-60, Sum P(2) = 2.3e-60
Identities = 97/298 (32%), Positives = 161/298 (54%)
Query: 293 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 351
HL R L E+ AT FS N+LG+G F VYKG L DG LVA++ + K E
Sbjct: 275 HLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGEL 334
Query: 352 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 411
+F + +++ H N++RLRGFC + E L+Y + G ++ L + + LDW
Sbjct: 335 QFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPEGNPALDW 392
Query: 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471
R I +G A+G+ YLH K I+HR++ +L+D++F ++ D GL KL+ +
Sbjct: 393 PKRKHIALGSARGLAYLHDHCDQK--IIHRDVKAANILLDEEFEAVVGDFGLAKLMNYND 450
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 518
+G++APEY++TG+ +E++D+F +GV++L+++TG ++L
Sbjct: 451 SHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIML 510
Query: 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + E+ +D L+GK+ E+E +L +MAL+CT RP M V+ L
Sbjct: 511 LDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRML 568
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 2.9e-60, Sum P(2) = 2.9e-60
Identities = 100/293 (34%), Positives = 159/293 (54%)
Query: 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL 357
R E++ AT FSE N+LG+G F VYKG L D T VA++ + +A F + +
Sbjct: 277 RFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREV 336
Query: 358 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 417
+++ H N++RL GFC ++ E L+Y F L+ L + + VLDW TR I
Sbjct: 337 EMISVAVHRNLLRLIGFCTTQT--ERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRI 394
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
+G A+G YLH E P I+HR++ VL+D+ F ++ D GL KL+ +
Sbjct: 395 ALGAARGFEYLH--EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQ 452
Query: 478 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF------ 531
MG++APEY++TG+ +ER+D+F +G+++L+++TG + S RL E
Sbjct: 453 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS-RLEEEDDVLLLDHVK 511
Query: 532 --EN------FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E +D+NL G++ + E + ++AL+CT PE+RP M V+ L
Sbjct: 512 KLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRML 564
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 6.1e-58, Sum P(2) = 6.1e-58
Identities = 97/298 (32%), Positives = 165/298 (55%)
Query: 293 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 351
+L F R +L E+ AT+ FS+ N+LGKG F +YKG L D TLVA++ +N K E
Sbjct: 256 YLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGEL 315
Query: 352 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 411
+F + +++ H N++RLRGFC + E L+Y + G ++ L + + LDW
Sbjct: 316 QFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPEGNPALDW 373
Query: 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471
R I +G A+G+ YLH K I+H ++ +L+D++F ++ D GL KL+ +
Sbjct: 374 PKRKHIALGSARGLAYLHDHCDQK--IIHLDVKAANILLDEEFEAVVGDFGLAKLMNYND 431
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 518
+G++APEY++TG+ +E++D+F +GV++L+++TG ++L
Sbjct: 432 SHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIML 491
Query: 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + E+ +D L+GK+ E+E +L +MAL+CT RP M V+ L
Sbjct: 492 LDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRML 549
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 589 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-18 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.003 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.003 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.004 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 35/280 (12%)
Query: 315 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F VYKG L+ T VA++++ + + E +F+K ++ L H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIGIAKGI 425
L G C +L+ ++ G L YL + L +S I IAKG+
Sbjct: 61 LLGVC--TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--G 483
YL S K VHR+L+ L+ + I+D GL + + DD + KT +
Sbjct: 119 EYLAS---KK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIR 172
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---SATFENFIDRNLK 540
++APE + G FT +SD+++FGV++ +I T L A + E ++ K
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVLEYLRK 222
Query: 541 G---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577
G E +L ++ L C DPE+RPT ++E L
Sbjct: 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 76/265 (28%), Positives = 131/265 (49%), Gaps = 18/265 (6%)
Query: 317 LGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LG+G F VYKGTL+ VA++++ + + + EF++ ++ L H NI++L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G C ++ ++ P G L YL + L S +S + IA+G+ YL S
Sbjct: 67 LGVCTEEEPL--MIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES- 121
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 491
K +HR+L+ L+ + I+D GL + L DD + V + ++APE +
Sbjct: 122 ---KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 492 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551
G+FT +SD+++FGV++ +I T M +A ++ + + + +L
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM----SNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 552 GKMALVCTHEDPENRPTMEAVIEEL 576
K+ L C EDPE+RPT ++E L
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 1e-39
Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 25/268 (9%)
Query: 317 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LG+G F VYKG L+ VA++++ + + + EF++ ++ L H N+++L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G C +++ ++ G L YL + L S +S + IA+G+ YL S
Sbjct: 67 LGVCTEEEPL--YIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES- 120
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 491
K +HR+L+ L+ + I+D GL + L DD + + ++APE +
Sbjct: 121 ---KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 492 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA--- 548
G+FT +SD+++FGV++ +I T M + E ++ G
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-------SNEEVLEYLKNGYRLPQPPNCP 229
Query: 549 AKLGKMALVCTHEDPENRPTMEAVIEEL 576
+L + L C EDPE+RPT ++E L
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 51/263 (19%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG+G F +VY + G VAI+ I S E ++ + +L L H NI++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
+L+ ++ G L L + EG L + I++ I +G+ YLHS+
Sbjct: 61 --EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSNG--- 112
Query: 436 PAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE-YVTTG 493
I+HR+L E +L+D +AD GL KLL D Y+APE + G
Sbjct: 113 --IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK-TIVGTPAYMAPEVLLGKG 169
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553
++E+SDI++ GVI+ ++ ++ I +
Sbjct: 170 YYSEKSDIWSLGVILYEL-----------------PELKDLIRK---------------- 196
Query: 554 MALVCTHEDPENRPTMEAVIEEL 576
+DPE RP+ + ++E L
Sbjct: 197 ----MLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 30/271 (11%)
Query: 317 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LG+G F VYKGTL+ T VA++++ + + E EF++ ++ L H NI+RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G C +++ ++ P G L +L + L + + + IAKG+ YL S
Sbjct: 67 LGVC--TQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLES- 120
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----A 486
K VHR+L+ L+ + I+D GL + + +D + G L A
Sbjct: 121 ---KN-FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMA 172
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-FENFIDRNLKGKFSE 545
PE + G+FT +SD+++FGV++ +I T S ++ + E
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL-----GEQPYPGMSNEEVLELLEDGYRLPRPE 227
Query: 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ +L ++ L C DPE+RPT ++E+L
Sbjct: 228 NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 368
+ + LG G+F +VYK + G +VA++ + S KS++ + + + +L L H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+RL + +L+ ++ G L YL + L I + I +G+ YL
Sbjct: 61 VRLIDAFEDKDH--LYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYL 114
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLA 486
HS+ I+HR+L E +L+D+ IAD GL K L + S T+ Y+A
Sbjct: 115 HSN-----GIIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMA 166
Query: 487 PEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545
PE + G + + D+++ GVI+ ++LTG + L I R L
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ-----LIRRILGPPLEF 221
Query: 546 SEAAKLGKMALV------CTHEDPENRPTMEAVIE 574
E C ++DP RPT E +++
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 314 VNLLGKGNFSSVYKGT---LRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
+ LG+G+F V L D T VA++S+N + + ++F + + +L +L HENI
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
++ +G C G LI ++ P G L YL + + ++ + I KG+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT---SAAMGYL 485
S +HR+L+ +L++ + I+D GL K+L +D + +K S Y
Sbjct: 126 GSQRY-----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILT 513
APE + T +F+ SD+++FGV + ++ T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ + LG+G+F VY + G LVAI+ I K + ++ + +L L+H NI+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
RL + +L+ ++ G L L + L + I + YLH
Sbjct: 61 RLYDVFEDED--KLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLH 114
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLAPE 488
S IVHR+L E +L+D+ + +AD GL + L L T Y+APE
Sbjct: 115 S---KG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFVGTPEYMAPE 166
Query: 489 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--- 545
+ + + DI++ GVI+ ++LTG +L F+ E
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEWDI 223
Query: 546 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
S AK + K+ LV +DPE R T E ++
Sbjct: 224 SPEAKDLIRKL-LV---KDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 65/267 (24%), Positives = 122/267 (45%), Gaps = 23/267 (8%)
Query: 316 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
+GKGNF VYKG L+ T VA+++ T + +F++ +L H NI++L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
+ +++ + P G L +L N L + + + A G+ YL S
Sbjct: 62 VQ--KQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC-- 114
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-----YLAPEYV 490
+HR+L+ L+ + I+D G+ + + +++V S + + APE +
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTV---SDGLKQIPIKWTAPEAL 167
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
GR+T SD++++G+++ + + M + T E I+ + + +
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGM---SNQQTRE-RIESGYRMPAPQLCPEE 223
Query: 551 LGKMALVCTHEDPENRPTMEAVIEELT 577
+ ++ L C DPENRP+ + EL
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 17/255 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V+ GT T VA++++ + E F++ ++ LRH+ +++L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVC- 70
Query: 377 SRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
E +++ ++ KG L +L EG L V + IA+G+ YL S
Sbjct: 71 --SEEEPIYIVTEYMSKGSLLDFLKSGEGKK--LRLPQLVDMAAQIAEGMAYLESRNY-- 124
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 495
+HR+L+ +L+ + IAD GL +L+ DD + + + APE GRF
Sbjct: 125 ---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 496 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 555
T +SD+++FG+++ +I+T V M E ++R + + +L +
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQ-VERGYRMPRPPNCPEELYDLM 237
Query: 556 LVCTHEDPENRPTME 570
L C +DPE RPT E
Sbjct: 238 LQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 70/268 (26%), Positives = 128/268 (47%), Gaps = 19/268 (7%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
F+ LG G F V++G ++ VAI+ + ++ +F K + L LRH+++I
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLIS 66
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L C S G ++I + KG L +L EG VL ++ + + +A+G+ YL
Sbjct: 67 LFAVC-SVGE-PVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE 122
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
+HR+L+ +L+ + +AD GL +L+ +D V+ + APE
Sbjct: 123 QN-----SIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAA 176
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF--IDRNLKGKFSESEA 548
+ G F+ +SD+++FG+++ ++ T V M E + I +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM------NNHEVYDQITAGYRMPCPAKCP 230
Query: 549 AKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ K+ L C +PE+RP+ +A+ EEL
Sbjct: 231 QEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 16/209 (7%)
Query: 314 VNLLGKGNFSSVYK---GTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
+ LGKGNF SV L+D T +VA++ + ++ +F + + +L SL+H+NI
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNI 67
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
++ +G C S GR L+ ++ P G L YL + LD + I KG+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL 124
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 486
S VHR+L+ +L++ + I D GL K+L D + ++ + + + A
Sbjct: 125 GSKRY-----VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGS 515
PE +T +F+ SD+++FGV++ ++ T S
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFTYS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 314 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRL 371
LLG+G+F SVY +D G L+A++S+ ++ EE E ++ + +L+SL+H NI+R
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTRVSIIIGIAKGIGY 427
G + + ++ G LS L + E + ++ + I +G+ Y
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--PVIRKYTRQ------ILEGLAY 116
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
LHS N IVHR++ +L+D +AD G K L D + G +
Sbjct: 117 LHS---NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR--GTPYW 169
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTG 514
+APE + + +DI++ G ++++ TG
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 314 VNLLGKGNFSSVYKGTLR-DGTL----VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
+ +LG G F +VYKG +G VAI+ + + E + Y++ S+ H ++
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIAKGI 425
+RL G C S + LI P G L Y+ + GS +L+W + IAKG+
Sbjct: 72 VRLLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGM 122
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--- 482
YL +VHR+L+ VL+ + I D GL KLL D+
Sbjct: 123 SYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL--DVDEKEYHAEGGKVPI 175
Query: 483 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542
++A E + +T +SD++++GV + +++T + E +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK------GER 229
Query: 543 FSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 580
+ + M LV C D E+RPT + +I E + A
Sbjct: 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 62/267 (23%), Positives = 128/267 (47%), Gaps = 27/267 (10%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V+ T T VA++++ S E F+ ++ +L+H+ +++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSS----NVLDWSTRVSIIIGIAKGIGYLHSSE 432
+ ++I +F KG L +L +EGS ++D+S + IA+G+ +
Sbjct: 72 ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF----- 117
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 492
+ + +HR+L +L+ IAD GL +++ D+ + + + APE +
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 177
Query: 493 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 552
G FT +SD+++FG+++++I+T + M + ++R + E+ +L
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELY 233
Query: 553 KMALVCTHEDPENRPT---MEAVIEEL 576
+ + C PE RPT +++V+++
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 9e-22
Identities = 62/256 (24%), Positives = 120/256 (46%), Gaps = 17/256 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V++G + T VA++++ + + +F+ ++ LRH +I+L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 377 SRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
E +++ + G L +YL G + L + + +A G+ YL +
Sbjct: 72 ---LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 495
+HR+L+ VL+ + +AD GL +++ +DI + + + APE RF
Sbjct: 124 --YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRF 181
Query: 496 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 555
+ +SD+++FG+++ +I+T + M +A +D+ + +L +
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPGM----TNAEVLQQVDQGYRMPCPPGCPKELYDIM 237
Query: 556 LVCTHEDPENRPTMEA 571
L C EDP++RPT E
Sbjct: 238 LDCWKEDPDDRPTFET 253
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 316 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA-----EFVKGLYLLTSLRHENIIR 370
+G+G F VY+G I ++ V +CK+ + +F++ Y++ H +I++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKI-AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L G +++ + AP G+L YL LD ++ + ++ + YL S
Sbjct: 72 LIGVITEN---PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES 125
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
VHR+++ VL+ + D GL + L D+ + K + ++APE +
Sbjct: 126 KR-----FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180
Query: 491 TTGRFTERSDIFAFGVIILQIL 512
RFT SD++ FGV + +IL
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 66/263 (25%), Positives = 123/263 (46%), Gaps = 14/263 (5%)
Query: 316 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LLGKGNF V+KGTL+D T VA+++ + + +F+ +L H NI++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
R +++ + P G +L +++ + L V + A G+ YL S
Sbjct: 62 TQ--RQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKNC-- 114
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 495
+HR+L+ L+ + I+D G+ + D I S + + APE + GR+
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 496 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 555
+ SD++++G+++ + T SL + + + A + +++ + + + K+
Sbjct: 172 SSESDVWSYGILLWE--TFSLGVCPYPGMTNQQAREQ--VEKGYRMSCPQKCPDDVYKVM 227
Query: 556 LVCTHEDPENRPTMEAVIEELTV 578
C PENRP + +EL
Sbjct: 228 QRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 53/113 (46%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 50 NQ-LTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL 108
NQ L G IP I L+ L + L N + G IP SLG++ L+ LDLS+NS G+IPESL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 109 ANNAELLFLDVQNNTLSGIVPSAL--KRLNGG-FQFQNNPGLCGDGIASLRAC 158
L L++ N+LSG VP+AL + L+ F F +N GLC GI LRAC
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC--GIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 68/266 (25%), Positives = 127/266 (47%), Gaps = 31/266 (11%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 368
F +N +GKG+F V+K + D + A++ I+++ + E E + +L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--SNVLDWSTRVSIIIGIAKGIG 426
IR + +G+ ++ ++A G L K L + G W + I++G+A
Sbjct: 62 IRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGY 484
+LHS + I+HR++ + +D N I D G+ KLL+D+ F +++ T Y
Sbjct: 116 HLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY---Y 167
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF- 543
L+PE + E+SD++A GV++ + TG ++ + A I + ++G F
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------LILKIIRGVFP 219
Query: 544 --SESEAAKLGKMALVCTHEDPENRP 567
S+ + +L ++ C +D RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 16/256 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG+G F V+ GT T VAI+++ + E F++ ++ LRH+ ++ L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA--FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
+++ +F KG L +L +EG L V + IA G+ Y + +
Sbjct: 72 EE---PIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAY-----IERM 121
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
+HR+L +L+ IAD GL +L+ D+ + + + APE GRFT
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 497 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 556
+SD+++FG+++ +++T V M E ++R + + L ++
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQ-VERGYRMPCPQGCPESLHELMK 237
Query: 557 VCTHEDPENRPTMEAV 572
+C +DP+ RPT E +
Sbjct: 238 LCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 36/271 (13%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V+ G R VAI+ I + SE+ +F++ ++ L H N+++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SED-DFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
+ F++ ++ G L YL + +G L + + + + + YL S+
Sbjct: 70 KQR--PIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNGF--- 121
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
+HR+L+ L+ + ++D GL + + DD S T + + PE RF+
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 497 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 556
+SD+++FGV++ ++ + +E F N + S S +L + L
Sbjct: 180 SKSDVWSFGVLMWEVFSEG------------KMPYERF--SNSEVVESVSAGYRLYRPKL 225
Query: 557 V----------CTHEDPENRPTMEAVIEELT 577
C HE PE+RP + ++ +LT
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 16/254 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V+ GT T VA++++ + E F++ ++ LRH+ +++L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
+++ ++ KG L +L EG + L V + +A G+ Y + +
Sbjct: 72 EE---PIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAY-----IERM 121
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
+HR+L +L+ IAD GL +L+ D+ + + + APE GRFT
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 497 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 556
+SD+++FG+++ +++T V M E ++R + + L ++ L
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQ-VERGYRMPCPQDCPISLHELML 237
Query: 557 VCTHEDPENRPTME 570
C +DPE RPT E
Sbjct: 238 QCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG+G F V+ GT T VAI+++ + E F++ ++ LRHE +++L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
+++ ++ KG L +L E G L V + IA G+ Y V +
Sbjct: 72 EE---PIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAY-----VERM 121
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
VHR+L +L+ + +AD GL +L+ D+ + + + APE GRFT
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 497 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 556
+SD+++FG+++ ++ T V M + + ++R + L +
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERGYRMPCPPECPESLHDLMC 237
Query: 557 VCTHEDPENRPTME 570
C ++PE RPT E
Sbjct: 238 QCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 16/257 (6%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
V LG G F V+ G T VAI+S+ S F+ L+ L+H ++RL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
+ ++I ++ G L +L EG L + + + IA+G+ ++
Sbjct: 69 VVT---QEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNY 123
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 493
+HR+L +L+ + IAD GL +L+ D+ + + + APE + G
Sbjct: 124 -----IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553
FT +SD+++FG+++ +I+T + M +N ++R + ++ +L +
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQN-LERGYRMPRPDNCPEELYE 234
Query: 554 MALVCTHEDPENRPTME 570
+ +C E PE RPT E
Sbjct: 235 LMRLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
V LG G F V+ G + T VA++++ + + F++ L+ +L+H+ ++RL
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--FLEEANLMKTLQHDKLVRL-- 66
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL----DWSTRVSIIIGIAKGIGYLH 429
+ ++I ++ KG L +L +EG +L D+S + IA+G+ Y
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAY-- 118
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
+ + +HR+L VL+ + IAD GL +++ D+ + + + APE
Sbjct: 119 ---IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549
+ G FT +SD+++FG+++ +I+T + M ++ + + R + E+
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM----SNSDVMSALQRGYRMPRMENCPD 231
Query: 550 KLGKMALVCTHEDPENRPTME 570
+L + C E E RPT +
Sbjct: 232 ELYDIMKTCWKEKAEERPTFD 252
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 64/280 (22%), Positives = 128/280 (45%), Gaps = 29/280 (10%)
Query: 312 SEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 365
E+ LG+G F V+ + TLV ++++ T ++ ++EF + L + L H
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIG 420
+N++RL G C R ++I ++ G L ++L E+ L +V++
Sbjct: 68 KNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
IA G+ +L ++ VHR+L+ L+ Q ++ L K + + + +
Sbjct: 126 IALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--- 537
+ +LAPE V F+ +SD+++FGV++ ++ T L + E ++R
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-------QGELPFYGLSDEEVLNRLQA 233
Query: 538 -NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L+ E ++L K+ C +P++RP+ ++ L
Sbjct: 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 317 LGKGNFSSVY------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G+F V +G G VA++S+ S + A+ K + +L +L HENI++
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
+G C G LI +F P G L +YL + + N ++ ++ + I KG+ YL S
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPE 488
+ VHR+L+ VL++ + I D GL K + D + +K + + + APE
Sbjct: 128 RQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 489 YVTTGRFTERSDIFAFGVIILQILT 513
+ +F SD+++FGV + ++LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 310 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 365
++ ++G G F V++G L R VAI+++ + + +F+ ++ H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
NIIRL G +I ++ G L KYL +G + V ++ GIA G+
Sbjct: 66 HNIIRLEGVVTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGM 120
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMG 483
YL S++N VHR+L+ +L++ ++D GL ++L DD ++ +
Sbjct: 121 KYL--SDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ APE + +FT SD+++FG+++ ++++
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 6e-20
Identities = 90/281 (32%), Positives = 138/281 (49%), Gaps = 43/281 (15%)
Query: 313 EVNLLGKGNFSSVYKG-TLRDGTLVAIRSIN-VTSCKSEE-AEFVKGLYLLTSLRHENII 369
E N++ +G + YKG ++++G ++ IN V S S E A+ K L+H NI+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK-------LQHPNIV 746
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+L G C R +LI+++ LS+ L L W R I IGIAK + +LH
Sbjct: 747 KLIGLC--RSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLH 797
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
PA+V NLS EK++ID + P + L LL D +SA Y+APE
Sbjct: 798 CR--CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--TKCFISSA---YVAPET 849
Query: 490 VTTGRFTERSDIFAFGVIILQILTG------------SLVLTSSMRLAAESATFENFIDR 537
T TE+SDI+ FG+I++++LTG S+V R + +ID
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--EWARYCYSDCHLDMWIDP 907
Query: 538 NLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+++G S ++E ++ +AL CT DP RP V++ L
Sbjct: 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 317 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F VYKG L T VAI+++ + + EF + L++ L+H NI+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSII 418
L G C ++ + C L +++ G L ++L +E + LD S + I
Sbjct: 73 LLGVC-TKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
I IA G+ YL S VHR+L+ L+ + I+D GL + + + V
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 479 SA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQI 511
S + ++ PE + G+FT SDI++FGV++ +I
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 32/277 (11%)
Query: 317 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G+F VY+G + T VAI+++N + E EF+ ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ---EEGSSNVLDWSTRVSII---IGIAKG 424
L G S G+ ++ + KG L YL E ++ L T I IA G
Sbjct: 74 LLGVV-STGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 482
+ YL + + VHR+L+ ++ + I D G+ DI + K +
Sbjct: 132 MAYLAAKK-----FVHRDLAARNCMVAEDLTVKIGDFGM----TRDIYETDYYRKGGKGL 182
Query: 483 ---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539
++APE + G FT +SD+++FGV++ ++ T L L+ E F+
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNEEVL--KFVIDGG 238
Query: 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E+ KL ++ +C +P+ RPT ++ L
Sbjct: 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 66/275 (24%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 312 SEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
SE+ L +G G F V+ G + VAI++I SEE +F++ ++ L H +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEE-DFIEEAQVMMKLSHPKL 61
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
++L G C R L+++F G LS YL + G T + + + + +G+ YL
Sbjct: 62 VQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYL 116
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 488
SS V +HR+L+ L+ + ++D G+ + + DD S T + + +PE
Sbjct: 117 ESSNV-----IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171
Query: 489 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGK 542
+ +++ +SD+++FGV++ ++ S + E+ + ++ R K +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVF-------SEGKTPYENRSNSEVVETINAGFRLYKPR 224
Query: 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577
+ +L + C E PE+RP+ ++ +L
Sbjct: 225 LASQSVYELMQH---CWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 37/287 (12%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTL----VAIRSINVTSCKSEEAEFVKGLYLLTS 362
++ LLG G F +V+KG + +G VAI++I S + E + + S
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN---VLDWSTRVSIII 419
L H I+RL G C L+ +P G L ++ Q S + +L+W +
Sbjct: 66 LDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ----- 117
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD---IVFSVL 476
IAKG+ YL +VHRNL+ +L+ IAD G+ LL D +S
Sbjct: 118 -IAKGMYYLEEH-----RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 477 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536
KT + ++A E + GR+T +SD++++GV + ++++ + MR E
Sbjct: 172 KTP--IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---- 225
Query: 537 RNLKG-KFSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 580
KG + ++ + + M +V C D RPT + + E T A
Sbjct: 226 ---KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 30/274 (10%)
Query: 315 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
++GKG+F VY GTL D A++S+N + E +F+K ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L G C G ++ + G L ++ E + V D + + +AKG+ YL S
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLAS 116
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MGYLAP 487
+ VHR+L+ ++D+ F +AD GL + + D +SV + A + ++A
Sbjct: 117 KK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRNLKGK 542
E + T +FT +SD+++FGV++ +++T R A +S ++ + +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVDSFDITVYLLQGRRLL 222
Query: 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E L ++ L C H PE RPT ++ +
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 35/282 (12%)
Query: 315 NLLGKGNFSSVYKGTLRD----GT---LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
N LG G F VY+GT D G+ VA++++ + E+ EF+K +L+++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 424
I++L G C ++I + G L YL E +L + I + +AKG
Sbjct: 61 IVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-----IADCGLHKLLADDIVFSVLKTS 479
YL + +HR+L+ L+ ++ I D GL A DI S
Sbjct: 119 CVYLE-----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL----ARDIYKSDYYRK 169
Query: 480 AAMG-----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534
G ++APE + G+FT +SD+++FGV++ +ILT L A +
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----LGQQPYPALNNQEVLQH 225
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + E+ K+ ++ C +DP RPT + + E L
Sbjct: 226 VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 64/263 (24%), Positives = 121/263 (46%), Gaps = 18/263 (6%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
+G+GNF V+ G LR D T VA++S T +A+F++ +L H NI+RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
+ +++ + G +L + EG L + ++ A G+ YL S
Sbjct: 63 TQ--KQPIYIVMELVQGGDFLTFL-RTEGPR--LKVKELIQMVENAAAGMEYLESKHC-- 115
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV--LKTSAAMGYLAPEYVTTG 493
+HR+L+ L+ ++ I+D G+ + D + S +K + + APE + G
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK-QIPVKWTAPEALNYG 171
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553
R++ SD+++FG+++ + + L + + I++ ++ E + +
Sbjct: 172 RYSSESDVWSFGILLWEAFS----LGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR 227
Query: 554 MALVCTHEDPENRPTMEAVIEEL 576
+ C DP RP+ V +EL
Sbjct: 228 LMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 310 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 365
+ ++G G F V +G L + VAI+++ S + +F+ ++ H
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH 64
Query: 366 ENIIRLRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
NIIRL G + +I ++ G L K+L + +G V ++ GIA G
Sbjct: 65 PNIIRLEGVVT---KSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASG 118
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFSVLKTSAAMG 483
+ YL SE+N VHR+L+ +L++ ++D GL + L D + ++ +
Sbjct: 119 MKYL--SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ APE + +FT SD+++FG+++ ++++
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 48/275 (17%)
Query: 317 LGKGNFSSVYKGTLR--DGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
LG GNF SV KG G VA++++ + + EF++ ++ L H I+RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 373 GFCCSRGRGECF-LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
G C +GE L+ + AP G L KYL +E S++ + + +V A G+ YL
Sbjct: 63 GVC----KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE 112
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAP 487
S VHR+L+ VL+ + I+D G+ + L + T+ + + AP
Sbjct: 113 SKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
Query: 488 EYVTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFENFIDR 537
E + G+F+ +SD++++GV + + + G+ V+ ++
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA--------------MLES 213
Query: 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 572
+ E ++ + L C PE+RPT +
Sbjct: 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 317 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F V+ G D LVA++++ T+ +F + LLT+ +HENI++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 371 LRGFCCSRGRGEC-FLIYDFAPKGKLSKYL-------------DQEEGSSNVLDWSTRVS 416
G C G+ +++++ G L+K+L D G L S +
Sbjct: 73 FYGVC---TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE---LTLSQLLQ 126
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 476
I + IA G+ YL S VHR+L+ L+ I D G+ + + + V
Sbjct: 127 IAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 477 -KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
T + ++ PE + +FT SD+++FGV++ +I T
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 301 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLV----AIRSINVTSCKSEEAEFVK 355
L+E E V +LG G F +VYKG + +G V AI+ +N T+ EF+
Sbjct: 4 LKETE-----LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD 58
Query: 356 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 412
++ S+ H +++RL G C S L+ P G L Y+ + + GS +L+W
Sbjct: 59 EALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 471
+ IAKG+ YL +VHR+L+ VL+ + I D GL +LL D+
Sbjct: 116 VQ------IAKGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
++ + ++A E + +FT +SD++++GV I +++T
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 63/285 (22%), Positives = 123/285 (43%), Gaps = 53/285 (18%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 368
+ + +GKG+F VY DG L ++ I++++ +E E + +L L H NI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 369 IRLRGFCCSRGRGECFL-------IYDFAPKGKLSKYLDQ--EEGSS----NVLDWSTRV 415
I+ E F + ++A G LS+ + + +EG +LDW +
Sbjct: 62 IKYY---------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ- 111
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
+ + YLHS K I+HR++ + + + + D G+ K+L+ +
Sbjct: 112 -----LCLALKYLHS---RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDL 159
Query: 476 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532
KT G YL+PE + +SDI++ G ++ ++ T ++ E
Sbjct: 160 AKTVV--GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT--------LKHPFEGENLL 209
Query: 533 NFIDRNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ LKG++ +++L + +DPE RP++ +++
Sbjct: 210 ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 61/268 (22%), Positives = 117/268 (43%), Gaps = 28/268 (10%)
Query: 316 LLGKGNFSSVYKGTLRDGTLVAIRSI--NVTSCKS--EEAEFVKGLYLLTSLRHENIIRL 371
+GKG F V G R G VA++ + + T+ ++ EA +T+LRH N+++L
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASV------MTTLRHPNLVQL 65
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G +++ ++ KG L YL + L ++ + + +G+ YL
Sbjct: 66 LGVVLQGN--PLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK 121
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 491
VHR+L+ VL+ + ++D GL A + + + APE +
Sbjct: 122 N-----FVHRDLAARNVLVSEDLVAKVSDFGL----AKEASQGQDSGKLPVKWTAPEALR 172
Query: 492 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551
+F+ +SD+++FG+++ +I + V + L E + + E ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----GYRMEAPEGCPPEV 228
Query: 552 GKMALVCTHEDPENRPTMEAVIEELTVA 579
K+ C DP RPT + + E+L +
Sbjct: 229 YKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 64/264 (24%), Positives = 122/264 (46%), Gaps = 22/264 (8%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V+ G R VAI++IN SEE +F++ ++ L H +++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
+ +++ +F G L YL Q +G S ++L +S+ + +G+ YL +
Sbjct: 70 QQK--PLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN--- 119
Query: 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR 494
+ +HR+L+ L+ ++D G+ + + DD S + + PE +
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 495 FTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553
++ +SD+++FGV++ ++ T G + F R + K + + + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--RLYRPKLA---SMTVYE 232
Query: 554 MALVCTHEDPENRPTMEAVIEELT 577
+ C HE PE RPT ++ +T
Sbjct: 233 VMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 85.9 bits (211), Expect = 4e-18
Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 29/280 (10%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIR--SINVTSCKSEEAEFVKGLYLLTSLRHE-NIIR 370
+ LG+G+F VY RD LVA++ + + S E F++ + +L SL H NI++
Sbjct: 5 LRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L F + G +L+ ++ G L L + G L S + I+ I + YLHS
Sbjct: 63 LYDFF--QDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKLLADDIVFSVLKTSAA-----MGY 484
I+HR++ E +L+D+ + D GL KLL D S + + GY
Sbjct: 120 K-----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 485 LAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------- 534
+APE + + SDI++ G+ + ++LTG +A S T +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ L E + + +DP+NR + + +
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 65/276 (23%), Positives = 123/276 (44%), Gaps = 39/276 (14%)
Query: 311 FSEVNLLGKGNFSSVYK-GTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENI 368
F + LGKG++ SVYK L D A++ +++ S + E + V + +L S+ H NI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 369 IRLRGFCCSRGRGECFL-------IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 421
I + E FL + ++AP G LSK + + + ++ I I +
Sbjct: 62 ISYK---------EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 481
+G+ LH + I+HR+L +L+ I D G+ K+L ++ + + T
Sbjct: 113 LRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH- 166
Query: 482 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540
Y+APE V GR ++ +SDI++ G ++ ++ T E+ + ++ + +
Sbjct: 167 --YMAPE-VWKGRPYSYKSDIWSLGCLLYEMATF--------APPFEARSMQDLRYKVQR 215
Query: 541 GKF---SESEAAKLGKMALVCTHEDPENRPTMEAVI 573
GK+ + L P+ RP + ++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 317 LGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G+F V Y DGT +VA++++ + + + K + +L +L HENI++
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 371 LRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAKGIGYL 428
+G CCS G+ LI ++ P G L YL + + + +L ++ + I +G+ YL
Sbjct: 71 YKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYL 123
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLA 486
HS +HR+L+ VL+D I D GL K + + + ++ + + + A
Sbjct: 124 HSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILT 513
E + +F+ SD+++FGV + ++LT
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 75/304 (24%), Positives = 128/304 (42%), Gaps = 39/304 (12%)
Query: 289 FSREHLNSFRLNLEEVESATQCFSEV-NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK 347
F R+ LN F L E + E L + LVA++ + +
Sbjct: 2 FPRQPLN-FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 348 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--- 404
+ +F+K + +L+ L NI RL G C +I ++ G L+++L +
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 405 ----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460
+S L +ST + + IA G+ YL +N VHR+L+ L+ + + IAD
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYL--ESLN---FVHRDLATRNCLVGKNYTIKIAD 173
Query: 461 CGLHK-LLADDIVFSVLKTSAAMG--YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 517
G+ + L + D + ++ A + ++A E V G+FT +SD++AFGV + +I
Sbjct: 174 FGMSRNLYSSD--YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI------ 225
Query: 518 LTSSMRLAAESATFENFIDRNLKGKFSESE-----------AAKLGKMALVCTHEDPENR 566
LT E T + I+ N F + + ++ L C D E+R
Sbjct: 226 LTLCREQPYEHLTDQQVIE-NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284
Query: 567 PTME 570
PT
Sbjct: 285 PTFR 288
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 21/273 (7%)
Query: 316 LLGKGNFSSVYKGTLR--DGTL--VAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIR 370
+LG+G F SV +G L DG+ VA++++ + E E F+ + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 371 LRGFCCSRGRGECF----LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 424
L G C + +I F G L +L + G L T + ++ IA G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 483
+ YL + +HR+L+ ++ + +AD GL K+ + D +
Sbjct: 126 MEYLSNRN-----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
++A E + +T +SD++AFGV + +I T + E+ +++ + K
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVENHEIYDYLRHGNRLKQ 236
Query: 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E +L + C DP++RPT + E L
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 316 LLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
++G G F V +G L + VAI+++ + + +F+ ++ H NII L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G ++ R +I +F G L +L Q +G V+ V ++ GIA G+ YL S
Sbjct: 71 EGVV-TKSR-PVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL--S 123
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD----IVFSVLKTSAAMGYLAP 487
E+N VHR+L+ +L++ ++D GL + L DD S L + + AP
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 488 EYVTTGRFTERSDIFAFGVIILQILT 513
E + +FT SD++++G+++ ++++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 301 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVK 355
L+E E F ++ +LG G F +VYKG + +G VAI+ + + E +
Sbjct: 4 LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58
Query: 356 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 412
Y++ S+ + ++ RL G C + LI P G L Y+ + + GS +L+W
Sbjct: 59 EAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 471
+ IAKG+ YL +VHR+L+ VL+ + I D GL KLL AD+
Sbjct: 116 VQ------IAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ + ++A E + +T +SD++++GV + +++T
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 57/286 (19%)
Query: 316 LLGKGNFSSVYKGTLRD--GTL--VAI---RSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
LG G+F V +G G + VA+ +S ++ + F+K ++ SL HEN+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENL 58
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKG 424
IRL G + ++ + AP G L L ++ S + D++ + IA G
Sbjct: 59 IRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANG 109
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAM 482
+ YL S +HR+L+ +L+ I D GL + L +D
Sbjct: 110 MRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 483 GYLAPEYVTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFE 532
+ APE + T F+ SD++ FGV + ++ L+GS +L
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK------------ 212
Query: 533 NFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVIEEL 576
ID+ + + EA + + L C +P +RPT A+ E L
Sbjct: 213 --IDKEGE-RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 27/241 (11%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE-EAEFVKG-LYLLTSLRHENIIRLRG 373
LGKG+F V +D G L A++ + E E +L+ + H I++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSE 432
+ + +L+ ++AP G+L +L +E R I + YLHS
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKE----GRFS-EERARFYAAEIVLALEYLHSLG 113
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 489
I++R+L E +L+D + + D GL K L+ + +T+ G YLAPE
Sbjct: 114 -----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----RTNTFCGTPEYLAPEV 164
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549
+ + + D ++ GV++ ++LTG + R +E + L+ S A
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPEFLSPEA 220
Query: 550 K 550
+
Sbjct: 221 R 221
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 314 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 366
LG+G F V K + VA++ + + + + ++ V + ++ + +H+
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD----QEEGSSNVLDWSTR-------- 414
NII L G C+ G +++ ++A G L +L E +S
Sbjct: 77 NIINLLG-VCT-QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--V 472
VS +A+G+ +L S + +HR+L+ VL+ + IAD GL A DI +
Sbjct: 135 VSFAYQVARGMEFLASKK-----CIHRDLAARNVLVTEDHVMKIADFGL----ARDIHHI 185
Query: 473 FSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAE 527
KT+ + ++APE + +T +SD+++FGV++ +I T GS +
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 240
Query: 528 SATFENFIDRNLK-GKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
E LK G E +L + C HE P RPT + ++E+L
Sbjct: 241 ----EELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 48/297 (16%)
Query: 301 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVK 355
L+E E +V +LG G F +VYKG + DG VAI+ + + E +
Sbjct: 4 LKETE-----LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD 58
Query: 356 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 412
Y++ + + RL G C + L+ P G L Y+ + + GS ++L+W
Sbjct: 59 EAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC 115
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 471
+ IAKG+ YL EV +VHR+L+ VL+ + I D GL +LL D+
Sbjct: 116 VQ------IAKGMSYLE--EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531
+ + ++A E + RFT +SD++++GV + +++T + +
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFG------------AKPY 212
Query: 532 ENFIDRNLKGKFSESE-------AAKLGKMALV-CTHEDPENRPTMEAVIEELTVAA 580
+ R + + E M +V C D E RP +++E + A
Sbjct: 213 DGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 317 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LG+ F +YKG L LVAI+++ + + EF + L+ L H NI+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYL-------------DQEEGSSNVLDWSTRVSII 418
G ++ + C L +++ +G L ++L D++ + LD + I
Sbjct: 73 LG-VVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-K 477
I IA G+ YL S VH++L+ +LI +Q + I+D GL + + + V K
Sbjct: 131 IQIAAGMEYLSSH-----FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 478 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
+ + ++ PE + G+F+ SDI++FGV++ +I + L
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL 224
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 56/263 (21%), Positives = 120/263 (45%), Gaps = 16/263 (6%)
Query: 315 NLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+ LG G + VY+G + VA++++ + + EE F+K ++ ++H N+++L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 69
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
C ++I +F G L YL E + ++ + + I+ + YL
Sbjct: 70 VCTREP--PFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 493
+HR+L+ L+ + +AD GL +L+ D + + + APE +
Sbjct: 125 ----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553
+F+ +SD++AFGV++ +I T + S + + +++ + + E K+ +
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGM----SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236
Query: 554 MALVCTHEDPENRPTMEAVIEEL 576
+ C +P +RP+ + +
Sbjct: 237 LMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 21/264 (7%)
Query: 310 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
F + +GKG F VYK R G VAI+ I + S + +E + + + +L +H NI
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-KIINEIQILKKCKHPNI 59
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
++ + + E +++ +F G L L ++ L S + + KG+ YL
Sbjct: 60 VKY--YGSYLKKDELWIVMEFCSGGSLKDLLK---STNQTLTESQIAYVCKELLKGLEYL 114
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 488
HS N I+HR++ +L+ + D GL L+D + ++APE
Sbjct: 115 HS---NG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMVGTPYWMAPE 167
Query: 489 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA--ESATFENFIDRNLKGKFSES 546
+ + ++DI++ G+ +++ G + + A + AT RN + K+S+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPE-KWSDE 226
Query: 547 EAAKLGKMALVCTHEDPENRPTME 570
C ++PE RPT E
Sbjct: 227 ----FKDFLKKCLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 69/259 (26%), Positives = 120/259 (46%), Gaps = 20/259 (7%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V G R VAI+ I S E EF++ ++ L HE +++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYG-VC 68
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
++ R +++ ++ G L YL +E G S + + + +G+ YL S +
Sbjct: 69 TKQR-PIYIVTEYMSNGCLLNYL-REHGKR--FQPSQLLEMCKDVCEGMAYLESKQ---- 120
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
+HR+L+ L+D Q ++D GL + + DD S + + + + PE + +F+
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 497 ERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID-RNLKGKFSESEAAKLGKM 554
+SD++AFGV++ ++ + G + S T E L SE K+ +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKM----PYERFNNSETVEKVSQGLRLYRPHLASE--KVYAI 233
Query: 555 ALVCTHEDPENRPTMEAVI 573
C HE E RPT + ++
Sbjct: 234 MYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 39/89 (43%), Positives = 53/89 (59%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L NQL G IP ++G +KSL + L +N L+G IP +G L L LDL +N+L G
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSAL 132
IP SL N L +L + N LSG +P ++
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 46/287 (16%)
Query: 316 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
++G+G+FS+V + AI+ ++ + K + ++ L H II+L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+ + + + ++AP G+L +Y+ ++ GS LD I + YLHS
Sbjct: 68 --YYTFQDEENLYFVLEYAPNGELLQYI-RKYGS---LDEKCTRFYAAEILLALEYLHSK 121
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-------- 483
I+HR+L E +L+D+ + I D G K+L + K A
Sbjct: 122 -----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 484 -----------YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532
Y++PE + + SD++A G II Q+LTG R + E TF+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG----KPPFRGSNEYLTFQ 232
Query: 533 NFIDRNLKGKFSE--SEAAK-LGKMALVCTHEDPENRPTMEAVIEEL 576
+ F AK L + LV DP++R + +EL
Sbjct: 233 KILKLEY--SFPPNFPPDAKDLIEKLLV---LDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 317 LGKGNFSSVYKGT--LRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
LG GNF V KG +R + VAI+ + + KS E ++ ++ L + I+R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
C + L+ + A G L+K+L E SNV++ +VS+ G+ YL
Sbjct: 63 VCEAEA---LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM------GMKYLEG 113
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPE 488
VHR+L+ VL+ Q I+D GL K L D + +++ + + APE
Sbjct: 114 KN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
Query: 489 YVTTGRFTERSDIFAFGVIILQILT 513
+ +F+ RSD++++G+ + + +
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 316 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 370
LLG G+F SVY+G L DG A++ +++ E VK L LL+ L+H NI++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--SNVLDWSTRVSIIIGIAKGIGYL 428
G FL + P G L+K L ++ GS V+ TR I G+ YL
Sbjct: 67 YLGTEREEDNLYIFL--ELVPGGSLAKLL-KKYGSFPEPVIRLYTR-----QILLGLEYL 118
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 488
H VHR++ +L+D +AD G+ K + + K S ++APE
Sbjct: 119 HDRN-----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY--WMAPE 171
Query: 489 YV-TTGRFTERSDIFAFGVIILQILTG 514
+ G + +DI++ G +L++ TG
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 63/268 (23%), Positives = 119/268 (44%), Gaps = 34/268 (12%)
Query: 317 LGKGNFSSVYKG---TLRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
LG GNF +V KG + VA++ + N + + + E ++ ++ L + I+R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 373 GFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRVSIIIGIAKGIGYLH 429
G C E + L+ + A G L+K+L + + + N+ + +VS+ G+ YL
Sbjct: 63 GIC----EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE 112
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAP 487
+ VHR+L+ VL+ Q I+D GL K L D + KT + + AP
Sbjct: 113 ETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
E + +F+ +SD+++FGV++ + + M+ + E+ G+ E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------GERMECP 220
Query: 548 AA---KLGKMALVCTHEDPENRPTMEAV 572
++ + +C + RP V
Sbjct: 221 QRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 315 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 372
+L+G+G F VYKG L G VAI+ I++ K E + + + LL +L+H NI++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI-IIGIAKGIGYLHSS 431
G ++I ++A G L + + + L V++ + + +G+ YLH
Sbjct: 66 GS--IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-----VAVYVYQVLQGLAYLHEQ 118
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPEY 489
++HR++ +L + +AD G+ L D SV+ T M APE
Sbjct: 119 -----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM---APEV 170
Query: 490 VTTGRFTERSDIFAFGVIILQILTG 514
+ + SDI++ G ++++LTG
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 28/264 (10%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
+GKG F V G R G VA++ I + F+ ++T LRH N+++L G
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
+G +++ ++ KG L YL + G S VL + + + + + YL ++
Sbjct: 70 EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---- 122
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRF 495
VHR+L+ VL+ + ++D GL K + S T + + APE + +F
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKF 176
Query: 496 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKM 554
+ +SD+++FG+++ +I S R+ ++ + R KG K +
Sbjct: 177 STKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229
Query: 555 ALV--CTHEDPENRPTMEAVIEEL 576
++ C H D RP+ + E+L
Sbjct: 230 DVMKQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 48/210 (22%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 310 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 365
C ++G G F V G L+ VAI+++ + + +F+ ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
NII L G ++ + ++ ++ G L +L + +G V+ V ++ GIA G+
Sbjct: 65 PNIIHLEG-VVTKSK-PVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGM 119
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMG 483
YL VHR+L+ +L++ ++D GL ++L DD ++ +
Sbjct: 120 KYLSDM-----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ APE + +FT SD++++G+++ ++++
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 316 LLGKGNFSSVYKGTLR--DGTL--VAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIR 370
+LGKG F SV + L+ DG+ VA++ + S+ EF++ + H N+I+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 371 LRGFCC-SRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSN--VLDWSTRVSIIIGIAKG 424
L G SR +G +I F G L +L L T V +I IA G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 483
+ YL S +HR+L+ ++++ +AD GL K+ + D + +
Sbjct: 126 MEYLSSKN-----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
+LA E + +T SD++AFGV + +I+T + E++ N++ + + K
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT----RGQTPYAGVENSEIYNYLIKGNRLKQ 236
Query: 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ ++ C +P+ RP+ + + ++L
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 317 LGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G+F VY KG ++D T VAI+++N + E EF+ ++ +++R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIG-IAKG 424
L G S+G+ +I + +G L YL + E ++ + G IA G
Sbjct: 74 LLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 483
+ YL++++ VHR+L+ ++ + F I D G+ + + D K +
Sbjct: 132 MAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+++PE + G FT SD+++FGV++ +I T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 317 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F V+ +D LVA++++ S +S +F + LLT L+H++I+R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS-----------III 419
G C+ GR +++++ G L+++L + +L V+ I
Sbjct: 72 FYG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 478
IA G+ YL S VHR+L+ L+ Q I D G+ + + + V +T
Sbjct: 130 QIASGMVYLASLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 479 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ ++ PE + +FT SDI++FGV++ +I T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 53/215 (24%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 315 NLLGKGNFSSVYKGTLR-DGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 370
+++G+GNF V + ++ DG + AI+ + + +++ +F L +L L H NII
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSII 418
L G C RG ++ ++AP G L +L + E G+++ L +
Sbjct: 68 LLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
+A G+ YL + +HR+L+ VL+ + IAD GL + +++
Sbjct: 126 SDVATGMQYLSEKQ-----FIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMG 178
Query: 479 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ ++A E + +T +SD+++FGV++ +I++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 23/155 (14%)
Query: 317 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF-------VKGLYLLTSLRHENI 368
+G+G + VYK + G LVA++ I + ++E+ F +K LL LRH NI
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIK---LLQKLRHPNI 60
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+RL+ S+G+G ++++++ L+ LD E S + + +G+ YL
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYL 116
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
HS+ I+HR++ +LI+ +AD GL
Sbjct: 117 HSN-----GILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 315 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 370
+++G+GNF V K ++ L AI+ + + K + +F L +L L H NII
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSII 418
L G C RG +L ++AP G L +L + +++ L +
Sbjct: 61 LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
+A+G+ YL + +HR+L+ +L+ + + IAD GL + ++
Sbjct: 119 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 171
Query: 479 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ ++A E + +T SD++++GV++ +I++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-14
Identities = 38/89 (42%), Positives = 51/89 (57%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+L L N TG IP + SL L VL L N+ +G IP +LG L LDLS N+L G
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSAL 132
IPE L ++ L L + +N+L G +P +L
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 23/194 (11%)
Query: 335 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394
LVA++ + + K+ +F+K + +L+ L+ NIIRL G C +I ++ G
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGD 105
Query: 395 LSKY-----LDQEEGSSN----------VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 439
L+++ LD +E + N + +S+ + + + IA G+ YL S +N V
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLN---FV 160
Query: 440 HRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTER 498
HR+L+ L+ + IAD G+ + L A D + + ++A E + G+FT
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 499 SDIFAFGVIILQIL 512
SD++AFGV + +IL
Sbjct: 221 SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 317 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 367
LG+G F V K ++ VA++ + + + + ++ V + ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 415
II L G C++ G ++I ++A KG L +YL D + + V
Sbjct: 83 IINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 474
S +A+G+ YL S + +HR+L+ VL+ + IAD GL + + + D
Sbjct: 141 SCTYQVARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 475 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534
+ ++APE + +T +SD+++FGV++ +I T L S
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 251
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + +L M C H P +RPT + ++E+L
Sbjct: 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 316 LLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
+LG G F + +G L + VAI ++ + F+ L H NI+RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 372 RGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
G RG +I ++ G L +L + EG L + ++ G+A G+ YL
Sbjct: 72 EGVIT---RGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL-- 123
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAAMGYLAPE 488
SE+ VH+ L+ KVL++ I+ G +L D +++ + + + + APE
Sbjct: 124 SEM---GYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 489 YVTTGRFTERSDIFAFGVIILQILT 513
+ F+ SD+++FG+++ ++++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 38/287 (13%)
Query: 317 LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F V K T R G T VA++ + + SE + + LL + H ++I+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTR-------------- 414
L G C G LI ++A G L +L + G S + R
Sbjct: 68 LYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 415 ----VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLAD 469
+S I++G+ YL +E+ +VHR+L+ VL+ + I+D GL + + +
Sbjct: 126 MGDLISFAWQISRGMQYL--AEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529
D K + ++A E + +T +SD+++FGV++ +I+T L +
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGIAPE 236
Query: 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
N + + + E+ + ++ + L C ++P+ RPT + +EL
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-14
Identities = 43/103 (41%), Positives = 56/103 (54%), Gaps = 3/103 (2%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L N L G IP + +L SL LTL N+L G IP LG + LK + L +N+L G
Sbjct: 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSA---LKRLNGGFQFQN 143
IP + L LD+ N L+G +PS+ LK L F +QN
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270
|
Length = 968 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 20/271 (7%)
Query: 317 LGKGNFSSVYKGTLR--DGTL-VAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLR 372
LG+G F SV +G L D L VA++++ + C +SE +F+ + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 373 GFCCSRGRGECF----LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIG 426
G C E + +I F G L +L + L V + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYL 485
YL S +HR+L+ ++++ N +AD GL K + + + + + + ++
Sbjct: 127 YLSSKS-----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545
A E + +T +SD+++FGV + +I T + E++ +++ + + K
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRG----QTPYPGVENSEIYDYLRQGNRLKQPP 237
Query: 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L + C +P++RP+ E + EL
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 62/253 (24%), Positives = 119/253 (47%), Gaps = 24/253 (9%)
Query: 335 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394
LVA++ + K+ +F+K + +++ L++ NIIRL G C S +I ++ G
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGD 103
Query: 395 LSKYLDQEEGSSNV--------LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446
L+++L Q E S + + + + + IA G+ YL S VHR+L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLATR 158
Query: 447 KVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFG 505
L+ + IAD G+ + L + + + + ++A E + G+FT SD++AFG
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 506 VIILQILTGSLVLTSSMRLAAESATFEN----FIDRNLKGKFSESE--AAKLGKMALVCT 559
V + ++ T L L ++ EN F ++ + S++ + + K+ + C
Sbjct: 219 VTLWEMFT--LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCW 276
Query: 560 HEDPENRPTMEAV 572
D ++RPT +
Sbjct: 277 SRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 315 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 370
+++G+GNF V K ++ L AI+ + + K + +F L +L L H NII
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 418
L G C RG +L ++AP G L +L + +++ L +
Sbjct: 73 LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
+A+G+ YL + +HR+L+ +L+ + + IAD GL + ++
Sbjct: 131 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 183
Query: 479 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ ++A E + +T SD++++GV++ +I++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-14
Identities = 40/86 (46%), Positives = 55/86 (63%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N L+G IP +IG L SL+ L L +N L G IP SLGNL L+ L L N L G IP S+
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
+ +L+ LD+ +N+LSG +P + +L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQL 307
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 49/290 (16%)
Query: 317 LGKGNFSSVYK----GTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 367
LG+G F V + G + VA++ + + + A+ + + L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 415
II L G C G ++I ++A KG L ++L D + L + V
Sbjct: 80 IINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
S +A+G+ YL S +HR+L+ VL+ + IAD GL + + D +
Sbjct: 138 SCAYQVARGMEYLESRRC-----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK- 191
Query: 476 LKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GS----LVLTSSMRLAA 526
KTS + ++APE + +T +SD+++FG+++ +I T GS + + +L
Sbjct: 192 -KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250
Query: 527 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E + K S M C H P RPT + ++E L
Sbjct: 251 EGHRMD---------KPSNCTHELYMLMR-ECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 48/127 (37%), Positives = 65/127 (51%), Gaps = 12/127 (9%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L+L N+L+G IP ++ S K L L L HN+L+G IP S + L +LDLS N L G I
Sbjct: 504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEI 563
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQN------NPGLCGDGIAS-LRA 157
P++L N L+ +++ +N L G +PS G F N N LCG S L
Sbjct: 564 PKNLGNVESLVQVNISHNHLHGSLPS-----TGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 158 CTVYDNT 164
C T
Sbjct: 619 CKRVRKT 625
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 39/92 (42%), Positives = 54/92 (58%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VLQL N+ +G IP +G +L+VL L N L G IP+ L + G L +L L NSL G
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP+SL L + +Q+N+ SG +PS +L
Sbjct: 396 IPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
|
Length = 968 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 57/259 (22%), Positives = 108/259 (41%), Gaps = 23/259 (8%)
Query: 324 SVYKGTLRDGTLVAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381
S+YKG + V IR+ K + L + NI+++ GF
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 382 ECF--LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 439
LI ++ +G L + LD+E+ L + T++ + I KG+ L+ NKP
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY-TNKP--- 145
Query: 440 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTE 497
++NL+ L+ + + I GL K+L+ K M Y + + + +T
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNFMVYFSYKMLNDIFSEYTI 201
Query: 498 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV 557
+ DI++ GV++ +I TG + + ++ I++N K ++ +
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFEN----LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257
Query: 558 CTHEDPENRPTMEAVIEEL 576
CT D RP ++ ++ L
Sbjct: 258 CTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 317 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
+G+G F V++ T+VA++ + + +A+F + L+ H NI++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------DQEEGSS----------NVLDWST- 413
L G C+ G+ C L++++ G L+++L Q S N L S
Sbjct: 73 LLG-VCAVGKPMC-LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 414 -RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDI 471
++ I +A G+ YL SE K VHR+L+ L+ + IAD GL + + D
Sbjct: 131 EQLCIAKQVAAGMAYL--SE-RK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ + + ++ PE + R+T SD++A+GV++ +I +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 57/270 (21%), Positives = 123/270 (45%), Gaps = 31/270 (11%)
Query: 314 VNLLGKGNFSS--VYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIR 370
+ +LGKG F +Y+ T D +LV + +N+T +E + +L+ L+H NII
Sbjct: 5 IRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 371 -LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
F + ++A G L + +++G + + + + I + Y+H
Sbjct: 64 YYNHFMDD---NTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIH 118
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLAP 487
K I+HR++ + + + + D G+ K+L + +V+ T Y++P
Sbjct: 119 -----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY---YMSP 170
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--- 544
E ++ +SDI+A G ++ ++LT ++ ++ N + + ++G ++
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT--------LKRTFDATNPLNLVVKIVQGNYTPVV 222
Query: 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+++L + +DPE RPT + V++
Sbjct: 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 59/279 (21%)
Query: 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
V +LG+G+ VYK + G + A++ I+V + + ++ L L S +++
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGIAKGIGYLHS 430
G GE ++ ++ G L+ L + V I I KG+ YLH
Sbjct: 66 GAFYK--EGEISIVLEYMDGGSLADLLKKVGK------IPEPVLAYIARQILKGLDYLH- 116
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKTSAAMGYLAPE 488
K I+HR++ +LI+ + IAD G+ K+L + D + + T Y++PE
Sbjct: 117 ---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT---YMSPE 170
Query: 489 YVTTGRFTERSDIFAFGVIILQILTG-----------------SLVLTSSMRLAAE--SA 529
+ ++ +DI++ G+ +L+ G ++ L AE S
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
F +FI C +DP+ RP+
Sbjct: 231 EFRDFISA--------------------CLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 47/280 (16%)
Query: 317 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
+G G + VY L + VAI+ I++ C++ E K + ++ H N++ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---KYY 65
Query: 376 CSRGRGEC-FLIYDFAPKGKL-----SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
S G+ +L+ + G L S Y LD + +++ + KG+ YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 486
S+ +HR++ +L+ + + IAD G+ LAD + +G ++A
Sbjct: 120 SN-----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 487 PEYVTTGR-FTERSDIFAFGVIILQILTG-----------SLVLTSSMRLAAESATFENF 534
PE + + ++DI++FG+ +++ TG L+LT L + + E
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT----LQNDPPSLETG 230
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
D K+S+S KM +C +DP RPT E +++
Sbjct: 231 AD---YKKYSKS----FRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 317 LGKGNFSSVYKGT------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F V+ +D LVA++++ + + + +F + LLT+L+HE+I++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVK 71
Query: 371 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSI 417
G C G G+ +++++ G L+K+L Q + L S + I
Sbjct: 72 FYGVC---GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL- 476
IA G+ YL S VHR+L+ L+ I D G+ + + + V
Sbjct: 129 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 477 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
T + ++ PE + +FT SD+++FGVI+ +I T
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 48/197 (24%), Positives = 101/197 (51%), Gaps = 18/197 (9%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
+G+G F +V +G G VA+++I C F++ ++T L H+N++RL G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
G +++ + KG L +L + G + V + + +A+G+ YL S +
Sbjct: 70 HNG---LYIVMELMSKGNLVNFL-RTRGRALV-SVIQLLQFSLDVAEGMEYLESKK---- 120
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
+VHR+L+ +L+ + ++D GL ++ + + S L + APE + +F+
Sbjct: 121 -LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFS 175
Query: 497 ERSDIFAFGVIILQILT 513
+SD++++GV++ ++ +
Sbjct: 176 SKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 42/91 (46%), Positives = 55/91 (60%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L N LTG IP+ +G+LK+L L L N+L+G IP S+ +L KL LDLS NSL G I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
PE + L L + +N +G +P AL L
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 54/214 (25%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 316 LLGKGNFSSVYKG-TLRDGTLVAIR-----SINVTSCKSEEA--EFVKG-LYLLTSLRHE 366
L+G G+F SVY G G L+A++ S++ +S + + + + + LL L+HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
NI++ G FL Y P G ++ L+ + + + + I KG+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEY--VPGGSVAALLNN----YGAFEETLVRNFVRQILKGLN 120
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-----AA 481
YLH+ I+HR++ +L+D + I+D G+ K L + + + + +
Sbjct: 121 YLHNRG-----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 482 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 515
+ ++APE V +T ++DI++ G +++++LTG
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 46/202 (22%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+ LG GN V K R G ++A+++I + ++ + + ++ L +L I+
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
G + G + + ++ G L K L + +G + I + + KG+ YLH
Sbjct: 66 GAFYNNG--DISICMEYMDGGSLDKILKEVQG---RIPERILGKIAVAVLKGLTYLHE-- 118
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 492
K I+HR++ +L++ + + D G+ L + + + + TS+ Y+APE +
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---YMAPERIQG 173
Query: 493 GRFTERSDIFAFGVIILQILTG 514
++ +SDI++ G+ ++++ TG
Sbjct: 174 NDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 30/276 (10%)
Query: 317 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G+F VY+G RD T VA++++N ++ E EF+ ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVL-DWSTRVSIIIGIAKG 424
L G S+G+ ++ + G L YL + E + + IA G
Sbjct: 74 LLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 483
+ YL N VHR+L+ ++ F I D G+ + + D K +
Sbjct: 132 MAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
++APE + G FT SD+++FGV++ +I TS + + E + + G +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 544 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ ++ + +C +P+ RPT ++ L
Sbjct: 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 28/233 (12%)
Query: 303 EVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKG 356
E+ +T F E LG+ F VYKG L VAI+++ + EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 357 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEG 404
+ + L+H NI+ L G +I+ + L ++L D ++
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 405 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464
+ L+ + V I+ IA G+ +L S V VH++L+ VL+ + N I+D GL
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHV-----VHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 465 KLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
+ + + ++ S + +++PE + G+F+ SDI+++GV++ ++ + L
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 36/270 (13%)
Query: 315 NLLGKGNFSSVYKGTLRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENII 369
+LGKG + +VY G G L+A++ + NV + + E + + + LL SL+H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYL 428
+ G C F+ +F P G +S L++ V T+ I G+ YL
Sbjct: 66 QYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAYL 118
Query: 429 HSSEVNKPAIVHRNLSVEKV---------LIDQQFNPLIADCGLHKLLADDIVFSVLKTS 479
H++ V VHR++ V LID +A GLH ++ +LK+
Sbjct: 119 HNNCV-----VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN-----MLKSM 168
Query: 480 AAMGY-LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538
Y +APE + + +SDI++ G + ++ TG L S RLA A F R
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYIGAHRG 225
Query: 539 LKGKFSESEAAKLGKMALVCTHEDPENRPT 568
L + +S +A C D RP+
Sbjct: 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 58/208 (27%), Positives = 110/208 (52%), Gaps = 14/208 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
F ++ LG+G +++VYKG R G +VA++ I++ + + + ++ + L+ L+HENI+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
RL + + L++++ K L KY+D G LD +T S + KGI + H
Sbjct: 62 RLHDVIHTENK--LMLVFEYMDK-DLKKYMDT-HGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPE 488
+ V +HR+L + +LI+++ +AD GL + + FS + Y AP+
Sbjct: 118 ENRV-----LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS--NEVVTLWYRAPD 170
Query: 489 YVTTGR-FTERSDIFAFGVIILQILTGS 515
+ R ++ DI++ G I+ +++TG
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 50/187 (26%), Positives = 96/187 (51%), Gaps = 15/187 (8%)
Query: 335 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394
LVA++ + + K+ +F+K + +++ L+ NIIRL C + +I ++ G
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGD 105
Query: 395 LSKYL-------DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 447
L+++L E+ + +ST + + IA G+ YL S +N VHR+L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL--SSLN---FVHRDLATRN 160
Query: 448 VLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGV 506
L+ + + IAD G+ + L + + + + +++ E + G+FT SD++AFGV
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 507 IILQILT 513
+ +ILT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 316 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLRHEN 367
LG G FSS Y+ RD GTL+A++ + S E E V K + L+ L H +
Sbjct: 7 QLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
IIR+ G C F+ ++ G +S L + + ++ + +G+ Y
Sbjct: 65 IIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKE----AVIINYTEQLLRGLSY 118
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG--- 483
LH ++ I+HR++ +LID L IAD G LA + +G
Sbjct: 119 LHENQ-----IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
++APE + ++ D+++ G +I+++ T
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 33/261 (12%)
Query: 334 TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFAPK 392
T VA++ + + + + ++ + + ++ + +H+NII L G C G ++I ++A K
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASK 108
Query: 393 GKLSKYL------------DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 440
G L +YL + + L + VS +A+G+ YL S + +H
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC-----IH 163
Query: 441 RNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAA---MGYLAPEYVTTGRF 495
R+L+ VL+ + IAD GL A DI + KT+ + ++APE + +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGL----ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219
Query: 496 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 555
T +SD+++FGV++ +I T L S + + + +L M
Sbjct: 220 THQSDVWSFGVLLWEIFT----LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMM 275
Query: 556 LVCTHEDPENRPTMEAVIEEL 576
C H P RPT + ++E+L
Sbjct: 276 RDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 45/210 (21%), Positives = 95/210 (45%), Gaps = 9/210 (4%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 368
+ + +GKG+F +V K DG ++ + I+ + +E + V + +L L+H NI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+R R +++ ++ G L++ + + + ++ I+ + +
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 485
H+ ++HR+L + +D N + D GL K+L D F +G Y+
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF----AKTYVGTPYYM 177
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILTGS 515
+PE + + E+SDI++ G +I ++ S
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 63/282 (22%), Positives = 131/282 (46%), Gaps = 46/282 (16%)
Query: 310 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTS 362
CF V ++GKG++ V +L DG I+ +N+ + E AE + LL+
Sbjct: 3 CF--VRVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQ 55
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSII 418
L+H NI+ R G +++ F G L L +++G + V++W
Sbjct: 56 LKHPNIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------F 108
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVL 476
+ IA + YLH I+HR+L + V + + + D G+ ++L + D+ +++
Sbjct: 109 VQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
Query: 477 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536
T Y++PE + + +SD++A G + ++ T ++ A + + +
Sbjct: 164 GTPY---YMSPELFSNKPYNYKSDVWALGCCVYEMAT--------LKHAFNAKDMNSLVY 212
Query: 537 RNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575
R ++GK + + +LG++ + PE RP++++++ +
Sbjct: 213 RIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 317 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F V+ +D LVA++++ S + +F + LLT+L+HE+I++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVK 71
Query: 371 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYLDQ---------EEGSSNVLDWSTRVSIIIG 420
G C G+ +++++ G L+K+L E L S + I
Sbjct: 72 FYGVCV---EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTS 479
IA G+ YL S VHR+L+ L+ + I D G+ + + + V T
Sbjct: 129 IAAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 480 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ ++ PE + +FT SD+++ GV++ +I T
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-----FVKGLYLLTSLRHENII 369
+LL +G F ++ G L D + V + K +E ++ LL L H+NI+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTR--VSIIIGIAK 423
+ C F++Y + G L +L Q E + L ST+ V + I IA
Sbjct: 72 PILH-VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIAC 128
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVL--KTSA 480
G+ YLH V +H++++ +ID++ I D L + L D + L +
Sbjct: 129 GMSYLHKRGV-----IHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNENR 181
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ ++A E + ++ SD+++FGV++ +++T
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 34/88 (38%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L + N L G I ++ + SL +L+L N+ GG+PDS G+ +L+ LDLS N G +
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSAL 132
P L + +EL+ L + N LSG +P L
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDEL 519
|
Length = 968 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 52/216 (24%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH---E 366
+ + L+G+G + +VY+G + G +VA++ IN+ + + ++ + + LL+ LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGK---LSKYLDQEEGSSNVLDWSTRVSIIIGIAK 423
NI + G +G ++I ++A G L K E +V II +
Sbjct: 63 NITKYYG-SYLKGP-RLWIIMEYAEGGSVRTLMKAGPIAEKYISV--------IIREVLV 112
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 483
+ Y+H ++HR++ +L+ N + D G+ LL + K S +G
Sbjct: 113 ALKYIHKV-----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----NSSKRSTFVG 163
Query: 484 ---YLAPEYVTTGR-FTERSDIFAFGVIILQILTGS 515
++APE +T G+ + ++DI++ G+ I ++ TG+
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHEN 367
F + ++GKG F V RD + A++ +N C K + +L L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 368 IIRLR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGI 425
++ L F +L+ D G L +L Q+ S +V I I +
Sbjct: 62 LVNLWYSFQ---DEENMYLVVDLLLGGDLRYHLSQKVKFS-----EEQVKFWICEIVLAL 113
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 485
YLHS I+HR++ + +L+D+Q + I D + + D + TS GY+
Sbjct: 114 EYLHSK-----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYM 166
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILTG 514
APE + ++ D ++ GV + L G
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 65/273 (23%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENI 368
+ ++ ++G+G F V+ + D LV I+ I V K E +L L H NI
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 369 IR-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I F + ++ ++AP G L++Y+ + S +LD T + + I + +
Sbjct: 62 IEYYENFLEDKALM---IVMEYAPGGTLAEYIQKRCNS--LLDEDTILHFFVQILLALHH 116
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG--- 483
+H+ I+HR+L + +L+D+ + I D G+ K+L+ S K +G
Sbjct: 117 VHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKILS-----SKSKAYTVVGTPC 166
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
Y++PE + ++SDI+A G ++ ++ S++ A E+A + + + G F
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELA--------SLKRAFEAANLPALVLKIMSGTF 218
Query: 544 ---SESEAAKLGKMALVCTHEDPENRPTMEAVI 573
S+ + L ++ L + DP RP + ++
Sbjct: 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 40/97 (41%), Positives = 50/97 (51%)
Query: 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98
+ L L N L+G IP IGS SL VL L N L G IP+SL NL L+ L L+ N
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198
Query: 99 SLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
L G IP L L ++ + N LSG +P + L
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
|
Length = 968 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 22/261 (8%)
Query: 317 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 369
LG G F V + T D + VA++ + T+ SE + L +++ L HENI+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
L G C+ G G +I ++ G L +L ++ S L +S +AKG+ +L
Sbjct: 103 NLLG-ACTIG-GPILVITEYCCYGDLLNFLRRKRES--FLTLEDLLSFSYQVAKGMAFLA 158
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAP 487
S +HR+L+ VL+ I D GL + + +D + V+K +A + ++AP
Sbjct: 159 SKNC-----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAP 212
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
E + +T SD++++G+++ +I SL + +S F I + E
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIF--SLGSNPYPGMPVDS-KFYKLIKEGYRMAQPEHA 269
Query: 548 AAKLGKMALVCTHEDPENRPT 568
A++ + C DP RPT
Sbjct: 270 PAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 40/91 (43%), Positives = 51/91 (56%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L NQ +G +P ++GSL L L L N+L+G IPD L + KL LDLS N L G I
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
P S + L LD+ N LSG +P L +
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
|
Length = 968 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 60/266 (22%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 317 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRLRG 373
+G+G FS VY+ T L DG VA++ + + +A + +K + LL L H N+I+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
E ++ + A G LS+ + + ++ T + + + ++HS
Sbjct: 70 SFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLAP 487
++HR++ V I + D GL + + KT+AA Y++P
Sbjct: 127 ----VMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMSP 175
Query: 488 EYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546
E + + +SDI++ G ++ ++ S M L + E L S+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP---SDH 232
Query: 547 EAAKLGKMALVCTHEDPENRPTMEAV 572
+ +L ++ +C + DPE RP + V
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 43/285 (15%)
Query: 317 LGKGNFSSVYKGTLRDGTLVA---IRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+G G F V G G A ++ + ++ E+ F++ + L H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSE 432
C L+ +F P G L YL G + + + +A G+ +LH
Sbjct: 63 QCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYVT 491
+ +H +L++ + + I D GL + +D + + + +LAPE V
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 492 -------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
T++S+I++ GV + ++ T A + + D + +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT------------AADQPYPDLSDEQVLKQVV 223
Query: 545 ESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 577
+ KL K L + D PE RPT E V E LT
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 53/281 (18%)
Query: 317 LGKGNFSSVYKGT-LRDGTLVAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIR-LR 372
+GKG FS VYK L DG +VA++ + + + +K + LL L H N+I+ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
F E ++ + A G LS+ + + ++ T + + + ++HS
Sbjct: 70 SFI---ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLA 486
I+HR++ V I + D GL + + KT+AA Y++
Sbjct: 127 -----IMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMS 174
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NL------ 539
PE + + +SDI++ G ++ + +AA + F D+ NL
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYE-------------MAALQSPFYG--DKMNLYSLCKK 219
Query: 540 --KGKF----SESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
K + ++ + +L + C + DPE RP + V++
Sbjct: 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 43/209 (20%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 310 CFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
E++ LG+G SV K L++ G + A+++I + + ++ L + S + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS------IIIGIA 422
++ G + ++ G L V R+ I +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVL 115
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
KG+ YLHS + I+HR++ +L+ ++ + D G+ L + + + TS
Sbjct: 116 KGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-- 168
Query: 483 GYLAPEYVTTGRFTERSDIFAFGVIILQI 511
Y+APE + ++ SD+++ G+ +L++
Sbjct: 169 -YMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 35/88 (39%), Positives = 54/88 (61%), Gaps = 1/88 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+L L N+ G +P GS K L L L N+ +G +P LG+L +L +L LS N L G
Sbjct: 456 MLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSA 131
IP+ L++ +L+ LD+ +N LSG +P++
Sbjct: 515 IPDELSSCKKLVSLDLSHNQLSGQIPAS 542
|
Length = 968 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 311 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEE----AEFVKGLYLLTSLRH 365
++++ +G+G + VYKG + G +VA++ I + +SEE + ++ + LL L+H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQH 58
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
NI+ L+ R +LI++F L KYLD +D S + I +GI
Sbjct: 59 PNIVCLQDVLMQESR--LYLIFEFLSM-DLKKYLDSL-PKGQYMDAELVKSYLYQILQGI 114
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGY 484
+ HS V +HR+L + +LID + +AD GL + A I V + Y
Sbjct: 115 LFCHSRRV-----LHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 485 LAPEYVTTG--RFTERSDIFAFGVIILQILT 513
APE V G R++ DI++ G I ++ T
Sbjct: 168 RAPE-VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 39/91 (42%), Positives = 52/91 (57%), Gaps = 2/91 (2%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L N TG+IP GS+ +L L L +N L+G IP+ +G+ LK LDL N L G I
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
P SL N L FL + +N L G +P L ++
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
|
Length = 968 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 33/291 (11%)
Query: 317 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 367
LG+G F V K VA++ + + + ++ V + ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 415
II L G C++ G +++ ++A KG L +YL D + L + V
Sbjct: 80 IINLLG-ACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 474
S +A+G+ YL S + +HR+L+ VL+ + IAD GL + + + D
Sbjct: 138 SCAYQVARGMEYLASQKC-----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 475 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534
+ ++APE + +T +SD+++FGV++ +I T L S
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----LGGSPYPGIPVEELFKL 248
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT 585
+ + + +L + C H P RPT + ++E+L V +T
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 367
+ +G G F V+ R A++ + + + ++ + V +L + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
IIRL F + +++ ++ P G+L YL SN ST + I + Y
Sbjct: 63 IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN----STGLFYASEIVCALEY 116
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
LHS E IV+R+L E +L+D++ + + D G K L D +T G Y
Sbjct: 117 LHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------RTWTLCGTPEY 164
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTG 514
LAPE + + + D +A G++I ++L G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 305 ESATQCFSEVNLLGKGNFSSVYKGTL--RDGTL----VAIRSINVTSCKSEEAEFVKGLY 358
E + + LG G F VY+G RDG VA++++ + + +E++F+
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRV 415
+++ H+NI+RL G R F++ + G L +L + + L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP----LIADCGLHKLLADDI 471
+AKG YL + +HR+++ L+ + P IAD G +A DI
Sbjct: 120 FCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCK-GPGRVAKIADFG----MARDI 169
Query: 472 VFS--VLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ K AM ++ PE G FT ++D+++FGV++ +I +
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 60/271 (22%), Positives = 124/271 (45%), Gaps = 27/271 (9%)
Query: 309 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ F+++ +GKG+F V+KG R +VAI+ I++ + E + + + +L+
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 368 IIRLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
+ + G S +G + ++I ++ G L + D +++ I KG+
Sbjct: 64 VTKYYG---SYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLD 115
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
YLHS + +HR++ VL+ +Q + +AD G+ L D + +K + +G
Sbjct: 116 YLHSEKK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPF 166
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
++APE + + ++DI++ G+ +++ G S M L G+F
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEF 225
Query: 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
S+ + C ++DP RPT + +++
Sbjct: 226 SKP----FKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA-------EFVKGLYLLTS 362
+ E+ +G+G + +VYK L G VA++ + V SEE E + L L S
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTLRE-IALLKQLES 57
Query: 363 LRHENIIRLRGFC--CSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 419
H NI+RL C R + L+++ + L+ YL + L T ++
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKDLMR 114
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT 478
+ +G+ +LHS IVHR+L + +L+ IAD GL ++ + ++ SV+ T
Sbjct: 115 QLLRGVDFLHSH-----RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169
Query: 479 SAAMGYLAPE------YVTTGRFTERSDIFAFGVII 508
+ Y APE Y T D+++ G I
Sbjct: 170 ---LWYRAPEVLLQSSYATP------VDMWSVGCIF 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 314 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHEN 367
+ ++G+G + V K + G +VAI+ +SE+ E VK L L LRHEN
Sbjct: 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFK----ESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I+ L+ +GR +L++++ + L+ E S L S I + + I Y
Sbjct: 62 IVNLKEAFRRKGR--LYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
HS I+HR++ E +L+ + + D G + L + A Y AP
Sbjct: 116 CHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 488 E-YVTTGRFTERSDIFAFGVIILQILTG 514
E V + + D++A G I+ ++L G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 48/217 (22%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ F + LG+G++ SVYK ++ G +VAI+ + V + E +K + +L
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPY 59
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLS-------KYLDQEEGSSNVLDWSTRVSIIIG 420
I++ G + +++ ++ G +S K L +EE + +I+
Sbjct: 60 IVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA----------AILYQ 107
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
KG+ YLHS++ +HR++ +L++++ +AD G+ L D ++ K +
Sbjct: 108 TLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----TMAKRNT 158
Query: 481 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
+G ++APE + + ++DI++ G+ +++ G
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 39/217 (17%)
Query: 317 LGKGNFSSVY---KGTLRDGTLVAIRSIN---------VTSCKSEEAEFVKGLYLLTSLR 364
+ KG + V+ K + D + AI+ I V +E +L+ +
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERD-------ILSQAQ 51
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
+++L + +G+ +L+ ++ P G L+ L+ LD I I
Sbjct: 52 SPYVVKL--YYSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLA 105
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-------LLADDIVFSVLK 477
+ YLHS+ I+HR+L + +LID + + D GL K + +D +
Sbjct: 106 LEYLHSN-----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 478 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
Y+APE + ++ D ++ G I+ + L G
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 62/271 (22%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ F+++ +GKG+F VYKG R +VAI+ I++ + E + + + +L+
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 368 IIRLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
I R G S +G + ++I ++ G L L+ + +I+ I KG+
Sbjct: 64 ITRYYG---SYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
YLHS +HR++ VL+ +Q + +AD G+ L D + +K + +G
Sbjct: 116 YLHSERK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPF 166
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
++APE + + ++DI++ G+ +++ G + L F I +N
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGE---PPNSDLHPMRVLF--LIPKNSPPTL 221
Query: 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ + C ++DP RPT + +++
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 370
LLG+G F VY D G +A++ + E + V L LL +L+HE I++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLH 429
G C R + ++ P G + L + V TR I +G+ YLH
Sbjct: 69 YYG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH 121
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 486
S+ IVHR++ +L D N + D G K L I S + G +++
Sbjct: 122 SNM-----IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMS 175
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILT 513
PE ++ + ++D+++ G ++++LT
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 316 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 370
+LGKG + VY L +AI+ I ++ +V+ L+ L + L+H NI++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 371 LRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKGI 425
G S F I+ + P G LS L + G + + + T+ I +G+
Sbjct: 70 YLG-SDS--ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGL 121
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKT-SAAMG 483
YLH ++ IVHR++ + VL++ + I+D G K LA + +T + +
Sbjct: 122 KYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQ 174
Query: 484 YLAPEYVTTGR--FTERSDIFAFGVIILQILTG 514
Y+APE + G + +DI++ G I+++ TG
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 62/274 (22%), Positives = 126/274 (45%), Gaps = 33/274 (12%)
Query: 309 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ F+++ +GKG+F V+KG R +VAI+ I++ + E + + + +L+
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
+ + G + ++I ++ G L E G LD + +I+ I KG+ Y
Sbjct: 64 VTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--EPGP---LDETQIATILREILKGLDY 116
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
LHS + +HR++ VL+ + +AD G+ L D + +K + +G +
Sbjct: 117 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFW 167
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 540
+APE + + ++DI++ G+ +++ G L F I +N L+
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGE---PPHSELHPMKVLF--LIPKNNPPTLE 222
Query: 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
G +S+ L + C +++P RPT + +++
Sbjct: 223 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 62/292 (21%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL-----YLLTSLRHENII 369
L+G+G++ V K ++ G +VAI+ +SE+ + VK + +L LRHEN++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
L R + +L+++F LD E N LD S + I +GI + H
Sbjct: 64 NLIEVF--RRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA------DDIVFSVLKTSAAMG 483
S I+HR++ E +L+ Q + D G + LA D V A
Sbjct: 118 SHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-------ATRW 165
Query: 484 YLAPEY-VTTGRFTERSDIFAFGVIILQILTGSLVLTSS----------MRLAAESATFE 532
Y APE V ++ DI+A G ++ ++LTG + L +
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225
Query: 533 NFIDRN----------------LKGKFSESEAAKLGKMALVCTHEDPENRPT 568
+N L+ +F + L C DP++RP+
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ-CLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 33/88 (37%), Positives = 48/88 (54%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L N L+G IP + L++L +L L N G IP +L +L +L+ L L N G I
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSAL 132
P++L + L LD+ N L+G +P L
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
|
Length = 968 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 29/269 (10%)
Query: 317 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR-LR 372
+G+G FS VY+ T L D VA++ + + +A + VK + LL L H N+I+ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
F E ++ + A G LS+ + + ++ T + + + ++HS
Sbjct: 70 SFIED---NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLA 486
V +HR++ V I + D GL + + KT+AA Y++
Sbjct: 127 V-----MHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMS 174
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545
PE + + +SDI++ G ++ ++ S M L + E L E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT---E 231
Query: 546 SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ KL ++ +C + DP+ RP + V +
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 56/278 (20%), Positives = 130/278 (46%), Gaps = 39/278 (14%)
Query: 311 FSEVNLLGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENI 368
+ +V +G+G+F ++ + DG I+ IN++ +E E K + +L++++H NI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 369 IRLR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAK 423
++ + F G +++ D+ G L K ++ + G +LDW + I
Sbjct: 62 VQYQESF---EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICL 112
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 483
+ ++H + I+HR++ + + + + + D G+ ++L +V +G
Sbjct: 113 ALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----TVELARTCIG 163
Query: 484 ---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540
YL+PE + +SDI+A G ++ ++ T ++ A E+ +N + + ++
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT--------LKHAFEAGNMKNLVLKIIR 215
Query: 541 GKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575
G + S + L + +P +RP++ +++E+
Sbjct: 216 GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 23/206 (11%)
Query: 317 LGKGNFSSVYKG-TLRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
+G+G + VYK G +VAI+ I + K+ E LL L H NII+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNIIK 62
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L R +G+ +L+++F L K + L S S + + +G+ + HS
Sbjct: 63 LLDVF--RHKGDLYLVFEFM-DTDLYKLIK---DRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE-Y 489
I+HR+L E +LI+ + +AD GL + + Y APE
Sbjct: 117 H-----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELL 170
Query: 490 VTTGRFTERSDIFAFGVIILQILTGS 515
+ ++ DI++ G I ++L+
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 370
LLG+G F VY D G +A + + E ++ V L LL +L+HE I++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 371 LRGFCCSRGRGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
G C R R E L ++ P G + DQ + + + TR I +G+ YL
Sbjct: 69 YYG--CLRDRAEKTLTIFMEYMPGGSVK---DQLKAYGALTESVTR-KYTRQILEGMSYL 122
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 485
HS+ IVHR++ +L D N + D G K L I S + G ++
Sbjct: 123 HSN-----MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWM 176
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILT 513
+PE ++ + ++D+++ G ++++LT
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 57/266 (21%), Positives = 109/266 (40%), Gaps = 33/266 (12%)
Query: 317 LGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG GN SV K + GT++A + +++ + S + ++ L ++ R I+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG-- 70
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
+ +F G L + ++ G +L I + + +G+ YL+
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILG-----KIAVAVVEGLTYLY---- 120
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 493
N I+HR++ +L++ + + D G+ L + I + + TS Y++PE + G
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST---YMSPERIQGG 177
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-----------RNLKGK 542
++T +SD+++ G+ I+++ G S +D R
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 543 FSESEAAKLGKMALVCTHEDPENRPT 568
F E L C +DP RPT
Sbjct: 238 FPED----LRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 311 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 368
F +V +G+G + VYK G +VA++ I + T + + ++ + LL L H NI
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
++L + + +L+++F + L K++D S + S + + +G+ +
Sbjct: 62 VKLLDVIHTENK--LYLVFEFLHQ-DLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFC 116
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV-LKT----SAAMG 483
HS V +HR+L + +LI+ + +AD GL + F V ++T +
Sbjct: 117 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLW 165
Query: 484 YLAPEYVTTGRF-TERSDIFAFGVIILQILT 513
Y APE + ++ + DI++ G I +++T
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 311 FSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSIN---------VTSCKSEEAEFVKGL 357
F + +LG+G+F V YK T G L AI+++ V S E+ F
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFE--- 54
Query: 358 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 417
S RH ++ L F C + + ++A G L ++ + V V
Sbjct: 55 -TANSERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFY 106
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
+ G+ YLH NK IV+R+L ++ +L+D + IAD GL K + + F +
Sbjct: 107 AACVVLGLQYLHE---NK--IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGD-R 157
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
TS G +LAPE +T +T D + GV+I ++L G
Sbjct: 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 50/275 (18%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
F+ + +GKG+F VYK R +VAI+ I++ + E + + + L+ R I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 370 RLRGFCCSRGRGECFL-------IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
+ G FL I ++ G L LD + I+ +
Sbjct: 63 KYYG---------SFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVL 108
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
G+ YLH K +HR++ +L+ ++ + +AD G ++ + ++ K + +
Sbjct: 109 LGLEYLHEE--GK---IHRDIKAANILLSEEGDVKLADFG----VSGQLTSTMSKRNTFV 159
Query: 483 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS--SMRLAAESATFE---NF 534
G ++APE + + E++DI++ G+ +++ G L+ MR F N
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLIPKNN 214
Query: 535 IDRNLKGKFSESEAAKLGKMAL-VCTHEDPENRPT 568
KFS K K + +C ++DP+ RP+
Sbjct: 215 PPSLEGNKFS-----KPFKDFVSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 42/281 (14%)
Query: 316 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSC-----KSEEAEFVKGLY----LLTSLRH 365
L+GKG + VY + G ++A++ + + + S + + VK L L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGK----LSKYLDQEEGSSNVLDWSTRVSIIIGI 421
NI++ GF + FL Y P G L Y EE +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEY--VPGGSIGSCLRTYGRFEE--------QLVRFFTEQV 117
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-- 479
+G+ YLHS I+HR+L + +L+D I+D G+ K +DDI + S
Sbjct: 118 LEGLAYLHSK-----GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQ 171
Query: 480 AAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537
++ ++APE + + ++ + DI++ G ++L++ G + A +A F+ R
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAIAAMFKLGNKR 228
Query: 538 NLKGKFSESEAAKLGKMAL----VCTHEDPENRPTMEAVIE 574
+ + L +AL C +P+NRPT +++
Sbjct: 229 S-APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 69/293 (23%), Positives = 131/293 (44%), Gaps = 37/293 (12%)
Query: 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL 357
++L + F V ++G G + VYKG ++ G L AI+ ++VT + EE E +
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEI 63
Query: 358 YLLTSL-RHENIIRLRG-FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 412
+L H NI G F G + +L+ +F G ++ + +G++ DW
Sbjct: 64 NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI 123
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472
+ I +G+ +LH+ +V +HR++ + VL+ + + D G+ L
Sbjct: 124 AYIC--REILRGLAHLHAHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--- 173
Query: 473 FSVLKTSAAMG---YLAPEYVTT-----GRFTERSDIFAFGVIILQILTGS--LVLTSSM 522
+V + + +G ++APE + + RSDI++ G+ +++ G+ L M
Sbjct: 174 -TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
Query: 523 RLAAESATFENFIDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
R A F I RN K S+ + K C ++ +RP+ E +++
Sbjct: 233 R-----ALF--LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 66/271 (24%), Positives = 115/271 (42%), Gaps = 38/271 (14%)
Query: 316 LLGKGNFSSVYKGTLRDG--TLVAIRSINVTS-----CKSEEAEFVKGL-----YLLTSL 363
LG G F VYK ++ L+A++ INV + K E + + + + L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 364 RHENIIRLRGFCCSRGRGECFLIYDF---APKGKLSKYLDQEEGS-SNVLDWSTRVSIII 419
RH NI+R R +++ D AP G+ L +++ + W+ I +
Sbjct: 67 RHPNIVRYYKTFLENDR--LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFV 120
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 479
+ + YLH + IVHR+L+ +++ + I D GL K + K +
Sbjct: 121 QMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-----SKLT 171
Query: 480 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536
+ +G Y PE V + E++D++AFG I+ Q+ T S+ L+ + E +
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231
Query: 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRP 567
+G +SE + + C D E RP
Sbjct: 232 PLPEGMYSE----DVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 61/303 (20%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGL---YLLTSLR 364
F ++N +G+G + VY+ RD G +VA++ + + + + L LL +LR
Sbjct: 9 FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMD--NERDGIPISSLREITLLLNLR 64
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------SI 417
H NI+ L+ + FL+ + Y +Q+ S +LD +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVME---------YCEQDLAS--LLDNMPTPFSESQVKCL 113
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
++ + +G+ YLH + I+HR+L V +L+ + IAD GL + +
Sbjct: 114 MLQLLRGLQYLHEN-----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-LPAKPMTP 167
Query: 478 TSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---------- 526
+ Y APE + +T D++A G I+ ++L +L +
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227
Query: 527 -ESATFENFID--------------RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 571
+ + F D NLK KF A L + + + DP+ R T E
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY-DPKKRATAEE 286
Query: 572 VIE 574
+E
Sbjct: 287 ALE 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 315 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 372
N +G G F VY L G L+A++ I + + + + + +L L+H N+++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 373 GFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G R E I+ ++ G L + L E G +LD + + +G+ YLHS
Sbjct: 66 GVEVHR---EKVYIFMEYCSGGTLEELL--EHG--RILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLAD--DIVFSVLKTSA--AMGYL 485
IVHR++ + +D N +I D G L + + +++ A Y+
Sbjct: 119 -----GIVHRDIKPANIFLD--HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA-YM 170
Query: 486 APEYVTTGRFTER---SDIFAFGVIILQILTGS 515
APE +T G+ +DI++ G ++L++ TG
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 17/157 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHE 366
+ ++ LG+G + VYK + G +VA++ I + EE + ++ + LL L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHP 58
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
NI++L + + +L++++ L KYLD+ G L + SI+ + +G+
Sbjct: 59 NIVKLLDVIHTERK--LYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLA 112
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
Y HS ++ I+HR+L + +LI++ +AD GL
Sbjct: 113 YCHS---HR--ILHRDLKPQNILINRDGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 311 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLR 364
+ +V +G+G + VYK G +VA++ I + + E E V + + LL L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET----EDEGVPSTAIREISLLKELN 56
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
H NI+RL S + +L+++F L KY+D LD S + + +G
Sbjct: 57 HPNIVRLLDVVHSENK--LYLVFEFLDL-DLKKYMDSS--PLTGLDPPLIKSYLYQLLQG 111
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
I Y HS ++HR+L + +LID++ +AD GL
Sbjct: 112 IAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 33/87 (37%), Positives = 47/87 (54%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N+L+G IP I SL+ L L L N L+G IP+ + L L+ L L N+ G IP +L
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRLN 136
+ L L + +N SG +P L + N
Sbjct: 330 SLPRLQVLQLWSNKFSGEIPKNLGKHN 356
|
Length = 968 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 65/281 (23%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENI 368
F V L+G G + VYKG ++ G L AI+ ++VT EE E + + +L H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65
Query: 369 IRLRGFCCSRG----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
G + + +L+ +F G ++ + +G++ +W I I +G
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRG 123
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 483
+ +LH +V +HR++ + VL+ + + D G+ L +V + + +G
Sbjct: 124 LSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR----TVGRRNTFIGT 174
Query: 484 --YLAPEYVTT-----GRFTERSDIFAFGVIILQILTGS--LVLTSSMRLAAESATFENF 534
++APE + + +SD+++ G+ +++ G+ L MR A F
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF--L 227
Query: 535 IDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
I RN + S+ + K C ++ RPT E +++
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 61/296 (20%), Positives = 122/296 (41%), Gaps = 58/296 (19%)
Query: 305 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLT 361
E + F+++ +G G+F +VY +R +VAI+ ++ + +S E + +K + L
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 362 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 421
++H N I +G C +L+ ++ L D E L +I G
Sbjct: 81 RIKHPNSIEYKG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAITHGA 134
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 481
+G+ YLHS ++HR++ +L+ + +AD G + + F
Sbjct: 135 LQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GT 184
Query: 482 MGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-------ESAT- 530
++APE + G++ + D+++ G+ +++ L + ++A ES T
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244
Query: 531 --------FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578
F NF+D C + P++RPT E +++ + V
Sbjct: 245 QSNEWSDYFRNFVDS--------------------CLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 73/306 (23%), Positives = 119/306 (38%), Gaps = 69/306 (22%)
Query: 306 SATQCFSE---VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLT 361
SA + SE VN +G G +VYK R G L A++ I + + + + +L
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127
Query: 362 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLS-KYLDQEEGSSNVLDWSTRVSIIIG 420
+ H N+++ GE ++ +F G L ++ E+ ++V R
Sbjct: 128 DVNHPNVVKCHDM--FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV----AR-----Q 176
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKT 478
I GI YLH IVHR++ +LI+ N IAD G+ ++LA D S + T
Sbjct: 177 ILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGT 231
Query: 479 SAAMGYLAPEYVTT----GRFTERS-DIFAFGVIILQILTG-------------SLVLTS 520
A Y++PE + T G + + DI++ GV IL+ G SL+
Sbjct: 232 IA---YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI 288
Query: 521 SMRLAAE-----SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575
M E S F +FI C +P R + +++
Sbjct: 289 CMSQPPEAPATASREFRHFISC--------------------CLQREPAKRWSAMQLLQH 328
Query: 576 LTVAAP 581
+
Sbjct: 329 PFILRA 334
|
Length = 353 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 316 LLGKGNFSSVY---KGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY-LLTSLRHENIIR 370
+LG+G+F V+ K T D G L A++ + + K + K +L + H I++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 371 LR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYL 428
L F + G+ +LI DF G L L +E V+ V + +A + +L
Sbjct: 63 LHYAF---QTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHL 114
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAAMGYLA 486
HS I++R+L E +L+D++ + + D GL K D +S T + Y+A
Sbjct: 115 HSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---VEYMA 166
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSL 516
PE V T+ +D ++FGV++ ++LTGSL
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 370
LLG+G F VY D G +A++ + E ++ V L LL +L HE I++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLH 429
G + + P G + L + NV TR I +G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILEGVSYLH 123
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 486
S+ IVHR++ +L D N + D G K L I S + G +++
Sbjct: 124 SN-----MIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMS 177
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILT 513
PE ++ + ++DI++ G ++++LT
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 53/235 (22%), Positives = 108/235 (45%), Gaps = 24/235 (10%)
Query: 293 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA 351
NS L LE + T + + +GKG + VYK T +DG+L A++ ++ S EE
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI 65
Query: 352 EFVKGLYLLTSL-RHENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSN 407
E +L SL H N+++ G + G+ +L+ + G +++ +
Sbjct: 66 E--AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 408 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467
LD + I+ G G+ +LH++ I+HR++ +L+ + + D G+ L
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
Query: 468 ADDIVFSVLKTSAAMG---YLAPEYVTTGR-----FTERSDIFAFGVIILQILTG 514
+ L+ + ++G ++APE + + + R D+++ G+ +++ G
Sbjct: 179 TS----TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 23/182 (12%)
Query: 349 EEAEFVKGLYLLTSLRHENIIRL--RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 406
+ A F + L L H NI+ L G G F ++++ P L + L +G
Sbjct: 21 QRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFEYVPGRTLREVL-AADG-- 74
Query: 407 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL 463
L +++ + + H+ IVHR+L + +++ + + + D G+
Sbjct: 75 -ALPAGETGRLMLQVLDALACAHNQ-----GIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 464 HKLLA---DDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 517
LL D V ++ +T+ +G Y APE + T SD++A+G+I L+ LTG V
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188
Query: 518 LT 519
+
Sbjct: 189 VQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 42/221 (19%)
Query: 317 LGKGNFSSVYKGTLRDG------TLVAIRS--INVTSCKSEEAEFVKGLYLLTSLRHENI 368
+G+G + VYK +DG L I I++++C+ + LL L+H N+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE--------IALLRELKHPNV 60
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDW--STRVSIIIGIAKG 424
I L+ S + +L++D+A + K+ + + + S S++ I G
Sbjct: 61 IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
I YLH++ V +HR+L +L+ ++ IAD G +L S LK A
Sbjct: 121 IHYLHANWV-----LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLA 170
Query: 481 AMG-------YLAPEYVTTGR-FTERSDIFAFGVIILQILT 513
+ Y APE + R +T+ DI+A G I ++LT
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 46/213 (21%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 368
+ + +G+G+F +Y + D I+ I++T +E E K + LL ++H NI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKG 424
+ F + G F++ ++ G L K ++++ G +L W ++S+ G
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------G 113
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA---DCGLHKLLADDIVFSVLKTSAA 481
+ ++H + I+HR++ + + + + N ++A D G+ + L D + + T
Sbjct: 114 LKHIHDRK-----ILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELA--YTCVG 164
Query: 482 MGY-LAPEYVTTGRFTERSDIFAFGVIILQILT 513
Y L+PE + ++DI++ G ++ ++ T
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 42/221 (19%)
Query: 317 LGKGNFSSVYKGTLRDG------TLVAIRS--INVTSCKSEEAEFVKGLYLLTSLRHENI 368
+G+G + VYK +DG L I I++++C+ + LL L+H N+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE--------IALLRELKHPNV 60
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRV--SIIIGIAKG 424
I L+ S + +L++D+A + K+ + + + + S++ I G
Sbjct: 61 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
I YLH++ V +HR+L +L+ ++ IAD G +L S LK A
Sbjct: 121 IHYLHANWV-----LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLA 170
Query: 481 AMG-------YLAPEYVTTGR-FTERSDIFAFGVIILQILT 513
+ Y APE + R +T+ DI+A G I ++LT
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 311 FSEVNLLGKGNFSSVYKG---TLRDGTLVAIRSINVTSCKSEEAEF-------VKGLYLL 360
+ +G+G + VYK +DG AI+ K ++ ++ + + LL
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALL 56
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPK--GKLSKYLDQEEGSSNVLDWSTRVSII 418
L+HEN++ L +L++D+A ++ K+ Q + S + S S++
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVS--IPPSMVKSLL 114
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIV-- 472
I G+ YLHS+ ++HR+L +L+ ++ I D GL +L +
Sbjct: 115 WQILNGVHYLHSN-----WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 473 FSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILT 513
+ + Y APE + R +T+ DI+A G I ++LT
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 43/279 (15%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINV------TSCKSEEAEFVKGLYLLTSLRHENII 369
LG+G F+ ++KG R+ G + V S ++ F + +++ L H++++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY-L 428
G C E ++ ++ G L YL + + N+ W V AK + + L
Sbjct: 63 LNYGVCV--CGDESIMVQEYVKFGSLDTYLKKNKNLINIS-WKLEV------AKQLAWAL 113
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS---AAMGYL 485
H E + H N+ + VL+ ++ + + KL I +VL + ++
Sbjct: 114 HFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 486 APEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
PE + + + +D ++FG + +I +G L+A +D K +F
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSA--------LDSQKKLQFY 218
Query: 545 ESE----AAKLGKMALV---CTHEDPENRPTMEAVIEEL 576
E A K ++A + C +P+ RP+ A+I +L
Sbjct: 219 EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEA------EFVKGLY 358
Q + V +G+G + V+K RD G VA++ + V + EE V L
Sbjct: 1 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLR 56
Query: 359 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 414
L + H N++RL C SR E L F + L+ YLD+ E G T
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 112
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
++ + +G+ +LHS V VHR+L + +L+ +AD GL ++ + + +
Sbjct: 113 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 167
Query: 475 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 512
+ + + Y APE + + D+++ G I ++
Sbjct: 168 SVVVT--LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 24/159 (15%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY--------LLTSLR 364
LG+G ++ VYK G +VAI+ I + E E G+ LL L+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELK 60
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
H NII L + L+++F L K + S VL + S ++ +G
Sbjct: 61 HPNIIGLLDVFGHKSN--INLVFEFME-TDLEKVIKD---KSIVLTPADIKSYMLMTLRG 114
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ YLHS+ I+HR+L +LI +AD GL
Sbjct: 115 LEYLHSN-----WILHRDLKPNNLLIASDGVLKLADFGL 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 47/209 (22%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ + +++ LG+G +++VYKG + LVA++ I + + ++ + LL L+H N
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I+ L + L++++ K L +YLD N ++ + + +G+ Y
Sbjct: 66 IVTLHDIIHT--EKSLTLVFEYLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNY 119
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
H +V +HR+L + +LI+++ +AD GL + A I + P
Sbjct: 120 CHRRKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRP 172
Query: 488 EYVTTGR--FTERSDIFAFGVIILQILTG 514
+ G ++ + D++ G I ++ TG
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+A+G+ +L S + +HR+L+ +L+ + I D GL + + D + V K SA
Sbjct: 183 VARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSA 236
Query: 481 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538
+ ++APE + +T +SD+++FGV++ +I + L +S + E F R
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQ--INEEFCQRL 290
Query: 539 LKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
G + E+ ++ ++ L C DP+ RPT A++E L
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 15/194 (7%)
Query: 389 FAPKGKLSKYLDQEEGSS----NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 444
F + LS ++E VL + +AKG+ +L S + +HR+L+
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC-----IHRDLA 206
Query: 445 VEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYVTTGRFTERSDIF 502
+L+ + I D GL + + D + V K A + ++APE + +T +SD++
Sbjct: 207 ARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVW 265
Query: 503 AFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHED 562
+FGV++ +I + +++ E F + + + + ++ + L C H +
Sbjct: 266 SFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322
Query: 563 PENRPTMEAVIEEL 576
P RPT ++E L
Sbjct: 323 PSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSLR 364
F + ++G+G + V K ++ +VAI+ SEE E VK L +L +L+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLK 58
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
ENI+ L+ R RG+ +L++++ K L EE + V R S I + K
Sbjct: 59 QENIVELKE--AFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKA 112
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 484
I + H ++ IVHR++ E +LI + D G + L++ + + A Y
Sbjct: 113 IHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTG 514
+PE + + + D+++ G I+ ++ G
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 370
LLG+G F VY D G +A++ + E ++ V L LL +LRH+ I++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 371 LRGFCCSRGRGECFL--IYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGY 427
G C R E L ++ P G + L + NV TR I +G+ Y
Sbjct: 69 YYG--CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QILQGVSY 121
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
LHS+ IVHR++ +L D N + D G K + I S + G +
Sbjct: 122 LHSN-----MIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYW 175
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILT 513
++PE ++ + ++D+++ ++++LT
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 46/196 (23%), Positives = 89/196 (45%), Gaps = 18/196 (9%)
Query: 387 YDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 444
Y + ++ L D EG + LD +S +A+G+ +L S VHR+L+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLT-TLDL---LSFTYQVARGMEFLASKNC-----VHRDLA 264
Query: 445 VEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFA 503
VL+ Q I D GL + ++ D S T + ++APE + +T SD+++
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324
Query: 504 FGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDP 563
+G+++ +I + M + +TF N I + + ++ + + C + +P
Sbjct: 325 YGILLWEIFSLGGTPYPGMIV---DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEP 381
Query: 564 ENRPT---MEAVIEEL 576
E RP+ + ++E L
Sbjct: 382 EKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 48/235 (20%), Positives = 86/235 (36%), Gaps = 44/235 (18%)
Query: 315 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF-------------VKGLYLL 360
LG+G + V K G +VAI+ + + ++ + ++ L ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 361 TSLRHENIIRLRGFCCSRGRGECF--LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
++HENI+ L F L+ D L K +D L S I+
Sbjct: 75 NEIKHENIMGLVDVYVEGD----FINLVMDIM-ASDLKKVVD----RKIRLTESQVKCIL 125
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF---SV 475
+ I G+ LH +HR+LS + I+ + IAD GL + S
Sbjct: 126 LQILNGLNVLHKW-----YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 476 LKTSAAMGYLAPEYVT-----------TGRFTERSDIFAFGVIILQILTGSLVLT 519
+T + + VT ++ D+++ G I ++LTG +
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235
|
Length = 335 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 317 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRHENIIRL 371
LG+G F VYK ++ G +VA++ I + +E+ F ++ + +L L+H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 372 ------RGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-----EGSSNVLDWSTRVSIIIG 420
R R RG +++ + Y+D + E S L S ++
Sbjct: 73 IDMAVERPDKSKRKRGSVYMV---------TPYMDHDLSGLLENPSVKLTESQIKCYMLQ 123
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+ +GI YLH + I+HR++ +LID Q IAD GL + K
Sbjct: 124 LLEGINYLHENH-----ILHRDIKAANILIDNQGILKIADFGLARPYDGPP--PNPKGGG 176
Query: 481 AMG------------YLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 518
G Y PE + R +T DI+ G + ++ T +L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 59/269 (21%), Positives = 106/269 (39%), Gaps = 50/269 (18%)
Query: 316 LLGKGNFSSV----YKGT--------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL 363
+LGKG+F V KGT L+ ++ + T + LT L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 364 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 423
C + + F + ++ G L ++ + S D I
Sbjct: 62 ----------HSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVL 107
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LLADDIVFSVLKTSAA 481
G+ +LH I++R+L ++ VL+D + + IAD G+ K +L TS
Sbjct: 108 GLQFLHER-----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV------TTSTF 156
Query: 482 MG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538
G Y+APE ++ + D +A GV++ ++L G S E F++ ++
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ----SPFEGDDEDELFQSILEDE 212
Query: 539 LK-GKFSESEAAKLGKMALVCTHEDPENR 566
++ ++ EA + K L ++PE R
Sbjct: 213 VRYPRWLSKEAKSILKSFLT---KNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLR 364
+ +V +G+G + VYK R +A++ I + +E E V + + LL ++
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL----EQEDEGVPSTAIREISLLKEMQ 59
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGIA 422
H NI+RL+ S R +L++++ L K++D SS + R+ + + I
Sbjct: 60 HGNIVRLQDVVHSEKR--LYLVFEYLDL-DLKKHMD----SSPDFAKNPRLIKTYLYQIL 112
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDI-VFSVLKTSA 480
+GI Y HS V +HR+L + +LID++ N L +AD GL + A I V +
Sbjct: 113 RGIAYCHSHRV-----LHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVV 165
Query: 481 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILT 513
+ Y APE + R ++ DI++ G I +++
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 56/281 (19%), Positives = 119/281 (42%), Gaps = 57/281 (20%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ + +G+G VYK T R G VAI+ + + +++E + + ++ +H NI+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKEL-IINEILIMKDCKHPNIV 78
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYL 428
E +++ ++ G L+ + Q N +++ + + +G+ YL
Sbjct: 79 DYYD--SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN----EPQIAYVCREVLQGLEYL 132
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAMGYLA 486
HS V +HR++ + +L+ + + +AD G L SV+ T M A
Sbjct: 133 HSQNV-----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM---A 184
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTG-----------SLVLTSS-----MRLAAE-SA 529
PE + + + DI++ G++ +++ G +L L ++ ++ + S
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244
Query: 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 570
F++F+++ C +DPE RP+ E
Sbjct: 245 EFKDFLNK--------------------CLVKDPEKRPSAE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 39/153 (25%), Positives = 76/153 (49%), Gaps = 21/153 (13%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLRHENIIR 370
+G+G + +V+K R+ +VA++ + + ++ E V + + LL L+H+NI+R
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRL----DDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L + + L++++ + L KY D G +D S + + KG+ + HS
Sbjct: 64 L--YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHS 117
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
V +HR+L + +LI++ +AD GL
Sbjct: 118 HNV-----LHRDLKPQNLLINKNGELKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ ++ LG+G++++VYKG + +G LVA++ I + + ++ LL L+H NI+
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
L + + L++++ L +Y+D+ G L + + +G+ Y+H
Sbjct: 67 LLHDIIHT--KETLTLVFEYV-HTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLSYIH 120
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
+ I+HR+L + +LI +AD GL + A + + P
Sbjct: 121 -----QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173
Query: 490 VTTGRFTERS---DIFAFGVIILQILTG 514
V G TE S D++ G I ++++ G
Sbjct: 174 VLLGS-TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 374
LG G F VYK ++ G A + I + S EE E F+ + +L+ +H NI+ L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGL--Y 68
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
+ +++ +F G L + + E L + + + + +LHS +V
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHKV- 124
Query: 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 491
+HR+L +L+ + +AD G+ + K +G ++APE V
Sbjct: 125 ----IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL----QKRDTFIGTPYWMAPEVVA 176
Query: 492 TGRFTE-----RSDIFAFGVIILQILTGSL--VLTSSMR-----LAAESATFENFIDRNL 539
F + ++DI++ G+ ++++ + MR L +E T +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ------ 230
Query: 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
K+S S L C +DP++RPT +++
Sbjct: 231 PSKWSSSFNDFLKS----CLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 60/286 (20%), Positives = 119/286 (41%), Gaps = 58/286 (20%)
Query: 311 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 367
FS++ +G G+F +VY +R+ +VAI+ ++ + +S E + +K + L LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I+ RG C +L+ ++ L D E L ++ G +G+ Y
Sbjct: 77 TIQYRG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
LHS ++HR++ +L+ + + D G ++A F ++AP
Sbjct: 131 LHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAP 180
Query: 488 EYVTT---GRFTERSDIFAFGVIILQI------LTGSLVLTSSMRLAAE----------S 528
E + G++ + D+++ G+ +++ L +++ +A S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
F NF+D C + P++RPT E +++
Sbjct: 241 EYFRNFVDS--------------------CLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 34/261 (13%)
Query: 316 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
+LGKG+F V+ L+ AI+++ V E V+ L + H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+C + + F + ++ G L ++ S + D I G+ +LHS
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LLADDIVFSVLKTSAAMG---YLA 486
IV+R+L ++ +L+D + IAD G+ K +L D KT G Y+A
Sbjct: 116 -----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD------AKTCTFCGTPDYIA 164
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-IDRNLKGKFSE 545
PE + ++ D ++FGV++ ++L G S E F++ +D ++
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ----SPFHGHDEEELFQSIRMDNPCYPRWLT 220
Query: 546 SEAAKLGKMALVCTHEDPENR 566
EA + V +PE R
Sbjct: 221 REAKDILVKLFV---REPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 34/154 (22%), Positives = 68/154 (44%), Gaps = 13/154 (8%)
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
LL ++ H ++IR++ G C ++ + L YL + L + I
Sbjct: 110 LLQNVNHPSVIRMKD-TLVSGAITCMVLPHY--SSDLYTYLTKRSRP---LPIDQALIIE 163
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
I +G+ YLH+ I+HR++ E + I+ I D G + F L
Sbjct: 164 KQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--LGL 216
Query: 479 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 512
+ + APE + ++ ++DI++ G+++ ++L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 45/209 (21%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ + ++ LG+G +++V+KG + LVA++ I + + ++ + LL L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I+ L + L++++ K L +Y+D N++ + I +G+ Y
Sbjct: 66 IVTLHDIVHT--DKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAY 119
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
H +V +HR+L + +LI+++ +AD GL + A + + P
Sbjct: 120 CHRRKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRP 172
Query: 488 EYVTTG--RFTERSDIFAFGVIILQILTG 514
V G ++ + D++ G I ++ +G
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 317 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEE----AEFVKGLYLLTSLRHEN-IIR 370
+G+G + VYK G LVA++ T + +E ++ + LL L I+R
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 371 LRGFCC-----SRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKG 424
L G+ +L++++ L K++D G L T S + + KG
Sbjct: 66 L--LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTS---- 479
+ + H K ++HR+L + +L+D+Q L IAD GL + FS+ S
Sbjct: 123 VAHCH-----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHE 171
Query: 480 -AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTG 514
+ Y APE + ++ DI++ G I ++
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 316 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
+LGKG+F V L+ G A++++ V E V+ L +L EN
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVL--ALAWENPFLT 59
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+C + + F + +F G L ++ Q++G ++ + + I+ G+ +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVC---GLQFLHSK 115
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 488
I++R+L ++ V++D+ + IAD G+ K + VF + S G Y+APE
Sbjct: 116 -----GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPE 166
Query: 489 YVTTGRFTERSDIFAFGVIILQILTG 514
+ ++T D ++FGV++ ++L G
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 312 SEVNL--LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLRH 365
S +NL LG+G++++VYKG R +G LVA++ V S K+EE ++ LL L+H
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALK---VISMKTEEGVPFTAIREASLLKGLKH 62
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIA 422
NI+ L ++ Y L++Y+ Q G NV + +
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEY---MHTDLAQYMIQHPGGLHPYNVR------LFMFQLL 113
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
+G+ Y+H I+HR+L + +LI +AD GL + A I +
Sbjct: 114 RGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVT 166
Query: 483 GYLAPEYVTTG--RFTERSDIFAFGVIILQILTGS 515
+ P V G ++ DI+ G I +++L G
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 443
LI D+ G+L +L Q E V I G I + +LH K I++R++
Sbjct: 82 LILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHLH-----KLGIIYRDI 131
Query: 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 501
+E +L+D + ++ D GL K +D V + Y+AP+ V G + D
Sbjct: 132 KLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191
Query: 502 FAFGVIILQILTGSLVLT 519
++ GV++ ++LTG+ T
Sbjct: 192 WSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 48/287 (16%)
Query: 317 LGKGNFSSVYKGTLRDGTLVA---IRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+G G F V + T VA ++ + + E+ EF++ L+H NI++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIAKGIGYLHS 430
C L++++ G L YL QE+ +S +L + IA G+ ++H
Sbjct: 63 QCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH- 116
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEY 489
K +H +L++ + + D G+ +D + + + +LAPE
Sbjct: 117 ----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 490 VT-------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542
V T T+ S+++A GV + ++ AA+ + + DR +
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFEN----------AAQP--YSHLSDREVLNH 220
Query: 543 FSESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 577
+ + KL K L + + PE R T E V LT
Sbjct: 221 VIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ + +++ LG+G +++V+KG + LVA++ I + + ++ + LL +L+H N
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 368 IIRLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
I+ L + C L++++ L +YLD N++ + + +G+
Sbjct: 65 IVTLHDIIHTE---RCLTLVFEYL-DSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLS 117
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 486
Y H K I+HR+L + +LI+++ +AD GL + A + +
Sbjct: 118 YCH-----KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYR 170
Query: 487 PEYVTTGRFTERS---DIFAFGVIILQILTG 514
P V G TE S D++ G I+ ++ TG
Sbjct: 171 PPDVLLGS-TEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 21/57 (36%), Positives = 27/57 (47%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100
L L N+LT L +L VL L N L P++ L L+ LDLS N+L
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 41/245 (16%), Positives = 101/245 (41%), Gaps = 31/245 (12%)
Query: 337 AIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR-GFCCSRGRGECFLIYDFAPKGKL 395
A++ I + S + K LL ++H NI+ + F G +++ ++ G L
Sbjct: 29 AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF---EADGHLYIVMEYCDGGDL 85
Query: 396 SKYLDQEEG----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 451
+ + + G +L W ++ + G+ ++H V +HR++ + + +
Sbjct: 86 MQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEKRV-----LHRDIKSKNIFLT 134
Query: 452 QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 511
Q + D G +LL ++ Y+ PE + +SDI++ G I+ ++
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACTYVGTPY-YVPPEIWENMPYNNKSDIWSLGCILYEL 193
Query: 512 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH---EDPENRPT 568
T ++ ++ +++N I + +G + + ++ + +P +RP+
Sbjct: 194 CT--------LKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPS 245
Query: 569 MEAVI 573
++
Sbjct: 246 ATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRL 371
LG G F SVY ++ G LVAI+ + EE E VK L L H NI++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE-VKSLRKLNE--HPNIVKL 63
Query: 372 RG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
+ F R E + ++++ +G L + + +G S SII I +G+ ++H
Sbjct: 64 KEVF---RENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIH- 116
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
K HR+L E +L+ IAD GL + + ++ +YV
Sbjct: 117 ----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-------------DYV 159
Query: 491 TTG--RFTE---RS-------DIFAFGVIILQILT 513
+T R E RS DI+A G I+ ++ T
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 31/152 (20%)
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 476
I + I K + YLHS K +++HR++ VLI++ + D G+ L D SV
Sbjct: 108 IAVSIVKALEYLHS----KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD----SVA 159
Query: 477 KTSAA--MGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGS--------------- 515
KT A Y+APE + + +SD+++ G+ ++++ TG
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219
Query: 516 LVLTSSMRLAAE--SATFENFIDRNLKGKFSE 545
+V S +L AE S F++F+++ LK + E
Sbjct: 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKE 251
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 39/158 (24%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+A+G+ +L S + +HR+L+ +L+ + I D GL + + D + V K A
Sbjct: 182 VARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDA 235
Query: 481 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538
+ ++APE + +T +SD+++FGV++ +I + +++ E F +
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCRRLKEG 292
Query: 539 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + E ++ + L C H +PE+RPT ++E L
Sbjct: 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 317 LGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+GKG+F V + T R L IR ++ S +SE + +L + I+ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 373 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHS 430
F + + +L+ F G+L +L Q EG + +R + + LH
Sbjct: 60 FSF---QSPEKLYLVLAFINGGELFHHL-QREGRFD----LSRARFYTAELLCALENLHK 111
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTSAAMG---YLA 486
V ++R+L E +L+D Q + + D GL KL + DD KT+ G YLA
Sbjct: 112 FNV-----IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-----KTNTFCGTPEYLA 161
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTG 514
PE + +T+ D + GV++ ++LTG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 43/285 (15%)
Query: 317 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+G G F V G + G V ++ + V++ E+ +F++ SL+H N+++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL-DWSTRVSIIIGIAKGIGYLHSSE 432
C L+ +F P G L YL + + D +T + IA G+ +LH
Sbjct: 63 QCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYV- 490
K +H +L++ L+ I D GL H +D + + + ++APE V
Sbjct: 118 --KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 491 -TTGRF-----TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
G T+ S++++ GV I ++ S + + D +
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELG------------SQPYRHLSDEQVLTYTV 223
Query: 545 ESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 577
+ KL K L D PE RP+ E V L+
Sbjct: 224 REQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKS-LSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L N +T +IP IG LKS L L L N++ +P L NL LK LDLSFN L
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 103 TIPESLANNAELLFLDVQNNTLSGI-----VPSALKRLN 136
+P+ L+N + L LD+ N +S + + SAL+ L+
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELD 215
|
Length = 394 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLRHENIIRLR 372
+G+G V+K R+ G VA++ + + + E + ++ + L + +H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALR--RLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 373 G-FCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
F G F L+ ++ P LS+ L EE L + S + + KG+ Y+H+
Sbjct: 66 DVFPH----GSGFVLVMEYMPSD-LSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
+ I+HR+L +LI IAD GL +L +++ A Y APE +
Sbjct: 118 N-----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 491 TTGR-FTERSDIFAFGVIILQILTGS 515
R + D++A G I ++L GS
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 39/238 (16%)
Query: 289 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK 347
F RE +N L E ++ + +G G + SV R G VAI+ + +
Sbjct: 1 FYREEVNKTVWELPER------YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SR 50
Query: 348 SEEAE-FVKGLY----LLTSLRHENIIRLRGFCCSRGRGECFLIYDF---AP--KGKLSK 397
++E F K Y LL ++HEN+I L S G+ F DF P + L K
Sbjct: 51 PFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF--QDFYLVMPYMQTDLQK 108
Query: 398 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457
+ V ++ + G+ Y+HS+ I+HR+L + +++
Sbjct: 109 IMGHPLSEDKVQ------YLVYQMLCGLKYIHSA-----GIIHRDLKPGNLAVNEDCELK 157
Query: 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 514
I D GL + ++ V+ Y APE + + + DI++ G I+ ++LTG
Sbjct: 158 ILDFGLARHADAEMTGYVV----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 316 LLGKGNFSSVY----KGTLRDGTLVAIRSI--NVTSCKSEEAEFVKGLYLLTSLRHENII 369
LLGKG F V K T G A++ + V K E A + +L + RH +
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKGIGY 427
L+ + R CF++ ++A G+L +L +E S + R G I +GY
Sbjct: 59 ALKYSFQTHDR-LCFVM-EYANGGELFFHLSRERVFS---EDRAR---FYGAEIVSALGY 110
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
LHS + +V+R+L +E +++D+ + I D GL K + I G Y
Sbjct: 111 LHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGA-TMKTFCGTPEY 161
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
LAPE + + D + GV++ +++ G L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N +G +P++ L + L + +N L G I ++ L+ L L+ N FG +P+S
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
+ L LD+ N SG VP L L
Sbjct: 474 SK-RLENLDLSRNQFSGAVPRKLGSL 498
|
Length = 968 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 316 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFV-KGLYLLTSLRHENIIRL 371
++GKG+F V + DG+ A++ + + K E+ + + LL +L+H ++ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 372 R-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 429
F + + + + D+ G+L +L +E R +A IGYLH
Sbjct: 62 HYSFQTAE---KLYFVLDYVNGGELFFHLQRERCFL-----EPRARFYAAEVASAIGYLH 113
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 486
S I++R+L E +L+D Q + ++ D GL K + V TS G YLA
Sbjct: 114 SLN-----IIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLA 164
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTG 514
PE + + D + G ++ ++L G
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 316 LLGKGNFSSVYKGTL-RDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
++GKG+F V DG A++ + V + K ++ + LL +++H ++ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 372 R-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 429
F + + + + DF G+L +L +E R IA +GYLH
Sbjct: 62 HYSFQTTE---KLYFVLDFVNGGELFFHLQRERSFP-----EPRARFYAAEIASALGYLH 113
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAP 487
S IV+R+L E +L+D Q + ++ D GL K + I S T+ YLAP
Sbjct: 114 SIN-----IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAP 165
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTG 514
E + + D + G ++ ++L G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG-KLKRLDLSFNSLF 101
V + L ++G I + I L + + L +N+L+G IPD + L+ L+LS N+
Sbjct: 72 VSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFT 131
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVP------SALKRLNGG 138
G+IP N E LD+ NN LSG +P S+LK L+ G
Sbjct: 132 GSIPRGSIPNLET--LDLSNNMLSGEIPNDIGSFSSLKVLDLG 172
|
Length = 968 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 360 LTSLRHENIIRLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
L S+RH ++ L G F +L+ ++ P G+L +L + + +
Sbjct: 55 LQSIRHPFLVNLYGSFQDDS---NLYLVMEYVPGGELFSHLRKSGRFPE--PVARFYAAQ 109
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
+ +A + YLHS + IV+R+L E +L+D I D G K + +T
Sbjct: 110 VVLA--LEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-------RT 155
Query: 479 SAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
G YLAPE + + + + D +A G++I ++L G
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 10/91 (10%)
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 483
G+ LH + I+HR++ E +LIDQ + + D GL + K
Sbjct: 109 GVEDLH-----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPD 158
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
YLAPE + + SD ++ G +I + L G
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 44/205 (21%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 311 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ + +G G + VYK + G LVAI+ I + + + + +L RH NI+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIV 63
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGY 427
G R + +++ ++ G L G S + + R ++ KG+ Y
Sbjct: 64 AYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAY 116
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
LH + +HR++ +L+ + + +AD G ++ + ++ K + +G +
Sbjct: 117 LHETGK-----IHRDIKGANILLTEDGDVKLADFG----VSAQLTATIAKRKSFIGTPYW 167
Query: 485 LAPEYV---TTGRFTERSDIFAFGV 506
+APE G + + DI+A G+
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 21/191 (10%)
Query: 394 KLSKYLDQE------EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 447
+ Y+DQ+ E LD +S +AKG+ +L S +HR+L+
Sbjct: 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC-----IHRDLAARN 244
Query: 448 VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFG 505
+L+ I D GL + + +D + V+K +A + ++APE + +T SD++++G
Sbjct: 245 ILLTHGRITKICDFGLARDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 303
Query: 506 VIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDP 563
+++ +I SL + + +S ++ + R L + + SE + K C DP
Sbjct: 304 ILLWEIF--SLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK---SCWDADP 358
Query: 564 ENRPTMEAVIE 574
RPT + +++
Sbjct: 359 LKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 9/95 (9%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
I G+ +LH IV+R+L E VL+D N I+D GL L +K A
Sbjct: 104 IICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRA 155
Query: 481 AM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
GY+APE + + D FA G + +++ G
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRH 365
+ ++ +G G + V G VAI+ + S + A K Y LL + H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---SRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 366 ENIIRLRG-FCCSRGRGECFLIYDFAP--KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
EN+I L F + + +Y L+ + ++ S + + + ++ I
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-----LVYQIL 128
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
+G+ Y+HS+ I+HR+L + +++ I D GL + D++ V A
Sbjct: 129 RGLKYIHSA-----GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV----ATR 179
Query: 483 GYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 514
Y APE + + + DI++ G I+ ++LTG
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 443
LI D+ G+L +L Q E + + V + I I + +LH + I++R++
Sbjct: 82 LILDYVNGGELFTHLYQREHFT-----ESEVRVYIAEIVLALDHLH-----QLGIIYRDI 131
Query: 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 501
+E +L+D + + ++ D GL K + + Y+APE + G + D
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191
Query: 502 FAFGVIILQILTGS 515
++ GV+ ++LTG+
Sbjct: 192 WSLGVLTFELLTGA 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 41/205 (20%)
Query: 333 GTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387
G VA++ + N T K E V LL + H+NII L +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISL--------------LN 87
Query: 388 DFAPKGKLSK----YLDQEEGSSNV-------LDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
F P+ L + YL E +N+ LD ++ + GI +LHS+
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA----- 142
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
I+HR+L +++ I D GL + + F + Y APE + +
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYK 200
Query: 497 ERSDIFAFGVIILQILTGSLVLTSS 521
E DI++ G I+ +++ GS++ +
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIFQGT 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 25/154 (16%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTS 479
I G+ LH IV+R+L E +L+D + I+D GL ++ + + + T
Sbjct: 111 ITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT- 164
Query: 480 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539
+GY+APE V R+T D + G +I +++ G S R E E ++R +
Sbjct: 165 --VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK----SPFRQRKEKVKREE-VERRV 217
Query: 540 K-------GKFSESEAAKLGKMALVCTHEDPENR 566
K KFSE A + + L +DP R
Sbjct: 218 KEDQEEYSEKFSE-AARSICRQLL---TKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTS 479
I G+ LH + V+R+L E +L+D + I+D GL K+ + + + T
Sbjct: 111 ILCGLEDLH-----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT- 164
Query: 480 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539
+GY+APE + R+T D + G +I +++ G S R E E R L
Sbjct: 165 --VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ----SPFRGRKEKVKREEVDRRVL 218
Query: 540 K------GKFSESEAAKLGKMALVCTHEDPENR 566
+ KFSE EA + KM L +DP+ R
Sbjct: 219 ETEEVYSAKFSE-EAKSICKMLLT---KDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 45/213 (21%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 369
F ++ LG GN V K + L+ R I++ + + ++ L +L I+
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 421
G F G++S ++ +G S VL + R+ + I +
Sbjct: 67 GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 481
+G+ YL K I+HR++ +L++ + + D G+ L D + S + T +
Sbjct: 113 LRGLAYLRE----KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 167
Query: 482 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
Y++PE + ++ +SDI++ G+ ++++ G
Sbjct: 168 --YMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 316 LLGKGNFSSVYKGTLRD---GTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LLGKG F V +R+ G A++ + V K E A + +L + RH +
Sbjct: 2 LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L+ ++ R CF++ ++ G+L +L +E S + TR I + YLHS
Sbjct: 60 LKYSFQTKDR-LCFVM-EYVNGGELFFHLSRERVFS---EDRTRF-YGAEIVSALDYLHS 113
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEY 489
+ IV+R+L +E +++D+ + I D GL K D + +KT YLAPE
Sbjct: 114 GK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEV 166
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSL 516
+ + D + GV++ +++ G L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 46/213 (21%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 369
F +++ LG GN V+K + + L+ R I++ + + ++ L +L I+
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 421
G F G++S ++ +G S VL + R+ + I +
Sbjct: 67 GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 481
KG+ YL K I+HR++ +L++ + + D G+ L D + S + T +
Sbjct: 113 IKGLTYLRE----KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 167
Query: 482 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
Y++PE + ++ +SDI++ G+ ++++ G
Sbjct: 168 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 316 LLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LLGKG F V K T R + +R V K E A V +L + RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+ + R CF++ ++A G+L +L +E V I + YLHS
Sbjct: 61 KYAFQTHDR-LCFVM-EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR 114
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEYV 490
+V V+R++ +E +++D+ + I D GL K D + +KT YLAPE +
Sbjct: 115 DV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 167
Query: 491 TTGRFTERSDIFAFGVIILQILTGSL 516
+ D + GV++ +++ G L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 43/209 (20%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
++ +G+G +V+ + G VAI+ IN+ +E + + ++ L++ NI+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL-IINEILVMKELKNPNIV 79
Query: 370 RLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
F S G E F++ ++ G L+ + + +D + ++ + + +L
Sbjct: 80 ---NFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFL 131
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 485
H+++V +HR++ + VL+ + + D G I K S +G ++
Sbjct: 132 HANQV-----IHRDIKSDNVLLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWM 182
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILTG 514
APE VT + + DI++ G++ ++++ G
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 308 TQCFSEVNLLGKGNFSSV--YKGTLRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLR 364
T + ++ +G G F V + L G VAI+ I S + L LL LR
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
HENII L S + + + + L + L + + + I +G
Sbjct: 68 HENIISLSDIFISP-LEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-----FLYQILRG 120
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 484
+ Y+HS+ V VHR+L +LI++ + I D GL ++ + V + Y
Sbjct: 121 LKYVHSAGV-----VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV----STRYY 171
Query: 485 LAPEYVTT-GRFTERSDIFAFGVIILQILTG 514
APE + T ++ DI++ G I ++L G
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
I GI +LHS + IV+R++ E VL+D Q N ++D GL L D ++ + +
Sbjct: 104 ITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
GY+APE + ++ D FA G I +++ G
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLR-- 364
+ V +G G + +VYK G VA++S+ V + +E+ V+ + LL L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQT--NEDGLPLSTVREVALLKRLEAF 59
Query: 365 -HENIIRLRGFCCS-RGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
H NI+RL C + R E L+++ + L YLD+ + T ++
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE--TIKDLMRQ 116
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+G+ +LH++ IVHR+L E +L+ +AD GL ++ + + + + +
Sbjct: 117 FLRGLDFLHAN-----CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT- 170
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 512
+ Y APE + + D+++ G I ++
Sbjct: 171 -LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 28/136 (20%)
Query: 395 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454
LSK + E +S +SI I I Y+HS ++HR+L + +L+
Sbjct: 102 LSK--ELAEKTS----VGAFLSIFHKICATIEYVHSK-----GVLHRDLKPDNILLGLFG 150
Query: 455 NPLIADCGLHK--------LLADD-----IVFSVL----KTSAAMGYLAPEYVTTGRFTE 497
+I D G LL D I +S + K Y+APE + +E
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210
Query: 498 RSDIFAFGVIILQILT 513
+DI+A GVI+ Q+LT
Sbjct: 211 STDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 28/85 (32%), Positives = 40/85 (47%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L N L G IP +G+ +SL + LQ N +G +P L + LD+S N+L G I
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
Query: 105 PESLANNAELLFLDVQNNTLSGIVP 129
+ L L + N G +P
Sbjct: 445 NSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 21/58 (36%), Positives = 28/58 (48%)
Query: 65 SLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 122
+L L L +NRL + L LK LDLS N+L PE+ + L LD+ N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
IA G+ +LHS I++R+L ++ V++D + + IAD G+ K + +F T
Sbjct: 110 IAIGLFFLHSK-----GIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRT 160
Query: 481 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
G Y+APE + + + D +AFGV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 18/142 (12%)
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 491
++ + IV+R+L E +L+D + + I+D GL + + +V +GY+APE +
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVIN 174
Query: 492 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-------KFS 544
++T D + G +I +++ G S R E E +DR +K KFS
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ----SPFRKRKERVKREE-VDRRVKEDQEEYSEKFS 229
Query: 545 ESEAAKLGKMALVCTHEDPENR 566
E +A + +M L ++P+ R
Sbjct: 230 E-DAKSICRMLLT---KNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 406 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465
S L + V +A G+ +L S VHR+L+ VLI + I D GL +
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFLASKNC-----VHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 466 -LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
++ D S T + ++APE + +T SD+++FG+++ +I T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 48/205 (23%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG G F VYK ++ G L A + I T + E +++ + +L + H I++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATCNHPYIVKLLG-- 76
Query: 376 CSRGRGECFLIYDFAPKGKL-SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
G+ +++ +F P G + + L+ + G + + +V I + + + YLHS +
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQV-ICRQMLEALQYLHSMK-- 130
Query: 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 491
I+HR+L VL+ + +AD G ++ V ++ + + +G ++APE V
Sbjct: 131 ---IIHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 492 TGRFTE-----RSDIFAFGVIILQI 511
+ ++DI++ G+ ++++
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
IA G+ +LHS I++R+L ++ V++D + + IAD G+ K + ++ + T
Sbjct: 110 IAIGLFFLHSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKT 160
Query: 481 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
G Y+APE + + + D +AFGV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 26/213 (12%)
Query: 317 LGKGNFSSVYKGTL-RDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL- 371
LG G F V + A++ + + +E F + +L H I++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKE-ILEECNHPFIVKLY 59
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
R F + + +++ ++ G+L L ++ G D T I + YLH+
Sbjct: 60 RTF---KDKKYIYMLMEYCLGGELWTIL-RDRGL---FDEYTARFYIACVVLAFEYLHNR 112
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 488
I++R+L E +L+D + D G K + S KT G Y+APE
Sbjct: 113 G-----IIYRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPE 162
Query: 489 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 521
+ + D ++ G+++ ++LTG
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 29/270 (10%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG-F 374
LGKGN+ SVYK R G +A++ I + +S+ + + L +L I+ G F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
G ++ ++ G L K L ++ + I + KG+ +L E N
Sbjct: 69 FI---EGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEHN 123
Query: 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYVTTG 493
I+HR++ VL++ + D G ++ ++V S+ KT+ Y+APE + +G
Sbjct: 124 ---IIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 494 ------RFTERSDIFAFGVIILQILTGSLVL---TSSMRLAAESATFENFIDRNLKGKFS 544
+T +SD+++ G+ IL++ G T + A SA + L +S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-LPSGYS 235
Query: 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+A C ++ P RPT ++E
Sbjct: 236 -DDAQDFVAK---CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 316 LLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+LGKG+F V L+ G L A++ + + ++ E + SL + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
+CC + F + +F G L ++ + S D + I + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-- 115
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYV 490
I++R+L ++ VL+D + + +AD G+ K + +F+ TS G Y+APE +
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 491 TTGRFTERSDIFAFGVIILQILTG 514
+ D +A GV++ ++L G
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 62/280 (22%), Positives = 130/280 (46%), Gaps = 42/280 (15%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRS----INVT-----SCKSEEAEFVKGLYLLTSLRHEN 367
LG+G F+++YKG LR + + I ++V S + F + L++ L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
+++L G C R E ++ ++ G L +L +E+ + ++ W ++ + +A + Y
Sbjct: 63 LVKLYGVCV---RDENIMVEEYVKFGPLDVFLHREKNNVSLH-W--KLDVAKQLASALHY 116
Query: 428 LHSSEVNKPAIVH-----RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
L E K +VH +N+ V + +++ + P I KL I +VL +
Sbjct: 117 L---EDKK--LVHGNVCGKNILVARYGLNEGYVPFI------KLSDPGIPITVLSREERV 165
Query: 483 G---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537
++APE + G+ T +D ++FG +L+I + S++ + + +++
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---- 221
Query: 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577
+ + + A+L + C DP RP+ A++ +L
Sbjct: 222 --QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 23/83 (27%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 491
++++ IV+R+L E +L+D + I+D GL + + ++ +GY+APE V
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVK 174
Query: 492 TGRFTERSDIFAFGVIILQILTG 514
R+T D +A G ++ +++ G
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 311 FSEVNLLGKGNFSSV-YKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLY----LLTSLR 364
+ ++ +G G + +V R G VAI+ + + ++E F K Y LL ++
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMK 72
Query: 365 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
HEN+I L + F L+ F L K + E+ S + + + ++
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQF-----LVYQ 126
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+ KG+ Y+H++ I+HR+L + +++ I D GL + ++ V+
Sbjct: 127 MLKGLKYIHAA-----GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV---- 177
Query: 481 AMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 514
Y APE + +T+ DI++ G I+ ++LTG
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 16/133 (12%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
IA +GYLHS IV+R+L E +L+D Q + ++ D GL K + + TS
Sbjct: 105 IASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTST 155
Query: 481 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537
G YLAPE + + D + G ++ ++L G S R AE ++N +++
Sbjct: 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAE--MYDNILNK 211
Query: 538 NLKGKFSESEAAK 550
L+ K + + +A+
Sbjct: 212 PLQLKPNITNSAR 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 25/162 (15%)
Query: 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRHENI 368
+ +G+G F V+K + +VA++ + + ++E+ F ++ + +L L+HEN+
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLM---ENEKEGFPITALREIKILQLLKHENV 73
Query: 369 IRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV-LDWSTRVSIIIGI 421
+ L C +R +G +L+++F L+ L NV S ++ +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKML 128
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
G+ Y+H NK I+HR++ +LI + +AD GL
Sbjct: 129 LNGLYYIHR---NK--ILHRDMKAANILITKDGILKLADFGL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGL--YLLTSLRHENIIRLR 372
+GKG+F V + DG A++ + + K +E + + LL +++H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 373 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHS 430
F + + + + D+ G+L +L +E R IA +GYLHS
Sbjct: 63 YSF---QTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHS 114
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 487
I++R+L E +L+D Q + ++ D GL K + I S TS G YLAP
Sbjct: 115 LN-----IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSK-TTSTFCGTPEYLAP 165
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTG 514
E + + D + G ++ ++L G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)
Query: 289 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSIN----- 342
F R+ LN + EV Q S V G G + SV + G VA++ ++
Sbjct: 3 FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 56
Query: 343 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-- 400
+ K E L LL ++HEN+I L F P L ++ D
Sbjct: 57 IIHAKRTYRE----LRLLKHMKHENVIGLLDV--------------FTPARSLEEFNDVY 98
Query: 401 -----QEEGSSNVLDWSTRVS-----IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450
+N++ +I I +G+ Y+HS++ I+HR+L + +
Sbjct: 99 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAV 153
Query: 451 DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIIL 509
++ I D GL + D++ V A Y APE + + + DI++ G I+
Sbjct: 154 NEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 510 QILTG 514
++LTG
Sbjct: 210 ELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 316 LLGKGNFSSVYKGTLRDGT-LVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
+LGKG+F V L+ AI+++ V E V+ L + H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
FC + + F + ++ G L ++ S D + I G+ +LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 488
I++R+L ++ VL+D+ + IAD G+ K + K S G Y+APE
Sbjct: 116 -----GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN----MNGEGKASTFCGTPDYIAPE 166
Query: 489 YVTTGRFTERSDIFAFGVIILQILTG 514
+ ++ E D ++FGV++ ++L G
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 316 LLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LLGKG F V K T R + ++ V K E A + +L + RH + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKGIGYLH 429
+ + R CF++ ++A G+L +L +E +S + G I + YLH
Sbjct: 61 KYSFQTHDR-LCFVM-EYANGGELFFHLSRERV------FSEDRARFYGAEIVSALDYLH 112
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPE 488
S + +V+R+L +E +++D+ + I D GL K D + +KT YLAPE
Sbjct: 113 SEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPE 166
Query: 489 YVTTGRFTERSDIFAFGVIILQILTGSL 516
+ + D + GV++ +++ G L
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 50/273 (18%), Positives = 122/273 (44%), Gaps = 30/273 (10%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
+G+G+ V T++ G LVA++ +++ + E F + + ++ +HEN++ + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNE-VVIMRDYQHENVVEM--YN 84
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
E +++ +F G L+ + + + ++ + + K + LH+
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQ---- 135
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 492
++HR++ + +L+ ++D G ++ + V + + +G ++APE ++
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPELISR 190
Query: 493 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 550
+ DI++ G+++++++ G + L A +N + NL K S S
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLH-KVSPSLKGF 249
Query: 551 LGKMALVCTHEDPENRPTMEAVIEE--LTVAAP 581
L ++ + DP R T +++ L A P
Sbjct: 250 LDRLLV----RDPAQRATAAELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 9/88 (10%)
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 486
YLHS + I++R+L E +L+D + + + D G K + D F++ T YLA
Sbjct: 133 YLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGTPE---YLA 183
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTG 514
PE + + + D + GV++ + + G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 24/167 (14%)
Query: 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 440
G+ +LI ++ G+L +L++E + T + I+ + +LH + I++
Sbjct: 73 GKLYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLH-----QQGIIY 123
Query: 441 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTE 497
R+L E +L+D Q + + D GL K + + T G Y+APE + +
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179
Query: 498 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
D ++ G ++ +LTG+ T+ R + ID+ LKGK +
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLN 218
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 25/98 (25%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 476
I I + +G+ YL K I+HR++ +L++ + + D G+ L D + S +
Sbjct: 104 ISIAVLRGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159
Query: 477 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
T + Y++PE + +T +SDI++ G+ ++++ G
Sbjct: 160 GTRS---YMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 9e-04
Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 54/291 (18%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR----H 365
F V ++G+G + VYK + G LVAI+ +++ + EE + LR H
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-----YNILRKYSNH 62
Query: 366 ENIIRLRG-FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS----- 416
NI G F G + +L+ + G ++ + + R+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIA 116
Query: 417 -IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
I+ +G+ YLH ++V +HR++ + +L+ + + D G+ L ++
Sbjct: 117 YILRETLRGLAYLHENKV-----IHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TL 167
Query: 476 LKTSAAMG---YLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTS--SMRLA 525
+ + +G ++APE + + RSD+++ G+ +++ G L MR
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-- 225
Query: 526 AESATFENFIDRNLKGKFSESE--AAKLGKMALVCTHEDPENRPTMEAVIE 574
A F+ I RN E + K C ++ E RP ME ++E
Sbjct: 226 ---ALFK--IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 317 LGKG--NFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS-LRHENIIRLR 372
+G+G N +SVY GTLV +R ++ +C E + ++ +L+ RH NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS- 64
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
+ ++I F G + L EG S L +I+ G +G+ YLH
Sbjct: 65 -WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQ 119
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL------------HKLLADDIVFSVLKT 478
+ +HRN+ +LI + L++ GL K++ D FS
Sbjct: 120 N-----GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS---- 168
Query: 479 SAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTG 514
++ + +L+PE + + +SDI++ G+ ++ TG
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 55/265 (20%), Positives = 111/265 (41%), Gaps = 27/265 (10%)
Query: 305 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTS 362
ES + + +G G F V+ R ++I+ K E+++ V + ++
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
L+H+NI+R ++ + +++ +F G LS+ + + ++ V I +
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 423 KGIGYLHSSE--VNKPAIVHRNLSVEKVL----------IDQQFNPL-------IADCGL 463
+ Y H+ + N ++HR+L + + I Q N L I D GL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 464 HKLLA-DDIVFSVLKTSAAMGYLAPEYV--TTGRFTERSDIFAFGVIILQILTGSLVLTS 520
K + + + S + T Y +PE + T + ++SD++A G II ++ +G
Sbjct: 189 SKNIGIESMAHSCVGTPY---YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 521 SMRLAAESATFENFIDRNLKGKFSE 545
+ + + + D +KGK E
Sbjct: 246 ANNFSQLISELKRGPDLPIKGKSKE 270
|
Length = 1021 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 317 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG GN +VYK L ++A++ I + + + + L +L II G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
R + +F G L Y E +VL I + + KG+ YL S +
Sbjct: 69 FVENR--ISICTEFMDGGSLDVYRKIPE---HVLG-----RIAVAVVKGLTYLWSLK--- 115
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 495
I+HR++ +L++ + + D G+ L + I + + T+A Y+APE ++ ++
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA---YMAPERISGEQY 170
Query: 496 TERSDIFAFGVIILQILTGSL 516
SD+++ G+ +++ G
Sbjct: 171 GIHSDVWSLGISFMELALGRF 191
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
++GKG++ V G VAI+ I +V S+ ++ + LL LRH +I+ ++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 374 FCCSRGRGE---CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
R E +++++ + L Q +++ L + + + + Y+H+
Sbjct: 67 IMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAPE 488
+ V HR+L + +L + I D GL ++ +D ++ T A Y APE
Sbjct: 122 ANV-----FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 489 YVTT--GRFTERSDIFAFGVIILQILTG 514
+ ++T DI++ G I ++LTG
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 12/133 (9%)
Query: 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 443
LI D+ G++ +L Q + S V G I + +LH K IV+R++
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEIILALEHLH-----KLGIVYRDI 131
Query: 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV-TTGRFTERSDIF 502
+E +L+D + + ++ D GL K + + Y+APE + G + D +
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWW 191
Query: 503 AFGVIILQILTGS 515
+ G++I ++LTG+
Sbjct: 192 SLGILIFELLTGA 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 26/97 (26%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
I+ G+ +LH + I++R+L ++ V++D + + IAD G+ K + + + T
Sbjct: 110 ISVGLFFLH-----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRT 160
Query: 481 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
G Y+APE + + + D +A+GV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEF--VKGLYLLTSLRHENIIRLRG 373
LG+G++++VYKG + G LVA++ I + E A F ++ LL L+H NI+ L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
+ L++++ L +Y+D L + + +G+ Y H
Sbjct: 71 II--HTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
++HR+L + +LI ++ +AD GL
Sbjct: 124 ----VLHRDLKPQNLLISERGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 24/231 (10%)
Query: 289 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS 348
F R+ LN + EV Q + V G+ S Y LR V S S
Sbjct: 1 FYRQELNK---TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH 57
Query: 349 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEG 404
+ + L LL ++HEN+I L E F L+ + L+ + ++
Sbjct: 58 ARRTY-RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKL 115
Query: 405 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464
S + + +I + +G+ Y+HS+ I+HR+L V +++ I D GL
Sbjct: 116 SDEHVQF-----LIYQLLRGLKYIHSA-----GIIHRDLKPSNVAVNEDCELRILDFGLA 165
Query: 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 514
+ D++ V A Y APE + + + DI++ G I+ ++L G
Sbjct: 166 RQADDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV----KGLYLLTSLRHENIIR 370
++G+G F VY D G + A++ ++ K ++ E + + + L S I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
+ CF I D G L +L Q S II+G+ ++H+
Sbjct: 61 CMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE----HMHN 115
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAP 487
V V+R+L +L+D+ + I+D G LA D FS K A++ GY+AP
Sbjct: 116 RFV-----VYRDLKPANILLDEHGHVRISDLG----LACD--FSKKKPHASVGTHGYMAP 164
Query: 488 EYVTTGR-FTERSDIFAFGVIILQILTG 514
E + G + +D F+ G ++ ++L G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 317 LGKGNFSSVY----KGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRL 371
LGKG+F +VY K + + L ++ I V +E + + LL+ L H I++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK- 66
Query: 372 RGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
F S + F +I ++ L L++ + + L + I + G+ Y+H
Sbjct: 67 --FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
I+HR+L + + + I D G+ +LL + T Y++PE +
Sbjct: 125 RR-----ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPY-YMSPEAL 177
Query: 491 TTGRFTERSDIFAFGVIILQI 511
+ +SDI++ G I+ ++
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 12/95 (12%)
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-- 478
I G+ +LH I++R+L E VL+D N I+D GL L D KT
Sbjct: 106 IISGLEHLHQRR-----IIYRDLKPENVLLDNDGNVRISDLGLAVELKD----GQSKTKG 156
Query: 479 -SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 512
+ G++APE + + D FA GV + +++
Sbjct: 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 71/332 (21%), Positives = 128/332 (38%), Gaps = 88/332 (26%)
Query: 317 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 369
LG G F V + T D L VA++ + ++ E + L +L+ L +H+NI+
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 370 RLRGFC------------CSRG--------RGECFLIYDFAP------------------ 391
L G C C G + E FL + A
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK 165
Query: 392 -----KGKLSK----YLDQEEGSSNV-----------------LDWSTRVSIIIGIAKGI 425
G S+ Y++ SS+ LD + +A+G+
Sbjct: 166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM 225
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--G 483
+L S +HR+++ VL+ I D GL + + +D + V+K +A +
Sbjct: 226 DFLASKNC-----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-VVKGNARLPVK 279
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--- 540
++APE + +T +SD++++G+++ +I SL + + S F + R +
Sbjct: 280 WMAPESIFDCVYTVQSDVWSYGILLWEIF--SLGKSPYPGILVNS-KFYKMVKRGYQMSR 336
Query: 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAV 572
F+ E + KM C + +P RPT +
Sbjct: 337 PDFAPPEIYSIMKM---CWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 589 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.48 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.14 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.97 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.94 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.8 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.78 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.59 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.58 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.49 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.35 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.29 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.25 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.07 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.07 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.06 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.05 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.04 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.0 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-57 Score=527.33 Aligned_cols=258 Identities=31% Similarity=0.549 Sum_probs=202.9
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeec
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 377 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 377 (589)
++++++. ..|...++||+|+||.||+|+. .++..||||++..... ....|++.+++++|||||+++|+|.+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEc
Confidence 3444443 4567788999999999999997 4789999999865432 11245888999999999999999954
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
.+..++||||+++|+|.++++. ++|..+.+|+.|+|+||+|||+.. .++|+||||||+||+++.++.++
T Consensus 755 --~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlkp~Nil~~~~~~~~ 823 (968)
T PLN00113 755 --EKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRC--SPAVVVGNLSPEKIIIDGKDEPH 823 (968)
T ss_pred --CCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCC--CCCeecCCCCHHhEEECCCCceE
Confidence 4678999999999999999952 899999999999999999999653 45699999999999999999988
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHH----HHHh------
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR----LAAE------ 527 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~----~~~~------ 527 (589)
+. ||.+...... ....++.+|+|||++.+..++.++|||||||++|||+||+.|++.... ...+
T Consensus 824 ~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 897 (968)
T PLN00113 824 LR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897 (968)
T ss_pred EE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC
Confidence 75 6655433221 122467889999999999999999999999999999999999853211 0001
Q ss_pred hhhHHHhhccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 528 SATFENFIDRNLKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 528 ~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
......++|+.+.. .....+..++.+++.+||+.||++||+|+||++.|+.+.+
T Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 11223344544432 2345667788999999999999999999999999998765
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=458.51 Aligned_cols=277 Identities=39% Similarity=0.765 Sum_probs=238.4
Q ss_pred cccCHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeee
Q 007788 297 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376 (589)
Q Consensus 297 ~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 376 (589)
..|+++|+..||++|+..++||+|+||.||+|.+++|..||||++....... ..+|.+|++++++++|||+|+++|||.
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 3689999999999999999999999999999999999999999887765332 567999999999999999999999997
Q ss_pred cCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCce
Q 007788 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP 456 (589)
Q Consensus 377 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~ 456 (589)
+.+. +.++|||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.. .|+||||||||+|||||+++++
T Consensus 142 e~~~-~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~--~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 142 EGGE-HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGC--PPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred cCCc-eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCC--CCCEecCCCCHHHeeECCCCCE
Confidence 6422 699999999999999999987643 6999999999999999999999864 7899999999999999999999
Q ss_pred EEccccccccccC-CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhH--------HH---
Q 007788 457 LIADCGLHKLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM--------RL--- 524 (589)
Q Consensus 457 kl~DfGla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~--------~~--- 524 (589)
||+|||+|+.... ........ .||.+|+|||++..+..++|+|||||||+|+||+||+.+.+... .+
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999999976654 22211111 78999999999999999999999999999999999998776321 11
Q ss_pred HHhhhhHHHhhccccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 525 AAESATFENFIDRNLK-GKFSE-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
......+.+++|+.+. ..+.. .+...+.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1222367889999987 55554 67888999999999999999999999999996654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=403.70 Aligned_cols=256 Identities=28% Similarity=0.524 Sum_probs=215.1
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
.+.||+|+||+||+|.++....||||++...... ...++|.+|+.+|.+++|||||+++|+|.+. .....+|||||++
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~-~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP-PGSLCIVTEYMPG 124 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCceEEEEEeCCC
Confidence 3559999999999999985555999999865432 2257899999999999999999999999543 2268999999999
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEccccccccccCCc
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKLLADDI 471 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 471 (589)
|+|.++++.. ....++|..+++||.|||+||.|||+.+ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~---~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEG---P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---C-eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999885 2235999999999999999999999876 3 99999999999999998 99999999998766432
Q ss_pred eeeeecCCccccccCccccc--CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHH
Q 007788 472 VFSVLKTSAAMGYLAPEYVT--TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (589)
.......||..|||||++. ...|++|+|||||||+||||+||+.||...... .....++....+...+..+..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCccCCH
Confidence 1233367899999999999 568999999999999999999999999876542 122334445556666667888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 550 KLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 550 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+..++.+||+.||+.||++.+++..|+.+..
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 99999999999999999999999999997654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=400.88 Aligned_cols=262 Identities=28% Similarity=0.549 Sum_probs=225.7
Q ss_pred cccCHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeee
Q 007788 297 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376 (589)
Q Consensus 297 ~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 376 (589)
+.++.+++.. .+.||+|.||.||.|.++....||||.++... ....+|.+|+.+|++++|+|||+++|+|.
T Consensus 201 wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 201 WEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred eeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 4555566544 46799999999999999988899999998763 33467999999999999999999999995
Q ss_pred cCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCce
Q 007788 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP 456 (589)
Q Consensus 377 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~ 456 (589)
.+ +.++||||||+.|+|.++|+...+ ..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+
T Consensus 272 ~~--~piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~~-----~IHRDLAARNiLV~~~~~v 342 (468)
T KOG0197|consen 272 KQ--EPIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESKN-----YIHRDLAARNILVDEDLVV 342 (468)
T ss_pred cC--CceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhCC-----ccchhhhhhheeeccCceE
Confidence 43 579999999999999999997433 35888999999999999999999998 9999999999999999999
Q ss_pred EEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhh
Q 007788 457 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 457 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 535 (589)
||+|||+|+...++.+.......-.+.|.|||.+..++++.|||||||||+||||+| |+.|+..... ...-+.+
T Consensus 343 KIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----~ev~~~l 417 (468)
T KOG0197|consen 343 KISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----EEVLELL 417 (468)
T ss_pred EEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----HHHHHHH
Confidence 999999999777766656666666788999999999999999999999999999999 6667654432 2345566
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 536 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+...+-..++.+++.+.+++..||+.+|++|||++.+...|+.+..
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 6777778889999999999999999999999999999888887653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=377.81 Aligned_cols=262 Identities=20% Similarity=0.392 Sum_probs=218.9
Q ss_pred ccCHHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeee
Q 007788 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376 (589)
Q Consensus 298 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 376 (589)
.+++.|++. .+.||+|..|+|||+.++ +++.+|+|++.........++..+|++++.+.+||+||+++|.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355666654 578999999999999987 789999999977766777789999999999999999999999997
Q ss_pred cCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCCCeeecCCCc
Q 007788 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 377 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
.... +..|+||||++|||++++.... .+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|+
T Consensus 148 ~~~~-~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~-----IIHRDIKPsNlLvNskGe 217 (364)
T KOG0581|consen 148 SNGE-EISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK-----IIHRDIKPSNLLVNSKGE 217 (364)
T ss_pred eCCc-eEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC-----eeeccCCHHHeeeccCCC
Confidence 6543 6999999999999999998653 38999999999999999999996 55 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHH-HHHhhhhHHHh
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-LAAESATFENF 534 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~ 534 (589)
+||||||.++.+.... .....||..|||||.+.+..|+.++||||||++++|+.+|+.|+..... ...+-.-+..+
T Consensus 218 VKicDFGVS~~lvnS~---a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I 294 (364)
T KOG0581|consen 218 VKICDFGVSGILVNSI---ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI 294 (364)
T ss_pred EEeccccccHHhhhhh---cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence 9999999999886652 2345688889999999999999999999999999999999999976421 11122223334
Q ss_pred hccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 535 IDRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 535 ~~~~~~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
++. ..+..+.+ .+.++..++..|+++||.+||+++|+++|-+..+
T Consensus 295 v~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 295 VDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred hcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 432 22334444 7889999999999999999999999999866543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=405.80 Aligned_cols=259 Identities=25% Similarity=0.446 Sum_probs=220.7
Q ss_pred ccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 312 SEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
...+.||+|+||+||+|+.. +...||||.++.....+...+|.+|+++++.++|||||+++|+|.+ .+..++
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~~P~~M 566 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE--GDPLCM 566 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--CCeeEE
Confidence 34567999999999999853 3568999999998877688999999999999999999999999954 578999
Q ss_pred EEEeCCCCChHHHhhhhcCC----------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 386 IYDFAPKGKLSKYLDQEEGS----------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
|+|||..|||.+||..+... ..+++-.+.+.||.|||.||+||-+.+ +|||||.++|+||.++..
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-----FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-----FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-----ccccchhhhhceeccceE
Confidence 99999999999999865421 233888999999999999999999887 999999999999999999
Q ss_pred eEEccccccccccCCceeeee-cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHH
Q 007788 456 PLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 533 (589)
+||+|||+++..-...+++.. ...-.++|||||.+..++|+++||||||||||||++| |+.|+++..... -++.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----VIe~ 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----VIEC 717 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----HHHH
Confidence 999999999976555454444 4556789999999999999999999999999999998 788887754321 2223
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
+.+..+ ...++.++.+++.|+..||+..|++||+++||-..|+...+.
T Consensus 718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 333333 567889999999999999999999999999999999977654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=354.87 Aligned_cols=200 Identities=26% Similarity=0.456 Sum_probs=176.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.+|...+.||+|+||+||+|+++ ++..||||.+.... .+...+-...|+++|++++|||||++++++. ..+.+++|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~--~~~~i~lV 87 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE--DDDFIYLV 87 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe--cCCeEEEE
Confidence 45666777999999999999986 68999999998764 3455667889999999999999999999984 45799999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC------CceEEcc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ------FNPLIAD 460 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~------~~~kl~D 460 (589)
||||.+|||.+|++.++. +++.+...++.|+|.||++||+++ ||||||||+||||+.. -.+||+|
T Consensus 88 MEyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~~-----IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHENN-----IIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCcceEEeccCCCCCCCceEEecc
Confidence 999999999999998753 899999999999999999999998 9999999999999875 4579999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
||+|+.+..... .....|++-|||||++..++|+.|+|+||.|++||++++|+.||...
T Consensus 159 FGfAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 159 FGFARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred cchhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999876542 23456888899999999999999999999999999999999999754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=342.71 Aligned_cols=262 Identities=19% Similarity=0.348 Sum_probs=213.7
Q ss_pred cCccccccccCCCccEEEEE-ecCCcEEEEEEeccCC-CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|.+.+.||+|.||+||++. +.+|..||.|.+.-.. .....++...|+.+|++++|||||+++++-..++.+..+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 35566889999999999998 4689999999987443 244567899999999999999999999965555555589999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+..|||...+..-+.....+++.+.+++..|+++||.++|+.- -+..|.||||||.||+++++|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999876656667999999999999999999999843 1234999999999999999999999999999998
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC-HH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-ES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 546 (589)
...... .....||+.||+||.+.+.+|+.|+||||+||++|||+.-+.||++..-..- ...+.+ .-....+ .-
T Consensus 179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L-~~KI~q----gd~~~~p~~~ 252 (375)
T KOG0591|consen 179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL-CKKIEQ----GDYPPLPDEH 252 (375)
T ss_pred cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH-HHHHHc----CCCCCCcHHH
Confidence 765432 2346799999999999999999999999999999999999999987633211 112221 1122233 66
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+..+..++..|+..||+.||+...+++.++.
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 78899999999999999999996556555543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=383.67 Aligned_cols=260 Identities=23% Similarity=0.465 Sum_probs=227.7
Q ss_pred ccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
....+.++||.|.||.||+|+++ ....||||.++....+..+.+|+.|..+|.++.||||++|.|+.. ..+.++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeE
Confidence 34556789999999999999986 246799999999888888899999999999999999999999984 457899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
||+|||+||+|+.||+.+.+. ++|.+..-|..+||.||.||-+.+ +|||||.++|||++.+..+|++|||++
T Consensus 707 IiTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm~-----YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDMN-----YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhcC-----chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999988764 999999999999999999999888 999999999999999999999999999
Q ss_pred ccccCCc--eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 465 KLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 465 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
+.+.++. .+...+....++|.|||.+.-++++.++|||||||||||.++ |..||.+... ++....+...++.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----QdVIkaIe~gyRL 853 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVIKAIEQGYRL 853 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----HHHHHHHHhccCC
Confidence 9886554 333333444678999999999999999999999999999887 8889876543 3445556677787
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
+.+.+++..+.+|++.||++|-.+||.+.|++..|+.+....
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 888999999999999999999999999999999999765544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=365.96 Aligned_cols=252 Identities=20% Similarity=0.394 Sum_probs=213.9
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.+|...++||+|||+.+|+++. ..|..||+|++.+... ........+||++-++++|||||++++++ ++.+.+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceEE
Confidence 4688899999999999999997 7899999999976432 34456788999999999999999999999 55689999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|.|+|++++|.+++..+. ++++.++..+..||+.||.|||+.+ |+|||||..|++|++++++||+|||+|.
T Consensus 96 vLELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~~-----IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSLG-----IIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred EEEecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhcC-----ceecccchhheeecCcCcEEecccceee
Confidence 999999999999998443 5999999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
.+..+.. ......||+.|+|||++.....+..+||||+|||||-|++|++||....-.. .+..+..... ..+.
T Consensus 167 ~le~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----ty~~Ik~~~Y--~~P~ 239 (592)
T KOG0575|consen 167 QLEYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----TYNKIKLNEY--SMPS 239 (592)
T ss_pred eecCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----HHHHHHhcCc--cccc
Confidence 8864432 2334569999999999999999999999999999999999999997653221 1222221111 2345
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
....+..+|+...++.+|.+|||+++|+.+-..
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 667788999999999999999999999987554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=354.56 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=206.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch------HHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
+.|...+.||+|+||.|-+|..+ +|+.||||++....... ......+|+++|+++.|||||++++++. ..+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~--~~d 249 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE--VPD 249 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee--cCC
Confidence 45667889999999999999864 79999999997653211 2233569999999999999999999994 457
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC---CceEE
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLI 458 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl 458 (589)
..|+|||||+||+|.+.+-.... +.+..-..++.|++.|+.|||+.| |+||||||+|||++.+ ..+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~G-----I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQG-----IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcC-----cccccCCcceEEeccCCcceEEEe
Confidence 78999999999999999976653 667777889999999999999999 9999999999999876 77999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCC---CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF---TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 535 (589)
+|||+|+..+.... .....||+.|.|||++.+..+ ..++|+||+|||||-+++|.+||.+...... -.+++.
T Consensus 321 tDFGlAK~~g~~sf--m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~eQI~ 395 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSF--MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKEQIL 395 (475)
T ss_pred cccchhhcccccee--hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHHHHh
Confidence 99999998875432 234568999999999987653 3488999999999999999999976533210 012222
Q ss_pred cccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 536 DRNL--KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 536 ~~~~--~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+ .+....+..++..+++.+++..||++|||++|++++-|.-
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 2222 2233466788999999999999999999999999998865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=366.73 Aligned_cols=255 Identities=26% Similarity=0.457 Sum_probs=216.3
Q ss_pred ccccCHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 296 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 296 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
.|.+++++|.. .+-||.|+.|.||+|+++ ++.||||+++... ..+|+.|++++||||+.+.|+|
T Consensus 118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeee
Confidence 35666666643 577999999999999997 6789999876432 2468899999999999999999
Q ss_pred ecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 376 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
.....++||||||+.|-|.+.|.... +++-.....|..+||.||.|||... |||||||+-||||+.+..
T Consensus 182 --tqsPcyCIiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK-----IIHRDLKSPNiLIs~~d~ 250 (904)
T KOG4721|consen 182 --TQSPCYCIIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK-----IIHRDLKSPNILISYDDV 250 (904)
T ss_pred --cCCceeEEeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh-----HhhhccCCCceEeeccce
Confidence 44567899999999999999998654 4777888999999999999999988 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 535 (589)
+||+|||.++...+.. ......||..|||||++.+.++++|+||||||||||||+||..||.+-.. ...+..+-
T Consensus 251 VKIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG 324 (904)
T KOG4721|consen 251 VKISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG 324 (904)
T ss_pred EEeccccchHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc
Confidence 9999999998776542 23345688999999999999999999999999999999999999965432 22334444
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 536 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
...+....+..+++.+.-|+..||+..|.+||++++++.||+.+.+..
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 455666778899999999999999999999999999999999887753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=354.64 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=219.2
Q ss_pred hhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+.+.....+.||+|-||.|..+....+..||||+++....+..+.+|.+|+++|.+++|||||+++|+|..+ +..++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI 613 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMI 613 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHH
Confidence 344556678999999999999999888999999999998888889999999999999999999999999654 678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+|||++|+|.+++..+.... +.-..-++|+.|||.||+||.+.+ +|||||.++|+|+|+++++||+|||.++.
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n-----fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN-----FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc-----hhhccccccceeecCcccEEecCcccccc
Confidence 99999999999998875432 344556789999999999999988 99999999999999999999999999996
Q ss_pred ccCCceeeee-cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh--CCCCcchhHHHHHhhhhHHHhhcccc---C
Q 007788 467 LADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNL---K 540 (589)
Q Consensus 467 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 540 (589)
+-....+... ...-.++|||+|.+..++++.++|||+|||+|||+++ ...||....+....+ ....+++..- .
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve-n~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE-NAGEFFRDQGRQVV 765 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH-hhhhhcCCCCccee
Confidence 6554444433 3445678999999999999999999999999999875 567887655433221 2223333221 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+.-++..+.+++.+||..|-++||+++++...|++.+
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2346678889999999999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=391.52 Aligned_cols=262 Identities=27% Similarity=0.521 Sum_probs=217.0
Q ss_pred cCccccccccCCCccEEEEEecC--Cc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRD--GT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
+.+..+.||+|+||.||.|...+ |. .||||.++......+..+|.+|..+|++++|||||+++|+|.+ ....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCc
Confidence 34456789999999999999753 43 4999999988777888999999999999999999999999976 4678
Q ss_pred EEEEEeCCCCChHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+|++|||++|||..||++.+. ....++....+.++.|||+|+.||++++ +|||||.++|+||++...+||+|
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-----fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-----FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-----CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999987632 2345899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCceeeee-cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccc
Q 007788 461 CGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 461 fGla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
||+|+......++... ...-..+|||||.+..+.++.|+|||||||+|||++| |..||.+.... +.+..+....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~~~~~gg 921 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLLDVLEGG 921 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHHHHHhCC
Confidence 9999954443333333 3244568999999999999999999999999999999 56666543321 1112222223
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 539 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
+...+..+++.+++++..||+.+|++||+++.+++++..+.+..
T Consensus 922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 55678889999999999999999999999999999887665543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=360.99 Aligned_cols=265 Identities=23% Similarity=0.411 Sum_probs=208.1
Q ss_pred hhccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG 379 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 379 (589)
+.++|...+.||+|+||.||+|.. .+++.||||++...........+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 456788889999999999999974 235789999997654444556799999999999 899999999988543
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCC------------------------------------------------------
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGS------------------------------------------------------ 405 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~------------------------------------------------------ 405 (589)
.+..++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 35689999999999999999753210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee-eeecCCc
Q 007788 406 ----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSA 480 (589)
Q Consensus 406 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~ 480 (589)
..++++...+.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ......+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 134888999999999999999999988 999999999999999999999999999865432211 1122334
Q ss_pred cccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhc
Q 007788 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCT 559 (589)
Q Consensus 481 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~ 559 (589)
+..|+|||++.+..++.++|||||||++|||++ |..||....... .+...+........+...+..+.+++..||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGTRMRAPENATPEIYRIMLACW 314 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 567999999999999999999999999999997 999986532111 111111111112223445667999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhc
Q 007788 560 HEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 560 ~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+.||++|||+.|+++.|+.+.+
T Consensus 315 ~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 315 QGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=343.60 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=207.6
Q ss_pred cCccccccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++...+.||+|+||.||++...+ |...|||......... .+.+.+|+.+|.+++|||||+.+|.........+++.||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34556899999999999999764 8999999987663222 566889999999999999999999753332236899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGla~~~ 467 (589)
|+++|+|.+++....+ .+++....+++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g-----~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG-----IVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999987654 3999999999999999999999988 999999999999999 799999999999877
Q ss_pred cC--CceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 468 AD--DIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 468 ~~--~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
.. ..........||+.|||||++..+. ...++||||+||++.||+||+.||...... ....+..... ...+..+
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~--~~~~~~ig~~-~~~P~ip 245 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE--AEALLLIGRE-DSLPEIP 245 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch--HHHHHHHhcc-CCCCCCC
Confidence 63 2222233467889999999999643 335999999999999999999998763111 1111111111 2223566
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+.+..+++..|++.||++|||+++++++.....
T Consensus 246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 677888999999999999999999999999876543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.47 Aligned_cols=265 Identities=25% Similarity=0.400 Sum_probs=210.6
Q ss_pred CHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC
Q 007788 300 NLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR 378 (589)
Q Consensus 300 ~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 378 (589)
+.++|+...+.+...+.||+|.||+||+|.|.. .||||++..... ....+.|.+|+..+++-+|.||+=+.|||..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~- 459 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN- 459 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-
Confidence 345555555666677899999999999999963 599999987764 3445789999999999999999999999954
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEE
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
....||+.+++|-+|..+||..+. .++..+.+.||.|||.||.|||.++ |||||||+.||++.++++|||
T Consensus 460 --p~~AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK~-----IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 460 --PPLAIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAKN-----IIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred --CceeeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhhh-----hhhhhccccceEEccCCcEEE
Confidence 234999999999999999997763 4999999999999999999999998 999999999999999999999
Q ss_pred ccccccccccCCc-eeeeecCCccccccCcccccCC---CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 459 ADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 459 ~DfGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
+|||++..-..-. ........+.+.|||||++..+ +|+..+||||||+|+|||+||..||....+.. .+..+
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----IifmV 605 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIFMV 605 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEEEe
Confidence 9999976432110 0011223456779999999753 58999999999999999999999997443211 11111
Q ss_pred hccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 535 IDRNLK---GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 535 ~~~~~~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
-...+. ......+..++.+|+..||..++++||.+.+++..|+.+.+
T Consensus 606 GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 001001 12235678899999999999999999999999998887765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=360.81 Aligned_cols=267 Identities=24% Similarity=0.443 Sum_probs=216.9
Q ss_pred HHHHhhccCccccccccCCCccEEEEEecC--C--cE-EEEEEecc--CCCchHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 303 EVESATQCFSEVNLLGKGNFSSVYKGTLRD--G--TL-VAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 303 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~l~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
.|+...++-...+.||+|+||.||+|+++. + .. ||||..+. ...+....+|++|.++|++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344444444556899999999999999763 2 23 89999885 23356678999999999999999999999999
Q ss_pred ecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 376 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
.. ....++|||+|+||+|.++|..... .++..+++.++.+.|.||+|||+.+ ++||||.++|+|++.++.
T Consensus 231 ~~--~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~-----~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 231 VL--EEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN-----CIHRDIAARNCLYSKKGV 300 (474)
T ss_pred cC--CCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC-----CcchhHhHHHheecCCCe
Confidence 55 4779999999999999999987654 4999999999999999999999998 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHh
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 534 (589)
+||+|||+++.-.. ...........++|+|||.+..+.|+.++|||||||++||+++ |..||.+....... ..+
T Consensus 301 vKISDFGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~----~kI 375 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK----AKI 375 (474)
T ss_pred EEeCccccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH----HHH
Confidence 99999999886541 1111112234578999999999999999999999999999999 78888765433221 222
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
+....+...+...+..+..++..||..+|++||+|.++.+.++.+.....
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 23344445556778889999999999999999999999999998876643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=338.26 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=200.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|+..++||+|+||+||.++.+ +++.+|+|++++... ..+.+....|..+|.+++||+||+++-.+ ++.+..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEE
Confidence 357888999999999999999865 689999999987654 23456788999999999999999997555 6678999
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+|+||+.||.|..+|+... .+++.++.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||++
T Consensus 102 lVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g-----IiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG-----IIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred EEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHeeecCCCcEEEeccccc
Confidence 9999999999999998664 3889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+..-.... ......||+.|||||++.+..|+..+|+||+|+++|||++|..||......... +.+..... ...+
T Consensus 173 k~~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~----~~I~~~k~-~~~p 246 (357)
T KOG0598|consen 173 KEDLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY----DKILKGKL-PLPP 246 (357)
T ss_pred hhcccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH----HHHhcCcC-CCCC
Confidence 85433221 222357899999999999999999999999999999999999999876543222 22222221 1122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC
Q 007788 545 ESEAAKLGKMALVCTHEDPENRP 567 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RP 567 (589)
.-......+++...++.||++|-
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhc
Confidence 33456677888888899999995
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=343.13 Aligned_cols=261 Identities=21% Similarity=0.351 Sum_probs=209.4
Q ss_pred ccCHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 298 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
.++.+++.. .....||+|++|.||+|.+ +|+.||||+++..... ...+.|.+|+.++.+++||||++++|++
T Consensus 14 ~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 14 CIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 345566532 2236799999999999998 6889999999765322 2246788999999999999999999998
Q ss_pred ec--CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecC
Q 007788 376 CS--RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 376 ~~--~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~ 452 (589)
.+ ......++||||+++|+|.+++.... .++|..+++++.+++.||+|||+. + ++||||||+||++++
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~-----~~Hrdlkp~nill~~ 158 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN-----KPYKNLTSVSFLVTE 158 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC-----CCCCcCChhhEEECC
Confidence 66 44457899999999999999997643 489999999999999999999975 5 789999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 530 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 530 (589)
++.+||+|||+++.+.... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----~ 230 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----I 230 (283)
T ss_pred CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----H
Confidence 9999999999998654322 22346778999999976 679999999999999999999999997543221 1
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
...+.........+...+..+.+++.+||+.||++|||++|+++.|++...
T Consensus 231 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 231 YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 122222222223344567789999999999999999999999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=325.79 Aligned_cols=254 Identities=19% Similarity=0.309 Sum_probs=199.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+.|+....+|+|+||.||+++.+ +|+.||||++..... +.-.+-.++|+++|++++|||+|.++.+| ......++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEEE
Confidence 34667788999999999999987 599999999976654 33345678999999999999999999999 445789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+||++..-|+++=+-. +-++.....+++.|+++|+.|+|+.+ +|||||||+|||++.++.+||||||+|+.
T Consensus 80 FE~~dhTvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n-----~IHRDIKPENILit~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN-----CIHRDIKPENILITQNGVVKLCDFGFART 150 (396)
T ss_pred eeecchHHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC-----eecccCChhheEEecCCcEEeccchhhHh
Confidence 9999885554443322 23888899999999999999999988 99999999999999999999999999998
Q ss_pred ccC-CceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh----------hHHHh
Q 007788 467 LAD-DIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----------TFENF 534 (589)
Q Consensus 467 ~~~-~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~----------~~~~~ 534 (589)
+.. +.. .+...+|..|+|||.+.+ .+|+..+||||.||++.||++|.+.|.+..+...-.. ....+
T Consensus 151 L~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 151 LSAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred hcCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 863 222 234557788999999987 7899999999999999999999998876543322111 01111
Q ss_pred hc----------cccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 535 ID----------RNLKGK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 535 ~~----------~~~~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+. +..... -.+.....+.+++..|++.||++|++.+|++.+
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11 110000 012335578899999999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=343.65 Aligned_cols=259 Identities=20% Similarity=0.346 Sum_probs=209.4
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+.|+.++.||+|.||.||+|+. .+|+.||+|++..+.. .....-..+||.+|+++.||||++|.+...+.....+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4466678899999999999985 5899999999987653 3334566799999999999999999999987767899999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+|||+. ||..++....- .++..++..++.|++.||+|+|+++ |.|||||.+|||||.+|.+||+|||+|++
T Consensus 197 FeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~g-----vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSRG-----VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred Eecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhcC-----eeeccccccceEEcCCCCEEeccccceee
Confidence 999987 88888875432 4899999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc--------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-------- 537 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 537 (589)
+........+....|..|+|||.+.+. .|+.++|+||.||||.||++|+..+.+..+..+-...++-.-.+
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 876655455566778899999999875 69999999999999999999999998766554333222111000
Q ss_pred cc------CC--CC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 538 NL------KG--KF-------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 538 ~~------~~--~~-------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.+ +. .+ ....+....+|+..++..||.+|.|+.++++.=
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 00 00 00 112245677888889999999999999998653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=335.89 Aligned_cols=256 Identities=19% Similarity=0.386 Sum_probs=206.6
Q ss_pred ccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|.++ .+..||+|.++..........|.+|+..+.+++||||++++|++.. .+..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCcE
Confidence 46778899999999999999864 4678999999876544555689999999999999999999999854 56889
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~-----iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG-----YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeeccccHhhEEEcCCCcEEECCCccc
Confidence 9999999999999997643 24899999999999999999999987 999999999999999999999999987
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
...............++..|+|||.+.+..++.++|||||||++||+++ |+.||........ ... +........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~----~~~-~~~~~~~~~ 229 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV----IKA-VEDGFRLPA 229 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHH-HHCCCCCCC
Confidence 6543322222222334567999999999999999999999999999875 9999865432111 111 111222233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+..++..+.+++..||+.+|++||+++++++.|...
T Consensus 230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 455677899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=339.88 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=203.2
Q ss_pred ccCccccccccCCCccEEEEEecC-----------------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccce
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD-----------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l 371 (589)
++|...+.||+|+||.||+|.+++ +..||+|.+..........+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999998642 347999999876545556789999999999999999999
Q ss_pred eeeeecCCCCeEEEEEEeCCCCChHHHhhhhcC---------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCC
Q 007788 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436 (589)
Q Consensus 372 ~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ 436 (589)
++++.. .+..++||||+++|+|.+++..... ....++|...++++.||+.||+|||+.+
T Consensus 85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---- 158 (304)
T cd05096 85 LGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---- 158 (304)
T ss_pred EEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC----
Confidence 999854 4678999999999999999865321 1134788999999999999999999988
Q ss_pred CeEecCCCCCCeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh--
Q 007788 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-- 513 (589)
Q Consensus 437 ~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-- 513 (589)
|+||||||+||++++++.+||+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++
T Consensus 159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred -ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999999998664432222 122334678999999998899999999999999999997
Q ss_pred CCCCcchhHHHHHhhhhHHHhhcc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 514 GSLVLTSSMRLAAESATFENFIDR---NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 514 g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+..||.......... ........ ......+..++..+.+++.+||+.||++|||+.||.+.|++
T Consensus 238 ~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTDEQVIE-NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCHHHHHH-HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 456665432211111 11111111 11111223456789999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=352.21 Aligned_cols=261 Identities=23% Similarity=0.403 Sum_probs=205.5
Q ss_pred hccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~ 380 (589)
.++|+..+.||+|+||.||+|.. .++..||||+++..........+.+|+.++..+ +||||++++++|.. .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--G 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence 45677889999999999999974 246689999997654444556789999999999 89999999999944 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcC--------------------------------------------------------
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEG-------------------------------------------------------- 404 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 404 (589)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 678999999999999999965321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 405 ---------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 405 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
....++|..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 0124789999999999999999999987 99999999999999999999999999986644
Q ss_pred Cceeee-ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 470 DIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 470 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .....+........+...
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 342 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIKEGYRMLSPECA 342 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHHhCccCCCCCCC
Confidence 322111 11234567999999999999999999999999999998 788886432111 112222222222222334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.++.+++..||+.||++||++.|+++.|++.
T Consensus 343 ~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 343 PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 56789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=350.30 Aligned_cols=263 Identities=21% Similarity=0.399 Sum_probs=207.3
Q ss_pred HhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
...++|+..+.||+|+||.||+|... ++..||||+++..........+.+|+++++.+ +|+||++++++|..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~- 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH- 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-
Confidence 34457888899999999999999742 34579999998665444556788999999999 89999999999844
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------------------------------------------------
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------------------------------------------------ 404 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------------------------------------------------ 404 (589)
.+..++||||+++|+|.++++....
T Consensus 114 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 114 -GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred -CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 4689999999999999999864321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce
Q 007788 405 ------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472 (589)
Q Consensus 405 ------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 472 (589)
...++++...++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-----CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 1134788999999999999999999987 99999999999999999999999999986544322
Q ss_pred eeee-cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 473 FSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 473 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.... ...++..|+|||++.+..++.++|||||||++|||++ |+.||....... .....+........+...+..
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHHHHcccCccCCCCCCHH
Confidence 1111 2234567999999998899999999999999999997 999986543211 112222222222222233567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 551 LGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.+++..||+.||++||++.++++.|+.+
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 89999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=343.15 Aligned_cols=251 Identities=18% Similarity=0.330 Sum_probs=211.9
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
...|.....||+|+.|.||.|.. .+++.||||++.... .....-..+|+.+|+..+|+|||.++.-|... ++.++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEE
Confidence 45677778999999999999985 478999999998764 23344577999999999999999999987543 789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||||++|+|.+.+.... +++.+...|+.+++.||+|||..+ |+|||||++|||++.++.+||+|||++..
T Consensus 349 MEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g-----IiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG-----IIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred EeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc-----eeeeccccceeEeccCCcEEEeeeeeeec
Confidence 99999999999997553 899999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
+..... ......||+.|||||+.....|++|+||||||++++||+-|..||.......... .-..........++.
T Consensus 419 i~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly---LIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 419 ISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTPKLKNPEK 494 (550)
T ss_pred cccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH---HHhhcCCCCcCCccc
Confidence 766543 3445679999999999999999999999999999999999999997543321111 111122233345677
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.+..+.++..+|++.|+++||++.|+|+|
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 78899999999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=327.58 Aligned_cols=261 Identities=20% Similarity=0.320 Sum_probs=208.4
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.+.|+..+.||.|..++||+|.. +.+..||||++..+.+....+...+|+..|+.++||||++++..|.. ....|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEEe
Confidence 35677889999999999999985 47899999999998887778899999999999999999999877744 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|.||.+|++.+.+...... -+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..
T Consensus 103 mpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G-----~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG-----HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred ehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC-----ceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999876543 3899999999999999999999998 89999999999999999999999998766
Q ss_pred ccCCce---eeeecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh----cc
Q 007788 467 LADDIV---FSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI----DR 537 (589)
Q Consensus 467 ~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----~~ 537 (589)
+-+... .......+++.|||||++.. ..|+.|+||||||++..||.+|..||........--..+..-. ..
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 543321 11133468899999999543 4599999999999999999999999965432211111110000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.+..+........+.+++..|+++||++|||+++++++-.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 0111112233557889999999999999999999998744
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=308.85 Aligned_cols=260 Identities=22% Similarity=0.343 Sum_probs=206.5
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchH-HHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.+|...+.+|+|.||.||+|+. .+|+.||||+++....+++ .....+||+.|+.++|+||+.+++++. ..+...+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEE
Confidence 3577778999999999999986 4799999999987754433 356889999999999999999999984 45778999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+|||+. ||+..++.... .++-.....++.++.+|++|||+.. |+||||||.|+|++.+|.+||+|||+|+.
T Consensus 80 fEfm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~~-----IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSKW-----ILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred EEeccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhhh-----hhcccCCccceEEcCCCcEEeecccchhc
Confidence 999965 99999987643 5888999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH-------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE------------- 532 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~------------- 532 (589)
+......... ...|..|+|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+..+..+-...+.
T Consensus 151 f~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 151 FGSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred cCCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 8754332222 2456779999988875 599999999999999999999887776544332222111
Q ss_pred ----Hhhccc-----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 533 ----NFIDRN-----LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 533 ----~~~~~~-----~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
+...-. .....-..+.....+++..++..+|.+|.++.|++++-....
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 111100 001122344566799999999999999999999998865543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.88 Aligned_cols=262 Identities=22% Similarity=0.409 Sum_probs=224.3
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
++|+-...+....+.||-|.||.||.|.|+. ...||||.++.+. .+..+|+.|..+|+.++|||+|+++|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~E-- 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-- 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccC--
Confidence 4444444455667899999999999999874 6789999998764 4567999999999999999999999999654
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...|||+|||..|+|.+||+.+... .++-...+.||.||+.||+||..++ +|||||.++|+|+.++..+|++|
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkkn-----FIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHhh-----hhhhhhhhhhccccccceEEeec
Confidence 5789999999999999999988653 4677778999999999999999888 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
||+++++..+.+....+..-.+.|.|||.+....++.|+|||+|||+||||.| |-.||.+-.. ....+++...+
T Consensus 409 FGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----SqVY~LLEkgy 483 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYGLLEKGY 483 (1157)
T ss_pred cchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HHHHHHHhccc
Confidence 99999998876655545555678999999999999999999999999999998 6667654322 23456666777
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+-+.++.|+..+++|++.||+..|++||+++|+-+.++.+
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 7778889999999999999999999999999999988754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.48 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=208.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.+|+..+.||+|+||.||+|.+. ++. .||+|.++.........+|.+|+.+++.++||||++++|+|.. +..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence 46888899999999999999864 333 4899998765444556789999999999999999999999854 356
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++|+||+++|+|.+++..... .+++...+.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~-----iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred eeeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEecCCCcEEEccccc
Confidence 799999999999999986532 4889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... ........+..|+|||++.+..++.++|||||||++|||++ |+.||.+..... +...+......
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~ 230 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEKGERL 230 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhCCCCC
Confidence 987654322 11222334567999999999999999999999999999998 999986532211 12222222222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+..+...+.+++..||+.+|++||++.+++..+..+....
T Consensus 231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 233345567899999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=327.40 Aligned_cols=252 Identities=23% Similarity=0.455 Sum_probs=203.1
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||++.++++..+|+|.+.... ....+|.+|++++++++||||+++++++.. .+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEE
Confidence 3567778899999999999999888899999886543 234678999999999999999999999843 467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.++++.... .++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++...
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 80 FMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS-----FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred cCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999999975432 4899999999999999999999988 9999999999999999999999999988664
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...........++..|+|||++.+..++.++||||||+++|||++ |+.||........ ...+.. ......+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~----~~~i~~-~~~~~~~~~~ 226 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV----VEMISR-GFRLYRPKLA 226 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHC-CCCCCCCCCC
Confidence 433222223334567999999998889999999999999999999 8888865432111 111111 1111122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
+..+.+++.+||+.+|++||++.++++.|.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=327.68 Aligned_cols=256 Identities=23% Similarity=0.462 Sum_probs=208.5
Q ss_pred ccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|.+. +...||||.++.........+|.+|+.++++++||||+++++++.. .+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCceE
Confidence 56888899999999999999975 2468999998876555566789999999999999999999998843 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++....+ .++|..+++++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 82 iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 82 IITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred EEEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCCEEECccchh
Confidence 99999999999999976543 4899999999999999999999987 999999999999999999999999999
Q ss_pred ccccC-CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 465 KLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 465 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
+.... ..........++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-----~~~~~~~~~~~ 228 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-----IKAVEDGYRLP 228 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-----HHHHHcCCCCC
Confidence 87752 22222222334567999999998899999999999999999998 9888864432111 11111111222
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+...+..+.+++.+||+.+|++||+++|++++|+.+
T Consensus 229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=334.03 Aligned_cols=249 Identities=30% Similarity=0.598 Sum_probs=195.6
Q ss_pred ccccccCCCccEEEEEec-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 314 VNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
.+.||.|.||.||+|.+. .+..|+||.++.........+|.+|++.+++++||||++++|+|.. .+..++|||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc--ccccccccc
Confidence 467999999999999987 3678999999765545557899999999999999999999999973 356899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.++|.... ...+++..++.|+.|||+||+|||+.+ ++|+||+++||++++++.+||+|||++....
T Consensus 82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN-----IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT-----EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccc
Confidence 999999999998872 234899999999999999999999987 9999999999999999999999999998763
Q ss_pred CCc-eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 469 DDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 469 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
... ............|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....+ ........+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~-~~~~~~~~~~~ 229 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKL-KQGQRLPIPDN 229 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHH-HTTEETTSBTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccc-cccccceeccc
Confidence 222 112222335567999999999889999999999999999999 678875542211 11222 22222334445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
++..+.+++..||+.+|++||+|+++++.|
T Consensus 230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=338.23 Aligned_cols=261 Identities=18% Similarity=0.315 Sum_probs=207.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||++... ++..||+|.+...........+.+|++++++++||||+++++++.. .+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEE
Confidence 367888899999999999999976 6889999999865444455679999999999999999999999854 4689999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+. |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKHQ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred eecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCC----EEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 99999999999997643 38899999999999999999998532 99999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh-----------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----------------- 529 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~----------------- 529 (589)
..... .....++..|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 154 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 154 LIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 54322 1233577889999999998999999999999999999999999964221100000
Q ss_pred ------------------------hHHHhhccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 530 ------------------------TFENFIDRNLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 530 ------------------------~~~~~~~~~~~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
...+.+....... .......++.+++.+||+.||++|||++|++++.+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000000000001 011245678999999999999999999999999876443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.78 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=208.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|...+.||+|+||.||+|.+. +++ .|++|.+..........++..|+..++++.||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence 35667789999999999999874 344 4788887654433444678888999999999999999998742 456
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++++||+++|+|.+++..... .++|..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred EEEEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEEcCCcc
Confidence 889999999999999976442 4899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... .......++..|+|||.+.++.++.++||||||+++||++| |+.||.+..... ..+.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~ 230 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----VPDLLEKGERL 230 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCcC
Confidence 986543221 11223345678999999998899999999999999999998 999986543211 12222222121
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccccccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLF 588 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~~~ 588 (589)
..+..+...+.+++.+||+.+|++|||+.|+++.|..+......+|+
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~~~ 277 (279)
T cd05111 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYLV 277 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcceec
Confidence 22223455678899999999999999999999999998887777664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=337.47 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=207.4
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|...+.||.|.||.||+|+- ..|..||||+++.....-++..=++|++.|+++. |||||++..++.+.+. ..++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEeee
Confidence 5777889999999999999985 4789999999988765555555678999999998 9999999999866533 89999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||||+. +|.+++..+. ..+++..+..|+.||.+||+|+|..| +.|||+||+|||+.....+||+|||+|+.
T Consensus 89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G-----fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG-----FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCChhheEecccceeEecccccccc
Confidence 999955 9999998773 46999999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCceeeeecCCccccccCccccc-CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh----------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---------------- 529 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~---------------- 529 (589)
......+ +....|..|+|||++. .+-|+.+.|+||+|||++|+.+-++.|.+..+...-.+
T Consensus 160 v~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 160 VRSKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 7665433 3455677899999876 46689999999999999999999999976544322111
Q ss_pred -hHHHhhcccc---CC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 530 -TFENFIDRNL---KG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 530 -~~~~~~~~~~---~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.+...+.-.+ .+ ..-+....+..+++.+|++.||.+|||+.|++++-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111111111 11 11123678899999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=313.83 Aligned_cols=237 Identities=22% Similarity=0.370 Sum_probs=200.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||.|+||+|.+++.+ +|..+|+|++..... ....+...+|..+|+.+.||+++++++-| .+.+..++
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCeEEE
Confidence 35667789999999999999976 689999999986542 22335677899999999999999999888 44688999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||++||-|..+|+.... ++.+.+..+|.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+
T Consensus 122 vmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~-----iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLD-----IIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcC-----eeeccCChHHeeeccCCcEEEEeccceE
Confidence 9999999999999998753 899999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..... .....||+.|+|||.+.+..|..++|+|||||++|||+.|..||+++..... ++.++...+. ++.
T Consensus 193 ~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i----Y~KI~~~~v~--fP~ 262 (355)
T KOG0616|consen 193 RVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI----YEKILEGKVK--FPS 262 (355)
T ss_pred EecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH----HHHHHhCccc--CCc
Confidence 88764 3345689999999999999999999999999999999999999998876433 3344433332 444
Q ss_pred HHHHHHHHHHHHhcccCCCCC
Q 007788 546 SEAAKLGKMALVCTHEDPENR 566 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~R 566 (589)
-....+.+|+...++.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 555667777777788888888
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=330.85 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=208.2
Q ss_pred ccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|+..+.||+|+||.||+|.... ...||+|.+..........+|.+|++.+.+++||||+++++++.. .+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CCc
Confidence 356777899999999999998643 257999999765544556679999999999999999999999853 467
Q ss_pred EEEEEEeCCCCChHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill 450 (589)
.+++|||+++|+|.+++...... ...+++...+.++.|++.||+|||+.+ ++||||||+||++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nil~ 157 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLV 157 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccccceEEE
Confidence 89999999999999999764211 145889999999999999999999988 9999999999999
Q ss_pred cCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhh
Q 007788 451 DQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAES 528 (589)
Q Consensus 451 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 528 (589)
++++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---- 233 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---- 233 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 9999999999999876533221 11222345677999999998899999999999999999998 99998754321
Q ss_pred hhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.....+........+...+..+.+++.+||+.||.+||+++||+++|+.
T Consensus 234 -~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 -EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1122222222333455667889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.99 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=197.1
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHh--ccCCCCccceeeeeecCC--CCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT--SLRHENIIRLRGFCCSRG--RGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~g~~~~~~--~~~~~lv~Ey~ 390 (589)
++||+|.||.||||++. ++.||||++.. ...+.|.+|-++.+ .++|+||++++++-...+ ..+.+||+||.
T Consensus 216 eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 57999999999999996 58999999973 45667888877765 558999999998653221 34789999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC----CCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS----EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
++|+|.+||... .++|....+|+..+++||+|||+. ++.+|+|+|||||++||||.+|+++.|+|||+|..
T Consensus 291 ~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 291 PKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred cCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999765 499999999999999999999974 33589999999999999999999999999999988
Q ss_pred ccCCce-eeeecCCccccccCcccccCCC-CC-----CcchhhhHHHHHHHHHhCCCCcc-h-------hHHH----HHh
Q 007788 467 LADDIV-FSVLKTSAAMGYLAPEYVTTGR-FT-----ERSDIFAFGVIILQILTGSLVLT-S-------SMRL----AAE 527 (589)
Q Consensus 467 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Dv~s~Gvvl~elltg~~p~~-~-------~~~~----~~~ 527 (589)
+..+.. .......||.+|||||++.+.. +. .+.||||+|.|||||++.-.-.+ + ..+. ...
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 764332 2334467999999999998753 22 36899999999999998633221 0 0110 000
Q ss_pred hhhHH-HhhccccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 528 SATFE-NFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 528 ~~~~~-~~~~~~~~~~~~~-----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
-..+. -++....++.++. ..+..+.+.+..||+.||+.|.|+.=|-++++++.-.
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 01111 2222333333322 3477899999999999999999999888887766543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=327.36 Aligned_cols=255 Identities=24% Similarity=0.444 Sum_probs=206.8
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++. ..+..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEE
Confidence 35678889999999999999998888899999986543 23567999999999999999999999884 456789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 81 EYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN-----YIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred ecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999976532 34889999999999999999999987 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
............++..|+|||++....++.++|||||||++|||+| |+.||......... ..+...........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~ 228 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-----SALQRGYRMPRMEN 228 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH-----HHHHcCCCCCCCCC
Confidence 5433222222334567999999998889999999999999999999 89998654321111 11111112222233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 45678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=326.84 Aligned_cols=256 Identities=23% Similarity=0.452 Sum_probs=208.5
Q ss_pred hhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
..++|+..+.||+|++|.||+|...+++.||+|.++... ....+|.+|++++++++||||+++++++.. .+..++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeee
Confidence 345688889999999999999998888899999987543 234678999999999999999999998844 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++.... ...++|..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 99999999999997654 235899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..............+..|+|||++.+..++.++||||||+++|||+| |+.||.+...... ...+........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~ 227 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-----LQQVDQGYRMPCPP 227 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHHcCCCCCCCC
Confidence 65432222222223457999999999899999999999999999999 8888865432211 11112222222334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 556789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=335.81 Aligned_cols=248 Identities=20% Similarity=0.361 Sum_probs=210.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|...+.||+|.||.||||+-+ +.+.||+|.+.+... +.+.+...+|++++++++|||||.++++| +...+.++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEE
Confidence 46777889999999999999866 689999999976543 44556789999999999999999999998 566899999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+||+.+ +|..+|.... .+++.....|+.++..||.|||+.+ |+|||+||+|||++.++.+|++|||+|+.
T Consensus 80 te~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r-----ilhrd~kPqniLl~~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR-----ILHRDMKPQNILLEKGGTLKLCDFGLARA 149 (808)
T ss_pred ehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCCcceeeecCCCceeechhhhhhh
Confidence 999977 9999998654 3999999999999999999999988 99999999999999999999999999998
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
+..... ......||+-|||||...++.|+..+|.||+||++||+++|++||+...-..- .+.+..... ..+..
T Consensus 150 m~~~t~-vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L----v~~I~~d~v--~~p~~ 222 (808)
T KOG0597|consen 150 MSTNTS-VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL----VKSILKDPV--KPPST 222 (808)
T ss_pred cccCce-eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH----HHHHhcCCC--CCccc
Confidence 876543 34456799999999999999999999999999999999999999975432111 111221111 23446
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....+..++...+.+||.+|.+..+++.|
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 77788999999999999999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=332.82 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=202.6
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
|+..+.||+|+||.||+|... +|+.||||.+..... ......+.+|++++.+++|+||+++.+++.+ .+..++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEE
Confidence 667789999999999999864 789999999875432 2233467899999999999999999998843 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 80 e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 80 TIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER-----IVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred EecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 99999999988865432 24899999999999999999999988 999999999999999999999999999875
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... .....++..|+|||++.+..++.++|||||||++|||++|+.||.................. .....+...
T Consensus 153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 228 (285)
T cd05631 153 PEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKF 228 (285)
T ss_pred CCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccC
Confidence 43321 22345788999999999999999999999999999999999999754321111111111111 111233445
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPT-----MEAVIEELT 577 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~ 577 (589)
+..+.+++..||+.||++||+ +++++++-+
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 667899999999999999997 899998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=336.70 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=207.4
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|...+.||+|+|.+|++|+.. .++.+|||++.+.-. +...+....|-.+|.+| .||.|++|+-.+ .+....
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDEESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecccce
Confidence 457888899999999999999865 699999999976432 22234566788899999 899999997666 556789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
|+|+||.++|+|.++++..+. +++.....+|.+|+.||+|||+.| ||||||||+|||||+||++||+|||.
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~G-----IIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSNG-----IIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeEcCCCcEEEeeccc
Confidence 999999999999999987753 888889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcee----------ee--ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 464 HKLLADDIVF----------SV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 464 a~~~~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
|+.+.+.... .. ..-.||..|.+||++..+..+..+|+|+|||+||.|+.|.+||....+... +
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----F 296 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----F 296 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----H
Confidence 9988643211 11 224578889999999999999999999999999999999999988766443 3
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+.+++-.+ .+++..++.+.+|+.+.+..||.+|++..++-+|
T Consensus 297 qkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 44433222 2344445678888888889999999999999865
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.16 Aligned_cols=265 Identities=23% Similarity=0.402 Sum_probs=208.0
Q ss_pred hhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG 379 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 379 (589)
+.++|++.+.||+|+||.||+|... +++.||+|+++..........+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 3457888899999999999999742 35789999997654444456788999999999 799999999988643
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCC------------------------------------------------------
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGS------------------------------------------------------ 405 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~------------------------------------------------------ 405 (589)
....+++|||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45788999999999999998643210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee-eeecCCcc
Q 007788 406 ---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAA 481 (589)
Q Consensus 406 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~ 481 (589)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++.+...... ......++
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 135899999999999999999999987 999999999999999999999999999876432211 11123345
Q ss_pred ccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcc
Q 007788 482 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH 560 (589)
Q Consensus 482 ~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~ 560 (589)
..|+|||++.+..++.++|||||||++|||++ |..||....... .+...+........+......+.+++.+||+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHHHHHhccCCCCCCccCCHHHHHHHHHHcc
Confidence 67999999999999999999999999999998 999986422111 1111222222222233455678999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhhc
Q 007788 561 EDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 561 ~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+|++||++.|++++|+.+-+
T Consensus 315 ~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 315 NNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=326.10 Aligned_cols=255 Identities=22% Similarity=0.422 Sum_probs=207.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.+|...+.||+|++|.||+|..+ .++.||+|.+... .....++.+|++++.+++||||+++++++.. .+..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEEE
Confidence 34667788999999999999975 5889999998754 3345679999999999999999999999854 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 82 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 82 EFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 99999999999976432 34899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
.............+.+|+|||.+.+..++.++|||||||++|||++ |..|+....... ....+........+..
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~ 229 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKGYRMERPEG 229 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCCCCCCCC
Confidence 5543322222334567999999999999999999999999999998 888886532211 1111222223333445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.58 Aligned_cols=265 Identities=25% Similarity=0.408 Sum_probs=209.2
Q ss_pred HhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecC
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR 378 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~ 378 (589)
...++|.+.+.||+|+||.||+|... .+..||||++...........|.+|+++++++. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~-- 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT-- 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--
Confidence 34567888899999999999999853 235799999976654455568999999999996 999999999994
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------------------------------------------------
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------------------------------------------------ 404 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------------------------------------------------ 404 (589)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 35789999999999999999875321
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 405 --------------------------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 405 --------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
....+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dikp~ 266 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-----CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChH
Confidence 0124788999999999999999999987 999999999
Q ss_pred CeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999998865432211 1122335567999999999899999999999999999997 88888653221
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
. .+...+........+...+..+.+++..||+.||++||++.++++.|+.+-+
T Consensus 347 ~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 S----TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H----HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 1111111222223344556789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=326.14 Aligned_cols=257 Identities=25% Similarity=0.503 Sum_probs=210.9
Q ss_pred HhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.+..+|+..+.||+|+||.||+|...++..+++|.+.... .....++..|+.++++++||||+++++++.. .+..++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYI 79 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEE
Confidence 3456788889999999999999999889999999987654 3345678999999999999999999999844 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++....+ ..+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+.
T Consensus 80 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~-----i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN-----SIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred EEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccCcceEEEcCCceEEEccccchh
Confidence 9999999999999986532 35899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
........ .....++..|+|||.+....++.++||||||+++|||++ |+.||....... .+..+ ........+
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----~~~~~-~~~~~~~~~ 226 (261)
T cd05148 153 LIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----VYDQI-TAGYRMPCP 226 (261)
T ss_pred hcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHH-HhCCcCCCC
Confidence 76543221 223345667999999998899999999999999999998 888886543211 11111 122222334
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+..+.+++.+||+.||++|||++++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 4556789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=327.61 Aligned_cols=260 Identities=22% Similarity=0.391 Sum_probs=205.5
Q ss_pred hhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
++++|+..+.||+|+||.||+|... .+..||||++..........+|.+|+.++++++||||+++++++. ..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 4677889999999999999999853 356799999865443345567999999999999999999999984 44
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCC------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGS------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~ 454 (589)
...++||||+++|+|.+++...... ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCcchheEEEcCCC
Confidence 6789999999999999999753321 234688999999999999999999987 99999999999999999
Q ss_pred ceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHH
Q 007788 455 NPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 455 ~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 532 (589)
.++|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~----~~~ 232 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----VLR 232 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence 99999999987654332211 112234667999999998899999999999999999999 678876543211 111
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...... ....+...+..+.+++.+|++.+|++||++.|++++|+.
T Consensus 233 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 112234456689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=337.05 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=208.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC---c-hHHHHHHHHHHHHhccC-CCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC---K-SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~ 381 (589)
.+.|...+.||+|+||+|+.|... ++..||+|++..... . .......+|+.++++++ ||||++++.++.. ..
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~ 93 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--PT 93 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--CC
Confidence 457788899999999999999865 789999997765411 1 22345567999999999 9999999999944 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceEEcc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIAD 460 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~D 460 (589)
..++||||+.+|+|.+++.... .+.+....+++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g-----i~HRDLK~ENilld~~~~~~Kl~D 164 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG-----IVHRDLKPENILLDGNEGNLKLSD 164 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEecCCCCCEEEec
Confidence 6999999999999999998743 3888999999999999999999998 9999999999999999 9999999
Q ss_pred cccccccc-CCceeeeecCCccccccCcccccCCC-CC-CcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 461 CGLHKLLA-DDIVFSVLKTSAAMGYLAPEYVTTGR-FT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 461 fGla~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
||++.... .+. ......|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+......... +...
T Consensus 165 FG~s~~~~~~~~--~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----i~~~ 238 (370)
T KOG0583|consen 165 FGLSAISPGEDG--LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----IRKG 238 (370)
T ss_pred cccccccCCCCC--cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----HhcC
Confidence 99999873 221 334556889999999999977 85 789999999999999999999987543322222 2221
Q ss_pred ccCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 538 NLKGKFSESE-AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 538 ~~~~~~~~~~-~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.. .++... +.++..++.+|+..||.+|+++.+++.+-|...
T Consensus 239 ~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 EF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred Cc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11 223333 778999999999999999999999998877665
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=337.44 Aligned_cols=255 Identities=25% Similarity=0.474 Sum_probs=220.2
Q ss_pred CccccccccCCCccEEEEEecC---C--cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRD---G--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
....++||.|-||.||+|.+.+ | -.||||.-+.+...+..+.|+.|..+|++++|||||+++|+|.+ ...+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeE
Confidence 3445789999999999998642 3 45888988876666778899999999999999999999999965 57899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|||.++-|.|..||+.... .++..+...++.||+.||+|||+.. +|||||..+|||+.....+||+|||+++
T Consensus 468 vmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr-----fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR-----FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred EEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc-----hhhhhhhhhheeecCcceeeecccchhh
Confidence 9999999999999987654 4888899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
.+.++.++......-.+.|||||.+.-.+++.++|||-|||.+||++. |..||.+-.. .+....+...-+.+.+
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----sDVI~~iEnGeRlP~P 614 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----SDVIGHIENGERLPCP 614 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----cceEEEecCCCCCCCC
Confidence 999988887777777789999999999999999999999999999986 8889875422 1112222334455678
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+.++..++.++.+||++||.+||.+.++...|..+.+
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 8899999999999999999999999999998887655
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.09 Aligned_cols=261 Identities=18% Similarity=0.310 Sum_probs=208.9
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchH-HHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.|+..+.|++|.||.||+|+.+ +++.||+|+++.+..+.+ ....++||.+|.+++|||||.+..+.+...-+.+|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4556788999999999999976 789999999987653222 24578999999999999999999998877788899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
|||+. ||..+++... +++...+...+..|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.+
T Consensus 157 e~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w-----ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW-----ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce-----eEecccchhheeeccCCcEEecccchhhhh
Confidence 99977 9999998664 45889999999999999999999998 999999999999999999999999999988
Q ss_pred cCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc------c---
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------R--- 537 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------~--- 537 (589)
+... .+.+...-|..|+|||.+.+.+ |++..|+||+|||+.|++++++.|.+..+..+-...+..+-. +
T Consensus 228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 7642 2334455678899999998765 999999999999999999999999765443332222211100 0
Q ss_pred ----------------ccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 538 ----------------NLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 538 ----------------~~~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.++..+... ..+.-.++....+..||.+|-|+.|.+++=+...
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 011111111 3466778888899999999999999998866544
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.07 Aligned_cols=262 Identities=26% Similarity=0.451 Sum_probs=205.6
Q ss_pred ccCccccccccCCCccEEEEEec-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|..+ ++..||+|++.... ......|.+|++++++++||||+++++++...+....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46777889999999999999853 57899999987554 3445678999999999999999999998865555678
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... .++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSKR-----YVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHhhEEECCCCeEEECCCcc
Confidence 999999999999999975432 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeee--cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-----------hhh
Q 007788 464 HKLLADDIVFSVL--KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----------SAT 530 (589)
Q Consensus 464 a~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-----------~~~ 530 (589)
+............ ...++..|+|||++.+..++.++|||||||++|||++|..++......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 9876543221111 112334599999999889999999999999999999987765432211000 001
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.+.+........+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1122222222222334566899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.48 Aligned_cols=259 Identities=24% Similarity=0.424 Sum_probs=205.7
Q ss_pred ccccccccCCCccEEEEEe-----cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 312 SEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
...+.||+|+||+||++.. .+++.||+|.+...........|.+|++++++++||||+++++++........++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988653 36789999999765433455678999999999999999999999866555678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++... .++|..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999753 3899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH----------hhhhHHHh
Q 007788 467 LADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATFENF 534 (589)
Q Consensus 467 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~----------~~~~~~~~ 534 (589)
........ .....++..|+|||.+.+..++.++||||||+++|||+||..|+........ ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 65432111 1112344569999999888899999999999999999999999754221100 00111222
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
++.......+...+..+.+++..||+.+|++|||++++++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222222233445678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.99 Aligned_cols=251 Identities=25% Similarity=0.448 Sum_probs=202.9
Q ss_pred cCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
+|...+.||+|+||.||+|...++..||||.+.... ....+|.+|+.++.+++||||+++++++.. .+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEc
Confidence 466778899999999999998877789999987543 234579999999999999999999999843 4678999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|+|.+++..... .++|..+++++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.++....
T Consensus 81 ~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 81 MSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQ-----FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999999976432 4899999999999999999999988 99999999999999999999999999886654
Q ss_pred CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+.. ......+...+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~ 227 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET----VEKVSQ-GLRLYRPHLAS 227 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHHHhc-CCCCCCCCCCC
Confidence 43322233345567999999998889999999999999999999 8888864332111 111111 11112223346
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..+.+++.+||+.+|++||++.++++.|+
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 78999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.68 Aligned_cols=249 Identities=19% Similarity=0.383 Sum_probs=210.6
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
.|+..+.||+|.||.||+|... .++.||+|++..+..+....+..+|+.++++++++||.+++|.+... ..++++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g--~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG--TKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec--ccHHHHHH
Confidence 4566688999999999999975 68999999999988788888899999999999999999999988653 67899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+.+|++.+.|..... +++....-|..++..||.|||+.+ .+|||||+.||++..+|.+||+|||++..+.
T Consensus 92 y~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~~-----kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSEK-----KIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhcc-----eecccccccceeEeccCcEEEEecceeeeee
Confidence 9999999999976542 466666778999999999999998 8999999999999999999999999998877
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
...... ....||+-|||||++....|+.|+||||+|++.+||.+|.+|+...... .+.-.+.....+.......
T Consensus 163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----rvlflIpk~~PP~L~~~~S 236 (467)
T KOG0201|consen 163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----RVLFLIPKSAPPRLDGDFS 236 (467)
T ss_pred chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----eEEEeccCCCCCccccccC
Confidence 655433 5567999999999999889999999999999999999999999765431 1111222222333344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
..+.+++..|++++|+.||++.+++++
T Consensus 237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 789999999999999999999999976
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.65 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=204.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++. +.+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEE
Confidence 36788899999999999999976 689999999865321 223456889999999999999999998874 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 79 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 79 LMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEEecCcch
Confidence 999999999999997543 3889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... ....+++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..... ..+.
T Consensus 150 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~--~~~~ 219 (291)
T cd05612 150 KLRDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI----YEKILAGKL--EFPR 219 (291)
T ss_pred hccCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCc--CCCc
Confidence 764422 123577889999999998899999999999999999999999976432211 122222111 2233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
.....+.+++.+|++.||.+||+ +.|++++-+.
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 34567899999999999999995 9999988765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=326.03 Aligned_cols=262 Identities=19% Similarity=0.305 Sum_probs=213.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-------------hHHHHHHHHHHHHhccCCCCcccee
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------------SEEAEFVKGLYLLTSLRHENIIRLR 372 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~l~ 372 (589)
..++|+....||+|.||.|-+|... +++.||||++.+.... ...+...+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467888899999999999999965 7999999999643211 1224788999999999999999999
Q ss_pred eeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 373 g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
.+..+...+..|+|+|||..|.+...=. ....++..++++++.++..||+|||.++ ||||||||+|+||++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg-----iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG-----IIHRDIKPSNLLLSS 245 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEEcC
Confidence 9987777788999999999887643321 1122899999999999999999999998 999999999999999
Q ss_pred CCceEEccccccccccCC----ceeeeecCCccccccCcccccCCC----CCCcchhhhHHHHHHHHHhCCCCcchhHHH
Q 007788 453 QFNPLIADCGLHKLLADD----IVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRL 524 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~ 524 (589)
++++||+|||.+.....+ .......+.||+.|+|||...++. .+.+.||||+||+||.++.|+.||.+....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999998866322 111223478999999999988743 356889999999999999999999887654
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.. ++.++...+..+..+++...+.+|+.+++++||+.|.+..+|..|.|....
T Consensus 326 ~l----~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 EL----FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HH----HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 33 345555555544455678889999999999999999999999999886554
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.73 Aligned_cols=250 Identities=23% Similarity=0.441 Sum_probs=201.7
Q ss_pred cCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
+|+..+.||+|+||.||+|.++++..+|+|.+.... ....+|.+|++++++++||||+++++++. ..+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEEec
Confidence 466778899999999999998878889999986543 23457889999999999999999999884 44678999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++++|.+++..... .++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 81 MANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG-----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999999976432 4899999999999999999999988 99999999999999999999999999876644
Q ss_pred CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
...........+..|+|||.+.+..++.++||||||+++||+++ |+.||......... ..+........+...+
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 227 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-----ESVSAGYRLYRPKLAP 227 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-----HHHHcCCcCCCCCCCC
Confidence 32222222234457999999999899999999999999999999 78888643221111 1111111222233456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
..+.+++.+||+.+|++|||+.|+++.|
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=318.68 Aligned_cols=249 Identities=25% Similarity=0.461 Sum_probs=200.0
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
+.||+|+||.||+|... +++.||+|.+...........|.+|++++++++||||++++++|.. .+..++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence 36999999999999975 7899999988755444555789999999999999999999999844 46789999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++.... ..++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 79 ~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 79 DFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH-----CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 9999997543 24899999999999999999999988 999999999999999999999999998765432211
Q ss_pred eee-cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHH
Q 007788 474 SVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551 (589)
Q Consensus 474 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 551 (589)
... ....+..|+|||.+.++.++.++||||||+++|||++ |..|+...... .....+........+...+..+
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 225 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----QTREAIEQGVRLPCPELCPDAV 225 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----HHHHHHHcCCCCCCcccCCHHH
Confidence 111 1122346999999999999999999999999999998 88887543221 1122222222333444556789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 552 GKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 552 ~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+++.+|++.+|++||++.++++.|+.
T Consensus 226 ~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=324.57 Aligned_cols=263 Identities=21% Similarity=0.364 Sum_probs=212.4
Q ss_pred hccCccccccccCCCccEEEEEecC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
.++|...+.||+|+||.||+|...+ +..|++|++...........+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCC
Confidence 4678888999999999999999865 7889999987655455567789999999999999999999988653 457
Q ss_pred EEEEEEeCCCCChHHHhhhhcCC----CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
.++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCHhhEEEcCCCcEEE
Confidence 89999999999999999765322 145899999999999999999999987 999999999999999999999
Q ss_pred ccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhc
Q 007788 459 ADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
+|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||....... +...+.
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~ 233 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----MAAYLK 233 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----HHHHHH
Confidence 9999998664332211 122334567999999998889999999999999999999 999986543221 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
...........+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122222233446678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=323.92 Aligned_cols=262 Identities=24% Similarity=0.421 Sum_probs=210.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|.+. +++ .||+|.+..........++.+|+.++..+.||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCc
Confidence 46777899999999999999854 444 4899999766555556789999999999999999999999853 356
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~-----iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEVR-----LVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccceEEEcCCCcEEECCCCc
Confidence 799999999999999976432 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++........ ......++..|+|||...+..++.++||||||+++|||++ |..||...... .....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~ 230 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPDLLEKGERL 230 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCCcC
Confidence 9876533211 1122234567999999998899999999999999999998 88888643221 112222222222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATF 586 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~ 586 (589)
..+...+..+.+++..||+.||++||++.++++.|+.++.....+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05109 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275 (279)
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence 233445678899999999999999999999999999887766544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.43 Aligned_cols=266 Identities=21% Similarity=0.341 Sum_probs=215.6
Q ss_pred hhccCccccccccCCCccEEEEE-ecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC---CCCe
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGE 382 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~---~~~~ 382 (589)
..++|.+.+.+|+|||.-||.++ ..++..+|+|++.... ..+....++|++.-++++|||++++++++..+ ...+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34689999999999999999998 6689999999998776 45667889999999999999999999988643 3457
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.|+++.|...|+|.+.+......+..+++.+.++|+.+|++||++||+.. ||++||||||.|||+++.+.+++.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~---~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE---PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC---CcccccCCCcceeEecCCCceEEEecc
Confidence 89999999999999999987766778999999999999999999999876 789999999999999999999999999
Q ss_pred ccccccCCcee--------eeecCCccccccCcccccCC---CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 463 LHKLLADDIVF--------SVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 463 la~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
.+....-.... .......|+-|+|||.+.-. ..++++|||||||+||+|+.|..||...... ...+
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---GgSl 251 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---GGSL 251 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---CCeE
Confidence 98765421110 11123457789999988643 4688999999999999999999999643321 1111
Q ss_pred -HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 532 -ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 532 -~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
-.+....+..+.....++.+.+++.+|++.||.+||++.+++.+++.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111122222233334788899999999999999999999999988764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=320.92 Aligned_cols=261 Identities=20% Similarity=0.321 Sum_probs=208.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|+.. +++.||||.+.... .......|.+|++++++++||||+++++++.. .+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 46788899999999999999965 78999999886432 23344678999999999999999999998854 468899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|+||+++|+|.+++.........+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCCHHHEEEcCCCCEEECccccce
Confidence 99999999999998754433345888999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc-ccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 544 (589)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .....+.. .......
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (267)
T cd08228 155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKIEQCDYPPLPT 230 (267)
T ss_pred eccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHHhcCCCCCCCh
Confidence 7643221 11123466789999999888899999999999999999999999865422111 11111111 1111223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
......+.+++.+||+.+|++||++.+|++.+++++
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 345678999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=317.55 Aligned_cols=248 Identities=26% Similarity=0.484 Sum_probs=201.0
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCCC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gs 394 (589)
++||+|+||.||+|..+++..||+|.+...........|.+|++++++++||||+++++++.. .+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCCc
Confidence 368999999999999888999999998766544445678999999999999999999999854 467899999999999
Q ss_pred hHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCceee
Q 007788 395 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474 (589)
Q Consensus 395 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 474 (589)
|.+++..... .++|..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 79 L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 79 FLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence 9999875432 3889999999999999999999987 9999999999999999999999999987654332211
Q ss_pred eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 475 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 475 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......+..|+|||++.+..++.++||||||+++||+++ |..||......... ..+........+...+..+.+
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-----EQVEKGYRMSCPQKCPDDVYK 225 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-----HHHHcCCCCCCCCCCCHHHHH
Confidence 112233567999999998899999999999999999998 88898654322111 111112222233445678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 007788 554 MALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 554 l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
++.+|++.+|++||++.|+++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=324.22 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=206.3
Q ss_pred ccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|...+.||+|+||.||+|...+ +..||||.++..........|.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CCC
Confidence 456777899999999999998643 478999999876544456789999999999999999999999854 467
Q ss_pred EEEEEEeCCCCChHHHhhhhcC----------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEG----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
.++||||+++++|.+++..... ....+++.....++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~ 157 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGY 157 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eeccccccceEEEcC
Confidence 8999999999999999976431 2245889999999999999999999988 999999999999999
Q ss_pred CCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhh
Q 007788 453 QFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT 530 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 530 (589)
++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~ 233 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----V 233 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----H
Confidence 999999999998765332211 1122334577999999999999999999999999999999 999986532211 1
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.+.+........+...+..+.+++..||+.||++||++.|+++.|+
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 -IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111122223445678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.14 Aligned_cols=263 Identities=23% Similarity=0.428 Sum_probs=209.7
Q ss_pred HHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeec
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS 377 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 377 (589)
....++|+..+.||+|+||.||++... ....+|+|.+..........++.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 334566788899999999999999864 23689999988654444556789999999999 89999999999843
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCC
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV 445 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~ 445 (589)
.+..+++|||+++|+|.++++... .....++|..+++++.|++.||+|||+.+ |+||||||
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp 160 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-----CIHRDLAA 160 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----ccccccce
Confidence 467899999999999999997532 12345899999999999999999999987 99999999
Q ss_pred CCeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHH
Q 007788 446 EKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMR 523 (589)
Q Consensus 446 ~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~ 523 (589)
+||++++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 99999999999999999998765432211 122234567999999988899999999999999999998 8888864322
Q ss_pred HHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.. ..+.+........+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 241 ~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 EE-----LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HH-----HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 1122222222233445567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.37 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=195.7
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
|+..+.||+|+||.||+|... +++.||||++...........+.+|++++++++|+||+++++++. ..+..++||||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~ 153 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLLEF 153 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEEec
Confidence 344678999999999999975 689999999976554445577999999999999999999999984 45789999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|+|.+.. ...+.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999986532 2556778889999999999999988 99999999999999999999999999986643
Q ss_pred CceeeeecCCccccccCcccccC-----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
... ......++..|+|||++.. ...+.++|||||||++|||++|+.||...... .+....... .........
T Consensus 221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~-~~~~~~~~~ 297 (353)
T PLN00034 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAI-CMSQPPEAP 297 (353)
T ss_pred ccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHH-hccCCCCCC
Confidence 221 1223457889999998743 22456899999999999999999999632110 000011111 111112233
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
......+.+++.+||+.||++||++.|++++-+...
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 445678999999999999999999999999866544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=335.46 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=197.8
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
+.||+|+||.||+|... +|+.||+|+++.... ......+.+|++++++++||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 36999999999999875 789999999975431 2334568889999999999999999998843 578999999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
+|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 79 GGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence 999999987543 4899999999999999999999988 9999999999999999999999999987532211
Q ss_pred eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHH
Q 007788 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 551 (589)
. ......+++.|+|||.+.+..++.++|||||||++|||+||+.||........ ...+.... ...+......+
T Consensus 150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~~~~~~--~~~p~~~~~~~ 222 (323)
T cd05571 150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEE--IRFPRTLSPEA 222 (323)
T ss_pred C-cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCC--CCCCCCCCHHH
Confidence 1 11223478899999999999999999999999999999999999965432111 11111111 12334456678
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 552 GKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 552 ~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
.+++.+|++.||++|| ++.+++++-+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 9999999999999999 8999987644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.05 Aligned_cols=256 Identities=19% Similarity=0.313 Sum_probs=199.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|+.+ +++.||||++..... ......+.+|+.++++++||||+++++++. ..+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEE
Confidence 36888899999999999999986 688999999976432 233457889999999999999999999884 34789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||++++++..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 79 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 79 FEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred EecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 9999987776554322 24889999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh-----------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI----------- 535 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------- 535 (589)
.............++..|+|||++.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLF 228 (287)
T ss_pred ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhh
Confidence 65432222223457788999999999899999999999999999999999997532211100 000000
Q ss_pred --cccc--------CCC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 536 --DRNL--------KGK------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 536 --~~~~--------~~~------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
++.. ... .....+..+.+++.+|++.||++|||++|++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 0000 000 0112355689999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=322.75 Aligned_cols=259 Identities=21% Similarity=0.434 Sum_probs=206.2
Q ss_pred hccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
+++|...+.||+|++|.||+|.+.+ +..||+|.+...........|..|+.++++++|+||+++++++.+ .+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence 4678888999999999999999753 568999988765545556679999999999999999999998854 45
Q ss_pred eEEEEEEeCCCCChHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC---c
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---N 455 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~---~ 455 (589)
..++||||+++++|.+++..... ....++|..++.++.||+.||+|||+.+ ++||||||+||+++.++ .
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchheEEEeccCCCcc
Confidence 67999999999999999976532 1235899999999999999999999988 99999999999998754 5
Q ss_pred eEEccccccccccCCceeee-ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHH
Q 007788 456 PLIADCGLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 533 (589)
+||+|||+++.......... .....+..|+|||++.+..++.++|||||||++|||++ |..||...... ...+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~ 232 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVME 232 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 89999999987643222111 11222457999999998899999999999999999997 88888654321 1122
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+........+...+..+.+++.+|++.+|++||++.+|+++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 222222233344456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.00 Aligned_cols=260 Identities=19% Similarity=0.329 Sum_probs=204.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|++++++++||||++++++|.+ .+..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence 367888999999999999999976 6889999998765444455679999999999999999999999965 4689999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.... .+++.....++.+++.||+|||+.+ .|+||||||+|||++.++.+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999999997543 3888999999999999999999753 299999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh-----------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----------------- 529 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~----------------- 529 (589)
..... .....++..|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 154 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 154 LIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 53321 1223567889999999988899999999999999999999999864321100000
Q ss_pred ----------------------hHHHhhccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 530 ----------------------TFENFIDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 530 ----------------------~~~~~~~~~~~~~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+.+........ ......++.+++.+||+.||++|||+.|++++-+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00000000000000 0113456889999999999999999999998866533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=336.75 Aligned_cols=249 Identities=19% Similarity=0.288 Sum_probs=203.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|..+ +++.||||++..... ......+.+|+.++.+++||||+++++++.+ .+..++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEEE
Confidence 46778899999999999999976 689999999875421 2234578899999999999999999998854 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred EEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEECCCCCEEEeeccCce
Confidence 999999999999997643 3788889999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ...+++.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..+.
T Consensus 167 ~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~--~~p~ 236 (329)
T PTZ00263 167 KVPDRTF----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI----YEKILAGRL--KFPN 236 (329)
T ss_pred EcCCCcc----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCc--CCCC
Confidence 7654321 23578889999999999999999999999999999999999975432211 122222211 1223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
.....+.+++..||+.||++||+ +++++.+-+.
T Consensus 237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 34557889999999999999986 7899877553
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.94 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=207.4
Q ss_pred HHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeec
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCS 377 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~ 377 (589)
....++|...+.||+|+||.||+|.++ .+..||||+++..........+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 334455677789999999999999864 346899999986644444567899999999997 9999999999854
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcC-----------------------------------------------------
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEG----------------------------------------------------- 404 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~----------------------------------------------------- 404 (589)
.+..++||||+++|+|.++++....
T Consensus 113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4678999999999999999975321
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC
Q 007788 405 -----------------------------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 443 (589)
Q Consensus 405 -----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl 443 (589)
....++|...++++.|++.||+|||+.+ |+||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrdl 265 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-----CVHRDL 265 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cCcccC
Confidence 1124788889999999999999999887 999999
Q ss_pred CCCCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchh
Q 007788 444 SVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSS 521 (589)
Q Consensus 444 k~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~ 521 (589)
||+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986533211 11122345677999999998889999999999999999998 88888543
Q ss_pred HHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 522 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.... .....+........+......+.+++..||+.+|++||+++|+++.|+.+
T Consensus 346 ~~~~----~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 346 PMNE----QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CchH----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2111 11222222222233334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=323.08 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=204.1
Q ss_pred ccCccccccccCCCccEEEEEe-----cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|.+ .++..|++|.+...........|.+|++++++++||||+++++++.. .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCce
Confidence 3566778999999999999985 25678999999865544455678999999999999999999998844 4678
Q ss_pred EEEEEeCCCCChHHHhhhhcC-------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee
Q 007788 384 FLIYDFAPKGKLSKYLDQEEG-------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill 450 (589)
++||||+++++|.+++..... ....+++...+.++.|++.||+|||+.+ |+||||||+||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~nili 157 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILI 157 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-----eehhccccceEEE
Confidence 999999999999999864321 1234889999999999999999999988 9999999999999
Q ss_pred cCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhh
Q 007788 451 DQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAES 528 (589)
Q Consensus 451 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 528 (589)
++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---- 233 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---- 233 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 9999999999999986543221 11222334567999999988889999999999999999999 88888654321
Q ss_pred hhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+.+........+...+..+.+++.+||+.||++||++.+++++|+.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111222221222334456778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=323.38 Aligned_cols=263 Identities=23% Similarity=0.389 Sum_probs=208.7
Q ss_pred ccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
.+|...+.||+|+||.||+|... ++..+++|.+.... ....+.|.+|++.+++++||||+++++++.. .+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCc
Confidence 35667789999999999999843 35678999887544 3344678999999999999999999999854 467
Q ss_pred EEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill 450 (589)
.++||||+++++|.+++..... ....++|..+++++.|++.||+|||+.+ |+||||||+||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~Nil~ 156 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLV 156 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEE
Confidence 8999999999999999975431 1234899999999999999999999988 9999999999999
Q ss_pred cCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhh
Q 007788 451 DQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAES 528 (589)
Q Consensus 451 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 528 (589)
+.++.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 234 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-- 234 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999997654432211 122334677999999999999999999999999999999 9999865432211
Q ss_pred hhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
.+.+........+...+..+.+++.+||+.+|++||+++++++.|+.+.....
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 235 ---IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred ---HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 11111112222233456779999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=319.86 Aligned_cols=253 Identities=24% Similarity=0.467 Sum_probs=205.3
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||+|...++..||+|.+..... ....|.+|+.++++++|+|++++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEEEE
Confidence 46777889999999999999988888999999876432 3457999999999999999999999873 245789999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++.... ...+++..++.++.+++.||+|||+.+ |+||||||+||++++++.++|+|||++..+.
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN-----YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 999999999997643 234899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+........+...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 228 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQVERGYRMPCPQDC 228 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCCCCCcC
Confidence 432222222334567999999988889999999999999999999 88888653221 111122222223334455
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6789999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.05 Aligned_cols=260 Identities=19% Similarity=0.346 Sum_probs=199.2
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.. .+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEE
Confidence 467888999999999999999976 6899999999765433344567889999999999999999999844 4689999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 82 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY-----ILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECCCCccee
Confidence 99995 68888886543 23888999999999999999999988 99999999999999999999999999875
Q ss_pred ccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc---------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--------- 536 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 536 (589)
...... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..+.............
T Consensus 153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 153 KSVPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred ccCCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 432211 1223446788999998865 45789999999999999999999999753221111110000000
Q ss_pred --------c-ccCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 537 --------R-NLKGKFSE---------SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 537 --------~-~~~~~~~~---------~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+ ......+. .....+.+++..|++.||++|||+.|++++-+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 0 00000000 0124678999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=297.11 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=212.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|++.+.||+|.||.||.|+.+ ++..||+|++.+... .....++.+|+++-+.++||||+++++|+.+ ....|+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riyL 99 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIYL 99 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeEE
Confidence 46778899999999999999975 678999999976542 2234689999999999999999999999955 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
++||.++|+|...|..... ..++......++.|+|.||.|+|..+ |+||||||+|+|++.++..|++|||.+.
T Consensus 100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~-----VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR-----VIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC-----cccCCCCHHHhccCCCCCeeccCCCcee
Confidence 9999999999999985442 34778888899999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... .....||..|.+||...+..++.++|+|++|++.||++.|..||.+.... ..+..+.... ..++.
T Consensus 173 ~~p~~k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----etYkrI~k~~--~~~p~ 243 (281)
T KOG0580|consen 173 HAPSNK---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----ETYKRIRKVD--LKFPS 243 (281)
T ss_pred ecCCCC---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----HHHHHHHHcc--ccCCc
Confidence 554322 22345788899999999999999999999999999999999999876532 2233332222 23446
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
..+....+++.+|+..+|.+|.+..|++.+-|..+
T Consensus 244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 244 TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 66778999999999999999999999999987654
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=316.60 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=198.9
Q ss_pred cccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||+|+||.||+|.+. .+..||+|++.........+.|.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCCC
Confidence 899999999999864 456799999976654445567999999999999999999999873 24679999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++.... ..+++..+++++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 80 PLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC-----eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 9999997543 24899999999999999999999987 999999999999999999999999999865433211
Q ss_pred e--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 474 S--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 474 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
. .....++..|+|||.+....++.++|||||||++||+++ |..||....... ....+........+.....+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VMSFIEQGKRLDCPAECPPE 226 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHHHCCCCCCCCCCCCHH
Confidence 1 111223467999999988889999999999999999996 999986543211 11222222222334455678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 551 LGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.+++..||+.+|++||++.+|.+.|+..
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=324.12 Aligned_cols=262 Identities=21% Similarity=0.396 Sum_probs=206.1
Q ss_pred ccCccccccccCCCccEEEEEecC-C--cEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD-G--TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|++.+.||+|+||.||+|..++ + ..+++|.++........+.|.+|+.++.++ +||||+++++++.. .+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 567888999999999999998753 3 347888887544344556799999999999 79999999998843 46789
Q ss_pred EEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 385 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+|+||+++|+|.++++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~ 154 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-----FIHRDLAARNVLVGE 154 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCcCCcceEEECC
Confidence 99999999999999975421 1134889999999999999999999987 999999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF 531 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 531 (589)
++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||+| |+.||........
T Consensus 155 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~----- 227 (297)
T cd05089 155 NLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL----- 227 (297)
T ss_pred CCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999986432211 1111223456999999998889999999999999999998 9999865432111
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
...+........+...+..+.+++.+||+.+|.+||+++++++.|+.+.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11122222222334456778999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=323.35 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=206.8
Q ss_pred cCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
+|...+.||+|+||.||+|... ....+++|.+...........+.+|+.++++++||||+++++.|.. .+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCCc
Confidence 3566789999999999999853 2357999988766544455679999999999999999999998844 4678
Q ss_pred EEEEEeCCCCChHHHhhhhcC--------------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC
Q 007788 384 FLIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 443 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl 443 (589)
++|+||+++|+|.+++..... ....+++...+.++.|++.||+|||+.+ |+||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~di 153 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-----LVHRDL 153 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-----eehhhh
Confidence 999999999999999865321 1235889999999999999999999887 999999
Q ss_pred CCCCeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchh
Q 007788 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSS 521 (589)
Q Consensus 444 k~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~ 521 (589)
||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999998765332211 1122234567999999988889999999999999999999 88888654
Q ss_pred HHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 522 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
... .+...+........+......+.+++..|++.+|++||++.|+++.|+.+..
T Consensus 234 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 APE-----RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CHH-----HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 321 1122223223333344556789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.27 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=198.6
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||+|+||+||++... +++.||||.+...... .....+..|++++++++||||+++.+++. .....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence 699999999999875 7899999998754321 22356788999999999999999998874 346799999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~- 152 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS- 152 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence 999888654333446899999999999999999999988 99999999999999999999999999876543321
Q ss_pred eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......++..|+|||.+.+..++.++|||||||++|||++|+.||.................... ...+...+..+.+
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 230 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTYPDKFSPASKS 230 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CCCcccCCHHHHH
Confidence 12234577889999999999999999999999999999999999965322111111111111111 1233445678899
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 554 MALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 554 l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
++..|++.||++|| ++++++++-+
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 99999999999999 7888887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=318.65 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=205.2
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|...+.||+|+||.||+|...+...||+|++.... .....|.+|++++++++||||+++++++.. ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEE
Confidence 35688889999999999999998777789999997543 234578999999999999999999998632 4578999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++..... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++..
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 80 EYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcccEEEcCCCcEEeccCCceeec
Confidence 99999999999976432 34799999999999999999999987 999999999999999999999999999866
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
............++..|+|||+..+..++.++||||||+++|||+| |..||........ .. .+........+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----~~-~~~~~~~~~~~~~ 227 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----LD-QVERGYRMPCPPE 227 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----HH-HHhcCCCCCCccc
Confidence 5433222223345567999999988899999999999999999999 7778765432111 11 1111112223445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 667889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.68 Aligned_cols=255 Identities=16% Similarity=0.244 Sum_probs=204.0
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+|+..+.||+|+||.||+|... +++.||||++..... ......+.+|++++.+++||||+++++++. ..+..++|
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEEE
Confidence 6788899999999999999976 589999999975421 233457889999999999999999999884 45789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG-----YIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 99999999999997543 3889999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh--hHHHhhccccCCCCC
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA--TFENFIDRNLKGKFS 544 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 544 (589)
... ......+++.|+|||++.+..++.++|||||||++|||++|+.||........... ...............
T Consensus 151 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 226 (333)
T cd05600 151 IVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226 (333)
T ss_pred ccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc
Confidence 543 12234578889999999999999999999999999999999999975432211110 000111110000001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+..+.+++..|++.+|.+||++++++++.+..
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 13466788999999999999999999999886543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.40 Aligned_cols=264 Identities=23% Similarity=0.409 Sum_probs=205.5
Q ss_pred hccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~ 380 (589)
.++|...+.||+|+||.||+|.. .+++.||||+++..........+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 45788889999999999999974 357899999998655444556788999999999 689999999988543 3
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCC-------------------------------------------------------
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGS------------------------------------------------------- 405 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~------------------------------------------------------- 405 (589)
...++||||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999999999998753210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce-eeee
Q 007788 406 --------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVL 476 (589)
Q Consensus 406 --------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~ 476 (589)
...++|..+.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++........ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 124788899999999999999999988 99999999999999999999999999876533221 1111
Q ss_pred cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHH
Q 007788 477 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 555 (589)
Q Consensus 477 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 555 (589)
...++..|+|||.+.+..++.++||||||+++|||++ |..||....... .....+........+......+.+++
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTRMRAPDYTTPEMYQTM 315 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 2234567999999988899999999999999999997 888885432110 11111111111122222345789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 556 LVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 556 ~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..||+.+|++||++.|++++|+.+.+
T Consensus 316 ~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=325.38 Aligned_cols=256 Identities=19% Similarity=0.360 Sum_probs=197.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|..+ +++.||+|+++..........+.+|++++++++||||+++++++.. .+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEE
Confidence 46888899999999999999875 6899999999765433344568899999999999999999998843 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 83 e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 83 EYLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK-----ILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred eCCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 99975 9999887543 24788999999999999999999988 999999999999999999999999998764
Q ss_pred cCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh----------------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT---------------- 530 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~---------------- 530 (589)
..... ......++..|+|||.+.+ ..++.++||||+||++|||+||+.||............
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 154 SVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred cCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 32211 1123346788999998865 56899999999999999999999999653221110000
Q ss_pred ----HHHhhccccCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 531 ----FENFIDRNLKGKF----SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 531 ----~~~~~~~~~~~~~----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
+.....+...... ......+..+++.+|++.||.+|||++|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 0000000000000 012245678999999999999999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=318.21 Aligned_cols=254 Identities=25% Similarity=0.453 Sum_probs=206.6
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|...+.||+|+||.||+|..++++.||+|.+.... ....+|.+|+.++++++||||+++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEE
Confidence 45678889999999999999999899999999987654 23457899999999999999999999863 35689999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++....+ ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN-----YIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHHhEEEcCCCCEEEccCcceeec
Confidence 99999999999876432 35899999999999999999999987 999999999999999999999999999776
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
............++..|+|||++....++.++||||||+++||+++ |+.||........ ...+........+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 227 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-----IQNLERGYRMPRPDN 227 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-----HHHHHcCCCCCCCCC
Confidence 5332222222334567999999998889999999999999999999 9999865432111 111122222223344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+..+.+++.+|++.+|++||++++++..|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 55689999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=321.95 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=206.9
Q ss_pred ccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|...+.||+|+||.||++... ++..+|+|.+.... ......|.+|++++.+++||||+++++++.. .+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence 46778899999999999999852 35678999887554 3445679999999999999999999999854 467
Q ss_pred EEEEEEeCCCCChHHHhhhhcC---------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEG---------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
.++||||+++++|.+++..... ....++|..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-----i~H~dlkp~Nili~~~ 156 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGEN 156 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEccC
Confidence 8999999999999999975431 1234899999999999999999999988 9999999999999999
Q ss_pred CceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhH
Q 007788 454 FNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF 531 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 531 (589)
+.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||........ .
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~----~ 232 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----I 232 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----H
Confidence 99999999999865433221 1122334667999999998889999999999999999999 8888865432111 1
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..+.... ....+...+..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 233 ~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 1111223456799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.33 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=206.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
..++|+....||+|+||.||+|+-+ +|..+|+|++++..- .........|-.+|....+|.||+++-.+ ++.+..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCee
Confidence 4567888899999999999999966 699999999986542 34446678899999999999999997555 677899
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
||||||++|||+..+|.... .|++.....++.+++.|++-+|..| +|||||||+|+|||..|++||+|||+
T Consensus 217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g-----yIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG-----YIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC-----cccccCChhheeecCCCCEeeccccc
Confidence 99999999999999998664 3888889999999999999999998 99999999999999999999999999
Q ss_pred cccccC-----------------------Cce-----ee------------------eecCCccccccCcccccCCCCCC
Q 007788 464 HKLLAD-----------------------DIV-----FS------------------VLKTSAAMGYLAPEYVTTGRFTE 497 (589)
Q Consensus 464 a~~~~~-----------------------~~~-----~~------------------~~~~~~~~~y~aPE~~~~~~~~~ 497 (589)
+.-+.. +.. .. .....||+.|+|||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 854321 000 00 01256889999999999999999
Q ss_pred cchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 007788 498 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP---TMEAVIE 574 (589)
Q Consensus 498 ~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP---s~~evl~ 574 (589)
.+|+||+|||+|||+.|.+||.+......+..... + ...+..+.......+..++|.+|+. ||++|- .+.||-+
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n-w-r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN-W-RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-H-hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999999999998776555443221 1 1112222233445788899999998 999996 4777766
Q ss_pred HHH
Q 007788 575 ELT 577 (589)
Q Consensus 575 ~L~ 577 (589)
|-+
T Consensus 445 HPf 447 (550)
T KOG0605|consen 445 HPF 447 (550)
T ss_pred CCc
Confidence 544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.64 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=197.3
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
+.||+|+||.||++... +|+.||+|++.... .......+.+|++++++++||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 36999999999999975 68999999997542 12344567889999999999999999998844 468999999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
+|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 79 GGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence 999999887543 4899999999999999999999988 9999999999999999999999999987532211
Q ss_pred eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHH
Q 007788 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 551 (589)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..+......+
T Consensus 150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~~~~~~~--~~p~~~~~~~ 222 (323)
T cd05595 150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEI--RFPRTLSPEA 222 (323)
T ss_pred C-ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCC--CCCCCCCHHH
Confidence 1 12234578899999999999999999999999999999999999965432211 111111111 1233445678
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 552 GKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 552 ~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
.+++..|++.||++|| ++.+++++-+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 8999999999999998 8999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.47 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=192.4
Q ss_pred ccccCCCccEEEEEecC---CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 316 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
.||+|+||.||+|...+ +..+|+|.++..........|.+|+.++++++||||+++++++.+ ....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCCC
Confidence 58999999999998653 457999998766544455679999999999999999999998843 4678999999999
Q ss_pred CChHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 393 GKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 393 gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
|+|.++++..... ....++..+..++.|++.||+|||+.+ ++||||||+||+++.++++||+|||+++......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999999764322 234678888899999999999999988 9999999999999999999999999987554332
Q ss_pred eee-eecCCccccccCcccccCC-------CCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 472 VFS-VLKTSAAMGYLAPEYVTTG-------RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 472 ~~~-~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||........................
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 211 1123356779999988642 35789999999999999996 99998654322111111111000011111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
........+.+++..|| .+|++|||++||++.|+
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11223456788999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.27 Aligned_cols=256 Identities=23% Similarity=0.464 Sum_probs=205.1
Q ss_pred ccCccccccccCCCccEEEEEec-CC---cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|... ++ ..+|+|.+.........++|..|++++.+++||||+++++++.. .+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCcE
Confidence 46777899999999999999975 23 37999998765444456789999999999999999999999844 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++....+ .++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 83 IITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMN-----YVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999976432 4899999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 465 KLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 465 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
.......... ......+..|+|||++.+..++.++|||||||++||+++ |+.||....... ....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~~i~~~~~~ 229 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMKAINDGFRL 229 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhcCCCC
Confidence 7664322111 111223457999999998889999999999999999998 999986432211 11111112222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22334567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=321.94 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=202.6
Q ss_pred CccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
|...+.||+|+||.||+|... +++.||+|++...........|.+|+.++.+++||||+++++++.. .+..+
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~ 84 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQPLS 84 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CCceE
Confidence 455678999999999999864 3578999999865533445678899999999999999999999844 46789
Q ss_pred EEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 385 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+++||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-----i~H~dlkp~Nil~~~ 159 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFD 159 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccccchhheEecC
Confidence 99999999999999853211 1234889999999999999999999988 999999999999999
Q ss_pred CCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhh
Q 007788 453 QFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT 530 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 530 (589)
++.+||+|||+++......... .....+++.|+|||.+.++.++.++||||||+++|||++ |..||...... ..
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~ 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DV 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 9999999999988664332211 122334568999999988889999999999999999998 77777543221 11
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+.+.. ....+...+..+.+++..||+.+|++||+++++++.|+.
T Consensus 236 ~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 12222221 223345567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.88 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=204.6
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|...+.||+|++|.||+|...++..||+|.+.... ...+.|.+|++++++++|||++++++++. .+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEE
Confidence 4577778999999999999998877789999886543 23457889999999999999999999873 245789999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.++++.... ..++|..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 81 FMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN-----YIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred cCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 9999999999976432 34899999999999999999999987 9999999999999999999999999997664
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...........++..|+|||...+..++.++||||||+++|||+| |+.||......... .. +........+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~-~~~~~~~~~~~~~ 228 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL----EQ-VERGYRMPCPQGC 228 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH-HHcCCCCCCCccc
Confidence 432212222334567999999998899999999999999999999 88888754332211 11 1112222334456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.87 Aligned_cols=246 Identities=22% Similarity=0.403 Sum_probs=199.0
Q ss_pred ccccCCCccEEEEEec---CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 316 LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
.||+|+||.||+|.++ ++..+|+|+++.... ....++|..|+.++++++||||+++++++. .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence 5899999999999753 578999999875542 234567999999999999999999999883 246789999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 79 LGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 999999997543 4889999999999999999999988 9999999999999999999999999998765433
Q ss_pred eee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 472 VFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 472 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
... .....++..|+|||.+....++.++||||||+++|||++ |+.||....... ....+........+...+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~i~~~~~~~~~~~~~ 224 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQMIESGERMECPQRCP 224 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHCCCCCCCCCCCC
Confidence 211 112223467999999988889999999999999999998 999987543221 122222222333444566
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+.+++.+||+.||++||++++|++.|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.58 Aligned_cols=262 Identities=26% Similarity=0.442 Sum_probs=205.3
Q ss_pred cCccccccccCCCccEEEEEe-----cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.|...+.||+|+||.||++.+ .++..||+|.++..........|.+|++++++++||||+++++++...+....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356778999999999999984 257899999987655444556799999999999999999999998665456789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... ..++|..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g-----i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999996543 24899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCcee--eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH----------hhhhHH
Q 007788 465 KLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATFE 532 (589)
Q Consensus 465 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~----------~~~~~~ 532 (589)
+........ ......++..|+|||++.+..++.++||||||+++|||+|++.|......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876433211 11123345669999999888899999999999999999998776533211000 000011
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+............+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111112222334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=323.47 Aligned_cols=257 Identities=19% Similarity=0.367 Sum_probs=195.1
Q ss_pred ccCccccccccCCCccEEEEEec--CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcc---CCCCccceeeeeecC---C
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSR---G 379 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~---~ 379 (589)
++|+..+.||+|+||.||+|+.. +++.||||++...... .....+.+|+.+++++ +||||++++++|... .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36788899999999999999863 4788999998754322 2234566777766655 699999999988532 2
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~-----iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEcCCCCEEEc
Confidence 346899999996 699999875432 34899999999999999999999988 9999999999999999999999
Q ss_pred cccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh----
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI---- 535 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---- 535 (589)
|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.+...............
T Consensus 153 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 153 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred cccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 999997654331 22234577889999999988999999999999999999999999975433211111110000
Q ss_pred ----------ccccC--CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 536 ----------DRNLK--GK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 536 ----------~~~~~--~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+. .. ........+.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 00 011234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=324.70 Aligned_cols=263 Identities=23% Similarity=0.411 Sum_probs=205.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCc--EEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|.++ ++. .+++|.++..........|.+|++++.++ +||||+++++++.. .+..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCce
Confidence 46777889999999999999975 443 46788776544345557889999999999 89999999999843 46789
Q ss_pred EEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 385 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+||||+++|+|.++++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dlkp~Nili~~ 159 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE 159 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEecC
Confidence 99999999999999975431 1235889999999999999999999988 999999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF 531 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 531 (589)
++.+||+|||+++...... .......+..|+|||++.+..++.++|||||||++|||+| |..||........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----- 232 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 232 (303)
T ss_pred CCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-----
Confidence 9999999999986432111 1111223457999999988889999999999999999998 9999864322111
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccccc
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT 585 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~ 585 (589)
.+.+........+...+..+.+++.+||+.+|++||++++++++|+.+-+...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 233 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 111111112222233456789999999999999999999999999887665543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.79 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=200.1
Q ss_pred ccccccccCCCccEEEEEecC-Cc--EEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CCeE
Q 007788 312 SEVNLLGKGNFSSVYKGTLRD-GT--LVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGEC 383 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~ 383 (589)
...+.||+|+||.||+|.+.+ +. .||+|.++.... ......|..|++++++++||||++++++|.... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999764 32 689998876432 344567899999999999999999999875321 2246
Q ss_pred EEEEEeCCCCChHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
+++|||+++|+|.+++..... ....++|.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-----FIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhheEEcCCCCEEECCC
Confidence 899999999999998853321 2345899999999999999999999987 999999999999999999999999
Q ss_pred cccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 462 GLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 462 Gla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
|+++......... ......+..|+|||+..+..++.++||||||+++|||++ |+.||....... ..+.+....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~~~~~ 231 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-----IYDYLRQGN 231 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHcCC
Confidence 9998765432211 112234567999999999899999999999999999999 788886432211 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
....+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1122334566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=315.11 Aligned_cols=261 Identities=20% Similarity=0.333 Sum_probs=209.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|... +|+.||+|.++... .......+.+|++++++++|+|++++++++.. .+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 56888899999999999999987 79999999886432 22335678999999999999999999999854 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.........+++..++.++.+++.||+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-----IMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecCCcChhhEEECCCCcEEEeccceee
Confidence 99999999999999764433455899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+.+........+.
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (267)
T cd08224 155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEKCDYPPLPA 230 (267)
T ss_pred eccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH---HHHhhhhcCCCCCCCh
Confidence 6543221 11223466779999999988899999999999999999999999864321100 0111111111122222
Q ss_pred -HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 546 -SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 546 -~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.....+.+++..||+.+|++||++.++++.|+.+.
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 55678999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.53 Aligned_cols=249 Identities=19% Similarity=0.270 Sum_probs=202.7
Q ss_pred ccCccccccccCCCccEEEEEecC--CcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|...+.||+|+||.||+|..++ +..||+|++..... ......+.+|++++..++||||+++++++.+ .+..+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCEEE
Confidence 457788999999999999998653 36899999865321 2334578899999999999999999999854 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN-----IVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEecCCCC
Confidence 9999999999999997653 3889999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..+
T Consensus 179 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~~--~~p 248 (340)
T PTZ00426 179 KVVDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGII--YFP 248 (340)
T ss_pred eecCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCCC--CCC
Confidence 8764322 234578889999999988899999999999999999999999976533221 112222111 123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
......+.+++..|++.||++|+ ++++++++.+.
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 33455688999999999999995 89999988553
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=324.94 Aligned_cols=263 Identities=24% Similarity=0.410 Sum_probs=208.1
Q ss_pred hccCccccccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
.++|.+.+.||+|+||.||++... +...+|+|.+..........++..|++++.++ +||||++++++|..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 356888899999999999999853 23579999998654344556788999999999 79999999999854
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
.+..++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+.+ ++||||||+
T Consensus 96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~ 169 (307)
T cd05098 96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-----CIHRDLAAR 169 (307)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHH
Confidence 4678999999999999999976432 1235899999999999999999999987 999999999
Q ss_pred CeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999999999998765432111 1112223467999999998889999999999999999998 77887543211
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.....+........+......+.+++..|++.+|++||++.++++.|+.+.+.
T Consensus 250 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 -----ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -----HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11112222222233445567889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.16 Aligned_cols=256 Identities=22% Similarity=0.446 Sum_probs=204.8
Q ss_pred ccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|... .+..+|+|.++..........|.+|+.++.+++||||+++++++.. .+..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccE
Confidence 46778899999999999999864 2347999998765444455789999999999999999999999843 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++..... .+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EeehhhchhcEEECCCCeEEeCCCCcc
Confidence 99999999999999976532 4899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeee--ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 465 KLLADDIVFSV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 465 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
........... .....+..|+|||++.+..++.++||||||+++||+++ |..||........ ...+. .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~----~~~~~-~~~~~ 228 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV----IKAIE-EGYRL 228 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH----HHHHh-CCCcC
Confidence 87654322111 12223457999999998899999999999999999887 9999865322111 11111 11122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+...+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 22334566789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.03 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=195.8
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||+|+||.||+|... +++.||+|++.... .......+..|+.++.+++||||+++++++. ..+..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ--SPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe--cCCeEEEEEcCCCCC
Confidence 699999999999976 58899999987532 1334467889999999999999999999884 357899999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 148 (312)
T cd05585 79 ELFHHLQREG----RFDLSRARFYTAELLCALENLHKFN-----VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD- 148 (312)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-
Confidence 9999997543 3899999999999999999999988 99999999999999999999999999875432211
Q ss_pred eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......+++.|+|||.+.+..++.++|||||||++|||+||+.||........ ........ ...+......+.+
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~ 222 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM----YRKILQEP--LRFPDGFDRDAKD 222 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH----HHHHHcCC--CCCCCcCCHHHHH
Confidence 12234578899999999999999999999999999999999999975432211 11222111 1233445667899
Q ss_pred HHHHhcccCCCCCC---CHHHHHHHHH
Q 007788 554 MALVCTHEDPENRP---TMEAVIEELT 577 (589)
Q Consensus 554 l~~~C~~~dp~~RP---s~~evl~~L~ 577 (589)
++..|++.||++|| ++.|++.+-+
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 99999999999997 5678777644
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.01 Aligned_cols=264 Identities=15% Similarity=0.246 Sum_probs=210.1
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG 379 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 379 (589)
++.....++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+..+..++|+||+++...+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344445678999999999999999999864 789999999976532 344567889999999999999999987664322
Q ss_pred C------CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 380 R------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 380 ~------~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
. ...++||||+++|+|.+++.........+++.....++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-----IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-----MIHRDIKSANILLCSN 179 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEeCC
Confidence 1 1368999999999999999865544556899999999999999999999987 9999999999999999
Q ss_pred CceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH
Q 007788 454 FNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 532 (589)
+.+||+|||+++.+...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~~~ 255 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMH 255 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHH
Confidence 99999999999866432211 1223457889999999999999999999999999999999999996543211 111
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...... ....+...+..+.+++..||+.||.+||++.+++++
T Consensus 256 ~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 112334556789999999999999999999999876
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=321.37 Aligned_cols=262 Identities=21% Similarity=0.392 Sum_probs=205.1
Q ss_pred HhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG 379 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 379 (589)
..+++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+..+++++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-- 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 35678889999999999999999754 2458999998755434445678899999999999999999998843
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcC------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEG------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
.+..++||||+++|+|.+++..... .....++.....++.|++.||+|||+.+ |+||||||+||+++++
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dikp~nili~~~ 155 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHD 155 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCCChheEEEcCC
Confidence 4678999999999999999975321 1234677888999999999999999987 9999999999999999
Q ss_pred CceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhH
Q 007788 454 FNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF 531 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 531 (589)
+.++|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... ...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----~~~ 231 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----QVL 231 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence 99999999998865432211 1112234567999999998899999999999999999999 67787543211 111
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+.+. .....+...+..+.+++.+|++.||++|||+.++++.|+..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 KFVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111211 11122334467899999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.10 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=202.5
Q ss_pred hccCccccccccCCCccEEEEEecC---------------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCcccee
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD---------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~ 372 (589)
.++|...+.||+|+||.||++...+ ...||+|.+...........|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987642 2358999997654445556799999999999999999999
Q ss_pred eeeecCCCCeEEEEEEeCCCCChHHHhhhhcC--------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCC
Q 007788 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 444 (589)
Q Consensus 373 g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk 444 (589)
+++.. .+..++||||+++++|.+++..... ....++|..++.++.|++.||+|||+.+ ++|||||
T Consensus 84 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlk 156 (295)
T cd05097 84 GVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLA 156 (295)
T ss_pred EEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-----eeccccC
Confidence 99854 4678999999999999999965421 1124789999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh--CCCCcchh
Q 007788 445 VEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSS 521 (589)
Q Consensus 445 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--g~~p~~~~ 521 (589)
|+||++++++.+||+|||++.......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999999987654332211 112234567999999998899999999999999999998 55676543
Q ss_pred HHHHHhhhhHHHhhc---cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 522 MRLAAESATFENFID---RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
....... ....... .......+...+..+.+++.+||+.+|++||+|++|++.|++
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 237 SDEQVIE-NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ChHHHHH-HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2211111 1111111 111111223345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.90 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=207.9
Q ss_pred cccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 313 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
..+.||.|+.|.|..|+.. +|+.+|||++..... ........+||-+|+-+.|||++++++++ ++..++|+|.||
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lylvlEy 93 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYLVLEY 93 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEEEEEe
Confidence 3467999999999999964 899999999977632 23345678999999999999999999998 556899999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|-|++++-.++. +.+.+..+++.||..|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-.+
T Consensus 94 v~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~~-----icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAFN-----ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred cCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhhc-----ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999987653 888999999999999999999998 99999999999999999999999999987554
Q ss_pred CceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC--CCCHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSES 546 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 546 (589)
+.. .....|++.|.|||++.+.+| +.++||||.|||||.|+||+.||++.+- ..++...-+| ..+..
T Consensus 165 gkl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G~f~MPs~ 234 (786)
T KOG0588|consen 165 GKL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRGVFEMPSN 234 (786)
T ss_pred Ccc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCcccCCCc
Confidence 432 234568899999999999998 5789999999999999999999986532 2222222222 34567
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+.+..+|+.+++..||++|.|++||++|.+-.
T Consensus 235 Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 235 ISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred CCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 778899999999999999999999999997744
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=315.81 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=203.9
Q ss_pred CccccccccCCCccEEEEEecC----CcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC----C
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G 381 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----~ 381 (589)
|...+.||+|+||.||+|.... +..||+|+++.... ......+.+|++.+++++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998752 36799999976533 3344679999999999999999999998854322 2
Q ss_pred eEEEEEEeCCCCChHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
..++|+||+++|+|.+++..... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-----FIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchheEEECCCCeEEEC
Confidence 37899999999999999865432 2245899999999999999999999987 9999999999999999999999
Q ss_pred cccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcc
Q 007788 460 DCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 460 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|||+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+..... ..... ..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~~-~~ 230 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYL-RH 230 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH-Hc
Confidence 999998664332211 111234567999999988889999999999999999999 888886533211 11111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+......+.+++.+||+.||.+||++.|+++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222233445667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=344.41 Aligned_cols=252 Identities=17% Similarity=0.260 Sum_probs=202.3
Q ss_pred CccccccccCCCccEEEEEec-C-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-D-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|...+.||+|+||.||+|... + +..||+|.+.... ......+..|+.+++.++|||||++++++.. .+..++|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E 145 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIME 145 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEE
Confidence 677789999999999999864 3 6788888775443 3344567889999999999999999999854 478999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.+++........++++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-----MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 99999999998764433446889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......||++|+|||++.+..++.++|||||||++|||++|+.||....... .+........ ...+...
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~-~~~~~~~ 295 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKY-DPFPCPV 295 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCC-CCCCccC
Confidence 43211 1223457889999999999999999999999999999999999996543211 1111111111 1223345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+..+.+++..||+.||++||++++++.+
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 5679999999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=329.87 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=197.7
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
+.||+|+||.||++... +++.||||++..... ......+.+|++++++++||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence 36899999999999875 689999999975431 234467889999999999999999998884 3578999999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
+|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 79 GGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence 999999886543 4899999999999999999999988 9999999999999999999999999987543221
Q ss_pred eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHH
Q 007788 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 551 (589)
. ......+++.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ...+......+
T Consensus 150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----~~~~~~~~--~~~p~~~~~~~ 222 (328)
T cd05593 150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMED--IKFPRTLSADA 222 (328)
T ss_pred c-ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH----HHHhccCC--ccCCCCCCHHH
Confidence 1 12234578899999999998999999999999999999999999965432111 11111111 12233445678
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 552 GKMALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 552 ~~l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
.+++.+|++.||++|| ++.|++++.+.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 8999999999999997 89999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.22 Aligned_cols=263 Identities=24% Similarity=0.416 Sum_probs=206.9
Q ss_pred hccCccccccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
.++|...+.||+|+||.||+|... ++..||+|.+..........++.+|+.++..+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 456777889999999999999741 34579999987654344557899999999999 89999999999854
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
....++||||+++|+|.+++..... ....++|.+++.++.||+.||+|||+.+ |+||||||+
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~ 166 (304)
T cd05101 93 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-----CIHRDLAAR 166 (304)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-----eeecccccc
Confidence 4678999999999999999976432 1235889999999999999999999988 999999999
Q ss_pred CeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999999998764322211 122334567999999998889999999999999999998 77777543211
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
. ....+........+...+..+.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 247 ~-----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 E-----LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H-----HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 1111111122222344567899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.85 Aligned_cols=262 Identities=19% Similarity=0.337 Sum_probs=208.4
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|++|.||+|.. .+++.+|||.+..... .....+|.+|+.+++.++||||+++++++.+ .+..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 3577778999999999999996 4789999998865322 2344678999999999999999999999854 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
+|||+++++|.+++.........++|..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 99999999999999754434456899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......++..|+|||++.+..++.++||||||+++|||++|..||........ .....+...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (267)
T cd08229 155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQCDYPPLPSD 231 (267)
T ss_pred ccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHhhhhhcCCCCCCCcc
Confidence 6643321 11223467789999999888899999999999999999999999864322110 01111111111111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.....+.+++.+||+.+|++||||.+|++.++++.
T Consensus 232 ~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 232 HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 45678999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.76 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=206.3
Q ss_pred hccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~ 380 (589)
.++|...+.||+|+||.||+|... .+..||||.++..........+.+|+.+++++ +||||+++++++.. .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--G 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--C
Confidence 456888899999999999999742 35689999987654344456799999999999 79999999999854 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++|+|.++++.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.++++|
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhccceEEEcCCCeEEECC
Confidence 678999999999999999975432 23899999999999999999999987 99999999999999999999999
Q ss_pred ccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccc
Q 007788 461 CGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 461 fGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+...+...
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~~~~~~~~ 260 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KFYKLIKEG 260 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HHHHHHHcC
Confidence 9999866443211 1112234567999999999899999999999999999998 888886533211 111222222
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 539 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.....+...+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 22222233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.09 Aligned_cols=263 Identities=24% Similarity=0.401 Sum_probs=203.6
Q ss_pred hccCccccccccCCCccEEEEEec-----------------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccc
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-----------------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 370 (589)
.++|+..+.||+|+||.||++... ++..||+|++..........+|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888899999999999998642 245799999986554555678999999999999999999
Q ss_pred eeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCC-------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC
Q 007788 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 443 (589)
Q Consensus 371 l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl 443 (589)
+++++.. .+..++||||+++|+|.+++...... ...+++.+...++.|++.||+|||+.+ ++||||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dl 156 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-----FVHRDL 156 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccC
Confidence 9999854 46789999999999999999764321 134788999999999999999999988 999999
Q ss_pred CCCCeeecCCCceEEccccccccccCCceeee-ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh--CCCCcch
Q 007788 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTS 520 (589)
Q Consensus 444 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--g~~p~~~ 520 (589)
||+||+++.++.++|+|||+++.+........ .....+..|+|||...++.++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999986543322111 11223567999999888899999999999999999998 6677754
Q ss_pred hHHHHHhhhhHHHhhcc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 521 SMRLAAESATFENFIDR---NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 521 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
........ ........ ......+..++..+.+++.+||+.||.+||++.++++.|++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 237 LSDEQVIE-NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cChHHHHH-HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 32211111 11111111 11111223455789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=336.34 Aligned_cols=257 Identities=14% Similarity=0.241 Sum_probs=204.1
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
...++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.+++.++||||+++++++. +.+.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCE
Confidence 34568889999999999999999975 68899999996432 1223345788999999999999999998874 4578
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEcCCCCEEEEecc
Confidence 99999999999999998653 2777888899999999999999988 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCC----CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
++...............+++.|+|||++.+. .++.++|||||||++|||++|+.||....... .+..+....
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~ 263 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMDHK 263 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCC
Confidence 9987654322222334578899999998653 37889999999999999999999997643321 122232221
Q ss_pred cCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHh
Q 007788 539 LKGKFS--ESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTV 578 (589)
Q Consensus 539 ~~~~~~--~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~ 578 (589)
.....+ ...+..+.+++..|++.+|.+ ||++.|++++-+.
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 111111 234678889999999999988 9999999988653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=319.46 Aligned_cols=258 Identities=22% Similarity=0.415 Sum_probs=206.0
Q ss_pred hccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
.++|...+.||+|+||.||+|...+ +..||+|.+...........|.+|+.++..++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--CC
Confidence 3567788999999999999998652 468999998766544555689999999999999999999999854 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCC------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGS------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
..++||||+++|+|.+++...... ...++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~di~p~nill~~~~~ 157 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-----FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccChheEEEcCCCC
Confidence 789999999999999999754321 224789999999999999999999987 999999999999999999
Q ss_pred eEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHH
Q 007788 456 PLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 533 (589)
+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++||++| |..||........ ..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----~~ 232 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-----LK 232 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-----HH
Confidence 999999998765433221 1122334678999999988889999999999999999998 8888854322111 11
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.+........+...+..+.+++..||+.+|++|||+.++++.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111122234445778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.96 Aligned_cols=255 Identities=24% Similarity=0.478 Sum_probs=203.1
Q ss_pred cCccccccccCCCccEEEEEecC-C---cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRD-G---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
+|...+.||+|+||.||+|.... + ..||||.+..........+|..|+.++++++||||+++++++. +.+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCceEE
Confidence 46677899999999999999752 3 4699999876544455678999999999999999999999884 4567899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++....+ .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~g-----~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 83 ITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EEecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccChheEEEcCCCcEEECCCcccc
Confidence 9999999999999976432 4899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeee----ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 466 LLADDIVFSV----LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 466 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
.......... .....+..|+|||.+.+..++.++|||||||++||+++ |..||........ ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~-----~~~i~~~~~ 229 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-----INAIEQDYR 229 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH-----HHHHHcCCc
Confidence 6543221111 11112346999999999999999999999999999987 9999865432111 111111122
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+...+..+.+++..||+.+|.+||++++++..|+.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 223344566789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.82 Aligned_cols=261 Identities=20% Similarity=0.308 Sum_probs=213.8
Q ss_pred hccCccccccccCCCccEEEEEecCC-cEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceee-eeec---CC-C
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRG-FCCS---RG-R 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g-~~~~---~~-~ 380 (589)
..++++.+.|.+|||+.||.|....+ ..||+|++... .+...+...+|+++|++|+ |+|||.+++ .... .. .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 34556778999999999999998765 99999999877 4667788999999999997 999999999 3221 11 3
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
-+++|.||||++|.|-+++..+... .|++.++++|+.++++|+++||.. +|||||||||-+||||+.++..||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~---~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL---KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC---CCccchhhhhhhheEEcCCCCEEeCc
Confidence 4789999999999999999876543 399999999999999999999975 59999999999999999999999999
Q ss_pred ccccccccCCc--------eeeeecCCccccccCcccc---cCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh
Q 007788 461 CGLHKLLADDI--------VFSVLKTSAAMGYLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529 (589)
Q Consensus 461 fGla~~~~~~~--------~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~ 529 (589)
||.+...-... .........|+.|+|||.+ .+...++|+||||+||+||-|+....||+.....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 99876432111 0011233457889999976 4567899999999999999999999999766443
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+++..+..+..+.+...+.+||..|++.+|.+||++-+|+..+..++..
T Consensus 265 ---aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 ---AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 23333444344467899999999999999999999999999999887654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=312.90 Aligned_cols=252 Identities=25% Similarity=0.466 Sum_probs=195.1
Q ss_pred cccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|.+. ++..||+|++...........+.+|+.+++.++||||+++++++... .+..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 46899999999999864 24679999986544344557889999999999999999999987543 34578999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++..... ..++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 80 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 80 KHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999975432 3678888999999999999999987 999999999999999999999999998765432
Q ss_pred ceeee---ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCC-CcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 471 IVFSV---LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-VLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 471 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+. |+....... ....+........+..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 226 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-----ITVYLLQGRRLLQPEY 226 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhcCCCCCCCCc
Confidence 21111 12234567999999988899999999999999999999655 443322111 1111111111122233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.+..+.+++..||+.+|++||++.|+++.|+.+-
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 4567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=330.36 Aligned_cols=255 Identities=18% Similarity=0.252 Sum_probs=198.8
Q ss_pred cCccccccccCCCccEEEEEe----cCCcEEEEEEeccCCC---chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCC
Q 007788 310 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 381 (589)
+|+..+.||+|+||.||+++. .+++.||+|++..... ......+..|+.++.++ +||||+++++++. ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence 477789999999999999985 3588999999865321 22335678899999999 4999999998874 356
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG-----IVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHeEECCCCCEEEeeC
Confidence 7899999999999999997543 3889999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
|+++..............++..|+|||.+.+.. ++.++|||||||++|||+||+.||...............+.. ..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~ 227 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CD 227 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CC
Confidence 999865433222223345788999999988654 788999999999999999999999643211111111111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
...+......+.+++.+|++.||++|| ++++++++-+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 223334556788999999999999999 7889987754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=315.68 Aligned_cols=253 Identities=21% Similarity=0.322 Sum_probs=194.4
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC---eEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG---ECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~---~~~l 385 (589)
.|...+++|+|+||.||+|.+. ++..||||+...+.. .--+|+.+|++++|||||++.-++.....+ ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3555689999999999999976 578999999876542 112688999999999999999888765444 3457
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceEEcccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLH 464 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfGla 464 (589)
||||||. +|.++++.....+..++.....-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||||||.|
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-----IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG-----ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC-----cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 9999987 999999864333445777778889999999999999987 9999999999999986 89999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh-----------hH-
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------TF- 531 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~-----------~~- 531 (589)
+.+..+... .....+.-|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.....+-.. .+
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 987654321 223345569999999875 599999999999999999999999875422111100 00
Q ss_pred ------HHhhccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 532 ------ENFIDRNLKG-----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 532 ------~~~~~~~~~~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.+.-.+.+.. ........+..+++.++++.+|.+|.++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111111111 1234457789999999999999999999999976
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=321.03 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=204.7
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.|+..+.||+|+||.||++... +++.||||++...... .....+.+|+.++++++||||+++++.+. ..+..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec--CCCeEEEE
Confidence 3677889999999999999975 6899999999754322 22346788999999999999999999884 34689999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 79 LTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999999886542 234899999999999999999999988 99999999999999999999999999886
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+.. .....+..
T Consensus 152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~ 227 (285)
T cd05605 152 IPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKE-DQEEYSEK 227 (285)
T ss_pred cCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhh-cccccCcc
Confidence 543321 12335678899999999889999999999999999999999999754321111 111111111 11223445
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~ 579 (589)
.+..+.+++..||+.||++|| ++++++++-+..
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 667889999999999999999 888998875544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.19 Aligned_cols=256 Identities=27% Similarity=0.499 Sum_probs=207.2
Q ss_pred hhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
..++|.+.+.||+|+||.||+|..++++.||||.+.... ....++.+|+.++++++|+||+++++++. .....++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeee--cCCceEEE
Confidence 346788889999999999999998888899999987543 23467999999999999999999999884 34678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++....+ ..+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.++|+|||.+..
T Consensus 80 ~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN-----YIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred EeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcchheEEEcCCCCEEECcccccee
Confidence 999999999999976532 34899999999999999999999988 99999999999999999999999999887
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..............+..|+|||.+.+..++.++||||||+++||++| |+.||....... .... +........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~ 227 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----VLEQ-VERGYRMPRPP 227 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-HHcCCCCCCCC
Confidence 65432212222334567999999998889999999999999999999 898886432211 1111 11122222233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 346689999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.18 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=209.3
Q ss_pred cCccccccccCCCccEEEEEec-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.|...+.||+|+||.||+|.+. ++..||||++...........|.+|++.++++.||||+++++++........+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566688999999999999864 36899999998665333467899999999999999999999998665566789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++..... .++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+
T Consensus 85 lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQR-----YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999976542 4899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCcee-e-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH----------hhhhHH
Q 007788 465 KLLADDIVF-S-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATFE 532 (589)
Q Consensus 465 ~~~~~~~~~-~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~----------~~~~~~ 532 (589)
......... . ......+..|+|||.+.+..++.++||||||+++|||+||+.|+........ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 877532211 1 1122344569999999988999999999999999999999998864321110 011222
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.+........+..++..+.+++.+||+.+|++||+|.|++++|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222223233445567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.82 Aligned_cols=259 Identities=22% Similarity=0.414 Sum_probs=204.9
Q ss_pred hccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
.++|+..+.||+|+||.||+|... ++..||+|++..........+|.+|+.++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV--GK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CC
Confidence 457888899999999999999864 4678999999765544555779999999999999999999998854 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcC------------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEG------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 443 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl 443 (589)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dl 156 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-----FVHRDL 156 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----eecccc
Confidence 78999999999999999975321 1124788999999999999999999987 999999
Q ss_pred CCCCeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchh
Q 007788 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSS 521 (589)
Q Consensus 444 k~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~ 521 (589)
||+||++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998765432211 1112234567999999998899999999999999999998 77888643
Q ss_pred HHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 522 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.... ....+.+... ...+...+..+.+++.+|++.+|++||++.|+++.|+.
T Consensus 237 ~~~~----~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEE----VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHH----HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2211 1111111111 12233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.16 Aligned_cols=254 Identities=19% Similarity=0.296 Sum_probs=205.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|... +++.||||++..... ......+..|++++..++||||+++++++. +.+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence 36888899999999999999976 689999999975421 234467889999999999999999999884 3578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 79 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g-----iiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKLG-----FIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 999999999999997652 4889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCc----------------------------eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCC
Q 007788 466 LLADDI----------------------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 517 (589)
Q Consensus 466 ~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p 517 (589)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 665432 0112234578889999999999999999999999999999999999
Q ss_pred cchhHHHHHhhhhHHHhhc--cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHh
Q 007788 518 LTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRPT-MEAVIEELTV 578 (589)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L~~ 578 (589)
|........ ...+.. ...........+..+.+++..|++ ||.+||+ +++++++.+.
T Consensus 230 f~~~~~~~~----~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 230 FYSDTLQET----YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred CCCCCHHHH----HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 976543221 111222 111111112246778899999997 9999999 9999987553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=331.41 Aligned_cols=243 Identities=19% Similarity=0.323 Sum_probs=200.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~ 383 (589)
-++|....+||+|.||+|+++.++ +++.+|||++++... .++....+.|.+++.-. +||.++.++..+ .+.+.+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~l 444 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEHL 444 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCeE
Confidence 467888999999999999999987 688999999998753 44556677888777766 599999998777 677899
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+.|||+..+.+.. .+++..+.-+|..|+.||+|||+++ |||||||.+|||||.+|.+||+|||+
T Consensus 445 ~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~~-----IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHENG-----IIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred EEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhcC-----ceeeecchhheEEcccCcEEeccccc
Confidence 9999999999955444422 3999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
++..-.... ....-.||+.|||||++.+..|+..+|+|||||+||||+.|..||.+..+. ..++.++... ..+
T Consensus 515 cKe~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----e~FdsI~~d~--~~y 587 (694)
T KOG0694|consen 515 CKEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----EVFDSIVNDE--VRY 587 (694)
T ss_pred ccccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCC--CCC
Confidence 986432111 233456899999999999999999999999999999999999999876542 2223333222 234
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTM 569 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~ 569 (589)
+...+.+...++.+.+.++|++|..+
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCC
Confidence 56667788899999999999999866
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=311.28 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=204.8
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||+|..+ +++.|++|.+.... ......++.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 3667789999999999999975 68999999987543 23455789999999999999999999999854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.++++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++..
T Consensus 79 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~-----i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 79 EYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEeCCCCEEEcccccceec
Confidence 9999999999998653 235899999999999999999999987 999999999999999999999999998866
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...... .....++..|+|||+..+..++.++||||||+++|||++|+.||........ ...... ......+...
T Consensus 152 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~ 225 (256)
T cd08529 152 SDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL----ILKIIR-GVFPPVSQMY 225 (256)
T ss_pred cCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHc-CCCCCCcccc
Confidence 543221 1223466789999999998999999999999999999999999975432111 111111 1122233456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 6789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.21 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=204.5
Q ss_pred hccCccccccccCCCccEEEEEecC-----------------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccc
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD-----------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 370 (589)
.++|+..+.||+|+||.||+|...+ +..||+|.+...........|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3567888999999999999998642 24689999987655556678999999999999999999
Q ss_pred eeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCC-------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC
Q 007788 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 443 (589)
Q Consensus 371 l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl 443 (589)
+++++.. .+..++|+||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl 156 (296)
T cd05051 84 LLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDL 156 (296)
T ss_pred EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-----cccccc
Confidence 9999854 36789999999999999999765421 225899999999999999999999987 999999
Q ss_pred CCCCeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh--CCCCcch
Q 007788 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTS 520 (589)
Q Consensus 444 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--g~~p~~~ 520 (589)
||+||+++.++.++|+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..|+..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999987654332211 122334567999999998899999999999999999998 6677754
Q ss_pred hHHHHHhhhhHHHhh---ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 521 SMRLAAESATFENFI---DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 521 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......... ..... ........+...+..+.+++.+|++.||++|||+.|+++.|++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 237 LTDQQVIEN-AGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cChHHHHHH-HHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 322111110 01110 0011111223345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=314.09 Aligned_cols=251 Identities=23% Similarity=0.442 Sum_probs=196.7
Q ss_pred cccccCCCccEEEEEecC-Cc--EEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLRD-GT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
++||+|+||.||+|.+++ +. .+++|.++..........+.+|++++.++ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 368999999999999763 43 57888887554445556899999999999 79999999999854 46789999999
Q ss_pred CCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEE
Q 007788 391 PKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 391 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccccceEEEcCCCeEEE
Confidence 99999999975431 1234889999999999999999999987 999999999999999999999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcc
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
+|||++....... .......+..|+|||++....++.++||||||+++|||++ |+.||....... ....+..
T Consensus 154 ~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~~~ 226 (270)
T cd05047 154 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKLPQ 226 (270)
T ss_pred CCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHHHhC
Confidence 9999986332111 1111223456999999988889999999999999999997 999986432211 1111112
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 222222333456789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.17 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=206.6
Q ss_pred hccCccccccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
.++|...+.||+|+||.||+|... ....||+|.++.........++..|++++.++ +||||++++++|..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 356778899999999999999742 34579999988654445566789999999999 69999999999844
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
.+..++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+.+ |+||||||+
T Consensus 90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~ 163 (314)
T cd05099 90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-----CIHRDLAAR 163 (314)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-----eeeccccce
Confidence 4678999999999999999976431 1235899999999999999999999987 999999999
Q ss_pred CeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998664322111 111223456999999998899999999999999999999 88888543211
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
. ....+........+...+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 244 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 E-----LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred H-----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1 111111111222334456678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.30 Aligned_cols=257 Identities=23% Similarity=0.426 Sum_probs=206.5
Q ss_pred ccCccccccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|...+.||+|+||.||+|...+ ...||||...........+.|.+|+.++++++||||+++++++.. +..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 356677899999999999998653 246899998766544556789999999999999999999998843 4578
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... ..+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR-----FVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccChheEEEecCCCeEEccCcee
Confidence 9999999999999997543 24899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
+..............++..|+|||.+....++.++||||||+++||+++ |..||......... .. +........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~----~~-~~~~~~~~~ 229 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----GR-IENGERLPM 229 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HH-HHcCCcCCC
Confidence 8765543323223334567999999988889999999999999999996 99998654322111 11 111111123
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+...+..+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus 230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 34556789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.13 Aligned_cols=259 Identities=20% Similarity=0.358 Sum_probs=197.2
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC---CeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~~ 384 (589)
+|+..+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777889999999999999965 689999999875322 2334578899999999999999999998854322 3579
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999995 68999886543 3899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCce--eeeecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh------------
Q 007788 465 KLLADDIV--FSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------ 528 (589)
Q Consensus 465 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~------------ 528 (589)
+....... .......++..|+|||++.+ ..++.++|||||||++|||+||+.||..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 76432211 11123457888999999876 678999999999999999999999996432111000
Q ss_pred -------hhHHHhhc---cccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 529 -------ATFENFID---RNLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 529 -------~~~~~~~~---~~~~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+. ........ +.....+.+++.+|++.||++||+++|++++-+.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 00000000 00000000 1124567899999999999999999999988654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.60 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=193.1
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||+|+||.||++..+ +|+.||+|++..... ......+..|++++++++||||+++++++. .....++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence 699999999999875 689999999865322 223345667999999999999999998884 357899999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 149 (277)
T cd05607 79 DLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-- 149 (277)
T ss_pred CHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence 99998865432 34889999999999999999999988 9999999999999999999999999988765432
Q ss_pred eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......++..|+|||++.+..++.++|||||||++|||++|+.||...................... ........++.+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKD 228 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHH
Confidence 2223457888999999999899999999999999999999999996532211111111111111111 111234667899
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 007788 554 MALVCTHEDPENRPTMEAVIE 574 (589)
Q Consensus 554 l~~~C~~~dp~~RPs~~evl~ 574 (589)
++..|++.||++||+++|+++
T Consensus 229 li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHhccCHhhCCCCccchh
Confidence 999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=332.83 Aligned_cols=261 Identities=13% Similarity=0.242 Sum_probs=204.9
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecC
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR 378 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 378 (589)
.++....++|+..+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-- 113 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-- 113 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--
Confidence 334445678999999999999999999976 58899999986432 1223456788999999999999999999884
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEE
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
+.+..++||||+++|+|.+++... .+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~-----IvHrDLKp~NILl~~~~~~kL 183 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG-----LIHRDVKPDNMLLDKHGHLKL 183 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEE
Confidence 457899999999999999999643 2788889999999999999999988 999999999999999999999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCC----CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
+|||++...............+|+.|+|||++.+.. ++.++||||+||++|||++|+.||....... ....+
T Consensus 184 ~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----~~~~i 259 (370)
T cd05621 184 ADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----TYSKI 259 (370)
T ss_pred EecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence 999999876543322233456889999999987543 7889999999999999999999997653321 22233
Q ss_pred hccccCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHh
Q 007788 535 IDRNLKGKFS--ESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTV 578 (589)
Q Consensus 535 ~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~ 578 (589)
.+.......+ ......+.+++..|++.++.+ |+++.|++++-+.
T Consensus 260 ~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 260 MDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred HhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 3222111112 234566788888888755544 8999999998664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=331.02 Aligned_cols=254 Identities=19% Similarity=0.272 Sum_probs=202.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||++... +|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+ .+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 36788899999999999999975 689999999976432 2344568889999999999999999988843 467999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++..... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 79 v~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~-----i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQMG-----YVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred EECCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eEcccCchHheEECCCCCEEeccCCCCe
Confidence 9999999999999976532 4899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCccccc------CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc-
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVT------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN- 538 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 538 (589)
..............++..|+|||++. ...++.++|||||||++|||++|+.||........ +..+....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~ 226 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT----YNNIMNFQR 226 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH----HHHHHcCCC
Confidence 76544332333345788999999986 45678999999999999999999999965432211 12222111
Q ss_pred -cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 539 -LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 539 -~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
............+.+++..|++ +|++||++.+++++-+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 1111112345678889999998 9999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.95 Aligned_cols=252 Identities=23% Similarity=0.486 Sum_probs=201.1
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ...+|.+|++++++++|||++++++++. .....++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEEE
Confidence 35667789999999999999987788999999875432 3457899999999999999999999884 3467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++....+ .+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 80 FMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN-----VIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred cCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccccceEEEcCCCeEEECCCcceeecc
Confidence 9999999999976432 4889999999999999999999987 9999999999999999999999999987654
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
............+.+|+|||.+.++.++.++||||||+++|||++ |+.||........ ... +........+...
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~ 226 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV----VET-INAGFRLYKPRLA 226 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH----HHH-HhCCCCCCCCCCC
Confidence 332212222334568999999998899999999999999999998 8888864322111 111 1111111112224
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
+..+.+++.+||+.+|++||++.|++++|+
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 567999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.02 Aligned_cols=245 Identities=20% Similarity=0.324 Sum_probs=196.6
Q ss_pred cccccCCCccEEEEEe----cCCcEEEEEEeccCCC---chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 315 NLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.||+|+||.||+++. .+++.||||+++.... ......+..|++++++++||||+++++++.. .+..++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 5799999999999985 3578999999875321 2233567889999999999999999998854 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++.... .+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 80 EYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG-----IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred eCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999999987543 3788888999999999999999988 999999999999999999999999998754
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... ..+...
T Consensus 151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~--~~~~~~ 223 (323)
T cd05584 151 IHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKL--NLPPYL 223 (323)
T ss_pred ccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCC--CCCCCC
Confidence 32211 1123457889999999998889999999999999999999999997643321 1122222211 223344
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
...+.+++..|++.||++|| ++.+++++-+
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 56789999999999999999 8999887654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=310.80 Aligned_cols=249 Identities=25% Similarity=0.438 Sum_probs=200.0
Q ss_pred cccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|.+.. +..||+|.+..........++.+|+++++++.||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence 369999999999998642 26899999987654445678999999999999999999999874 24679999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 78 PLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC-----eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 9999999997653 4899999999999999999999987 999999999999999999999999999866433
Q ss_pred ceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 471 IVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 471 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+........+...
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 223 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----VIAMLESGERLPRPEEC 223 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHHcCCcCCCCCCC
Confidence 2211 111223457999999998899999999999999999998 899886532211 11111111122233445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
+..+.+++.+||+.+|++||++.++++.|+...
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=312.34 Aligned_cols=254 Identities=23% Similarity=0.443 Sum_probs=205.2
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|...+.||+|+||.||++...++..+|+|.+... ......|.+|++++++++|+||+++++++.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEE
Confidence 4567788999999999999999888888999988754 2345678999999999999999999998743 5689999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... ..++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+...
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 80 EFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCCcceeec
Confidence 99999999999976432 34889999999999999999999987 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
............++..|+|||++....++.++|+|||||++||++| |+.||........ ...+...........
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 227 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----IRALERGYRMPRPEN 227 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCCCCCCccc
Confidence 4332212222334567999999998889999999999999999999 8888865432111 111112222223344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 56679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=313.02 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=190.9
Q ss_pred ccccCCCccEEEEEecC---CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 316 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
.||+|+||.||+|...+ ...+++|.+...........|.+|+..++.++||||+++++.+.. ....++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCCC
Confidence 58999999999997643 357888987765444555678999999999999999999999843 4678999999999
Q ss_pred CChHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 393 GKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 393 gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
|+|.+++...... ....++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-----EecccccHhheEecCCCcEEEeccccccccccch
Confidence 9999999765432 233567888999999999999999988 9999999999999999999999999987543322
Q ss_pred e-eeeecCCccccccCcccccC-------CCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 472 V-FSVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 472 ~-~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
. .......++..|+|||++.. ..++.++|||||||++|||++ |..||........................
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 11222334567999998643 356889999999999999999 77777544322111111111000011112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.+......+.+++..|| .||++||++++|++.|.
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 23345567778889999 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=311.62 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=204.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc----hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|...+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++++.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 46788899999999999999864 6899999998754321 223578899999999999999999999854 4689
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++|+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||+
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred EEEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99999999999999987543 3888999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeee--ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIVFSV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++.......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~ 226 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----IFKIATQPTNP 226 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----HHHHhccCCCC
Confidence 876543211111 223456779999999998899999999999999999999999865422111 11122222223
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..+......+.+++..||+.+|.+||++.|++++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 344556678899999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=316.19 Aligned_cols=252 Identities=19% Similarity=0.313 Sum_probs=200.3
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||+|+||.||+|... +++.||+|.+..........+|.+|++++.+++||||+++++++.. .+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 5677789999999999999864 7889999998765444455679999999999999999999999854 467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK-----ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 99999997652 2678888999999999999999988 9999999999999999999999999987654
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH---hhhhHHHhhccccCCCCCH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---ESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 545 (589)
... .....++..|+|||++.+..++.++||||||+++|||++|+.||........ .........+.........
T Consensus 147 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 147 NSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred ccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 322 1223567789999999998999999999999999999999999965321110 0011111111111111122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.....+.+++.+|++.+|++||+++|++++.+..
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 3455788999999999999999999999886643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=314.00 Aligned_cols=263 Identities=25% Similarity=0.451 Sum_probs=210.4
Q ss_pred ccCccccccccCCCccEEEEEec-CC----cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.+|...+.||+|+||.||+|..+ +| ..||+|.+..........++.+|+..+++++||||++++++|.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence 45677789999999999999865 23 36899988766544555789999999999999999999999854 578
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred EEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EEecccCcceEEEcCCCeEEECCCcc
Confidence 999999999999999976533 3899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... ........+..|+|||.+....++.++|+||||+++||+++ |+.||....... +.+.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~ 230 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLEKGERL 230 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHhCCCCC
Confidence 987653321 11112223467999999988899999999999999999999 999987543211 11122222222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccccccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 587 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~~ 587 (589)
..+..+...+.+++..||..+|.+||++.++++.|+.+......++
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~ 276 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYL 276 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcceE
Confidence 2333455678899999999999999999999999999876655543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.18 Aligned_cols=254 Identities=18% Similarity=0.271 Sum_probs=193.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|... +++.||||++..... ......+..|+.++.+++||||+++++.+. +....++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEE
Confidence 46888899999999999999865 689999999975321 223356788999999999999999999884 3578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 79 v~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g-----ivHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG-----FIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 999999999999997643 4899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCcee----------------------------------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHH
Q 007788 466 LLADDIVF----------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 511 (589)
Q Consensus 466 ~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~el 511 (589)
.+...... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 54321100 01123578899999999999999999999999999999
Q ss_pred HhCCCCcchhHHHHHhhhhHHHhhc--cccCCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHHHHH
Q 007788 512 LTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 512 ltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~--C~~~dp~~RPs~~evl~~L~ 577 (589)
++|+.||.+....... ..+.. ..+...........+.+++.+ |...++..||+++|++++-+
T Consensus 230 l~G~~Pf~~~~~~~~~----~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 230 LIGYPPFCSETPQETY----KKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred HhCCCCCCCCCHHHHH----HHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCC
Confidence 9999999764332211 11111 011000000122344445444 33344556799999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.78 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=205.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|.+. +|. .||+|.+..........++.+|+.++++++||||++++|+|.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 45677889999999999999864 443 5789988765544445678999999999999999999999853 346
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred eeeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcC-----eeccccccceeeecCCCceEEccccc
Confidence 799999999999999876532 3889999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++........ ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.+.... ...+.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~ 230 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EIPDLLEKGERL 230 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHCCCCC
Confidence 9876533211 1122334567999999998899999999999999999998 88888653211 111222222222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+..+...+.+++..||..+|++||+++++++.|+.+....
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 223334567899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=310.23 Aligned_cols=250 Identities=23% Similarity=0.433 Sum_probs=201.3
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
.+|...+.||+|+||.||++..+ |..||+|.++... ..+.|.+|+.++++++|+|++++++++... .+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEEE
Confidence 35777889999999999999875 7789999986532 345789999999999999999999976543 456899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++..... ..++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccccchheEEEcCCCcEEecCCccceecc
Confidence 9999999999976532 34889999999999999999999988 9999999999999999999999999987553
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
... .....+..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+............
T Consensus 154 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05082 154 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYKMDAPDGC 224 (256)
T ss_pred ccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhcCCCCCCCCCC
Confidence 321 12233457999999998889999999999999999998 88888643211 111111112222233445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 67899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=309.11 Aligned_cols=249 Identities=23% Similarity=0.461 Sum_probs=204.8
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.. .+..++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEE
Confidence 45677789999999999999875 78899999976542 45789999999999999999999999854 577899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++..... ..++|..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.++...
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 81 YMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN-----FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999999976542 24899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
.... ....+..|+|||.+.++.++.++||||||+++||+++ |+.||....... ....+........+...
T Consensus 154 ~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 224 (256)
T cd05039 154 QGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVEKGYRMEAPEGC 224 (256)
T ss_pred cccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhcCCCCCCccCC
Confidence 3221 2234567999999998899999999999999999997 998886442211 11111112222333445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+..+.+++.+|++.+|++||++.|+++.|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 6789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=328.43 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=196.2
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
+.||+|+||.||++... +|+.||+|++..... ......+..|++++..++||||+++.+++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 36999999999999865 789999999975421 2334567889999999999999999988843 478999999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
+|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~-----ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 79 GGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence 999999886543 48999999999999999999997 56 999999999999999999999999998754322
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||++.+..++.++|||||||++|||+||+.||........ ...+..... ..+......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~--~~p~~~~~~ 222 (325)
T cd05594 150 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEI--RFPRTLSPE 222 (325)
T ss_pred Cc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCC--CCCCCCCHH
Confidence 11 11233578899999999999999999999999999999999999965432111 111111111 123334567
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 551 LGKMALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
+.+++.+|++.||++|+ ++.+++++.+.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 88999999999999996 89999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.26 Aligned_cols=261 Identities=23% Similarity=0.409 Sum_probs=206.4
Q ss_pred hccCccccccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
..+|.+.+.||+|+||.||+|... .+..||+|.+..........++.+|++++.++ +||||++++++|..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 346788899999999999999742 12478999887654444567899999999999 79999999999854
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
.+..+++|||+++|+|.+++..... ....++|..+++++.|++.||+|||+.+ |+||||||+
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~ 163 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-----CIHRDLAAR 163 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccc
Confidence 4678999999999999999975421 2235899999999999999999999988 999999999
Q ss_pred CeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999988664322111 112223457999999999999999999999999999998 77887543211
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
. ....+........+......+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 244 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 E-----LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred H-----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1 11111122222233445668999999999999999999999999999776
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=310.95 Aligned_cols=254 Identities=19% Similarity=0.317 Sum_probs=187.3
Q ss_pred ccccCCCccEEEEEecCC---cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 316 LLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
.||+|+||.||+|...++ ..+++|.+...........|.+|+..++.++||||++++++|.. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCCC
Confidence 599999999999986433 35667777655444456789999999999999999999999854 4678999999999
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC-c
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD-I 471 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~-~ 471 (589)
|+|.++++.........++.....++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999999865433344677788899999999999999987 999999999999999999999999997643221 1
Q ss_pred eeeeecCCccccccCcccccC-------CCCCCcchhhhHHHHHHHHHhC-CCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 472 VFSVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
........++..|+|||++.. ..++.++|||||||++|||+++ ..||.........................
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 111123345678999998753 2457899999999999999975 55664332211111111110000011111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.......+.+++..|| .+|++||+++++++.|.
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2224566788999999 57999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=329.07 Aligned_cols=253 Identities=18% Similarity=0.236 Sum_probs=196.8
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++.. ....++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEE
Confidence 467999999999999999999975 68899999643 2346789999999999999999998854 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+||+. ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 162 ~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~-----IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR-----IIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EecCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 99995 68988886543 3889999999999999999999988 99999999999999999999999999975
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH-------H-------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-------A------------- 526 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-------~------------- 526 (589)
.............+|+.|+|||++.+..++.++|||||||++|||+||+.|+....... .
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 43322112233468899999999999999999999999999999999998874321000 0
Q ss_pred -----hhhhHHHhh----ccccC--CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 527 -----ESATFENFI----DRNLK--GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 527 -----~~~~~~~~~----~~~~~--~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......... ..... ... ....+..+.+++.+|++.||++|||++|++++-+..
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 000000000 00000 000 012355788999999999999999999999887653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=334.84 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=219.9
Q ss_pred cccccccCCCccEEEEEe-cCC----cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 313 EVNLLGKGNFSSVYKGTL-RDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
..++||+|+||+||+|.+ ..| .+||+|++......+...++++|+-+|.+++|||+++++|+|... .+.||+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlvt 776 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLVT 776 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHHH
Confidence 357899999999999986 333 469999998877666778999999999999999999999999653 478999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
+||+.|+|.++++.++. .+.-...+.|..|||+||.|||++. +|||||.++||||.+-..+||.|||+++.+
T Consensus 777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr-----lVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR-----LVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc-----hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 99999999999998764 3788889999999999999999887 999999999999999999999999999988
Q ss_pred cCCc-eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 468 ADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 468 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..+. .+......-.+.|||-|.+....|+.++|||||||++||++| |..|+.+.. ...+.+++....+...++
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----~~eI~dlle~geRLsqPp 923 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----AEEIPDLLEKGERLSQPP 923 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----HHHhhHHHhccccCCCCC
Confidence 6543 222223333467999999999999999999999999999998 777876532 234566666666777888
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccccc
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATF 586 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~ 586 (589)
.+...+..++..||..|+..||+++++...+.+.+.....+
T Consensus 924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 99999999999999999999999999999999887665443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.72 Aligned_cols=254 Identities=18% Similarity=0.253 Sum_probs=196.3
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.|...+.||+|+||+||+|... +++.||||++..... ......+.+|++++.+++||||+++++++.+ .+..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 5778899999999999999865 688999999975431 2334578899999999999999999999854 5789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 80 MDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG-----FIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999999997643 3888888999999999999999988 99999999999999999999999999764
Q ss_pred ccCCcee----------------------------------------------eeecCCccccccCcccccCCCCCCcch
Q 007788 467 LADDIVF----------------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSD 500 (589)
Q Consensus 467 ~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 500 (589)
+...... ......||..|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 3210000 001235788999999999888999999
Q ss_pred hhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc--cccCCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHHHH
Q 007788 501 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 501 v~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~--C~~~dp~~RPs~~evl~~L 576 (589)
||||||++|||+||+.||......... ..++. .............++.+++.+ |+..++..||+++|++++-
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQ----LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHH----HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 999999999999999999754322111 11111 111111111233455666655 6677777899999999885
Q ss_pred Hh
Q 007788 577 TV 578 (589)
Q Consensus 577 ~~ 578 (589)
+.
T Consensus 307 ~f 308 (381)
T cd05626 307 FF 308 (381)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=322.78 Aligned_cols=252 Identities=19% Similarity=0.362 Sum_probs=213.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe-EEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE-CFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~-~~l 385 (589)
++|...+.+|+|+||.++..+.+ +++.+++|.+..... ...++...+|+.++++++|||||.+.+.+.+. +. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~--~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED--GQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC--CceEEE
Confidence 46777899999999999999876 688999999987653 33445788999999999999999999998654 44 899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||+|++||++.+.+....+ ..+++.+.++++.|++.|+.|||+.+ |+|||||+.||+++.+..+||.|||+|+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~~-----iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHENR-----VLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred EEeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhhh-----hhcccchhhhhhccccCceeecchhhhh
Confidence 9999999999999987763 35889999999999999999999877 9999999999999999999999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
.+..... ......||+.|++||.+.+.+|..|+|+||+||++|||++-+.+|....-..-..+.. +......+.
T Consensus 155 ~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-----~~~~~Plp~ 228 (426)
T KOG0589|consen 155 ILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-----RGLYSPLPS 228 (426)
T ss_pred hcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-----hccCCCCCc
Confidence 9876541 2234568999999999999999999999999999999999999997654322222222 222345567
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.+..++..++..|++.+|+.||++.+++.+
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 788899999999999999999999999987
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.66 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=194.7
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHH---hccCCCCccceeeeeecCCCCeEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLL---TSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l---~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
|...+.||+|+||.||+|... +++.||||+++.... ......+..|++++ ++++||||+++++++. ..+..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEE
Confidence 556789999999999999875 689999999975421 22334566666554 5678999999999884 457899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|..+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 79 lv~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred EEEcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCcEEeCcccCC
Confidence 999999999999888642 3899999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+....... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+.... ...+
T Consensus 149 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~--~~~p 221 (324)
T cd05589 149 KEGMGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV----FDSIVNDE--VRYP 221 (324)
T ss_pred ccCCCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCC--CCCC
Confidence 75322111 12234578889999999999999999999999999999999999975432211 11121111 1223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
...+..+.+++.+|++.||.+|| ++.+++++.+
T Consensus 222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 34466788999999999999999 5777777643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=315.18 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=201.4
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCC----
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG---- 379 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~---- 379 (589)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 35677888899999999999999875 68899999987543 3345788999999998 6999999999986532
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
....++||||+++++|.+++..... ..++|..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHEEECCCCCEEEc
Confidence 2468999999999999999976432 35899999999999999999999987 9999999999999999999999
Q ss_pred cccccccccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
|||++........ ......++..|+|||++. ...++.++|||||||++|||++|+.||.......... ..
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----~~ 228 (272)
T cd06637 154 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LI 228 (272)
T ss_pred cCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH----HH
Confidence 9999876543211 122234677899999986 3357889999999999999999999996433221111 11
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.............+..+.+++.+||..+|.+|||+.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 270 (272)
T cd06637 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270 (272)
T ss_pred hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence 111111111223456789999999999999999999998753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.17 Aligned_cols=258 Identities=19% Similarity=0.326 Sum_probs=203.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||++... ++..+|+|.+..........++.+|++++.+++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEe
Confidence 36788899999999999999875 6888999998765434445678899999999999999999999854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||+++++|.+++.... .+++..+..++.|+++||+|||+. + ++||||||+||+++.++.+||+|||++..
T Consensus 79 ey~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 79 EHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred eccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCC-----EEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9999999999997642 488999999999999999999974 4 99999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh-----------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----------------- 529 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~----------------- 529 (589)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 150 LIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 53321 1223467789999999888899999999999999999999999864321110000
Q ss_pred -----------hHHHhhcc---ccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 530 -----------TFENFIDR---NLKGKFS-ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 530 -----------~~~~~~~~---~~~~~~~-~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+..+. ......+ ......+.+++.+|++.+|++||++.|++++.+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000 0000000 123456889999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=313.79 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=202.3
Q ss_pred ccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
.+|...+.||+|+||.||++... ++..+|+|.+.... ......|.+|++++++++|+||+++++++.. .+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCc
Confidence 35666789999999999999742 46689999887544 4455689999999999999999999998854 467
Q ss_pred EEEEEEeCCCCChHHHhhhhcC-----------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEG-----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 451 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~ 451 (589)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~nil~~ 156 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-----FVHRDLATRNCLVG 156 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccccHhhEEEc
Confidence 8999999999999999976432 1134899999999999999999999988 99999999999999
Q ss_pred CCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhh
Q 007788 452 QQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA 529 (589)
Q Consensus 452 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 529 (589)
+++.+||+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--- 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---
Confidence 99999999999987654332211 112234567999999999999999999999999999998 8888865332111
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.... ........+...+..+.+++.+||+.||.+||++.|+++.|+
T Consensus 234 -~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 -IECI-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHH-HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111 111112223345567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.14 Aligned_cols=245 Identities=19% Similarity=0.277 Sum_probs=195.0
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|+.+ +++.||||++.... .......+..|..++..+ +||||+++++++. ..+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence 36999999999999976 68899999987542 123345677888888876 6999999999884 457899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~-----ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 79 NGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred CCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence 9999999987553 3889999999999999999999988 999999999999999999999999998754222
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......+++.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ...+......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~--~~~~~~~~~~ 222 (320)
T cd05590 150 GK-TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDE--VVYPTWLSQD 222 (320)
T ss_pred CC-cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCC--CCCCCCCCHH
Confidence 11 12234578899999999998999999999999999999999999975433211 11121111 1123334567
Q ss_pred HHHHHHHhcccCCCCCCCH------HHHHHHHH
Q 007788 551 LGKMALVCTHEDPENRPTM------EAVIEELT 577 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~------~evl~~L~ 577 (589)
+.+++..|++.||++||++ ++++++-+
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred HHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 8999999999999999998 77776644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=313.80 Aligned_cols=254 Identities=19% Similarity=0.303 Sum_probs=198.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++.. .+..++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEE
Confidence 46778899999999999999974 78899999987543 2344568889999999999999999999854 46889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.++++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...
T Consensus 86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 86 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKG-----KMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEECcCccceee
Confidence 9999999999987543 4889999999999999999999987 999999999999999999999999998866
Q ss_pred cCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
..... ......++..|+|||.+. ...++.++|||||||++|||++|+.|+..................+. .....
T Consensus 157 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (267)
T cd06646 157 TATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP-KLKDK 234 (267)
T ss_pred ccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC-CCccc
Confidence 43211 112234667899999874 34578899999999999999999999854322111000000000000 00111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
...+..+.+++.+||+.+|++||++++++++|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 23456889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=315.39 Aligned_cols=261 Identities=19% Similarity=0.319 Sum_probs=207.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||++... +++.||+|++...........+.+|++++..++||||+++++++.. .+..++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEE
Confidence 45667789999999999999875 6889999998765544556789999999999999999999999854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||+++++|.+++.... .+++.....++.+++.||.|||+. + ++||||||+||++++++.++|+|||++..
T Consensus 83 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~-----i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 83 EFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred ecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC-----eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999999987543 489999999999999999999974 4 99999999999999999999999999875
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH---hh----hhHHHhhcccc
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---ES----ATFENFIDRNL 539 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~---~~----~~~~~~~~~~~ 539 (589)
..... .....++..|+|||++.+..++.++|||||||++||++||+.||........ .. ......+....
T Consensus 154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 154 LINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred hhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 43221 1123567889999999888999999999999999999999999975432100 00 11122221111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
........+..+.+++.+|++.||++||++.|++++...+....
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 11111235567899999999999999999999999876655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.76 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=195.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC------C
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR------G 379 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~ 379 (589)
...+|...+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3567999999999999999999975 68899999886432 1234799999999999999999876432 1
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEE
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLI 458 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl 458 (589)
....++||||+++ +|.+++.........+++.....++.||+.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-----IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-----ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCcCHHHEEEcCCCCceee
Confidence 1246789999975 787777654333446899999999999999999999988 99999999999999664 7999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH----
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN---- 533 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---- 533 (589)
+|||+++.+.... ......++..|+|||++.+. .++.++|||||||++|||+||..||.+.............
T Consensus 213 ~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 213 CDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998664322 12234567889999998764 6899999999999999999999999754321111110000
Q ss_pred ------hhccc-------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 534 ------FIDRN-------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 534 ------~~~~~-------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+. +...++...+.++.+++.+||+.||.+|||+.|++++-+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 00000 0001112234678999999999999999999999988664
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.15 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=200.2
Q ss_pred cccccCCCccEEEEEecC--C--cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLRD--G--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|++|.||+|.+.+ + ..||||.+.........+.|.+|+..+++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 368999999999998753 3 36999999876644556789999999999999999999999854 6789999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++++|.+++..... ..++|...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999986542 35899999999999999999999988 999999999999999999999999999876442
Q ss_pred cee--eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 471 IVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 471 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
... ......++..|+|||++.+..++.++||||||+++|||++ |+.||........ ...+.........+...
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~ 226 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI----LKKIDKEGERLERPEAC 226 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCcCCCCccC
Confidence 211 1112345678999999998899999999999999999999 9999854322111 11111111112223345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
+..+.+++.+|++.+|++||++.++++.|.
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.76 Aligned_cols=248 Identities=25% Similarity=0.466 Sum_probs=200.8
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCCC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gs 394 (589)
+.||+|+||.||++...+++.||+|.+...........|.+|++++++++||||+++++++.. .+..++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCCCc
Confidence 369999999999999877999999998776544456789999999999999999999999854 467899999999999
Q ss_pred hHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCceee
Q 007788 395 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474 (589)
Q Consensus 395 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 474 (589)
|.+++..... .+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 79 l~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 79 LLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence 9999976432 4789999999999999999999988 9999999999999999999999999988654322111
Q ss_pred e-ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHH
Q 007788 475 V-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 552 (589)
Q Consensus 475 ~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 552 (589)
. .....+..|+|||.+.++.++.++|||||||++|||+| |..||....... ....+........+...+..+.
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIESGYRMPAPQLCPEEIY 225 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHHhcCCCCCCCccCCHHHH
Confidence 1 11223456999999998899999999999999999999 778876543211 1111222222223445567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 553 KMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 553 ~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
+++.+|++.+|.+||++.|+++.|+
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.25 Aligned_cols=243 Identities=19% Similarity=0.305 Sum_probs=190.4
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhc-cCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTS-LRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +++.||||+++.... ......+..|..++.. .+||||+++++++. ..+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 36999999999999975 588999999975421 2233455667666665 48999999999884 357899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 79 NGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG-----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149 (316)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence 9999999987543 3888999999999999999999988 999999999999999999999999998754322
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+.. .....+......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~--~~~~~~~~~~~~ 222 (316)
T cd05592 150 EG-KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL----FDSILN--DRPHFPRWISKE 222 (316)
T ss_pred CC-ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHc--CCCCCCCCCCHH
Confidence 11 22234578899999999998999999999999999999999999975432211 111111 112233345567
Q ss_pred HHHHHHHhcccCCCCCCCHH-HHHHH
Q 007788 551 LGKMALVCTHEDPENRPTME-AVIEE 575 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~-evl~~ 575 (589)
+.+++..||+.||++||++. +++++
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHcC
Confidence 88999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.70 Aligned_cols=265 Identities=23% Similarity=0.383 Sum_probs=204.3
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc--CCCCccceeeeeecC--CCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL--RHENIIRLRGFCCSR--GRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l--~H~niv~l~g~~~~~--~~~~~ 383 (589)
..+....+.||+|.||.||+|.++ |..||||++... +++.|.+|.++.+.+ +|+||+.+++.-.-+ .-.+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345566789999999999999997 889999999743 455677888887765 999999998853221 12378
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCC---CCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE---VNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+||++|-+.|||.+||... .++-...++++..+|.||+|||..- .++|.|+|||||+.||||..++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999864 3888999999999999999999421 1589999999999999999999999999
Q ss_pred ccccccccCCc---eeeeecCCccccccCcccccCCC----C--CCcchhhhHHHHHHHHHhC----------CCCcchh
Q 007788 461 CGLHKLLADDI---VFSVLKTSAAMGYLAPEYVTTGR----F--TERSDIFAFGVIILQILTG----------SLVLTSS 521 (589)
Q Consensus 461 fGla~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~Dv~s~Gvvl~elltg----------~~p~~~~ 521 (589)
+|+|....... ........||.+|||||++.... + -..+||||||.|+||+... +.||++.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99997765432 22334567999999999986543 1 2368999999999999763 4677655
Q ss_pred HHHHHhhhhHHHhh-ccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 522 MRLAAESATFENFI-DRNLKGK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 522 ~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+.......+.+++ .+.+++. .+......+.+++..||..+|..|-|+--+-+.|.++.+.
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 43322222222221 1223322 2456788899999999999999999999999998887754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.41 Aligned_cols=254 Identities=17% Similarity=0.258 Sum_probs=200.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++..++||||+++++++. +.+..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEE
Confidence 36888899999999999999975 689999999975421 233456788999999999999999999884 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 79 v~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG-----YIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEeecccce
Confidence 999999999999997643 3899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCcee-------------------------------------eeecCCccccccCcccccCCCCCCcchhhhHHHHH
Q 007788 466 LLADDIVF-------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVII 508 (589)
Q Consensus 466 ~~~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl 508 (589)
.+...... ......||+.|+|||++....++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 54321100 00123478899999999999999999999999999
Q ss_pred HHHHhCCCCcchhHHHHHhhhhHHHhhcc--ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHh
Q 007788 509 LQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTV 578 (589)
Q Consensus 509 ~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs---~~evl~~L~~ 578 (589)
|||++|+.||........ ...+... .+...........+.+++.+|+. +|.+|++ ++|++++-+.
T Consensus 230 ~el~~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 230 YEMLVGYPPFCSDNPQET----YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred HHhhcCCCCCCCCCHHHH----HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 999999999976433211 1111111 11111111234567788888886 9999997 9999987543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.92 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=202.9
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++.. .+..++||||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 83 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIMEY 83 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEEc
Confidence 455678999999999999865 6789999998765444555678999999999999999999998854 4678999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-----ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 84 LGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSER-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCC-----eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999998642 4889999999999999999999987 99999999999999999999999999876654
Q ss_pred CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (589)
... ......++..|+|||++.+..++.++||||||+++|||+||+.|+........ ...+............+.
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 227 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LFLIPKNSPPTLEGQYSK 227 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----HhhhhcCCCCCCCcccCH
Confidence 321 11123456789999999998899999999999999999999999864422111 111111222223344567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 550 KLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 550 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+.+++.+||+.+|++||+|.+++++-+.
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 78999999999999999999999998664
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.88 Aligned_cols=251 Identities=30% Similarity=0.526 Sum_probs=204.6
Q ss_pred cccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|.... +..|++|.+...........+.+|++.+.+++|+||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 469999999999999764 889999999876544446789999999999999999999999854 57899999999
Q ss_pred CCCChHHHhhhhcCC-----CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 391 PKGKLSKYLDQEEGS-----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-----FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-----cccCccCcceEEECCCCcEEEccccccc
Confidence 999999999875211 245899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 466 LLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 466 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
....... .......++..|+|||.+....++.++||||+|+++|||++ |..||........ ...... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~ 228 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV----LEYLRK-GYRLPK 228 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHc-CCCCCC
Confidence 7654321 12223446778999999988889999999999999999999 5888865422111 111111 222233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
+...+..+.+++.+|++.+|++||++.|++++|+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 4455778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=316.59 Aligned_cols=254 Identities=16% Similarity=0.307 Sum_probs=204.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.+|+..+.||+|++|.||+|... +++.|++|.+..... .....+.+|+.+++.++||||+++++++.. ....++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEee
Confidence 46777889999999999999864 688999999876543 334678899999999999999999998854 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 97 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g-----i~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred cccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 999999999998643 3789999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......... .............+...
T Consensus 167 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~ 242 (296)
T cd06654 167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLIATNGTPELQNPEKL 242 (296)
T ss_pred ccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH---HHHhcCCCCCCCCcccc
Confidence 43221 112234677899999999888999999999999999999999999654321111 11111111111223445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+.+++.+||..+|++||++.+++++-+..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~ 274 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence 67789999999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=309.27 Aligned_cols=249 Identities=22% Similarity=0.383 Sum_probs=207.6
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHH--HHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.+|++.+.||+|.||.|-+|.. ..|+.||||.++++..++.. -...+||++|+.++||||++++.+| +..+...|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEE
Confidence 4667778899999999999986 58999999999887655443 4577999999999999999999998 55678999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||..+|.|.+|+..+.. +++....+++.||..|+.|+|..+ ++|||||.+|||+|.++++||+|||++.
T Consensus 131 vMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHknr-----VvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKNR-----VVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhcc-----ceecccchhheeecCCCCeeeeccchhh
Confidence 9999999999999987753 899999999999999999999887 9999999999999999999999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
++.+... .....|++-|.+||.+.+.+| ++.+|.||+||+||-|+.|.-||++..... -+.++-...++ .
T Consensus 202 ly~~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~----lvrQIs~GaYr---E 272 (668)
T KOG0611|consen 202 LYADKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR----LVRQISRGAYR---E 272 (668)
T ss_pred hhccccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH----HHHHhhccccc---C
Confidence 8876542 123457788999999999988 678999999999999999999998653211 11222222222 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
+..+....-++++++..+|++|.|+.+|..+-|
T Consensus 273 P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 223445677899999999999999999998876
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.49 Aligned_cols=248 Identities=16% Similarity=0.267 Sum_probs=193.7
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +++.||+|+++.... ......+..|+.++.++ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 46999999999999975 688999999976432 23345677888888777 79999999998844 47899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 79 NGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence 9999998886543 3899999999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHH-----HHhhhhHHHhhccccCCCCCH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-----AAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 545 (589)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||...... .........+.... ...+.
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~ 226 (329)
T cd05618 150 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPR 226 (329)
T ss_pred CC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCC
Confidence 11 112345788899999999999999999999999999999999999521100 00000111111111 12344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC------HHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPT------MEAVIEEL 576 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs------~~evl~~L 576 (589)
.....+.+++.+|++.||++||+ +.+++++-
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 45667889999999999999998 57887664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=311.54 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=199.1
Q ss_pred cccccCCCccEEEEEecC-------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 315 NLLGKGNFSSVYKGTLRD-------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.||+|+||.||+|+..+ +..||+|.+..........+|.+|+.++++++||||+++++++.. .+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence 368999999999998653 257999988765434456789999999999999999999999854 46789999
Q ss_pred EeCCCCChHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-----ceEEc
Q 007788 388 DFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-----NPLIA 459 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-----~~kl~ 459 (589)
||+++++|.+++..... ....++|..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChheEEEecCCCCCCcceEEC
Confidence 99999999999975432 1234889999999999999999999987 99999999999999887 89999
Q ss_pred cccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcc
Q 007788 460 DCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 460 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|||+++......... ......+..|+|||++.++.++.++|||||||++|||+| |+.||....... ....+..
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~ 228 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VLQHVTA 228 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HHHHHhc
Confidence 999987654322111 112234567999999999999999999999999999998 999886432211 1111122
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 22222334456788999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.89 Aligned_cols=250 Identities=16% Similarity=0.271 Sum_probs=195.6
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +++.||||+++.... ......+..|..++.++ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 36899999999999975 688999999975432 23345688899999988 69999999998843 47899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 79 SGGDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence 9999999886543 4899999999999999999999988 999999999999999999999999998753211
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH-----HhhhhHHHhhccccCCCCCH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 545 (589)
.. ......++..|+|||++.+..++.++|||||||++|||+||+.||....... ........+..... ..+.
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~ 226 (329)
T cd05588 150 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPR 226 (329)
T ss_pred CC-ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCC
Confidence 11 1223457888999999999999999999999999999999999996321100 00011111222111 2233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC------HHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPT------MEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs------~~evl~~L~~ 578 (589)
.....+.+++..|++.||.+||+ +++++++-+.
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 44567899999999999999987 7888876443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.20 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=195.7
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCC-CccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHE-NIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~~~l 385 (589)
+|+..+.||+|+||.||+|... +++.||||++.... .......+..|.+++..++|+ +|+++++++.. .+..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 4777899999999999999976 57899999997542 123445788899999999765 57788877743 468999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 79 v~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 999999999999987543 3889999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......++..|+|||++.+..++.++|||||||++|||+||+.||........ ...+... ....+.
T Consensus 150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~~~--~~~~~~ 222 (324)
T cd05587 150 ENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQSIMEH--NVSYPK 222 (324)
T ss_pred ecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHcC--CCCCCC
Confidence 4321111 12234578899999999999999999999999999999999999975432211 1112111 112233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEE 575 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~ 575 (589)
.....+.+++.+|++.||++|++. +++.++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 223 SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 445678899999999999999976 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=329.18 Aligned_cols=260 Identities=19% Similarity=0.261 Sum_probs=198.2
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC---CCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~~ 384 (589)
+|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++||||+++++++.... ....+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677899999999999999964 789999999865422 233467889999999999999999999885432 12689
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+|+||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG-----ILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHHEEECCCCCEEeccccce
Confidence 9999996 5888877543 24899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh--------------
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-------------- 529 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~-------------- 529 (589)
+..............++..|+|||.+.+. .++.++|||||||++|||++|+.||...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 86543322222233467789999998874 478999999999999999999999965322111000
Q ss_pred ----hHHHhhcc-ccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 530 ----TFENFIDR-NLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 530 ----~~~~~~~~-~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.....+.. .... .........+.+++.+|++.||++|||+.|++++-+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 292 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence 00000100 0000 01112356788999999999999999999999886643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.36 Aligned_cols=262 Identities=13% Similarity=0.237 Sum_probs=205.2
Q ss_pred HHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeec
Q 007788 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 377 (589)
Q Consensus 301 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 377 (589)
+.++....++|+..+.||+|+||.||++..+ +++.||+|++..... ......+.+|+.+++.++||||+++++.+.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~- 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ- 113 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 3445556789999999999999999999976 688999999864321 223456788999999999999999999884
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
+.+..++||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 114 -~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 114 -DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred -cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHEEECCCCCEE
Confidence 357899999999999999998653 2778888899999999999999988 99999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCC----CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 533 (589)
|+|||+++..............+|+.|+|||++.... ++.++|||||||++|||++|+.||....... ....
T Consensus 183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~ 258 (371)
T cd05622 183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSK 258 (371)
T ss_pred EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----HHHH
Confidence 9999999876543322223455889999999987543 7899999999999999999999997643321 1222
Q ss_pred hhccc--cCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHh
Q 007788 534 FIDRN--LKGKFSESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTV 578 (589)
Q Consensus 534 ~~~~~--~~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~ 578 (589)
+.... +...........+.+++..|+..++.+ ||++.|++++.+.
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 259 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred HHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 22211 111112245667888999999844443 7899999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.02 Aligned_cols=245 Identities=17% Similarity=0.282 Sum_probs=195.1
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|+.. +++.||||++..... ......+..|.+++..+ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 36999999999999976 578999999875421 23345677888888866 79999999998843 46899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 79 NGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG-----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN 149 (321)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence 9999999987543 3889999999999999999999988 999999999999999999999999998754322
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..+......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----~~~i~~~~~--~~p~~~~~~ 222 (321)
T cd05591 150 GV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----FESILHDDV--LYPVWLSKE 222 (321)
T ss_pred Cc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCC--CCCCCCCHH
Confidence 11 11233478889999999998999999999999999999999999975533211 112211111 122234567
Q ss_pred HHHHHHHhcccCCCCCC-------CHHHHHHHHH
Q 007788 551 LGKMALVCTHEDPENRP-------TMEAVIEELT 577 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RP-------s~~evl~~L~ 577 (589)
+.+++..|++.||++|| ++.+++++-+
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 88999999999999999 8888887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.52 Aligned_cols=258 Identities=24% Similarity=0.458 Sum_probs=204.0
Q ss_pred ccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|.....||+|+||.||+|+.+ +.+.|++|.+...........|.+|++++++++||||+++++++.+ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCc
Confidence 46778889999999999999964 3467999988765433345789999999999999999999999843 467
Q ss_pred EEEEEEeCCCCChHHHhhhhcCC-----CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGS-----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-----cccCcCccceEEEeCCCcEE
Confidence 89999999999999999765421 125899999999999999999999988 99999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhc
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
++|||++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ ......
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~----~~~~~~ 233 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV----LNRLQA 233 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH----HHHHHc
Confidence 99999987543322222223344567999999988889999999999999999999 7778854322111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.......+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 12222223345568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.10 Aligned_cols=267 Identities=15% Similarity=0.309 Sum_probs=207.5
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeee
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC 376 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 376 (589)
+.++.+..++++|+..+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++.++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 344666778899999999999999999999875 68899999886432 2335688899999999 6999999999875
Q ss_pred cC---CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 377 SR---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 377 ~~---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
.. ..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~ 160 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK-----TIHRDVKGNNILLTTE 160 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCHHhEEECCC
Confidence 32 235689999999999999998754333345889999999999999999999987 9999999999999999
Q ss_pred CceEEccccccccccCCceeeeecCCccccccCcccccC-----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh
Q 007788 454 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~ 528 (589)
+.++|+|||+++....... ......++..|+|||++.. ..++.++|||||||++|||++|+.|+.........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~- 238 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL- 238 (286)
T ss_pred CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-
Confidence 9999999999876543221 1223357788999998753 44788999999999999999999998654321111
Q ss_pred hhHHHhhccc-cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 529 ATFENFIDRN-LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 529 ~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....... .....+......+.+++.+||+.||++||++.|++++++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 239 ---FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ---hhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 1110000 000112223457899999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.32 Aligned_cols=262 Identities=18% Similarity=0.316 Sum_probs=207.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||.|++|.||++... +++.+|+|.+..........++.+|++++++++||||++++++|.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999985 68899999998654445567899999999999999999999998766666789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.........+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999988754433445889999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH-hhc---cccCCCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-FID---RNLKGKF 543 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~---~~~~~~~ 543 (589)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||............... ..+ +.+....
T Consensus 156 ~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 156 VNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred ccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 43221 1223566799999999889999999999999999999999999754210000001111 111 1111111
Q ss_pred --CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 544 --SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 544 --~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.......+.+++.+||+.+|++|||+.|++++-+.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 12245678999999999999999999999987665
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.98 Aligned_cols=260 Identities=20% Similarity=0.371 Sum_probs=208.4
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||.|+||.||++... +++.||+|.+..... ......+..|++++++++||||+++++++........+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3667789999999999999864 688999999875432 33456788999999999999999999988765566789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.........+++..++.++.|++.||+|||..+.....++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999977544445699999999999999999999922111123999999999999999999999999998876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+.+........+...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 234 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASKIKEGKFRRIPYRY 234 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHHHhcCCCCCCcccc
Confidence 543321 12234677899999999888999999999999999999999999754321 111222222223345566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+.+++.+|++.+|++||++.+|+++
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 7889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.50 Aligned_cols=243 Identities=19% Similarity=0.300 Sum_probs=191.0
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhc-cCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTS-LRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +++.||||+++.... ......+..|..++.. ++||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 36999999999999976 578999999975421 2233456677777776 489999999998854 46899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 79 NGGDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG-----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG 149 (316)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence 9999999997543 3889999999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ....+......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~--~~~~~~~~~~~ 222 (316)
T cd05619 150 DA-KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRMD--NPCYPRWLTRE 222 (316)
T ss_pred CC-ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhC--CCCCCccCCHH
Confidence 11 12234578889999999998999999999999999999999999965432111 1111110 11223334567
Q ss_pred HHHHHHHhcccCCCCCCCHH-HHHHH
Q 007788 551 LGKMALVCTHEDPENRPTME-AVIEE 575 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~-evl~~ 575 (589)
+.+++.+|++.||++||++. ++.++
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHcC
Confidence 88999999999999999997 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=297.19 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=206.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|.|+.||++... +|+.+|+|++..... ....++..+|+++.+.++|||||++...+. .....|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEEE
Confidence 45666688999999999999864 799999998865432 234567889999999999999999998774 34788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec---CCCceEEccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfGl 463 (589)
+|+|.|++|..-+-.+. ..++...-+.+.||+++|.|+|.++ |||||+||+|+++- ..--+||+|||+
T Consensus 89 Fe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n~-----IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSNG-----IVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred EecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeeeeccCCCceeecccce
Confidence 99999999977665442 3777888999999999999999998 99999999999994 344589999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
|..+.+.. ...+..||++|||||++...+|+..+|||+.||+||-|+.|..||++.......++...... ...+.+
T Consensus 160 Ai~l~~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y--d~~~~~ 235 (355)
T KOG0033|consen 160 AIEVNDGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY--DYPSPE 235 (355)
T ss_pred EEEeCCcc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc--CCCCcc
Confidence 99887443 34466799999999999999999999999999999999999999987433222222222111 122233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+...++..+++++|+..||++|.|+.|.+++-|..
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 445667889999999999999999999999988754
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.19 Aligned_cols=260 Identities=24% Similarity=0.322 Sum_probs=201.8
Q ss_pred HHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++.+++++.....||+|+||.||+|... ++..|++|.+.... ......+.+|+.++++++|+||+++++++.. .+.
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 79 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGF 79 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCE
Confidence 4456667777789999999999999965 67889999887654 3345678999999999999999999999854 478
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADC 461 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~Df 461 (589)
.++|+||+++++|.+++...... ...++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~-----i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCeEEEecc
Confidence 99999999999999999864321 11278888999999999999999987 999999999999986 679999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCC--CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
|++........ ......++..|+|||++.... ++.++||||||+++|||++|+.|+......... .........
T Consensus 154 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~~ 229 (268)
T cd06624 154 GTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFKI 229 (268)
T ss_pred hhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhcc
Confidence 99876543211 112234677899999986644 788999999999999999999998643211110 000000111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
....+......+.+++.+||+.+|++||++.|++++-
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 2233445567789999999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.70 Aligned_cols=254 Identities=18% Similarity=0.229 Sum_probs=197.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||++... +++.||||++.... .......+.+|++++.+++||||+++++++. +.+..++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEE
Confidence 36788899999999999999865 78999999986532 1233457888999999999999999999884 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 79 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG-----FIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999997543 3888889999999999999999988 9999999999999999999999999986
Q ss_pred cccCCcee----------------------------------------------eeecCCccccccCcccccCCCCCCcc
Q 007788 466 LLADDIVF----------------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERS 499 (589)
Q Consensus 466 ~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 499 (589)
.+...... ......||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 43210000 00013478899999999998999999
Q ss_pred hhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc--cccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 007788 500 DIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENR---PTMEAVIE 574 (589)
Q Consensus 500 Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~C~~~dp~~R---Ps~~evl~ 574 (589)
|||||||++|||+||+.||........ +..+.. ..+...........+.+++..|+. +|.+| +++.|+++
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHET----YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHH----HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 999999999999999999965432111 111111 111111111235678889999997 66665 69999998
Q ss_pred HHHh
Q 007788 575 ELTV 578 (589)
Q Consensus 575 ~L~~ 578 (589)
+.+.
T Consensus 305 hp~~ 308 (377)
T cd05629 305 HPFF 308 (377)
T ss_pred CCCc
Confidence 8654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=321.34 Aligned_cols=244 Identities=19% Similarity=0.305 Sum_probs=195.0
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +++.||||+++.... ......+..|.+++..+ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 36999999999999976 578999999975421 23345677888888887 69999999998844 57899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 79 NGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG-----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG 149 (318)
T ss_pred CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence 9999999887543 3899999999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ...+...+..
T Consensus 150 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~--~~~~~~~~~~ 222 (318)
T cd05570 150 GV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDE--VRYPRWLSKE 222 (318)
T ss_pred CC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCC--CCCCCcCCHH
Confidence 11 11223467889999999999999999999999999999999999965432111 11111111 1223345667
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHHHH
Q 007788 551 LGKMALVCTHEDPENRPTM-----EAVIEEL 576 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~-----~evl~~L 576 (589)
+.+++.+||+.||.+||++ .+++++-
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 8999999999999999999 8888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.68 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=196.2
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l 385 (589)
+|...+.||+|+||.||+|... +++.||||++..... ......+..|..++..+ +|++|+++++++.. .+..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 4677889999999999999876 578999999975432 22334567788888777 58999999988743 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 79 v~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEecCCCHHHeEECCCCcEEEccCCCce
Confidence 999999999999987543 3889999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......+++.|+|||++.+..++.++|||||||++|||+||+.||........ ...+.... ...+.
T Consensus 150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~--~~~p~ 222 (323)
T cd05616 150 ENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHN--VAYPK 222 (323)
T ss_pred ecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCC--CCCCC
Confidence 5432211 12234578899999999999999999999999999999999999975432211 12222211 12334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEE 575 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~ 575 (589)
.....+.+++.+|++.||++|++. .++.++
T Consensus 223 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 223 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 456778999999999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.59 Aligned_cols=244 Identities=19% Similarity=0.272 Sum_probs=191.3
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|..+ +|+.||+|.++.... ......+..|..++... +||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 36999999999999976 688999999975421 22344566777777654 89999999998843 57899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 79 ~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 79 NGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG-----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence 9999999987543 3889999999999999999999988 999999999999999999999999998743211
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ....+......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~~~--~~~~~~~~~~~ 222 (316)
T cd05620 150 DN-RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIRVD--TPHYPRWITKE 222 (316)
T ss_pred CC-ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhC--CCCCCCCCCHH
Confidence 11 12234578899999999999999999999999999999999999975432211 1111111 11222334567
Q ss_pred HHHHHHHhcccCCCCCCCHH-HHHHHH
Q 007788 551 LGKMALVCTHEDPENRPTME-AVIEEL 576 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~-evl~~L 576 (589)
+.+++..|++.||++||++. +++++-
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 88999999999999999985 665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.18 Aligned_cols=251 Identities=16% Similarity=0.309 Sum_probs=202.9
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||+|+||.||++... ++..+|+|.++........+.+.+|+.++++++||||+++++.+. +.+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEe
Confidence 4667789999999999999875 688999999876544445567889999999999999999999884 3578999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.+++..... ..+++...+.++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+....
T Consensus 79 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 79 YCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR-----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred eCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 9999999999875432 34788999999999999999999988 9999999999999999999999999987664
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
..... .....++..|+|||++.+..++.++||||||+++|+|++|+.||........ ...... ......+....
T Consensus 152 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~ 225 (255)
T cd08219 152 SPGAY-ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQ-GSYKPLPSHYS 225 (255)
T ss_pred ccccc-cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH----HHHHhc-CCCCCCCcccC
Confidence 33211 1223467789999999988899999999999999999999999975432111 111111 11122334456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
..+.+++.+||+.||++||++.+++..
T Consensus 226 ~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.02 Aligned_cols=256 Identities=20% Similarity=0.362 Sum_probs=208.6
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++++.||||+++++++.+ ....++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEe
Confidence 4666788999999999999975 5889999998765444556789999999999999999999999854 468999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.+++... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~-----ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 83 YLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 99999999998642 3788899999999999999999987 9999999999999999999999999987664
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
.... ......++..|+|||.+.+..++.++|||||||++|||+||..|+....... ....+............+
T Consensus 153 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 226 (277)
T cd06640 153 DTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLFLIPKNNPPTLTGEFS 226 (277)
T ss_pred CCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----HhhhhhcCCCCCCchhhh
Confidence 4321 1122345677999999988889999999999999999999999986543211 111112222334455677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+.+++..||+.+|++||++.+++++-+......
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 88999999999999999999999999866555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.59 Aligned_cols=266 Identities=21% Similarity=0.361 Sum_probs=208.6
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeee
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC 376 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 376 (589)
++++++..++++|...+.||+|+||.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 556777788999999999999999999999975 68899999986542 2345677899999999 7999999999986
Q ss_pred cCC---CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 377 SRG---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 377 ~~~---~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
..+ .+..++||||+++++|.++++........++|..++.++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~nili~~~ 164 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTTE 164 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCC
Confidence 432 24689999999999999998754333345899999999999999999999987 9999999999999999
Q ss_pred CceEEccccccccccCCceeeeecCCccccccCcccccCC-----CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh
Q 007788 454 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~ 528 (589)
+.+||+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.||........
T Consensus 165 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-- 241 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-- 241 (291)
T ss_pred CCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--
Confidence 9999999999876543221 11223467789999987643 368899999999999999999999865432111
Q ss_pred hhHHHhhcc-ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 529 ATFENFIDR-NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 529 ~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
....... ......+......+.+++.+||+.+|++||++.|++++-
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 242 --LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred --HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 1111111 001112234456799999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=346.49 Aligned_cols=262 Identities=16% Similarity=0.297 Sum_probs=203.7
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
..++|.+.+.||+|+||.||+|... .+..||+|.+..... ......|..|+.++.+++|||||++++++........+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3467889999999999999999975 578899999875432 33456789999999999999999999988766667899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC--CCCCeEecCCCCCCeeecCC---------
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV--NKPAIVHRNLSVEKVLIDQQ--------- 453 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~--~~~~ivH~dlk~~Nill~~~--------- 453 (589)
+||||+++|+|.++|.........+++...+.|+.||+.||+|||+.+. ...+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999998654333459999999999999999999998431 11349999999999999642
Q ss_pred --------CceEEccccccccccCCceeeeecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCcchhHH
Q 007788 454 --------FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMR 523 (589)
Q Consensus 454 --------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~ 523 (589)
..+||+|||++........ .....+++.|+|||++.+ ..++.++|||||||+||||+||+.||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3489999999987644321 123457889999999854 4588999999999999999999999964332
Q ss_pred HHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
..... ..+...... .....+..+.+++..||+.+|.+||++.|++.+
T Consensus 249 ~~qli----~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 FSQLI----SELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHH----HHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21111 111111110 112235678999999999999999999999965
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=307.03 Aligned_cols=255 Identities=22% Similarity=0.363 Sum_probs=201.6
Q ss_pred cCccccccccCCCccEEEEEecC--CcEEEEEEeccCC---------CchHHHHHHHHHHHHhc-cCCCCccceeeeeec
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSINVTS---------CKSEEAEFVKGLYLLTS-LRHENIIRLRGFCCS 377 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~---------~~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~ 377 (589)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677899999999999999865 7889999886431 12233567788888875 799999999999854
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCCCeeecCCCce
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNP 456 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~~ 456 (589)
.+..++||||+++++|.+++.........+++..+++++.|++.||.|||+ .+ ++|+||+|+||+++.++.+
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-----i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-----IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc-----eeecCCCHHHEEECCCCcE
Confidence 478999999999999999986543334468999999999999999999996 45 9999999999999999999
Q ss_pred EEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 457 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 457 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
+|+|||.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+..
T Consensus 154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~~~~~ 227 (269)
T cd08528 154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----ATKIVE 227 (269)
T ss_pred EEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----HHHHhh
Confidence 999999998765432 22334567789999999988899999999999999999999999865432211 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..............+.+++.+||+.||++||++.|+..+++
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111234567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.69 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=194.7
Q ss_pred cccccCCCccEEEEEe----cCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 315 NLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
+.||+|+||.||+++. .+|+.||+|++...... .....+..|++++++++||||+++++++.. .+..++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 5799999999999875 36889999999754321 233467789999999999999999998844 5789999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 80 ~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 80 LRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 99999999986543 4899999999999999999999988 99999999999999999999999999876543
Q ss_pred CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (589)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+.... ...+.....
T Consensus 151 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~--~~~p~~~~~ 223 (318)
T cd05582 151 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAK--LGMPQFLSP 223 (318)
T ss_pred CCC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCC--CCCCCCCCH
Confidence 311 12234578889999999988899999999999999999999999975432211 11121111 123334566
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007788 550 KLGKMALVCTHEDPENRPT-----MEAVIEE 575 (589)
Q Consensus 550 ~l~~l~~~C~~~dp~~RPs-----~~evl~~ 575 (589)
.+.+++..|++.||++||+ +.+++++
T Consensus 224 ~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 7889999999999999999 5556654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=306.63 Aligned_cols=253 Identities=20% Similarity=0.332 Sum_probs=198.7
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC----chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
+|...+.||+|+||.||+|... ++..||+|++..... ......+.+|+.++++++||||+++++++........+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6778899999999999999875 689999999864421 12335688899999999999999999988655456789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+++||+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 83 l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~-----i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999997543 3889999999999999999999887 999999999999999999999999998
Q ss_pred ccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 465 KLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 465 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
+....... .......++.+|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~ 229 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIFKIATQPTNPQ 229 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHHHHhcCCCCCC
Confidence 76532111 01112346778999999998889999999999999999999999996542211 1111111111223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.+......+..++ .||..+|++||+++|++++-
T Consensus 230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 3344455566666 78889999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.17 Aligned_cols=257 Identities=19% Similarity=0.321 Sum_probs=198.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~ 381 (589)
.++|...+.||+|+||.||++... +|..||||++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468889999999999999999875 689999999975432 234467889999999999999999999875332 13
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEecC
Confidence 57999999965 56666642 2788889999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh------------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA------------ 529 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~------------ 529 (589)
|+++...... ......++..|+|||.+.+..++.++|||||||++|||+||+.||...........
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9997653322 12234567889999999999999999999999999999999999964322111100
Q ss_pred ------hHHHhhccc--cCC----------------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 530 ------TFENFIDRN--LKG----------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 530 ------~~~~~~~~~--~~~----------------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......... ..+ .........+.+++.+|++.||++|||+.|++++-+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 001111100 000 0011124568899999999999999999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=303.99 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=200.0
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCC-ccceeeeeecCC----CCe
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRG----RGE 382 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~----~~~ 382 (589)
.|...+.||+|+||+||+|+.+ +|+.||+|++..... +.......+|+.++++++|+| ||++++++.... ...
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3445577999999999999965 789999999987754 223356789999999999999 999999996542 126
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++|+||++. +|..++.........++......++.||++||+|||+.+ |+||||||+|||++++|.+||+|||
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-----IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-----ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCcceEEECCCCcEeeeccc
Confidence 8899999965 999999876532234677889999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI------ 535 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------ 535 (589)
+|+...-... .......|..|.|||++.+. .|+...||||+||++.||++++..|.+..+...-...+.-+-
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9996652211 12344567789999999887 699999999999999999999998876554322211111100
Q ss_pred --------ccc--cCCCC-C----H---HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 536 --------DRN--LKGKF-S----E---SEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 536 --------~~~--~~~~~-~----~---~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+.. ..... + . .......+++..|++.+|.+|.|++.++.|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 00000 0 1 112467899999999999999999999987
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=317.51 Aligned_cols=260 Identities=18% Similarity=0.364 Sum_probs=200.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|++++++++||||+++++++.. .+..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEE
Confidence 46788899999999999999876 6789999999765444444568899999999999999999999854 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 84 EYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred eCCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECccccceec
Confidence 99975 8888886543 24788999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh-----------HH---
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------FE--- 532 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~-----------~~--- 532 (589)
..... ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||............ +.
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 155 SVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred CCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 33221 1122345778999998865 45889999999999999999999999653221110000 00
Q ss_pred ---HhhccccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 533 ---NFIDRNLKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 533 ---~~~~~~~~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+...... ........+.+++.+|++.||.+|||++|++++-+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0000000000 01123456789999999999999999999999877654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.60 Aligned_cols=253 Identities=19% Similarity=0.285 Sum_probs=200.3
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
|+..+.||+|+||+||+|... +++.||+|.+...... .....+.+|++++++++|+||+++.+++.. .+..++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence 566788999999999999875 6899999998754322 223457889999999999999999988743 46889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~-----iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 80 TIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN-----TVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred EeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 99999999998875432 24999999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... .....++..|+|||++.+..++.++|+||||+++|||++|+.||................... ........
T Consensus 153 ~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 228 (285)
T cd05632 153 PEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKF 228 (285)
T ss_pred CCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccC
Confidence 43221 123457888999999998899999999999999999999999997543221111111111111 11233345
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPT-----MEAVIEEL 576 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L 576 (589)
...+.+++..|++.||++||+ +++++.+-
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP 262 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence 567889999999999999999 77887763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=321.55 Aligned_cols=244 Identities=21% Similarity=0.345 Sum_probs=190.5
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHH-HHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +|+.||||++..... .....++..|.. +++.++||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 36999999999999975 689999999975421 222344555544 5678999999999998843 57899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g-----ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 79 NGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence 9999999987543 4889999999999999999999988 999999999999999999999999998754221
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......+++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .........
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~--~~~~~~~~~ 222 (323)
T cd05575 150 SK-TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----MYDNILNKPL--RLKPNISVS 222 (323)
T ss_pred CC-ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCCC--CCCCCCCHH
Confidence 11 1223357888999999999999999999999999999999999997543211 1122222111 122334667
Q ss_pred HHHHHHHhcccCCCCCCCH----HHHHHHH
Q 007788 551 LGKMALVCTHEDPENRPTM----EAVIEEL 576 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~----~evl~~L 576 (589)
+.+++.+|++.||++||++ .+++++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~ 252 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHV 252 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence 8899999999999999987 4666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=309.53 Aligned_cols=255 Identities=20% Similarity=0.383 Sum_probs=207.0
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||.|++|.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++.+. ...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEEE
Confidence 5777789999999999999976 68999999997654445556789999999999999999999988543 68899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++... .+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG-----KIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999754 4899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH-H
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES-E 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 547 (589)
.... ......++..|+|||++.+..++.++||||||+++|||+||+.||........ . ..+........... .
T Consensus 150 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~----~-~~~~~~~~~~~~~~~~ 223 (274)
T cd06609 150 STMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV----L-FLIPKNNPPSLEGNKF 223 (274)
T ss_pred cccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH----H-HHhhhcCCCCCccccc
Confidence 4321 12233466789999999998899999999999999999999999965432111 1 11111111111222 4
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
+..+.+++.+||..+|++||++++++++-+.....
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 56788999999999999999999999886655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.22 Aligned_cols=252 Identities=17% Similarity=0.270 Sum_probs=193.0
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++.+.+ .+..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 5778899999999999999875 688999999875321 2334578899999999999999999999854 5789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 80 ~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 80 MDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999999997543 3788888999999999999999988 99999999999999999999999999753
Q ss_pred ccCCce----------------------------------------------eeeecCCccccccCcccccCCCCCCcch
Q 007788 467 LADDIV----------------------------------------------FSVLKTSAAMGYLAPEYVTTGRFTERSD 500 (589)
Q Consensus 467 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 500 (589)
+..... .......||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 210000 0001234788899999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc--cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 007788 501 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEE 575 (589)
Q Consensus 501 v~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs---~~evl~~ 575 (589)
||||||++|||++|+.||......... ..+.. ................+++.+++ .+|++|++ +.+++++
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~----~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQTPLETQ----MKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCCHHHHH----HHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999999999764322111 11111 11111111223345556555554 49999987 8888876
Q ss_pred HH
Q 007788 576 LT 577 (589)
Q Consensus 576 L~ 577 (589)
-+
T Consensus 306 p~ 307 (382)
T cd05625 306 PF 307 (382)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.75 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=203.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|... +|+.||+|++..... ....+.|.+|++++++++||||+++++++.+ .+..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 46888899999999999999975 689999999975432 2334679999999999999999999999854 478899
Q ss_pred EEEeCCCCChHHHhhhhcC-------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEE
Q 007788 386 IYDFAPKGKLSKYLDQEEG-------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
||||+++|+|.+++..... ....+++..+++++.||++||+|||+.+ |+||||||+||+++.++.++|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-----IIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-----VLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchheEEEcCCCCEEE
Confidence 9999999999999875321 1234678888999999999999999988 999999999999999999999
Q ss_pred ccccccccccCCce-----------------eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 459 ADCGLHKLLADDIV-----------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 459 ~DfGla~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999986521100 0011234788999999999999999999999999999999999999653
Q ss_pred HHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhc
Q 007788 522 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAAP 581 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~~~ 581 (589)
........ ....++. ........+..+.+++.+|++.||++|| +++++++.|+...+
T Consensus 235 ~~~ki~~~--~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 235 KGRKISYR--DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred chhhhhhh--hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 21111000 0111110 0001123456788999999999999995 67777777776543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.85 Aligned_cols=258 Identities=17% Similarity=0.286 Sum_probs=198.9
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----C
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----R 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~ 380 (589)
..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468889999999999999999865 688999999875432 233467888999999999999999999875332 2
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEECCCCCEEEee
Confidence 357999999965 67666642 2788899999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh----------
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT---------- 530 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~---------- 530 (589)
||+++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||.+..........
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99998654432 122345678899999999989999999999999999999999999653221111100
Q ss_pred --------HHHhhccccC------------------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 531 --------FENFIDRNLK------------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 531 --------~~~~~~~~~~------------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+++.... ..........+.+++.+|++.||++|||+.|++++-+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 0111110000 00011224567899999999999999999999998544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.58 Aligned_cols=256 Identities=18% Similarity=0.238 Sum_probs=196.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+++.. +++.||+|++.... .......|.+|+.++..++|+||+++++++. +.+..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEE
Confidence 46888899999999999999975 68999999987422 1233456889999999999999999999884 3578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 79 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG-----YVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred EEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEECCCCHHHEEECCCCCEEEEECCcee
Confidence 999999999999997543 23889999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccC-----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
..............+++.|+|||++.. ..++.++|||||||++|||++|+.||........ ...+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----~~~i~~~~~~ 226 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHKEH 226 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCc
Confidence 654432222223457889999999863 4578899999999999999999999975432211 1111111100
Q ss_pred C---CCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHh
Q 007788 541 G---KFSESEAAKLGKMALVCTHE--DPENRPTMEAVIEELTV 578 (589)
Q Consensus 541 ~---~~~~~~~~~l~~l~~~C~~~--dp~~RPs~~evl~~L~~ 578 (589)
. ......+..+.+++.+|+.. ++..||++++++++-+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 0 11112355667777776644 44448899999988653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=307.76 Aligned_cols=255 Identities=19% Similarity=0.375 Sum_probs=206.0
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||+|++|.||++..+ +++.||+|++..........++.+|++++++++||||+++++++.. .+..++|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEEE
Confidence 5667788999999999999986 6899999999876545566789999999999999999999999854 478999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
|+++++|.+++.... ..+++.....++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+...
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~-----i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK-----IIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC-----eecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 999999999997653 348899999999999999999999 77 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-hhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-SATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 546 (589)
...... ...++..|+|||.+.+..++.++||||||+++|||++|+.||......... ........... ....+..
T Consensus 152 ~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 227 (265)
T cd06605 152 VNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSG 227 (265)
T ss_pred HHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCChh
Confidence 432211 144667899999999999999999999999999999999999654211110 01111222211 1122222
Q ss_pred -HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 547 -EAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 547 -~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
....+.+++..||..+|++|||+.+++.+-+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 56779999999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=309.09 Aligned_cols=253 Identities=18% Similarity=0.273 Sum_probs=199.2
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
|+..+.||+|+||.||+|... ++..+++|.+.... ......|.+|+++++.++||||+++++++.. .+..++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEe
Confidence 455678999999999999976 57888999886543 3445678999999999999999999999854 4688999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++++|..++.... ..++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 84 CAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred cCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 99999999887533 24899999999999999999999988 99999999999999999999999999876543
Q ss_pred CceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
... ......++..|+|||++. +..++.++|||||||++|||++|+.||............ .....+ ....+
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~~ 231 (282)
T cd06643 156 TIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPP--TLAQP 231 (282)
T ss_pred ccc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH-hhcCCC--CCCCc
Confidence 221 122335678899999884 345788999999999999999999998654321111110 000000 11123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+.+++..||+.+|.+||++.+++++-+.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 265 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence 3445688999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.96 Aligned_cols=239 Identities=21% Similarity=0.436 Sum_probs=185.2
Q ss_pred ccccCCCccEEEEEecC-------------------------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccc
Q 007788 316 LLGKGNFSSVYKGTLRD-------------------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 370 (589)
.||+|+||.||+|.+.. ...|++|++.... .....+|.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999998521 1358899886543 233457889999999999999999
Q ss_pred eeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee
Q 007788 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450 (589)
Q Consensus 371 l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill 450 (589)
++++|.. ....++||||+++|+|..++....+ .+++..+++++.|+++||+|||+.+ |+||||||+||++
T Consensus 81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~Nill 150 (274)
T cd05076 81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDKN-----LVHGNVCAKNILL 150 (274)
T ss_pred EEEEEEe--CCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcCC-----ccCCCCCcccEEE
Confidence 9999965 4678999999999999999875432 4889999999999999999999987 9999999999999
Q ss_pred cCCC-------ceEEccccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHH-hCCCCcchh
Q 007788 451 DQQF-------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQIL-TGSLVLTSS 521 (589)
Q Consensus 451 ~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~ell-tg~~p~~~~ 521 (589)
+..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||...
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred eccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 8654 3799999987644221 12235667999998875 56899999999999999995 788888654
Q ss_pred HHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 522 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..... ......... .+......+.+++.+||+.+|++||++.++++.|.
T Consensus 226 ~~~~~-----~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 226 TPSEK-----ERFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ChHHH-----HHHHHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 22111 111111111 11222346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=304.90 Aligned_cols=249 Identities=20% Similarity=0.395 Sum_probs=202.4
Q ss_pred ccCccccccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||+|...+ ++.|++|.+.... ...++.+|++++++++||||+++++++.. ....++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEE
Confidence 578888999999999999999874 7899999987543 25689999999999999999999999854 47889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.... ..++|.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 78 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 78 EYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred ecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEECCCCcEEEcccccchhc
Confidence 9999999999997543 34899999999999999999999988 999999999999999999999999998876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc-cccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-RNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 546 (589)
..... ......++..|+|||++.+..++.++||||||+++|||++|+.|+......... ..... .......+..
T Consensus 150 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 150 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI----FMIPNKPPPTLSDPEK 224 (256)
T ss_pred ccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh----hhhccCCCCCCCchhh
Confidence 54321 112233567899999999889999999999999999999999998653221110 00000 0011112334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....+.+++.+||+.+|++||++.|++++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 45678999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=305.19 Aligned_cols=239 Identities=20% Similarity=0.420 Sum_probs=186.0
Q ss_pred cccccCCCccEEEEEecC-------------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 315 NLLGKGNFSSVYKGTLRD-------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
+.||+|+||.||+|.+.+ ...|++|.+.... ......|.+|+.++.+++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR--DV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CC
Confidence 358999999999998542 2358889876543 3344578899999999999999999999854 45
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc------
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN------ 455 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~------ 455 (589)
..++||||+++|+|..++.... ..+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD-----LVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC-----eECCCCCcccEEEecCCccCCCCc
Confidence 6799999999999999887543 24899999999999999999999988 999999999999987664
Q ss_pred -eEEccccccccccCCceeeeecCCccccccCccccc-CCCCCCcchhhhHHHHHHHHH-hCCCCcchhHHHHHhhhhHH
Q 007788 456 -PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQIL-TGSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 456 -~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~ 532 (589)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+........ .
T Consensus 150 ~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----~ 219 (262)
T cd05077 150 FIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-----E 219 (262)
T ss_pred eeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----H
Confidence 899999998755322 1234567799999887 466899999999999999998 57777754321111 1
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.+...... ........+.+++.+||+.||.+||++.++++.+
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11111111 1111245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.50 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=202.4
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
|+..+.||+|+||.||++... +++.||||.+...... .....+.+|+.++++++|+|++++++.+.. .+..++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence 566788999999999999876 6899999998754322 223457789999999999999999998844 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...
T Consensus 80 e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 80 TLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER-----IVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred EecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 99999999999865432 34899999999999999999999987 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ......... .....+...
T Consensus 153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~~ 228 (285)
T cd05630 153 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-VQEEYSEKF 228 (285)
T ss_pred CCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhh-hhhhcCccC
Confidence 43321 12335788899999999999999999999999999999999999754221110 011111111 111123334
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~~ 579 (589)
...+.+++..||+.||++||| +.|++++-+..
T Consensus 229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 567889999999999999999 89999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.53 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=194.8
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l 385 (589)
+|+..+.||+|+||.||+|... +|+.||+|++..... ......+..|..++..+. |++|+++.+++.. .+..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 3667789999999999999875 689999999875421 233456778888888886 5677788887743 467999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEecccccc
Confidence 999999999999987543 3899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......++..|+|||++.+..++.++|||||||++|||+||+.||....... ....+..... ..+.
T Consensus 150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~~--~~p~ 222 (323)
T cd05615 150 EHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNV--SYPK 222 (323)
T ss_pred ccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCC--CCCc
Confidence 5432211 1223347889999999999899999999999999999999999997643221 1122222111 2333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEE 575 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~ 575 (589)
.....+.+++.+|++.+|.+|++. +++.++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 223 SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 455678899999999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=302.47 Aligned_cols=251 Identities=29% Similarity=0.535 Sum_probs=201.7
Q ss_pred ccccccccCCCccEEEEEecC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 312 SEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+..+.||+|+||.||++...+ +..||+|++...........+..|++.+.+++|+||+++++++.+ .+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEEE
Confidence 456789999999999999764 488999999766544466789999999999999999999999854 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++...... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..
T Consensus 80 ~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~-----~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESKN-----FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred EeccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcCC-----eeecccccceEEEccCCeEEEcccCCcee
Confidence 9999999999999764321 2899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
.............++..|+|||.+.+..++.++||||+|+++|||++ |+.|+....... ....+........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~ 227 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-----VLEYLKKGYRLPKPE 227 (258)
T ss_pred cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhcCCCCCCCC
Confidence 65443222222335678999999988889999999999999999999 777775432111 111111111222333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
..+..+.+++.+|++.+|++|||+.|+++.|
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 4567899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=320.40 Aligned_cols=244 Identities=21% Similarity=0.342 Sum_probs=189.5
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHH-HHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
++||+|+||.||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++. +.+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 36999999999999975 688999999875321 222344555554 678899999999998884 357899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|..++.... .+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 79 NGGELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence 9999998886542 3788888999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+.... ...+......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~--~~~~~~~~~~ 222 (321)
T cd05603 150 EE-TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILHKP--LQLPGGKTVA 222 (321)
T ss_pred CC-ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhcCC--CCCCCCCCHH
Confidence 11 12234578889999999988999999999999999999999999976432111 12222211 1223345667
Q ss_pred HHHHHHHhcccCCCCCCCHH----HHHHHH
Q 007788 551 LGKMALVCTHEDPENRPTME----AVIEEL 576 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~----evl~~L 576 (589)
+.+++.+|++.||.+||+.. +++++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 89999999999999998753 555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=322.74 Aligned_cols=246 Identities=25% Similarity=0.433 Sum_probs=204.8
Q ss_pred ccccccCCCccEEEEEec--CC--cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 314 VNLLGKGNFSSVYKGTLR--DG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
.++||+|.||.|++|.|. +| ..||||.++.........+|++|+.+|.+++|||+++|||+..+ ....+|||.
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~EL 191 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFEL 191 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhh
Confidence 478999999999999986 34 35899999987755567899999999999999999999999854 467899999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
++.|+|.+.|++.. ...|-......++.|||.||+||.+++ +|||||.++|+||-..-.+||+|||+.+.+..
T Consensus 192 aplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLeskr-----lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESKR-----LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred cccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhhh-----hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999822 234777888899999999999999988 99999999999999999999999999998865
Q ss_pred Cce-eeee-cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 470 DIV-FSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 470 ~~~-~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
... +... ...-.+.|.|||.+...+++.++|||+|||++|||+| |..||-+-.. ..+-+.+|..-+...++.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----IQILKNIDAGERLPRPKY 339 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----HHHHHhccccccCCCCCC
Confidence 432 2221 1223456999999999999999999999999999999 4566654321 123344455555567888
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIE 574 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~ 574 (589)
+++.+++++..||..+|++||++.++.+
T Consensus 340 csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHH
Confidence 9999999999999999999999999973
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=303.99 Aligned_cols=247 Identities=21% Similarity=0.455 Sum_probs=199.6
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||++.. +++.||+|.+.... ....|.+|+.++.+++|||++++++++.. +..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEE
Confidence 3577789999999999999985 57889999986542 34578999999999999999999998843 34689999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 79 LMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK-----LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 9999999999976532 34889999999999999999999987 9999999999999999999999999987543
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+........+...
T Consensus 152 ~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 222 (254)
T cd05083 152 MGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECVEKGYRMEPPEGC 222 (254)
T ss_pred ccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHhCCCCCCCCCcC
Confidence 221 12223456999999998899999999999999999998 888886542211 11122222222233445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 6788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=328.51 Aligned_cols=255 Identities=16% Similarity=0.249 Sum_probs=195.2
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++.+++||||+++++.+.+ .+..++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 6888899999999999999965 689999999864321 2234568899999999999999999998844 5789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 80 ~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 99999999999997643 3788888899999999999999988 99999999999999999999999999753
Q ss_pred ccCCc------------------------------------------eeeeecCCccccccCcccccCCCCCCcchhhhH
Q 007788 467 LADDI------------------------------------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAF 504 (589)
Q Consensus 467 ~~~~~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~ 504 (589)
+.... ........||+.|+|||++.+..++.++|||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 31000 000012357889999999999999999999999
Q ss_pred HHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHh
Q 007788 505 GVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP---TMEAVIEELTV 578 (589)
Q Consensus 505 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP---s~~evl~~L~~ 578 (589)
||++|||++|+.||........... +... ...............+.+++.+|+ .+|.+|+ ++.+++++-+.
T Consensus 231 Gvilyell~G~~Pf~~~~~~~~~~~-i~~~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~ 304 (376)
T cd05598 231 GVILYEMLVGQPPFLADTPAETQLK-VINW-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304 (376)
T ss_pred cceeeehhhCCCCCCCCCHHHHHHH-Hhcc-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence 9999999999999976533211111 0000 011111111123445666676665 4999999 89999988553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.15 Aligned_cols=255 Identities=18% Similarity=0.249 Sum_probs=199.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+++.. +++.||+|++.... .......+.+|+.++..++|+||+++++++. +.+..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 46888899999999999999976 67899999986532 1233456888999999999999999999884 3578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 79 v~Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~-----iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLH-----YVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EEeCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCchHHEEEcCCCCEEEEecccee
Confidence 9999999999999976432 4889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccC-----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
..............++++|+|||++.+ +.++.++|||||||++|||++|+.||....... ....+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~ 226 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHEER 226 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----HHHHHHcCCCc
Confidence 765443322233457889999999875 567899999999999999999999997543221 11222221111
Q ss_pred CCC---CHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 007788 541 GKF---SESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELT 577 (589)
Q Consensus 541 ~~~---~~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~ 577 (589)
... ....+..+.+++.+|+..++.+ |+++++++++.+
T Consensus 227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 111 1223567888888888765544 568999987744
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=303.62 Aligned_cols=254 Identities=19% Similarity=0.275 Sum_probs=200.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC----chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|... +++.||||.+..... ......+.+|+.++++++||||+++++++.+......
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46778899999999999999875 589999998864321 1234578889999999999999999998755445578
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++++|.+++.... .+++...++++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM-----IVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEecCCCCEEECcCcc
Confidence 89999999999999987543 3788889999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
+........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~ 228 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----IFKIATQPTNP 228 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----HHHHhcCCCCC
Confidence 876542111 011223467789999999888899999999999999999999999965422111 11111112223
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
..+......+.+++..|+. +|++||+++|++++-
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 3455666778889999985 999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.08 Aligned_cols=257 Identities=17% Similarity=0.293 Sum_probs=198.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~ 381 (589)
.++|...+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888999999999999999865 688999999975432 334467889999999999999999999874321 23
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEECCCCcEEEEeC
Confidence 57999999965 77777642 2788899999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH---------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--------- 532 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------- 532 (589)
|+++....... .....++..|+|||++.+..++.++|||||||++|||++|+.||............+.
T Consensus 171 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 171 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CCccccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99986644321 1234567889999999999999999999999999999999999965432211111000
Q ss_pred ---------Hhhccc--cC----------------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 533 ---------NFIDRN--LK----------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 533 ---------~~~~~~--~~----------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...... .. ..........+.+++.+|++.||.+|||+.|++++-+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 000000 00 00011123567899999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.15 Aligned_cols=239 Identities=21% Similarity=0.333 Sum_probs=186.4
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHH-HHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~-~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|. .+++.++||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 36999999999999976 678899999875321 12223444444 45678899999999998843 47899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+.+.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g-----iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 79 NGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence 9999999997543 3778888889999999999999988 999999999999999999999999998754321
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......+++.|+|||++.+..++.++|||||||++|||++|+.||........ +..+..... ...+.....
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~--~~~~~~~~~ 222 (325)
T cd05602 150 NG-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----YDNILNKPL--QLKPNITNS 222 (325)
T ss_pred CC-CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCc--CCCCCCCHH
Confidence 11 12234578899999999999999999999999999999999999975432211 112221111 122344567
Q ss_pred HHHHHHHhcccCCCCCCCHHH
Q 007788 551 LGKMALVCTHEDPENRPTMEA 571 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~e 571 (589)
+.+++..|++.||.+||++.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCC
Confidence 889999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.59 Aligned_cols=255 Identities=15% Similarity=0.297 Sum_probs=204.2
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.. .+..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEee
Confidence 5788889999999999999996 478999999997654 2344568899999999999999999999854 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 96 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~-----i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred cccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 999999999998643 3788999999999999999999987 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......+++.|+|||.+.+..++.++|||||||++||+++|+.||.......... ............+...
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTPELQNPERL 241 (297)
T ss_pred cCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eeccCCCCCCCCcccc
Confidence 43321 1112346678999999998889999999999999999999999996543211100 0000011111123445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+.+++.+||+.+|++||++++++++-+...
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 667889999999999999999999998766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=309.75 Aligned_cols=253 Identities=16% Similarity=0.318 Sum_probs=204.3
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.+|+..+.||.|++|.||+|.. .+++.|++|.+.... ......+.+|+..++.++||||+++++++.. .+..++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEEE
Confidence 4688889999999999999986 478999999987554 2335678899999999999999999999854 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++... .+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~-----i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 96 EYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ-----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 999999999998643 3899999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh-ccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 546 (589)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......... .... ........+..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIATNGTPELQNPEK 240 (296)
T ss_pred ccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCcccCCccc
Confidence 43321 112234677899999999888999999999999999999999999654322111 1111 11111112334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
....+.+++.+||+.||++||++.+++++=+..
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 556788999999999999999999999876653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=308.20 Aligned_cols=259 Identities=18% Similarity=0.336 Sum_probs=199.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHH-HhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYL-LTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|... +|+.||+|+++.........++..|+.. ++..+||||+++++++.. .+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 36788899999999999999976 6999999999765444445566667665 566689999999999854 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|||++ |+|.+++.........+++...+.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++.
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-----i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-----VIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99996 689888876443345699999999999999999999986 5 9999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccC----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTT----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
....... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... .............
T Consensus 153 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~ 227 (283)
T cd06617 153 YLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---QQLKQVVEEPSPQ 227 (283)
T ss_pred ccccccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---HHHHHHHhcCCCC
Confidence 6543221 122346778999998865 446889999999999999999999986432111 1111222211111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
......+..+.+++..||+.+|++||++.+++++-+...
T Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 112234567899999999999999999999998755443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=306.28 Aligned_cols=255 Identities=20% Similarity=0.330 Sum_probs=197.1
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc---------hHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK---------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
|...+.||+|+||.||+|... +|+.||+|.++..... ...+.+..|+.++++++|||++++++++. ..
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~ 80 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--TE 80 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec--cC
Confidence 556788999999999999864 6899999988643211 11246788999999999999999999984 45
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG-----ILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC-----eeecCCChhhEEEcCCCeEEEee
Confidence 78899999999999999997652 4889999999999999999999987 99999999999999999999999
Q ss_pred ccccccccCCcee-eeecCCccccccCcccccCCC--CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 461 CGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 461 fGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
||+++........ ......++..|+|||.+.... ++.++||||||+++||+++|..|+...................
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP 231 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC
Confidence 9998765432111 112334677899999987654 7899999999999999999999986432211111000000011
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
..........+..+.+++..||+.+|++||++++++++-
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 111112223467899999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=307.45 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=203.9
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||+|+||.||++... ++..||+|.+...........+.+|+.++.+++||||+++++++.. .+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEe
Confidence 5677889999999999999976 7899999998765434445689999999999999999999998854 478999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
|+++++|.+++.... ....+++..+..++.+++.||.|||+. + |+||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC-----EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999987542 123589999999999999999999964 5 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCC------CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
..... ....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||........ ...+..+.+. ...
T Consensus 154 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-~~~ 228 (286)
T cd06622 154 VASLA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVDG-DPP 228 (286)
T ss_pred cCCcc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHHHhhc-CCC
Confidence 43221 1234567899999986543 48899999999999999999999964322111 1111222221 122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+......+.+++.+||+.+|++||++++++.+-+.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 3445567889999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.86 Aligned_cols=241 Identities=19% Similarity=0.423 Sum_probs=187.1
Q ss_pred cccccCCCccEEEEEecC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 315 NLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+.||+|+||.||+|.... ...|++|.+.... ....+.|.+|+.++++++||||+++++++.. .+..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEE
Confidence 369999999999998642 2348888876443 3344678899999999999999999999864 3568999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc--------eEE
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--------PLI 458 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~--------~kl 458 (589)
|||+++|+|.++++.... .++|..++.++.||+.||+|||+.+ |+||||||+||+++.++. +++
T Consensus 78 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG-----LTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred EecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCccceEEEecccccccCCCceEEe
Confidence 999999999999986542 4899999999999999999999988 999999999999987765 599
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
+|||++....... ...++..|+|||++.+. .++.++||||||+++|||++|..++......... ......
T Consensus 150 ~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~----~~~~~~ 220 (258)
T cd05078 150 SDPGISITVLPKE-----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK----LQFYED 220 (258)
T ss_pred cccccccccCCch-----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH----HHHHHc
Confidence 9999887554321 23456779999999874 5789999999999999999996443322211111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+......+.+++..||+.||++|||++++++.|.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11223333467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.67 Aligned_cols=248 Identities=15% Similarity=0.266 Sum_probs=193.3
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +++.||+|++..... ......+..|+.++.++ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 36999999999999975 678999999986432 23345688899999888 69999999998843 47899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 79 NGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG-----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence 9999999886543 4899999999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH---HhhhhHHHhhccccCCCCCHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA---AESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||....... ........+..... ..+...
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~ 226 (327)
T cd05617 150 GD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFL 226 (327)
T ss_pred CC-ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCC
Confidence 11 1223457889999999999999999999999999999999999995321100 00011111111111 223344
Q ss_pred HHHHHHHHHHhcccCCCCCCC------HHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPT------MEAVIEEL 576 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs------~~evl~~L 576 (589)
+..+.+++.+|++.||++|++ +.+++++-
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 567889999999999999998 46777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=304.39 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=200.2
Q ss_pred cCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-----chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
+|...+.||+|+||.||+|...+++.+|||.+..... ......+.+|++.+++++|+||+++++++.+ .+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEE
Confidence 3667789999999999999988899999999875421 1223568899999999999999999999854 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++
T Consensus 79 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~ 149 (265)
T cd06631 79 IFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC-----VVHRDIKGNNVMLMPNGIIKLIDFGCA 149 (265)
T ss_pred EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHhEEECCCCeEEeccchhh
Confidence 9999999999999997543 3789999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCc-----eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc-c
Q 007788 465 KLLADDI-----VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-N 538 (589)
Q Consensus 465 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~ 538 (589)
....... ........++..|+|||++.+..++.++||||||+++|||++|+.||......... ...... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~ 225 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM----FYIGAHRG 225 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----HHhhhccC
Confidence 7653211 11112234677899999999888999999999999999999999999653221111 011111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 539 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.....+......+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122334456778999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=319.64 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=186.8
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHH-HHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 36999999999999875 689999999975421 223345556654 5677999999999988843 57899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~g-----ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 79 NGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSIN-----IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence 9999998886543 4889999999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ...+.....
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~~~~~~~--~~~~~~~~~ 222 (325)
T cd05604 150 SD-TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----YDNILHKPL--VLRPGASLT 222 (325)
T ss_pred CC-CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----HHHHHcCCc--cCCCCCCHH
Confidence 11 12234578889999999999999999999999999999999999975432211 112222111 112234566
Q ss_pred HHHHHHHhcccCCCCCCCHH
Q 007788 551 LGKMALVCTHEDPENRPTME 570 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~~ 570 (589)
+.+++..|++.+|.+||+++
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHhccCHHhcCCCC
Confidence 78999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=309.48 Aligned_cols=257 Identities=21% Similarity=0.361 Sum_probs=193.4
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhcc---CCCCccceeeeeecC---CCC
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL---RHENIIRLRGFCCSR---GRG 381 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~---~~~ 381 (589)
+|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+.+++++ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999876 68999999987543221 223455677666655 799999999987532 234
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECcc
Confidence 57999999974 89888875432 34899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh-------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------- 534 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~------- 534 (589)
|+++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 153 GLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred CccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 9998664322 1123346778999999998899999999999999999999999986432211111110000
Q ss_pred hcc-------ccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 535 IDR-------NLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 535 ~~~-------~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
... .... ...+.....+.+++.+|++.||++|||+.|++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 000 0000 00112356678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.30 Aligned_cols=253 Identities=26% Similarity=0.473 Sum_probs=199.5
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHH-HHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~-~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|+..+.||+|+||.||++... +++.||+|++......... ....+|+.++.+++||||+++++++.. .+..++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 456789999999999999976 5678999999877533322 234569999999999999999999855 578899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+....
T Consensus 79 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~~-----i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSKG-----IVHRDIKPENILLDENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EETTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHTT-----EEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred ccccccccccccccc----ccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccc
Confidence 999999999998332 3899999999999999999999988 9999999999999999999999999987542
Q ss_pred CCceeeeecCCccccccCccccc-CCCCCCcchhhhHHHHHHHHHhCCCCcchhH---HHHHhhhhHHHhhccccCCCCC
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSM---RLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
... .......++..|+|||.+. +..++.++||||+|+++|+|++|+.|+.... .................. ..
T Consensus 150 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 226 (260)
T PF00069_consen 150 ENN-ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ--QS 226 (260)
T ss_dssp STT-SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--SH
T ss_pred ccc-cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--cc
Confidence 111 1333456778899999998 7889999999999999999999999997651 111111111111111111 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
......+.+++..|++.||++||++.+++++-+
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 111378999999999999999999999997643
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=302.04 Aligned_cols=238 Identities=22% Similarity=0.454 Sum_probs=187.8
Q ss_pred cccccCCCccEEEEEecCCc-----------EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 315 NLLGKGNFSSVYKGTLRDGT-----------LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR---DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec---CCc
Confidence 36899999999999986432 5788877654322 5789999999999999999999999855 457
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-------ce
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-------NP 456 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-------~~ 456 (589)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dlkp~Nill~~~~~~~~~~~~~ 147 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK-----LVHGNVCGKNILVARYGLNEGYVPFI 147 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC-----eecccCccceEEEecCccccCCceeE
Confidence 899999999999999986542 4899999999999999999999987 99999999999999888 79
Q ss_pred EEccccccccccCCceeeeecCCccccccCcccccCC--CCCCcchhhhHHHHHHHHHhC-CCCcchhHHHHHhhhhHHH
Q 007788 457 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 457 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~ 533 (589)
||+|||++...... ....++..|+|||++.+. .++.++||||||+++|||++| ..|+...... .......
T Consensus 148 kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~- 220 (259)
T cd05037 148 KLSDPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ- 220 (259)
T ss_pred EeCCCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh-
Confidence 99999998865431 122345679999999876 789999999999999999994 6666543211 1111111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.... .+......+.+++..||+.+|++||++.++++.|+
T Consensus 221 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111 11111268899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.86 Aligned_cols=252 Identities=21% Similarity=0.393 Sum_probs=202.1
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||++..+ +++.||+|++..... ....+.+.+|++++++++|+|++++++.+.. .....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 4777899999999999999975 578999999875432 3344678899999999999999999987643 234678999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... ..+++.+++.++.+++.|++|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~-----i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 80 GFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred cccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCchhEEEecCCcEEEecccceEEe
Confidence 99999999999976432 35899999999999999999999988 999999999999999999999999998766
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ......+...
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~ 226 (257)
T cd08223 153 ENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----VYRIIE-GKLPPMPKDY 226 (257)
T ss_pred cccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHh-cCCCCCcccc
Confidence 43221 11223467789999999999999999999999999999999999865322111 111111 1112234456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+.+++.+|++.+|++||++.+++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 6789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=301.20 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=200.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeec---CCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS---RGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~---~~~~~~ 383 (589)
..|...+.||+|+||.|++|..+ +|..||||++..... ....+.-.+|+++|+.++|+||+.+.+++.. ..-+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 34555688999999999999975 789999999874332 3344667899999999999999999998754 234578
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
|+|+|+| ..||...++... .++......+..|+++||.|+|+.+ |+||||||+|++++.+...||+|||+
T Consensus 102 YiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn-----ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN-----VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred EEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc-----ccccccchhheeeccCCCEEeccccc
Confidence 9999999 669999987553 3888899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCc-eeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh-------------
Q 007788 464 HKLLADDI-VFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------- 528 (589)
Q Consensus 464 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~------------- 528 (589)
|+...... ....+....|..|.|||.+.. ..|+...||||.||++.||++|+..|.+......-.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 99885421 112234556788999998865 569999999999999999999999987643221110
Q ss_pred ------hhHHHhhcccc-CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 529 ------ATFENFIDRNL-KGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 529 ------~~~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
......+.... .... -+......+++..+++..||.+|+|++|++++.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 01111111100 0111 123456788999999999999999999999873
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.97 Aligned_cols=258 Identities=21% Similarity=0.385 Sum_probs=204.0
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCC----
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG---- 379 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~---- 379 (589)
.++++|+..+.||+|++|.||+|..+ +++.+++|++.... .....|.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35688999999999999999999985 67899999987653 2446789999999999 6999999999986533
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
....++||||+++++|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-----VIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEEccCCeEEEC
Confidence 34589999999999999998765433346899999999999999999999988 9999999999999999999999
Q ss_pred cccccccccCCceeeeecCCccccccCcccccC-----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
|||.+........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ ...+
T Consensus 156 d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~ 230 (275)
T cd06608 156 DFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKI 230 (275)
T ss_pred CCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH----HHHh
Confidence 9999876543221 1122346778999998754 3467899999999999999999999965322111 1111
Q ss_pred hcccc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 535 IDRNL-KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 535 ~~~~~-~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
..... ....+......+.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 111223356788999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.68 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=200.4
Q ss_pred CccccccccCCCccEEEEEec----CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCC----
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG---- 381 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~---- 381 (589)
|...+.||+|+||.||+|.+. +++.||||++..... ....+++.+|++++++++||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999864 368899999976532 33456788999999999999999999988543221
Q ss_pred eEEEEEEeCCCCChHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
..++++||+++|+|.+++..... ....+++...++++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-----FIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccchhhEEEcCCCCEEEC
Confidence 34789999999999988754321 1234788999999999999999999987 9999999999999999999999
Q ss_pred cccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcc
Q 007788 460 DCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 460 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|||+++......... .....++..|++||.+.+..++.++||||||+++|||++ |+.|+........ ...+...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~ 231 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNYLIKG 231 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHHHHcC
Confidence 999988664332211 122234467999999998889999999999999999999 7888764432111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.....+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 232 -~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 -NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11112233456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.40 Aligned_cols=255 Identities=17% Similarity=0.242 Sum_probs=196.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+++.+ +++.||+|++.... .......|.+|+.++..++|+||+++++++. +.+..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEE
Confidence 36788899999999999999976 57889999986432 1223345888999999999999999999884 3578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 79 v~ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~-----iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EEeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEeecchhe
Confidence 9999999999999976432 4889999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
..............+|+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~ 226 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKER 226 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH----HHHHHhCCCcc
Confidence 65433222223345788999999986 3468899999999999999999999997543211 11122221111
Q ss_pred C---CCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHHH
Q 007788 541 G---KFSESEAAKLGKMALVCTHEDPE--NRPTMEAVIEELT 577 (589)
Q Consensus 541 ~---~~~~~~~~~l~~l~~~C~~~dp~--~RPs~~evl~~L~ 577 (589)
. .........+.+++.+|+..++. .|++++|++++-+
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 1 11123456677888887755444 4789999998843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=288.96 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=206.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhcc-CCCCccceeeeeecCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG 379 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 379 (589)
+.|...++||.|..+.|-++..+ +|...|+|++...... .-..+-.+|+.+|+++ .||+|+.+.+++ +.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ES 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cC
Confidence 45667788999999999999865 6889999999764421 1123456789999998 699999999999 55
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
...+++|+|.|+.|.|.++|...- .+++....+|+.|+.+|++|||..+ ||||||||+|||+|++.++||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~~-----IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHARN-----IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHhh-----hhhcccChhheeeccccceEEe
Confidence 578899999999999999998664 3889999999999999999999988 9999999999999999999999
Q ss_pred cccccccccCCceeeeecCCccccccCcccccCC------CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG------RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 533 (589)
|||++..+..+. ......||++|.|||.+.-. .|+..+|.||.||+||.|+.|..||+.-.....-. .
T Consensus 166 DFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR----~ 239 (411)
T KOG0599|consen 166 DFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR----M 239 (411)
T ss_pred ccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH----H
Confidence 999999887653 34456799999999988643 47889999999999999999999997654332211 1
Q ss_pred hhccc--cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 534 FIDRN--LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 534 ~~~~~--~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+.... ...+...+.++...+++.+|++.||++|.|++|++++-+.
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 11111 2223345667889999999999999999999999988665
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=307.79 Aligned_cols=263 Identities=22% Similarity=0.372 Sum_probs=205.2
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeee
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC 376 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 376 (589)
.++.++..+.+.|+..+.||+|+||.||+|... +++.||+|++.... ....++..|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 355666667788999999999999999999975 68899999986542 3445788899999998 6999999999885
Q ss_pred cC----CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 377 SR----GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 377 ~~----~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
.. ..+..+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dl~~~nili~~ 156 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK-----VIHRDIKGQNVLLTE 156 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECC
Confidence 32 23578999999999999999976432 34788889999999999999999988 999999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 527 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~ 527 (589)
++.++|+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|+.||........
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~- 234 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA- 234 (282)
T ss_pred CCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-
Confidence 99999999999876532211 112234677899999876 34578899999999999999999999965432111
Q ss_pred hhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 528 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.................+..+.+++..||+.||.+||++.|++++
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 235 ---LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111111111111122356689999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.07 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=202.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||+|... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.. .+..+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEEE
Confidence 56888899999999999999975 57889999998654 2355788999999999999999999998854 46799999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.... ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.++|+|||.+...
T Consensus 80 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 80 EYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG-----KIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred eCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCChhhEEECCCCCEEECccccchhh
Confidence 9999999999987652 24889999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCC---CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
..... ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+.................. .......
T Consensus 152 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (262)
T cd06613 152 TATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDK 229 (262)
T ss_pred hhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-Cccccch
Confidence 43221 11223456779999999776 7899999999999999999999998654321111110000000 0111123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=307.04 Aligned_cols=257 Identities=18% Similarity=0.328 Sum_probs=204.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ......|..|++++++++||||+++++++.. ....++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEE
Confidence 456778889999999999999975 68999999987553 3445679999999999999999999999854 5688999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++..... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 81 IEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSHK-----VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999999876432 4899999999999999999999988 99999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc-cC
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LK 540 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~ 540 (589)
...... ......++..|+|||.+. ...++.++||||||+++|||++|+.||....... ....+.... ..
T Consensus 153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~ 227 (280)
T cd06611 153 NKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----VLLKILKSEPPT 227 (280)
T ss_pred hccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH----HHHHHhcCCCCC
Confidence 543221 112234677899999875 3457789999999999999999999996542211 111111111 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+......+.+++..||+.+|.+||++.+++++-+...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 1123344567889999999999999999999998866443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.39 Aligned_cols=253 Identities=19% Similarity=0.319 Sum_probs=199.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.|+..+.||+|+||.||+|+.. +++.|++|.+.... ......+.+|+.++++++||||+++++.+.. .+..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEE
Confidence 56777889999999999999976 58899999987654 3445678999999999999999999998854 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|..++..... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 89 e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 89 EFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSMK-----IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred ecCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC-----eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999988865432 4899999999999999999999987 999999999999999999999999998754
Q ss_pred cCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc-CC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KG 541 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 541 (589)
..... ......++..|+|||++. ...++.++|||||||++|||++|+.|+....... .......... ..
T Consensus 161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 235 (292)
T cd06644 161 VKTLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSEPPTL 235 (292)
T ss_pred ccccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH----HHHHHhcCCCccC
Confidence 32211 112234567899999985 3457889999999999999999999986543211 1111111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..+......+.+++.+||+.+|++||++.+++++-+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 122344567889999999999999999999998644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.83 Aligned_cols=252 Identities=20% Similarity=0.366 Sum_probs=204.4
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|+||.||.++.. +++.+++|.+..... .....++.+|++++++++|+||+++++++.+ .+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 4778899999999999999864 688999999875532 3445678999999999999999999999854 47889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG-----ILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 9999999999997653 235899999999999999999999988 999999999999999999999999998866
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+...... ......
T Consensus 152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~ 225 (256)
T cd08221 152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----LVVKIVQGNYT-PVVSVY 225 (256)
T ss_pred ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCC-CCcccc
Confidence 44331 1223446788999999988889999999999999999999999986533211 11122211111 223445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
+..+.+++..||+.+|++||++.++++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 67789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=303.26 Aligned_cols=249 Identities=22% Similarity=0.415 Sum_probs=199.1
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch--------HHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS--------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
|.....||+|++|.||+|... +++.||+|.+....... ....+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--AD 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Confidence 566788999999999999865 68899999887543211 12467889999999999999999999854 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~-----ivH~di~p~nil~~~~~~~~l~df 150 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG-----IIHRDIKGANILVDNKGGIKISDF 150 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC-----cccccCCHHHEEEcCCCCEEeccc
Confidence 7899999999999999997543 3888999999999999999999987 999999999999999999999999
Q ss_pred cccccccCCceee-----eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 462 GLHKLLADDIVFS-----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 462 Gla~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
|.++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~ 226 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ----AIFKIGE 226 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH----HHHHHhc
Confidence 9988765321110 112236678999999998889999999999999999999999997543211 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
......+...+..+.+++.+||+.||.+||++.|++++
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 -NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11223334556788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=310.94 Aligned_cols=260 Identities=18% Similarity=0.356 Sum_probs=199.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.++++++||||+++++++.. .+..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEEEE
Confidence 46778899999999999999875 6889999998765434444567889999999999999999999853 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||++ ++|.+++..... .+++.....++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...
T Consensus 84 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 84 EYLD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred eccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 9997 599998875432 4889999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh-----------hHHHhh
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------TFENFI 535 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~-----------~~~~~~ 535 (589)
..... ......++..|+|||.+.+. .++.++|||||||++|||+||+.||........... .+..+.
T Consensus 155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 155 SIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 32211 11123456789999988654 478899999999999999999999965322111000 000000
Q ss_pred cc------ccC---CC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 536 DR------NLK---GK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 536 ~~------~~~---~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.. ... .. ........+.+++.+|++.||.+|||+.|++++-+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00 000 00 01123456789999999999999999999998866543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=303.04 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=203.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||.|+||.||+|... ++..+++|++.........+.+.+|++.++.++|+||+++++.+.. .+..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEE
Confidence 36788899999999999999965 6889999999765544466789999999999999999999998844 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+
T Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~-----i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG-----QIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 99999999999976432 134899999999999999999999988 999999999999999999999999998766
Q ss_pred cCCcee---eeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc---ccC
Q 007788 468 ADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR---NLK 540 (589)
Q Consensus 468 ~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 540 (589)
...... ......++..|+|||.+... .++.++|||||||++|||++|+.||....... ...+.... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~ 228 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQNDPPSLE 228 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcCCCCCcC
Confidence 543221 11223467789999998877 78999999999999999999999996543211 11111111 111
Q ss_pred CCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 541 GKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 541 ~~~-~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
... ....+..+.+++..|++.||++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 110 12445778999999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=296.09 Aligned_cols=275 Identities=19% Similarity=0.325 Sum_probs=228.1
Q ss_pred ccccCHHHHHHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCcc
Q 007788 296 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369 (589)
Q Consensus 296 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv 369 (589)
.+...+.++.....+++...++.+|.||.||+|.|+ +.+.|-||.++.....-....|..|...+..+.|||+.
T Consensus 271 e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 271 EFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred HHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 344556777777888888899999999999999765 34567889888777666777899999999999999999
Q ss_pred ceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCC----CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCC
Q 007788 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV 445 (589)
Q Consensus 370 ~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~ 445 (589)
++.+++.++ ....+++|.++.-|+|..+|..+++. .+.++-.+...+|.|++.||+|||..+ |||.||.+
T Consensus 351 ~V~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-----ViHkDiAa 424 (563)
T KOG1024|consen 351 SVLGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-----VIHKDIAA 424 (563)
T ss_pred ceeEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-----cccchhhh
Confidence 999999764 56788999999999999999855432 245777788999999999999999988 99999999
Q ss_pred CCeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHH
Q 007788 446 EKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMR 523 (589)
Q Consensus 446 ~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~ 523 (589)
+|+++|+..++||+|=.+++.+-+..++ -.........||+||.+....|+.++|||||||+||||+| |+.|+..-..
T Consensus 425 RNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 425 RNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred hcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 9999999999999999999865433322 2334456678999999999999999999999999999998 7777754322
Q ss_pred HHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
. ++...+....+...+-++++++..++..||+.+|++||+++|++.-|.+..-
T Consensus 505 f-----Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 505 F-----EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred H-----HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2 2344555566667788999999999999999999999999999999987653
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=313.39 Aligned_cols=255 Identities=20% Similarity=0.319 Sum_probs=214.6
Q ss_pred hccCccccccccCCCccEEEEEecC-CcEEEEEEeccCCCch--HHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~ 383 (589)
...|+..+.||+|.||.||+++.+. |+.+|+|.+.+..... ......+|+.+|+++. |||||.+.+.+ ++...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e~~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF--EDPDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE--EcCCeE
Confidence 3467777899999999999999874 9999999998765432 3367889999999998 99999999999 445789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC----CceEEc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLIA 459 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 459 (589)
++|||++.||.|.+.+... . +++.....++.|++.+++|||+.+ |+||||||+|+|+... +.+|++
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH~~g-----vvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLHSLG-----VVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred EEEEEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCHHHeeeccccCCCCcEEEe
Confidence 9999999999999999766 2 889999999999999999999988 9999999999999643 579999
Q ss_pred cccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc-
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN- 538 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 538 (589)
|||++...... .......||+.|+|||++....|+..+||||.||++|.|++|..||.+..+.... ..+....
T Consensus 182 DFGla~~~~~~--~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~----~~i~~~~~ 255 (382)
T KOG0032|consen 182 DFGLAKFIKPG--ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF----LAILRGDF 255 (382)
T ss_pred eCCCceEccCC--ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH----HHHHcCCC
Confidence 99999988763 2445667999999999999999999999999999999999999999876543222 2222222
Q ss_pred -cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 539 -LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 539 -~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
......+.....+.+++..|+..||.+|+|+.++++|.|...
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 223344566788999999999999999999999999987554
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.35 Aligned_cols=253 Identities=19% Similarity=0.266 Sum_probs=195.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||++... +++.||+|++.... .......+..|+.++.+++||||+++++.+. +.+..++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 36788899999999999999875 68999999997432 1233456888999999999999999999884 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 79 v~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g-----ivHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG-----FIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 999999999999997543 3889999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCcee----------------------------------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHH
Q 007788 466 LLADDIVF----------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 511 (589)
Q Consensus 466 ~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~el 511 (589)
........ ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 54321100 01123578899999999999999999999999999999
Q ss_pred HhCCCCcchhHHHHHhhhhHHHhhcc--ccCCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHHHH
Q 007788 512 LTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAKLGKMALVCTHEDPENRP---TMEAVIEELT 577 (589)
Q Consensus 512 ltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP---s~~evl~~L~ 577 (589)
+||+.||......... ..+... .+...........+.+++.+++. ||.+|+ +++|++++-+
T Consensus 230 ~tG~~Pf~~~~~~~~~----~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 230 LIGYPPFCSETPQETY----RKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred ccCCCCCCCCCHHHHH----HHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 9999999764332211 111111 11100011124456667766554 999998 4788887754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=305.04 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=196.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++.. .+..++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEE
Confidence 35666788999999999999865 68899999987653 3334568889999999999999999998854 47889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.... .+++.+.+.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 86 EFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG-----KMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred eccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 9999999999987543 4889999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH-HHhhccccCCCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-ENFIDRNLKGKF 543 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 543 (589)
..... ......++..|+|||++. ...++.++|||||||++|||++|+.|+............. .....+... .
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 233 (267)
T cd06645 157 TATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--D 233 (267)
T ss_pred cCccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--c
Confidence 43221 122335778899999874 4568899999999999999999999986432211100000 000000010 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....+..+.+++.+|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11234568899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=335.42 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=218.6
Q ss_pred HHHhhccCccccccccCCCccEEEEEec----C----CcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeee
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR----D----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGF 374 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~ 374 (589)
++...++....+.+|+|.||.|++|... . ...||||.++......+.+.+..|+++|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444445555668999999999999854 1 4579999999887777788999999999999 59999999999
Q ss_pred eecCCCCeEEEEEEeCCCCChHHHhhhhc---------C-CC--CCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecC
Q 007788 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEE---------G-SS--NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 442 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~---------~-~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~d 442 (589)
|.. .+..++|+||+..|+|.++|+..+ . .. ..++....+.++.|||.||+||++.. +||||
T Consensus 371 ~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-----~vHRD 443 (609)
T KOG0200|consen 371 CTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-----CVHRD 443 (609)
T ss_pred ecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-----ccchh
Confidence 955 678999999999999999998776 1 01 13888999999999999999999987 99999
Q ss_pred CCCCCeeecCCCceEEccccccccccCCceeeeecCC--ccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcc
Q 007788 443 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLT 519 (589)
Q Consensus 443 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~ 519 (589)
|.++|||+.++..+||+|||+++.......+...... -...|||||.+....|+.|+|||||||+||||+| |..|+.
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999976655544433333 3457999999999999999999999999999999 556665
Q ss_pred hhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 520 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.. . ...+.+.+....+...+..+..++.+++..||+.+|++||++.++++.++..
T Consensus 524 ~~~-~---~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 524 GIP-P---TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCC-c---HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 411 0 1122335556666677888899999999999999999999999999998873
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.87 Aligned_cols=251 Identities=19% Similarity=0.362 Sum_probs=202.7
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|+||.||++... +|+.||+|++..... .....++.+|++++++++||||+++++++. ..+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEE
Confidence 4777899999999999999865 689999999875432 334467899999999999999999999884 457899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 79 DYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 99999999999875432 24789999999999999999999987 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||+..+..++.++|||||||++|||++|+.|+....... ....+... .....+...
T Consensus 152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~ 225 (256)
T cd08218 152 NSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIRG-SYPPVSSHY 225 (256)
T ss_pred Ccchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----HHHHHhcC-CCCCCcccC
Confidence 43221 1112346677999999998899999999999999999999999986432211 11111111 112234455
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+.+++.+||+.+|++||++++|+++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 6789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=312.88 Aligned_cols=256 Identities=16% Similarity=0.318 Sum_probs=192.1
Q ss_pred ccccccC--CCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 314 VNLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 314 ~~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
.++||+| +|++||++..+ +|+.||+|++...... .....+.+|+++++.++||||+++++++.. .+..++||||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~ 80 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSF 80 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEec
Confidence 4679999 78899999875 7899999999765433 233556779999999999999999999854 4688999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 81 MAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred cCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 999999999975432 24899999999999999999999988 99999999999999999999999986543321
Q ss_pred Cce-ee-----eecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh----hHHHhhc-
Q 007788 470 DIV-FS-----VLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----TFENFID- 536 (589)
Q Consensus 470 ~~~-~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~- 536 (589)
... .. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .....++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 110 00 011234566999999876 4589999999999999999999999964321110000 0000000
Q ss_pred ------------------ccc-----------------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 537 ------------------RNL-----------------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 537 ------------------~~~-----------------~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
... ...........+.+++.+||+.||++|||++|++++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 000 000112235678899999999999999999999987554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=309.19 Aligned_cols=251 Identities=15% Similarity=0.322 Sum_probs=199.1
Q ss_pred cccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 313 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
....||+|+||.||++... ++..||||.+.... ......+.+|+..+++++||||+++++.+.. .+..++||||++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~ 102 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEFLE 102 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeCCC
Confidence 3466999999999999875 68899999986543 3445678899999999999999999998854 478899999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
+++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG-----VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999988532 3889999999999999999999987 9999999999999999999999999987554322
Q ss_pred eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHH
Q 007788 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 551 (589)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ............ ........+
T Consensus 173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~ 248 (292)
T cd06658 173 P-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLPPRVK--DSHKVSSVL 248 (292)
T ss_pred c-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCccc--cccccCHHH
Confidence 1 112234677899999998888999999999999999999999998754322111 111111111111 122345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 552 GKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 552 ~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.+++..|++.||++|||++|++++-+...
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 89999999999999999999998855543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.96 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=200.3
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC----chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
+|+..+.||+|++|.||+|... ++..|++|.+..... +.....+.+|+.++++++|+||+++++++.. .+..+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 3666788999999999999986 789999999865432 2244678999999999999999999998844 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+|+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++
T Consensus 79 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN-----TVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred EEEEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999997542 3889999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
....... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||......... ............
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~ 223 (258)
T cd06632 150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIGRSKELPPI 223 (258)
T ss_pred eeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHHhcccCCCc
Confidence 7654332 122344677899999987766 899999999999999999999998654321111 111110111223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+......+.+++.+||+.+|.+||++.+++++
T Consensus 224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 34456778899999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.02 Aligned_cols=252 Identities=21% Similarity=0.386 Sum_probs=203.6
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
-|+..+.||+|+||.||+|... ++..||+|.+...........|.+|+..+.+++||||+++++++.. .+..++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEEE
Confidence 3566788999999999999864 6889999998765444555778999999999999999999999854 467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++... .+++.....++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 83 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152 (277)
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC-----eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence 99999999998643 3889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
.... ......++..|+|||.+.+..++.++|||||||++|||++|..|+........ ...+............+
T Consensus 153 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 226 (277)
T cd06641 153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-----LFLIPKNNPPTLEGNYS 226 (277)
T ss_pred cchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-----HHHHhcCCCCCCCcccC
Confidence 3221 11123456779999999888899999999999999999999999865432111 11111111222334456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+.+++.+||+.+|.+||++.+++++-...
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 7789999999999999999999999975443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.68 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=200.6
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|...+.||+|+||.||+|... +++.|++|.++..... .....+..|+.++++++|+||+++++++. ..+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence 4677889999999999999865 6899999999766432 35578999999999999999999999874 457899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.... .+++..+..++.+++.||+|||+.+ |+|+||+|+||++++++.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 79 EYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG-----IVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred ecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccccccccc
Confidence 9999999999997542 3788999999999999999999988 999999999999999999999999998876
Q ss_pred cCCceeee---ecCCccccccCcccccCCC---CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 468 ADDIVFSV---LKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 468 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
........ ....++..|+|||++.+.. ++.++||||||+++||+++|+.||.............. .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~ 225 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG----AGHKP 225 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh----cCCCC
Confidence 54332111 1234667899999998766 88999999999999999999999964321111100000 01111
Q ss_pred CCCH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 542 KFSE--SEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 542 ~~~~--~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
..+. .....+.+++..||+.+|.+||++.|++.+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1222 236678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=328.73 Aligned_cols=262 Identities=17% Similarity=0.237 Sum_probs=195.4
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC------CCccceeee
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH------ENIIRLRGF 374 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~g~ 374 (589)
+++...+++|.+.+.||+|+||.||+|... .++.||||+++... ....++..|+.++.+++| +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344556788999999999999999999875 68899999996432 223345567777666654 458888888
Q ss_pred eecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCC
Q 007788 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~ 453 (589)
+... ....++|||++ +++|.+++.... .+++..+..|+.||+.||+|||+. + |+||||||+|||++.+
T Consensus 200 ~~~~-~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g-----IiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 200 FQNE-TGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH-----LMHTDLKPENILMETS 268 (467)
T ss_pred EEcC-CceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHHEEEecC
Confidence 7543 45788999988 778998887543 489999999999999999999974 6 9999999999999876
Q ss_pred C----------------ceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCC
Q 007788 454 F----------------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 517 (589)
Q Consensus 454 ~----------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p 517 (589)
+ .+||+|||.+...... .....+|..|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 5 4999999987643221 2234578899999999999999999999999999999999999
Q ss_pred cchhHHHHHhhh-------------------hHHHhhccc--cCCCCC---------------HHHHHHHHHHHHHhccc
Q 007788 518 LTSSMRLAAESA-------------------TFENFIDRN--LKGKFS---------------ESEAAKLGKMALVCTHE 561 (589)
Q Consensus 518 ~~~~~~~~~~~~-------------------~~~~~~~~~--~~~~~~---------------~~~~~~l~~l~~~C~~~ 561 (589)
|........... ....+.+.. +..... ......+.+++..|++.
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 965332110000 000011000 000000 01235577999999999
Q ss_pred CCCCCCCHHHHHHHHHhhh
Q 007788 562 DPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 562 dp~~RPs~~evl~~L~~~~ 580 (589)
||++|||++|+++|-+...
T Consensus 425 dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred ChhhCCCHHHHhcCccccc
Confidence 9999999999999876544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=297.58 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=206.3
Q ss_pred CccccccccCCCccEEEEEecC-CcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
|+..+.||+|.-|+||++++++ +..+|+|++.+... .........|-++|+.+.||.+..|++.+ +..+..++||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~m 156 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVM 156 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEE
Confidence 4446789999999999999874 68999999987643 22334567789999999999999999988 5568899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
|||+||+|+.+++.+.+ ..++...+..+|.+|+.||+|||-.| ||+|||||+||||.++|++-|+||.++...
T Consensus 157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG-----ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG-----IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc-----eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999987654 45999999999999999999999998 999999999999999999999999987654
Q ss_pred cCCcee-------------------------------e------------------------eecCCccccccCcccccC
Q 007788 468 ADDIVF-------------------------------S------------------------VLKTSAAMGYLAPEYVTT 492 (589)
Q Consensus 468 ~~~~~~-------------------------------~------------------------~~~~~~~~~y~aPE~~~~ 492 (589)
...... . ...-.||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 210000 0 001135566999999999
Q ss_pred CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----
Q 007788 493 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT---- 568 (589)
Q Consensus 493 ~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs---- 568 (589)
...+.++|+|+|||++|||+.|.-||.+... ..++..++-..+.....+..+..+.+||+..+.+||++|-.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 9999999999999999999999999987654 34555666655554444566788999999999999999988
Q ss_pred HHHHHHH
Q 007788 569 MEAVIEE 575 (589)
Q Consensus 569 ~~evl~~ 575 (589)
+.||-+|
T Consensus 386 A~eIK~H 392 (459)
T KOG0610|consen 386 AAEIKRH 392 (459)
T ss_pred hHHhhcC
Confidence 7777655
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.39 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=188.3
Q ss_pred ccccccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 314 VNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++........++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 367999999999999865 46789999987543 234577899999999999999999988766566789999999
Q ss_pred CCCChHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee----cCCCceEEccc
Q 007788 391 PKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADC 461 (589)
Q Consensus 391 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~Df 461 (589)
. ++|.+++..... ....+++.....++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 5 588888754321 1234889999999999999999999988 9999999999999 45678999999
Q ss_pred cccccccCCce--eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-----hhhHHH
Q 007788 462 GLHKLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----SATFEN 533 (589)
Q Consensus 462 Gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-----~~~~~~ 533 (589)
|+++....... .......+|..|+|||++.+. .++.++||||+||++|||++|+.||......... ...+..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 99987653321 112234568889999998774 5899999999999999999999998532210000 000000
Q ss_pred hhc-----------------------cccCC-CC------------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 534 FID-----------------------RNLKG-KF------------SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 534 ~~~-----------------------~~~~~-~~------------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
++. ..... .. .......+.+++..|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000 00 00012357789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.15 Aligned_cols=253 Identities=18% Similarity=0.212 Sum_probs=193.8
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
...|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++.. .+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEE
Confidence 346888999999999999999976 578899996432 246789999999999999999999854 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+. ++|.+++..... .++|..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 239 ~e~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGEG-----IIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred EEccC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 99994 789888865432 4999999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH---hhhhHHHhhcc-----
Q 007788 467 LADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---ESATFENFIDR----- 537 (589)
Q Consensus 467 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~----- 537 (589)
....... ......+|..|+|||++.+..++.++|||||||++|||++|..++........ ....+..++..
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~ 389 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV 389 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence 6432211 11234578899999999999999999999999999999998866543211000 00000000000
Q ss_pred ---------------------ccCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 538 ---------------------NLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 538 ---------------------~~~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
....... ......+.+++.+|++.||.+|||+.|++++-+.
T Consensus 390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 0000000 0123467899999999999999999999987553
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=306.19 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=195.5
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||+|... ++..||||++..... ......+.+|+.++.+++||||+++++++.+ .+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 3677789999999999999975 689999999875432 2234578899999999999999999999854 47889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||++ ++|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 79 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 79 EFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR-----VLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred ecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 9997 689888865432 245899999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH---------------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF--------------- 531 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------------- 531 (589)
..... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||.............
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 152 GIPVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred CCCcc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 43211 11223456789999988654 47899999999999999999999996532211110000
Q ss_pred -----HHhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 532 -----ENFIDRNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 532 -----~~~~~~~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....+..... ........++.+++.+|++.||++|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 0011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.08 Aligned_cols=256 Identities=19% Similarity=0.367 Sum_probs=194.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++||||+++++++. +.+..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeEEEEE
Confidence 56788899999999999999976 689999999876543333346778999999999999999999984 347899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++ +|.+++..... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRR-----VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred ecCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 99975 99998875432 4889999999999999999999988 999999999999999999999999998754
Q ss_pred cCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh-----------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI----------- 535 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------- 535 (589)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............+.+
T Consensus 154 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 154 SVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred CCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 32111 1112235677999998875 4588999999999999999999999864321110000000000
Q ss_pred -c------cccCCC--C-----CHHH--HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 536 -D------RNLKGK--F-----SESE--AAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 536 -~------~~~~~~--~-----~~~~--~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
. ...... . .... ...+.+++..|++.+|++||++.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 0 000000 0 0011 25678999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.94 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=199.0
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEecc---CCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINV---TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
.+||+|+|-+||||.+. +|..||.-.++. .........|..|+.+|+.|+||||++++.++.+......-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 57999999999999975 688888544332 22234447899999999999999999999999888777889999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEccccccccccC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLAD 469 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGla~~~~~ 469 (589)
..|+|..|+.+.+. ++.....+|+.||++||.|||++. |||||||||-.||+|+. -|.|||+|.|+|..+..
T Consensus 126 TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~---PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD---PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC---CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999987764 788889999999999999999975 99999999999999986 48999999999998876
Q ss_pred CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (589)
.... ...||+-|||||... ..|++.+||||||+.|+||+|+..||..=...+. .++.++...-...+..-...
T Consensus 199 s~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---IYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 199 SHAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ---IYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---HHHHHHcCCCHHHhhccCCH
Confidence 5432 257999999999887 7899999999999999999999999953222221 22222221111111111245
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 550 KLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 550 ~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
++.+++..|+.. .++|||+.|++++-
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 789999999998 99999999999763
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.37 Aligned_cols=254 Identities=20% Similarity=0.373 Sum_probs=206.9
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||+|++|.||+|... +++.|+||++...........+.+|++.+.+++|+||+++++++.. .+..++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEEE
Confidence 5778899999999999999987 5999999999876543456789999999999999999999999854 478999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
|+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~-----~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH-----IIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC-----CccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99999999999765 248999999999999999999999 87 999999999999999999999999998866
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH-
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES- 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 546 (589)
...... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+....+. ........+... .....+..
T Consensus 151 ~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~ 227 (264)
T cd06623 151 ENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDG-PPPSLPAEE 227 (264)
T ss_pred ccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcC-CCCCCCccc
Confidence 443221 11234567799999999988999999999999999999999999665320 011111222221 11222333
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.+..+.+++..|++.+|++||++.+++++-+
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 5678999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.05 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=196.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|..+ +++.||+|++...... .....+.+|++++++++||||+++++++. ..+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence 36778899999999999999986 5899999998654322 23457889999999999999999999984 45789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.++..... .++|..++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++..
T Consensus 79 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~-----i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 79 FEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred EecCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 99999999988765432 3899999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh----------HHHh-
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------FENF- 534 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~----------~~~~- 534 (589)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||............ ....
T Consensus 150 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 150 LAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred ccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 543221 1122345678999999875 44788999999999999999999888643221110000 0000
Q ss_pred -----hccccCCC---------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 535 -----IDRNLKGK---------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 535 -----~~~~~~~~---------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.+...... ..+..+..+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000 011335678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.88 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=204.3
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+|+..+.||+|++|.||+|... +++.||+|.+...... .....+..|++++..++||||+++++.+. ..+..++|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEEE
Confidence 6778899999999999999976 5899999999765433 24467889999999999999999999884 35788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 80 MDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG-----IVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 99999999999987543 235899999999999999999999988 99999999999999999999999999875
Q ss_pred ccCCcee----------------------------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCc
Q 007788 467 LADDIVF----------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL 518 (589)
Q Consensus 467 ~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~ 518 (589)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence 5322100 001124567899999999888999999999999999999999999
Q ss_pred chhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHHHH
Q 007788 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT----MEAVIEELT 577 (589)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs----~~evl~~L~ 577 (589)
...... ..+..+.............+..+.+++.+|++.||++||+ +.|++++-+
T Consensus 233 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 233 KGSNRD----ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred CCCchH----HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 654322 1222233322222222235778999999999999999999 888887644
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.94 Aligned_cols=252 Identities=15% Similarity=0.298 Sum_probs=199.8
Q ss_pred ccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
...||+|+||.||+|... +++.||+|.+.... ......+.+|+..+..++||||+++++++.. .+..++|+||+++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~~~ 102 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFLQG 102 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecCCC
Confidence 457999999999999875 68999999987544 2345678899999999999999999998854 4788999999999
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 472 (589)
++|.+++... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999987542 3889999999999999999999988 99999999999999999999999999875543321
Q ss_pred eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHH
Q 007788 473 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 552 (589)
Q Consensus 473 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 552 (589)
......++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+..... ............+.
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~l~ 248 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPP--PKLKNAHKISPVLR 248 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhccCC--CCccccCCCCHHHH
Confidence 112344678899999999889999999999999999999999998643321111 01110000 01111223456788
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 553 KMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 553 ~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
+++..|++.+|++||++.+++++-......
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 999999999999999999999986665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.47 Aligned_cols=252 Identities=17% Similarity=0.268 Sum_probs=190.7
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
...+|...+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++.. .+..++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence 3457999999999999999999976 5778999975432 23468999999999999999999854 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|+||+. ++|.+++.... ..++|..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 135 v~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred EEEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEecCcccc
Confidence 999994 68988886543 34899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHH------HHHhhhhHHHhhc---
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR------LAAESATFENFID--- 536 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~------~~~~~~~~~~~~~--- 536 (589)
...... ......++..|+|||++.+..++.++|||||||++|||+++..++..... .......+...+.
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 206 FPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred ccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 543221 12234578889999999999999999999999999999997665522100 0000000000000
Q ss_pred ---cccC-----------------C--CC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 537 ---RNLK-----------------G--KF-------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 537 ---~~~~-----------------~--~~-------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+. . .. .........+++..|++.||++|||+.|++++-+.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 0000 0 00 00123345569999999999999999999987543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=315.71 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=201.5
Q ss_pred ccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCCC
Q 007788 316 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 394 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gs 394 (589)
+||+|.||+||-|+.. +...+|||.+.... ....+-..+||.+-++++|.|||+++|.| ...+..-|.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCCCc
Confidence 6999999999999976 46679999997654 33445678899999999999999999998 44578889999999999
Q ss_pred hHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEccccccccccCCcee
Q 007788 395 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 395 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~ 473 (589)
|.++|+...+.-. =.+.+.-.+..||++||.|||+.. |||||||..|||++. .|.+||+|||.++.+..-..
T Consensus 659 LSsLLrskWGPlK-DNEstm~fYtkQILeGLkYLHen~-----IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLK-DNESTMNFYTKQILEGLKYLHENK-----IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP- 731 (1226)
T ss_pred HHHHHHhccCCCc-cchhHHHHHHHHHHHHhhhhhhcc-----eeeccccCCcEEEeeccceEEecccccchhhccCCc-
Confidence 9999998776411 156777788999999999999988 999999999999975 78899999999998754222
Q ss_pred eeecCCccccccCcccccCCC--CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 551 (589)
......||..|||||++..++ |+.++|||||||++.||.||++||........ -+-.+-.....++.+++..++.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIPEELSAEA 808 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCcHHHHHHH
Confidence 222345889999999998764 89999999999999999999999964322111 0111112234567889999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 007788 552 GKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 552 ~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
..++.+|+.+||..||++.++++.
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccC
Confidence 999999999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.13 Aligned_cols=256 Identities=19% Similarity=0.294 Sum_probs=196.7
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----C
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----R 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~ 380 (589)
..++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3578899999999999999999864 688999999875432 223356778999999999999999998774321 2
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSAG-----IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCChhhEEECCCCCEEEcC
Confidence 3578999988 78998887532 3899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh---------
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT--------- 530 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~--------- 530 (589)
||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 162 fg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 162 FGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99998765422 23356788999999877 56899999999999999999999999643211100000
Q ss_pred ----------HHHhhccccCCCCC--------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 531 ----------FENFIDRNLKGKFS--------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 531 ----------~~~~~~~~~~~~~~--------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
....+. .+. ..+ ......+.+++.+|++.||.+|||+.|++++-+..
T Consensus 238 ~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 238 EVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 000000 000 000 01123477999999999999999999999886543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=306.78 Aligned_cols=256 Identities=18% Similarity=0.322 Sum_probs=194.5
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++++++||||+++++++.+ .+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4677789999999999999975 689999999875432 2223467889999999999999999999843 46889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||++ ++|.+++.... ..+++...+.++.||++||+|||+.+ |+||||||+||+++.++.++|+|||+++..
T Consensus 79 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 79 EYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred ecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 9997 58888876543 24899999999999999999999988 999999999999999999999999998865
Q ss_pred cCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH---------------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF--------------- 531 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------------- 531 (589)
..... ......++..|+|||.+.+.. ++.++|||||||++|||+||+.|+............+
T Consensus 150 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 150 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 43211 112234567899999887644 7899999999999999999999864322111000000
Q ss_pred HHhhccccCCC---------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 532 ENFIDRNLKGK---------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 532 ~~~~~~~~~~~---------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+...... ........+.+++.+|++.||.+|||+.+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 00001000000 01123567889999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.14 Aligned_cols=256 Identities=18% Similarity=0.303 Sum_probs=196.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|++|.||+|..+ +|+.||+|++..... ....+.+.+|+.++++++|||++++++++.. .+..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 36778889999999999999986 689999999875432 2233568899999999999999999999854 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|..+..... .++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 79 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 79 FEYCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHN-----CIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred EeccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCChhhEEEcCCCcEEECcccccee
Confidence 99999998888765432 3899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh---hH-------HHhh
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TF-------ENFI 535 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~---~~-------~~~~ 535 (589)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... .. ....
T Consensus 150 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 150 LTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 654321 1112235667999999876 4578999999999999999999999964322111000 00 0000
Q ss_pred cc----------ccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 536 DR----------NLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 536 ~~----------~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
+. ...... ....+..+.+++.+||+.+|++||++.|++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 00 000000 012356788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.84 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=188.0
Q ss_pred cccccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 315 NLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
..||+|+||.||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++........++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999975 45789999986543 2345788999999999999999999987666678899999986
Q ss_pred CCChHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee----cCCCceEEcccc
Q 007788 392 KGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCG 462 (589)
Q Consensus 392 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG 462 (589)
+ +|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 5 78877753221 1235889999999999999999999988 9999999999999 566789999999
Q ss_pred ccccccCCce--eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-----hh-----
Q 007788 463 LHKLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----SA----- 529 (589)
Q Consensus 463 la~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-----~~----- 529 (589)
+++....... .......++..|+|||.+.+. .++.++|||||||++|||+||+.||......... ..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 9987643321 112233567889999998764 5799999999999999999999998632211000 00
Q ss_pred ----------hHHHhh--------cccc-CC------------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 530 ----------TFENFI--------DRNL-KG------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 530 ----------~~~~~~--------~~~~-~~------------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
....+. .... .. .........+.+++.+|++.||.+|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 000000 0000 00 00001134577899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.14 Aligned_cols=258 Identities=21% Similarity=0.357 Sum_probs=210.3
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.|...+.||.|+||.||-|... +..+||||++.-.... ....+.++|++.|.+++|||++.+.|+|..+ ...|+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHHH
Confidence 3555678999999999999864 7889999999755422 2336789999999999999999999998654 578999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||| -|+-.+++.-... ++.+..+..|+.|.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|..
T Consensus 105 MEYC-lGSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~~-----~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN-----RIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred HHHH-hccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHhh-----HHhhhccccceEecCCCeeeeccccchhh
Confidence 9999 5688888765543 4888899999999999999999988 89999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
..+. ....||+.|||||++. .+.|+-|+||||+|++..||.-.++|+...+....- ..+.......-.
T Consensus 176 ~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL----YHIAQNesPtLq 246 (948)
T KOG0577|consen 176 MAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPTLQ 246 (948)
T ss_pred cCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH----HHHHhcCCCCCC
Confidence 6543 3456899999999986 467999999999999999999999998765432211 112222222223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccccccc
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 587 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~~ 587 (589)
..+.++.+.+++..|+++-|.+|||.++++++--..++...+.|
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 56778899999999999999999999999998777776665543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.10 Aligned_cols=257 Identities=20% Similarity=0.326 Sum_probs=194.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++++|...+.||+|+||.||+|... ++..||+|++...........+.+|+.++++++|+||+++.+++.. .+..++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 4567888999999999999999865 6889999999765434444567889999999999999999999854 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+. ++|.+++.... ..+.+..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++
T Consensus 81 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred EEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEEcCCCcEEEecccccc
Confidence 999995 67877765432 23788888999999999999999987 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh----------
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF---------- 534 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---------- 534 (589)
....... ......++..|+|||.+.+. .++.++|||||||++|||+||+.||.........-......
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 152 AKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred ccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 5432211 11223357789999998754 47889999999999999999999996543211100000000
Q ss_pred --------hccccCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 535 --------IDRNLKGKFS---------ESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 535 --------~~~~~~~~~~---------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.......... ......+.+++.+|++.||++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000 0114567899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.55 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=199.9
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.. .+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4677889999999999999975 689999999976542 2334678999999999999999999999854 57889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+...
T Consensus 79 e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 79 EYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG-----IMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred ccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 999 999999987544 34899999999999999999999988 999999999999999999999999998876
Q ss_pred cCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh------------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------------ 534 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~------------ 534 (589)
............++..|+|||.+.+.. ++.++||||+|+++|||+||+.+|.+.............+
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 543211122345677899999986544 6899999999999999999987775433211111100000
Q ss_pred --------hccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 535 --------IDRNLKG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 535 --------~~~~~~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..+.... ...++....+.+++.+|++.+|++||++++++++-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 0000000 001123578899999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=297.00 Aligned_cols=249 Identities=20% Similarity=0.356 Sum_probs=209.5
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
|.+.+.||+|+||.||+|.++ .|++||||.+..+. ..++..+|+.+|++++.|++|+++|.|.. ....++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeehhh
Confidence 455688999999999999876 69999999988754 56789999999999999999999997743 3679999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
|-.|+..+.++.++. ++.+.+...++...++||+|||... -+|||||+.|||++.+|.+||+|||.+..+.+
T Consensus 110 CGAGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~~-----KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 110 CGAGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDLK-----KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred cCCCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHHH-----HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999999999987653 5999999999999999999999876 69999999999999999999999999988766
Q ss_pred CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (589)
... ......||+-|||||++..-.|+.++||||+|++..||..|++||.+-.... ..+.--..+.....-++..+.
T Consensus 182 TMA-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 182 TMA-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTFKKPEEWSS 257 (502)
T ss_pred hHH-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCCCChHhhhh
Confidence 433 3445678999999999999999999999999999999999999997643321 111111111112234677789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 550 KLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 550 ~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
++.++++.|+-+.|++|-|+.+++++-
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 999999999999999999999999873
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=296.08 Aligned_cols=250 Identities=22% Similarity=0.397 Sum_probs=200.6
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||++... +++.+|||.+..... ......+.+|++++++++|||++++++.+.. .+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4677889999999999999875 688999999875432 3345678999999999999999999998743 46889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfGla~~ 466 (589)
||+++++|.+++..... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++++ +.+||+|||.+..
T Consensus 79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 79 EYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred ecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 99999999999976532 34899999999999999999999988 9999999999999865 4679999999887
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ......+..
T Consensus 152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~ 224 (256)
T cd08220 152 LSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----VLKIMS-GTFAPISDR 224 (256)
T ss_pred cCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----HHHHHh-cCCCCCCCC
Confidence 654321 1223466789999999988899999999999999999999999865432111 111111 111122334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....+.+++..||+.+|++|||++|++++
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 56678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.06 Aligned_cols=252 Identities=21% Similarity=0.419 Sum_probs=201.2
Q ss_pred cCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC---CCCccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~l 385 (589)
.|+..+.||+|+||.||+|.. .+++.||+|.+..........++.+|+.++++++ |||++++++++.. ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 466678899999999999996 4789999999876554555667889999999997 9999999998854 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++... .+++...+.++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG-----VIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 99999999999998643 4899999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
....... ......++..|+|||.+.++ .++.++|||||||++|||++|+.||........ .. .+.........
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~-~~~~~~~~~~~ 223 (277)
T cd06917 150 LLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----MM-LIPKSKPPRLE 223 (277)
T ss_pred ecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----hh-ccccCCCCCCC
Confidence 7654331 12233567789999988754 468999999999999999999999965422111 00 01111111111
Q ss_pred H-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 545 E-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 545 ~-~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
. .....+.+++.+||+.||++||++.|++++-+..
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 224 DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence 1 2456789999999999999999999999876653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=302.88 Aligned_cols=253 Identities=15% Similarity=0.323 Sum_probs=200.8
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|...+.||+|++|.||++... +++.|++|++.... ......+.+|+.++++++||||+++++++.. .+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEe
Confidence 4555678999999999999864 78899999986543 3344568899999999999999999998854 478899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+....
T Consensus 97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 97 FLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG-----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 99999999998762 3889999999999999999999988 9999999999999999999999999887554
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......... .......+.. ......+
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~ 242 (285)
T cd06648 167 KEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLPPKL--KNLHKVS 242 (285)
T ss_pred cCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-HHHhcCCCCC--cccccCC
Confidence 3221 1122346778999999988889999999999999999999999986543221111 1111111111 1122245
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+.+++.+||+.+|++||++.+++++-...
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 273 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence 6899999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.48 Aligned_cols=255 Identities=20% Similarity=0.388 Sum_probs=195.4
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. ||||+++++++.. .+..+++||
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~e 83 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICME 83 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEEe
Confidence 444578999999999999875 689999999986554455678899999999996 9999999998854 467899999
Q ss_pred eCCCCChHHHhhhh-cCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 389 FAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 389 y~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|+.. ++.++.... ......+++....+++.+++.||+|||+. + |+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-----IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 9864 655543221 11123589999999999999999999975 5 99999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCcccccCC---CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc---cccC
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---RNLK 540 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~ 540 (589)
...... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ....... +.+.
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~ 232 (288)
T cd06616 158 LVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD---QLTQVVKGDPPILS 232 (288)
T ss_pred hccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH---HHhhhcCCCCCcCC
Confidence 543221 1223467789999998876 689999999999999999999999865431111 1111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.......+..+.+++.+||+.+|++||++.+++++-+.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 12223356789999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=303.41 Aligned_cols=253 Identities=21% Similarity=0.371 Sum_probs=199.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..|...+.||+|+||.||+|... +++.||+|.+..... .....++.+|++++++++||||++++++|.. .+..++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 45777889999999999999875 689999999864432 2333578899999999999999999999954 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.
T Consensus 93 v~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~-----i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 93 VMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE-----RIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred EHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEECCCCCEEEeecCcce
Confidence 999996 57777775433 24899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
...... ...++..|+|||++. .+.++.++||||||+++|||+||+.|+......... ...........
T Consensus 164 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~ 234 (307)
T cd06607 164 LVSPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNDSPTL 234 (307)
T ss_pred ecCCCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH----HHHhcCCCCCC
Confidence 654321 234567799999874 456889999999999999999999998654322111 11111111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.....+..+.+++.+||+.+|++||++.+++.+.+....
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 123456789999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.26 Aligned_cols=253 Identities=17% Similarity=0.250 Sum_probs=196.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||++... .++.|++|.+..... ......+.+|+++++.++||||+++++.+. ..+..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEE
Confidence 36778899999999999999976 578999999876532 233457889999999999999999999884 3468899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 79 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 79 VMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 999999999999996543 4889999999999999999999987 9999999999999999999999999986
Q ss_pred cccCCce--------------eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 466 LLADDIV--------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 466 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
....... .......++..|+|||.+....++.++|+||||+++||+++|..||.+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~---- 225 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF---- 225 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----
Confidence 4211100 0001123567899999998888999999999999999999999999754321111
Q ss_pred HHhhccccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHHHH
Q 007788 532 ENFIDRNLK-GKFSESEAAKLGKMALVCTHEDPENRPTM---EAVIEEL 576 (589)
Q Consensus 532 ~~~~~~~~~-~~~~~~~~~~l~~l~~~C~~~dp~~RPs~---~evl~~L 576 (589)
......... .......+..+.+++.+||+.+|++||++ .+++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 226 GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111111111 11112346678999999999999999985 5555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=297.45 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=201.6
Q ss_pred cCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
+|+..+.||+|++|.||+|.. .+++.||+|++...... .....+..|++++++++|+||+++++++. +.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence 367778999999999999986 47899999998754321 13467889999999999999999999984 45788
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEcccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCG 462 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG 462 (589)
++||||+++++|.+++.... ++++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~-----i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ-----IIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred EEEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEcccc
Confidence 99999999999999997543 4889999999999999999999988 99999999999998776 58999999
Q ss_pred ccccccCCceee---eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 463 LHKLLADDIVFS---VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 463 la~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
.+.......... .....++..|+|||.+.+..++.++||||+|+++|||++|..||........ ............
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~ 228 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASATT 228 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhccCC
Confidence 987765431110 1122456789999999888899999999999999999999999864321111 111111111122
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
....+......+.+++.+|++.+|++||++.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~ 265 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence 2344556678899999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=313.96 Aligned_cols=244 Identities=20% Similarity=0.257 Sum_probs=187.4
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc---CCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
||+|+||.||+|+.. +++.||||++..... ......+..|..++.+. +||||+++++++. ..+..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence 699999999999975 689999999864321 12233455677777665 6999999998884 357899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++.....
T Consensus 79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 79 SGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD-----IVYRDLKPENILLDATGHIALCDFGLSKANLTD 149 (330)
T ss_pred CCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence 9999999987543 3889999999999999999999988 999999999999999999999999998754322
Q ss_pred ceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (589)
.. ......++..|+|||.+.+. .++.++|||||||++|||+||+.||........ ...+....... .......
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~-~~~~~~~ 223 (330)
T cd05586 150 NK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFGKVRF-PKNVLSD 223 (330)
T ss_pred CC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcCCCCC-CCccCCH
Confidence 11 12234578899999998765 479999999999999999999999975432211 11111111111 1112356
Q ss_pred HHHHHHHHhcccCCCCCC----CHHHHHHHHH
Q 007788 550 KLGKMALVCTHEDPENRP----TMEAVIEELT 577 (589)
Q Consensus 550 ~l~~l~~~C~~~dp~~RP----s~~evl~~L~ 577 (589)
.+.+++.+|++.||.+|| ++.+++++-+
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 778999999999999998 6777777644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.18 Aligned_cols=254 Identities=16% Similarity=0.254 Sum_probs=196.8
Q ss_pred hccCccccccccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
..+|...+.||+|+||.||++... .+..||||.+.... .+.+|++++++++||||+++++++.. ....+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW--KSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee--CCEEE
Confidence 357889999999999999999754 35789999876432 35679999999999999999998843 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+. ++|.+++... ..++|..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 163 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g-----ivHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG-----IIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred EEehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEccCccc
Confidence 9999995 6888888433 24899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH---Hhhh-----------
Q 007788 465 KLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA---AESA----------- 529 (589)
Q Consensus 465 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~---~~~~----------- 529 (589)
......... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.+..... ....
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 766543221 1223457889999999999999999999999999999999999996432100 0000
Q ss_pred -----------hHHHhhccccCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 530 -----------TFENFIDRNLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 530 -----------~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.+... ....+.... ......+.+++.+|+..||++||++.|++.+-+..+
T Consensus 313 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 313 FPQNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cCCccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 00000 000010000 112456778999999999999999999999877654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=301.90 Aligned_cols=254 Identities=16% Similarity=0.311 Sum_probs=202.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. .+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEEE
Confidence 56778899999999999999864 68899999986543 3344678899999999999999999999854 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g-----i~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred ecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 999999999998653 3789999999999999999999988 999999999999999999999999988765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||.+....++.++||||||+++||+++|+.||.......... .. ..............
T Consensus 166 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~--~~~~~~~~~~~~~~ 241 (293)
T cd06647 166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI--ATNGTPELQNPEKL 241 (293)
T ss_pred ccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-eh--hcCCCCCCCCcccc
Confidence 43321 1122346678999999988889999999999999999999999996543211100 00 00111111122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+.+++..||+.+|++||++++++.+-+..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~ 273 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 56788999999999999999999999885543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.83 Aligned_cols=255 Identities=20% Similarity=0.376 Sum_probs=194.3
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||.|++|.||+|... +++.||||++..... ......+.+|++++++++||||+++++++. +.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence 4777889999999999999875 689999999875432 223357889999999999999999999984 356789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++...
T Consensus 79 e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 79 EFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred eccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 9996 689998876432 34899999999999999999999987 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH-------------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN------------- 533 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~------------- 533 (589)
..... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...............
T Consensus 151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 151 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 43211 111223567799999887644 588999999999999999999998653221111000000
Q ss_pred -h---hc--cccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 534 -F---ID--RNLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 534 -~---~~--~~~~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
. .. +..... ........+.+++.+|++.||++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 00 000000 001124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.75 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=197.5
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc----hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
+|+..+.||+|++|.||+|... +++.||||++...... .....+..|++++++++|+||+++++++.+ .+..+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 3667788999999999999975 6899999999765432 123457789999999999999999999854 57889
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+ +|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 79 lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~ 149 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW-----ILHRDLKPNNLLIASDGVLKLADFGLA 149 (298)
T ss_pred EEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCChhhEEEcCCCCEEEccceee
Confidence 999999 999999997543 24899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh---------
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF--------- 534 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------- 534 (589)
+....... ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|...............+
T Consensus 150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 150 RSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred eeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 86644321 1112234567999998865 457899999999999999999977775432211111110000
Q ss_pred --------hccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 535 --------IDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 535 --------~~~~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......... .......+.+++..||+.||++|||+.|++++=+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~ 285 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence 000000000 12235678899999999999999999999987443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=301.58 Aligned_cols=248 Identities=20% Similarity=0.312 Sum_probs=202.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|++|.||++... +++.||+|++..... ......+.+|++++++++||||+++++++.. .+..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 36778899999999999999976 689999999865321 2334678899999999999999999998854 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||++.
T Consensus 79 v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 79 VMEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred EEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 999999999999997653 4889999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......... ...+.
T Consensus 150 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~--~~~~~ 219 (290)
T cd05580 150 RVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGK--VRFPS 219 (290)
T ss_pred ccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCC--ccCCc
Confidence 76543 223346788999999988888999999999999999999999986543211 111122111 12333
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
.....+.+++.+||+.+|.+|+ +++|++++-+
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 4467889999999999999999 8888886644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.34 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=202.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC----CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|...+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++.+......
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46788899999999999999875 68999999875321 12334678899999999999999999998866555678
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++|+||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcccc
Confidence 89999999999999987543 3788899999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... .......++..|+|||++.+..++.++|||||||++|||++|+.||....... ...+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~ 228 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----AIFKIATQPTKP 228 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----HHHHHHcCCCCC
Confidence 876532110 01112346778999999998889999999999999999999999996542221 112222222233
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
..+......+.+++.+|++ +|..||+..+++.+
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 4456667889999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.58 Aligned_cols=259 Identities=19% Similarity=0.355 Sum_probs=208.2
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++.|+..+.||+|++|.||+|..+ ++..|++|++..... ....+.+|++.+++++|+|++++++++... +..++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence 4566777889999999999999987 688999999976542 456788999999999999999999998654 78999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|+||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 999999999999998754 24999999999999999999999987 9999999999999999999999999887
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC-CCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 544 (589)
....... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+......... .......... ...
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~ 239 (286)
T cd06614 165 QLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPPLKNP 239 (286)
T ss_pred hhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCCCCcch
Confidence 5543221 111223567899999998888999999999999999999999998643221111 1111111111 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+..+.+++.+|++.+|.+||++.+++++......+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 23567799999999999999999999999877665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.71 Aligned_cols=254 Identities=19% Similarity=0.368 Sum_probs=200.9
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
|...+.||+|+||.||+|... ++..||+|++..... ......+.+|++++++++|||++++++++.+ .+..++||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 104 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLVM 104 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEEE
Confidence 556688999999999999965 688999999875432 2334578899999999999999999999854 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||++ |+|.+.+.... ..++|..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++...
T Consensus 105 e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 105 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred eCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 9996 58888776443 24899999999999999999999988 999999999999999999999999998755
Q ss_pred cCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
... ....++..|+|||++. .+.++.++|||||||++|||++|+.||........ ...+..........
T Consensus 176 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~ 246 (317)
T cd06635 176 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPTLQS 246 (317)
T ss_pred CCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhccCCCCCC
Confidence 432 1234667899999974 45688999999999999999999999865422111 11222222222223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
......+.+++.+||+.+|.+||++.+++++++.......
T Consensus 247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 3456678999999999999999999999998877665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=295.66 Aligned_cols=252 Identities=18% Similarity=0.372 Sum_probs=201.1
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|...+.||+|+||.||+|..+ +|..||+|.+..... ....+.+.+|+.++++++|+||+++++++. ..+..++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence 4677889999999999999976 588999999876432 234457889999999999999999999884 357899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGla~~ 466 (589)
||+++++|.+++..... ..++|..+..++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||.+..
T Consensus 79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 79 EYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK-----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEcCCCCeEEecccccchh
Confidence 99999999999976432 34899999999999999999999988 99999999999999885 469999999876
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... ......++..|+|||+..+..++.++||||||+++|||++|+.||....... .......... ......
T Consensus 152 ~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~~~~~ 225 (257)
T cd08225 152 LNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----LVLKICQGYF-APISPN 225 (257)
T ss_pred ccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHhcccC-CCCCCC
Confidence 654321 1122346778999999988889999999999999999999999986432211 1112222111 122233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
....+.+++.+|++.+|++|||+.|++++-
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 456799999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=302.50 Aligned_cols=255 Identities=20% Similarity=0.373 Sum_probs=198.0
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||+|..+ +++.||||+++.... ......+.+|++++++++|+||+++++++.. .+..++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence 5788899999999999999976 588999999875432 3334678999999999999999999999854 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||++++.+..+.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++...
T Consensus 80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 80 EYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred ecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 999987776665432 23889999999999999999999988 999999999999999999999999998876
Q ss_pred cCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------HHhh-
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------ENFI- 535 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~----------~~~~- 535 (589)
............++..|+|||++.+. .++.++||||||+++|||++|+.||............. ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 54332122223456779999999888 78999999999999999999999886432211000000 0000
Q ss_pred -ccccCC--------------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 536 -DRNLKG--------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 536 -~~~~~~--------------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+....+ .++...+..+.+++..||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 0111236789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=302.33 Aligned_cols=257 Identities=17% Similarity=0.326 Sum_probs=198.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|..+ +++.+|+|.++..... .....+.+|+.++.+++||||+++++++...+.+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 45777889999999999999986 6889999999755322 223457789999999999999999999866555789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||++ ++|.+++..... .+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNW-----ILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCcEEEeecCceee
Confidence 99997 599998876432 4899999999999999999999988 99999999999999999999999999887
Q ss_pred ccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN------------ 533 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~------------ 533 (589)
...... ......++..|+|||.+.+.. ++.++|+||||+++|||++|+.||...............
T Consensus 156 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 156 YGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred ccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 654321 112234567799999887644 689999999999999999999998643221111100000
Q ss_pred --hh-----------ccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 534 --FI-----------DRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 534 --~~-----------~~~~~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+. ...+....+.. ....+.+++..|++.+|++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00001111111 35678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.01 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=206.6
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||++... +++.+|+|.+..... .....++.+|++++++++|+||+++++++.+ ....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4677889999999999999865 688999999875432 3345678899999999999999999998854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-----i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 999999999999775433456899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
.... .....++..|+|||...+..++.++|+||||+++|||++|+.||....... +...+........+...
T Consensus 154 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 225 (256)
T cd08530 154 KKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYKVQRGKYPPIPPIY 225 (256)
T ss_pred ccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCCCCCchhh
Confidence 5542 112346778999999999889999999999999999999999996543211 11112222233344567
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+.+++..|++.+|++||++.|++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 226 SQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 7889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=300.36 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=195.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccC-CCCccceeeeeecCCC---Ce
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGR---GE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~---~~ 382 (589)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.++++++ ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999975 6899999998754322 23356888999999995 6999999998854321 23
Q ss_pred EEEEEEeCCCCChHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEcc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIAD 460 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~D 460 (589)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEecCCCeEEEee
Confidence 7999999985 899888754332 346899999999999999999999988 999999999999998 89999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc--
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-- 537 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 537 (589)
||+++....... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||..................+
T Consensus 155 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 155 LGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred cccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999876533211 1112235677999998865 457899999999999999999999986543221111100000000
Q ss_pred ----------------ccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 538 ----------------NLKG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 538 ----------------~~~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.... ...+.....+.+++..|++.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0012245678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=296.33 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=201.7
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+|+..+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|++.+++++||||+++++++ .+....++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEEE
Confidence 4777899999999999999976 689999999975432 23457899999999999999999999988 345789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+||+++++|.+++... ..+++.....++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+..
T Consensus 79 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 79 VDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG-----IIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred EeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 9999999999999765 24889999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ...+...... .....+..
T Consensus 150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~~~~~~~~ 224 (258)
T cd05578 150 VTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQET-ADVLYPAT 224 (258)
T ss_pred cCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhcc-ccccCccc
Confidence 65432 1223446677999999998889999999999999999999999987543210 1111111111 22233445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTM--EAVIE 574 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~--~evl~ 574 (589)
.+..+.+++.+||+.||.+||++ +|+++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 56889999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.47 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=193.5
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|+..+.||+|+||.||+|... +++.||+|+++............+|+..+.++. |+|++++++++.+...+..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456688999999999999965 689999999876533333345567888898885 999999999986654478899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|++ |+|.+++.... ..++|..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++...
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG-----IFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 996 58888886543 24899999999999999999999988 999999999999999 999999999998764
Q ss_pred CCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh----------HHHhhcc
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------FENFIDR 537 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~----------~~~~~~~ 537 (589)
..... ....++..|+|||.+.. +.++.++|||||||++|||++|..||............ .......
T Consensus 151 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 151 SKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred cCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 33211 12345678999997654 55788999999999999999999999654321110000 0000000
Q ss_pred c--cCCCC-----------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 538 N--LKGKF-----------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 538 ~--~~~~~-----------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
. ..... ....+..+.+++.+|++.+|++||++++++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 0 00000 123467899999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.63 Aligned_cols=257 Identities=23% Similarity=0.408 Sum_probs=196.6
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|+..+.||+|++|.||+|... +++.+|+|++.... .......+.+|++++++++|||++++++++.....+..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999976 58999999998664 2233457889999999999999999999986543468999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~-----~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG-----ILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 9975 8988886542 24899999999999999999999987 9999999999999999999999999988765
Q ss_pred CCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh-----------c
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-----------D 536 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~ 536 (589)
...........++..|+|||.+.+ ..++.++||||||+++|||+||+.||................- +
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 432111222345667999997765 4578999999999999999999999865432111110000000 0
Q ss_pred ----cccC--C--------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 537 ----RNLK--G--------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 537 ----~~~~--~--------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.... . .....++..+.+++..|++.+|++||++.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 0000 0 00011256789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=293.68 Aligned_cols=247 Identities=18% Similarity=0.278 Sum_probs=200.0
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||.|++|.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.+ .+..++|+||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 689999999999976 589999999975432 2344678999999999999999999998843 46789999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~-----~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-- 147 (262)
T cd05572 79 ELWTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG-----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-- 147 (262)
T ss_pred cHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence 9999997643 3889999999999999999999987 9999999999999999999999999998765432
Q ss_pred eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......++..|+|||.+.+..++.++|+||||+++|||++|..||....... ......+.+.......+......+.+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKD 225 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHH
Confidence 1122345678999999988889999999999999999999999997553211 11122222222233344445778999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 554 MALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 554 l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
++..||+.+|++||+ ++|++++-+.
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 999999999999999 8888876554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.29 Aligned_cols=256 Identities=23% Similarity=0.413 Sum_probs=197.5
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||.|++|.||+|... +|..||||++...........+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence 4777899999999999999986 6899999999866544445677889999999999999999999854 467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++ +|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 79 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 79 YMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR-----VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred cCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 9985 89888865432 235899999999999999999999987 9999999999999999999999999987654
Q ss_pred CCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH-----------HHhhc
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-----------ENFID 536 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~-----------~~~~~ 536 (589)
.... ......++..|++||.+.+. .++.++|||||||++|||++|+.||.+........... ..+.+
T Consensus 152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 3211 11223456789999988654 47889999999999999999999986543211111100 00000
Q ss_pred -cccCCC-----------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 537 -RNLKGK-----------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 537 -~~~~~~-----------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+.+... ..+..+..+.+++..|++.||.+||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 012235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=290.27 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=207.2
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|+..+++++||||+++++.+.....+..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999987 789999999876542 24457889999999999999999999998654336789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.... .++|..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG-----IVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 9999999999997653 4899999999999999999999987 999999999999999999999999998876
Q ss_pred cCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...............+..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGSSGEPPEIPEH 228 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccccCCCcCCCcc
Confidence 544321 1123346678999999998889999999999999999999999996543111 111122211222334455
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
....+.+++.+|++.+|++||++.|++++-
T Consensus 229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 229 LSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred cCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 578899999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.12 Aligned_cols=255 Identities=18% Similarity=0.365 Sum_probs=197.1
Q ss_pred ccCccccccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|..++ ++.||||.++.........++..|+.++.+.. ||||++++++|.. ....++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEEE
Confidence 456677899999999999999874 89999999976544445566777887777775 9999999999854 4679999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|||++ ++|.+++..... .+++..+..++.|++.||+|||+. + |+||||+|+||++++++.+||+|||++.
T Consensus 93 ~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~~-----i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred eeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC-----EecCCCcHHHEEEcCCCCEEECccccch
Confidence 99985 477777655332 589999999999999999999974 5 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCC----CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC-
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK- 540 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 540 (589)
....... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .............
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 238 (296)
T cd06618 164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPS 238 (296)
T ss_pred hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCC
Confidence 6643321 12234567899999987654 788999999999999999999999653211 1111222222111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..........+.+++.+||+.||.+||++.+++++.+..
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 111113456789999999999999999999999887643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.17 Aligned_cols=262 Identities=22% Similarity=0.369 Sum_probs=200.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|+..+.||+|+||.||+|... +|+.||+|+++..... .....+.+|+.++.+++|+||+++++++.....+..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 356888899999999999999975 6899999998754322 22235678999999999999999999987655567899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF-----IIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECccceee
Confidence 999996 48988887543 34899999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH-----------H
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-----------N 533 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~-----------~ 533 (589)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 157 TYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred ecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 7653221 1122234667999999865 4578999999999999999999999965432211110000 0
Q ss_pred hhccc------cCCC-C------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 534 FIDRN------LKGK-F------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 534 ~~~~~------~~~~-~------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.+.. .... . .......+.+++..|++.||++|||+.|++++-+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 00000 0000 0 011356678999999999999999999999987764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=288.45 Aligned_cols=248 Identities=23% Similarity=0.425 Sum_probs=201.2
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++.+++++|+|++++++++.. .+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEe
Confidence 3667789999999999999986 689999999976543 355689999999999999999999998854 367899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.++|+|||.+....
T Consensus 78 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 78 FCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred cCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC-----EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 999999999987653 24899999999999999999999987 9999999999999999999999999988765
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC--HH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--ES 546 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 546 (589)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... .... ....... ..
T Consensus 150 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~ 222 (253)
T cd05122 150 DTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF----KIAT-NGPPGLRNPEK 222 (253)
T ss_pred cccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH----HHHh-cCCCCcCcccc
Confidence 4321 123346677999999998889999999999999999999999986542111100 0000 1111111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....+.+++.+|++.||++|||+.|++++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 25679999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.71 Aligned_cols=258 Identities=20% Similarity=0.333 Sum_probs=197.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++++ +||||+++++++...+....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456778889999999999999976 68899999886432 223345677899999999 999999999998655556789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||++ ++|.+++... .++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~-----i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN-----VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 9999997 5999888653 3889999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCcee----eeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh----------
Q 007788 465 KLLADDIVF----SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---------- 529 (589)
Q Consensus 465 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~---------- 529 (589)
......... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 866432211 1122346778999998765 4578899999999999999999999864321110000
Q ss_pred ---------hHHHhhccccC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 530 ---------TFENFIDRNLK------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 530 ---------~~~~~~~~~~~------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
....+++.... ..........+.+++..||+.||++|||+.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 00011110000 000112356789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.37 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=194.3
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|+..+.||.|++|.||+|... +|..||+|++...... .....+.+|++.+++++|||++++++++.. .+..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 456788999999999999875 7999999998755322 223568899999999999999999999854 478999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|++ ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 79 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 79 FLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred ccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 995 699999876542 34899999999999999999999987 9999999999999999999999999987654
Q ss_pred CCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH---------------
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--------------- 532 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------------- 532 (589)
.... ......++..|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 151 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 151 VPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred CCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 3211 11122346779999988664 478899999999999999999999864322111000000
Q ss_pred --Hhhccc--cC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 533 --NFIDRN--LK----GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 533 --~~~~~~--~~----~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+..... .. ..........+.+++.+|++.||++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00 00112234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=306.92 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=196.8
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC---CCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~ 383 (589)
+++|...+.||+|+||.||+|... +|+.||+|++...........+.+|+.++++++||||+++++++.... ....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467888999999999999999864 689999999875433444567889999999999999999999875432 2357
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++|+||+++ +|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEECcccc
Confidence 999999964 888777543 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceee--eecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh-----------h
Q 007788 464 HKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-----------A 529 (589)
Q Consensus 464 a~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-----------~ 529 (589)
+.......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 87654322111 112346778999998754 468999999999999999999999986432111000 0
Q ss_pred hHHHhhccc-------c--CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 530 TFENFIDRN-------L--KGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 530 ~~~~~~~~~-------~--~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+.+.. . .... .+.....+.+++.+||+.||++||++.|++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 011101000 0 0000 0123466889999999999999999999998843
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.49 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=205.4
Q ss_pred HHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
....+.|...++||+|+||.||-++.+ +|+.+|.|.+.+... +..+.-.++|-.+|.++..+.||.+--.+ ++.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd 258 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKD 258 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCC
Confidence 334577888999999999999999876 699999999876543 23345677899999999999999985444 5678
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++|+..|.||||.-+|...+. ..+++.+.+.+|.+|+.||++||... ||+|||||+|||||+.|+++|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~-----iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR-----IVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc-----eeeccCChhheeeccCCCeEeecc
Confidence 89999999999999999987654 34999999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
|+|..+..... .....||.||||||++.++.|+...|+||+||++|||+.|+.||.....-..+. .++..+- ....
T Consensus 332 GLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-Evdrr~~-~~~~ 407 (591)
T KOG0986|consen 332 GLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-EVDRRTL-EDPE 407 (591)
T ss_pred ceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-HHHHHHh-cchh
Confidence 99998876543 234479999999999999999999999999999999999999996543322111 1111111 1122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTME 570 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ 570 (589)
++++..+++...+....++.||++|...+
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 45566677788888888999999997554
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=295.60 Aligned_cols=251 Identities=20% Similarity=0.346 Sum_probs=209.4
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|...+.||+|.|..|-+|+.- .|..||||++.+... ......+.+|++-|+-++|||||++|.+. +.+...|+|.|
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLiLE 97 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLILE 97 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEEEE
Confidence 344467999999999999853 799999999987643 33346788999999999999999999987 55678999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee-cCCCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI-DQQFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill-~~~~~~kl~DfGla~~~ 467 (589)
.-++|+|++|+-++.. -+.+....+++.||+.|+.|+|..+ +|||||||+||.+ ..-|-+||.|||++..+
T Consensus 98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH-----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH-----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh-----hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999987653 3888999999999999999999998 9999999999966 56688999999999877
Q ss_pred cCCceeeeecCCccccccCcccccCCCCC-CcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
.++. ......|+..|.|||.+.+..|+ +++||||+|||||-|++|+.||...++ ...+..++|-.+ ..+.-
T Consensus 170 ~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----SETLTmImDCKY--tvPsh 241 (864)
T KOG4717|consen 170 QPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----SETLTMIMDCKY--TVPSH 241 (864)
T ss_pred CCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----hhhhhhhhcccc--cCchh
Confidence 6543 33345677889999999999985 579999999999999999999976554 234445555433 35677
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+..+++..|+..||.+|.+.++|+..-|-.
T Consensus 242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred hhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 788899999999999999999999999876643
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=295.46 Aligned_cols=248 Identities=18% Similarity=0.274 Sum_probs=190.3
Q ss_pred ccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHH---HhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 316 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYL---LTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~---l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
+||+|+||.||++... +++.||+|.+...... .....+.+|..+ +...+||||+.+.+++.. .+..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999975 6899999998754322 222334445433 334479999999988844 4678999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|+|.+++.... .++|.....++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 79 ~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 79 MNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 99999999987543 4899999999999999999999988 99999999999999999999999999875543
Q ss_pred CceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
.. .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......... ..... ........+....
T Consensus 150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~-~~~~~~~~~~~~~ 223 (279)
T cd05633 150 KK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM-TLTVNVELPDSFS 223 (279)
T ss_pred cC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHH-hhcCCcCCccccC
Confidence 21 122357888999998864 55899999999999999999999999643211100 11111 1111223344566
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhh
Q 007788 549 AKLGKMALVCTHEDPENRP-----TMEAVIEELTVAA 580 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~~ 580 (589)
..+.+++..|++.||++|| +++|++++.+...
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 7889999999999999999 6999998866543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=288.12 Aligned_cols=253 Identities=19% Similarity=0.384 Sum_probs=205.7
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|...+.||+|+||.||++... ++..|++|++..... .....++.+|++++++++|||++++++.+.. .+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 4677789999999999999976 689999999976543 2455678899999999999999999998854 37889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++.........+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHHeEEcCCCcEEECCccceeec
Confidence 999999999999875433356999999999999999999999987 999999999999999999999999998876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||...+..++.++||||+|+++|+|++|+.||....... ........ .....+...
T Consensus 154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~ 227 (258)
T cd08215 154 SSTVD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKG-QYPPIPSQY 227 (258)
T ss_pred ccCcc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcC-CCCCCCCCC
Confidence 54431 1122346677999999988889999999999999999999999986542111 11111111 122233355
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+.+++.+||..+|++||++.+++++
T Consensus 228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 228 SSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 6788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.27 Aligned_cols=258 Identities=18% Similarity=0.312 Sum_probs=198.6
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----C
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----R 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~ 380 (589)
..++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467889999999999999999975 789999999865322 233456788999999999999999999875332 2
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...++||||+. ++|.+.+... +++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEcc
Confidence 35799999995 5888877532 788889999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh----------
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT---------- 530 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~---------- 530 (589)
||+++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999987654321 12234677899999999999999999999999999999999998643211110000
Q ss_pred --------HHHhhcccc---------------CC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 531 --------FENFIDRNL---------------KG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 531 --------~~~~~~~~~---------------~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.....+... .. .........+.+++.+|++.||++|||+.|++++-+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 000000000 00 0011235678899999999999999999999988643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=294.95 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=195.1
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||+|+||+||+|... +|+.||+|.+..... ......+..|++++++++||||+++++++.. .+..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 689999999999865 689999999875432 2234567789999999999999999988843 46889999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 149 (277)
T cd05577 79 DLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-- 149 (277)
T ss_pred cHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--
Confidence 99999976542 34899999999999999999999988 9999999999999999999999999987654321
Q ss_pred eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......++..|+|||++.+..++.++||||||+++|||++|+.||.......... .+..... ......+......+.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRTL-EMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHhccc-cccccCCccCCHHHHH
Confidence 1122345678999999988889999999999999999999999996543211100 1111111 1111233345677899
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 554 MALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 554 l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
++..||+.+|++|| ++.+++.+-+.
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 99999999999999 77778766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.49 Aligned_cols=260 Identities=18% Similarity=0.327 Sum_probs=197.1
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---- 379 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---- 379 (589)
...++|+..+.||+|+||.||+|..+ +|+.||+|+++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888899999999999999986 589999999975432 233356788999999999999999999885432
Q ss_pred ----CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 380 ----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 380 ----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
....++|+||+++ ++...+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN-----FLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCc
Confidence 2378999999976 7777776442 24899999999999999999999987 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRL 233 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHH
Confidence 9999999988765432211122234567999998765 35788999999999999999999999653221110 000000
Q ss_pred hc------------cccC-------------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 535 ID------------RNLK-------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 535 ~~------------~~~~-------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.. .... .......+..+.+++..||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000 00011235678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.26 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=195.4
Q ss_pred cCccccccccCCCccEEEEEec---CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.|...+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++.+++||||+++++++.+...+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667788999999999999975 47899999998632 122235678899999999999999999999765557899
Q ss_pred EEEEeCCCCChHHHhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC----CCceEEc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSS-NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ----QFNPLIA 459 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~----~~~~kl~ 459 (589)
+||||+++ +|.+++....... ..+++...+.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-----VLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEEcCCCCccceEEEC
Confidence 99999975 7777775443222 25889999999999999999999988 999999999999999 9999999
Q ss_pred cccccccccCCce--eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHH-----HhhhhH
Q 007788 460 DCGLHKLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATF 531 (589)
Q Consensus 460 DfGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-----~~~~~~ 531 (589)
|||++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .....+
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9999887643321 112233457789999987764 57899999999999999999999986432211 000000
Q ss_pred H------------------------HhhccccCCCCC-----H------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 532 E------------------------NFIDRNLKGKFS-----E------SEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 532 ~------------------------~~~~~~~~~~~~-----~------~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
. ...+.......+ . .....+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000000000111 0 234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.19 Aligned_cols=256 Identities=20% Similarity=0.345 Sum_probs=192.8
Q ss_pred cccccC--CCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
..||+| +||+||+++.. +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.. .+..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 346766 89999999975 799999999876542 2334678899999999999999999999854 46789999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+......
T Consensus 82 ~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 82 AYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG-----YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred cCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 99999999876532 24889999999999999999999987 999999999999999999999999865432211
Q ss_pred ce-ee-----eecCCccccccCcccccCC--CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH----------
Q 007788 471 IV-FS-----VLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------- 532 (589)
Q Consensus 471 ~~-~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~---------- 532 (589)
.. .. .....++..|+|||++.+. .++.++|||||||++|||++|+.||..............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 10 00 0011234569999998764 478999999999999999999999965422111000000
Q ss_pred -------------------------------HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 533 -------------------------------NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 533 -------------------------------~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+..............+.+++.+||+.||++|||+.|++++-+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00001111122334567889999999999999999999999886643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=276.22 Aligned_cols=246 Identities=18% Similarity=0.366 Sum_probs=195.3
Q ss_pred ccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
...||.|..|.|++++.+ .|..+|||.+.....+.+.+..+..++++.... .|+||+.+||+... ..+++.||.|.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~IcMelMs 174 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFICMELMS 174 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHHHHHHH
Confidence 456999999999999976 589999999998877777778888888877765 89999999999654 56889999984
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
..++.+|....+ ++++...=++...+.+||.||-+++. |+|||+||+|||+|+.|++|++|||++..+.+..
T Consensus 175 -~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH~----viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 175 -TCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred -HHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhcc----eeecccCccceEEccCCCEEeecccccceeeccc
Confidence 356666655443 48887778899999999999998774 9999999999999999999999999998876654
Q ss_pred eeeeecCCccccccCcccccC---CCCCCcchhhhHHHHHHHHHhCCCCcchh-HHHHHhhhhHHHhhccccC-CCCCHH
Q 007788 472 VFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSS-MRLAAESATFENFIDRNLK-GKFSES 546 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~ 546 (589)
. .....|-+.|||||.+.- .+|+.++||||||+.|+||.||+.||..- .+... +..+++.... ......
T Consensus 247 A--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~----ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 247 A--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV----LTKVLNEEPPLLPGHMG 320 (391)
T ss_pred c--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH----HHHHHhcCCCCCCcccC
Confidence 3 234556778999999864 46899999999999999999999999752 22211 2222221111 111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.+..+.+++..|+++|+.+||...+++++
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 56789999999999999999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=293.77 Aligned_cols=248 Identities=16% Similarity=0.333 Sum_probs=196.8
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
..||+|+||.||++..+ +++.||||++.... ......+.+|+.++++++|+||+++++++.. .+..++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCC
Confidence 56999999999999875 78999999986543 3445678999999999999999999998854 47899999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++... .+++.....++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 103 ~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g-----ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 103 ALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred cHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 999987532 3789999999999999999999988 99999999999999999999999998876543221
Q ss_pred eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......++..|+|||.+.+..++.++||||||+++|||++|..||........ ...........+. ........+.+
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~l~~ 248 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPPKLK--NLHKVSPSLKG 248 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhCCcccC--CcccCCHHHHH
Confidence 11223467789999999888899999999999999999999999865322111 0111111111111 11234556889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 554 MALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 554 l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
++.+|++.+|.+||++.+++++=+..
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~ 274 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLA 274 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHh
Confidence 99999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=293.72 Aligned_cols=258 Identities=15% Similarity=0.158 Sum_probs=183.6
Q ss_pred ccCccccccccCCCccEEEEEecC----CcEEEEEEeccCCCchH----------HHHHHHHHHHHhccCCCCccceeee
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSE----------EAEFVKGLYLLTSLRHENIIRLRGF 374 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~----------~~~~~~e~~~l~~l~H~niv~l~g~ 374 (589)
++|.+.+.||+|+||.||+|...+ +..+|+|.......... ......+...+..+.|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578888999999999999999764 35566665433221110 0122334455667789999999987
Q ss_pred eecCCCC--eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 375 CCSRGRG--ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 375 ~~~~~~~--~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+...... ..++++|++.. ++.+.+.... ..++.....|+.|++.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDiKp~Nill~~ 161 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDG 161 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcC
Confidence 6433221 34677887643 6666654332 2567888999999999999999987 999999999999999
Q ss_pred CCceEEccccccccccCCce------eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH
Q 007788 453 QFNPLIADCGLHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 526 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~ 526 (589)
++.++|+|||+++.+..... .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999986642211 011223578899999999999999999999999999999999999965421110
Q ss_pred -hhhhHHHhhccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 527 -ESATFENFIDRNLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 527 -~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
......+++.....+. .....+..+.+++..|++.+|++||++.++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000011111111111 1223457799999999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=295.98 Aligned_cols=254 Identities=20% Similarity=0.375 Sum_probs=199.0
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.|+..+.||+|+||.||+|... ++..||+|.+.... ......++.+|+++++.++|+|++++++++.. ....++|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 93 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEEE
Confidence 3556678999999999999975 67899999986432 12334578899999999999999999999854 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+. |++.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 94 ~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 94 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHhEEECCCCcEEECCccccee
Confidence 99996 68888776443 24889999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
..... ...++..|+|||.+. .+.++.++|||||||++|||++|+.|+........ .............
T Consensus 165 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~ 235 (308)
T cd06634 165 MAPAN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPALQ 235 (308)
T ss_pred ecCcc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH----HHHHhhcCCCCcC
Confidence 54321 234667899999874 35678899999999999999999999865322111 1111111111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.......+.+++.+||+.+|++||++.+++++.+......
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 3345677899999999999999999999999887665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.10 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=198.7
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-C-----CCccceeeeeecCCCCe
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-H-----ENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~g~~~~~~~~~ 382 (589)
+|.+.++||+|.||.|-+|... +++.||||+++.. +.-..+-..|+.+|..++ | -|+|++++|+.. ++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccc
Confidence 7888999999999999999965 6999999999875 345567778999999996 3 499999999954 589
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC--CceEEcc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ--FNPLIAD 460 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~--~~~kl~D 460 (589)
.+||+|.+.. +|.+++...... .++......|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|
T Consensus 263 lciVfELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l~-----IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHELG-----IIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCChhheeeccCCcCceeEEe
Confidence 9999999954 999999877543 4899999999999999999999988 9999999999999653 4789999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh-----------
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----------- 529 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~----------- 529 (589)
||.|........ ...-+.-|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+...-..
T Consensus 335 FGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 335 FGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 999987765433 12233459999999999999999999999999999999877765422110000
Q ss_pred ------hHHHh--------------------------------hccccCC--------CCCHHHHHHHHHHHHHhcccCC
Q 007788 530 ------TFENF--------------------------------IDRNLKG--------KFSESEAAKLGKMALVCTHEDP 563 (589)
Q Consensus 530 ------~~~~~--------------------------------~~~~~~~--------~~~~~~~~~l~~l~~~C~~~dp 563 (589)
....+ .+....+ ......-..+.+++.+|+..||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 00000 0000000 0011335668999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 007788 564 ENRPTMEAVIEELTV 578 (589)
Q Consensus 564 ~~RPs~~evl~~L~~ 578 (589)
.+|+|..|+++|-+.
T Consensus 491 ~~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 491 AERITPAQALNHPFL 505 (586)
T ss_pred hhcCCHHHHhcCccc
Confidence 999999999988654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=293.53 Aligned_cols=253 Identities=19% Similarity=0.295 Sum_probs=195.8
Q ss_pred cCccccccccCCCccEEEEEe----cCCcEEEEEEeccCCC---chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCC
Q 007788 310 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 381 (589)
+|+..+.||+|+||.||++.. .+|..||+|++..... ......+.+|++++.++ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 366778999999999999986 3689999999875321 22345678899999999 59999999988743 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEECCCCCEEEeeC
Confidence 7899999999999999997543 3788899999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCC--CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
|++...............++..|+|||.+... .++.++||||||+++|||++|+.|+...................
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 99887644322222234467789999998753 46789999999999999999999986422111111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEE 575 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~ 575 (589)
....+......+.+++.+|++.||++|| ++++++.+
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1123344567789999999999999997 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.19 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=195.5
Q ss_pred cCccccccccCCCccEEEEEec----CCcEEEEEEeccCCC---chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCC
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 381 (589)
+|+..+.||+|++|.||++... +++.||||.++.... ......+.+|+.++.++ +||||+++++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 3667789999999999999853 578899999874321 12335688999999999 5999999998874 346
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++|+|.+++.... .+++.....++.|+++||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLG-----IIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEEEC
Confidence 7899999999999999987542 4889999999999999999999987 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCC--CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
|+++..............++..|+|||.+.+.. .+.++||||||+++|||++|..||...................
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence 998765433221222234677899999987665 7889999999999999999999985322111111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+......+.+++.+||+.+|++|||+.++.+.|.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 12233345567889999999999999999776655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=293.65 Aligned_cols=259 Identities=20% Similarity=0.339 Sum_probs=194.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|++|.||+|... +|+.||+|.+..... ......+.+|++++++++||||+++++++.. .+..++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 46788899999999999999976 689999999865432 2233568899999999999999999999854 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHK 465 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGla~ 465 (589)
|||++ ++|.+++..... ..+++.....++.||+.||+|||+.+ ++||||||+||+++. ++.+||+|||++.
T Consensus 80 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dl~p~nill~~~~~~~kl~dfg~~~ 151 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (294)
T ss_pred Eeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCcceEEEECCCCEEEEccccccc
Confidence 99996 588888754432 23678888899999999999999987 999999999999985 5678999999997
Q ss_pred cccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH-------Hhh--
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-------NFI-- 535 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~-------~~~-- 535 (589)
....... ......++..|+|||++.+. .++.++||||||+++|||+||+.||............+. ...
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 152 AFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred ccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 6543211 11123456789999988664 578999999999999999999999965422111111000 000
Q ss_pred --------c--cccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 536 --------D--RNLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 536 --------~--~~~~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
. +..... ..+.....+.+++.+|++.+|++||++.+++++-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~ 287 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence 0 000000 011234568899999999999999999999987554
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.67 Aligned_cols=250 Identities=19% Similarity=0.247 Sum_probs=191.5
Q ss_pred HHHHhhccCcccccc--ccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 303 EVESATQCFSEVNLL--GKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 303 ~l~~~~~~f~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
+.....++|+..+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++.+..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEec-
Confidence 334445566676666 99999999999865 688899999865421111 12122112 79999999999854
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceE
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPL 457 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~k 457 (589)
.+..++||||+++++|.+++.... .++|..+..++.|+++||+|||+.+ ++||||||+||+++.++ .++
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN-----IIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEeCCCCeEE
Confidence 468999999999999999997653 4899999999999999999999988 99999999999999998 999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|+|||++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||............+......
T Consensus 151 l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (267)
T PHA03390 151 LCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK 225 (267)
T ss_pred EecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc
Confidence 99999987654332 2346778999999999899999999999999999999999997432211111111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHH
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPT-MEAVIEEL 576 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L 576 (589)
. .......+..+.+++..|++.+|.+||+ ++|++++-
T Consensus 226 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 226 K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 1 1223356678999999999999999995 69998753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.94 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=197.4
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|...+.||+|++|.||+|... +++.+++|++...... .....+..|++++++++|+||+++++++.. .+..++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 455678999999999999875 7899999998765432 345678899999999999999999999854 478999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||.+....
T Consensus 79 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 79 FMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG-----ILHRDLKPENLLINTEGVLKLADFGLARSFG 149 (283)
T ss_pred ccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence 9975 8888887643 24899999999999999999999988 9999999999999999999999999987765
Q ss_pred CCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH-----------hhc
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-----------FID 536 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-----------~~~ 536 (589)
.... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||............... +.+
T Consensus 150 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 150 SPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred CCcc-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 4331 11223456679999998876 7899999999999999999999998643321111000000 000
Q ss_pred ---------cccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 537 ---------RNLK----GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 537 ---------~~~~----~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
+... ....+.....+.+++..||+.||.+||++.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 0000 011123567899999999999999999999998753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.19 Aligned_cols=252 Identities=18% Similarity=0.317 Sum_probs=196.3
Q ss_pred cCccccccccCCCccEEEEEecC-CcEEEEEEeccCC----CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
+|...+.||+|+||.||++.... +..+++|.++... ......++..|+.++++++||||+++++++.. .+..+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 46777899999999999998753 4445555554321 12334467788999999999999999998843 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.++|+|||++
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-----ILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCChhheEeec-CCEeecccCce
Confidence 999999999999999764444456999999999999999999999988 999999999999986 56999999998
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
........ ......++..|+|||...+..++.++|+||||+++|+|++|..|+........ ...... ......+
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~ 226 (260)
T cd08222 153 RLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV----VLRIVE-GPTPSLP 226 (260)
T ss_pred eecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHc-CCCCCCc
Confidence 76643321 11223467789999999888889999999999999999999999864332111 111111 1222334
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
......+.+++.+||+.+|++||++.|++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 5667789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=284.31 Aligned_cols=249 Identities=23% Similarity=0.406 Sum_probs=202.5
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+|+..+.||+|++|.||++... +++.|++|.+...... .....+.+|++++++++|||++++++++.+ .+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 3667789999999999999875 6789999999766431 345679999999999999999999998854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+...
T Consensus 79 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 79 EYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG-----VIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred ecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEECCCCCEEEeccccceec
Confidence 999999999998755 24899999999999999999999988 999999999999999999999999998876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...... .....++..|+|||...+..++.++||||+|+++|||++|+.|+......... .... .......+...
T Consensus 150 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~ 223 (254)
T cd06627 150 NDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----FRIV-QDDHPPLPEGI 223 (254)
T ss_pred CCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHh-ccCCCCCCCCC
Confidence 543221 12234677899999998888899999999999999999999998654321111 1111 11122233445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+.+++.+|+..+|++||++.+++.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 6788999999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=289.07 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=192.6
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||+|+||.||+++.. +|+.|++|.+..... ......+.+|++++.+++||||+++++.+. ..+..++||||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence 689999999999987 489999999875432 234567889999999999999999998874 357889999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce-
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV- 472 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 472 (589)
+|.+++.... .+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 79 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 79 DLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG-----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC-----eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 9999997643 4899999999999999999999988 99999999999999999999999999875433211
Q ss_pred ------eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 473 ------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 473 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
.......++..|+|||......++.++||||||+++||+++|..||....... .................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 225 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IFQNILNGKIEWPEDVE 225 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCcCCCcccc
Confidence 01122345677999999988889999999999999999999999986543211 11112111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTM---EAVIEE 575 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~---~evl~~ 575 (589)
.+..+.+++..|++.+|++|||+ .+++++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 26788999999999999999999 555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=291.30 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=194.2
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|...+.||+|++|.||+|... +++.|+||++.............+|+..+.+++ ||||+++++++.. .+..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 456788999999999999986 578999999876543333445667999999999 9999999999854 578999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+ +|+|.+++.... ...++|..++.++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 79 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 79 YM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG-----FFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred cC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 99 889999987654 234899999999999999999999988 9999999999999999999999999988664
Q ss_pred CCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh-----------------
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------------- 530 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~----------------- 530 (589)
.... .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||............
T Consensus 151 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 151 SRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred CCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 4321 122345677999998754 45789999999999999999999988543221110000
Q ss_pred HHHhhccccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 531 FENFIDRNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 531 ~~~~~~~~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....++..... .........+.+++..||+.+|++||+++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0001124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=289.46 Aligned_cols=255 Identities=20% Similarity=0.352 Sum_probs=193.0
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcc---CCCCccceeeeeecCCC---Ce
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRGR---GE 382 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~---~~ 382 (589)
|+..+.||+|+||.||+|+.+ +++.||+|++...... .....+.+|+.++.++ +|||++++++++...+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999987 4899999999754322 2234566777766655 69999999999865422 13
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.+++|||+++ +|.+++..... ..++|..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~-----i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR-----IVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhEEEccCCCEEEeccC
Confidence 8999999974 89998875432 24899999999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh--------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-------- 534 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-------- 534 (589)
.+........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||................
T Consensus 153 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 153 LARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred cceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 9877643321 122335677999999999899999999999999999999998886543221111111100
Q ss_pred ----------hccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 535 ----------IDRNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 535 ----------~~~~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....... .........+.+++.+||+.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 0012335677899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.14 Aligned_cols=265 Identities=16% Similarity=0.214 Sum_probs=187.6
Q ss_pred hccCccccccccCCCccEEEEEecC--CcEEEEEEe--------------cc--CCCchHHHHHHHHHHHHhccCCCCcc
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSI--------------NV--TSCKSEEAEFVKGLYLLTSLRHENII 369 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l--------------~~--~~~~~~~~~~~~e~~~l~~l~H~niv 369 (589)
.++|...+.||+|+||.||++..+. +..+++|.+ .. .........+.+|+.++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987642 222222211 00 01122345688999999999999999
Q ss_pred ceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCe
Q 007788 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV 448 (589)
Q Consensus 370 ~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Ni 448 (589)
++++++.. .+..++|+|++. ++|.+++...... ...........|+.||+.||+|||+.+ |+||||||+||
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-----IiHrDLKP~NI 298 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-----LIHRDIKLENI 298 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHE
Confidence 99999854 467899999984 5777777543211 112335566789999999999999988 99999999999
Q ss_pred eecCCCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcch-hHHH--H
Q 007788 449 LIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS-SMRL--A 525 (589)
Q Consensus 449 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~-~~~~--~ 525 (589)
|++.++.+||+|||+++.+............++..|+|||++.+..++.++|||||||++|||++|..++.. .... .
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999987654332222334578899999999999999999999999999999999865432 1100 0
Q ss_pred Hhh-----------------hhHHHhhccccCCCC----C-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 526 AES-----------------ATFENFIDRNLKGKF----S-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 526 ~~~-----------------~~~~~~~~~~~~~~~----~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
... ..+.+.++....... + ......+.+++.+|++.||.+|||+.|++.+-+..
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 000 000111110000000 0 01134567788999999999999999999887654
Q ss_pred h
Q 007788 580 A 580 (589)
Q Consensus 580 ~ 580 (589)
.
T Consensus 459 ~ 459 (501)
T PHA03210 459 A 459 (501)
T ss_pred c
Confidence 3
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.33 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=202.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 384 (589)
++|...+.||+|++|.||+|... +++.||+|++..... ......+..|.+++.+++ ||||+++++++. ..+..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence 36778889999999999999976 789999999875322 233467889999999998 999999999884 457889
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++
T Consensus 79 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~-----~~H~dl~~~ni~i~~~~~~~l~df~~~ 149 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG-----IIHRDLKPENILLDKDMHIKITDFGTA 149 (280)
T ss_pred EEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEecCCccc
Confidence 9999999999999997653 4999999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCce-------------------eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH
Q 007788 465 KLLADDIV-------------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 525 (589)
Q Consensus 465 ~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~ 525 (589)
........ .......++..|+|||...+..++.++||||||++++|+++|+.||.......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 86644321 11112235678999999988889999999999999999999999997543211
Q ss_pred HhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 007788 526 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTM----EAVIEE 575 (589)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~----~evl~~ 575 (589)
.+..... .....+...+..+.+++..|++.+|.+||++ ++++++
T Consensus 230 ----~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 ----TFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ----HHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1122221 1222344456789999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=300.23 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=191.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~ 382 (589)
++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.... ...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 68888999999999999999965 689999999875322 223356889999999999999999999875432 135
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 95 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG-----IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred EEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCC
Confidence 6899999964 7766642 13889999999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------- 531 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~---------- 531 (589)
+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 163 LARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 987654321 12345667999999876 458899999999999999999999997542211100000
Q ss_pred ---------HHhhcc--cc-CCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 532 ---------ENFIDR--NL-KGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 532 ---------~~~~~~--~~-~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...... .. .... .+.....+.+++.+|++.||++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00 0000 01234568899999999999999999999977
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.65 Aligned_cols=258 Identities=17% Similarity=0.331 Sum_probs=192.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC------C
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~ 380 (589)
++|+..+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++||||++++++|.... .
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999975 689999999865432 222345678999999999999999999885432 2
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...++||||+. ++|.+++.... ..+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK-----ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEECCCCcEEECc
Confidence 35699999996 48888876543 24899999999999999999999987 99999999999999999999999
Q ss_pred ccccccccCCcee---eeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh-
Q 007788 461 CGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI- 535 (589)
Q Consensus 461 fGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~- 535 (589)
||++......... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.......... .+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~ 241 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCG 241 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhC
Confidence 9998766432211 111223567799999886644 7889999999999999999999886543211100 000000
Q ss_pred ----------------cc-ccCCCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 536 ----------------DR-NLKGKF---------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 536 ----------------~~-~~~~~~---------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
+. ...... +......+.+++.+|++.||++|||++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 00 000000 001134567899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.22 Aligned_cols=254 Identities=15% Similarity=0.257 Sum_probs=189.6
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccC-CCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVT-SCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
+.+|.|+++.||++.. +++.||||++... ........+.+|++++++++||||+++++++.. .+..+++|||+++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~ 84 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYG 84 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCC
Confidence 3344555555555544 6899999999765 234455689999999999999999999998854 46789999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce-
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV- 472 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 472 (589)
+|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~-----ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG-----FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 99999986532 24888899999999999999999988 99999999999999999999999998865432111
Q ss_pred -----eeeecCCccccccCcccccCC--CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH----Hhhc-----
Q 007788 473 -----FSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----NFID----- 536 (589)
Q Consensus 473 -----~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~----~~~~----- 536 (589)
.......++..|+|||.+... .++.++|||||||++|||++|+.||.............. ..++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 011122355679999998763 588999999999999999999999975322111000000 0000
Q ss_pred ---------------c----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 537 ---------------R----NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 537 ---------------~----~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
. .............+.+++..||+.||++|||+++++++-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 0 00011123345678899999999999999999999988664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.05 Aligned_cols=244 Identities=20% Similarity=0.253 Sum_probs=187.6
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHH-HhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYL-LTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|... +++.||||.+..... ......+..|..+ ....+|+|++++++++.. .+..++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 46899999999999875 689999999875432 1122334455444 445589999999999843 46899999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 80 ~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 150 (260)
T cd05611 80 NGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG-----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150 (260)
T ss_pred CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEeecccceecccc
Confidence 9999999997543 3888999999999999999999987 999999999999999999999999998754331
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc--cCCCCCHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKGKFSESEA 548 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 548 (589)
....++..|+|||.+.+..++.++||||||+++|||++|..||......... ....... .........+
T Consensus 151 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 221 (260)
T cd05611 151 -----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF----DNILSRRINWPEEVKEFCS 221 (260)
T ss_pred -----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcccCCCCcccccCC
Confidence 1234667799999998888999999999999999999999999654322111 1111111 1111223456
Q ss_pred HHHHHHHHHhcccCCCCCCCH---HHHHHHHHh
Q 007788 549 AKLGKMALVCTHEDPENRPTM---EAVIEELTV 578 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~---~evl~~L~~ 578 (589)
..+.+++..|++.+|++||++ .|++.+-+.
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 789999999999999999965 566655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.71 Aligned_cols=248 Identities=19% Similarity=0.358 Sum_probs=194.2
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
|...+.||+|+||.||+|... +++.|++|++..... ......+.+|++++++++|||++++++++.+ .+..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEE
Confidence 445677999999999999875 688999999875432 2333568899999999999999999999854 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+. |++.+++.... ..++|..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++...
T Consensus 101 e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 101 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred ecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 9995 57888776543 24899999999999999999999988 999999999999999999999999998654
Q ss_pred cCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
... ....++..|+|||++. ...++.++|||||||++|||++|+.|+.......... ............
T Consensus 172 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~ 242 (313)
T cd06633 172 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNDSPTLQS 242 (313)
T ss_pred CCC-----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhcCCCCCCc
Confidence 321 1234677899999984 4568889999999999999999999986543211111 111111111112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+.+++.+|++.+|.+||++.+++++-+.
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 2344568899999999999999999999987544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=299.15 Aligned_cols=261 Identities=19% Similarity=0.316 Sum_probs=199.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC--CCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~ 384 (589)
++|+..+.||+|+||.||+|... +|..||+|++..... ......+.+|+.++.+++||||+++++++... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999865 689999999876432 23345677899999999999999999987432 234689
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+. ++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEecccccc
Confidence 9999995 68999886542 3899999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCcee---eeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-------------
Q 007788 465 KLLADDIVF---SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE------------- 527 (589)
Q Consensus 465 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~------------- 527 (589)
......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 765432211 1112346778999998765 45889999999999999999999999643211000
Q ss_pred ------hhhHHHhhcc-ccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 528 ------SATFENFIDR-NLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 528 ------~~~~~~~~~~-~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
........+. ...... ....+..+.+++..|++.+|++||++.+++.+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 0001111110 000011 123467799999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.77 Aligned_cols=257 Identities=22% Similarity=0.381 Sum_probs=196.5
Q ss_pred HHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC----
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---- 379 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---- 379 (589)
.+...+|++..+||+||||.||+++.+ ||+.||||++.............+|++.+++++|||||+++..+.+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345567888899999999999999987 899999999987764455567889999999999999999985332200
Q ss_pred --------------------------------------------------------------------------------
Q 007788 380 -------------------------------------------------------------------------------- 379 (589)
Q Consensus 380 -------------------------------------------------------------------------------- 379 (589)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhH
Q 007788 380 -------------------------R--------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426 (589)
Q Consensus 380 -------------------------~--------~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 426 (589)
. ...||=||||+..++.++++...... .-...++++.+|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence 0 23578899998877777776554210 24567899999999999
Q ss_pred HhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc-----------------CCceeeeecCCccccccCccc
Q 007788 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA-----------------DDIVFSVLKTSAAMGYLAPEY 489 (589)
Q Consensus 427 ~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~~~~~y~aPE~ 489 (589)
|+|+.+ ||||||||.||++|++..+||+|||+|.... .......+...||.-|+|||+
T Consensus 712 YIH~~g-----iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 712 YIHDQG-----IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHhCc-----eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999998 9999999999999999999999999998721 000112334567888999999
Q ss_pred ccCCC---CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC--CCHHHHHHHHHHHHHhcccCCC
Q 007788 490 VTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSESEAAKLGKMALVCTHEDPE 564 (589)
Q Consensus 490 ~~~~~---~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~C~~~dp~ 564 (589)
+.+.. |+.|+|+||+|||++||+. ||...++.+. .+..+.+..+..+ +.......-.+++.++++.||.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~---iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS---ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHH---HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence 98765 9999999999999999985 5665554433 2233333333222 2334455667899999999999
Q ss_pred CCCCHHHHHHH
Q 007788 565 NRPTMEAVIEE 575 (589)
Q Consensus 565 ~RPs~~evl~~ 575 (589)
+|||+.|+++.
T Consensus 861 kRPtA~eLL~s 871 (1351)
T KOG1035|consen 861 KRPTATELLNS 871 (1351)
T ss_pred cCCCHHHHhhc
Confidence 99999999864
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=288.15 Aligned_cols=247 Identities=19% Similarity=0.278 Sum_probs=189.2
Q ss_pred ccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHH---HHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 316 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLY---LLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~---~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
+||+|+||.||+|... +++.||+|.+...... .....+..|.. .++...||||+++++++.+ .+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999864 6889999998754322 22223444433 4445679999999988843 4688999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|+|.+++.... .++|..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 79 ~~g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 79 MNGGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 99999999886432 4899999999999999999999987 99999999999999999999999999876543
Q ss_pred CceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
... ....++..|+|||.+.++ .++.++||||+||++|||++|+.||.......... ..... .......+...+
T Consensus 150 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~~~~~-~~~~~~~~~~~s 223 (278)
T cd05606 150 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT-LTMAVELPDSFS 223 (278)
T ss_pred cCC---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--HHHHh-hccCCCCCCcCC
Confidence 221 223577889999998754 58999999999999999999999997542111110 01111 011122333446
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhh
Q 007788 549 AKLGKMALVCTHEDPENRP-----TMEAVIEELTVA 579 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~ 579 (589)
..+.+++.+|+..+|++|| ++.+++++-+..
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 7899999999999999999 999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.15 Aligned_cols=260 Identities=17% Similarity=0.304 Sum_probs=197.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC-CchHHHHHHHHHHHHhccCCCCccceeeeeecCCC---Ce
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GE 382 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---~~ 382 (589)
.++|...+.||+|+||.||+|... +++.||||.+.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999865 68999999987532 12334567789999999999999999998754321 35
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+. ++|.+++.... .+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcCc
Confidence 799999996 68988886432 4899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh-------------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------- 528 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~------------- 528 (589)
+++....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..........
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 154 LARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cccccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 9986643321 1122345678999998765 468899999999999999999999986432110000
Q ss_pred ------hhHHHhhcccc---CC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 529 ------ATFENFIDRNL---KG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 529 ------~~~~~~~~~~~---~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+.... .. ...+..+..+.+++.+|++.+|++|||++|++++-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 00000110000 00 0012345678899999999999999999999998443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=302.60 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=200.7
Q ss_pred ccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC----CCeEEEEEE
Q 007788 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGECFLIYD 388 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~~lv~E 388 (589)
.+.||+|+||.||+|+.+ .|+.||||.++........+.+.+|+++|++++|||||+++++=.... .....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 467999999999999954 799999999998777777888999999999999999999998753333 456789999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec--CCCc--eEEcccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFN--PLIADCGLH 464 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~--~~~~--~kl~DfGla 464 (589)
||++|||...|+.... ..-+++...+.+..+++.||.|||+.+ |+||||||.||++- ++|+ -||+|||.|
T Consensus 98 yC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~-----IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG-----IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999987653 344999999999999999999999988 99999999999984 3344 499999999
Q ss_pred ccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHH-----HHhhh---hHHH--
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRL-----AAESA---TFEN-- 533 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~-----~~~~~---~~~~-- 533 (589)
+.++++. ......||..|.+||.... ..|+..+|.|||||++||..||..||-..... ..+.. .-..
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9998776 4455679999999999994 88999999999999999999999999543211 11100 0000
Q ss_pred -hhcccc------------CCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhhcc
Q 007788 534 -FIDRNL------------KGKFSESEAAKLGKMALVCTHEDPENRP--TMEAVIEELTVAAPV 582 (589)
Q Consensus 534 -~~~~~~------------~~~~~~~~~~~l~~l~~~C~~~dp~~RP--s~~evl~~L~~~~~~ 582 (589)
..++.. ...........+.+.....+..+|++|- .+.+....+..+-..
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 000000 1112234455566666667777888887 666666655555443
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.98 Aligned_cols=253 Identities=17% Similarity=0.264 Sum_probs=200.6
Q ss_pred ccccccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 312 SEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
.++..||.|+||.||+|..++ +-..|-|++...+ .....+|+-||++|+.++||+||++++.|+.+ +..+++.|||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEFC 111 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEFC 111 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEeec
Confidence 345679999999999999875 4445677776554 45667899999999999999999999977544 6789999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
.||..+..+-.-. ..++..++..++.+++.||.|||+.+ |||||||+.|||++-+|.++|+|||.+......
T Consensus 112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~-----iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN-----IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc-----hhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999998876554 35999999999999999999999998 999999999999999999999999997644322
Q ss_pred ceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
. .......||+.|||||+.. ..+|+.++||||||++|.||..+.+|-.........-.. ..--.+. ...+.
T Consensus 184 ~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-aKSePPT--LlqPS 259 (1187)
T KOG0579|consen 184 R-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPT--LLQPS 259 (1187)
T ss_pred H-hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-hhcCCCc--ccCcc
Confidence 1 1223456899999999864 567999999999999999999999887654332111110 0000111 12356
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.....+.++...|+..+|..||++.+++++-+..
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 6778899999999999999999999999987654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.17 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=200.4
Q ss_pred HHHHHHhhccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC
Q 007788 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR 378 (589)
Q Consensus 301 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 378 (589)
..++...+++|...+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 355666789999999999999999999986 4789999999875432 22345688899999999999999999987532
Q ss_pred C----CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC
Q 007788 379 G----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454 (589)
Q Consensus 379 ~----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~ 454 (589)
. ....++++|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEcCCC
Confidence 1 23467888876 78998887543 3899999999999999999999988 99999999999999999
Q ss_pred ceEEccccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh----
Q 007788 455 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---- 529 (589)
Q Consensus 455 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~---- 529 (589)
.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999998765432 123346778999998866 4688899999999999999999999854321110000
Q ss_pred ------h---------HHHhh---ccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 530 ------T---------FENFI---DRNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 530 ------~---------~~~~~---~~~~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
. ....+ ........ .......+.+++.+|++.||.+||++.+++++-+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 0 00000 00000000 001245678999999999999999999999886643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.74 Aligned_cols=259 Identities=21% Similarity=0.320 Sum_probs=200.1
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC---CCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~~ 384 (589)
+|...+.||+|++|.||+|... +++.||||++..... ....+.+.+|+..++.++||||+++++++.... ....+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999976 589999999876542 334467899999999999999999999885432 23689
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||.||+++.++.++|+|||++
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g-----i~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccCce
Confidence 9999997 58988886543 5899999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCce--eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------
Q 007788 465 KLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------- 531 (589)
Q Consensus 465 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~---------- 531 (589)
........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.+...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 87654321 111223456779999999887 78999999999999999999999996543211100000
Q ss_pred ---------HHhhcc-ccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 ---------ENFIDR-NLKGK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 ---------~~~~~~-~~~~~-----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+.. ..... ........+.+++.+||+.+|++||++.+++++-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 000000 00000 011235678899999999999999999999988543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=292.04 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=198.4
Q ss_pred HHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
+...+++|+..+.||+|+||.||+|... +++.||||++..... ......+..|++++.+++||||+++++++... .+
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence 3446788999999999999999999865 789999998865322 23346688999999999999999999988543 35
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++|+||+ +++|.+++... .+++.....++.|++.||+|||+.+ |+||||||+||++++++.++|+||
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~-----iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG-----VVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEeECCCCCEEeCcc
Confidence 688999998 56898888642 3788888899999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh------------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------ 528 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~------------ 528 (589)
|.+....... ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||..........
T Consensus 153 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 153 GLARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228 (328)
T ss_pred ccccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9987553321 12345677999998766 568999999999999999999999986432210000
Q ss_pred -------hhHHHhhc-cccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 529 -------ATFENFID-RNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 529 -------~~~~~~~~-~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
....+++. .......+ ......+.+++.+|++.+|++||++.+++.+-+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 00000000 00011111 1234678999999999999999999999988443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.43 Aligned_cols=252 Identities=19% Similarity=0.337 Sum_probs=202.0
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCC-CchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv 386 (589)
..|++.+.||+||...||++...+.+.+|+|++.... +....+-|.+|+..|.+++ |.+||++++|-.. .+..|+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEEEE
Confidence 4577789999999999999999888888888775443 3455678999999999995 9999999998754 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||- ..||..+|...... ...| .+..+..|++.|+.+.|..+ |||.||||.|+|+-. |.+||+|||+|..
T Consensus 439 mE~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~g-----IVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQHG-----IVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred eecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHhc-----eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9987 45999999887643 2445 67889999999999999998 999999999999875 6899999999998
Q ss_pred ccCCcee-eeecCCccccccCcccccCCC-----------CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 467 LADDIVF-SVLKTSAAMGYLAPEYVTTGR-----------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 467 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-----------~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
...+.+. -.....||+.||+||.+.... .+.++||||+|||||+|+-|+.||..-... ...+..+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~aKl~aI 585 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---IAKLHAI 585 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---HHHHHhh
Confidence 8765432 223456899999999885432 567999999999999999999999654321 2345566
Q ss_pred hccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 535 IDRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 535 ~~~~~~~~~~~~-~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.++....+++.- ...++.+++..|++.||.+||++.+++++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 666543333221 12239999999999999999999999976
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=290.76 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=193.9
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhccCCCCccceeeeeecCC------
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------ 379 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 379 (589)
.++|+..+.||+|+||.||+|... +++.||||++....... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888899999999999999975 68999999986543222 2345778999999999999999999875432
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
....++|+||+.. +|...+.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH-----ILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEC
Confidence 2357999999965 7777776432 24899999999999999999999988 9999999999999999999999
Q ss_pred cccccccccCCceee----------eecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh
Q 007788 460 DCGLHKLLADDIVFS----------VLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528 (589)
Q Consensus 460 DfGla~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~ 528 (589)
|||+++......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.+........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999987654322111 1112346679999987654 57899999999999999999999986543221111
Q ss_pred hhHH-----------------HhhccccCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 529 ATFE-----------------NFIDRNLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 529 ~~~~-----------------~~~~~~~~~~~~-------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.... ...+.......+ ......+.+++.+|++.||++|||+.|++.+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~ 309 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence 1000 000000000000 11235688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=292.29 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=193.5
Q ss_pred cCcc-ccccccCCCccEEEEEec-CCcEEEEEEeccCCCch-------------HHHHHHHHHHHHhccCCCCccceeee
Q 007788 310 CFSE-VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-------------EEAEFVKGLYLLTSLRHENIIRLRGF 374 (589)
Q Consensus 310 ~f~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-------------~~~~~~~e~~~l~~l~H~niv~l~g~ 374 (589)
+|.. .+.||+|+||.||+|... +++.||||++....... ....+.+|++++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 4443 467999999999999965 68999999986543211 01247789999999999999999999
Q ss_pred eecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC
Q 007788 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~ 454 (589)
+.. .+..++||||++ |+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 89 ~~~--~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~-----i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 89 YVE--GDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKWY-----FMHRDLSPANIFINSKG 156 (335)
T ss_pred Eec--CCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHeEECCCC
Confidence 854 468899999996 69999986532 3889999999999999999999988 99999999999999999
Q ss_pred ceEEccccccccccCCce-------------eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcch
Q 007788 455 NPLIADCGLHKLLADDIV-------------FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTS 520 (589)
Q Consensus 455 ~~kl~DfGla~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~ 520 (589)
.++|+|||.+........ .......++..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999876641110 011122346679999998764 468999999999999999999999975
Q ss_pred hHHHHHhhhhHHHhhccc---------------cCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 521 SMRLAAESATFENFIDRN---------------LKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~---------------~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..............-.+. ... .........+.+++..|++.+|++||+++|++.+.+.
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 433211111100000000 000 0011235678899999999999999999999987664
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=285.76 Aligned_cols=254 Identities=21% Similarity=0.384 Sum_probs=196.0
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|+..+.||+|++|.||+|+.. +++.||+|++..... ......+..|+.++++++|+|++++++++.+ .+..++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 445678999999999999976 589999999986531 2334578889999999999999999999854 478999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|++ ++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.++|+|||.++...
T Consensus 79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~ 149 (282)
T cd07829 79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR-----ILHRDLKPQNILINRDGVLKLADFGLARAFG 149 (282)
T ss_pred CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence 997 59999998653 24899999999999999999999988 9999999999999999999999999988664
Q ss_pred CCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh-----------HHHhh-
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------FENFI- 535 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~-----------~~~~~- 535 (589)
.... .......+..|+|||.+.+. .++.++||||||+++||+++|+.||............ ...+.
T Consensus 150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 150 IPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred CCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 3321 11122345679999998776 7899999999999999999999998654321110000 00000
Q ss_pred ----ccccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 536 ----DRNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 536 ----~~~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
+..... ...+.....+.+++..|++.+|++||++.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 000000 00012256799999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=293.76 Aligned_cols=257 Identities=21% Similarity=0.330 Sum_probs=196.5
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC----
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---- 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---- 380 (589)
..++|+..+.||+|+||.||+|... ++..||||++..... ......+.+|++++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999864 789999999865322 2234568899999999999999999998854321
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~g-----i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAAG-----IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEee
Confidence 2468999999 77998887642 3899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh---------
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT--------- 530 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~--------- 530 (589)
||++....... ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||............
T Consensus 162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99988654321 22345678999998876 45889999999999999999999999643221110000
Q ss_pred -HH---------Hhhcc--ccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 531 -FE---------NFIDR--NLKG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 531 -~~---------~~~~~--~~~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+. ..... .... .........+.+++.+|++.||++|||+.+++++-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~ 301 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence 00 00000 0000 0011234568899999999999999999999976443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=293.57 Aligned_cols=258 Identities=18% Similarity=0.319 Sum_probs=193.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC-------
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR------- 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------- 380 (589)
.+|...+.||.|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888899999999999999875 689999999876543 344678899999999999999999987643321
Q ss_pred -----CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-CCC
Q 007788 381 -----GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQF 454 (589)
Q Consensus 381 -----~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-~~~ 454 (589)
...++||||++ ++|.+++... .+++.....++.||+.||+|||+.+ |+||||||+||+++ +++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCc
Confidence 35789999997 5898887532 3889999999999999999999988 99999999999997 456
Q ss_pred ceEEccccccccccCCceee--eecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 455 NPLIADCGLHKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 455 ~~kl~DfGla~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
.+|++|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 78999999987654321111 112245677999998654 457889999999999999999999996543211110000
Q ss_pred H------------------Hhhc-cccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 E------------------NFID-RNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 ~------------------~~~~-~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
. .... .......+ .....++.+++..|++.||++||++.|++++-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 0 0000 00000001 1234678899999999999999999999977443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=275.16 Aligned_cols=249 Identities=18% Similarity=0.331 Sum_probs=192.8
Q ss_pred cccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
..||.|+||+|+|-.++ .|+..|||+++......++.+++.|.+...+- +.||||+++|.+..+ +..++.||.|+-
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWiCMELMd~ 147 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWICMELMDI 147 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--CceeeeHHHHhh
Confidence 56999999999999876 79999999999887777778899998876555 699999999998654 789999999954
Q ss_pred CChHHHhhhh-cCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCc
Q 007788 393 GKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471 (589)
Q Consensus 393 gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 471 (589)
||+.+-... .-....+++.-.-+|.....+||.||-+... |||||+||+|||+|..|.+||+|||++..+.++.
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk----iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK----IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh----hhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 665543211 0112347888788889999999999987643 9999999999999999999999999998776544
Q ss_pred eeeeecCCccccccCcccccCC--CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC-CCC---H
Q 007788 472 VFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFS---E 545 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~ 545 (589)
.. ....|-..|||||.+... .|+.++||||+|++|||+.||+.|+..+...-. .+.+++...... ..+ -
T Consensus 223 Ak--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe---ql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 223 AK--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE---QLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred Hh--hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH---HHHHHHcCCCCeecCccccc
Confidence 32 223344569999998643 489999999999999999999999987765321 122222211110 112 2
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.....+.+++..|+.+|-..||...++.+.
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 357789999999999999999999998754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=276.89 Aligned_cols=241 Identities=23% Similarity=0.334 Sum_probs=194.9
Q ss_pred cccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
||+|+||.||++... +++.+|+|.+...... .....+..|++++++++||||+++++.+. ..+..++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence 689999999999976 5899999998765432 24567889999999999999999998873 457899999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCcee
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 473 (589)
+|.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~-----~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~- 148 (250)
T cd05123 79 ELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG-----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS- 148 (250)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence 9999997553 3899999999999999999999987 99999999999999999999999999876544311
Q ss_pred eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 474 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 474 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
......++..|+|||...+...+.++|+||||+++||+++|+.||...... .....+.. .....+...+..+.+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~--~~~~~~~~~~~~l~~ 222 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILK--DPLRFPEFLSPEARD 222 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhc--CCCCCCCCCCHHHHH
Confidence 122344677899999998888899999999999999999999999654321 11122221 122334444678899
Q ss_pred HHHHhcccCCCCCCCH---HHHHHH
Q 007788 554 MALVCTHEDPENRPTM---EAVIEE 575 (589)
Q Consensus 554 l~~~C~~~dp~~RPs~---~evl~~ 575 (589)
++.+||..||++||++ ++++++
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHhC
Confidence 9999999999999999 565543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=292.75 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=203.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
...|.+...||+|.|+.|..|... .+..||+|.+.+.... ...+.+.+|+++|..++|||||+++.+. ..+...|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~--~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI--ETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee--eecceeEE
Confidence 456777889999999999999965 6999999999876543 3335688999999999999999999988 44578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||..+|.+++++..... +.......+..|+..|++|||+++ |+|||||++||||+.++++||+|||++.
T Consensus 133 V~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~-----ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN-----IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred EEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc-----eeccccchhhcccccccceeeeccccce
Confidence 9999999999999987764 445778889999999999999998 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC--
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK-- 542 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 542 (589)
.+.... ......|++.|.|||++.+.+| ++++|+||+|++||-|+.|..||++..- ...-++.+.+.
T Consensus 204 ~~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------k~Lr~rvl~gk~r 273 (596)
T KOG0586|consen 204 FFDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------KELRPRVLRGKYR 273 (596)
T ss_pred eecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------ccccchheeeeec
Confidence 876433 2233457788999999999886 6789999999999999999999986532 11122222221
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+.....+..++++..+-.+|.+|++++++.++-|.
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 122334456667777777899999999999987664
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.64 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=202.0
Q ss_pred hhccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.+-++.....||.|.||.||.|.. .+|...|||.++.... ........+|+.++..++|||+|+++|+-+. ++.++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHH
Confidence 355677788999999999999984 5799999999875432 2333567889999999999999999997644 57889
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
|.||||++|+|.+.+...+. .++..-..+-.|++.|++|||+.+ ||||||||.||+|+.+|.+|++|||.|
T Consensus 1311 IFMEyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~g-----IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEHG-----IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhcC-----ceecCCCccceeeecCCcEEeecccce
Confidence 99999999999999975532 455555668899999999999998 999999999999999999999999999
Q ss_pred ccccCCc---eeeeecCCccccccCcccccCCC---CCCcchhhhHHHHHHHHHhCCCCcchhH-HHHHhhhhHHHhhcc
Q 007788 465 KLLADDI---VFSVLKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSM-RLAAESATFENFIDR 537 (589)
Q Consensus 465 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~ 537 (589)
....... ........||+.|||||++.+.. ...+.||||+|||+.||+||+.||.... +++. +-.+ ..
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI----My~V-~~ 1456 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI----MYHV-AA 1456 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH----HhHH-hc
Confidence 8776542 11223456899999999998754 4668999999999999999999996432 1111 1111 12
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.-.+..++....+-.+++..|+..||++|.++.|++++
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 23345677788888999999999999999999888765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.26 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=198.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...++||+|.||+|-+++-+ .++.+|+|+++++.. +++...-+.|-++|...+||.+..+--.+ ...+..++
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drlCF 245 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRLCF 245 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceEEE
Confidence 46777899999999999999866 799999999987643 44555667889999999999999886444 56688999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||..||.|.-+|...+ .+++.....+-.+|..||.|||+++ ||.||||.+|.|+|.+|++||+|||+++
T Consensus 246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~-----ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN-----IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC-----eeeeechhhhheeccCCceEeeecccch
Confidence 999999999999997654 3788888889999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
.--... .....-.||+.|.|||++....|+..+|+|.+|||+|||++|+.||+..... .-++-++...++ ++.
T Consensus 317 E~I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----kLFeLIl~ed~k--FPr 389 (516)
T KOG0690|consen 317 EEIKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----KLFELILMEDLK--FPR 389 (516)
T ss_pred hccccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----HHHHHHHhhhcc--CCc
Confidence 532211 1233456899999999999999999999999999999999999999865321 112222222222 344
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEE 575 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~ 575 (589)
....+...+....+.+||.+|. .+.||.++
T Consensus 390 ~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 390 TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 4555667777777888999994 45555443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.03 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=192.7
Q ss_pred cCccccccccCCCccEEEEEec-C--CcEEEEEEeccCCC-chHHHHHHHHHHHHhcc-CCCCccceeeeeecC--CCCe
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-D--GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR--GRGE 382 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~--~~~~ 382 (589)
+|+..+.||+|+||.||++... . +..||+|++..... ......+.+|++++.++ +||||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4667789999999999999975 3 78999999875432 22345688899999999 599999999875322 2345
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++++||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSAN-----VLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHeEEcCCCCEEeCcCC
Confidence 788999985 68999886432 4899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCcee---eeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh---------
Q 007788 463 LHKLLADDIVF---SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA--------- 529 (589)
Q Consensus 463 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~--------- 529 (589)
+++........ ......++..|+|||++.+ ..++.++|||||||++||+++|+.||...........
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865432211 1122346778999998765 4689999999999999999999999864321110000
Q ss_pred --hHHHhhcc-----------ccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 530 --TFENFIDR-----------NLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 530 --~~~~~~~~-----------~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+..+ .... .........+.+++.+|++.||++|||+.+++++-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00000000 0000 001112467889999999999999999999997754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=268.95 Aligned_cols=258 Identities=18% Similarity=0.246 Sum_probs=201.7
Q ss_pred hccCcc-ccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC--CCCe
Q 007788 308 TQCFSE-VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR--GRGE 382 (589)
Q Consensus 308 ~~~f~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~--~~~~ 382 (589)
+++|++ .++||-|-.|.|-.+..+ +|+.+|+|++.+. ....+|+++--.. .|||||+++++|... ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 445544 468999999999999876 7899999998743 2345677653333 699999999988432 3456
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCceEEc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIA 459 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 459 (589)
.++|||.|+||.|...+++++. ..+++.++-.|+.||+.|+.|||+.+ |+||||||+|+|... |..+||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n-----IAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN-----IAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc-----hhhccCChhheeeecCCCCcceEec
Confidence 7899999999999999987754 45999999999999999999999998 999999999999964 5568999
Q ss_pred cccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
|||+|+.-.... ......-|+.|.|||++...+|+..+|+||+||++|-|++|.+||++....+...+.-..+.....
T Consensus 207 DfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 207 DFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 999999765322 223344578899999999999999999999999999999999999987654433222222222221
Q ss_pred C--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 540 K--GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 540 ~--~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
. .+.....++...++++..+..+|++|.|+.+++.+-|...
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 1 1222455777889999999999999999999999877543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=293.70 Aligned_cols=257 Identities=20% Similarity=0.318 Sum_probs=196.6
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC----
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---- 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---- 380 (589)
..++|...+.||+|++|.||+|... +++.||||++..... ......+.+|+.++++++|||++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999976 688999999865422 2234567789999999999999999987743321
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...++|+||+ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEcc
Confidence 2489999999 66999988642 4899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH--------
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-------- 531 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~-------- 531 (589)
||++...... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||.............
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 9998866432 122345677999998865 367899999999999999999999996443211100000
Q ss_pred -----------HHhhccccCC---CC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 -----------ENFIDRNLKG---KF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 -----------~~~~~~~~~~---~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..++...... .. .......+.+++.+|++.+|++|||+.+++++-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 0000000000 00 01235678999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.24 Aligned_cols=261 Identities=19% Similarity=0.260 Sum_probs=210.8
Q ss_pred HHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeec
Q 007788 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 377 (589)
Q Consensus 301 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 377 (589)
+.++....++|.+.++||+|+||.|..++.+ .+++||.|++.+.. ......-|..|-.+|..-..+-||.+.-.|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-- 144 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-- 144 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--
Confidence 3455566788999999999999999999986 68999999998632 134456799999999999999999997555
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
.+.++.|+|||||+||||-.++.... .+++..+..++..|..||.-+|+.| +|||||||+|||+|..|++|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg-----yVHRDiKPDNvLld~~GHik 215 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG-----YVHRDIKPDNVLLDKSGHIK 215 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc-----ceeccCCcceeEecccCcEe
Confidence 66689999999999999999998664 3888888899999999999999998 99999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccC-----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 532 (589)
|+|||.+-.+..+.........|||.|++||++.. +.|+..+|+||+||++|||+.|..||+...-.... .
T Consensus 216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY----~ 291 (1317)
T KOG0612|consen 216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY----G 291 (1317)
T ss_pred eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH----H
Confidence 99999998888666666677889999999999853 56999999999999999999999999876543332 3
Q ss_pred HhhccccCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 007788 533 NFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRPT---MEAVIEELT 577 (589)
Q Consensus 533 ~~~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~RPs---~~evl~~L~ 577 (589)
.+++..-...+| ...+....+++..-+. +|+.|.. +.++-.|..
T Consensus 292 KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 292 KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 333332111222 2345555666655443 7888887 888877643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=273.15 Aligned_cols=219 Identities=17% Similarity=0.186 Sum_probs=175.0
Q ss_pred CCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCCChHHH
Q 007788 320 GNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 398 (589)
Q Consensus 320 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~ 398 (589)
|.+|.||++... +++.||+|++.... .+..|...+....||||+++++++.+ .+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHHH
Confidence 899999999975 78999999987542 23445555666679999999998854 4789999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecC
Q 007788 399 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478 (589)
Q Consensus 399 l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 478 (589)
+.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+....... ...
T Consensus 76 l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~ 142 (237)
T cd05576 76 ISKFL----NIPEECVKRWAAEMVVALDALHREG-----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGE 142 (237)
T ss_pred HHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccC
Confidence 87543 3899999999999999999999988 9999999999999999999999999876654321 123
Q ss_pred CccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHh
Q 007788 479 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVC 558 (589)
Q Consensus 479 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 558 (589)
.++..|+|||.+.+..++.++||||+|+++|||++|+.|+....... ........+......+.+++.+|
T Consensus 143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTHTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccccccCCcccCCHHHHHHHHHH
Confidence 34566999999988889999999999999999999998764321100 00001112333456788999999
Q ss_pred cccCCCCCCCH
Q 007788 559 THEDPENRPTM 569 (589)
Q Consensus 559 ~~~dp~~RPs~ 569 (589)
++.||++||++
T Consensus 213 l~~dp~~R~~~ 223 (237)
T cd05576 213 LQFNPTERLGA 223 (237)
T ss_pred ccCCHHHhcCC
Confidence 99999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=267.49 Aligned_cols=205 Identities=26% Similarity=0.418 Sum_probs=169.0
Q ss_pred ccCccccccccCCCccEEEEEec---C--CcEEEEEEeccCCCchH-HHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR---D--GTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~l~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
..|+....||+|.||.||+|.-. + .+.+|+|+++......+ .....+|+.++++++|||++.++.++... ...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 35778889999999999999643 2 34799999987643222 24678999999999999999999988764 578
Q ss_pred EEEEEEeCCCCChHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC----CceE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPL 457 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~----~~~k 457 (589)
+++++||.+. ||...++-...+ ...++-.....|+.||+.|+.|||++- |+||||||.|||+..+ |.+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-----vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-----VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-----eeeccCCcceEEEeccCCccCeeE
Confidence 9999999977 898888754432 245888889999999999999999998 9999999999999887 8999
Q ss_pred EccccccccccCCc--eeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcch
Q 007788 458 IADCGLHKLLADDI--VFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTS 520 (589)
Q Consensus 458 l~DfGla~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~ 520 (589)
|+|+|+++.+...- .++.....-|+.|+|||.+.+.+ |+.+.||||.||++.||+|-.+.|.+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999999876432 22344556688999999998865 89999999999999999998766643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=308.82 Aligned_cols=146 Identities=23% Similarity=0.344 Sum_probs=128.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|.+.+.||+|+||.||+|... +++.||||++..... ......+..|+.++..++||||+++++++.. .+..++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEEE
Confidence 56888899999999999999976 689999999975432 2334678899999999999999999988744 468999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.... .+++...+.|+.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g-----IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG-----IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999997543 3788999999999999999999987 9999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.80 Aligned_cols=267 Identities=18% Similarity=0.283 Sum_probs=187.0
Q ss_pred hhccCccccccccCCCccEEEEEe-----------------cCCcEEEEEEeccCCCchHHHH--------------HHH
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL-----------------RDGTLVAIRSINVTSCKSEEAE--------------FVK 355 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~~--------------~~~ 355 (589)
..++|++.++||+|+||.||+|.+ .+++.||||++..... ...++ +..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999964 2456899999875432 22223 344
Q ss_pred HHHHHhccCCCCc-----cceeeeeecC------CCCeEEEEEEeCCCCChHHHhhhhcC--------------------
Q 007788 356 GLYLLTSLRHENI-----IRLRGFCCSR------GRGECFLIYDFAPKGKLSKYLDQEEG-------------------- 404 (589)
Q Consensus 356 e~~~l~~l~H~ni-----v~l~g~~~~~------~~~~~~lv~Ey~~~gsL~~~l~~~~~-------------------- 404 (589)
|+.++.+++|.++ +++++||... ..+..++||||+++|+|.++++...+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776654 7788887532 23568999999999999999975321
Q ss_pred CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecCCccccc
Q 007788 405 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 484 (589)
Q Consensus 405 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y 484 (589)
....++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++................++.|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~-----ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG-----IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 0123578889999999999999999987 99999999999999999999999999976543322222223346789
Q ss_pred cCcccccCCC--------------------C--CCcchhhhHHHHHHHHHhCCC-CcchhHHHHHh----hhhHH---Hh
Q 007788 485 LAPEYVTTGR--------------------F--TERSDIFAFGVIILQILTGSL-VLTSSMRLAAE----SATFE---NF 534 (589)
Q Consensus 485 ~aPE~~~~~~--------------------~--~~~~Dv~s~Gvvl~elltg~~-p~~~~~~~~~~----~~~~~---~~ 534 (589)
+|||.+.... + ..+.||||+||++|||++|.. |+........+ ..... ..
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999875432 1 134799999999999999986 55432111110 01111 11
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHHHhh
Q 007788 535 IDRNLKGKFSESEAAKLGKMALVCTHEDP---ENRPTMEAVIEELTVA 579 (589)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp---~~RPs~~evl~~L~~~ 579 (589)
..................+++..++..+| .+|+|++|+++|-+..
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 11111111123345667788888888765 6899999999987653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.52 Aligned_cols=243 Identities=19% Similarity=0.279 Sum_probs=197.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l 385 (589)
++.|.....+|.|+|+.|-++... +++..+||++..... +-.+|+.++... .||||+++.+.+ .+..+.++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeeccee--cCCceeee
Confidence 567777788999999999999865 688999999976521 233566555554 699999999998 55688999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee-cCCCceEEcccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI-DQQFNPLIADCGLH 464 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill-~~~~~~kl~DfGla 464 (589)
|||++.++-|.+.+..... .. ..+..|+.+|+.|+.|||+++ ||||||||+|||+ ++.++++|+|||.+
T Consensus 394 v~e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~g-----vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQG-----VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred eehhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhcC-----eeecCCChhheeecCCCCcEEEEEechh
Confidence 9999999988777765431 22 677789999999999999988 9999999999999 68999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+...... ....-|..|.|||+.....|++++|+||||++||||++|+.||...-.. .++......+++.
T Consensus 464 ~~~~~~~----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s 532 (612)
T KOG0603|consen 464 SELERSC----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS 532 (612)
T ss_pred hhCchhh----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc
Confidence 9876651 1223466799999999999999999999999999999999999654322 2222233344555
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...++...+|+.+|++.||.+||+|.++..+-|.
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 6778889999999999999999999999988776
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=290.95 Aligned_cols=264 Identities=21% Similarity=0.382 Sum_probs=215.4
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeee
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC 376 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 376 (589)
+.++.+...++-|++.+.||.|.+|.||+++. ++++.+|||++...... ..+...|.++++.. .|||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 34455566677888999999999999999985 57899999998776533 34556778888777 5999999999886
Q ss_pred cC---CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 377 SR---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 377 ~~---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
.. ..++.++|||||.+||..+++.... +..+.|.....|+.++++||++||... ++|||+|-.|||++++
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk-----viHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK-----VIHRDIKGQNVLLTEN 159 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc-----eeeecccCceEEEecc
Confidence 43 3568999999999999999998765 456999999999999999999999987 9999999999999999
Q ss_pred CceEEccccccccccCCceeeeecCCccccccCcccccCC-----CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh
Q 007788 454 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~ 528 (589)
+.+||+|||++..++.... ......||+.|||||++... .|+..+|+||+|++..||--|.+|+.+......-
T Consensus 160 ~~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL- 237 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL- 237 (953)
T ss_pred CcEEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-
Confidence 9999999999987765432 23345688999999998643 3778999999999999999999999876553211
Q ss_pred hhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+.-...+......+....+++.+++..|+.+|.++||++.+++++
T Consensus 238 --F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 --FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111112333334567889999999999999999999999999876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=260.44 Aligned_cols=260 Identities=20% Similarity=0.341 Sum_probs=197.6
Q ss_pred CHHHHHHhhccCccccccccCCCccEEEEE-ecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeec
Q 007788 300 NLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCS 377 (589)
Q Consensus 300 ~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~ 377 (589)
+++|+-..|+ ++||+|+++.|..+. +.+|..+|||++.+.. ...+....+|++++.+.+ |+||++++.|+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefF-- 145 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFF-- 145 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHh--
Confidence 3466665554 789999999999997 6789999999998774 455667889999999995 99999999999
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc--
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-- 455 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~-- 455 (589)
++....|+|||-|.||.|..+++++. .+++.++.++..+||.||.|||.++ |+||||||+|||......
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg-----IAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG-----IAHRDLKPENILCESPNKVS 216 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC-----cccccCCccceeecCCCCcC
Confidence 44577999999999999999998775 3889999999999999999999998 999999999999976543
Q ss_pred -eEEccccccccccCCc------eeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHH
Q 007788 456 -PLIADCGLHKLLADDI------VFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523 (589)
Q Consensus 456 -~kl~DfGla~~~~~~~------~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~ 523 (589)
+||+||.+..-..... ........|+..|||||+.. ...|+.++|.||+|||||-|++|..||.+...
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 7999998865432111 11122334566799999763 24589999999999999999999999964321
Q ss_pred H-HHh----------hhhHHHhhccccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 524 L-AAE----------SATFENFIDRNLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 524 ~-~~~----------~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
. ..| ..-++.+-+..+ ++++ ..+.+..+++...+..|+.+|-++.+++++-+.
T Consensus 297 ~dCGWdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 297 ADCGWDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred CcCCccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 0 001 111222222111 2233 335556677777778899999999999987664
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=271.54 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=197.6
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCc-hH-----HHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCK-SE-----EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-~~-----~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
++|-..++||+|||+.||+|.. ...+.||||+-.....- ++ .+...+|.++-+.+.||.||++++|+.-+ .+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-td 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-cc
Confidence 4566678999999999999984 56889999997654321 11 13456788999999999999999998654 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec---CCCceEE
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLI 458 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl 458 (589)
..+-|.||++|-+|+-||.... .+++.++..|+.||..||.||.+. +|||||-||||.||||- ..|.+||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi---kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI---KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc---CCCeeeeccCCccEEEecCcccceeEe
Confidence 7889999999999999998765 388999999999999999999876 59999999999999995 4578999
Q ss_pred ccccccccccCCcee------eeecCCccccccCcccccCC----CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh
Q 007788 459 ADCGLHKLLADDIVF------SVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528 (589)
Q Consensus 459 ~DfGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~ 528 (589)
+|||+++.++++... -.....||..|.+||.+.-+ +.+.|+||||.||++|..+.|+.||.........
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI- 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI- 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-
Confidence 999999999765433 22345688999999988654 4688999999999999999999999754321100
Q ss_pred hhHHHhhcc-ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 529 ATFENFIDR-NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 529 ~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.....++.. ....+.-+....+...++++|+++.-+.|.+..++..+
T Consensus 694 LqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred HhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 000111111 11111123345667889999999998888887777643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=261.77 Aligned_cols=239 Identities=25% Similarity=0.382 Sum_probs=191.8
Q ss_pred CCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHh
Q 007788 321 NFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL 399 (589)
Q Consensus 321 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l 399 (589)
+||.||+|... +++.+|+|++...........+.+|++.+++++|+|++++++++.. ....++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHH
Confidence 58999999987 4899999999876543326789999999999999999999999854 36789999999999999998
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecCC
Q 007788 400 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 479 (589)
Q Consensus 400 ~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 479 (589)
..... +++..++.++.+++.+++|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 79 ~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 147 (244)
T smart00220 79 KKRGR----LSEDEARFYARQILSALEYLHSNG-----IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV 147 (244)
T ss_pred HhccC----CCHHHHHHHHHHHHHHHHHHHHcC-----eecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence 76432 889999999999999999999987 9999999999999999999999999988765432 122344
Q ss_pred ccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH-HHHHHHHHHHHHh
Q 007788 480 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE-SEAAKLGKMALVC 558 (589)
Q Consensus 480 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~C 558 (589)
++..|++||......++.++||||||+++||+++|..|+........ ................ .....+.+++.+|
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE---LFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 66789999999888899999999999999999999999865211111 1111111111111111 1557899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 007788 559 THEDPENRPTMEAVIEE 575 (589)
Q Consensus 559 ~~~dp~~RPs~~evl~~ 575 (589)
+..+|++||++.+++++
T Consensus 225 l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 225 LVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccCCchhccCHHHHhhC
Confidence 99999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=267.39 Aligned_cols=241 Identities=21% Similarity=0.301 Sum_probs=190.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
.+|....+||+|+||.|-+|.-+ +.+.+|||+++++.. .+..+--+.|-++|+-- +-|.++++...+ .+.+..|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLy 426 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLY 426 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhhee
Confidence 46788899999999999999876 567899999987642 12222234556666555 578889888766 5567899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+.+|+|--.+++.+. +.++.+..+|.+||-||-|||+++ |++||||..|||||.+|++||+|||++
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg-----IiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC-----eeeeeccccceEeccCCceEeeecccc
Confidence 99999999999999887653 777888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+.---+.. ....-.||+.|+|||.+...+|+..+|+|||||+||||+.|+.||++..+.. -+..+.+.. ..++
T Consensus 498 KEni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----lF~aI~ehn--vsyP 570 (683)
T KOG0696|consen 498 KENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQAIMEHN--VSYP 570 (683)
T ss_pred cccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHcc--CcCc
Confidence 85322211 2223458899999999999999999999999999999999999998765422 223333332 2356
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC
Q 007788 545 ESEAAKLGKMALVCTHEDPENRP 567 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RP 567 (589)
...+.+...++..-+.+.|.+|.
T Consensus 571 KslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccccHHHHHHHHHHhhcCCcccc
Confidence 66677777888888888998884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=235.84 Aligned_cols=255 Identities=20% Similarity=0.368 Sum_probs=190.6
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch-HHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.|...+.||+|.||+||+|+.+ .++.||+|+++.+..++ ......+|+.+++.++|.|||++++...+ .+..-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 3455678999999999999965 68899999998765433 33578899999999999999999998743 46788999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+.. +|..+.....+. ++......++.|+++||.|+|+.+ +.||||||+|.|++.+|+.|++|||+++.+
T Consensus 81 e~cdq-dlkkyfdslng~---~d~~~~rsfmlqllrgl~fchshn-----vlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSHN-----VLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred HHhhH-HHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhhh-----hhhccCCcceEEeccCCcEEecccchhhhc
Confidence 99966 898888776653 889999999999999999999988 999999999999999999999999999987
Q ss_pred cCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCC-cchhHHHHHhhhhHH-------------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLV-LTSSMRLAAESATFE------------- 532 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p-~~~~~~~~~~~~~~~------------- 532 (589)
+-... ......-|..|.+|.++.+.+ |++..|+||-||++.|+.....| |.+......-.+.+.
T Consensus 152 gipvr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred CCceE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 65432 223344577899999998866 89999999999999999975544 443321111111111
Q ss_pred -HhhccccCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 533 -NFIDRNLKGKFS---------ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 533 -~~~~~~~~~~~~---------~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
..-|....+.++ +.....=.++....+.-+|.+|.++++.+++-
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 111111111111 11122233555555666999999999988763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=294.22 Aligned_cols=264 Identities=16% Similarity=0.181 Sum_probs=173.4
Q ss_pred hhccCccccccccCCCccEEEEEec-C----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeee----c
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-D----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC----S 377 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~----~ 377 (589)
..++|...+.||+|+||.||+|.+. + +..||||++.... ....+..| .+....+.+++.++..+. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4578899999999999999999976 4 6899999876432 11112221 122222333333222111 1
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCC----------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEec
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGS----------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR 441 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~ 441 (589)
......++||||+++++|.+++...... .....+.....++.|++.||+|||+.+ |+||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-----IiHR 279 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-----IVHR 279 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-----EEeC
Confidence 3346789999999999999998754210 001122345679999999999999987 9999
Q ss_pred CCCCCCeeecC-CCceEEccccccccccCCceeeeecCCccccccCcccccCC----------------------CCCCc
Q 007788 442 NLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----------------------RFTER 498 (589)
Q Consensus 442 dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~ 498 (589)
||||+|||+++ ++.+||+|||+++.+.....+......++++|+|||.+... .+..+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 57999999999986644332223334567889999965322 23456
Q ss_pred chhhhHHHHHHHHHhCCCCcchhHHHHH---h--hh---hHHHhhccccCCCC------CHHHHHHHHHHHHHhcccCCC
Q 007788 499 SDIFAFGVIILQILTGSLVLTSSMRLAA---E--SA---TFENFIDRNLKGKF------SESEAAKLGKMALVCTHEDPE 564 (589)
Q Consensus 499 ~Dv~s~Gvvl~elltg~~p~~~~~~~~~---~--~~---~~~~~~~~~~~~~~------~~~~~~~l~~l~~~C~~~dp~ 564 (589)
+|||||||+||||+++..+......... . .. .+...+........ .........+++.+|++.||+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 7999999999999998777654321100 0 00 01111111100000 000122345899999999999
Q ss_pred CCCCHHHHHHHHHhhh
Q 007788 565 NRPTMEAVIEELTVAA 580 (589)
Q Consensus 565 ~RPs~~evl~~L~~~~ 580 (589)
+|||++|+++|-+...
T Consensus 440 kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 440 QRISAKAALAHPYFDR 455 (566)
T ss_pred cCCCHHHHhCCcCcCC
Confidence 9999999999866543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=257.75 Aligned_cols=267 Identities=19% Similarity=0.344 Sum_probs=199.1
Q ss_pred CccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC------CCCe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR------GRGE 382 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~ 382 (589)
|....+||+|.||.||+|+.+ .|+.||+|+..-+.. ..-.....+|+++|..++|+|++.++..|... ....
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444578999999999999976 578899887654322 22234678999999999999999999988532 2335
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.|+||++++. +|..+|..... .++..++.+++.++..||.|+|... |+|||+|+.|||++.++.+||+|||
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~k-----ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRNK-----ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHhh-----HHhhcccHhhEEEcCCceEEeeccc
Confidence 8999999976 88888876532 4889999999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCcee---eeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh----------
Q 007788 463 LHKLLADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES---------- 528 (589)
Q Consensus 463 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~---------- 528 (589)
+++.+...... ......-|..|.+||.+.+. .|+++.|||.-|||+.||.|+.+.+.+..+...-.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99876432110 11223347789999998875 59999999999999999999998886654321110
Q ss_pred ---------hhHHHhhc--cccCCCCC--HH------HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccccc
Q 007788 529 ---------ATFENFID--RNLKGKFS--ES------EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATF 586 (589)
Q Consensus 529 ---------~~~~~~~~--~~~~~~~~--~~------~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~~ 586 (589)
-.+.+.+. +-..+... ++ ..+...+++...+..||.+|+++++++.+-..-+..++++
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqa 326 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQA 326 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchh
Confidence 01111110 00000000 01 1235678888889999999999999999988887777643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=274.18 Aligned_cols=248 Identities=21% Similarity=0.319 Sum_probs=198.1
Q ss_pred ccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
.++||+|.||+||-|+.+ +|+.||||++.+... ...+.+..+|+.+|++++||.||.+--.| ++++.+++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhc
Confidence 478999999999999975 799999999987654 34457899999999999999999997766 66789999999996
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC---CceEEcccccccccc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCGLHKLLA 468 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfGla~~~~ 468 (589)
|.=|+..|....+ .++...-..++.||+.||.|||.++ |+|+||||+|||+... -++||+|||.|+..+
T Consensus 647 GDMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~kn-----IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 647 GDMLEMILSSEKG---RLPERITKFLVTQILVALRYLHFKN-----IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred chHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhhcc-----eeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 6555555655443 3888888889999999999999998 9999999999999653 468999999999988
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
...... ...||+.|.|||++.+..|...-|+||.||++|--++|..||....+.....+... + .+......+..
T Consensus 719 EksFRr--sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-F---MyPp~PW~eis 792 (888)
T KOG4236|consen 719 EKSFRR--SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-F---MYPPNPWSEIS 792 (888)
T ss_pred hhhhhh--hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-c---ccCCCchhhcC
Confidence 765432 45689999999999999999999999999999999999999965433211111111 1 11122234556
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
...++++...++..-++|-|.+..+.+.|
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 67778888888888889999988876655
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=241.35 Aligned_cols=202 Identities=19% Similarity=0.353 Sum_probs=167.8
Q ss_pred ccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEe
Q 007788 312 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
.....||+|++|.|-+-++. +|+..|||++...-..+..+..+.|+.+..+. ..|.+|.++|.+.. ...+++.||.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIcME~ 126 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWICMEL 126 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEEeHHH
Confidence 34567999999999988864 79999999998877667778888899887665 69999999998754 4679999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
|+- ||..+-...-..+..+++...=+||..+.+||.|||++- .++|||+||+|||++.+|++|+||||++..+.+
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL----~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL----SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh----hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 954 888877654444556889999999999999999999864 399999999999999999999999999988766
Q ss_pred CceeeeecCCccccccCcccccC----CCCCCcchhhhHHHHHHHHHhCCCCcchhH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTT----GRFTERSDIFAFGVIILQILTGSLVLTSSM 522 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~ 522 (589)
+.... ...|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.|+..+.
T Consensus 202 SiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 SIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 54321 1234556999998864 358999999999999999999999998764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=260.80 Aligned_cols=257 Identities=17% Similarity=0.265 Sum_probs=197.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC--C----CccceeeeeecCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--E----NIIRLRGFCCSRGR 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~g~~~~~~~ 380 (589)
+++|.+...+|+|.||.|-++..+ .+..||||+++.- ..-....+-|++++.++.+ | -+|.+.+|+ +-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hcc
Confidence 678999999999999999999876 4789999998754 2334556789999999942 1 467777777 446
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC--------
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-------- 452 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-------- 452 (589)
+..+||+|.+ |-|+.++|....- .+++......|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~k-----l~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDLK-----LTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhcc-----eeecCCChheEEEeccceEEEec
Confidence 8899999998 6699999986543 45888899999999999999999998 999999999999831
Q ss_pred ------------CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcch
Q 007788 453 ------------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS 520 (589)
Q Consensus 453 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~ 520 (589)
+..+||+|||.|..-.... .....|..|.|||++.+-.++.++||||+||||+|+.||...|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 3458999999998765543 234467789999999999999999999999999999999988864
Q ss_pred hHHHH---HhhhhH----HHhhccc----------cC-----------------------CCCCHHHHHHHHHHHHHhcc
Q 007788 521 SMRLA---AESATF----ENFIDRN----------LK-----------------------GKFSESEAAKLGKMALVCTH 560 (589)
Q Consensus 521 ~~~~~---~~~~~~----~~~~~~~----------~~-----------------------~~~~~~~~~~l~~l~~~C~~ 560 (589)
..... ..+..+ ..++... +. -.....+..++.+|+..++.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 32111 100000 0000000 00 01124567789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhh
Q 007788 561 EDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 561 ~dp~~RPs~~evl~~L~~~~ 580 (589)
.||.+|+|++|++++-....
T Consensus 392 fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFAR 411 (415)
T ss_pred cCccccccHHHHhcCHHhhc
Confidence 99999999999998865543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=269.75 Aligned_cols=254 Identities=18% Similarity=0.272 Sum_probs=207.1
Q ss_pred ccCccccccccCCCccEEEEEecCCc-EEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGT-LVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++.....||-|+||.|-++..+... .+|+|.+++... ...+.....|-.+|.+.+.|.||+++.-| .+.+.+|+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~kyvYm 497 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSKYVYM 497 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccchhhhh
Confidence 34455667999999999999986544 388888875432 23345677899999999999999999888 55688999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
+||-|-||.|+..|+++.. ++..+...++..+.+|++|||+++ ||+|||||+|.|+|.+|-+||.|||+|+
T Consensus 498 LmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~-----iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG-----IIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC-----ceeccCChhheeeccCCceEEeehhhHH
Confidence 9999999999999987753 888888899999999999999998 9999999999999999999999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....+. ....-.||+.|.|||.+.+...+.++|.||+|+++|||+||++||.+..........+..+ | ...++.
T Consensus 569 ki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-d---~i~~Pr 642 (732)
T KOG0614|consen 569 KIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-D---KIEFPR 642 (732)
T ss_pred HhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-h---hhhccc
Confidence 887653 3445578999999999999999999999999999999999999998776554443333222 1 123445
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA 579 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~~ 579 (589)
.......+++.+.+..+|.+|.. +.|+-+|-|..
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 55666778888888889999975 78888887753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=283.45 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=185.9
Q ss_pred CccccccccCCCc-cEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEE
Q 007788 311 FSEVNLLGKGNFS-SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 311 f~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
|...+++|.|+-| .||+|.+. |+.||||++-.+. ..-..+|+..|+.- +|||||++ ||.+.++...||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEE--EeeccCCceEEEEeh
Confidence 3334678898877 58999995 7899999986432 33456899999888 59999999 566788889999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---C--CceEEccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---Q--FNPLIADCGL 463 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~--~~~kl~DfGl 463 (589)
.| ..+|.+++...........-...+.+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||+
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-----iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK-----IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc-----cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99 55999999874111111111344678899999999999988 999999999999976 3 5689999999
Q ss_pred cccccCCc--eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhC-CCCcchhHHHHHhhhhHHHhhccccC
Q 007788 464 HKLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 464 a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
++.+..+. ........||-||+|||.+....-+.++|+||+|||+|+.++| ..||.+..........-...+. .+.
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~-~L~ 736 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLV-HLE 736 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcccee-eec
Confidence 99886543 2234456788999999999999889999999999999999997 8999776443211100000000 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...++ +..+|+.++++.||..||++.+|+.|
T Consensus 737 --~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 737 --PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11112 78899999999999999999999965
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=266.91 Aligned_cols=236 Identities=19% Similarity=0.338 Sum_probs=186.7
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.-|..++.||-|+||.|.++.- ++...+|.|.+++... .........|-++|+....+-||+|+--| .+.+..|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEE
Confidence 3467778899999999999974 4577899999976542 23335567899999999999999996555 66789999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||++|||+-.+|...+ .+.+..+..++.+++.|+++.|..| +|||||||+|||||.+|++||+|||++.
T Consensus 707 VMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG-----FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred EEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc-----ceecccCccceEEccCCceeeeeccccc
Confidence 999999999999998664 3788888889999999999999988 9999999999999999999999999975
Q ss_pred ccc---CCceee--------------------------------------eecCCccccccCcccccCCCCCCcchhhhH
Q 007788 466 LLA---DDIVFS--------------------------------------VLKTSAAMGYLAPEYVTTGRFTERSDIFAF 504 (589)
Q Consensus 466 ~~~---~~~~~~--------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~ 504 (589)
-+. +..++. .....||..|+|||++....|+..+|+||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 431 000000 012357888999999999999999999999
Q ss_pred HHHHHHHHhCCCCcchhHHHHH--hhhhHHHhhccccCCCCCHHHHHHHHHHH
Q 007788 505 GVIILQILTGSLVLTSSMRLAA--ESATFENFIDRNLKGKFSESEAAKLGKMA 555 (589)
Q Consensus 505 Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 555 (589)
|||||||+.|+.||-....... ....++.+++-...+..+.++...+.+|+
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC 910 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh
Confidence 9999999999999965433221 12345566666666777777766666664
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=244.90 Aligned_cols=246 Identities=16% Similarity=0.284 Sum_probs=191.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|...++||+|+|.+|-.++++ +.+.+|+|+++++.. +...+....|-.+..+. +||.+|.+..++ .+....
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceE
Confidence 467888999999999999999975 678899999986543 22334445566666655 799999998877 455789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++|.||+++|+|--+++..+ .+++..+..+..+|..||.|||+++ ||.||||..|||+|..|.+||+|||.
T Consensus 327 ffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg-----iiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred EEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC-----eeeeeccccceEEccCCceeecccch
Confidence 99999999999987777654 3888888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhH----HHHHhhhhHHHhhcccc
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM----RLAAESATFENFIDRNL 539 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~ 539 (589)
++.--.... ......||+.|+|||.+.+..|...+|+|++||+++||+.|+.||+--. +...+.--+.-++...+
T Consensus 398 cke~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 398 CKEGLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred hhcCCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 875322111 2234468999999999999999999999999999999999999996321 11111112233333333
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRP 567 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RP 567 (589)
+ .+...+.....+...-+.+||.+|.
T Consensus 477 r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 3 3444555666777778889999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=231.33 Aligned_cols=253 Identities=17% Similarity=0.276 Sum_probs=194.6
Q ss_pred hccCccccccccCCCccEEEEE-ecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|++.+.+|+|.++.||.|. ..+++.++||+++. ...+...+|+.+|..++ ||||++++++..+.......+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4567788999999999999998 45788999999974 34567889999999997 999999999998887888999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceEEcccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLH 464 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfGla 464 (589)
|+||+.+.+...+-. .++......++.++++||.|+|+.| |.|||+||+|||+|.. -.++|+|+|+|
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G-----ImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG-----IMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC-----cccccCCcceeeechhhceeeeeecchH
Confidence 999999988777654 2667778889999999999999999 9999999999999964 56899999999
Q ss_pred ccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHH---HHH-------------h
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMR---LAA-------------E 527 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~---~~~-------------~ 527 (589)
.++.+...+... .++.-|.-||.+.. ..|+..-|+|||||+|.+|+..+.||..... +.. .
T Consensus 181 EFYHp~~eYnVR--VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 181 EFYHPGKEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hhcCCCceeeee--eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 998776554432 23334788998876 4588999999999999999999999953211 000 0
Q ss_pred --------hhhHHHhhccccCC--------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 528 --------SATFENFIDRNLKG--------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 528 --------~~~~~~~~~~~~~~--------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+.+++....+. ....-...+..+++...+..|-.+|+|++|.+.+-..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 00111111111110 0001123567788888889999999999999987544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=233.31 Aligned_cols=212 Identities=32% Similarity=0.566 Sum_probs=181.8
Q ss_pred cccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCCCh
Q 007788 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL 395 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL 395 (589)
||+|.+|.||++...+ ++.+++|++...........+.+|++.+++++|++++++++++.. ....++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcH
Confidence 6899999999999864 899999999866533235679999999999999999999999854 3688999999999999
Q ss_pred HHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEccccccccccCCceee
Q 007788 396 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFS 474 (589)
Q Consensus 396 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~ 474 (589)
.+++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~ 149 (215)
T cd00180 79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG-----IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L 149 (215)
T ss_pred HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence 99997653 24889999999999999999999987 999999999999999 89999999999886654321 1
Q ss_pred eecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHH
Q 007788 475 VLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553 (589)
Q Consensus 475 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (589)
.....+...|++||..... .++.+.|+|++|+++++| ..+.+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~ 192 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKD 192 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHH
Confidence 1223355679999999877 788999999999999998 57889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 007788 554 MALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 554 l~~~C~~~dp~~RPs~~evl~~L 576 (589)
++..|++.+|++||++.++++++
T Consensus 193 ~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 193 LIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHhhCCcccCcCHHHHhhCC
Confidence 99999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-30 Score=236.38 Aligned_cols=254 Identities=20% Similarity=0.343 Sum_probs=186.9
Q ss_pred cccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC---CeEEEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GECFLIY 387 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~~lv~ 387 (589)
..+.||-|+||.||...+. +|+.||.|++..-.. -...+.+.+|+++|.-++|.|++..+++...... .+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3478999999999999875 899999998864321 2233578899999999999999999987632222 2568888
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
|.|.. ||+..+- +.++++-....-+..||++||.|||+.+ |.||||||.|.|++.|...||+|||+++.-
T Consensus 137 ELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~-----ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 137 ELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTAN-----ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhcc-----hhhccCCCccEEeccCceEEeccccccccc
Confidence 88844 6666654 3456888888889999999999999998 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHH--------------------HH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRL--------------------AA 526 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~--------------------~~ 526 (589)
..+.........-|..|.|||.+.+. .|+.+.||||.||++.|++..+..|...... +-
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 55443333444456679999999875 5899999999999999999888777532211 00
Q ss_pred hhhhHHHhhccccCCC---------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 527 ESATFENFIDRNLKGK---------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 527 ~~~~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
+... ..++....+.. .+.....+...+...++..||..|.+..+.+.++.
T Consensus 287 EGAk-~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAK-NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhH-HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111 11121111110 01122344556667778999999999998887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=249.46 Aligned_cols=198 Identities=21% Similarity=0.294 Sum_probs=166.4
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hH-----HHHHHHHHHHHhccC---CCCccceeeeee
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SE-----EAEFVKGLYLLTSLR---HENIIRLRGFCC 376 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~-----~~~~~~e~~~l~~l~---H~niv~l~g~~~ 376 (589)
..+|+..+.+|.|+||.|+.|.++ +...|+||.+.++..- .. .-..-.||.+|..++ |+||+++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 346888899999999999999987 5678999998765421 00 112335899999997 99999999999
Q ss_pred cCCCCeEEEEEEeC-CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 377 SRGRGECFLIYDFA-PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 377 ~~~~~~~~lv~Ey~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
++.+..|++||-- ++-+|.+++..+. .+++.....|..||+.|+++||+.+ |||||||-+||.++.+|-
T Consensus 639 -Eddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~-----ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 639 -EDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG-----IVHRDIKDENVIVDSNGF 708 (772)
T ss_pred -ecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC-----ceecccccccEEEecCCe
Confidence 5568899999975 4569999997664 3899999999999999999999998 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcc
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLT 519 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~ 519 (589)
+||+|||.+.+...+.. ..-.||++|.|||++.+.+| +..-|||++|++||.++....||+
T Consensus 709 ~klidfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEeeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999887665533 23458899999999999987 566899999999999998888875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=227.75 Aligned_cols=200 Identities=28% Similarity=0.485 Sum_probs=168.5
Q ss_pred CccccccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
|...+.||+|++|.||++...+ ++.+++|.+.........+.+.+|++.+.+++|+|++++++++.. ....++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEec
Confidence 4456789999999999999875 899999999865433256788999999999999999999998854 4678999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++++|.+++...... +++.....++.+++.+++|||+.+ ++|+|+++.||+++.++.++|+|||.+.....
T Consensus 79 ~~~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 79 CEGGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSLG-----IVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred cCCCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 9999999999765321 789999999999999999999987 99999999999999999999999999887654
Q ss_pred CceeeeecCCccccccCcccc-cCCCCCCcchhhhHHHHHHHHHhCCCCcch
Q 007788 470 DIVFSVLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVLTS 520 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~ 520 (589)
..........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 320011122355679999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=230.48 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=191.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~ 382 (589)
.+|.....+|.|.- .|..|.+. .++.||+|++..... ....+...+|...+..+.|+||++++.++.... -.+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666677888887 66666644 588999998865432 223356678999999999999999999885321 135
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.|+|||||. .+|...++.. ++-.+...|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||
T Consensus 96 ~y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~-----IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSAG-----IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcc-----eeecccCcccceecchhheeeccch
Confidence 799999994 5898888732 677788899999999999999998 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH----------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------- 532 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~---------- 532 (589)
+|+.-..+ ........+.-|.|||++.+..+.+.+||||.||++.||++|+..|.+......+.+..+
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 99876554 233344455669999999998899999999999999999999988875433322221110
Q ss_pred -----------------------Hhh-ccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 533 -----------------------NFI-DRNLKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 533 -----------------------~~~-~~~~~~--~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
+.+ |..+.. +.+........+++.+++-.+|++|-+++++++|
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 000010 1122345677899999999999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=234.26 Aligned_cols=134 Identities=21% Similarity=0.311 Sum_probs=111.8
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-----C---CCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----H---ENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~g~~~~~ 378 (589)
..+|...++||-|.|++||+|.+. +.+.||+|+.+.. ..-....+.||++|++++ | ..||+|+++|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 367888999999999999999975 6789999998754 344456789999999884 2 4799999988654
Q ss_pred C--CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee
Q 007788 379 G--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450 (589)
Q Consensus 379 ~--~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill 450 (589)
. ...+++|+|++ |.+|..++....-. -++.....+|+.||+.||.|||.+.. |||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ecg----IIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHRECG----IIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhcC----ccccCCCcceeee
Confidence 3 34789999999 77999999765433 38889999999999999999998764 9999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=250.25 Aligned_cols=254 Identities=18% Similarity=0.282 Sum_probs=200.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|.....+|.|.+|.|||++.. .++..|||+++... .....-..+|+-+++..+|||||.++|-+... +..+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhh--cCcEEE
Confidence 356677789999999999999965 78999999998765 33344566889999999999999999988543 568999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+.+|+|++.-+... ++++.+...+++...+||+|||+.+ -+|||||-.||++++.+.+|++|||.+..
T Consensus 91 MEycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~g-----k~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQG-----KIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred EEecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcCC-----cccccccccceeecccCceeecccCchhh
Confidence 99999999999887654 4888888999999999999999998 69999999999999999999999999876
Q ss_pred ccCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
+..... +.....||+.|||||+.. .+.|.+++|||+.|+...|+---+.|..+........-..+...++ ...+.
T Consensus 162 itati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp-p~lkD 239 (829)
T KOG0576|consen 162 ITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP-PTLKD 239 (829)
T ss_pred hhhhhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC-CcccC
Confidence 654332 233456899999999874 4569999999999999999988888876554432211111111111 11122
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.....+.+-++++.|+..+|++||+++.++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 33456678899999999999999999887763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=219.71 Aligned_cols=248 Identities=20% Similarity=0.327 Sum_probs=178.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv 386 (589)
+.|.+.+.+|+|.||.+-+++++ ..+.+++|-+.... ...++|.+|..---.+ .|.||+.-++... +..+..+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEe
Confidence 46778899999999999999987 57889999887653 4567899988654455 5999999887653 345678899
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec--CCCceEEcccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPLIADCGLH 464 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfGla 464 (589)
+||+|.|||.+-+...+ +.+....+++.|++.|+.|||+++ +||||||.+|||+- +...+||+|||++
T Consensus 101 qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHskn-----lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKN-----LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred eccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccc-----hhhcccccceEEEecCCccEEEeeecccc
Confidence 99999999999886543 777888999999999999999998 99999999999993 4568999999998
Q ss_pred ccccCCceeeeecCCccccccCcccccCC-----CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
+..+.... ...-+..|.+||..... ...+.+|+|.||+++|.++||..||....-.......+..+.....
T Consensus 171 ~k~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 171 RKVGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cccCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 86654221 11223448999976532 2567899999999999999999999743211111112222221111
Q ss_pred C--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007788 540 K--GKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 573 (589)
Q Consensus 540 ~--~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl 573 (589)
. +..-......+.++..+-+..+|++|=-..++.
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 1 001112244566777777888998884444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=211.26 Aligned_cols=167 Identities=16% Similarity=0.201 Sum_probs=127.8
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 472 (589)
|+|.+++..... .++|..++.|+.|++.||+|||+.+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~~-----------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQA-----------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC-----------CcccEeEcCccceee--ccceEeecccc-
Confidence 789999976432 4999999999999999999999753 999999999999999 99988664422
Q ss_pred eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC--CCCHHHHH-
Q 007788 473 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSESEAA- 549 (589)
Q Consensus 473 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 549 (589)
..++..|+|||++.+..++.++|||||||++|||+||+.||....................... ........
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 2467889999999999999999999999999999999999965432211111111111111000 11222233
Q ss_pred -HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 550 -KLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 550 -~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+.+++.+||+.+|++||++.|++++++...+
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 68999999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=265.45 Aligned_cols=201 Identities=15% Similarity=0.162 Sum_probs=142.5
Q ss_pred ccCC-CCccceeeeeecC-----CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCC
Q 007788 362 SLRH-ENIIRLRGFCCSR-----GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435 (589)
Q Consensus 362 ~l~H-~niv~l~g~~~~~-----~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 435 (589)
.++| +||++++++|... ..+..+.++||+ +++|.++|.... ..+++.+++.++.||++||+|||+.+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3445 6888888876211 123467788988 669999997532 34899999999999999999999988
Q ss_pred CCeEecCCCCCCeeecC-------------------CCceEEccccccccccCCc---------------eeeeecCCcc
Q 007788 436 PAIVHRNLSVEKVLIDQ-------------------QFNPLIADCGLHKLLADDI---------------VFSVLKTSAA 481 (589)
Q Consensus 436 ~~ivH~dlk~~Nill~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~~~~~ 481 (589)
|+||||||+||||+. ++.+|++|||+++...... ........+|
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999954 4556777777765432100 0001112467
Q ss_pred ccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhccc
Q 007788 482 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHE 561 (589)
Q Consensus 482 ~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~ 561 (589)
+.|+|||++.+..++.++|||||||+||||++|..|+......... .......+ ...........++.+||+.
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSS--LRHRVLPP-----QILLNWPKEASFCLWLLHP 251 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHH--HHHhhcCh-----hhhhcCHHHHHHHHHhCCC
Confidence 7899999999999999999999999999999998886533211100 00111111 1111233456888899999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 007788 562 DPENRPTMEAVIEELTV 578 (589)
Q Consensus 562 dp~~RPs~~evl~~L~~ 578 (589)
+|.+||+|.|++++.+.
T Consensus 252 ~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 252 EPSCRPSMSELLQSEFI 268 (793)
T ss_pred ChhhCcChHHHhhchhh
Confidence 99999999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=231.76 Aligned_cols=255 Identities=17% Similarity=0.205 Sum_probs=193.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC------CCCccceeeeeecCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR------HENIIRLRGFCCSRGR 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~g~~~~~~~ 380 (589)
-.+|.+....|+|-|+.|.+|... -|..||||++.... ...+.=+.|+++|.+|. --++++++..| ...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F--~hk 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF--KHK 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh--hhc
Confidence 467888888999999999999975 47899999998763 33445568999999994 34788888777 345
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceEEc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIA 459 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~ 459 (589)
+..++|+|-+. -+|.++|..-+. .--|.......++.|+..||..|-..+ |+|.||||.|||+++. ..+|||
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~-----vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG-----VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC-----eeecccCccceEeccCcceeeec
Confidence 88999999884 489999986543 334777888999999999999999887 9999999999999875 457999
Q ss_pred cccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH-----hh------
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-----ES------ 528 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~-----~~------ 528 (589)
|||.|.........+ ..-+--|.|||.+.+-+|+...|+||.||.||||.||+..|.+.....+ +.
T Consensus 580 DfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 580 DFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 999998776543211 1122349999999999999999999999999999999999875321100 00
Q ss_pred ----------hh----------------------HHHhhcc------ccCC-----CCCHHHHHHHHHHHHHhcccCCCC
Q 007788 529 ----------AT----------------------FENFIDR------NLKG-----KFSESEAAKLGKMALVCTHEDPEN 565 (589)
Q Consensus 529 ----------~~----------------------~~~~~~~------~~~~-----~~~~~~~~~l~~l~~~C~~~dp~~ 565 (589)
+. +...+.+ .+.+ .........+.+|...|+..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 00 0000000 0111 112344677889999999999999
Q ss_pred CCCHHHHHHHH
Q 007788 566 RPTMEAVIEEL 576 (589)
Q Consensus 566 RPs~~evl~~L 576 (589)
|.|..++|+|.
T Consensus 737 Rit~nqAL~Hp 747 (752)
T KOG0670|consen 737 RITVNQALKHP 747 (752)
T ss_pred cCCHHHHhcCC
Confidence 99999998763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-27 Score=216.52 Aligned_cols=245 Identities=20% Similarity=0.394 Sum_probs=192.1
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCch-HHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
..|.+...|..|+|+++ |..+++|++....... ..++|.+|.-.|+-+.||||+.++|.| ..+....++..||+.|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceEeeeeccch
Confidence 35788899999999997 4456668887654322 236799999999999999999999999 4456788999999999
Q ss_pred ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc--cccccccccCCc
Q 007788 394 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA--DCGLHKLLADDI 471 (589)
Q Consensus 394 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~--DfGla~~~~~~~ 471 (589)
+|...|++..+ -..+-.+.+++|.++|+|++|||+.. |-|.--.|.+..|++|++.+++|+ |--++.
T Consensus 273 slynvlhe~t~--vvvd~sqav~faldiargmaflhsle---p~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 273 SLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE---PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred HHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc---hhhhhhhcccceEEecchhhhheecccceeee------
Confidence 99999997643 34677889999999999999999875 435555799999999999999875 221111
Q ss_pred eeeeecCCccccccCcccccCCCC---CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 472 VFSVLKTSAAMGYLAPEYVTTGRF---TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 472 ~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
...+..-.+.||+||.++..+- -..+|+|||.+++||+.|...||.+....... ..+.-..++..+++..+
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----mkialeglrv~ippgis 415 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----MKIALEGLRVHIPPGIS 415 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----hhhhhccccccCCCCcc
Confidence 1112222456999999987653 45799999999999999999999876543222 23334566677788888
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+.+++.-|+..||.+||.++.++-.|+..
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 9999999999999999999999999888764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-25 Score=214.82 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=190.8
Q ss_pred HHHhhccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecC
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR 378 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~ 378 (589)
+....+.|...++||.|.|++||++.+. .++.||+|.+...+. ......|+++|..+. +.||+++.+++ .
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~--r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCF--R 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhh--c
Confidence 3344567888999999999999999864 367899999976553 335778999999995 99999999877 4
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceE
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL 457 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~k 457 (589)
..+.+.+|+||++..+..++... ++......+...+..||+++|..| ||||||||+|+|.+.. +.-.
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G-----IvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG-----IVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC-----ccccCCCccccccccccCCce
Confidence 56789999999999999888863 667888899999999999999998 9999999999999865 4568
Q ss_pred EccccccccccC--------C-----c---------------------ee---------eeecCCccccccCcccccCC-
Q 007788 458 IADCGLHKLLAD--------D-----I---------------------VF---------SVLKTSAAMGYLAPEYVTTG- 493 (589)
Q Consensus 458 l~DfGla~~~~~--------~-----~---------------------~~---------~~~~~~~~~~y~aPE~~~~~- 493 (589)
|.|||+|..... . . .. ......||+||.|||++...
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 999999872210 0 0 00 01124588999999998764
Q ss_pred CCCCcchhhhHHHHHHHHHhCCCCcchhHHH-------H-------------------Hhh-h----------hHHHhhc
Q 007788 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRL-------A-------------------AES-A----------TFENFID 536 (589)
Q Consensus 494 ~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~-------~-------------------~~~-~----------~~~~~~~ 536 (589)
..++++||||-|||++.+++++.||...... + .+. . .+..+.-
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 4688999999999999999999999532110 0 000 0 0000000
Q ss_pred cccC--------CC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 537 RNLK--------GK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 537 ~~~~--------~~-~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
..+. .. ..+..+..+.++..+|+..+|.+|-|+++.+++-
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0000 00 0111244788999999999999999999999763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=215.06 Aligned_cols=166 Identities=16% Similarity=0.145 Sum_probs=127.3
Q ss_pred hhccCccccccccCCCccEEEEEec--CCcEEEEEEeccCC----CchHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
..++|...+.||+|+||+||+|..+ +++.||||++.... .......|.+|++++++++|+|+++.+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 3467888899999999999999875 57888999875331 122345689999999999999999643222
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC-CCCCeeecCCCceEEc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL-SVEKVLIDQQFNPLIA 459 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl-k~~Nill~~~~~~kl~ 459 (589)
+..++||||+++++|... .. .. ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~g-----IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRAG-----ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHCC-----CeeCCCCCcceEEEcCCCCEEEE
Confidence 357999999999999632 11 11 1467889999999999988 999999 9999999999999999
Q ss_pred cccccccccCCceee-------eecCCccccccCcccccCC
Q 007788 460 DCGLHKLLADDIVFS-------VLKTSAAMGYLAPEYVTTG 493 (589)
Q Consensus 460 DfGla~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~ 493 (589)
|||+++.+....... .....+++.|+|||.+...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999998765432111 1233456779999988654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=201.69 Aligned_cols=262 Identities=17% Similarity=0.183 Sum_probs=190.8
Q ss_pred cCccccccccCCCccEEEEEecCC--cEEEEEEeccCCCchHHHHHHHHHHHHhccCC----CCccceeeeeecCCCCeE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRDG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH----ENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~g~~~~~~~~~~ 383 (589)
+|.+.+.||+|+||.||.+...+. ..+|+|........... .+..|+.++..+.. +++..+++... ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence 788899999999999999997653 57888887765433222 57778888888763 57788877663 234578
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-----CceEE
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-----FNPLI 458 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-----~~~kl 458 (589)
++||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G-----~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG-----FIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC-----cccCCcCHHHeeecCCCCcccceEEE
Confidence 9999988 789999876544 345999999999999999999999998 9999999999999865 46899
Q ss_pred ccccccc--cccCCce----ee---eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh
Q 007788 459 ADCGLHK--LLADDIV----FS---VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529 (589)
Q Consensus 459 ~DfGla~--~~~~~~~----~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~ 529 (589)
.|||+++ .+..... .. .....||.+|.++....+...+.+.|+||++.++.|++.|..||......... .
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-~ 247 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-S 247 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-H
Confidence 9999998 3321110 01 12344889999999999999999999999999999999999999654321111 1
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+................+..+.++...+-..+...+|....+...++.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11111111111001122234555666666668999999999999888766543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-21 Score=195.86 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=195.1
Q ss_pred CccccccccCCCccEEEEEecCCcEEEEEEeccCCCch--HHHHHHHHHHHHhccCCC-CccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHE-NIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~~~lv~ 387 (589)
|.....||.|+||.||++... ..+++|.+....... ....|.+|+..++.+.|+ +++++.+++. .....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEEE
Confidence 455678999999999999987 889999998765444 367899999999999988 7999999883 334579999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGla~~ 466 (589)
||+.++++.+++...... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++... .++++|||.++.
T Consensus 78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~-----~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG-----IIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 999999999776654311 24788899999999999999999988 99999999999999998 799999999986
Q ss_pred ccCCcee-----eeecCCccccccCcccccC---CCCCCcchhhhHHHHHHHHHhCCCCcchhHH---HHHhhhhHHHhh
Q 007788 467 LADDIVF-----SVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMR---LAAESATFENFI 535 (589)
Q Consensus 467 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~---~~~~~~~~~~~~ 535 (589)
....... ......++..|+|||.+.+ ..+....|+||+|++++++++|..|+..... .......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 5543221 2244567888999999987 5788999999999999999999999755432 111111111111
Q ss_pred ccccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 536 DRNLKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 536 ~~~~~~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
.+....... ......+.+++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 110111111 1123578899999999999999999887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=173.66 Aligned_cols=256 Identities=16% Similarity=0.230 Sum_probs=191.2
Q ss_pred hccCccccccccCCCccEEEEE-ecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC-CCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~l 385 (589)
.+.|...+.||+|+||.+|.|. ..+|..||||.-.... ...+...|.++...++| ..|..+..|. .+...-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhc--ccccccee
Confidence 3578889999999999999998 5689999999876543 23457778888888864 5555565555 33466789
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC---CceEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG 462 (589)
|||.+ +.+|+++..-+.. .++..+.+-+|-|+..-++|+|.++ ++||||||+|+|..-+ ..+.++|||
T Consensus 89 VMdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~-----fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN-----FIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred eeecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc-----cccccCCccceeeccccccceEEEEecc
Confidence 99998 8899999987764 3899999999999999999999998 9999999999999643 457899999
Q ss_pred ccccccCCcee------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 463 LHKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 463 la~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
+|+.+.+.... ......||.+|.+--...+..-+.+.|+-|+|.+|.+.--|..||.+.... ...+..+.+..
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-tk~QKyEkI~E 238 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-TKKQKYEKISE 238 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-hHHHHHHHHHH
Confidence 99987543221 122345788898877776777788999999999999999999999865321 12223333333
Q ss_pred cccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 537 RNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 537 ~~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...... .....+.++.-.+..|-..--++-|+..-+-+..+.
T Consensus 239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 222211 123346677788888888888888887766655443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.5e-21 Score=177.52 Aligned_cols=140 Identities=17% Similarity=0.120 Sum_probs=107.9
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCch-H-------HH-----------------HHHHHHHHHhccCCCCc
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-E-------EA-----------------EFVKGLYLLTSLRHENI 368 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~-------~~-----------------~~~~e~~~l~~l~H~ni 368 (589)
...||+|+||.||+|...+|+.||||+++...... . .. ....|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999998899999999997542110 0 01 22348999999988877
Q ss_pred cceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHh-cCCCCCCCCeEecCCCCCC
Q 007788 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL-HSSEVNKPAIVHRNLSVEK 447 (589)
Q Consensus 369 v~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~~ivH~dlk~~N 447 (589)
.....+.. ...++||||++++++....... ..+++....+++.|++.+|+|+ |+.+ |+||||||+|
T Consensus 82 ~~p~~~~~----~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g-----iiHrDlkP~N 148 (190)
T cd05147 82 PCPEPILL----KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR-----LVHADLSEYN 148 (190)
T ss_pred CCCcEEEe----cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHH
Confidence 44333321 2238999999988776543222 2488899999999999999999 6777 9999999999
Q ss_pred eeecCCCceEEccccccccc
Q 007788 448 VLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 448 ill~~~~~~kl~DfGla~~~ 467 (589)
||++ ++.++|+|||++...
T Consensus 149 Ili~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 149 LLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEE-CCcEEEEEccccccC
Confidence 9998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=212.83 Aligned_cols=251 Identities=18% Similarity=0.251 Sum_probs=181.5
Q ss_pred cccccccCCCccEEEEEec-CCcEEEEEEec----cCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSIN----VTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~----~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
..+++|.|++|.|+..... .....+.|... .... ......+..|..+-..++|||++..+..+.+. ...+-+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchhh
Confidence 3578999999988877643 33334444332 1111 11112255677778889999998888776433 333445
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||++. ||..++.... .+....+-.+..|+..|+.|||+.+ |.|||+|++|++++.++.+||+|||.+..
T Consensus 400 mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G-----iahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG-----LAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC-----ceeccCccccEEEecCCceEEeecCccee
Confidence 999999 9999997652 2777788889999999999999998 99999999999999999999999999876
Q ss_pred ccCCce---eeeecCCccccccCcccccCCCCCC-cchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc----
Q 007788 467 LADDIV---FSVLKTSAAMGYLAPEYVTTGRFTE-RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN---- 538 (589)
Q Consensus 467 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 538 (589)
+.-... .......|+..|+|||.+.+..|.. ..||||.|+++..|++|+.||.......... .+.....
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~ 546 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNI 546 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcccccccc
Confidence 643322 2344556777899999999999876 5899999999999999999996543221100 0000000
Q ss_pred cCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 539 LKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 539 ~~~--~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+ ......+.....++.++++.||.+|-|+.+|++.=|.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 000 1123456677889999999999999999999987664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=180.90 Aligned_cols=174 Identities=11% Similarity=0.095 Sum_probs=134.0
Q ss_pred hhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHH--H------HHHHHHHHHhccCCCCccceeeeeecC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--A------EFVKGLYLLTSLRHENIIRLRGFCCSR 378 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~--~------~~~~e~~~l~~l~H~niv~l~g~~~~~ 378 (589)
..++|...+++|.|+||.||.+.. ++..+|||.+......... . .|.+|+..+.++.||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368899999999999999999766 5778999999755422221 1 267899999999999999999886533
Q ss_pred C------CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 379 G------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 379 ~------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
. .+..++||||++|.+|.++.. ++. ....+++.+|..+|..+ ++|||+||+||++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g-----i~H~Dikp~Nili~~ 170 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG-----MVSGDPHKGNFIVSK 170 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-----CccCCCChHHEEEeC
Confidence 2 235789999999999988732 222 24569999999999998 999999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 512 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ell 512 (589)
++ ++|+|||.......+... ..+.....+..++|+||||+.+.-..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999987655322110 11333445677999999999986553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=184.45 Aligned_cols=198 Identities=18% Similarity=0.245 Sum_probs=143.9
Q ss_pred CCCCccceeeeeecC-------------------------CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHH
Q 007788 364 RHENIIRLRGFCCSR-------------------------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418 (589)
Q Consensus 364 ~H~niv~l~g~~~~~-------------------------~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 418 (589)
+|||||++.+++.++ .....|+||.-++. +|.+++..+. .+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 699999999987653 13467999998855 9999997654 4556677899
Q ss_pred HHHHHHhHHhcCCCCCCCCeEecCCCCCCeee--cCCCc--eEEccccccccccC-----CceeeeecCCccccccCccc
Q 007788 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQFN--PLIADCGLHKLLAD-----DIVFSVLKTSAAMGYLAPEY 489 (589)
Q Consensus 419 ~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill--~~~~~--~kl~DfGla~~~~~-----~~~~~~~~~~~~~~y~aPE~ 489 (589)
.|+++|..|||..+ |.|||+|++|||+ |+|.. ..|+|||.+-.... ..........|...-||||+
T Consensus 348 aQlLEav~hL~~hg-----vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG-----VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHcc-----chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 99999999999988 9999999999999 44443 57999997643221 11111122335556899998
Q ss_pred ccCCC------CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCC
Q 007788 490 VTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDP 563 (589)
Q Consensus 490 ~~~~~------~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp 563 (589)
....+ --.|+|.|+.|.+.||+++...||++..+..-+...+.+- .-+..++.++..+.+++...++.||
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~----qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES----QLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh----hCCCCcccCChHHHHHHHHHhcCCc
Confidence 86543 2468999999999999999999999854433333333222 1223456667778889999999999
Q ss_pred CCCCCHHHHHHHH
Q 007788 564 ENRPTMEAVIEEL 576 (589)
Q Consensus 564 ~~RPs~~evl~~L 576 (589)
++|++.+-....|
T Consensus 499 skRvsp~iAANvl 511 (598)
T KOG4158|consen 499 SKRVSPNIAANVL 511 (598)
T ss_pred cccCCccHHHhHH
Confidence 9999876555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.8e-20 Score=174.18 Aligned_cols=254 Identities=18% Similarity=0.196 Sum_probs=186.1
Q ss_pred cCccccccccCCCccEEEEE-ecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.|.+.+.||+|.||.++.|+ +-+++.||||.-...+ +..+...|.+..+.+ ..+.|..++-|- .....-.+|+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhh
Confidence 47778999999999999998 4589999999765433 334566677666666 468888875433 4455678999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-----CceEEcccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-----FNPLIADCG 462 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-----~~~kl~DfG 462 (589)
|.+ |.||+++..-+.+ .++..+...||.|+..-++|+|++. +|.|||||+|+||..- ..+.++|||
T Consensus 104 dLL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k~-----LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEKD-----LIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhcc-----eeecccCccceeecCCCCCCCceEEEEecc
Confidence 998 8899999987765 3999999999999999999999998 9999999999999643 347899999
Q ss_pred ccccccCCceee------eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 463 LHKLLADDIVFS------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 463 la~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
+|+.+.+..+.. .....||.+||+--...+..-+.+-|+=|+|-|+++.+-|..||.+.... .....++.+-+
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-tnK~kYeKIGe 253 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-TNKEKYEKIGE 253 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-chHHHHHHhcc
Confidence 999886544322 23456899999999889999999999999999999999999999864321 11122222222
Q ss_pred cccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 537 RNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 537 ~~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..... ......+.++.+-+...-..+-.+-|+.+-+...+..
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 21111 1112234445444444445677788887766555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=194.01 Aligned_cols=213 Identities=25% Similarity=0.394 Sum_probs=159.9
Q ss_pred HhccCCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeE
Q 007788 360 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 439 (589)
Q Consensus 360 l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~iv 439 (589)
|+.+.|.|+.+++|.+.+. ...++|.+|+..|+|.+.+.... ..++|.-...+..+|++||+|||... -..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~----i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP----IGY 71 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc----cee
Confidence 3578899999999999765 78899999999999999998743 34999999999999999999999754 249
Q ss_pred ecCCCCCCeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCC-------CCCcchhhhHHHHHHHH
Q 007788 440 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGR-------FTERSDIFAFGVIILQI 511 (589)
Q Consensus 440 H~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~s~Gvvl~el 511 (589)
|+.+++.|+++|..+.+|++|||+.......... .........-|.|||.+.+.. .+.+.||||||++++|+
T Consensus 72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999999998776431110 111111234599999987642 46779999999999999
Q ss_pred HhCCCCcchhHHHHHhhhhHHHhhc---cccCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 512 LTGSLVLTSSMRLAAESATFENFID---RNLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 512 ltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
++.+.||............+..+.+ ..+++... .+....+..++..||..+|++||++++|-..++.+..
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999999754322111111111111 11222222 1334479999999999999999999999988876554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=171.38 Aligned_cols=141 Identities=17% Similarity=0.154 Sum_probs=110.9
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCch-------------------------HHHHHHHHHHHHhccCCCCc
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-------------------------EEAEFVKGLYLLTSLRHENI 368 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------~~~~~~~e~~~l~~l~H~ni 368 (589)
...||+|++|.||+|...+|+.||||+++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 36799999999999998889999999998653110 01123578899999999988
Q ss_pred cceeeeeecCCCCeEEEEEEeCCCCChHHH-hhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCC
Q 007788 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKY-LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVE 446 (589)
Q Consensus 369 v~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~ 446 (589)
.....+... ..++||||++++++... +.. ..++......++.+++.++.++|+ .+ |+||||||+
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g-----ivHrDlkP~ 147 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG-----LVHGDLSEY 147 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCChh
Confidence 655444322 24899999998865443 332 136778889999999999999999 77 999999999
Q ss_pred CeeecCCCceEEccccccccccC
Q 007788 447 KVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~ 469 (589)
||+++ ++.++|+|||++.....
T Consensus 148 NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE-CCCEEEEEcccceecCC
Confidence 99999 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-21 Score=205.04 Aligned_cols=247 Identities=20% Similarity=0.277 Sum_probs=175.5
Q ss_pred cCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHH--HhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYL--LTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++...+.||++.|=+|.+|+.+.|. |+||++-+....-....|.++++- ..-.+|||++.+.-+. ......|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~--~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL--VTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH--HhhHHHHHHH
Confidence 3455678999999999999999887 889998765544444555555443 4445899999987654 3335567888
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc-
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL- 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~- 466 (589)
+|+.. +|.+.|..+. -+...+..-||.|++.||..+|..+ |+|||||.+|||++...-+.|+||..-+.
T Consensus 101 qyvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~g-----VcHGDIKsENILiTSWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLG-----VCHGDIKSENILITSWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHcC-----ccccccccceEEEeeechhhhhcccccCCc
Confidence 88855 8888886543 3677778889999999999999998 99999999999999999999999986543
Q ss_pred -ccCCc----eeeeecCCccccccCcccccCC----------C-CCCcchhhhHHHHHHHHHhC-CCCcchhHHHHHhhh
Q 007788 467 -LADDI----VFSVLKTSAAMGYLAPEYVTTG----------R-FTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESA 529 (589)
Q Consensus 467 -~~~~~----~~~~~~~~~~~~y~aPE~~~~~----------~-~~~~~Dv~s~Gvvl~elltg-~~p~~~~~~~~~~~~ 529 (589)
+..+. .+-......-..|.|||.+... . .+++-||||.||++.||++- +++|.-..-.+-...
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence 22221 1112222333469999987542 1 56789999999999999985 666643211110000
Q ss_pred ---hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 530 ---TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 530 ---~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..+..+. .+ +...+.+++..|++.||++|-++++.++.-+
T Consensus 251 ~~~~~e~~Le-~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 251 NADDPEQLLE-KI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred CccCHHHHHH-hC-------cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1111111 11 1225789999999999999999999998744
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=166.80 Aligned_cols=186 Identities=13% Similarity=0.054 Sum_probs=135.1
Q ss_pred cccccccCCCccEEEEEecCCcEEEEEEeccCCC---chHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
....|++|+||+||.+.- .+..++.+.+..... .....-|.+|+++|+++. |+++.+++++ +..+++||
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvme 78 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRS 78 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEe
Confidence 346799999999997776 677888777765432 111225789999999995 5889999885 23689999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC-CCCCeeecCCCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL-SVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl-k~~Nill~~~~~~kl~DfGla~~~ 467 (589)
|+.|.+|...+.. ....++.|++.+|+++|+.+ |+|||| ||.|||++.++.++|+|||++...
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G-----IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG-----VAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc-----CccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 9999998754321 11357789999999999998 999999 799999999999999999999855
Q ss_pred cCCcee----e--------eecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 468 ADDIVF----S--------VLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 468 ~~~~~~----~--------~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
...... . ......++.|+.|+...- ..--...++++-|.-+|.++|++.+..+.
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 432210 0 000112344566653321 12225679999999999999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-20 Score=191.60 Aligned_cols=225 Identities=22% Similarity=0.347 Sum_probs=176.3
Q ss_pred cccCCCccEEEEE----ecCCcEEEEEEeccCCCchHH-HHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEEeC
Q 007788 317 LGKGNFSSVYKGT----LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 317 lg~G~~g~Vy~~~----~~~~~~vavK~l~~~~~~~~~-~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+|+|.||.|+.+. .+.|+.+|.|++++....... .....|..++..++ ||.+|++.-.+ ......+++.+|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhhc
Confidence 7899999999875 235778899888765432211 14556778888887 99999997555 4457789999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
.+|+|...+.... .++..........+|-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-..
T Consensus 80 rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~-----iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG-----IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred ccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH-----HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9999998887553 2666777778889999999999998 999999999999999999999999999876543
Q ss_pred ceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHH
Q 007788 471 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550 (589)
Q Consensus 471 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (589)
.. ..||.-|||||++. .....+|.||||++++||+||..||... ....+. ......+.+....
T Consensus 151 ~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------~~~~Il--~~~~~~p~~l~~~ 213 (612)
T KOG0603|consen 151 KI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------TMKRIL--KAELEMPRELSAE 213 (612)
T ss_pred hh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------HHHHHh--hhccCCchhhhHH
Confidence 22 15788899999987 5678999999999999999999999761 111111 1223456777778
Q ss_pred HHHHHHHhcccCCCCCCCH
Q 007788 551 LGKMALVCTHEDPENRPTM 569 (589)
Q Consensus 551 l~~l~~~C~~~dp~~RPs~ 569 (589)
...++...+..+|.+|--.
T Consensus 214 a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 214 ARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHhhCHHHHhcc
Confidence 8888888888899888644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=169.52 Aligned_cols=235 Identities=18% Similarity=0.276 Sum_probs=149.7
Q ss_pred ccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCC----------CCccceeeeeecC
Q 007788 312 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRH----------ENIIRLRGFCCSR 378 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H----------~niv~l~g~~~~~ 378 (589)
...+.||.|+++.||.+++. +|+.+|||++..... ....+++.+|.-....+.+ -.++.-++.....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999986 589999999865542 3344667777655554332 1111111111100
Q ss_pred --------C--CC-----eEEEEEEeCCCCChHHHhhh---hcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEe
Q 007788 379 --------G--RG-----ECFLIYDFAPKGKLSKYLDQ---EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 440 (589)
Q Consensus 379 --------~--~~-----~~~lv~Ey~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH 440 (589)
. .. ..+++|.-+ .+||.+++.. .......+....|+.+..|+.+.+++||+.+ ++|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-----lVH 168 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-----LVH 168 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-----EEE
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-----eEe
Confidence 0 01 235677777 5688887653 2222223556677888899999999999998 999
Q ss_pred cCCCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccC--------CCCCCcchhhhHHHHHHHHH
Q 007788 441 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--------GRFTERSDIFAFGVIILQIL 512 (589)
Q Consensus 441 ~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvvl~ell 512 (589)
+||||+|++++.+|.++|+||+.....+... .. ...+..|.+||.... -.++.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY--RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE--EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee--ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998766554321 11 233466999997643 24788999999999999999
Q ss_pred hCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 007788 513 TGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR 566 (589)
Q Consensus 513 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~R 566 (589)
+|+.||........... .+. ... +.++.+..|+...++.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~--------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999975432211111 111 222 778899999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=161.16 Aligned_cols=137 Identities=23% Similarity=0.328 Sum_probs=104.4
Q ss_pred ccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-----CCCCccceeeeeecCCC-CeEE
Q 007788 312 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-----RHENIIRLRGFCCSRGR-GECF 384 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~g~~~~~~~-~~~~ 384 (589)
...+.||+|+||.||. .+ ++.. +||++.... ....+.+.+|++++.++ .||||++++|++..... +.++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999996 43 4444 689887643 23456789999999999 57999999999855321 2433
Q ss_pred -EEEEe--CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHh-HHhcCCCCCCCCeEecCCCCCCeeecC----CCce
Q 007788 385 -LIYDF--APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI-GYLHSSEVNKPAIVHRNLSVEKVLIDQ----QFNP 456 (589)
Q Consensus 385 -lv~Ey--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~~~ivH~dlk~~Nill~~----~~~~ 456 (589)
+|+|| +++|+|.+++.... +++. ..++.+++.++ +|||+.+ |+||||||+|||++. +..+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~-----IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNR-----IVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEeccCCCCCcE
Confidence 78999 55799999996531 4544 35677888777 9999988 999999999999974 3479
Q ss_pred EEcccccc
Q 007788 457 LIADCGLH 464 (589)
Q Consensus 457 kl~DfGla 464 (589)
+|+||+-+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=154.96 Aligned_cols=147 Identities=18% Similarity=0.129 Sum_probs=112.5
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCc---------------------hHHHHHHHHHHHH
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---------------------SEEAEFVKGLYLL 360 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~~~~~~~~e~~~l 360 (589)
.++......|...+.||+|+||.||++..++|+.||||++...... .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444447778899999999999999888999999987643210 0112366788889
Q ss_pred hccCCCC--ccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCe
Q 007788 361 TSLRHEN--IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI 438 (589)
Q Consensus 361 ~~l~H~n--iv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~i 438 (589)
.++.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+.+ |
T Consensus 88 ~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g-----i 146 (198)
T cd05144 88 KALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG-----I 146 (198)
T ss_pred HHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC-----C
Confidence 9988874 4444432 345899999999998765431 224568899999999999987 9
Q ss_pred EecCCCCCCeeecCCCceEEccccccccccC
Q 007788 439 VHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 439 vH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+||||||.||++++++.++|+|||.+.....
T Consensus 147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=155.83 Aligned_cols=135 Identities=14% Similarity=0.284 Sum_probs=111.5
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCch-------HHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.||+|++|.||+|.. +|..|+||+........ ....+.+|++++..++|+++.....++... +..++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEEE
Confidence 5799999999999987 67788999865433211 124578899999999999988777766433 5678999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||+++++|.+++... .+ .+..++.+++.+|+++|+.+ ++|||++|.||+++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~-----i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG-----IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC-----cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998642 22 78899999999999999988 99999999999999 78999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.8e-17 Score=155.98 Aligned_cols=144 Identities=15% Similarity=0.101 Sum_probs=109.6
Q ss_pred cCccccccccCCCccEEEEE--ecCCcEEEEEEeccCCCc-------------------h----HHHHHHHHHHHHhccC
Q 007788 310 CFSEVNLLGKGNFSSVYKGT--LRDGTLVAIRSINVTSCK-------------------S----EEAEFVKGLYLLTSLR 364 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~-------------------~----~~~~~~~e~~~l~~l~ 364 (589)
-|.+.+.||+|++|.||+|. ..+|+.||||++...... . ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 568999999998754210 0 1123567999999997
Q ss_pred CCC--ccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecC
Q 007788 365 HEN--IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 442 (589)
Q Consensus 365 H~n--iv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~d 442 (589)
+.. +.+++++ ...++||||+++++|........ .+.......++.|++.+++|||+.+. |+|||
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g~----iiH~D 174 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEGE----LVHGD 174 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcCC----EEeCC
Confidence 533 3344432 13489999999988876643221 24555668899999999999998762 89999
Q ss_pred CCCCCeeecCCCceEEcccccccccc
Q 007788 443 LSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 443 lk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|||+||+++ ++.++|+|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=178.53 Aligned_cols=196 Identities=19% Similarity=0.272 Sum_probs=151.4
Q ss_pred HHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC---CCCccceeeeeecCCC
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGR 380 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~ 380 (589)
.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....- +|.--.+++.+|+ -+-|..+...+.. .
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~--~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVF--Q 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHcc--C
Confidence 34445778888999999999999999988999999987655421 2222234455555 1223333222222 3
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-------CC
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-------QQ 453 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-------~~ 453 (589)
+..++|+||.+.|+|.+++... ..++|...+.++.|+++-+++||..+ ||||||||+|.||. +.
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~~-----IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAMG-----IIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred CcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhcc-----eecccCCcceeEeecccCCCCcc
Confidence 5568999999999999999833 35999999999999999999999998 99999999999994 34
Q ss_pred CceEEccccccccc---cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCC
Q 007788 454 FNPLIADCGLHKLL---ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516 (589)
Q Consensus 454 ~~~kl~DfGla~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~ 516 (589)
..++|+|||.+-.+ .+. ........|-++-.+|...+.+++...|-|.++-+++-|+.|+.
T Consensus 838 ~~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 56899999988644 233 13344556777999999999999999999999999999999964
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.3e-17 Score=152.55 Aligned_cols=131 Identities=18% Similarity=0.288 Sum_probs=104.9
Q ss_pred ccccCCCccEEEEEecCCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 316 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+||+|+||.||+|.+ ++..|++|+....... .....+.+|++++..++|+++.....++... +..++|||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEEE
Confidence 489999999999996 5788999986543211 1125677899999999988765554444333 45689999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|+++++|.+++.... . .++.+++.+|++||+.+ ++|||++|.||+++ ++.+++.|||++..
T Consensus 78 ~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g-----i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG-----IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC-----eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999875421 0 78999999999999988 99999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.9e-18 Score=170.55 Aligned_cols=175 Identities=21% Similarity=0.333 Sum_probs=131.3
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..+|.|+++...+|.+|+..+.. ....+|...+.++.|++.|++| ++ .+|+|+||.||....+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~-----~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG-----LIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc-----chhhhccccccccccchhhhhhhh
Confidence 47899999999999999975543 3457889999999999999999 56 799999999999999999999999
Q ss_pred cccccccCCc-----eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhh
Q 007788 462 GLHKLLADDI-----VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 462 Gla~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 535 (589)
|+........ ........+|..||+||.+.+..|+.|+|+||+|++|+|+++ -.-.+ + ....+.++.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----e---r~~t~~d~r 473 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----E---RIATLTDIR 473 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----H---HHHhhhhhh
Confidence 9987665443 223445568889999999999999999999999999999997 22211 1 112233333
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007788 536 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 573 (589)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl 573 (589)
|..+....-.+ -..-..+..+.+...|.+||++.++.
T Consensus 474 ~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 474 DGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred cCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHh
Confidence 33322111111 12234678888999999999555543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=175.78 Aligned_cols=140 Identities=16% Similarity=0.194 Sum_probs=109.9
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-c-----hHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-K-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
...|...+.||+|+||.||+|.+.+...++.++...... + .....+.+|++++.+++|++++....++.. ..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CC
Confidence 344566789999999999999986544333222222111 1 123568899999999999999988777654 34
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++++|.+++. .+..++.+++++|+|||+.+ ++||||||+|||+ +++.++|+||
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g-----iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG-----IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC-----CccCCCChHHEEE-ECCcEEEEeC
Confidence 5689999999999999885 34678999999999999988 9999999999999 6789999999
Q ss_pred cccccc
Q 007788 462 GLHKLL 467 (589)
Q Consensus 462 Gla~~~ 467 (589)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 998753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.1e-17 Score=177.25 Aligned_cols=110 Identities=43% Similarity=0.660 Sum_probs=102.5
Q ss_pred cceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeecc
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQ 120 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~ 120 (589)
.++.|+|++|.|+|.+|..|+.|++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCchhHhhcc---CCccccCCCCCCCC
Q 007788 121 NNTLSGIVPSALKRLN---GGFQFQNNPGLCGD 150 (589)
Q Consensus 121 ~N~l~g~~p~~~~~~~---~~~~~~~n~~~c~~ 150 (589)
+|+|+|.+|..+..+. ..+.+.+|+++|+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 9999999999887542 24678899999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-16 Score=171.55 Aligned_cols=206 Identities=22% Similarity=0.332 Sum_probs=140.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|..+++|-.|++|.||..+++ ..+.+|.|+ .+... ++ +||..+. +..++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l------------il-----Rnilt~a--------~npfvv- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL------------IL-----RNILTFA--------GNPFVV- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch------------hh-----hcccccc--------CCccee-
Confidence 56778899999999999999876 356677743 22210 11 1233332 122333
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||-...+..... ++- +++.+++|||+.+ |+|||+||+|.++..-|.+|+.|||+++.-
T Consensus 136 -----gDc~tllk~~g~----lPv--------dmvla~Eylh~yg-----ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP----LPV--------DMVLAVEYLHSYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred -----chhhhhcccCCC----Ccc--------hhhHHhHhhccCC-----eecCCCCCCcceeeecccccccchhhhhhh
Confidence 555555543221 221 2378999999988 999999999999999999999999997643
Q ss_pred cCCc--------------eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH
Q 007788 468 ADDI--------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 468 ~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 533 (589)
.... ........+|+-|+|||++....|+..+|+|++|+++||.+.|..||.+......- ..
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf----g~ 269 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF----GQ 269 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH----hh
Confidence 2111 01112356889999999999999999999999999999999999999877432211 12
Q ss_pred hhccc-cCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007788 534 FIDRN-LKGKFSESEAAKLGKMALVCTHEDPENRP 567 (589)
Q Consensus 534 ~~~~~-~~~~~~~~~~~~l~~l~~~C~~~dp~~RP 567 (589)
++... ...+-++....+..+++.+.++.+|.+|-
T Consensus 270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 22111 11222334456677778888888999884
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.8e-15 Score=139.64 Aligned_cols=137 Identities=18% Similarity=0.189 Sum_probs=96.7
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchH-HHHH----------------------HHHHHHHhccCCCC--c
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEF----------------------VKGLYLLTSLRHEN--I 368 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-~~~~----------------------~~e~~~l~~l~H~n--i 368 (589)
.+.||+|+||.||+|...+++.||||++........ ...+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 367999999999999988899999999875432111 1111 24555555554332 3
Q ss_pred cceeeeeecCCCCeEEEEEEeCCCCChHHH-hhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCC
Q 007788 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKY-LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVE 446 (589)
Q Consensus 369 v~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~ 446 (589)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ |+||||||+
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~-----ivH~Dl~p~ 144 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG-----LVHGDLSEY 144 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC-----cCcCCCChh
Confidence 333332 235899999999654321 21111 11 4567899999999999998 76 999999999
Q ss_pred CeeecCCCceEEcccccccccc
Q 007788 447 KVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~ 468 (589)
||+++ ++.++++|||.+....
T Consensus 145 Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hEEEE-CCcEEEEECccccccc
Confidence 99999 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.9e-15 Score=131.20 Aligned_cols=134 Identities=16% Similarity=0.145 Sum_probs=110.4
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC--CCccceeeeeecCCCCeEEEEEEeCC
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++++.. ..+..+++|||++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~--~~~~~~~v~e~~~ 76 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGE--SDGWSYLLMEWIE 76 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCccEEEEEecC
Confidence 4679999999999999865 7899999865432 4578899999999976 58888888763 3467899999998
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
++.+..+ ++.....++.+++++|+++|... ...++|+|++|.||++++.+.+++.|||.+..
T Consensus 77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~--~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLP--LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCC--ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8776544 44566788999999999999853 23499999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=139.98 Aligned_cols=138 Identities=15% Similarity=0.133 Sum_probs=105.8
Q ss_pred ccccc-cCCCccEEEEEecCCcEEEEEEeccCCC------------chHHHHHHHHHHHHhccCCCCc--cceeeeeecC
Q 007788 314 VNLLG-KGNFSSVYKGTLRDGTLVAIRSINVTSC------------KSEEAEFVKGLYLLTSLRHENI--IRLRGFCCSR 378 (589)
Q Consensus 314 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~~~e~~~l~~l~H~ni--v~l~g~~~~~ 378 (589)
...|| .|+.|+||.+... +..++||.+..... ......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 36788 8999999999885 67788888853210 1223467889999999998875 6677765332
Q ss_pred CCC--eEEEEEEeCCC-CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 379 GRG--ECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 379 ~~~--~~~lv~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
... ..++||||+++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G-----I~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG-----VYHADLNAHNILLDPDGK 180 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC-----CCCCCCCchhEEEcCCCC
Confidence 211 23599999997 6999888542 24433 3678999999999998 999999999999999999
Q ss_pred eEEcccccccc
Q 007788 456 PLIADCGLHKL 466 (589)
Q Consensus 456 ~kl~DfGla~~ 466 (589)
++|+|||.+..
T Consensus 181 v~LIDfg~~~~ 191 (239)
T PRK01723 181 FWLIDFDRGEL 191 (239)
T ss_pred EEEEECCCccc
Confidence 99999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.9e-15 Score=162.74 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=181.4
Q ss_pred cCccccccccCCCccEEEEEecC--CcEEEEEEeccCC-CchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l 385 (589)
.|...+.||+|+|+.|-...... ...+|+|.+.... ..........|..+=..+. |+|++++++.. ...+..++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~~ 98 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYLL 98 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCccccc
Confidence 34455679999999999887643 4556677665443 1111222333555555565 99999999977 45678899
Q ss_pred EEEeCCCCChHHHh-hhhcCCCCCCCHHHHHHHHHHHHHHhHHhc-CCCCCCCCeEecCCCCCCeeecCCC-ceEEcccc
Q 007788 386 IYDFAPKGKLSKYL-DQEEGSSNVLDWSTRVSIIIGIAKGIGYLH-SSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG 462 (589)
..||..++++.+-+ +... ...+....-.+..|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||
T Consensus 99 ~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~-----~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG-----VTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred ccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc-----cccCCCCCccchhccCCCcccCCCch
Confidence 99999999999888 3322 12444556778999999999999 766 99999999999999999 99999999
Q ss_pred ccccccC--CceeeeecCCc-cccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 463 LHKLLAD--DIVFSVLKTSA-AMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 463 la~~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
+|..+.. +.........+ ++-|+|||...+. ...+..|+||.|+++.-+++|..|+........ .+..+....
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~ 247 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK 247 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc
Confidence 9987655 33334444556 8889999999884 457789999999999999999999875433221 111111111
Q ss_pred cC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 539 LK--GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 539 ~~--~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.. ............++...++..+|..|.+.+++...-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence 01 1112334455677777888899999999888765433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-14 Score=137.24 Aligned_cols=208 Identities=21% Similarity=0.289 Sum_probs=143.9
Q ss_pred HHHhccCCCCccceeeeeecC---CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCC
Q 007788 358 YLLTSLRHENIIRLRGFCCSR---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434 (589)
Q Consensus 358 ~~l~~l~H~niv~l~g~~~~~---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 434 (589)
.-+-++.|-|||++..|+.+. +.....++.|||..|++..+|++.......+....-.+|+.||..||.|||+.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~--- 195 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC--- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc---
Confidence 345566799999999988543 23457899999999999999987665445566666788999999999999974
Q ss_pred CCCeEecCCCCCCeeecCCCceEEccccccccccC----CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHH
Q 007788 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD----DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQ 510 (589)
Q Consensus 435 ~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~e 510 (589)
.|||+|+++..+-|++..++-+|+.- +....... ..........+.++|.|||+-.....+..+|||+||...+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 59999999999999999998888742 11111110 00011112335678999999888888899999999999999
Q ss_pred HHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 511 ILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 511 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
|..+..-......... .+..+...+.+ .+...-...+..|++..|..||+|++++.|.-
T Consensus 275 mailEiq~tnseS~~~----~ee~ia~~i~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVE----VEENIANVIIG----LENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHheeccCCCcceee----hhhhhhhheee----ccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 9887654221111000 01111111111 01112235778899999999999999987643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=144.62 Aligned_cols=143 Identities=17% Similarity=0.217 Sum_probs=103.6
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchH---------------------------------------HHHHHH
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE---------------------------------------EAEFVK 355 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---------------------------------------~~~~~~ 355 (589)
+.||.|++|.||+|++++|+.||||+.+....+.- +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421100 013555
Q ss_pred HHHHHhcc----CCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHH-HhHHhcC
Q 007788 356 GLYLLTSL----RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK-GIGYLHS 430 (589)
Q Consensus 356 e~~~l~~l----~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 430 (589)
|.+.+.++ +|.+-+.+-.++.+. ....++||||++|++|.++....... . .+.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence 66555555 233334444444322 34578999999999999887543211 2 24567777766 4788898
Q ss_pred CCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 431 ~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
.+ ++|+|+||.||++++++.+++.|||++..+..
T Consensus 276 ~g-----~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG-----FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC-----ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 87 99999999999999999999999999887654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=161.54 Aligned_cols=110 Identities=37% Similarity=0.523 Sum_probs=80.4
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|+++|.+|..|.++++|+.|+|++|+++|.+|.++++|++|+.|+|++|+++|.+|..+..+++|+.||
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 46677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccCCcCcccCchhHhhccC--CccccCCCCCC
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNNPGLC 148 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c 148 (589)
|++|+++|.+|..+..+.. .+.+.+|+..+
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 7777777777777665532 34455555443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.1e-12 Score=142.42 Aligned_cols=104 Identities=35% Similarity=0.485 Sum_probs=92.2
Q ss_pred ccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCcc
Q 007788 20 KEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 99 (589)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 99 (589)
+.+.+.+|..+.. |++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+
T Consensus 428 n~L~g~ip~~i~~------L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 428 QGLRGFIPNDISK------LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred CCccccCCHHHhC------CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 4555666766555 9999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCChhhhhcC-CCCceeeccCCcCcccCc
Q 007788 100 LFGTIPESLANN-AELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 100 l~g~~p~~~~~l-~~L~~l~l~~N~l~g~~p 129 (589)
|+|.+|..+..+ .++..+++++|...+..|
T Consensus 502 l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 502 LSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred ccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999998874 467889999998655444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-12 Score=134.33 Aligned_cols=148 Identities=11% Similarity=0.129 Sum_probs=95.9
Q ss_pred hccCccccccccCCCccEEEEEecC-CcEEEEEEeccCCCc---------------------------------hHH---
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCK---------------------------------SEE--- 350 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---------------------------------~~~--- 350 (589)
...|+. +.||+|++|+||+|++++ |+.||||+.+....+ ...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999987 999999999754210 000
Q ss_pred ---HHHHHHHHHHhccC----CCCccceeeeeecCCCCeEEEEEEeCCCCChHHHh--hhhcCCCCCCCHHHHHHHHHHH
Q 007788 351 ---AEFVKGLYLLTSLR----HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGI 421 (589)
Q Consensus 351 ---~~~~~e~~~l~~l~----H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i 421 (589)
-+|.+|...+.+++ +.+.+.+-.++++- ....++||||++|+.+.++- ...+.....+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence 12445555555542 44445444444332 34678999999999998753 221100001211122222333
Q ss_pred HHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC----ceEEccccccccccC
Q 007788 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLIADCGLHKLLAD 469 (589)
Q Consensus 422 a~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfGla~~~~~ 469 (589)
++..+ ++|+|+||.||+++.++ .+++.|||+...++.
T Consensus 276 ------if~~G-----ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ------VFRDG-----FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HHhCC-----eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33455 99999999999999988 999999999887754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.4e-12 Score=114.83 Aligned_cols=132 Identities=17% Similarity=0.087 Sum_probs=96.7
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCcc-ceeeeeecCCCCeEEEEEEeCCC
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII-RLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
.+.++.|.++.||++... +..|++|....... ....+..|++.+..+.+.+++ +++.+. . ...++||||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCC
Confidence 356889999999999975 77899998765431 223467888888888655554 444432 2 234799999999
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
.++.+. . . ....++.+++++|+.||..+.....++|+|++|.||+++ ++.+++.|||.+.
T Consensus 76 ~~l~~~----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTE----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Cccccc----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 877543 0 0 112456789999999998763234579999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.5e-13 Score=118.37 Aligned_cols=93 Identities=32% Similarity=0.528 Sum_probs=47.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccC-CChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG-TIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~l 117 (589)
|.+|++|+|++|+++ .+|.++++|++|+.|+++-|+|. .+|..||+++.|+.|||++|+|+. .+|..|..|+.|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 555555555555555 44555555555555555555555 555555555555555555555432 244444445555555
Q ss_pred eccCCcCcccCchhHhh
Q 007788 118 DVQNNTLSGIVPSALKR 134 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~ 134 (589)
+|+.|.|. .+|..+++
T Consensus 133 yl~dndfe-~lp~dvg~ 148 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGK 148 (264)
T ss_pred HhcCCCcc-cCChhhhh
Confidence 55555554 33433333
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=8e-12 Score=130.00 Aligned_cols=251 Identities=21% Similarity=0.256 Sum_probs=170.6
Q ss_pred cCcccccccc--CCCccEEEEEe---cCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCe
Q 007788 310 CFSEVNLLGK--GNFSSVYKGTL---RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 310 ~f~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~ 382 (589)
.|.....+|. |.+|.||.+.. .++..+|+|+=+.... ......=.+|...-.+++ |+|.++....+ .+.+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~~ 192 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSGI 192 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCCc
Confidence 3455677999 99999999987 3688899987433221 111112234555555664 99999976666 44577
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHH----HhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK----GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL 457 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~k 457 (589)
.++-+|++. .+|.++.+.... .++....+.+..+... ||.++|+.. ++|-|+||.||+...+ ...+
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~-----~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN-----IVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ceeeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc-----ccccccchhheecccccceee
Confidence 888888884 688888775543 2445555666666666 999999987 9999999999999999 8899
Q ss_pred EccccccccccCCceee----eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchh--HHHHHhhhhH
Q 007788 458 IADCGLHKLLADDIVFS----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS--MRLAAESATF 531 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~--~~~~~~~~~~ 531 (589)
+.|||+...+....... .....+...|++||... +.++.+.|+|++|.+..|..++..+.... ..+......
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~- 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG- 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-
Confidence 99999988876544221 12224556699999765 47889999999999999999987655322 111111110
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.+..++.......+...+..+++.+|..|++.+.+. .+..+.
T Consensus 342 ------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i~ 383 (524)
T KOG0601|consen 342 ------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVIH 383 (524)
T ss_pred ------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh-cccccc
Confidence 011122222234455588888999999999977665 444333
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-12 Score=113.15 Aligned_cols=101 Identities=27% Similarity=0.352 Sum_probs=63.9
Q ss_pred ccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCc-cCCccccCCCCCCeeeccCc
Q 007788 20 KEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFN 98 (589)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N 98 (589)
|.++|+|.....++ ..|+.|+.|+++-|+|. .+|..||+++.|++|||+.|.|+- .+|..|-.++.|..|+|+.|
T Consensus 62 n~~nnqie~lp~~i---ssl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dn 137 (264)
T KOG0617|consen 62 NLSNNQIEELPTSI---SSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDN 137 (264)
T ss_pred hcccchhhhcChhh---hhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCC
Confidence 55555554333332 33899999999999999 889999999999999999998873 34444444444444444444
Q ss_pred cccCCChhhhhcCCCCceeeccCCcCc
Q 007788 99 SLFGTIPESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 99 ~l~g~~p~~~~~l~~L~~l~l~~N~l~ 125 (589)
.|+ .+|+.++++++|+.|.+..|.|-
T Consensus 138 dfe-~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 138 DFE-ILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred Ccc-cCChhhhhhcceeEEeeccCchh
Confidence 444 44444444444444444444443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.9e-10 Score=119.50 Aligned_cols=166 Identities=16% Similarity=0.190 Sum_probs=117.8
Q ss_pred cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCC
Q 007788 331 RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLD 410 (589)
Q Consensus 331 ~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~ 410 (589)
.++..|.|..++.... .......+-++.|+.+|||||++++..+.. .+..|+|+|-+.- |..++....
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~P--l~~~lk~l~------- 102 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRP--LETVLKELG------- 102 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeecccc--HHHHHHHhH-------
Confidence 4688888888876653 333445677889999999999999997743 4688999998743 555554332
Q ss_pred HHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccc
Q 007788 411 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490 (589)
Q Consensus 411 ~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~ 490 (589)
-....-.+.||+.||.|||..+. ++|++|.-..|++++.|+.||++|-+......... ......--..|..|+.+
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~----lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCN----LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCC----eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 23344578999999999997653 99999999999999999999999987654432211 00000011235666644
Q ss_pred cCCCCCCcchhhhHHHHHHHHHhCC
Q 007788 491 TTGRFTERSDIFAFGVIILQILTGS 515 (589)
Q Consensus 491 ~~~~~~~~~Dv~s~Gvvl~elltg~ 515 (589)
.... -..|.|-||++++|++.|.
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCcc
Confidence 3222 2469999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.3e-11 Score=126.57 Aligned_cols=251 Identities=20% Similarity=0.219 Sum_probs=174.0
Q ss_pred hhccCccccccccCCCccEEEEEec--CCcEEEEEEeccCCCchHHHHH-HHHHHHHhcc-CCCCccceeeeeecCCCCe
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAEF-VKGLYLLTSL-RHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~-~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 382 (589)
.+.+|.....||.|.|+.|++...+ ++..+++|.+.........+.| ..|+.+...+ -|.++++...-+.. -+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--ccc
Confidence 4567888899999999999998754 6889999988766543333222 3455555555 48888886655422 245
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceEEccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADC 461 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df 461 (589)
.++=-||++++++...... ...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.||
T Consensus 341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~-----~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL-----FVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh-----hhcccccccceeeccchhhhhcccc
Confidence 6788999999988766621 223777888999999999999999887 9999999999999886 77899999
Q ss_pred cccccccCCceeeeecCCccccc-cCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGY-LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
|.+..+.-. .......+..| .+++......+..+.|+||||.-+.|.+++.........+.. +.....
T Consensus 412 ~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~--------i~~~~~ 480 (524)
T KOG0601|consen 412 GCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT--------IRSGDT 480 (524)
T ss_pred cccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee--------eecccc
Confidence 988653211 11111122224 355556667788999999999999999999765543322111 011111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
. ........+..+.......++..||.+.+...+.....
T Consensus 481 p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 481 P-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred c-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1 11122256677777788899999999998877665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-10 Score=109.38 Aligned_cols=147 Identities=18% Similarity=0.232 Sum_probs=110.5
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC--CCccceeeeeecCC-CCeEEEEEEeCC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRG-RGECFLIYDFAP 391 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~-~~~~~lv~Ey~~ 391 (589)
+.|+.|..+.||++...+|..+++|.............+..|.+++..+++ .++.+++.++.... .+..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999999877789999997654322234568889999999875 44677777663321 125689999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC--------------------------------------
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV-------------------------------------- 433 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-------------------------------------- 433 (589)
+.++.+.+.. ..++...+..++.+++++|++||+...
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888776532 136777888889999999999986321
Q ss_pred -------------CCCCeEecCCCCCCeeecC--CCceEEcccccccc
Q 007788 434 -------------NKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLHKL 466 (589)
Q Consensus 434 -------------~~~~ivH~dlk~~Nill~~--~~~~kl~DfGla~~ 466 (589)
....++|+|+++.||++++ +..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1355799999999999998 56688999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.2e-11 Score=119.69 Aligned_cols=93 Identities=33% Similarity=0.496 Sum_probs=70.4
Q ss_pred ccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCcc--------------------
Q 007788 24 NKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS-------------------- 83 (589)
Q Consensus 24 ~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-------------------- 83 (589)
+++|.++.+ +++|..|+|++|-|. .+|.+++.+..||.||||+|+|. .+|..
T Consensus 425 sfv~~~l~~------l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~v 496 (565)
T KOG0472|consen 425 SFVPLELSQ------LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSV 496 (565)
T ss_pred ccchHHHHh------hhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccccc
Confidence 377877777 899999999999988 89999999999999999999888 45543
Q ss_pred ----ccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCc
Q 007788 84 ----LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 84 ----~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 125 (589)
+.++.+|.+|||.+|.|. .+|+.+++|++|+.|++.+|.|+
T Consensus 497 d~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 497 DPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 555566666666666666 56666666666666666666665
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-12 Score=129.74 Aligned_cols=152 Identities=24% Similarity=0.264 Sum_probs=101.7
Q ss_pred cccccccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCc---cccCC
Q 007788 11 GIHGKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD---SLGNL 87 (589)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~---~~~~l 87 (589)
+|+-+...+++.+|+|...-. +.+..|..|+.|+|++|++.-.--..|..+++|+.|||++|.|++.|-+ .|..|
T Consensus 314 sftqkL~~LdLs~N~i~~l~~--~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl 391 (873)
T KOG4194|consen 314 SFTQKLKELDLSSNRITRLDE--GSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGL 391 (873)
T ss_pred hhcccceeEeccccccccCCh--hHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccc
Confidence 344444445555555543222 2444577777777777777744445677777888888888888776655 35667
Q ss_pred CCCCeeeccCccccCCCh-hhhhcCCCCceeeccCCcCcccCchhHhhcc-CCccccCCCCCCCCCCccCccccccCCCC
Q 007788 88 GKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSGIVPSALKRLN-GGFQFQNNPGLCGDGIASLRACTVYDNTQ 165 (589)
Q Consensus 88 ~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~-~~~~~~~n~~~c~~~~~~l~~~~~~~~~~ 165 (589)
++|+.|+|.+|+|. .|| .+|..+++|+.|||.+|.+...-|.+|..+. ..+.+..-..+|+|.+.+|..|......+
T Consensus 392 ~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq 470 (873)
T KOG4194|consen 392 PSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLYRRKLQ 470 (873)
T ss_pred hhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHHHHhcccc
Confidence 88888888888887 444 4677888888888888888877777776552 12334444678999999988776554443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-09 Score=101.51 Aligned_cols=137 Identities=15% Similarity=0.090 Sum_probs=96.8
Q ss_pred cccccCCCccEEEEEecC-------CcEEEEEEeccCCC---------------------chHHHHH----HHHHHHHhc
Q 007788 315 NLLGKGNFSSVYKGTLRD-------GTLVAIRSINVTSC---------------------KSEEAEF----VKGLYLLTS 362 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~---------------------~~~~~~~----~~e~~~l~~ 362 (589)
..||.|--+.||.|.-.+ +..+|||+.+.... ......+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 47999999863211 0112222 378888888
Q ss_pred cCC--CCccceeeeeecCCCCeEEEEEEeCCCCChHH-HhhhhcCCCCCCCHHHHHHHHHHHHHHhHHh-cCCCCCCCCe
Q 007788 363 LRH--ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSK-YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL-HSSEVNKPAI 438 (589)
Q Consensus 363 l~H--~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~~i 438 (589)
+.. -++.+.+++ ..-++||||+.++.+.. .+... .++......+..+++.+|..| |..+ |
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~g-----l 146 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECN-----L 146 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCC-----e
Confidence 853 456666553 23579999997654422 22211 144455667889999999999 7777 9
Q ss_pred EecCCCCCCeeecCCCceEEcccccccccc
Q 007788 439 VHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 439 vH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|||||++.||++++ +.+.|+|||.+....
T Consensus 147 VHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 147 VHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred ecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999999974 689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-09 Score=96.44 Aligned_cols=132 Identities=14% Similarity=0.248 Sum_probs=95.7
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCch-------HHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
..+++|+-+.+|.+.+.+. .+++|.-....... ....-.+|.+++.+++--.|..-.-|.++ ++...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEEE
Confidence 3588999999999987543 45555433222111 12345678899988864444333333332 45678999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||+++..|.+.+... +..++..+-+-+.-||..+ |+|+||.++||+++.+. +.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g-----ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG-----IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC-----eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999888654 2456777888888999998 99999999999998875 99999999874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1e-11 Score=121.95 Aligned_cols=92 Identities=28% Similarity=0.367 Sum_probs=46.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCcccc-CCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG-NLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
|.+|..|+|..|.+. .+| +|.++..|.+|+++.|++. .+|.+.+ +|++|..|||..|+|. ++|+.+.-+.+|..|
T Consensus 205 l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rL 280 (565)
T KOG0472|consen 205 LESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERL 280 (565)
T ss_pred hhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhh
Confidence 444444444444444 333 3444444444444444444 4444443 4555556666666665 556666656666666
Q ss_pred eccCCcCcccCchhHhhc
Q 007788 118 DVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~ 135 (589)
|||+|.+++ +|..++.+
T Consensus 281 DlSNN~is~-Lp~sLgnl 297 (565)
T KOG0472|consen 281 DLSNNDISS-LPYSLGNL 297 (565)
T ss_pred cccCCcccc-CCcccccc
Confidence 666666653 33344333
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.4e-09 Score=93.77 Aligned_cols=144 Identities=19% Similarity=0.259 Sum_probs=101.1
Q ss_pred cccccccCCCccEEEEEecCCcEEEEEEeccCCC-------chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-------KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
...++-+|+-+.|+++.+. |+...||.-..... +-......+|++.+.+++--.|..-.-++.+. ..-.+
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCeE
Confidence 3467899999999999986 66666665432221 12235677899999988644444433344443 23368
Q ss_pred EEEeCCC-CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc---eEEccc
Q 007788 386 IYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIADC 461 (589)
Q Consensus 386 v~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 461 (589)
+|||+++ .++.+++....... .........+..|-+.+.-||..+ |+||||.++||++..++. +.+.||
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~nd-----iiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDND-----IIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred EEEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhCC-----eecccccccceEEecCCCcCceEEEee
Confidence 8999977 47888887654321 222223678888999999999988 999999999999976543 579999
Q ss_pred ccccc
Q 007788 462 GLHKL 466 (589)
Q Consensus 462 Gla~~ 466 (589)
|++..
T Consensus 161 gls~~ 165 (229)
T KOG3087|consen 161 GLSSV 165 (229)
T ss_pred cchhc
Confidence 99753
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.9e-11 Score=121.72 Aligned_cols=93 Identities=26% Similarity=0.232 Sum_probs=70.1
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
|+.|+.|+||+|++....++++...++|.+||||+|+|+..-|.+|..|..|+.|+|++|.++-.--..|..+.+|+.||
T Consensus 292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld 371 (873)
T KOG4194|consen 292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD 371 (873)
T ss_pred cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence 77788888888888877777888888888888888888866666777777777777777777744344566777888888
Q ss_pred ccCCcCcccCchh
Q 007788 119 VQNNTLSGIVPSA 131 (589)
Q Consensus 119 l~~N~l~g~~p~~ 131 (589)
|++|.|++.|-++
T Consensus 372 Lr~N~ls~~IEDa 384 (873)
T KOG4194|consen 372 LRSNELSWCIEDA 384 (873)
T ss_pred CcCCeEEEEEecc
Confidence 8888887776553
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.2e-10 Score=83.69 Aligned_cols=60 Identities=38% Similarity=0.489 Sum_probs=37.2
Q ss_pred cceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccc
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l 100 (589)
+|+.|+|++|+|+...+..|.++++|++|+|++|+++...|.+|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 466666666666644445666666666666666666655555666666666666666654
|
... |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-10 Score=119.61 Aligned_cols=107 Identities=36% Similarity=0.440 Sum_probs=85.1
Q ss_pred ccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCC------------------
Q 007788 16 IIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN------------------ 77 (589)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~------------------ 77 (589)
.+.+|++.|+|-.+ +. +++.+|+.|-+||||+|+|. .+|+.+..|.+|+.|+||+|.|.
T Consensus 128 ~iVLNLS~N~IetI-Pn-~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 128 SIVLNLSYNNIETI-PN-SLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred cEEEEcccCccccC-Cc-hHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 34556666666532 22 46667899999999999999 77888999999999999998654
Q ss_pred -------ccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCcc
Q 007788 78 -------GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG 126 (589)
Q Consensus 78 -------g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 126 (589)
..+|.++-.|.+|..+|||.|+|. .+|+.+-++++|+.|+||+|+++.
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 247888888889999999999999 889998888888888888888763
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-10 Score=119.81 Aligned_cols=101 Identities=33% Similarity=0.553 Sum_probs=77.9
Q ss_pred ceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccC
Q 007788 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQN 121 (589)
Q Consensus 42 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~ 121 (589)
|++|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|+.++.|.+|..|.+..|++. .+|+.++.|+ |..||+|.
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfSc 220 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSC 220 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeeccc
Confidence 778888888887 77777887778888888888887 77778888888888888888877 6777777665 88888888
Q ss_pred CcCcccCchhHhhccC--CccccCCCCC
Q 007788 122 NTLSGIVPSALKRLNG--GFQFQNNPGL 147 (589)
Q Consensus 122 N~l~g~~p~~~~~~~~--~~~~~~n~~~ 147 (589)
|+++ .+|-.|..+.. .+++++||-.
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCC
Confidence 8888 67877776653 5677788743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.3e-10 Score=123.19 Aligned_cols=247 Identities=19% Similarity=0.195 Sum_probs=160.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
+.|.+.+-+.+|.++.++.+.-. .|...+.|+...... +........+-.+.-..+||-+++..--+ ......++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L 881 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPL 881 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcch
Confidence 44555667888999998887643 344444443322110 10111111222222223456666543221 23456799
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|++|..+++|...|+.... .+..-.......+..+++|||... +.|+|++|.|.+...++..+++|||...
T Consensus 882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~~-----r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSSL-----RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccch-----hhcccccccchhhcccCCcccCcccccc
Confidence 9999999999999987652 222223344556778899999876 8999999999999999999999998433
Q ss_pred cccC------C---------------c---------eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCC
Q 007788 466 LLAD------D---------------I---------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 515 (589)
Q Consensus 466 ~~~~------~---------------~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~ 515 (589)
.... . . ........+|+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 2210 0 0 00112345678899999999999999999999999999999999
Q ss_pred CCcchhHHHHHhhhhHHHhhccccCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 007788 516 LVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKMALVCTHEDPENRPTME 570 (589)
Q Consensus 516 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ 570 (589)
.||...... +.++.++.....+ ..+........+++..-+..+|.+|-.|.
T Consensus 1033 pp~na~tpq----~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQ----QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchh----hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999765442 2333333333322 23344556667777777788998887665
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.4e-10 Score=110.50 Aligned_cols=106 Identities=22% Similarity=0.236 Sum_probs=93.5
Q ss_pred CCCc-cccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHh
Q 007788 55 NIPA-QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALK 133 (589)
Q Consensus 55 ~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~ 133 (589)
.-|. -|..|++|+.|+|++|++++.-+.+|..+..|+.|+|..|+|.-.--..|.++.+|+.|+|.+|+++..-|.+|.
T Consensus 264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~ 343 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ 343 (498)
T ss_pred cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence 4453 689999999999999999999999999999999999999999965566789999999999999999999999887
Q ss_pred hccC--CccccCCCCCCCCCCccCccccc
Q 007788 134 RLNG--GFQFQNNPGLCGDGIASLRACTV 160 (589)
Q Consensus 134 ~~~~--~~~~~~n~~~c~~~~~~l~~~~~ 160 (589)
.+.. .+.+..|||.|+|.+.+|..|.-
T Consensus 344 ~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr 372 (498)
T KOG4237|consen 344 TLFSLSTLNLLSNPFNCNCRLAWLGEWLR 372 (498)
T ss_pred ccceeeeeehccCcccCccchHHHHHHHh
Confidence 7653 56788999999999998887653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.2e-10 Score=83.27 Aligned_cols=61 Identities=41% Similarity=0.583 Sum_probs=55.8
Q ss_pred CCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcC
Q 007788 64 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTL 124 (589)
Q Consensus 64 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l 124 (589)
++|+.|+|++|+|+...+..|.++++|+.|++++|+++...|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999965557889999999999999999977778999999999999999986
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.1e-08 Score=102.46 Aligned_cols=171 Identities=20% Similarity=0.299 Sum_probs=126.7
Q ss_pred CccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeec--CCCCeEEEEEEeCCC-CChHH
Q 007788 322 FSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS--RGRGECFLIYDFAPK-GKLSK 397 (589)
Q Consensus 322 ~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~~~lv~Ey~~~-gsL~~ 397 (589)
-.+.||+... ||..|+.|+++.... .....-..-++..+++.|+|+|++..++.. .+....++||+|.|+ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3578999865 899999999954332 111223345678899999999999987641 223468899999996 57776
Q ss_pred HhhhhcC-----------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 398 YLDQEEG-----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 398 ~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+-..... .+...++...|.++.|++.||.++|+.| +.-+-|.+.+|+++.+.+++|+.+|....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-----LAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-----LACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-----ceeecccHhHeEeeCcceEEEecccceee
Confidence 5432111 1234677889999999999999999998 78899999999999999999999998766
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCC
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~ 516 (589)
+..+.. |-+. --.+-|.-.||.+++.|.||..
T Consensus 443 l~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 544320 1111 1236799999999999999954
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-10 Score=119.98 Aligned_cols=106 Identities=31% Similarity=0.451 Sum_probs=56.4
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCc-cCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
..+|+.|+||.|+|+ .+|+.+++|++|+.|.+.+|+|+- .||+.||.|..|+.+..++|+|. .+|+.++.+..|+.|
T Consensus 267 W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL 344 (1255)
T KOG0444|consen 267 WENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKL 344 (1255)
T ss_pred Hhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHh
Confidence 344455555555555 455555555555555555555441 25555555555555555555555 555555555555555
Q ss_pred eccCCcCcccCchhHhhccC--CccccCCCCC
Q 007788 118 DVQNNTLSGIVPSALKRLNG--GFQFQNNPGL 147 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~ 147 (589)
.|+.|+|- .+|+++--+.. .+.+.+||.+
T Consensus 345 ~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 345 KLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred ccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 55555555 45555443332 2344455443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.3e-08 Score=97.06 Aligned_cols=144 Identities=13% Similarity=0.080 Sum_probs=100.3
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCc----------hHHHHHHHHHHHHhccCCCC--ccceeeeeecCC---
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK----------SEEAEFVKGLYLLTSLRHEN--IIRLRGFCCSRG--- 379 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~--- 379 (589)
+.+-......|++..+ +|+.|.||+....... .....+.+|.+.+.++..-+ ..+.+++.....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 5778999977433211 11124778888888874333 334455543211
Q ss_pred CCeEEEEEEeCCCC-ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC------
Q 007788 380 RGECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ------ 452 (589)
Q Consensus 380 ~~~~~lv~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~------ 452 (589)
....++|+|++++. +|.+++..... .+.+...+..++.+++..++-||..+ |+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G-----i~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG-----INHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc-----CccCCCChhhEEEeccccCCC
Confidence 23578999999986 89999854321 22455677889999999999999998 999999999999985
Q ss_pred -CCceEEcccccccc
Q 007788 453 -QFNPLIADCGLHKL 466 (589)
Q Consensus 453 -~~~~kl~DfGla~~ 466 (589)
+..+.++||+.+..
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46789999998753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.2e-09 Score=97.71 Aligned_cols=86 Identities=35% Similarity=0.430 Sum_probs=28.0
Q ss_pred HhhcccceEEEccCcccccCCCcccc-CCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhh-hcCCC
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIG-SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL-ANNAE 113 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~ 113 (589)
..+...++.|+|++|.++ .|. .++ .+++|+.||||+|+|+ .++ .+..|+.|+.|+|++|+|+ .+++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 344566888999999888 554 465 5788999999999988 565 5778889999999999998 565555 35888
Q ss_pred CceeeccCCcCcc
Q 007788 114 LLFLDVQNNTLSG 126 (589)
Q Consensus 114 L~~l~l~~N~l~g 126 (589)
|+.|+|++|++..
T Consensus 90 L~~L~L~~N~I~~ 102 (175)
T PF14580_consen 90 LQELYLSNNKISD 102 (175)
T ss_dssp --EEE-TTS---S
T ss_pred CCEEECcCCcCCC
Confidence 9999999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.2e-08 Score=91.66 Aligned_cols=126 Identities=21% Similarity=0.204 Sum_probs=81.3
Q ss_pred cEEEEEecCCcEEEEEEeccCCC-------------------------chHHHHHHHHHHHHhccCCC--Cccceeeeee
Q 007788 324 SVYKGTLRDGTLVAIRSINVTSC-------------------------KSEEAEFVKGLYLLTSLRHE--NIIRLRGFCC 376 (589)
Q Consensus 324 ~Vy~~~~~~~~~vavK~l~~~~~-------------------------~~~~~~~~~e~~~l~~l~H~--niv~l~g~~~ 376 (589)
.||.|...+|..+|||..+.... ........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999999999999999864210 00123456799999999765 456666542
Q ss_pred cCCCCeEEEEEEeCC--CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHH-hcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 377 SRGRGECFLIYDFAP--KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY-LHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 377 ~~~~~~~~lv~Ey~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
.-+|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+||||.+.||+++++
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g-----ivHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG-----IVHGDLSEYNILVDDG 143 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT-----EEESS-STTSEEEETT
T ss_pred -----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC-----ceecCCChhhEEeecc
Confidence 2379999998 54444433222 1122345677778776666 46777 9999999999999988
Q ss_pred CceEEccccccccc
Q 007788 454 FNPLIADCGLHKLL 467 (589)
Q Consensus 454 ~~~kl~DfGla~~~ 467 (589)
.+.++|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 9999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.6e-10 Score=119.52 Aligned_cols=109 Identities=34% Similarity=0.512 Sum_probs=90.6
Q ss_pred hHhhcccceEEEccCcccccCCCc-cccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCC
Q 007788 35 LKVILLCFVVLQLCCNQLTGNIPA-QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 113 (589)
Q Consensus 35 ~~~~l~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~ 113 (589)
.++....|++|+|++|+|. .+|+ .+.++..|+.|+||+|+|+ .+|.++.+++.|++|...+|+|. ..| .+..++.
T Consensus 378 ~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~q 453 (1081)
T KOG0618|consen 378 VLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQ 453 (1081)
T ss_pred hhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCc
Confidence 5677899999999999999 6664 7889999999999999999 89999999999999999999999 778 8999999
Q ss_pred CceeeccCCcCccc-CchhHh-hccCCccccCCCCC
Q 007788 114 LLFLDVQNNTLSGI-VPSALK-RLNGGFQFQNNPGL 147 (589)
Q Consensus 114 L~~l~l~~N~l~g~-~p~~~~-~~~~~~~~~~n~~~ 147 (589)
|+++|||.|+|+-. +|..+. .--.-+++.||.|+
T Consensus 454 L~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 454 LKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 99999999999743 444433 11234677888874
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.8e-09 Score=114.53 Aligned_cols=86 Identities=28% Similarity=0.335 Sum_probs=46.1
Q ss_pred cceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeecc
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQ 120 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~ 120 (589)
+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 3445555555555 23332 134555555555555 344322 34555666666665 556666666666666666
Q ss_pred CCcCcccCchhHhhc
Q 007788 121 NNTLSGIVPSALKRL 135 (589)
Q Consensus 121 ~N~l~g~~p~~~~~~ 135 (589)
+|+|+|.+|..+..+
T Consensus 454 ~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 454 GNPLSERTLQALREI 468 (788)
T ss_pred CCCCCchHHHHHHHH
Confidence 666666666555443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.8e-09 Score=94.99 Aligned_cols=101 Identities=31% Similarity=0.387 Sum_probs=44.2
Q ss_pred cccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccc-cCCCCCCeeeccC
Q 007788 19 FKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKRLDLSF 97 (589)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~ls~ 97 (589)
++...+.|+. |.. +...+.+|+.|+|++|.++ .++ .+..|++|+.|+|++|+|+ .+++.+ .++++|+.|+|++
T Consensus 24 L~L~~n~I~~-Ie~--L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~ 97 (175)
T PF14580_consen 24 LNLRGNQIST-IEN--LGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSN 97 (175)
T ss_dssp -------------S----TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TT
T ss_pred cccccccccc-ccc--hhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcC
Confidence 5666667763 332 2234789999999999999 555 5888999999999999999 676666 4699999999999
Q ss_pred ccccCCCh--hhhhcCCCCceeeccCCcCcc
Q 007788 98 NSLFGTIP--ESLANNAELLFLDVQNNTLSG 126 (589)
Q Consensus 98 N~l~g~~p--~~~~~l~~L~~l~l~~N~l~g 126 (589)
|+|.. +- ..+..+++|+.|+|.+|.++.
T Consensus 98 N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 98 NKISD-LNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp S---S-CCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CcCCC-hHHhHHHHcCCCcceeeccCCcccc
Confidence 99973 22 467789999999999999974
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.4e-07 Score=91.50 Aligned_cols=257 Identities=16% Similarity=0.164 Sum_probs=154.2
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeee----eecCCCC-eEEEEE
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGF----CCSRGRG-ECFLIY 387 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~----~~~~~~~-~~~lv~ 387 (589)
.+.||+|+-+.+|-.--- +..| -|++...... ...+ .+..|.+. .||-+-.-+.| .+..+.+ ..-++|
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa-~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPA-AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchh-hchh-heeecCCCch-HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 467999999999954311 2223 3776654321 1111 22333333 46544431111 1112222 256677
Q ss_pred EeCCCC-ChHHHhhh--hcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 388 DFAPKG-KLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 388 Ey~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
..+++. -..++++. ++.+-...+|.-.++.+..+|.+.+-||..| .+-||+.++|+|+++++.+.|.|-..-
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-----h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-----HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-----CcccccCccceeeecCceEEEEcccce
Confidence 766653 23333321 1223345889999999999999999999988 688999999999999999999874322
Q ss_pred ccccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhC-CCCcchhHHH---------HHhhh
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTG-SLVLTSSMRL---------AAESA 529 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg-~~p~~~~~~~---------~~~~~ 529 (589)
.....+.. .....+...|.+||.-. +-.-+...|-|.+||++++++.| +.||.+-... .....
T Consensus 165 qi~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QINANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eeccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 21122211 12234556799999765 23356789999999999999987 8888642111 01111
Q ss_pred hHHHhhc--cccC---CCCC-HHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhhhccc
Q 007788 530 TFENFID--RNLK---GKFS-ESEAAKLGKMALVCTHED--PENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 530 ~~~~~~~--~~~~---~~~~-~~~~~~l~~l~~~C~~~d--p~~RPs~~evl~~L~~~~~~~ 583 (589)
.+...-+ +.++ ...+ .-.+..+..+..+|+... +.-||+++..+..|..+++..
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1111111 1111 0111 233566778888888753 568999999999988776654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.7e-09 Score=109.63 Aligned_cols=125 Identities=29% Similarity=0.402 Sum_probs=98.1
Q ss_pred cchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCC
Q 007788 25 KIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104 (589)
Q Consensus 25 ~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 104 (589)
.||..+.. |..|.+|||+.|+++ .+|..++.|+ |++|-++||+++ .+|+.++.+..|..||.|.|++. .+
T Consensus 112 ~ip~~i~~------L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-sl 181 (722)
T KOG0532|consen 112 TIPEAICN------LEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SL 181 (722)
T ss_pred ecchhhhh------hhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hc
Confidence 45655555 788889999999998 8888888886 899999999998 89999998899999999999998 88
Q ss_pred hhhhhcCCCCceeeccCCcCcccCchhHhhccC-CccccCCC----CCCCCCCccCccccc
Q 007788 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLNG-GFQFQNNP----GLCGDGIASLRACTV 160 (589)
Q Consensus 105 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~-~~~~~~n~----~~c~~~~~~l~~~~~ 160 (589)
|..++.+.+|+.|++..|++. -+|..+..++- .+.|.+|. -.|-+.|..|.....
T Consensus 182 psql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis~iPv~fr~m~~Lq~l~L 241 (722)
T KOG0532|consen 182 PSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKISYLPVDFRKMRHLQVLQL 241 (722)
T ss_pred hHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCceeecchhhhhhhhheeeee
Confidence 999999999999999999998 56666666542 46677773 245555555554433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.1e-08 Score=108.38 Aligned_cols=150 Identities=21% Similarity=0.339 Sum_probs=100.4
Q ss_pred HHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeec--------CCccccccCccccc
Q 007788 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK--------TSAAMGYLAPEYVT 491 (589)
Q Consensus 420 ~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~--------~~~~~~y~aPE~~~ 491 (589)
+++.||.|+|.. +.+||++|.|++|.+++++..||+.|+.+........+.... ......|.|||++.
T Consensus 107 ~v~dgl~flh~s----Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRS----AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccC----cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 455999999965 449999999999999999999999999876544321111111 11224599999999
Q ss_pred CCCCCCcchhhhHHHHHHHHHhCCCCc-chhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 007788 492 TGRFTERSDIFAFGVIILQILTGSLVL-TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 570 (589)
Q Consensus 492 ~~~~~~~~Dv~s~Gvvl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~ 570 (589)
....+.++|+||+||++|.+..|+.+. ...... .. .......+..-...++...+.++.+-+.+.+..++..||++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc-ch-hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 988999999999999999999554443 222111 00 111111111111223345566777777777888999999887
Q ss_pred HHHHH
Q 007788 571 AVIEE 575 (589)
Q Consensus 571 evl~~ 575 (589)
++...
T Consensus 261 ~l~~~ 265 (700)
T KOG2137|consen 261 LLLSI 265 (700)
T ss_pred hhhcc
Confidence 77643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.5e-09 Score=104.31 Aligned_cols=94 Identities=26% Similarity=0.271 Sum_probs=63.3
Q ss_pred ceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeec-cCccccCCChhhhhcCCCCceeecc
Q 007788 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDL-SFNSLFGTIPESLANNAELLFLDVQ 120 (589)
Q Consensus 42 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l-s~N~l~g~~p~~~~~l~~L~~l~l~ 120 (589)
-+.++|..|+|+-..|..|+.+++|+.||||+|+|+-+-|++|.+|++|.+|-+ ++|+|+...-..|+.|.+|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 456777778887444457777888888888888887777777777777766644 4477773333456667777777777
Q ss_pred CCcCcccCchhHhhc
Q 007788 121 NNTLSGIVPSALKRL 135 (589)
Q Consensus 121 ~N~l~g~~p~~~~~~ 135 (589)
-|++.-...+.|..+
T Consensus 149 an~i~Cir~~al~dL 163 (498)
T KOG4237|consen 149 ANHINCIRQDALRDL 163 (498)
T ss_pred hhhhcchhHHHHHHh
Confidence 777765555555443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.4e-09 Score=87.12 Aligned_cols=109 Identities=22% Similarity=0.297 Sum_probs=86.5
Q ss_pred cccceEEEccCcccccCCCccccC-CCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGS-LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~-l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
...|+..+|++|.|. ..|+.|.. .+.++.|+|++|+|+ .+|.+++.++.|+.|+++.|.|. ..|..+..|.+|..|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 566788899999999 66666654 458999999999999 89999999999999999999999 789999999999999
Q ss_pred eccCCcCcccCchhHhh--ccCCccccCCCCCCCCC
Q 007788 118 DVQNNTLSGIVPSALKR--LNGGFQFQNNPGLCGDG 151 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~--~~~~~~~~~n~~~c~~~ 151 (589)
|..+|.+. .+|-.+.. +.....+.++||-.+|.
T Consensus 129 ds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 129 DSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 99999998 56654321 12233455666655553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-06 Score=81.60 Aligned_cols=141 Identities=11% Similarity=0.114 Sum_probs=103.1
Q ss_pred cccCCCccEEEEEecCCcEEEEEEeccCCC-----chHHHHHHHHHHHHhccCC--CCccceeeeee---cCCCCeEEEE
Q 007788 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRH--ENIIRLRGFCC---SRGRGECFLI 386 (589)
Q Consensus 317 lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~---~~~~~~~~lv 386 (589)
-|+||.+.|++-.+. |..+-+|+-..-.. ......|.+|...+.++.. -.+.+.+ ++. ....-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888899998875 44688887642111 3356789999999988852 2344444 331 1112346899
Q ss_pred EEeCCC-CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc--eEEccccc
Q 007788 387 YDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfGl 463 (589)
+|-+++ -||.+++..... .+.+...+..+..+++..++-||..+ +.|+|+.+.||+++.++. ++++||.-
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G-----v~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN-----RQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 998864 589999865432 23567778899999999999999998 999999999999986666 89999987
Q ss_pred ccc
Q 007788 464 HKL 466 (589)
Q Consensus 464 a~~ 466 (589)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 653
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.6e-08 Score=106.42 Aligned_cols=77 Identities=32% Similarity=0.349 Sum_probs=42.4
Q ss_pred cceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeecc
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQ 120 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~ 120 (589)
+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|.. .++|+.|+++
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS 410 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVS 410 (788)
T ss_pred ccceEecCCCccC-CCCCCC---cccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence 4666666666666 344322 34444555555555 24432 235667777777776 35542 2456667777
Q ss_pred CCcCcccCch
Q 007788 121 NNTLSGIVPS 130 (589)
Q Consensus 121 ~N~l~g~~p~ 130 (589)
+|+|++ +|.
T Consensus 411 ~N~Lss-IP~ 419 (788)
T PRK15387 411 GNRLTS-LPM 419 (788)
T ss_pred CCcCCC-CCc
Confidence 777764 444
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1e-08 Score=111.01 Aligned_cols=86 Identities=33% Similarity=0.392 Sum_probs=75.5
Q ss_pred hHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCC
Q 007788 35 LKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAEL 114 (589)
Q Consensus 35 ~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 114 (589)
...++..|+.|+||+|.|+ .+|.++.++.+|++|...+|+|. .+| ++..++.|+.+|||.|+|+-..-.....-++|
T Consensus 402 ~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~L 478 (1081)
T KOG0618|consen 402 KLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNL 478 (1081)
T ss_pred HHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCccc
Confidence 3445999999999999999 99999999999999999999999 899 99999999999999999984433333333899
Q ss_pred ceeeccCCc
Q 007788 115 LFLDVQNNT 123 (589)
Q Consensus 115 ~~l~l~~N~ 123 (589)
++|||++|.
T Consensus 479 kyLdlSGN~ 487 (1081)
T KOG0618|consen 479 KYLDLSGNT 487 (1081)
T ss_pred ceeeccCCc
Confidence 999999998
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=5e-07 Score=85.78 Aligned_cols=107 Identities=23% Similarity=0.249 Sum_probs=81.3
Q ss_pred HHHHHHHHHHhccC--CCCccceeeeeecCC--CCeEEEEEEeCCCC-ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 007788 351 AEFVKGLYLLTSLR--HENIIRLRGFCCSRG--RGECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425 (589)
Q Consensus 351 ~~~~~e~~~l~~l~--H~niv~l~g~~~~~~--~~~~~lv~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L 425 (589)
..+.+|...+.++. .-...+.+++..... ....++|+|++++. +|.+++..... .+...+..++.++++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 45677777777664 333455555553321 12458999999984 89999876432 44566788999999999
Q ss_pred HHhcCCCCCCCCeEecCCCCCCeeecCCC---ceEEcccccccc
Q 007788 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQF---NPLIADCGLHKL 466 (589)
Q Consensus 426 ~~LH~~~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfGla~~ 466 (589)
+-||..+ |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~g-----i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG-----IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc-----CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999998 99999999999999887 889999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.3e-08 Score=106.99 Aligned_cols=79 Identities=33% Similarity=0.497 Sum_probs=55.0
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
..+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|+.+. ++|+.|+
T Consensus 219 ~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~ 289 (754)
T PRK15370 219 QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLS 289 (754)
T ss_pred ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEE
Confidence 356777777777777 5565443 36777777777777 6676653 46778888888877 5676553 4678888
Q ss_pred ccCCcCcc
Q 007788 119 VQNNTLSG 126 (589)
Q Consensus 119 l~~N~l~g 126 (589)
|++|+|++
T Consensus 290 Ls~N~Lt~ 297 (754)
T PRK15370 290 VYDNSIRT 297 (754)
T ss_pred CCCCcccc
Confidence 88888875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.2e-07 Score=85.98 Aligned_cols=134 Identities=16% Similarity=0.147 Sum_probs=91.5
Q ss_pred ccccccccCCCccEEEEEecCCcEEEEEEeccCCCc---------------------hHHHHHHHHHHHHhccCCC--Cc
Q 007788 312 SEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---------------------SEEAEFVKGLYLLTSLRHE--NI 368 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~~~~~~~~e~~~l~~l~H~--ni 368 (589)
.+.+.||-|--+.||.|..+.|..+|||.-+..... .......+|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 345789999999999999999999999987543210 0123456788888888644 66
Q ss_pred cceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCe
Q 007788 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV 448 (589)
Q Consensus 369 v~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Ni 448 (589)
.+.+++ +...+||||+++--|...--. .-+... |+..|++-+.-+-..| |||+|+.+-||
T Consensus 174 P~P~~~------nRHaVvMe~ieG~eL~~~r~~------~en~~~---il~~il~~~~~~~~~G-----iVHGDlSefNI 233 (304)
T COG0478 174 PKPIAW------NRHAVVMEYIEGVELYRLRLD------VENPDE---ILDKILEEVRKAYRRG-----IVHGDLSEFNI 233 (304)
T ss_pred CCcccc------ccceeeeehcccceeecccCc------ccCHHH---HHHHHHHHHHHHHHcC-----ccccCCchheE
Confidence 666553 456899999988555433210 111222 3333333333333445 99999999999
Q ss_pred eecCCCceEEccccccc
Q 007788 449 LIDQQFNPLIADCGLHK 465 (589)
Q Consensus 449 ll~~~~~~kl~DfGla~ 465 (589)
+++++|.+.++||--+.
T Consensus 234 lV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 234 LVTEDGDIVVIDWPQAV 250 (304)
T ss_pred EEecCCCEEEEeCcccc
Confidence 99999999999997554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.4e-07 Score=94.10 Aligned_cols=143 Identities=13% Similarity=0.164 Sum_probs=94.0
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCch---------------------------------------HHHHHHH
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS---------------------------------------EEAEFVK 355 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---------------------------------------~~~~~~~ 355 (589)
+.|+.++-|+||+|++++|+.||||+.+..-.+. .+-+|..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999986432110 0113444
Q ss_pred HHHHHhcc----CCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHH-hHHhcC
Q 007788 356 GLYLLTSL----RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG-IGYLHS 430 (589)
Q Consensus 356 e~~~l~~l----~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~ 430 (589)
|...+.++ +...=+++=.+|++- .....++|||++|-.+.+...-... .++ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence 55555554 222233333344432 3467899999999888887432221 144 23344444333 222222
Q ss_pred CCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 431 ~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
.+ +.|.|..|-||+++.++...+.|||+...+.+
T Consensus 284 dg-----ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG-----FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC-----ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 34 89999999999999999999999999877654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-07 Score=105.97 Aligned_cols=79 Identities=25% Similarity=0.436 Sum_probs=52.2
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
..+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+
T Consensus 261 ~s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~ 331 (754)
T PRK15370 261 PSALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLE 331 (754)
T ss_pred hCCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceecc
Confidence 357888999999888 5777664 57888888888888 4665443 35666666666666 3454332 4555555
Q ss_pred ccCCcCcc
Q 007788 119 VQNNTLSG 126 (589)
Q Consensus 119 l~~N~l~g 126 (589)
+++|.|++
T Consensus 332 Ls~N~Lt~ 339 (754)
T PRK15370 332 AGENALTS 339 (754)
T ss_pred ccCCcccc
Confidence 66665553
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.9e-08 Score=91.95 Aligned_cols=83 Identities=25% Similarity=0.257 Sum_probs=50.0
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
...|+.||||+|.++ .|.++..-++.++.|+||+|++. .+- ++..|++|+.||||+|.|+ .+-.+=.++.+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 455666666666666 66666666666666666666665 333 2556666666666666666 4444444455566666
Q ss_pred ccCCcCc
Q 007788 119 VQNNTLS 125 (589)
Q Consensus 119 l~~N~l~ 125 (589)
|+.|.+.
T Consensus 359 La~N~iE 365 (490)
T KOG1259|consen 359 LAQNKIE 365 (490)
T ss_pred hhhhhHh
Confidence 6666553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.4e-06 Score=79.74 Aligned_cols=139 Identities=9% Similarity=0.125 Sum_probs=81.3
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCC--ccceeeeeecCCCCeEEEEEEeCCC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN--IIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
..||+|..+.||+.. |..+++|...... ......+|.+++..+..-. +.+.++++ ...+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeecCC
Confidence 568999999999842 4457788876533 2234577888888875333 35556655 334557889999998
Q ss_pred CC-hHHHh---------------------hhhcCCCCCCCHHHHHHHH-H----------HHHH-HhHHhcCCCCCCCCe
Q 007788 393 GK-LSKYL---------------------DQEEGSSNVLDWSTRVSII-I----------GIAK-GIGYLHSSEVNKPAI 438 (589)
Q Consensus 393 gs-L~~~l---------------------~~~~~~~~~l~~~~~~~i~-~----------~ia~-~L~~LH~~~~~~~~i 438 (589)
.+ +...+ |...... .....+..-. . .+.. ..++|... ...+.+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~-~~~~~~ 155 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV-PDTSTC 155 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC-CCCCce
Confidence 63 22111 1110011 1111110000 0 0111 12222221 234567
Q ss_pred EecCCCCCCeeecCCCceEEccccccc
Q 007788 439 VHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 439 vH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
+|+|+.|.||++++++ +.+.||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.9e-08 Score=90.91 Aligned_cols=83 Identities=25% Similarity=0.289 Sum_probs=70.9
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
++.+++|+||+|.+. .+-. +..|++|+.||||+|.|+ .+-..=..|.++++|.|+.|.|. .+ ..+.++-+|..||
T Consensus 306 ~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLD 380 (490)
T KOG1259|consen 306 APKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLD 380 (490)
T ss_pred ccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheecc
Confidence 788999999999998 5544 888999999999999998 56655567889999999999988 43 6788889999999
Q ss_pred ccCCcCcc
Q 007788 119 VQNNTLSG 126 (589)
Q Consensus 119 l~~N~l~g 126 (589)
+++|++..
T Consensus 381 l~~N~Ie~ 388 (490)
T KOG1259|consen 381 LSSNQIEE 388 (490)
T ss_pred ccccchhh
Confidence 99999963
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.29 E-value=5e-07 Score=62.06 Aligned_cols=35 Identities=31% Similarity=0.581 Sum_probs=13.6
Q ss_pred ceEEEccCcccccCCCccccCCCCCCeEeccCCcCC
Q 007788 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN 77 (589)
Q Consensus 42 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~ 77 (589)
|++|+|++|+|+ .+|+.+++|++|+.|+|++|+++
T Consensus 3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 344444444444 33333444444444444444443
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.1e-07 Score=61.30 Aligned_cols=40 Identities=38% Similarity=0.573 Sum_probs=34.8
Q ss_pred CCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCCh
Q 007788 64 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 105 (589)
Q Consensus 64 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 105 (589)
++|++|+|++|+|+ .+|+.|++|++|+.|+|++|+|+ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 57999999999999 78988999999999999999999 554
|
... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.4e-07 Score=90.39 Aligned_cols=88 Identities=26% Similarity=0.317 Sum_probs=62.1
Q ss_pred hcccceEEEccCcccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCccccCCChhhhh
Q 007788 38 ILLCFVVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 109 (589)
.+..|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.-+..+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 366788888888888842 344556667888888888888743 344566678888888888888753333333
Q ss_pred c-----CCCCceeeccCCcCc
Q 007788 110 N-----NAELLFLDVQNNTLS 125 (589)
Q Consensus 110 ~-----l~~L~~l~l~~N~l~ 125 (589)
. .+.|+.|++++|.++
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHhccCCCceEEEccCCCCC
Confidence 2 367888888888886
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-05 Score=85.76 Aligned_cols=144 Identities=11% Similarity=0.142 Sum_probs=91.1
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCch------------------------------------HHHHHHHHHH
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS------------------------------------EEAEFVKGLY 358 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------------~~~~~~~e~~ 358 (589)
+.||.-+.|.||+|++++|+.||||+-+..-.+. .+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999975432111 0113555655
Q ss_pred HHhcc----CCCCc---cceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC
Q 007788 359 LLTSL----RHENI---IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431 (589)
Q Consensus 359 ~l~~l----~H~ni---v~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 431 (589)
...++ +|-+. |.+=.++++- .....++||||+|..+.+.-.-... .++-.....-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHHhc--
Confidence 44443 45551 1122333332 3467899999999877655332211 1444433333333322222222
Q ss_pred CCCCCCeEecCCCCCCeeecC----CCceEEccccccccccC
Q 007788 432 EVNKPAIVHRNLSVEKVLIDQ----QFNPLIADCGLHKLLAD 469 (589)
Q Consensus 432 ~~~~~~ivH~dlk~~Nill~~----~~~~kl~DfGla~~~~~ 469 (589)
| ++|+|=.|-||+++. ++++.+-|||+......
T Consensus 321 G-----ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 G-----FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred C-----CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3 899999999999983 67899999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.9e-07 Score=94.91 Aligned_cols=185 Identities=17% Similarity=0.120 Sum_probs=128.8
Q ss_pred CccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCC-ccceeeeeecCCCCeEEEEEEe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~~~lv~Ey 389 (589)
+...+-+++|+++++||.+-...+...++.+... -...-++++|.+++||| .++.++-+ +.....+++++|
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i 315 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRI 315 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhhhh
Confidence 3334568899999999988654445556655433 23456788999999999 55555444 344577899999
Q ss_pred CCCC-ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 390 APKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 390 ~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
...+ +-...... +...+...+...+...-+++++|+|+.. =+|+| ||+..+ ...+..||+....+.
T Consensus 316 ~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~-----~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 316 CSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY-----KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc-----ccCcc----cccccc-cccccccccCCcccC
Confidence 9876 21111110 1112334444556777788999999863 38998 777666 678999999988776
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCc
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL 518 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~ 518 (589)
... ......++..|+|||+.....+..+.|+|+.|+=-.++--|-.|-
T Consensus 383 ~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 543 233455778899999999999999999999998766776665554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.8e-06 Score=90.96 Aligned_cols=89 Identities=42% Similarity=0.613 Sum_probs=80.3
Q ss_pred cccceEEEccCcccccCCCccccCCC-CCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLK-SLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
++.++.|++.+|+++ .+|...+.+. +|+.|++++|++. .+|..++.++.|+.|++++|+++ .+|...+.+++|..|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 577999999999999 8888888885 9999999999999 88888999999999999999999 888888789999999
Q ss_pred eccCCcCcccCchh
Q 007788 118 DVQNNTLSGIVPSA 131 (589)
Q Consensus 118 ~l~~N~l~g~~p~~ 131 (589)
++++|+++ .+|..
T Consensus 192 ~ls~N~i~-~l~~~ 204 (394)
T COG4886 192 DLSGNKIS-DLPPE 204 (394)
T ss_pred eccCCccc-cCchh
Confidence 99999999 55654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.9e-05 Score=72.05 Aligned_cols=153 Identities=18% Similarity=0.190 Sum_probs=97.3
Q ss_pred cCHHHHHHhhccCccccc---cccCCCccEEEEEecCCcEEEEEEeccCCCchH-----------------------HHH
Q 007788 299 LNLEEVESATQCFSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-----------------------EAE 352 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-----------------------~~~ 352 (589)
.+++.+....++..+... |.+|--+.||+|.-.++..+|||+++....... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 445555555555555444 456777799999988899999999975432110 012
Q ss_pred HHHHHHHHhccC--CCCccceeeeeecCCCCeEEEEEEeCCCCCh-HHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhc
Q 007788 353 FVKGLYLLTSLR--HENIIRLRGFCCSRGRGECFLIYDFAPKGKL-SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429 (589)
Q Consensus 353 ~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH 429 (589)
..+|...|.++. +-.+.+-+++. .-.+||||+..... .-.|.. .++.......+..++++.+.-|-
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHH
Confidence 235666666663 34444444433 23699999965311 111111 11222245566777777777776
Q ss_pred C-CCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 430 S-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 430 ~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
. .+ +||+||..-|||+. ++.+.++|||-|....
T Consensus 184 ~~a~-----LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KEAG-----LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HhcC-----cccccchhhheEEE-CCeEEEEECccccccC
Confidence 6 44 99999999999999 8899999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.8e-05 Score=88.29 Aligned_cols=82 Identities=15% Similarity=0.288 Sum_probs=57.5
Q ss_pred ccccccCCCccEEEEEecCC---cEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCc--cceeeeeecCC-CCeEEEE
Q 007788 314 VNLLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI--IRLRGFCCSRG-RGECFLI 386 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~ni--v~l~g~~~~~~-~~~~~lv 386 (589)
.+.++.|.+..+|+....++ ..+++|+............+.+|.++++.+. |.++ .+++++|.+.. .+..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46688999999999887654 4677777654332223356889999999985 6655 77777774321 2457899
Q ss_pred EEeCCCCCh
Q 007788 387 YDFAPKGKL 395 (589)
Q Consensus 387 ~Ey~~~gsL 395 (589)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.07 E-value=2e-05 Score=73.90 Aligned_cols=138 Identities=14% Similarity=0.119 Sum_probs=87.7
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHH---------HHHHHHHhccCC---CCccceeeee
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF---------VKGLYLLTSLRH---ENIIRLRGFC 375 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~---------~~e~~~l~~l~H---~niv~l~g~~ 375 (589)
..+|...+++-......|.+-.. +|..+++|..+.... ..++.| .+++..+.+++. -..+.++...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 46677777777766666666555 578888998876542 222222 233443444432 2222222111
Q ss_pred ec---CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 376 CS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 376 ~~---~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
.- .-....+++|||++|..|.+... ++. .++..++.++.-||..| +.|+|..|.|+++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G-----~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG-----FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC-----CccCCCCcCcEEEEC
Confidence 10 11235578999999988766542 222 25566778899999998 999999999999996
Q ss_pred CCceEEccccccc
Q 007788 453 QFNPLIADCGLHK 465 (589)
Q Consensus 453 ~~~~kl~DfGla~ 465 (589)
++ +++.||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 54 8999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.8e-06 Score=97.79 Aligned_cols=90 Identities=27% Similarity=0.260 Sum_probs=46.8
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+.+|+.|+|++|++. .+|..+..+++|+.|+|++|..-+.+|. ++.+++|+.|+|++|..-..+|..+.++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 345555555555555 4455555555555555555443334442 55555555555555443345555555555555555
Q ss_pred ccCCcCcccCch
Q 007788 119 VQNNTLSGIVPS 130 (589)
Q Consensus 119 l~~N~l~g~~p~ 130 (589)
+++|..-+.+|.
T Consensus 688 L~~c~~L~~Lp~ 699 (1153)
T PLN03210 688 MSRCENLEILPT 699 (1153)
T ss_pred CCCCCCcCccCC
Confidence 555433334443
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.3e-06 Score=87.21 Aligned_cols=90 Identities=28% Similarity=0.281 Sum_probs=72.9
Q ss_pred hcccceEEEccCcccccCCCccccCCCC---CCeEeccCCcCCc----cCCccccCC-CCCCeeeccCccccCC----Ch
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKS---LSVLTLQHNRLNG----GIPDSLGNL-GKLKRLDLSFNSLFGT----IP 105 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~---L~~L~L~~N~l~g----~~p~~~~~l-~~L~~L~ls~N~l~g~----~p 105 (589)
.+++|+.|+|++|.+.+..+..+..+.+ |+.|+|++|++++ .+...+..+ ++|+.|+|++|.+++. ++
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 3789999999999998777777777666 9999999999983 344566677 8999999999999954 33
Q ss_pred hhhhcCCCCceeeccCCcCccc
Q 007788 106 ESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 106 ~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
..+..+++|+.|++++|.+++.
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~ 180 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDA 180 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchH
Confidence 4566778899999999999853
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.2e-07 Score=76.99 Aligned_cols=98 Identities=23% Similarity=0.331 Sum_probs=82.8
Q ss_pred hHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCC
Q 007788 35 LKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAEL 114 (589)
Q Consensus 35 ~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 114 (589)
+....+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|.-|..|.+|.+||...|.+. +||-.+..-...
T Consensus 72 ft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~ 148 (177)
T KOG4579|consen 72 FTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLP 148 (177)
T ss_pred Hhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccH
Confidence 3444678899999999999 88999999999999999999999 88999999999999999999998 888775544455
Q ss_pred ceeeccCCcCcccCchhHhhc
Q 007788 115 LFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 115 ~~l~l~~N~l~g~~p~~~~~~ 135 (589)
-..++.+|.+.+.-|..+..+
T Consensus 149 al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 149 ALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred HHHHhcCCcccccCccccccc
Confidence 566778888988877766554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.6e-07 Score=95.92 Aligned_cols=104 Identities=31% Similarity=0.357 Sum_probs=80.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCc-cccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
++-|+.|||++|+++.. . .+..|+.|..|||+.|+|+ .+|. +..++. |+.|.|++|.++ ++ ..+.+|.+|..|
T Consensus 186 l~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL-~gie~LksL~~L 259 (1096)
T KOG1859|consen 186 LPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TL-RGIENLKSLYGL 259 (1096)
T ss_pred HHHhhhhccchhhhhhh-H-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hh-hhHHhhhhhhcc
Confidence 78889999999999944 2 7888999999999999999 6775 234455 999999999998 44 578899999999
Q ss_pred eccCCcCcccC---ch-hHhhccCCccccCCCCCCC
Q 007788 118 DVQNNTLSGIV---PS-ALKRLNGGFQFQNNPGLCG 149 (589)
Q Consensus 118 ~l~~N~l~g~~---p~-~~~~~~~~~~~~~n~~~c~ 149 (589)
||++|-|++-- |- .+..+ ..+.+.|||-.|.
T Consensus 260 DlsyNll~~hseL~pLwsLs~L-~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 260 DLSYNLLSEHSELEPLWSLSSL-IVLWLEGNPLCCA 294 (1096)
T ss_pred chhHhhhhcchhhhHHHHHHHH-HHHhhcCCccccC
Confidence 99999998642 21 12222 2467889987775
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.2e-05 Score=73.87 Aligned_cols=147 Identities=18% Similarity=0.156 Sum_probs=83.3
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCC--CccceeeeeecC-CCCeEEEEEEeCC
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE--NIIRLRGFCCSR-GRGECFLIYDFAP 391 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~g~~~~~-~~~~~~lv~Ey~~ 391 (589)
+.++.|..+.||+....+ ..+++|..... ........|..++..+... .+.+++.++... .....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999999887 58899987543 3445677888888777432 355666644322 2234689999999
Q ss_pred CCChHH----------------Hh---hhhcCCCCCCCHHHH---------HHH------------HHHHHH-HhHHhcC
Q 007788 392 KGKLSK----------------YL---DQEEGSSNVLDWSTR---------VSI------------IIGIAK-GIGYLHS 430 (589)
Q Consensus 392 ~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~ia~-~L~~LH~ 430 (589)
+..+.. .+ +..........+... ... ...+.+ .++.++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111111111111110 000 111222 2333332
Q ss_pred CC--CCCCCeEecCCCCCCeeec-CCCceEEccccccc
Q 007788 431 SE--VNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHK 465 (589)
Q Consensus 431 ~~--~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGla~ 465 (589)
.- .....++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 10 1234599999999999999 56666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.4e-06 Score=90.01 Aligned_cols=93 Identities=32% Similarity=0.451 Sum_probs=80.7
Q ss_pred cc-cceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LL-CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~-~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.++.|+.|++++|+++ .+|.....+..|..|
T Consensus 138 ~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l 214 (394)
T COG4886 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214 (394)
T ss_pred chhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhh
Confidence 53 8999999999999 88888999999999999999999 89988889999999999999999 889887777789999
Q ss_pred eccCCcCcccCchhHhhc
Q 007788 118 DVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~ 135 (589)
++++|++. .++..+..+
T Consensus 215 ~~~~N~~~-~~~~~~~~~ 231 (394)
T COG4886 215 DLSNNSII-ELLSSLSNL 231 (394)
T ss_pred hhcCCcce-ecchhhhhc
Confidence 99999644 345554444
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.5e-05 Score=72.64 Aligned_cols=100 Identities=19% Similarity=0.222 Sum_probs=78.1
Q ss_pred HHHHHHhccCC-CCccceeeeeecCCCCeEEEEEEeCCCCChHHH---hhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC
Q 007788 355 KGLYLLTSLRH-ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY---LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430 (589)
Q Consensus 355 ~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~---l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 430 (589)
.|.-++..+.+ +++.+++|+| + .++|.||...+++... +... ..-+|..|.+||.++++.+.++++
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C-----G-~~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC-----G-RFYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC-----C-CEEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHHHHhc
Confidence 46677888865 6999999999 2 2578999987766432 1111 126899999999999999999997
Q ss_pred CCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 431 ~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
.. ...+.-.|++++|+-+++++++|+.|......
T Consensus 78 ~~--~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GP--LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CC--CCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 54 22388899999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 589 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 5e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-80
Identities = 94/295 (31%), Positives = 165/295 (55%), Gaps = 21/295 (7%)
Query: 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL 357
R +L E++ A+ FS N+LG+G F VYKG L DGTLVA++ + + E +F +
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 358 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 417
+++ H N++RLRGFC + E L+Y + G ++ L + S LDW R I
Sbjct: 79 EMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
+G A+G+ YLH + P I+HR++ +L+D++F ++ D GL KL+ + +
Sbjct: 137 ALGSARGLAYLH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVT 192
Query: 478 TSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-------------SLVLTSSM 522
T+ +G++APEY++TG+ +E++D+F +GV++L+++TG ++L +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 523 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577
+ + E +D +L+G + + E +L ++AL+CT P RP M V+ L
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-73
Identities = 93/298 (31%), Positives = 145/298 (48%), Gaps = 24/298 (8%)
Query: 293 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE 352
S+R+ L ++E AT F L+G G F VYKG LRDG VA++ S + E E
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-E 81
Query: 353 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 412
F + L+ RH +++ L GFC R E LIY + G L ++L + + + W
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472
R+ I IG A+G+ YLH AI+HR++ +L+D+ F P I D G+ K +
Sbjct: 140 QRLEICIGAARGLHYLH-----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 473 FSVLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM------- 522
+ ++ GY+ PEY GR TE+SD+++FGV++ ++L + S+
Sbjct: 195 THL--STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 523 ----RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + E +D NL K K G A+ C E+RP+M V+ +L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 84/308 (27%), Positives = 146/308 (47%), Gaps = 41/308 (13%)
Query: 293 HLNSFRLNLEEVESATQCFSE------VNLLGKGNFSSVYKGTLRDGTLVAI----RSIN 342
+SF + E+++ T F E N +G+G F VYKG + + T VA+ ++
Sbjct: 11 RFHSF--SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67
Query: 343 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 402
+T+ + ++ +F + + ++ +HEN++ L GF + L+Y + P G L L
Sbjct: 68 ITTEELKQ-QFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLVYVYMPNGSLLDRLSCL 124
Query: 403 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462
+G+ L W R I G A GI +LH +HR++ +L+D+ F I+D G
Sbjct: 125 DGTP-PLSWHMRCKIAQGAANGINFLHE-----NHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 463 LHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG----- 514
L + + TS +G Y+APE + G T +SDI++FGV++L+I+TG
Sbjct: 179 LARASEKFAQTVM--TSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 515 ------SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
L+ + E T E++ID+ + + + +A C HE RP
Sbjct: 236 EHREPQLLL-DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 569 MEAVIEEL 576
++ V + L
Sbjct: 294 IKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-59
Identities = 70/319 (21%), Positives = 125/319 (39%), Gaps = 42/319 (13%)
Query: 290 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE 349
H + L E + + + + +G F V+K L VA++ + +S
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW 63
Query: 350 EAEFVKGLYLLTSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 407
+ E+ +Y L ++HENI++ G + + +LI F KG LS +L +N
Sbjct: 64 QNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KAN 116
Query: 408 VLDWSTRVSIIIGIAKGIGYLHS-----SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462
V+ W+ I +A+G+ YLH + +KPAI HR++ + VL+ IAD G
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 463 LHKLLADDIVFSVLKTSAAMG---YLAPEYV-----TTGRFTERSDIFAFGVIILQILTG 514
L S T +G Y+APE + R D++A G+++ ++ +
Sbjct: 177 LALKFEAGK--SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 515 SLVLTSSMR--------LAAESATFENFIDRNLKGK---------FSESEAAKLGKMALV 557
+ + + E+ + + K + A L +
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 558 CTHEDPENRPTMEAVIEEL 576
C D E R + V E +
Sbjct: 295 CWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 3e-49
Identities = 72/316 (22%), Positives = 125/316 (39%), Gaps = 49/316 (15%)
Query: 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 361
E + L+G+G + +VYKG+L VA++ + + ++ E K +Y +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE--KNIYRVP 62
Query: 362 SLRHENIIRLRGFC---CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
+ H+NI R + GR E L+ ++ P G L KYL S + DW + +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLA 117
Query: 419 IGIAKGIGYLHSSEVN----KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
+ +G+ YLH+ KPAI HR+L+ VL+ +I+D GL L + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 475 VLKTSAAM-------GYLAPEY-------VTTGRFTERSDIFAFGVIILQILTGSLVLTS 520
+ A Y+APE ++ D++A G+I +I L
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 521 S-----MRLAAESA-----TFENFIDRNLKGKF----------SESEAAKLGKMALVCTH 560
++A ++ TFE+ + K + L + C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 561 EDPENRPTMEAVIEEL 576
+D E R T + E +
Sbjct: 298 QDAEARLTAQXAEERM 313
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 40/294 (13%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+ +GKG + V++G+ + G VA++ + KS E LY LRHENI+
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69
Query: 374 FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
R + +LI + G L YL LD + + I++ IA G+ +LH
Sbjct: 70 -SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 431 ---SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
KPAI HR+L + +L+ + IAD GL + + + + +G Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 485 LAPE------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATF 531
+APE V +R DI+AFG+++ ++ + + +F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 532 ENFID----RNL-----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E+ FS+ L K+ C +++P R T + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
V +GKG + V+ G R G VA++ T S E +Y +RHENI+
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98
Query: 374 FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
+G G + +LI D+ G L YL S LD + + + G+ +LH+
Sbjct: 99 -ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 431 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
KPAI HR+L + +L+ + IAD GL D + + +G Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 485 LAPE------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATF 531
+ PE + +D+++FG+I+ ++ + L ++
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 532 ENFID----RNL-----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E+ + + L S+ ++GK+ C +P +R T V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 34/277 (12%)
Query: 311 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ E+ + +G+G F V K R VAI+ I +SE F+ L L+ + H N
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPN 62
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I++L G C + L+ ++A G L L E + +S + ++G+ Y
Sbjct: 63 IVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAY 117
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA--MGY 484
LHS + A++HR+L +L+ L I D G + T+ +
Sbjct: 118 LHSMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAW 169
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL----VLTSSMRLAAESATFENFIDRNLK 540
+APE ++E+ D+F++G+I+ +++T + + R+ + +
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-------VHNGTR 222
Query: 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577
++ + + C +DP RP+ME +++ +T
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 70/341 (20%), Positives = 120/341 (35%), Gaps = 43/341 (12%)
Query: 267 PLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQ-CFSEVNLLGKGNFSSV 325
P + + L D + S S L + A E +GKG F V
Sbjct: 3 PSLDRPFISEGTTLKDLIYDMTTS--GSGSGLPLLVQRTIARTIVLQES--IGKGRFGEV 58
Query: 326 YKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC--CSRGRGEC 383
++G R G VA++ + +S E +Y LRHENI+ + +
Sbjct: 59 WRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS---SEVNKPAIVH 440
+L+ D+ G L YL + + + + + A G+ +LH KPAI H
Sbjct: 116 WLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 441 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE------YVT 491
R+L + +L+ + IAD GL + + +G Y+APE +
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 492 TGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATFENFID----RNL- 539
+R+DI+A G++ +I + L + E + L
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 290
Query: 540 ----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
S + K+ C + + R T + + L
Sbjct: 291 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-40
Identities = 58/282 (20%), Positives = 117/282 (41%), Gaps = 41/282 (14%)
Query: 311 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 366
F ++N L + + ++KG + G + ++ + V + +F + L H
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
N++ + G C S LI + P G L L EG++ V+D S V + +A+G+
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMA 125
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
+LH+ +P I L+ V+ID+ I+ + ++ M
Sbjct: 126 FLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF---------SFQSPGRMYAPA 173
Query: 484 YLAPEYVTTGR----FTERSDIFAFGVIILQILTGS-----LVLTSSMRLAAESATFENF 534
++APE + +D+++F V++ +++T L S+M + + A
Sbjct: 174 WVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL---SNMEIGMKVAL---- 225
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L+ + + K+ +C +EDP RP + ++ L
Sbjct: 226 --EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 66/286 (23%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 311 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 366
+ ++N+ +G G+F +V++ G+ VA++ + +E EF++ + ++ LRH
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
NI+ G ++ ++ +G L + L + G+ LD R+S+ +AKG+
Sbjct: 95 NIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
YLH+ P IVHRNL +L+D+++ + D GL +L A + + +A G
Sbjct: 152 YLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL----SSKSAAGTPE 204
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-------------VLTSSMRLAAESAT 530
++APE + E+SD+++FGVI+ ++ T V RL
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------ 258
Query: 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + ++ + C +P RP+ +++ L
Sbjct: 259 -----------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-39
Identities = 69/292 (23%), Positives = 131/292 (44%), Gaps = 49/292 (16%)
Query: 311 FSEVNL---LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE------AEFVKGLYLL 360
+E+ +GKG F V+KG L D ++VAI+S+ + + E EF + ++++
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
++L H NI++L G ++ +F P G L L + ++ + WS ++ +++
Sbjct: 78 SNLNHPNIVKLYGLM----HNPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLD 130
Query: 421 IAKGIGYLHSSEVNKPAIVHR-----NLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
IA GI Y+ + P IVHR N+ ++ + + +AD GL +
Sbjct: 131 IALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----- 182
Query: 476 LKTSAAMG---YLAPEYVTTGR---FTERSDIFAFGVIILQILTGSL----VLTSSMRLA 525
S +G ++APE +TE++D ++F +I+ ILTG ++
Sbjct: 183 --VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 526 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577
+ L+ E +L + +C DP+ RP +++EL+
Sbjct: 240 NM------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 311 FSEVNL---LGKGNFSSVYKGTLRDGTLVAI---RSINVTSCKSEEAEFVKGLYLLTSLR 364
F+E+ L +G G F VY+ G VA+ R + L L+
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
H NII LRG C L+ +FA G L++ L + + V+ + IA+G
Sbjct: 65 HPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARG 117
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--------IADCGLHKLLADDIVFSVL 476
+ YLH I+HR+L +LI Q+ I D GL + S
Sbjct: 118 MNYLHDE--AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 477 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENF 534
A ++APE + F++ SD++++GV++ ++LTG + + +A A
Sbjct: 176 GAYA---WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----- 227
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L + K+ C + DP +RP+ ++++L
Sbjct: 228 -MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 54/276 (19%), Positives = 117/276 (42%), Gaps = 25/276 (9%)
Query: 311 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 366
++ + +G G+F +VYKG G VA++ +NVT+ + F + +L RH
Sbjct: 23 DGQITVGQRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
NI+ G + + ++ + L +L E + + I A+G+
Sbjct: 81 NILLFMG-YSTAPQ--LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMD 134
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYL 485
YLH+ +I+HR+L + + + I D GL + + + + ++
Sbjct: 135 YLHA-----KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 486 APE---YVTTGRFTERSDIFAFGVIILQILTGSL--VLTSSMRLAAESATFENFIDRNLK 540
APE + ++ +SD++AFG+++ +++TG L ++ E +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL--SPDL 247
Query: 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
K + ++ ++ C + + RP+ ++ E+
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 34/277 (12%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LGKG F K T R+ G ++ ++ + + + F+K + ++ L H N+++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
R I ++ G L + + WS RVS IA G+ YLHS
Sbjct: 77 YKDKR--LNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSMN--- 128
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----------VLKTSAAMG-- 483
I+HR+L+ L+ + N ++AD GL +L+ D+ K +G
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 484 -YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV---LTSSMRLAAESATFENFIDRNL 539
++APE + + E+ D+F+FG+++ +I+ + F + L
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR------TMDFGLNVRGFL 240
Query: 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + C DPE RP+ + L
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 67/284 (23%), Positives = 109/284 (38%), Gaps = 36/284 (12%)
Query: 311 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHE 366
F ++ + +GKG F VY G G VAIR I++ + + F + + RHE
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
N++ G C S +I L + + VLD + I I KG+G
Sbjct: 90 NVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMG 144
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMG-- 483
YLH+ I+H++L + V D +I D GL + K G
Sbjct: 145 YLHA-----KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 484 -YLAPEYVTTGR---------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533
+LAPE + F++ SD+FA G I ++ + A
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE-WPFKTQPAEAIIWQ--- 254
Query: 534 FIDRNLKGKFSESEA-AKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ +K S+ ++ + L C + E RPT +++ L
Sbjct: 255 -MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 27/277 (9%)
Query: 317 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LG+G+F V G +VA++++ + + + + + +L +L HE+II+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+G C G L+ ++ P G L YL + + + + I +G+ YLH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 489
+HR+L+ VL+D I D GL K + + + ++ + APE
Sbjct: 154 H-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 490 VTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
+ +F SD+++FGV + ++LT S + L L E
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 548 --------AAKLGKMALVCTHEDPENRPTMEAVIEEL 576
A++ + C + RPT E +I L
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 63/290 (21%), Positives = 128/290 (44%), Gaps = 18/290 (6%)
Query: 231 RYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFS 290
+ R + + D + + E + +++ + +
Sbjct: 13 HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72
Query: 291 REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSC 346
E + + + + S F+EV +G+G+F VY GTL D A++S+N +
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130
Query: 347 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 406
E ++F+ ++ H N++ L G C R G ++ + G L ++ E +
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 189
Query: 407 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466
V D + + +AKG+ +L + VHR+L+ ++D++F +AD GL +
Sbjct: 190 TVKD---LIGFGLQVAKGMKFL--ASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 241
Query: 467 LADDIVFSVLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+ D SV + A ++A E + T +FT +SD+++FGV++ +++T
Sbjct: 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 317 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LG+G+F V G VA++S+ S + A+ K + +L +L HENI++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+G C G LI +F P G L +YL + + ++ ++ + I KG+ YL S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 489
+ VHR+L+ VL++ + I D GL K + D + +K + APE
Sbjct: 146 Q-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 490 VTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
+ +F SD+++FGV + ++LT S ++ L T L E +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260
Query: 548 --------AAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ ++ C P NR + + +IE
Sbjct: 261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 315 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
++GKG+F VY G D AI+S++ + + F++ L+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L G G ++ + G L +++ + + V D +S + +A+G+ YL
Sbjct: 87 LIG-IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYL-- 140
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAP 487
K VHR+L+ ++D+ F +AD GL + + D +SV + A + A
Sbjct: 141 -AEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 488 EYVTTGRFTERSDIFAFGVIILQILT 513
E + T RFT +SD+++FGV++ ++LT
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 317 LGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LGKGNF SV G +VA++ + S + +F + + +L SL+H+NI++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+G C S GR LI ++ P G L YL + + +D + I KG+ YL +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 489
+HR+L+ +L++ + I D GL K+L D F +K + APE
Sbjct: 134 R-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TFENFIDRNLKGKFSES 546
+T +F+ SD+++FGV++ ++ T S I +L +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 547 E--------AAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + C + + RP+ + +
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 317 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LGKGNF SV G +VA++ + S + +F + + +L SL+H+NI++
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+G C S GR LI ++ P G L YL + + +D + I KG+ YL +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 164
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 489
+HR+L+ +L++ + I D GL K+L D + +K + APE
Sbjct: 165 R-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TFENFIDRNLKGKFSES 546
+T +F+ SD+++FGV++ ++ T S I +L +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 547 E--------AAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + C + + RP+ + +
Sbjct: 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 62/240 (25%), Positives = 119/240 (49%), Gaps = 22/240 (9%)
Query: 283 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAI 338
+++ + + E + + + + S F+EV +G+G+F VY GTL D A+
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 58
Query: 339 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 398
+S+N + E ++F+ ++ H N++ L G C R G ++ + G L +
Sbjct: 59 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNF 117
Query: 399 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458
+ E + V D + + +AKG+ YL + VHR+L+ ++D++F +
Sbjct: 118 IRNETHNPTVKD---LIGFGLQVAKGMKYL--ASKK---FVHRDLAARNCMLDEKFTVKV 169
Query: 459 ADCGLHKLLADDIVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
AD GL + + D +SV + A L A E + T +FT +SD+++FGV++ +++T
Sbjct: 170 ADFGLARDMYDKEYYSVHNKTGAK--LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 48/118 (40%), Positives = 66/118 (55%), Gaps = 11/118 (9%)
Query: 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSF 97
+ L + N L+G IP +IGS+ L +L L HN ++G IPD +G+L L LDLS
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689
Query: 98 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ------FQNNPGLCG 149
N L G IP++++ L +D+ NN LSG +P G F+ F NNPGLCG
Sbjct: 690 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-----MGQFETFPPAKFLNNPGLCG 742
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 38/92 (41%), Positives = 50/92 (54%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N L+G IP+ +GSL L L L N L G IP L + L+ L L FN L G
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP L+N L ++ + NN L+G +P + RL
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-24
Identities = 41/114 (35%), Positives = 52/114 (45%), Gaps = 4/114 (3%)
Query: 22 FSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP 81
FS I + Q + L L N TG IP + + L L L N L+G IP
Sbjct: 380 FSGPILPNLCQNPKNTL----QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 82 DSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
SLG+L KL+ L L N L G IP+ L L L + N L+G +PS L
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 34/92 (36%), Positives = 46/92 (50%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L+L N L G IP ++ +K+L L L N L G IP L N L + LS N L G
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP+ + L L + NN+ SG +P+ L
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-24
Identities = 35/92 (38%), Positives = 53/92 (57%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N LTG IP+ + + +L+ ++L +NRL G IP +G L L L LS NS G
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP L + L++LD+ N +G +P+A+ +
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 2/96 (2%)
Query: 43 VVLQLCCNQLTGNIPAQIG--SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100
+ L L N +G I + +L L LQ+N G IP +L N +L L LSFN L
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 101 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
GTIP SL + ++L L + N L G +P L +
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-21
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 2/94 (2%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L N+ TG IP + G+ +L+ L L N G +P G+ L+ L LS N+ G
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 103 TIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+P ++L L LD+ N SG +P +L L
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 366
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-21
Identities = 38/96 (39%), Positives = 49/96 (51%), Gaps = 2/96 (2%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP-DSLGNLGKLKRLDLSFNSLF 101
L L N G +P GS L L L N +G +P D+L + LK LDLSFN
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 102 GTIPESLAN-NAELLFLDVQNNTLSGIVPSALKRLN 136
G +PESL N +A LL LD+ +N SG + L +
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-21
Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 3/94 (3%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L + N+L+G+ I + L +L + N+ G IP L L+ L L+ N G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283
Query: 103 TIPESLANN-AELLFLDVQNNTLSGIVPSALKRL 135
IP+ L+ L LD+ N G VP
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 8e-21
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 3/90 (3%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L + N + IP +G +L L + N+L+G ++ +LK L++S N G
Sbjct: 203 EFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSAL 132
IP + L +L + N +G +P L
Sbjct: 262 PIPPLPLKS--LQYLSLAENKFTGEIPDFL 289
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-20
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ L N+LTG IP IG L++L++L L +N +G IP LG+ L LDL+ N G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
TIP ++ + N ++G +K
Sbjct: 553 TIPAAMFK----QSGKIAANFIAGKRYVYIKND 581
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-19
Identities = 24/115 (20%), Positives = 45/115 (39%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD 82
+N I + + + G Q+ L + + + G
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626
Query: 83 SLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 137
+ N G + LD+S+N L G IP+ + + L L++ +N +SG +P + L G
Sbjct: 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-18
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 6/96 (6%)
Query: 43 VVLQLCCNQLTGNIPAQI---GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 99
VL L N ++G L L + N+++G + + L+ LD+S N+
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211
Query: 100 LFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP L + + L LD+ N LSG A+
Sbjct: 212 FSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-16
Identities = 31/100 (31%), Positives = 40/100 (40%), Gaps = 7/100 (7%)
Query: 43 VVLQLCCNQLTGNIPA--QIGSLKSLSVLTLQHNRLNGGIPDSLG-NLGKLKRLDLSFNS 99
L L N L+G + +GS L L + N L+ S G L L+ LDLS NS
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162
Query: 100 LFGTIPESLA---NNAELLFLDVQNNTLSGIVP-SALKRL 135
+ G EL L + N +SG V S L
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNL 202
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-16
Identities = 26/97 (26%), Positives = 41/97 (42%), Gaps = 4/97 (4%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD--SLGNLGKLKRLDLSFNSL 100
L L + + G++ SL+ L L N L+G + SLG+ LK L++S N+L
Sbjct: 80 ESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL 138
Query: 101 FGTIPESLANN-AELLFLDVQNNTLSGIVPSALKRLN 136
S L LD+ N++SG +
Sbjct: 139 DFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 27/93 (29%), Positives = 40/93 (43%), Gaps = 6/93 (6%)
Query: 43 VVLQLCCNQLT---GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 99
+ L L + + + SL L L L ++ +NG + L LDLS NS
Sbjct: 53 TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNS 111
Query: 100 LFGTIPE--SLANNAELLFLDVQNNTLSGIVPS 130
L G + SL + + L FL+V +NTL
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 17/96 (17%), Positives = 27/96 (28%), Gaps = 6/96 (6%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN--SL 100
+ L L N G IPA + + N + G + N G K + N
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596
Query: 101 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
G E L + ++ + G
Sbjct: 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 19/70 (27%), Positives = 34/70 (48%), Gaps = 1/70 (1%)
Query: 61 GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQ 120
+ S+ + + N + SL +L L+ L LS + + G++ +A L LD+
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 121 NNTLSGIVPS 130
N+LSG V +
Sbjct: 109 RNSLSGPVTT 118
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 66/360 (18%), Positives = 134/360 (37%), Gaps = 55/360 (15%)
Query: 232 YRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEY-CHGWDPLGDYLNGTGFS 290
YR + G SS+ + +T L + + +L Y + Y +
Sbjct: 154 YRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYD 213
Query: 291 REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE 349
+ + + ++ LG G + VY+G + VA++++ + E
Sbjct: 214 KWEMERTDITMKHK------------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--ME 259
Query: 350 EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 409
EF+K ++ ++H N+++L G C+R ++I +F G L YL + +
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLG-VCTRE-PPFYIITEFMTYGNLLDYLRECNRQE--V 315
Query: 410 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469
+ + I+ + YL +HRNL+ L+ + +AD GL +L+
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKN-----FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370
Query: 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529
D + + + APE + +F+ +SD++AFGV++ +I T + +
Sbjct: 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------- 423
Query: 530 TFENFIDRNLKGKFSESEAAKLGKMA-------------LVCTHEDPENRPTMEAVIEEL 576
+ K +M C +P +RP+ + +
Sbjct: 424 DLSQVYELLEKD----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 16/263 (6%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
LG+G F V+ GT T VAI+++ + F++ ++ LRHE +++L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
+++ ++ KG L +L E G L V + IA G+ Y+
Sbjct: 247 VVSEEPI---YIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN- 300
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 493
VHR+L +L+ + +AD GL +L+ D+ + + + APE G
Sbjct: 301 ----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553
RFT +SD+++FG+++ ++ T V M + ++R + L
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD-QVERGYRMPCPPECPESLHD 412
Query: 554 MALVCTHEDPENRPTMEAVIEEL 576
+ C ++PE RPT E + L
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFL 435
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 63/277 (22%), Positives = 120/277 (43%), Gaps = 46/277 (16%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
+G+GNF V+ G LR D TLVA++S T +A+F++ +L H NI+RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 376 CSRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
+ + +++ + G +L E L T + ++ A G+ YL S
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCC- 234
Query: 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APEY 489
+HR+L+ L+ ++ I+D G+ + AD + + S + + APE
Sbjct: 235 ----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA----SGGLRQVPVKWTAPEA 286
Query: 490 VTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFENFIDRNL 539
+ GR++ SD+++FG+++ + L+ F+++
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--------------EFVEKGG 332
Query: 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ E + ++ C +P RP+ + +EL
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 40/288 (13%)
Query: 314 VNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
++ LGKGNF SV G LVA++ + + + +F + + +L +L + I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFI 86
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
++ RG GR L+ ++ P G L +L + LD S + I KG+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLA 486
S VHR+L+ +L++ + + IAD GL KLL D + V++ + A
Sbjct: 144 GSRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAESATFENFIDRNL 539
PE ++ F+ +SD+++FGV++ ++ T S M + ++
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 540 KGKFSESEAAKLGKMA----------LVCTHEDPENRPTMEAVIEELT 577
+G+ +L +C P++RP+ A+ +L
Sbjct: 259 EGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 16/263 (6%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
LG+G F V+ GT T VAI+++ + F++ ++ LRHE +++L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
+++ ++ KG L +L E G L V + IA G+ Y+
Sbjct: 330 VVSEEPI---YIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMN- 383
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 493
VHR+L +L+ + +AD GL +L+ D+ + + + APE G
Sbjct: 384 ----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 553
RFT +SD+++FG+++ ++ T V M + ++R + L
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD-QVERGYRMPCPPECPESLHD 495
Query: 554 MALVCTHEDPENRPTMEAVIEEL 576
+ C ++PE RPT E + L
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAFL 518
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 314 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
+ +LG G F +VYKG VAI+ + + E + Y++ S+ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
RL G C + LI P G L Y+ + + + + ++ + IAKG+ YL
Sbjct: 80 CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 133
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 485
+ +VHR+L+ VL+ + I D GL KLL + ++
Sbjct: 134 --EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM 186
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILT 513
A E + +T +SD++++GV + +++T
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
LG G F V+ T T VA++++ S F+ ++ +L+H+ +++L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
++I +F KG L +L +EGS + IA+G+ ++
Sbjct: 251 VVTKEP---IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQRN- 304
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 493
+HR+L +L+ IAD GL +++ D+ + + + APE + G
Sbjct: 305 ----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 494 RFTERSDIFAFGVIILQILT 513
FT +SD+++FG+++++I+T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 50/282 (17%), Positives = 113/282 (40%), Gaps = 28/282 (9%)
Query: 305 ESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTS 362
S + + + +G G++ K DG ++ + ++ S E + + + LL
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
L+H NI+R R +++ ++ G L+ + + LD + ++ +
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
+ H ++HR+L V +D + N + D GL ++L D F +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF----AKTFV 177
Query: 483 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539
G Y++PE + + E+SDI++ G ++ ++ + + + +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL--------MPPFTAFSQKELAGKIR 229
Query: 540 KGKFSE-----SEAAKLGKMALV--CTHEDPENRPTMEAVIE 574
+GKF S+ ++ + +RP++E ++E
Sbjct: 230 EGKFRRIPYRYSDELN----EIITRMLNLKDYHRPSVEEILE 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 47/197 (23%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
+G G F V+ G + VAI++I + E +F++ ++ L H +++L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYG-VC 72
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
L+ +F G LS YL + G T + + + + +G+ YL E
Sbjct: 73 LEQA-PICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL--EEAC-- 124
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
++HR+L+ L+ + ++D G+ + + DD S T + + +PE + R++
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 497 ERSDIFAFGVIILQILT 513
+SD+++FGV++ ++ +
Sbjct: 184 SKSDVWSFGVLMWEVFS 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG G + VY+G + +L VA++++ + E EF+K ++ ++H N+++L G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG-V 77
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
C+R ++I +F G L YL + + + + I+ + YL
Sbjct: 78 CTRE-PPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKKNF-- 132
Query: 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 495
+HR+L+ L+ + +AD GL +L+ D + + + APE + +F
Sbjct: 133 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 496 TERSDIFAFGVIILQILT 513
+ +SD++AFGV++ +I T
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 47/197 (23%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V G + VA++ I S E EF + + L H +++ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYG-VC 72
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
S+ +++ ++ G L YL + G L+ S + + + +G+ +L S +
Sbjct: 73 SKEY-PIYIVTEYISNGCLLNYL-RSHGKG--LEPSQLLEMCYDVCEGMAFLESHQF--- 125
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
+HR+L+ L+D+ ++D G+ + + DD S + T + + APE +++
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 497 ERSDIFAFGVIILQILT 513
+SD++AFG+++ ++ +
Sbjct: 184 SKSDVWAFGILMWEVFS 200
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 314 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
+ +LG G F +VYKG VAI+ + + E + Y++ S+ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
RL G C + LI P G L Y+ + + + + ++ + IAKG+ YL
Sbjct: 80 CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 133
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 485
+ +VHR+L+ VL+ + I D GL KLL + ++
Sbjct: 134 --EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM 186
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILT 513
A E + +T +SD++++GV + +++T
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
V LG G F V+ G T VA++S+ S F+ L+ L+H+ ++RL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
++I ++ G L +L G L + + + IA+G+ ++
Sbjct: 76 VVTQEPI---YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERNY 130
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 488
+HR+L +L+ + IAD GL +L+ D+ T+ APE
Sbjct: 131 -----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-----TAREGAKFPIKWTAPE 180
Query: 489 YVTTGRFTERSDIFAFGVIILQILT 513
+ G FT +SD+++FG+++ +I+T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 30/86 (34%), Positives = 45/86 (52%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N L G IP I L L L + H ++G IPD L + L LD S+N+L GT+P S++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
+ L+ + N +SG +P +
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSF 172
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 1/94 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + ++G IP + +K+L L +N L+G +P S+ +L L + N + G
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 104 IPESLANNAELL-FLDVQNNTLSGIVPSALKRLN 136
IP+S + ++L + + N L+G +P LN
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 2e-24
Identities = 39/143 (27%), Positives = 60/143 (41%), Gaps = 30/143 (20%)
Query: 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
F + + N+LTG IP +L +L+ + L N L G G+ +++ L+ NSL
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVP------SALKRLN-------------GGFQ-- 140
+ + + L LD++NN + G +P L LN G Q
Sbjct: 235 FDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF 293
Query: 141 ----FQNNPGLCGDGIASLRACT 159
+ NN LCG + L ACT
Sbjct: 294 DVSAYANNKCLCG---SPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 3/92 (3%)
Query: 47 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG--GIPDSLGNLGKLKRLDLS-FNSLFGT 103
C G + ++ L L L IP SL NL L L + N+L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP ++A +L +L + + +SG +P L ++
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+ +GKG F V G R G VA++ I + F+ ++T LRH N+++L G
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
+G +++ ++ KG L YL S L + + + + + YL +
Sbjct: 82 -VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 488
VHR+L+ VL+ + ++D GL + ++ G L APE
Sbjct: 139 -----VHRDLAARNVLVSEDNVAKVSDFGL----TKEAS-----STQDTGKLPVKWTAPE 184
Query: 489 YVTTGRFTERSDIFAFGVIILQILT 513
+ +F+ +SD+++FG+++ +I +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 317 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+G G+ V G LR VAI+++ + + +F+ ++ H NIIRL
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
G +RGR ++ ++ G L +L +G V ++ G+ G+ YL S+
Sbjct: 117 G-VVTRGR-LAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--SD 169
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-----MGYLAP 487
+ VHR+L+ VL+D ++D GL ++L DD + T AP
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT---AP 223
Query: 488 EYVTTGRFTERSDIFAFGVIILQILT 513
E + F+ SD+++FGV++ ++L
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 59/258 (22%), Positives = 103/258 (39%), Gaps = 19/258 (7%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRG 373
+G+G+F +VYKG VA + KSE F + +L L+H NI+R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 374 FCCSRGRGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
S +G+ + + + G L YL + V+ S I KG+ +LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
P I+HR+L + + I + I D GL L +V+ T M APE
Sbjct: 148 --RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM---APEMY 202
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
+ E D++AFG+ +L++ T + + F + +
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSE---YPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 551 LGKMALVCTHEDPENRPT 568
+ ++ C ++ + R +
Sbjct: 259 VKEIIEGCIRQNKDERYS 276
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 314 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
+ +LG G F +V+KG V I+ I S + + + SL H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+RL G C L+ + P G L ++ Q G+ L ++ + IAKG+ YL
Sbjct: 78 VRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL 131
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 485
E +VHRNL+ VL+ +AD G+ LL D S A ++
Sbjct: 132 --EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL--LYSEAKTPIKWM 184
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILT 513
A E + G++T +SD++++GV + +++T
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
LG G F V G R VAI+ I S E EF++ ++ +L HE +++L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYG-VC 88
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
++ R F+I ++ G L YL + + + + + + YL
Sbjct: 89 TKQR-PIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL--ESKQ-- 140
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
+HR+L+ L++ Q ++D GL + + DD S + + + + PE + +F+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 497 ERSDIFAFGVIILQILT 513
+SDI+AFGV++ +I +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 317 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
LG GNF SV +G R VAI+ + + K++ E ++ ++ L + I+RL G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
C + L+ + A G L K+L + + S ++ ++ G+ YL E
Sbjct: 78 VCQAEAL---MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EEK 129
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 488
N VHR+L+ VL+ + I+D GL K L D T+ + G APE
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPE 183
Query: 489 YVTTGRFTERSDIFAFGVIILQILT 513
+ +F+ RSD++++GV + + L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 32/294 (10%)
Query: 224 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 283
G F R K+ G + S +L+ + + S + +Y D Y
Sbjct: 322 NGATQSFIIRPQKE--GERALPSIPKLANNEKQGVRSH--TVSVSETDDYAEIIDEEDTY 377
Query: 284 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIR 339
+ E + R+ L +G+G F V++G VAI+
Sbjct: 378 TMPSTRDYE-IQRERIELGRC------------IGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 340 SINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL 399
+ + S +F++ + H +I++L G ++I + G+L +L
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFL 481
Query: 400 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459
+ S LD ++ + ++ + YL VHR+++ VL+ +
Sbjct: 482 QVRKFS---LDLASLILYAYQLSTALAYL--ESKR---FVHRDIAARNVLVSSNDCVKLG 533
Query: 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
D GL + + D + K + ++APE + RFT SD++ FGV + +IL
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
+GKG F V G R G VA++ I + F+ ++T LRH N+++L G
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLG-VI 255
Query: 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 436
+G +++ ++ KG L YL S L + + + + + YL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNN---- 309
Query: 437 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 496
VHR+L+ VL+ + ++D GL + + + + APE + +F+
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 497 ERSDIFAFGVIILQILT 513
+SD+++FG+++ +I +
Sbjct: 365 TKSDVWSFGILLWEIYS 381
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 317 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
LG+G F VY+G + VA+++ + +F+ ++ +L H +I++L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
G ++I + P G+L YL++ + S L T V + I K + YL
Sbjct: 80 GIIE---EEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYL--ES 131
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 492
+N VHR+++V +L+ + D GL + + D+ + T + +++PE +
Sbjct: 132 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 493 GRFTERSDIFAFGVIILQILT 513
RFT SD++ F V + +IL+
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 317 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+G+G F V++G VAI++ + S +F++ + H +I++L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
G ++I + G+L +L + S LD ++ + ++ + YL
Sbjct: 83 GVIT---ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 134
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 492
VHR+++ VL+ + D GL + + D + K + ++APE +
Sbjct: 135 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 493 GRFTERSDIFAFGVIILQILT 513
RFT SD++ FGV + +IL
Sbjct: 192 RRFTSASDVWMFGVCMWEILM 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 317 LGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
+G G F VYKG L+ + VAI+++ + + +F+ ++ H NIIRL
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G S+ + +I ++ G L K+L +++G V ++ GIA G+ YL +
Sbjct: 112 EG-VISKYK-PMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL--A 164
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YL 485
+N VHR+L+ +L++ ++D GL ++L DD T G +
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA----TYTTSGGKIPIRWT 217
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILT 513
APE ++ +FT SD+++FG+++ +++T
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 314 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ LG G F VY+G + VA++++ + +E +F+ +++ H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 424
I+R G + F++ + G L +L + L + + IA G
Sbjct: 95 IVRCIG-VSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAA 481
YL E N +HR+++ L+ I D G +A DI +
Sbjct: 153 CQYL---EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGG 203
Query: 482 MGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
L PE G FT ++D ++FGV++ +I +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 317 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
LG GNF SV +G R VAI+ + + K++ E ++ ++ L + I+RL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
C + L+ + A G L K+L + + S ++ ++ G+ YL E
Sbjct: 404 VCQAE---ALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EEK 455
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 488
N VHRNL+ VL+ + I+D GL K L D T+ + G APE
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPE 509
Query: 489 YVTTGRFTERSDIFAFGVIILQILT 513
+ +F+ RSD++++GV + + L+
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 48/203 (23%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 317 LGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+G G F V G L + VAI+++ V + + +F+ ++ H NIIRL
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
G ++ + ++ ++ G L +L + + V ++ GIA G+ YL S+
Sbjct: 113 G-VVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--SD 165
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL--APEYV 490
+ VHR+L+ +LI+ ++D GL ++L DD + + +PE +
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 491 TTGRFTERSDIFAFGVIILQILT 513
+FT SD++++G+++ ++++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 317 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRL 371
LGKG F SV + L+ VA++ + S+ EF++ + H ++ +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 372 RGFCCSRGRGEC-----FLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 424
G R R + +I F G L +L + + L T V ++ IA G
Sbjct: 91 VG-VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-- 482
+ YL +HR+L+ ++ + +AD GL + + + + A+
Sbjct: 150 MEYL---SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--QGCASKLP 202
Query: 483 -GYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
+LA E + +T SD++AFGV + +I+T
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 314 VNLLGKGNFSSVYKGTLRDG----TLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 368
+LG+G F SV +G L+ VA++++ + S + E EF+ + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 369 IRLRGFCC---SRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAK 423
IRL G C S+G + +I F G L YL + E + T + ++ IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 483
G+ YL S N +HR+L+ ++ +AD GL K + + + A
Sbjct: 159 GMEYL--SNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--QGRIAK- 210
Query: 484 YL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
+ A E + +T +SD++AFGV + +I T
Sbjct: 211 -MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 314 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ LG G F VY+G + VA++++ + +E +F+ +++ H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 424
I+R G + F++ + G L +L + L + + IA G
Sbjct: 136 IVRCIG-VSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAA 481
YL E N +HR+++ L+ I D G +A DI +
Sbjct: 194 CQYL---EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGG 244
Query: 482 MGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
L PE G FT ++D ++FGV++ +I +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 317 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G+F VY+G + T VAI+++N + E EF+ ++ +++R
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------DQEEGSSNVLDWSTRVSIIIGIAKG 424
L G S+G +I + +G L YL S + + IA G
Sbjct: 93 LLG-VVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 484
+ YL++ NK VHR+L+ ++ + F I D G+ + + + + K +
Sbjct: 151 MAYLNA---NK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--KGGKGL-- 201
Query: 485 L-----APEYVTTGRFTERSDIFAFGVIILQILT 513
L +PE + G FT SD+++FGV++ +I T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 43/290 (14%)
Query: 314 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 366
LG+G F V + VA++ + + SE + L +L + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTR 414
N++ L G C++ G +I +F G LS YL E+ + L
Sbjct: 92 NVVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
+ +AKG+ +L S + +HR+L+ +L+ ++ I D GL A DI
Sbjct: 151 ICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGL----ARDIYKD 201
Query: 475 VLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529
L APE + +T +SD+++FGV++ +I + +++ E
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259
Query: 530 TFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
F R +G + ++ + L C H +P RPT ++E L
Sbjct: 260 ----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 57/288 (19%), Positives = 115/288 (39%), Gaps = 39/288 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ + LG+G FS V L DG A++ I + + E + + H NI+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNIL 89
Query: 370 RLRGFCC--SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
RL +C + E +L+ F +G L +++ + N L + +++GI +G+
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----VLKTSAA-- 481
+H+ HR+L +L+ + P++ D G + S L+ AA
Sbjct: 150 IHA-----KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 482 --MGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-NFI 535
+ Y APE + ER+D+++ G ++ ++ G + + + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG--------EGPYDMVFQKGDSV 256
Query: 536 DRNLKGKFSE-------SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + S S +L + DP RP + ++ +L
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMT---VDPHQRPHIPLLLSQL 301
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 23/215 (10%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+LG+G ++V++G + G L AI+ N S ++ +L L H+NI++L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
LI +F P G L L +E ++ L S + ++ + G+ +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 435 KPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEY 489
IVHRN+ ++ D Q + D G + L DD + YL P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDM 186
Query: 490 VTTG--------RFTERSDIFAFGVIILQILTGSL 516
++ D+++ GV TGSL
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 61/310 (19%), Positives = 108/310 (34%), Gaps = 74/310 (23%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHEN 367
+L +G F+ VY+ + G A++ + + E F+K L H N
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL-----SGHPN 87
Query: 368 IIRLRGFCCSR------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 421
I++ G+ E L+ + G+L ++L + E S L T + I
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQT 145
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 481
+ + ++H KP I+HR+L VE +L+ Q + D G ++ +S A
Sbjct: 146 CRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 482 MG-----------YLAPEYVTTGR---FTERSDIFAFGVI---------------ILQIL 512
+ Y PE + E+ DI+A G I L+I+
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262
Query: 513 TGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 572
G + + F + I L+ +PE R ++ V
Sbjct: 263 NGKYSIPPHDT---QYTVFHSLIRAMLQ--------------------VNPEERLSIAEV 299
Query: 573 IEELTVAAPV 582
+ +L A
Sbjct: 300 VHQLQEIAAA 309
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 62/289 (21%), Positives = 112/289 (38%), Gaps = 46/289 (15%)
Query: 317 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 369
LG G F V + T VA++ + ++ +E + L +L+ L H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------DQEEGSSNVLDWSTRV 415
L G C+ G G +I ++ G L +L E LD +
Sbjct: 91 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
S +AKG+ +L S +HR+L+ +L+ I D GL + + +D +
Sbjct: 149 SFSYQVAKGMAFLAS---KN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-- 201
Query: 476 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 530
+ A L APE + +T SD++++G+ + ++ + M
Sbjct: 202 VVKGNAR--LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------PV 253
Query: 531 FENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
F +G S A++ + C DP RPT + +++ +
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 53/295 (17%)
Query: 314 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-R 364
LG+G F V VA++ + + + + ++ V + ++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWS 412
H+NII L G C++ G ++I ++A KG L +YL D + +
Sbjct: 146 HKNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472
VS +A+G+ YL S K +HR+L+ VL+ + IAD GL + + +
Sbjct: 204 DLVSCTYQLARGMEYLAS---QK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 473 FSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 527
+ KT+ L APE + +T +SD+++FGV++ +I T L
Sbjct: 259 Y--KKTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----------LGGS 304
Query: 528 ---SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
E +G + A +L M C H P RPT + ++E+L
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 23/215 (10%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+LG+G ++V++G + G L AI+ N S ++ +L L H+NI++L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
LI +F P G L L +E ++ L S + ++ + G+ +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 435 KPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEY 489
IVHRN+ ++ D Q + D G + L DD + YL P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDM 186
Query: 490 VTTG--------RFTERSDIFAFGVIILQILTGSL 516
++ D+++ GV TGSL
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 57/292 (19%), Positives = 110/292 (37%), Gaps = 50/292 (17%)
Query: 314 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 366
LG G F V + T VA++ + T+ E+ + L +++ L +HE
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL----------DQEEGSSNVLDWSTRVS 416
NI+ L G C+ G G +I ++ G L +L +++ +
Sbjct: 111 NIVNLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 476
+A+G+ +L +HR+++ VL+ I D GL + + +D + +
Sbjct: 169 FSSQVAQGMAFL---ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--I 221
Query: 477 KTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---- 527
A L APE + +T +SD++++G+++ +I + L
Sbjct: 222 VKGNAR--LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----------LGLNPYPG 269
Query: 528 SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
F G A + + C +P +RPT + + L
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 62/277 (22%), Positives = 109/277 (39%), Gaps = 36/277 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
F ++LG G ++ + D VA++ I + E V+ L S H N+IR
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE-VQ--LLRESDEHPNVIR 82
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
FC + R ++ + L +Y++Q++ + L+ ++++ G+ +LHS
Sbjct: 83 Y--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHS 136
Query: 431 SEVNKPAIVHRNLSVEKVLI-----DQQFNPLIADCGLHKLLADDIV-FSVLKTSAA-MG 483
IVHR+L +LI + +I+D GL K LA FS G
Sbjct: 137 LN-----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 484 YLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVL---TSSMRLAAESATFENFIDR 537
++APE + T DIF+ G + +++ + +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251
Query: 538 NLKGKFSESEAAK--LGKMALVCTHEDPENRPTMEAV 572
K E A+ + KM DP+ RP+ + V
Sbjct: 252 PEK---HEDVIARELIEKM----IAMDPQKRPSAKHV 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-23
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 51/285 (17%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENI 368
F E+ L+G G F V+K DG I+ + + K+E E + L L H NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK------ALAKLDHVNI 66
Query: 369 IRLRGF--------------CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 414
+ G F+ +F KG L +++++ G LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
+ + I KG+ Y+HS K +++R+L + + I D GL L +D
Sbjct: 125 LELFEQITKGVDYIHS---KK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---G 176
Query: 475 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531
S G Y++PE +++ + + D++A G+I+ ++L F
Sbjct: 177 KRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------CDTAF 222
Query: 532 E--NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
E F G S+ K + + PE+RP ++
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 52/274 (18%), Positives = 103/274 (37%), Gaps = 34/274 (12%)
Query: 309 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL-RH 365
Q F ++ LG G++ V+K DG L A++ + A + + + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
+RL G +L + L ++ + G+S L + + +
Sbjct: 117 PCCVRLEQ--AWEEGGILYLQTELC-GPSLQQHC-EAWGAS--LPEAQVWGYLRDTLLAL 170
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK-TSAAMGY 484
+LHS +VH ++ + + + + D GL L V + Y
Sbjct: 171 AHLHSQG-----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP---RY 222
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
+APE + G + +D+F+ G+ IL++ M L ++ L +F+
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEVACN-------MELPHGGEGWQQLRQGYLPPEFT 274
Query: 545 E--SEAAKLGKMALV--CTHEDPENRPTMEAVIE 574
S + +++ DP+ R T EA++
Sbjct: 275 AGLSSELR----SVLVMMLEPDPKLRATAEALLA 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 18/209 (8%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR--- 372
LG G F V + +D G VAI+ + + ++ L H N++ R
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 373 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
G L ++ G L KYL + + L +++ I+ + YLH +
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSA-AMGYLAP 487
I+HR+L E +++ L I D G K L + + YLAP
Sbjct: 141 R-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAP 192
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSL 516
E + ++T D ++FG + + +TG
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 317 LGKGNFSSVYKGTLRDG---TLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
LG GNF +V KG + VA++ + + + + E + ++ L + I+R+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
G C + L+ + A G L+KYL Q + + ++ ++ G+ YL E
Sbjct: 85 GICEAESW---MLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL--EE 135
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----AP 487
N VHR+L+ VL+ Q I+D GL K L D + G AP
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWYAP 189
Query: 488 EYVTTGRFTERSDIFAFGVIILQILT 513
E + +F+ +SD+++FGV++ + +
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 53/295 (17%)
Query: 314 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-R 364
LG+G F V VA++ + + + + ++ V + ++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWS 412
H+NII L G C++ G ++I ++A KG L +YL D + +
Sbjct: 100 HKNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472
VS +A+G+ YL S + +HR+L+ VL+ + IAD GL + + +
Sbjct: 158 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 473 FSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 527
+ KT+ L APE + +T +SD+++FGV++ +I T L
Sbjct: 213 YK--KTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----------LGGS 258
Query: 528 ---SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
E +G + A +L M C H P RPT + ++E+L
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 49/293 (16%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
F + LG+G F V++ D AI+ I + + + + ++ + L L H I+
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 370 RLRGFCC----------SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 419
R S + ++ K L +++ + S + I +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHIFL 125
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 479
IA+ + +LHS ++HR+L + + D GL + D + T
Sbjct: 126 QIAEAVEFLHS---KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 480 AAMG-----------YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528
Y++PE + ++ + DIF+ G+I+ ++L +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----------PFST 229
Query: 529 ATFENFIDRNLK-GKFSE------SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+++ KF + + P RP +IE
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD---MLSPSPMERPEAINIIE 279
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 52/288 (18%)
Query: 317 LGKGNFSSVYKGTLR----DGTLVAIRSI--NVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG G+F V +G VA++ + +V S +F++ + + SL H N+IR
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L G + ++ + AP G L L + +G T + +A+G+GYL
Sbjct: 86 LYGVVLTPPM---KMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL-- 137
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY--LAPE 488
+HR+L+ +L+ + I D GL + L + V++ + + APE
Sbjct: 138 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 489 YVTTGRFTERSDIFAFGVIILQILTG--------------SLVLTSSMRLAA-ESATFEN 533
+ T F+ SD + FGV + ++ T + RL E
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--- 251
Query: 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581
+ + + C PE+RPT A+ + L A P
Sbjct: 252 ---------------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 314 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
+ LG+ F VYKG L VAI+++ + EF L L+H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 415
++ L G ++ + +I+ + G L ++L D + + L+ V
Sbjct: 74 VVCLLG-VVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
++ IA G+ YL S + +VH++L+ VL+ + N I+D G L ++ +
Sbjct: 132 HLVAQIAAGMEYL--SSHH---VVHKDLATRNVLVYDKLNVKISDLG----LFREVYAAD 182
Query: 476 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
L APE + G+F+ SDI+++GV++ ++ +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 314 VNLLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 369
+++G+GNF V K ++ AI+ + + K + +F L +L L H NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSI 417
L G C G +L ++AP G L +L +++ L +
Sbjct: 90 NLLG-ACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
+A+G+ YL S+ +HR+L+ +L+ + + IAD GL + ++
Sbjct: 148 AADVARGMDYL--SQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEV-----Y 195
Query: 478 TSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
MG L A E + +T SD++++GV++ +I++
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 317 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F V K T T VA++ + + SE + + +L + H ++I+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------------DQEEGSSNVLD 410
L G CS+ G LI ++A G L +L + L
Sbjct: 91 LYG-ACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 411 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470
+S I++G+ YL +E+ +VHR+L+ +L+ + I+D GL + + ++
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 471 IVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 525
+ K S + A E + +T +SD+++FGV++ +I+T L
Sbjct: 204 DSYV--KRSQGR--IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------LG 249
Query: 526 A---ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
E + G E ++ ++ L C ++P+ RP + ++L
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 317 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
LG+G F V+ + LVA++++ + + +F + LLT+L+HE+I++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVK 81
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSII 418
G C G +++++ G L+K+L Q + L S + I
Sbjct: 82 FYG-VCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
IA G+ YL + + VHR+L+ L+ I D G+ + + +
Sbjct: 140 SQIASGMVYL--ASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--VG 192
Query: 479 SAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
M L PE + +FT SD+++FGVI+ +I T
Sbjct: 193 GHTM--LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 58/300 (19%)
Query: 314 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
V +G+G F V++ T+VA++ + + +A+F + L+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------------DQEEGSSN 407
I++L G C+ G L++++ G L+++L
Sbjct: 112 IVKLLG-VCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 408 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467
L + ++ I +A G+ YL K VHR+L+ L+ + IAD G L
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE---RK--FVHRDLATRNCLVGENMVVKIADFG----L 220
Query: 468 ADDIVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM 522
+ +I + + + PE + R+T SD++A+GV++ +I +
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--------- 271
Query: 523 RLAA---ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
E I G +L + +C + P +RP+ ++ L
Sbjct: 272 -YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 53/292 (18%)
Query: 317 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 367
LG+G F V T VA++ + + + + ++ + + ++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 415
II L G C++ G ++I ++A KG L +YL + L V
Sbjct: 137 IINLLG-ACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
S +A+G+ YL K +HR+L+ VL+ + IAD GL + + +
Sbjct: 195 SCAYQVARGMEYL---ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248
Query: 476 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE--- 527
KT+ L APE + +T +SD+++FGV++ +I T L
Sbjct: 249 -KTTNGR--LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----------LGGSPYP 295
Query: 528 SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
E +G + + +L M C H P RPT + ++E+L
Sbjct: 296 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 53/288 (18%), Positives = 115/288 (39%), Gaps = 61/288 (21%)
Query: 317 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 368
LG+G F+ ++KG R+ T V ++ ++ E F + +++ L H+++
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSHKHL 74
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+ G C G E L+ +F G L YL + + ++ ++ + +A + +L
Sbjct: 75 VLNYG-VCVCGD-ENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL--------IADCGLHKLLADDIVFSVLKTSA 480
E ++H N+ + +L+ ++ + ++D G+ +
Sbjct: 130 --EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---------- 174
Query: 481 AMGYL-------APEYVTTGR-FTERSDIFAFGVIILQILTGSLV----LTSSMRLAAES 528
L PE + + +D ++FG + +I +G L S +L
Sbjct: 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---- 228
Query: 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
F + + +AA+L + C +P++RP+ A+I +L
Sbjct: 229 ----QFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 314 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 367
LG+G F V+ + LVA++++ S +S +F + LLT L+H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQH 104
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-----------DQEEGSSNVLDWSTRVS 416
I+R G C+ GR +++++ G L+++L E+ + L ++
Sbjct: 105 IVRFFG-VCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 476
+ +A G+ YL + ++ VHR+L+ L+ Q I D G+ + DI +
Sbjct: 163 VASQVAAGMVYL--AGLH---FVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDY 213
Query: 477 KTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 513
L PE + +FT SD+++FGV++ +I T
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 67/298 (22%), Positives = 111/298 (37%), Gaps = 59/298 (19%)
Query: 317 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 369
LG G F V T VA++ + + SE + L ++T L HENI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL-------------------DQEEGSSNVLD 410
L G C+ G +LI+++ G L YL +EE NVL
Sbjct: 113 NLLG-ACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 411 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470
+ + +AKG+ +L VHR+L+ VL+ I D GL + + D
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 471 IVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 525
+ + A L APE + G +T +SD++++G+++ +I + L
Sbjct: 226 SNY--VVRGNAR--LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS----------LG 271
Query: 526 A----ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
NF G + ++ + C D RP+ + L
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 55/278 (19%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 368
+ + +G+G+F DG I+ IN++ S+E E + + +L +++H NI
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKG 424
++ R G +++ D+ G L K ++ ++G +LDW + I
Sbjct: 86 VQYRESFEENG--SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 483
+ ++H + I+HR++ + + + + + D G+ ++L + A +G
Sbjct: 138 LKHVHDRK-----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL----ARACIGT 188
Query: 484 --YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541
YL+PE + +SDI+A G ++ ++ T + A E+ + +N + + + G
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTL--------KHAFEAGSMKNLVLKIISG 240
Query: 542 KFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
F S + + +P +RP++ +++E
Sbjct: 241 SFPPVSLHYSYDLR--SLVSQLFKRNPRDRPSVNSILE 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 52/279 (18%), Positives = 110/279 (39%), Gaps = 37/279 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 367
F +G+G FS VY+ L DG VA++ + + +A + +K + LL L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 368 IIRLRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
+I+ I + A G LS+ + + ++ T + + +
Sbjct: 94 VIKYYASFIEDN---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
++HS + ++HR++ V I + D GL + + + + G
Sbjct: 151 HMHS---RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLV--GTPY 201
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA--AESATFENFIDRNLKG 541
Y++PE + + +SDI++ G ++ ++ + + + + +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAAL--------QSPFYGDKMNLYSLCKKIEQC 253
Query: 542 KFSE------SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ SE + ++ +C + DPE RP + V +
Sbjct: 254 DYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYVYD 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 43/273 (15%)
Query: 315 NLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHEN 367
LGKG F +VY + ++A++ + K++ +A L + + LRH N
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLF----KAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I+RL G+ R +LI ++AP G + + L Q+ D + I +A + Y
Sbjct: 71 ILRLYGYFHDATR--VYLILEYAPLGTVYREL-QKLSK---FDEQRTATYITELANALSY 124
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLA 486
HS V +HR++ E +L+ IAD G S + YL
Sbjct: 125 CHSKRV-----IHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLP 175
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-- 544
PE + E+ D+++ GV+ + L G + E+ T++ R + +F+
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 227
Query: 545 ---ESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
A L L +P RP + V+E
Sbjct: 228 DFVTEGARDLISRLLK---HNPSQRPMLREVLE 257
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 48/284 (16%), Positives = 107/284 (37%), Gaps = 49/284 (17%)
Query: 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--ENIIRL 371
+G G S V++ + AI+ +N+ ++ + + + L L+ + IIRL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+ +++ + L+ +L +++ S +D R S + + + +H
Sbjct: 94 YDYE--ITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHTIHQH 146
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 488
IVH +L LI + D G+ + D V + +G Y+ PE
Sbjct: 147 G-----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ--VGTVNYMPPE 198
Query: 489 -----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESATFENF 534
+ + + +SD+++ G I+ + G + + + +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI 252
Query: 535 IDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
ID N + +F + + + L C DP+ R ++ ++
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKC----CLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 48/284 (16%), Positives = 106/284 (37%), Gaps = 49/284 (17%)
Query: 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--ENIIRL 371
+G G S V++ + AI+ +N+ ++ + + + L L+ + IIRL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
+ +++ + L+ +L +++ S +D R S + + + +H
Sbjct: 75 YDY--EITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHTIHQH 127
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 488
IVH +L LI + D G+ + D V + G Y+ PE
Sbjct: 128 -----GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPE 179
Query: 489 -----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESATFENF 534
+ + + +SD+++ G I+ + G + + + +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI 233
Query: 535 IDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
ID N + +F + + + L C DP+ R ++ ++
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKC----CLKRDPKQRISIPELLA 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 52/271 (19%), Positives = 105/271 (38%), Gaps = 39/271 (14%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHENIIRLR 372
LGKG F+ ++ + + A + + + + + SL H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
GF F++ + + L + + + + + R + I G YLH +
Sbjct: 108 GFFEDNDF--VFVVLELCRRRSLLELH-KRRKA--LTEPEAR-YYLRQIVLGCQYLHRNR 161
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 489
V +HR+L + + +++ I D GL + D K G Y+APE
Sbjct: 162 V-----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC--GTPNYIAPEV 212
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 545
++ + D+++ G I+ +L G + E++ + R K ++S
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG--------KPPFETSCLKETYLRIKKNEYSIPKHI 264
Query: 546 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+ A + KM L DP RPT+ ++
Sbjct: 265 NPVAASLIQKM-LQ---TDPTARPTINELLN 291
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 41/297 (13%), Positives = 98/297 (32%), Gaps = 42/297 (14%)
Query: 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 355
E + ++ +LLG+G F+ VY+ T D ++ + E +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQ 116
Query: 356 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-EEGSSNVLDWSTR 414
+ L ++ + L+ + G L ++ + V+
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-----------IADCGL 463
+S + + I +H E I+H ++ + ++ F + D G
Sbjct: 175 ISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 464 ---HKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT 519
KL +F + +TS G+ E ++ + + D F + +L G+
Sbjct: 230 SIDMKLFPKGTIFTAKCETS---GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY--- 283
Query: 520 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ ++ E + + + + L D + P+++ + ++L
Sbjct: 284 ----MKVKNEGGECKPEGLFRRLPHLDMWNEFFHVML--NIPDCHHLPSLDLLRQKL 334
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 43/272 (15%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHENI 368
LGKG F +VY + ++A++ + KS+ + L + + LRH NI
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLF----KSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+R+ + R R +L+ +FAP+G+L K L Q+ G + + + + + +A + Y
Sbjct: 77 LRMYNYFHDRKR--IYLMLEFAPRGELYKEL-QKHGRFD--EQRSA-TFMEELADALHYC 130
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAP 487
H +V +HR++ E +L+ + IAD G +T + YL P
Sbjct: 131 HERKV-----IHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPP 181
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--- 544
E + E+ D++ GV+ + L G +S + R +
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG--------MPPFDSPSHTETHRRIVNVDLKFPP 233
Query: 545 --ESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ L L P R ++ V+E
Sbjct: 234 FLSDGSKDLISKLLR---YHPPQRLPLKGVME 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 52/271 (19%), Positives = 105/271 (38%), Gaps = 39/271 (14%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHENIIRLR 372
LGKG F+ ++ + + A + + + + + SL H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
GF F++ + + L + + + + + R + I G YLH +
Sbjct: 82 GFFEDNDF--VFVVLELCRRRSLLELH-KRRKA--LTEPEAR-YYLRQIVLGCQYLHRNR 135
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 489
V +HR+L + + +++ I D GL + D K G Y+APE
Sbjct: 136 V-----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC--GTPNYIAPEV 186
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 545
++ + D+++ G I+ +L G + E++ + R K ++S
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG--------KPPFETSCLKETYLRIKKNEYSIPKHI 238
Query: 546 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+ A + KM L DP RPT+ ++
Sbjct: 239 NPVAASLIQKM-LQ---TDPTARPTINELLN 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 49/288 (17%), Positives = 109/288 (37%), Gaps = 49/288 (17%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--EN 367
+S + +G G S V++ + AI+ +N+ ++ + + + L L+ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
IIRL + +++ + L+ +L +++ S +D R S + + +
Sbjct: 118 IIRLYDYE--ITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHT 170
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 484
+H IVH +L LI + D G+ + D V + G Y
Sbjct: 171 IHQHG-----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GAVNY 222
Query: 485 LAPE-----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESAT 530
+ PE + + + +SD+++ G I+ + G + + + +
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SK 276
Query: 531 FENFIDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
ID N + +F + + + L L DP+ R ++ ++
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCC-LK---RDPKQRISIPELLA 320
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 40/301 (13%), Positives = 99/301 (32%), Gaps = 60/301 (19%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSIN------------VTSCKSEEAEFVKGLY----LL 360
L +G F+ + +D A++ + K ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTRVS 416
T +++E + G + ++IY++ + K+ + ++ + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 476
II + Y+H+ + I HR++ +L+D+ ++D G + + D +
Sbjct: 156 IIKSVLNSFSYIHN----EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKI 207
Query: 477 KTSAAMG---YLAPEYVTTGRFT--ERSDIFAFGVIILQILTGSL--------------V 517
K S G ++ PE+ + + DI++ G+ + + + +
Sbjct: 208 KGS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 518 LTSSMRLAAESATFENFIDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVI 573
T ++ + F + + S L +P R T E +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK----NPAERITSEDAL 321
Query: 574 E 574
+
Sbjct: 322 K 322
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 42/273 (15%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHENI 368
LLGKG+F+ VY+ + G VAI+ I+ K +A V+ + + L+H +I
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMID----KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+ L + +L+ + G++++YL + R + I G+ YL
Sbjct: 74 LELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKP--FSENEAR-HFMHQIITGMLYL 128
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAP 487
HS + +HR+L++ +L+ + N IAD GL L T Y++P
Sbjct: 129 HSHGI-----LHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLCGTPNYISP 181
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE-- 545
E T SD+++ G + +L G R ++ T +N +++ + +
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIG--------RPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 546 --SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
S AK + ++ L +P +R ++ +V++
Sbjct: 234 FLSIEAKDLIHQL-LR---RNPADRLSLSSVLD 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 36/297 (12%), Positives = 69/297 (23%), Gaps = 51/297 (17%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHEN----- 367
L G+ S V+ + A++ + + S + + L E+
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 368 -------------------IIRLRGFCCSRGRGECFLIYDFAP--KGKLSKYLDQEEGSS 406
+L L+ A L LD
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 407 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466
+ + + L S +VH + + + + I ++ D L
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG-----LVHGHFTPDNLFIMPDGRLMLGDVSA--L 241
Query: 467 LADDIVFSVLKTSAAMGYLAPEYVT--TGRFTERSDIFAFGVIILQILTGSL-----VLT 519
Y E++ T FT + + G+ I ++ L
Sbjct: 242 WKVGTRGPASSVPVT--YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 520 SSMRLAAESATFENFIDRNLKGKFSESEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
S + K +G+ L D R +E
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF-LNF---DRRRRLLPLEAME 352
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 64/291 (21%), Positives = 103/291 (35%), Gaps = 47/291 (16%)
Query: 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+LG G+ +V G VA++ + + C E +K L S H N+IR +
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME-IK--LLTESDDHPNVIRY--Y 75
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR---VSIIIGIAKGIGYLHSS 431
C ++ + L ++ + S L +S++ IA G+ +LHS
Sbjct: 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 432 EVNKPAIVHRNLSVEKVLID-------------QQFNPLIADCGLHKLLADDIVFSVLKT 478
K I+HR+L + +L+ + LI+D GL K L
Sbjct: 134 --LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 479 SAAMG---YLAPE-------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528
+ G + APE T R T DIF+ G + IL+ + + ES
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRES 248
Query: 529 ATFE---NFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVIE 574
+ + S A L+ DP RPT V+
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEAT----DLISQMIDHDPLKRPTAMKVLR 295
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 36/230 (15%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
F E+ +LG+G F V K D AI+ I T + + + + + LL SL H+ ++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVV 65
Query: 370 RLRGFCCSRGRGEC-----------FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
R R F+ ++ G L + E + +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR---DEYWRLF 122
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
I + + Y+HS I+HR+L + ID+ N I D GL K + + L +
Sbjct: 123 RQILEALSYIHS---QG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 479 SAAMG-------------YLAPEYVT-TGRFTERSDIFAFGVIILQILTG 514
G Y+A E + TG + E+ D+++ G+I +++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 51/284 (17%), Positives = 100/284 (35%), Gaps = 43/284 (15%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL-R 364
T F E+ +G G F SV+K DG + AI+ S +E ++ +Y L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
H +++R + ++ G L+ + + + + +++ + +G
Sbjct: 70 HSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 425 IGYLHSSEVNKPAIVHR-----N--LSVEKVLIDQQFNPLIADCGLHKL---LAD-DIVF 473
+ Y+HS +VH N +S + D +K+ + D V
Sbjct: 128 LRYIHSMS-----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 474 SVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529
+ G +LA E + ++DIFA + ++ L
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-------EPLPRNGD 235
Query: 530 TFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPT 568
+ +G+ S+ ++ V H DPE RP+
Sbjct: 236 QWHEIR----QGRLPRIPQVLSQEFT--ELLKVMIHPDPERRPS 273
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 38/301 (12%), Positives = 77/301 (25%), Gaps = 64/301 (21%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA----------------------- 351
+LG+ + + + T G + T A
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 352 ----EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK--GKLSKYLDQEEGS 405
F+ L+ + + +IR+R F +Y + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 406 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465
L R+ + + + + + LH +VH L +++DQ+ +
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 466 LLADDIVFSVLKTSAAMGYLAPEYVT----------TGRFTERSDIFAFGVIILQILTGS 515
V + G+ PE T D + G+ I I
Sbjct: 260 RDGASAV-----SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA- 313
Query: 516 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVI 573
L + + + + + AL+ E+R +
Sbjct: 314 -------DLPNTDDAALGGSEWIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQAM 362
Query: 574 E 574
E
Sbjct: 363 E 363
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 44/302 (14%), Positives = 85/302 (28%), Gaps = 65/302 (21%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE---------------------- 352
+LG+ + + + T G + T A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 353 -----FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA--PKGKLSKYLDQEEGS 405
F+ L+ + + +IR+R F +Y + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 406 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465
L R+ + + + + + LH +VH L +++DQ+ +
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 466 LLADDIVFSVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTG 514
+V SV + G+ PE T D +A G++I I
Sbjct: 255 RDGARVVSSV-----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 515 SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAV 572
L +T A E + + + + AL+ E+R
Sbjct: 310 DLPITKD----AALGGSE----WIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQA 357
Query: 573 IE 574
+E
Sbjct: 358 ME 359
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 18/92 (19%), Positives = 29/92 (31%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N L S L VL L + + +L L L L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + + L L L+ + + L
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 24/109 (22%), Positives = 38/109 (34%), Gaps = 4/109 (3%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
VL++ N N I L++L+ L L +L P + +L L+ L++S N+ F
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGG---FQFQNNPGLC 148
L LD N + L+ N C
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 28/98 (28%), Positives = 41/98 (41%), Gaps = 5/98 (5%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG-IPDSLGNLGKLKRLDLSFNSLFG 102
L L IG LK+L L + HN + +P+ NL L+ LDLS N +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 103 TIPESLANNAEL----LFLDVQNNTLSGIVPSALKRLN 136
L ++ L LD+ N ++ I P A K +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 201
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 18/87 (20%), Positives = 30/87 (34%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L ++ SL LS L L N + + L L++L +L
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPS 130
+ + L L+V +N +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLP 142
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 2/94 (2%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L + L + SL++L L + H L L+ L ++ NS
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 103 TI-PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
P+ L FLD+ L + P+A L
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 3/86 (3%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
IP + S L L N L S + +L+ LDLS + +
Sbjct: 17 LNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
+ + L L + N + + A L
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGL 99
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 18/87 (20%), Positives = 27/87 (31%), Gaps = 3/87 (3%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL-GKLKRLDLSFNSLFGTIP-ES 107
N L SL VL N + L + L L+L+ N T +S
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 563
Query: 108 LANNA-ELLFLDVQNNTLSGIVPSALK 133
+ L V+ + PS +
Sbjct: 564 FLQWIKDQRQLLVEVERMECATPSDKQ 590
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 49 CNQLTGNIPAQIGSLKSLSVLTLQHNRLN---GGIPDSLGNLGKLKRLDLSFNSLFGTIP 105
L + + L +L++ + L+ I D L + L ++
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERV 297
Query: 106 ESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ + N L++ N LK L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 27/106 (25%), Positives = 42/106 (39%), Gaps = 11/106 (10%)
Query: 46 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGT 103
+L Q +LK S+ L GG S +L L+ LDLS N L G
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPS-----ALKRLNGGFQFQNN 144
+S L +LD+ N + + + L+ L+ FQ++
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLD----FQHS 406
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 14/89 (15%), Positives = 28/89 (31%), Gaps = 6/89 (6%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSV----LTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 99
L L N++ + L + + L L N +N P + + +L +L L N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNF 211
Query: 100 LFGTIPESLANNAELL-FLDVQNNTLSGI 127
+ ++ L +
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 16/109 (14%), Positives = 26/109 (23%), Gaps = 14/109 (12%)
Query: 42 FVVLQLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGI---PDSLGNLGKLKRLDLSF 97
L L N + N+ I L L V L L L L +
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 98 NSL------FGTIPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
L I + + + + T+ + + L
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 59/268 (22%), Positives = 120/268 (44%), Gaps = 37/268 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
F+++ +GKG+F V+KG R +VAI+ I++ + E + + + +L+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+ + + ++I ++ G L+ LD + +I+ I KG+ YLH
Sbjct: 84 KY--YGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH 136
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 486
S +HR++ VL+ + +AD G+ L D + +K + +G ++A
Sbjct: 137 SE-----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFWMA 187
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGS--LVLTSSMRLAAESATFENFIDRN----LK 540
PE + + ++DI++ G+ +++ G M+ F I +N L+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLF--LIPKNNPPTLE 240
Query: 541 GKFSESEAAKLGKMALVCTHEDPENRPT 568
G +S+ L + C +++P RPT
Sbjct: 241 GNYSKP----LKEFVEACLNKEPSFRPT 264
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 51/278 (18%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
LG G + V + AI+ I TS + + + +L L H NI++L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQ-----EEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+ +L+ + G+L + E ++ II + G+ YLH
Sbjct: 105 FEDKR--NYYLVMECYKGGELFDEIIHRMKFNEVDAAV---------IIKQVLSGVTYLH 153
Query: 430 SSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 486
IVHR+L E +L+ ++ I D GL + + +A Y+A
Sbjct: 154 KH-----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTA--YYIA 206
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--- 543
PE V ++ E+ D+++ GVI+ +L G + + KGK+
Sbjct: 207 PE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT----DQEILRK-V---EKGKYTFD 257
Query: 544 -----SESEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+ SE AK + +M L D + R + + +E
Sbjct: 258 SPEWKNVSEGAKDLIKQM-LQ---FDSQRRISAQQALE 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 75/318 (23%), Positives = 121/318 (38%), Gaps = 81/318 (25%)
Query: 292 EHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE 350
H +S R NL + + ++ V +LGKG+F V K R A++ IN S K+++
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 351 AEFVKG-LYLLTSLRHENIIRLRGFC------------CSRGRGECFLIYDFAPKGKLSK 397
+ + LL L H NI++L + G GE L + + + S
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT-G-GE--LFDEIIKRKRFS- 119
Query: 398 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQF 454
E ++ II + GI Y+H IVHR+L E +L+ ++
Sbjct: 120 ----EHDAAR---------IIKQVFSGITYMHKH-----NIVHRDLKPENILLESKEKDC 161
Query: 455 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
+ I D GL + +A Y+APE V G + E+ D+++ GVI+ +L+G
Sbjct: 162 DIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
Query: 515 SLVLTSSMRLAAESATFENFIDRNLKGKFSE----------------SEAAK--LGKMAL 556
+ F +N S+ AK + KM L
Sbjct: 219 TP----------------PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM-L 261
Query: 557 VCTHEDPENRPTMEAVIE 574
P R T +E
Sbjct: 262 TF---HPSLRITATQCLE 276
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 24/93 (25%), Positives = 34/93 (36%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L + N ++ P L L VL LQHN L+ + L L L NS+
Sbjct: 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
L+ LD+ +N LS +L
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 23/92 (25%), Positives = 37/92 (40%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L NQL A L+ L + N ++ P+ L LK L+L N L
Sbjct: 29 VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQL 88
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
++ A L L + +N++ I + +
Sbjct: 89 SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 22/93 (23%), Positives = 32/93 (34%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L N+L+ +L+ L L N + + L LDLS N L T
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ L L + NN + + L
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 21/102 (20%), Positives = 37/102 (36%), Gaps = 3/102 (2%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
+ G + L L +L L+ N + + +L +LK +DL N+L
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRLNGG---FQFQNNPGLC 148
N L L++Q N ++ + + NP C
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 20/89 (22%), Positives = 38/89 (42%), Gaps = 3/89 (3%)
Query: 50 NQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPE 106
N++ + Q L+++ + L +N+ +S + L+RL L +L + P
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474
Query: 107 SLANNAELLFLDVQNNTLSGIVPSALKRL 135
L LD+ NN ++ I L+ L
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGL 503
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 25/106 (23%), Positives = 38/106 (35%), Gaps = 3/106 (2%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG--GIPDSLGNLGKLKRLDLSFNSLF 101
+ L N+ + SL L L+ L P L L LDLS N++
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA 493
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 147
+ L +L LD+Q+N L+ + A F + L
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF-LKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 23/102 (22%), Positives = 36/102 (35%), Gaps = 2/102 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--KLKRLDLSFNSLF 101
L L N L+ L++L L L +N++ + L LK+L+LS N +
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQN 143
P L L + N L + L +N
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 26/119 (21%), Positives = 44/119 (36%), Gaps = 7/119 (5%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPA--QIGSLKSLSVLTLQHNRLNGGI 80
N + Q+++ L L L N++ I + SL L L N++
Sbjct: 130 HNGLSSTKLGTQVQLENL--QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 81 PDSLGNLGKLKRLDLSFNSLFGTIPESLA---NNAELLFLDVQNNTLSGIVPSALKRLN 136
P +G+L L L+ L ++ E L N + L + N+ LS + L
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 4/99 (4%)
Query: 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
F + L LK L L ++ N + G + L LK L LS +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 102 GTIPESLA----NNAELLFLDVQNNTLSGIVPSALKRLN 136
+ ++ L L++ N +S I A L
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 41 CFVVLQ-LCC--NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSF 97
C V + C +LT +P + +++VL L HN+L + +L LD+ F
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 98 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
N++ PE L L++Q+N LS +
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 10/102 (9%)
Query: 44 VLQLCCNQLTG--NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL- 100
L L L + P+ L++L++L L +N + D L L KL+ LDL N+L
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 101 -------FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
G L + L L++++N I K L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 27/128 (21%), Positives = 53/128 (41%), Gaps = 3/128 (2%)
Query: 23 SNKI-FVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLK--SLSVLTLQHNRLNGG 79
+ ++ + ++ L++ L L +QL+ LK +L++L L +N LN
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 80 IPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGF 139
DS L +L+ L +N++ SL + +L+++ + + A F
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323
Query: 140 QFQNNPGL 147
FQ L
Sbjct: 324 SFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 19/113 (16%), Positives = 34/113 (30%), Gaps = 14/113 (12%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHN---------RLNGGIPDSLGNLGKLKRLD 94
L N + + L ++ L L+ + L S L L+ L+
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 147
+ N + G L +L + N+ S + N F + L
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT-----NETFVSLAHSPL 383
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 13/75 (17%), Positives = 30/75 (40%), Gaps = 1/75 (1%)
Query: 62 SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQ 120
+ L +L L N+++ D+ LG L+ LDL N + + + + + +
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 121 NNTLSGIVPSALKRL 135
N + ++ +
Sbjct: 439 YNKYLQLTRNSFALV 453
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 16/86 (18%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG-NLGKLKRLDLSFNSLF 101
++ L N L + + SL L LQ N + G L LD+ FN
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
Query: 102 GTIPESLANNAELLFLDVQNNTLSGI 127
T + +++ + + +
Sbjct: 623 CTCESIAWF---VNWINETHTNIPEL 645
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 51/276 (18%)
Query: 317 LGKGNFSSVYKGT-LRDGTLVAIRSIN---VTSCKSEEAEFVKGLYL----LTSLRHENI 368
LG G F V+ V ++ I V E + + L L+ + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGK-LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I++ ++G L+ + G L ++D+ LD I + +GY
Sbjct: 92 IKVLDIFENQG--FFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGY 145
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLA 486
L I+HR++ E ++I + F + D G L + T + Y A
Sbjct: 146 LRLK-----DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCA 197
Query: 487 PEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
PE V G ++++ GV + ++ F + ++
Sbjct: 198 PE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN-------------PFCEL-EETVEAAIH 242
Query: 545 E----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
S+ + + PE R T+E ++
Sbjct: 243 PPYLVSKELMSLVSGLLQP----VPERRTTLEKLVT 274
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 63/289 (21%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSEEAEFVKGLY----LLTSLRHENI 368
LG G V R VAIR I+ + EA+ + +L L H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIA 422
I+++ F + + +++ + G+L +K L + +
Sbjct: 203 IKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQML 249
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 479
+ YLH + I+HR+L E VL+ Q I D G K+L + S+++T
Sbjct: 250 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTL 301
Query: 480 A-AMGYLAPE---YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535
YLAPE V T + D ++ GVI+ L+G +
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS------EHRTQVSLK- 354
Query: 536 DRNLKGKFSE--------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
D+ GK++ SE A + K+ +V DP+ R T E +
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVV----DPKARFTTEEALR 399
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 2/88 (2%)
Query: 44 VLQLCCNQL-TGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
++ + N L T + + +K L +L +N+L G + G+ KL L+L++N +
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE 367
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPS 130
++ L +N L I
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNI 395
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 10/95 (10%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQH------NRLNGGIPDSLGNLGKLKRLDLSF 97
+ L N + P Q + +L +++ NR P+ + L +L +
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 98 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 132
N + + E + N + LD+++N I S +
Sbjct: 576 NDI-RKVNEKITPN--ISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 10/105 (9%)
Query: 44 VLQLCCNQLTGNIPA--QIGSLKSLSVLTLQHNRLNG-------GIPDSLGNLGKLKRLD 94
L N+L IP S+ +S + +N + + + + ++
Sbjct: 381 NLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN 439
Query: 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGF 139
LS N + E + + L +++ N L+ I ++LK N F
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 12/104 (11%)
Query: 43 VVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSL--GNLGKLKRLDLSFNS 99
L L NQ+T IPA G + + L+ HN+L IP+ ++ + +D S+N
Sbjct: 356 ASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413
Query: 100 L-------FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ F + + + +++ NN +S +
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 19/96 (19%), Positives = 33/96 (34%), Gaps = 10/96 (10%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG-------GIPDSLGNLGKLKRLDLS 96
+ L NQ++ + LS + L N L ++ N L +DL
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 97 FNSLFGTIPESLA--NNAELLFLDVQNNTLSGIVPS 130
FN L + + L+ +D+ N+ S
Sbjct: 497 FNKL-TKLSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 12/95 (12%), Positives = 36/95 (37%), Gaps = 9/95 (9%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--------F 101
Q + +LK L+ + + + +P L L +++ ++++ N
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 102 GTIPESLANNAELLFLDVQNNTL-SGIVPSALKRL 135
++ + + N L + V ++L+++
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 14/99 (14%), Positives = 29/99 (29%), Gaps = 6/99 (6%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFN 98
L L +G +P IG L L VL L + P + ++
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 99 SLFGTIPESLANNA--ELLFLDVQNNTLSGIVPSALKRL 135
T + +L+ + ++ + + +
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 15/123 (12%), Positives = 30/123 (24%), Gaps = 20/123 (16%)
Query: 24 NKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG---- 79
N + I L + N +T + + L L + ++
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICE 225
Query: 80 ---------------IPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTL 124
NL L +++ +P L E+ ++V N
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
Query: 125 SGI 127
Sbjct: 286 ISG 288
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 14/92 (15%), Positives = 31/92 (33%), Gaps = 4/92 (4%)
Query: 49 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG----TI 104
+ + S ++ L+L+ +G +PD++G L +L+ L L +
Sbjct: 66 LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
P+ ++ N R +
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPRED 157
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 15/99 (15%), Positives = 30/99 (30%), Gaps = 7/99 (7%)
Query: 43 VVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--KLKRLDLS 96
VL L + N P I + S D L + ++
Sbjct: 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN 167
Query: 97 FNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ +I +S + + +N ++ + A+ RL
Sbjct: 168 SDPQQKSIKKSSRITLKDTQIGQLSNNITFV-SKAVMRL 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 43/207 (20%), Positives = 83/207 (40%), Gaps = 25/207 (12%)
Query: 315 NLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+G+G+F V++ + G A++ + + + EE L L I+ L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE------LVACAGLSSPRIVPLYG 117
Query: 374 FCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
G I+ + G L + + ++ G L + + +G+ YLH+
Sbjct: 118 AVRE---GPWVNIFMELLEGGSLGQLI-KQMGC---LPEDRALYYLGQALEGLEYLHTRR 170
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAM-G---YLAP 487
I+H ++ + VL+ + + D G L D + L T + G ++AP
Sbjct: 171 -----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTG 514
E V + DI++ ++L +L G
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 69/283 (24%), Positives = 112/283 (39%), Gaps = 61/283 (21%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
LGKG+F V K R A++ IN S K+++ + + LL L H NI++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
+++ + G+L D+ + + D + II + GI Y+H
Sbjct: 90 LED--SSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 433 VNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
IVHR+L E +L+ ++ + I D GL + +A Y+APE
Sbjct: 142 -----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE- 193
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--------LKG 541
V G + E+ D+++ GVI+ +L+G F +N G
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG----------------TPPFYGKNEYDILKRVETG 237
Query: 542 KF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
K+ S+ AK + KM L P R T +E
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKM-LTF---HPSLRITATQCLE 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 42/271 (15%)
Query: 317 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
+GKGNF+ V + G VAI+ I+ T + + + ++ L H NI++L F
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
+LI ++A G++ YL + S I + Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQK--- 133
Query: 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 491
IVHR+L E +L+D N IAD G L G Y APE +
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFC--GAPPYAAPE-LF 185
Query: 492 TGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 545
G+ + D+++ GVI+ +++GSL + + +R L+GK+
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYM 237
Query: 546 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
S + L + ++ +P R T+E +++
Sbjct: 238 STDCENLLKRFLVL----NPIKRGTLEQIMK 264
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 35/295 (11%)
Query: 293 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA 351
H +S R NL + F LG G F V+ R G I++IN +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 352 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 411
+ + +L SL H NII++ +++ + G+L + + + L
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLA 468
++ + + Y HS +VH++L E +L I D GL +L
Sbjct: 124 GYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528
D + +A Y+APE V T + DI++ GV++ +LTG L T + +
Sbjct: 179 SDEHSTNAAGTA--LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT----SLE 231
Query: 529 ATFENFIDRNLKGKF---SE----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+ + E + A L +M L DPE RP+ V+
Sbjct: 232 EVQQKA----TYKEPNYAVECRPLTPQAVDLLKQM-LTK---DPERRPSAAQVLH 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 47/302 (15%), Positives = 91/302 (30%), Gaps = 89/302 (29%)
Query: 316 LLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKS------EEAEFVKGLYLLTSLRHEN 367
+ G +Y +G V ++ + + E +F L + H +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF------LAEVVHPS 140
Query: 368 IIRLRGFCCSRGRGECFLIYDF----APKGKLSKYLDQE--EGSS------NVLDWSTRV 415
I++ I++F G Y+ E G S L + +
Sbjct: 141 IVQ---------------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI 185
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
+ ++ I + YLHS +V+ +L E +++ ++ + D G V +
Sbjct: 186 AYLLEILPALSYLHSI-----GLVYNDLKPENIMLTEE-QLKLIDLG--------AVSRI 231
Query: 476 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL--------VLTSSMRL 524
G + APE + T +DI+ G + + L +
Sbjct: 232 NSFGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPV 290
Query: 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEEL-TVAAPV 582
++ + R DP R T E + +L V V
Sbjct: 291 LKTYDSYGRLLRR--------------------AIDPDPRQRFTTAEEMSAQLTGVLREV 330
Query: 583 MA 584
+A
Sbjct: 331 VA 332
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 16/118 (13%), Positives = 39/118 (33%), Gaps = 16/118 (13%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD 82
++ + + + + N +LK L+ + L + +PD
Sbjct: 457 NSPFTYDNIAVDWEDANSDY-------AKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509
Query: 83 SLGNLGKLKRLDLSFNSL---------FGTIPESLANNAELLFLDVQNNTLSGIVPSA 131
L +L +L+ L+++ N + + + ++ + N L SA
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 10/101 (9%)
Query: 43 VVLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSF--- 97
+ L N+LT + +L LS + + +N + P N +LK +
Sbjct: 731 TTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788
Query: 98 ---NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
N + P + L+ L + +N + + +L
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQL 829
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 20/138 (14%), Positives = 37/138 (26%), Gaps = 20/138 (14%)
Query: 29 IIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG---------- 78
+ + I L + N++T I I L L ++ ++
Sbjct: 414 MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 79 ---------GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP 129
S NL L ++L +P+ L + EL L++ N
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 130 SALKRLNGGFQFQNNPGL 147
P +
Sbjct: 533 LKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 22/111 (19%), Positives = 39/111 (35%), Gaps = 16/111 (14%)
Query: 44 VLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ + N L A + + L +L HN++ ++ G KL L L +N +
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQI-E 608
Query: 103 TIPESLANNA-ELLFLDVQNNTLSGIVPSA-------LKRLNGGFQFQNNP 145
IPE ++ L +N L I + ++ F N
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVD----FSYNK 655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 11/103 (10%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRL-------NGGIPDSLGNLGKLKRLDL 95
+ L N++ + +S + L +N + + N L +DL
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 96 SFNSLFGTIPESLANNA--ELLFLDVQNNTLSGIVPSALKRLN 136
FN L ++ + L +DV N S P+ +
Sbjct: 736 RFNKL-TSLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSS 776
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 19/104 (18%), Positives = 40/104 (38%), Gaps = 8/104 (7%)
Query: 44 VLQLCCNQLTGNIP--AQIGSLKSLSVLTLQHNRL-----NGGIPDSLGNLGKLKRLDLS 96
L N+L IP S+ + + +N++ N + LS
Sbjct: 623 GLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681
Query: 97 FNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ 140
+N + E A + + + + NN ++ I ++LK +G ++
Sbjct: 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 11/82 (13%), Positives = 27/82 (32%)
Query: 49 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL 108
+ + + ++ L+L G +PD++G L +LK L +S +
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 109 ANNAELLFLDVQNNTLSGIVPS 130
+ + + +
Sbjct: 368 DEELTPDMSEERKHRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 18/138 (13%), Positives = 47/138 (34%), Gaps = 28/138 (20%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG---- 78
++I + ++ L + L + + N ++ +K S ++L+ ++
Sbjct: 380 KHRIRMHYKKMFLD-YDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNR 436
Query: 79 --GIPDSLGNLGKLKRLDLSFNSL-------------------FGTIPESLANNAELLFL 117
I ++ L KL+ + + + + S +N +L +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 118 DVQNNTLSGIVPSALKRL 135
++ N +P L L
Sbjct: 497 ELYNCPNMTQLPDFLYDL 514
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 13/86 (15%), Positives = 25/86 (29%), Gaps = 1/86 (1%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L G +P IG L L VL+ + + + +
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385
Query: 103 TIPE-SLANNAELLFLDVQNNTLSGI 127
+ L + L D+ + ++
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRN 411
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 15/83 (18%), Positives = 28/83 (33%), Gaps = 3/83 (3%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
N++ P I + SL L + N + + + L +L LD++ N
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISID 843
Query: 105 PESLANNAELLFLDVQNNTLSGI 127
S+ E + + I
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 10/56 (17%), Positives = 22/56 (39%)
Query: 72 QHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 127
+ + L N G++ L L+ G +P+++ EL L ++ +
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 14/98 (14%), Positives = 33/98 (33%), Gaps = 7/98 (7%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI-PDSLGNLGKLKRLDLSFNSL-- 100
VL + T + + + + +R+ L +L DL +++
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410
Query: 101 ---FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
I + + + + N ++ I A++RL
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRITFI-SKAIQRL 447
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 317 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA-EFVKG-LYLLTSLRHENIIRLRG 373
LGKG+F V + G A++ I+ K + E + + LL L H NI++L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQ-----EEGSSNVLDWSTRVSIIIGIAKGIGYL 428
F +G +L+ + G+L + E ++ II + GI Y+
Sbjct: 94 FFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAAR---------IIRQVLSGITYM 142
Query: 429 HSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 485
H + IVHR+L E +L+ + N I D GL +A Y+
Sbjct: 143 HKN-----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA--YYI 195
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF-- 543
APE V G + E+ D+++ GVI+ +L+G + E + + KGK+
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILKK-V---EKGKYTF 246
Query: 544 ------SESEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
SE+AK + KM L P R + ++
Sbjct: 247 ELPQWKKVSESAKDLIRKM-LT---YVPSMRISARDALD 281
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 66/288 (22%), Positives = 110/288 (38%), Gaps = 71/288 (24%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+LG G FS V+ R G L A++ I + + + + +L ++HENI+ L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-LENEIAVLKKIKHENIVTLEDI 74
Query: 375 CCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
S +L+ G+L Y E+ +S +I + + Y
Sbjct: 75 YESTT--HYYLVMQLVSGGELFDRILERGVY--TEKDASL---------VIQQVLSAVKY 121
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGY 484
LH + IVHR+L E +L + I D GL K+ + I+ + T GY
Sbjct: 122 LHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT---PGY 173
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN------ 538
+APE + +++ D ++ GVI +L G + F +
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG----------------YPPFYEETESKLFE 217
Query: 539 --LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+G + S SE+AK + + L DP R T E +
Sbjct: 218 KIKEGYYEFESPFWDDISESAKDFICHL-LEK---DPNERYTCEKALS 261
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 85/294 (28%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSLRHE--N 367
LLG G F SVY G + D VAI+ + + LL +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 368 IIRLRGFCCSR-----------GRGECFLIYDF-APKGKLS-----KYLDQEEGSSNVLD 410
+IRL + + F DF +G L + Q
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLF---DFITERGALQEELARSFFWQ--------- 157
Query: 411 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLAD 469
+ + + + H+ ++HR++ E +LID L + D G LL D
Sbjct: 158 ----------VLEAVRHCHNC-----GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
Query: 470 DIVFSVLKTSAAMG---YLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLA 525
+V G Y PE++ R+ + +++ G+++ ++ G +
Sbjct: 203 ----TVYTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--------- 247
Query: 526 AESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
FE+ + ++G+ SE L + L P +RPT E +
Sbjct: 248 ----PFEH-DEEIIRGQVFFRQRVSSECQHLIRWCLA---LRPSDRPTFEEIQN 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+LGKG + VY G L + +AI+ I + + L L+H+NI++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 375 CCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
I+ + P G LS L + G + + I +G+ YLH ++
Sbjct: 88 FSEN---GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQ- 142
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLAD--DIVFSVLKTSAAMGYLAPEYV 490
IVHR++ + VLI+ L I+D G K LA + T M APE +
Sbjct: 143 ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM---APEII 195
Query: 491 TTGR--FTERSDIFAFGVIILQILTG 514
G + + +DI++ G I+++ TG
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATG 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 52/228 (22%), Positives = 86/228 (37%), Gaps = 62/228 (27%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK------SEEAEFVKGLYL----LTSLR 364
LG G S+VY VAI K E+ E +K + L
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAI--------KAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGK-------------LSKYLDQEEGSSNVLDW 411
H+NI+ + D + LS+Y+ + G L
Sbjct: 70 HQNIVS---------------MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP---LSV 110
Query: 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471
T ++ I GI + H IVHR++ + +LID I D G+ K L++
Sbjct: 111 DTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET- 164
Query: 472 VFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
S+ +T+ +G Y +PE E +DI++ G+++ ++L G
Sbjct: 165 --SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 53/294 (18%), Positives = 96/294 (32%), Gaps = 83/294 (28%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG---------LYLLTSLRH 365
LLGKG F +V+ G L D VAI+ I + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 366 ENIIRLRGFCCSRGR-----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNV 408
+IRL + ++ + F D+ KG L + Q
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLF---DYITEKGPLGEGPSRCFFGQ------- 147
Query: 409 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLL 467
+ I + HS +VHR++ E +LID + + D G LL
Sbjct: 148 ------------VVAAIQHCHSR-----GVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
Query: 468 ADDIVFSVLKTSA-AMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLA 525
D Y PE+++ ++ + +++ G+++ ++ G +
Sbjct: 191 HD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI--------- 237
Query: 526 AESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
FE L+ + + L + L P +RP++E ++
Sbjct: 238 ----PFER-DQEILEAELHFPAHVSPDCCALIRRCLA---PKPSSRPSLEEILL 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
LGKG FS V + + G A + IN + + + ++ + L+H NI+RL
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 375 CCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+ +L++D G+L ++ + + S I I + I Y
Sbjct: 74 I--QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAYC 121
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGYL 485
HS+ IVHRNL E +L+ + + +AD GL + D + + GYL
Sbjct: 122 HSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYL 174
Query: 486 APEYVTTGRFTERSDIFAFGVI--IL 509
+PE + +++ DI+A GVI IL
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYIL 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 63/289 (21%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSEEAEFVKGLY----LLTSLRHENI 368
LG G V R VAI+ I+ + EA+ + +L L H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIA 422
I+++ F + + +++ + G+L +K L + +
Sbjct: 78 IKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQML 124
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 479
+ YLH + I+HR+L E VL+ Q I D G K+L + S+++T
Sbjct: 125 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTL 176
Query: 480 AAM-GYLAPE---YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535
YLAPE V T + D ++ GVI+ L+G +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS------EHRTQVSLK- 229
Query: 536 DRNLKGKFSE--------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
D+ GK++ SE A + K+ +V DP+ R T E +
Sbjct: 230 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVV----DPKARFTTEEALR 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 59/272 (21%), Positives = 105/272 (38%), Gaps = 40/272 (14%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
LG G F V++ T R G A + + + E V+ + ++ LRH ++ L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
E +IY+F G+L + + E + + V + + KG+ ++H +
Sbjct: 223 FEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDE---AVEYMRQVCKGLCHMHENN-- 275
Query: 435 KPAIVHRNLSVEKVLI-DQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 492
VH +L E ++ ++ N L + D GL L V +A + APE
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEG 330
Query: 493 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF---SE---- 545
+D+++ GV+ +L+G S + T N +
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSG----LSPFGGENDDETLRNV----KSCDWNMDDSAFSG 382
Query: 546 -SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
SE K + K+ L+ DP R T+ +E
Sbjct: 383 ISEDGKDFIRKL-LL---ADPNTRMTIHQALE 410
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 67/301 (22%), Positives = 106/301 (35%), Gaps = 82/301 (27%)
Query: 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSIN------------VTSCKSEEAEFVKGLYLLT 361
LG G + V + + AI+ I + + E + LL
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 362 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTR 414
SL H NII+L + +L+ +F G+L K+ E ++N
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKF--DECDAAN------- 150
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDI 471
I+ I GI YLH IVHR++ E +L+ + N I D GL + D
Sbjct: 151 --IMKQILSGICYLHKH-----NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 472 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531
+A Y+APE V ++ E+ D+++ GVI+ +L G
Sbjct: 204 KLRDRLGTA--YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP--------------- 245
Query: 532 ENFIDRNLKGKFSE----------------SEAAK--LGKMALVCTHEDPENRPTMEAVI 573
F +N + + S+ AK + M L D R T E +
Sbjct: 246 -PFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM-LT---YDYNKRCTAEEAL 300
Query: 574 E 574
Sbjct: 301 N 301
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 71/283 (25%), Positives = 111/283 (39%), Gaps = 63/283 (22%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 370
LG G F V G G VA++ +N K + V + L RH +II+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L + + F++ ++ G+L Y+ + ++ + I + Y H
Sbjct: 76 L--YQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHR 129
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 487
+VHR+L E VL+D N IAD GL +++D L+TS G Y AP
Sbjct: 130 H-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAP 179
Query: 488 EYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL------ 539
E V +GR DI++ GVI+ +L G+L F D ++
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTL----------------PFDDEHVPTLFKK 222
Query: 540 --KGKFSE----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
G F + + L M V DP R T++ + E
Sbjct: 223 IRGGVFYIPEYLNRSVATLLMHMLQV----DPLKRATIKDIRE 261
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 45/217 (20%), Positives = 87/217 (40%), Gaps = 34/217 (15%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK------SEEAEFVKGLYL----LTSLR 364
+LG G S V+ LRD VA+ K + + F +L
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAV--------KVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 365 HENIIRL--RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
H I+ + G + +++ ++ L + EG + + +I
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGP---MTPKRAIEVIADAC 126
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
+ + + H + I+HR++ ++I + D G+ + +AD SV +T+A +
Sbjct: 127 QALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVI 180
Query: 483 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
G YL+PE RSD+++ G ++ ++LTG
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 17/92 (18%), Positives = 28/92 (30%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ L N L + L L L + + L L L L+ N +
Sbjct: 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
P S + L L L+ + + +L
Sbjct: 96 SPGSFSGLTSLENLVAVETKLASLESFPIGQL 127
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 1/94 (1%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L++ N N + + + +L+ L L +L L +L+ L++S N+L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
L LD N +
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 19/89 (21%), Positives = 27/89 (30%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L ++ L LS L L N + P S L L+ L L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSAL 132
+ L L+V +N + A
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 21/82 (25%), Positives = 31/82 (37%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L QL +L L +L + HN L L L LD SFN + +
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 104 IPESLANNAELLFLDVQNNTLS 125
L F ++ NN+++
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 19/88 (21%), Positives = 27/88 (30%), Gaps = 2/88 (2%)
Query: 50 NQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES- 107
+ L SL+ L L + + L L L ++ NS +
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
Query: 108 LANNAELLFLDVQNNTLSGIVPSALKRL 135
AN L FLD+ L I L
Sbjct: 469 FANTTNLTFLDLSKCQLEQISWGVFDTL 496
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 20/86 (23%), Positives = 32/86 (37%), Gaps = 3/86 (3%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
+L+ +P I S S + L N L S N +L+ LDLS + ++
Sbjct: 21 QKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH 77
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
L L + N + P + L
Sbjct: 78 GLHHLSNLILTGNPIQSFSPGSFSGL 103
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--KLKRLDLSFNSLF 101
L L N+ + I + +L SLS L L N L+ S +LG L+ LDLSFN
Sbjct: 332 SLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVP 129
+ + EL LD Q++TL +
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 19/90 (21%), Positives = 30/90 (33%), Gaps = 4/90 (4%)
Query: 50 NQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES 107
N L+ G SL L L N + + L +L+ LD ++L S
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFS 418
Query: 108 -LANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ +LL+LD+ L
Sbjct: 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 23/100 (23%), Positives = 42/100 (42%), Gaps = 7/100 (7%)
Query: 44 VLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK----RLDLSFN 98
L + N + +PA +L +L + L +N + + L L + LD+S N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 99 SLFGTIPESLANNAELLFLDVQNNTLSG-IVPSALKRLNG 137
+ I + +L L ++ N S I+ + L+ L G
Sbjct: 192 PI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 20/133 (15%), Positives = 39/133 (29%), Gaps = 23/133 (17%)
Query: 24 NKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD- 82
+ + I + + +L + + L ++S ++L + + D
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDV 303
Query: 83 -------------------SLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT 123
+L LK L L+ N +I L +LD+ N
Sbjct: 304 PKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNA 361
Query: 124 LSGIVPSALKRLN 136
LS + L
Sbjct: 362 LSFSGCCSYSDLG 374
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 51/305 (16%), Positives = 116/305 (38%), Gaps = 26/305 (8%)
Query: 287 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS 345
F + L ++ E +++ LG GN V+K + + G ++A + I++
Sbjct: 18 EAFLTQKQKVGELKDDDFE-------KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 346 CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG- 404
+ + ++ L +L I+ G GE + + G L + L +
Sbjct: 71 KPAIRNQIIRELQVLHECNSPYIVGFYG--AFYSDGEISICMEHMDGGSLDQVLKKAGRI 128
Query: 405 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464
+L + I + KG+ YL K I+HR++ +L++ + + D G+
Sbjct: 129 PEQIL-----GKVSIAVIKGLTYLRE----KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 524
L D + S + T + Y++PE + ++ +SDI++ G+ ++++ G +
Sbjct: 180 GQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584
E + + + + ++ ++ E P +
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE---PPPKLP 293
Query: 585 TFLFS 589
+ +FS
Sbjct: 294 SGVFS 298
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
LGKG FS V + + G A + IN + + + ++ + L+H NI+RL
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 375 CCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+L++D G+L ++ + + S I I + I Y
Sbjct: 97 IQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAYC 144
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGYL 485
HS+ IVHRNL E +L+ + + +AD GL + D + + GYL
Sbjct: 145 HSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYL 197
Query: 486 APEYVTTGRFTERSDIFAFGVI--IL 509
+PE + +++ DI+A GVI IL
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYIL 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 69/300 (23%), Positives = 106/300 (35%), Gaps = 83/300 (27%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTS-----LR----HE 366
LG+G S V + + A++ I+VT S AE V+ L T LR H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIG 420
NII+L+ + FL++D KG+L L ++E I+
Sbjct: 85 NIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRK----------IMRA 132
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+ + I LH IVHR+L E +L+D N + D G L + +
Sbjct: 133 LLEVICALHKL-----NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 481 AMGYLAPE------YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFE 532
YLAPE + + D+++ GVI L L G
Sbjct: 188 --SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL--LAG----------------SP 227
Query: 533 NFIDRN--------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
F R + G + S S+ K + + +V P+ R T E +
Sbjct: 228 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV----QPQKRYTAEEALA 283
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 4/96 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGS---LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100
L L N + S L L +L L L+ + +L + +DLS N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 101 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ E+L++ + ++L++ +N +S I+PS L L+
Sbjct: 513 TSSSIEALSHL-KGIYLNLASNHISIILPSLLPILS 547
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 20/92 (21%), Positives = 26/92 (28%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L Q+ S L L L N L +L LK L +
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
L N L L + +N +S I
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 19/92 (20%), Positives = 31/92 (33%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L+ N L L +L+ L L ++ D+ + +L L L+ N L
Sbjct: 37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+L+ L L +S I L
Sbjct: 97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 27/96 (28%), Positives = 40/96 (41%), Gaps = 3/96 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI---PDSLGNLGKLKRLDLSFNSL 100
VL L + L + L +L L LQ N G +SL LG+L+ L LSF L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 101 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ + + +D+ +N L+ AL L
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 3/96 (3%)
Query: 44 VLQLCCNQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
L L + + Q+ +L L L L +N ++ +L+ LDL+F L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413
Query: 102 GTIPES-LANNAELLFLDVQNNTLSGIVPSALKRLN 136
+S N L L++ ++ L L
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 22/95 (23%), Positives = 30/95 (31%), Gaps = 1/95 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS-LGNLGKLKRLDLSFNSLFG 102
L L N+ L +L L RL S NL LK L+LS + L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 137
+ + L L++Q N L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 18/92 (19%), Positives = 29/92 (31%), Gaps = 3/92 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L IP + S L N L + L L LDL+ ++
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
++ + L L + N L + +AL
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 22/105 (20%), Positives = 36/105 (34%), Gaps = 9/105 (8%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L L+ +P+ + L +L L L N+ S N L L + N+
Sbjct: 282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340
Query: 104 I-PESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 147
+ L N L LD+ ++ + Q +N L
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCN-------LQLRNLSHL 378
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 22/90 (24%), Positives = 30/90 (33%), Gaps = 4/90 (4%)
Query: 50 NQLTGNIP-AQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI---P 105
+L + +L L VL L H+ L+ L L+ L+L N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 106 ESLANNAELLFLDVQNNTLSGIVPSALKRL 135
SL L L + LS I A L
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 19/115 (16%), Positives = 37/115 (32%), Gaps = 3/115 (2%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSV--LTLQHNRLNGGI 80
+ ++IF+ + + PA L +SV + LQ +
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 81 PDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
++ L+ LDL+ L +P L + L L + N + +
Sbjct: 271 SNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 17/95 (17%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR--LDLSFNSLF 101
L L N ++ + + L VL Q+N ++ + + +L + L+L+ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI- 191
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
I ++A L+ ++ LK
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 14/100 (14%), Positives = 24/100 (24%), Gaps = 5/100 (5%)
Query: 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN--LGKLKRLDLSF 97
+ L L N + G I L + I L N + L
Sbjct: 179 ATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
Query: 98 NSLFGTIPESLANNAE--LLFLDVQNNTLSGIVPSALKRL 135
P E + +++Q + I +
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100
+ L N+LT + + LK + L L N ++ +P L L + + ++L N L
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 25/101 (24%), Positives = 41/101 (40%), Gaps = 3/101 (2%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
V L+L L P Q L L +T+ L +PD++ L+ L L+ N L
Sbjct: 84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPL-R 140
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQN 143
+P S+A+ L L ++ +P L + + Q
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 1/92 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L++ + L+ + I L L L L+ P G LKRL L S T
Sbjct: 210 SLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+P + +L LD++ +PS + +L
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 21/102 (20%), Positives = 40/102 (39%), Gaps = 12/102 (11%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ + L +P + L LTL N L +P S+ +L +L+ L +
Sbjct: 108 HMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTE 165
Query: 104 IPESLANNAE---------LLFLDVQNNTLSGIVPSALKRLN 136
+PE LA+ L L ++ + + P+++ L
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQ 206
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 1/77 (1%)
Query: 49 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL 108
C L P G L L L+ +P + L +L++LDL +P +
Sbjct: 239 CTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
Query: 109 ANNAELLFLDVQNNTLS 125
A + V + +
Sbjct: 298 AQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 6/94 (6%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKS--LSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
+ L + L L+ L PD L L+ + + L
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL- 116
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+P+++ A L L + N L + P+++ L
Sbjct: 117 MELPDTMQQFAGLETLTLARNPLRAL-PASIASL 149
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 22/96 (22%), Positives = 39/96 (40%), Gaps = 12/96 (12%)
Query: 49 CNQLTGNIPAQIGS---------LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 99
C +LT +P + S L +L L L+ + +P S+ NL LK L + +
Sbjct: 160 CPELT-ELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSP 217
Query: 100 LFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
L + ++ + +L LD++ T P
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 10/60 (16%), Positives = 20/60 (33%), Gaps = 2/60 (3%)
Query: 49 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL 108
C+ L +P I L L L L+ +P + L + + + + +
Sbjct: 263 CSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ-AQLDQHR 320
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 45/278 (16%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+LG G V + R G A++ + + +E + + + +I+ +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVD-----HHWQASGGPHIVCILDV 90
Query: 375 CCSRGRGEC--FLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYL 428
+ G+ +I + G+L QE G ++ R I+ I I +L
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQA---FTEREAAEIMRDIGTAIQFL 144
Query: 429 HSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 485
HS I HR++ E +L ++ + D G K + + + T Y+
Sbjct: 145 HSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP---YYV 196
Query: 486 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF-- 543
APE + ++ + D+++ GVI+ +L G S+ A R G++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN----TGQAISPGMKRRIRLGQYGF 252
Query: 544 -SE-----SEAAK-LGKMALVCTHEDPENRPTMEAVIE 574
+ SE AK L ++ L DP R T+ +
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKT---DPTERLTITQFMN 287
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 57/301 (18%), Positives = 97/301 (32%), Gaps = 91/301 (30%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 371
LLG+G++ V + A++ + + + EA K + LL LRH+N+I+L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 372 RGFC--------------CSRGRGECFLIYDFAPKGKLS-----KYLDQEEGSSNVLDWS 412
C G E D P+ + Y Q
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQ----------- 117
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472
+I G+ YLHS IVH+++ +L+ I+ G+ + L
Sbjct: 118 ----LIDGLE----YLHSQ-----GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 473 FSVLKTSAAMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAE 527
+TS G + PE + DI++ GV + I TG
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY----------- 211
Query: 528 SATFENFIDRNL--------KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVI 573
F N+ KG ++ + L M +P R ++ +
Sbjct: 212 -----PFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEY----EPAKRFSIRQIR 262
Query: 574 E 574
+
Sbjct: 263 Q 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 79/292 (27%)
Query: 316 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRG 373
LG+G S VY+ + A++ + K+ + + V+ + +L L H NII+L+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 374 FCCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
+ E L+ + G+L Y E +++ + I + +
Sbjct: 116 IFETPT--EISLVLELVTGGELFDRIVEKGYY--SERDAAD---------AVKQILEAVA 162
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSA-AM 482
YLH + IVHR+L E +L PL IAD GL K++ ++KT
Sbjct: 163 YLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTP 214
Query: 483 GYLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN-- 538
GY APE + + D+++ G+I IL L G FE F D
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYIL--LCG----------------FEPFYDERGD 256
Query: 539 -------LKGKF---SE-----SEAAK-LGKMALVCTHEDPENRPTMEAVIE 574
L ++ S S AK L + +V DP+ R T ++
Sbjct: 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL---DPKKRLTTFQALQ 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 64/276 (23%), Positives = 121/276 (43%), Gaps = 29/276 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ ++G G + V VAI+ IN+ C++ E +K + ++ H NI+
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLS----KYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
+ + E +L+ G + + + E S VLD ST +I+ + +G+
Sbjct: 77 SY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-G- 483
YLH + +HR++ +L+ + + IAD G+ LA + K G
Sbjct: 135 EYLHKN-----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 484 --YLAPEYVTTGR-FTERSDIFAFGVIILQILTGS--LVLTSSMR---LAAESAT---FE 532
++APE + R + ++DI++FG+ +++ TG+ M+ L ++
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
D+ + K+ +S KM +C +DPE RPT
Sbjct: 250 GVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPT 281
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 61/277 (22%), Positives = 116/277 (41%), Gaps = 41/277 (14%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIRL 371
+GKG FS V + R+ G A++ ++V S + L + L+H +I+ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 372 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 431
S G +++++F L + + + V + + I + + Y H +
Sbjct: 92 LETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 432 EVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGL-HKLLADDIVFSVLKTSAAMGYLAP 487
I+HR++ VL+ + N P+ + G+ +L +V + ++AP
Sbjct: 150 N-----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP--HFMAP 202
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF---S 544
E V + + D++ GVI+ +L+G L + + FE I +KGK+
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-----KERLFEG-I---IKGKYKMNP 253
Query: 545 E-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
SE+AK + +M L+ DP R T+ +
Sbjct: 254 RQWSHISESAKDLVRRM-LML---DPAERITVYEALN 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 63/330 (19%), Positives = 118/330 (35%), Gaps = 79/330 (23%)
Query: 317 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 369
LG+G F V + VA++ + + SE + L +L + H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL---------------DQEEGSSNV------ 408
L G C++ G +I +F G LS YL +G V
Sbjct: 90 NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 409 ------LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN-------------------- 442
S++ S G + E P ++++
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 443 ----------LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAPEY 489
L+ +L+ ++ I D GL + + D + ++ A ++APE
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPET 266
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---RNLKGKFSES 546
+ +T +SD+++FGV++ +I + +++ E F + R ++
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDYTTP 323
Query: 547 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
E + M L C H +P RPT ++E L
Sbjct: 324 EMYQT--M-LDCWHGEPSQRPTFSELVEHL 350
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 52/284 (18%), Positives = 95/284 (33%), Gaps = 65/284 (22%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
+G+G++ V + A + I + + F + + ++ SL H NIIRL
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYETF 75
Query: 376 ------------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 423
C+ G GE F K E ++ I+ +
Sbjct: 76 EDNTDIYLVMELCT-G-GELF--ERVVHKRVFR-----ESDAAR---------IMKDVLS 117
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+ Y H + HR+L E L + D GL + +
Sbjct: 118 AVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540
Y++P+ V G + D ++ GV++ +L G ++ +S I +
Sbjct: 173 --YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP----TDSEVMLK-I---RE 221
Query: 541 GKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
G F + S A+ + ++ L P+ R T +E
Sbjct: 222 GTFTFPEKDWLNVSPQAESLIRRL-LTK---SPKQRITSLQALE 261
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 74/283 (26%), Positives = 110/283 (38%), Gaps = 63/283 (22%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 370
LG G F V G G VA++ +N K + V + L RH +II+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L + + F++ ++ G+L Y+ + LD + I G+ Y H
Sbjct: 81 L--YQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHR 134
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 487
+VHR+L E VL+D N IAD GL +++D L+TS G Y AP
Sbjct: 135 H-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAP 184
Query: 488 EYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL------ 539
E V +GR DI++ GVI+ +L G+L F D ++
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGTL----------------PFDDDHVPTLFKK 227
Query: 540 --KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVIE 574
G F L M V DP R T++ + E
Sbjct: 228 ICDGIFYTPQYLNPSVISLLKHMLQV----DPMKRATIKDIRE 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 60/227 (26%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 370
LG+G + V VA++ ++ + + + + L HEN+++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 371 LRGFCCSRGR----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTR 414
G GE F D P + ++ Q
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQ------------- 113
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
++ G+ YLH I HR++ E +L+D++ N I+D GL + +
Sbjct: 114 ---LMA---GVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 475 VLKTSAAMG---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSL 516
+L G Y+APE + R E D+++ G+++ +L G L
Sbjct: 163 LLNKMC--GTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGEL 206
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 44/227 (19%), Positives = 78/227 (34%), Gaps = 60/227 (26%)
Query: 316 LLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCK------SEEAEFVKGL----YLLTS 362
L+G+G VY+ D VA+ K S + F +
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVAL--------KLMSETLSSDPVFRTRMQREARTAGR 90
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--EGSS--------NVLDWS 412
L+ +++ I+DF Y+D G L
Sbjct: 91 LQEPHVVP---------------IHDFGEIDGQL-YVDMRLINGVDLAAMLRRQGPLAPP 134
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472
V+I+ I + H++ HR++ E +L+ + D G+ D+
Sbjct: 135 RAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIASATTDE-- 187
Query: 473 FSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
+ + +G Y+APE + T R+DI+A ++ + LTGS
Sbjct: 188 -KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 61/286 (21%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 370
LG G F+ V K + G A + I ++ + L + H NII
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
L +R + LI + G+L + L +EE +S I I G
Sbjct: 80 LHDVYENRT--DVVLILELVSGGELFDFLAQKESLSEEEATS----------FIKQILDG 127
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSA 480
+ YLH+ + I H +L E +++ + P+ + D GL + D + F + +
Sbjct: 128 VNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN 538
++APE V +D+++ GVI IL L+G S + T N I
Sbjct: 183 --EFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-I--- 230
Query: 539 LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+ E SE AK + K+ LV + R T++ +
Sbjct: 231 TAVSYDFDEEFFSQTSELAKDFIRKL-LVK---ETRKRLTIQEALR 272
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 30/121 (24%), Positives = 48/121 (39%), Gaps = 14/121 (11%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL + + LT +P + ++ L + N L +P L+ L++S N L +
Sbjct: 44 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQL-TS 95
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN-GGFQFQNNPGLCGDGIASLRACTVYD 162
+P EL L + PS L +L G Q + P L L+ +V D
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPAL-PSGLCKLWIFGNQLTSLPVL----PPGLQELSVSD 150
Query: 163 N 163
N
Sbjct: 151 N 151
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L + N+LT ++P LK L + NRL +P L L + N L +
Sbjct: 226 LIVSGNRLT-SLPVLPSELKELM---VSGNRLTS-LPMLPSGL---LSLSVYRNQL-TRL 276
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
PESL + + ++++ N LS AL+ +
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREI 307
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 14/94 (14%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L + NQL ++PA L L +N+L +P L+ L +S N L ++
Sbjct: 146 LSVSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSG---LQELSVSDNQL-ASL 196
Query: 105 PESLANNAELLFLDVQNNTLSGI--VPSALKRLN 136
P + L L NN L+ + +PS LK L
Sbjct: 197 PTLPSE---LYKLWAYNNRLTSLPALPSGLKELI 227
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 26/111 (23%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--- 100
L + N LT ++PA L++L + N+L +P L +L L
Sbjct: 65 TLVIPDNNLT-SLPALPPELRTL---EVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPAL 119
Query: 101 -------------FGTIPESLANNAELLFLDVQNNTLSGI--VPSALKRLN 136
++P L L V +N L+ + +PS L +L
Sbjct: 120 PSGLCKLWIFGNQLTSLPVLPPG---LQELSVSDNQLASLPALPSELCKLW 167
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 14/94 (14%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L NQLT ++P L+ L ++ N+L +P L KL + SL
Sbjct: 166 LWAYNNQLT-SLPMLPSGLQEL---SVSDNQLAS-LPTLPSELYKLWAYNNRLTSL---- 216
Query: 105 PESLANNAELLFLDVQNNTLSGI--VPSALKRLN 136
P + L L V N L+ + +PS LK L
Sbjct: 217 PALPSG---LKELIVSGNRLTSLPVLPSELKELM 247
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 20/106 (18%), Positives = 33/106 (31%), Gaps = 4/106 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + NQLT +P + L S + + L+ N L+ +L + F
Sbjct: 265 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR-FDM 322
Query: 104 IPESLANNAELLFLDVQNNTLSGIV--PSALKRLNGGFQFQNNPGL 147
S L L + + P+ R + Q N
Sbjct: 323 AGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAF 368
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 51/281 (18%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 370
LG G F+ V K + G A + I ++ + L + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 429
L +R + LI + G+L +L Q+E S + I I G+ YLH
Sbjct: 80 LHDVYENRT--DVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLH 132
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYL 485
+ + I H +L E +++ + P+ + D GL + D + F + + ++
Sbjct: 133 TKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--EFV 185
Query: 486 APEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
APE V +D+++ GVI IL L+G S + T N I +
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-I---TSVSY 235
Query: 544 ---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
E SE AK + K+ LV ++ R T++ +
Sbjct: 236 DFDEEFFSHTSELAKDFIRKL-LV---KETRKRLTIQEALR 272
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 60/227 (26%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 370
LG+G + V VA++ ++ + + + + L HEN+++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 371 LRGFCCSRGR----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTR 414
G GE F D P + ++ Q
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQ------------- 113
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
++ G+ YLH I HR++ E +L+D++ N I+D GL + +
Sbjct: 114 --LMAGVV----YLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 475 VLKTSAAMG---YLAPEYVTTGRF--TERSDIFAFGVIILQILTGSL 516
+L G Y+APE + R E D+++ G+++ +L G L
Sbjct: 163 LLNKMC--GTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGEL 206
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 56/271 (20%), Positives = 106/271 (39%), Gaps = 38/271 (14%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG G F V++ + G + + IN + + ++ L H +I L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAF 117
Query: 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435
+ E LI +F G+L + E+ + + ++ + +G+ ++H
Sbjct: 118 EDKY--EMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEHS--- 169
Query: 436 PAIVHRNLSVEKVLI-DQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 493
IVH ++ E ++ ++ + + I D GL L D + V +A + APE V
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAPEIVDRE 225
Query: 494 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSE------ 545
+D++A GV+ +L+G S + T +N + F E
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG----LSPFAGEDDLETLQNV----KRCDWEFDEDAFSSV 277
Query: 546 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
S AK + + L ++P R T+ +E
Sbjct: 278 SPEAKDFIKNL-LQ---KEPRKRLTVHDALE 304
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 48/198 (24%), Positives = 74/198 (37%), Gaps = 16/198 (8%)
Query: 44 VLQLCCNQLTGNIPAQI-----GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98
L L N L ++ L L VL L HN LN P +L L+ L L+ N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 99 SLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRAC 158
L L N L LD+ N L P L+ +N +C +++
Sbjct: 515 RLTVLSHNDLPAN--LEILDISRNQLLAPNPDVFVSLS-VLDITHNKFICECELSTFINW 571
Query: 159 TVYDNTQI--NPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTS 216
+ N I P + + + + + + S E C++ + S KF L V +
Sbjct: 572 LNHTNVTIAGPPADIYCVYPDSFSGVSLFSLS--TEGCDEEEVLKSLKFS----LFIVCT 625
Query: 217 VTVILAGTGILIFFRYRR 234
VT+ L IL ++R
Sbjct: 626 VTLTLFLMTILTVTKFRG 643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 25/118 (21%), Positives = 48/118 (40%), Gaps = 7/118 (5%)
Query: 19 FKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG 78
K+ F + + ++ L L + +LK L VL L +N++N
Sbjct: 252 IKDPDQNTFAGLARSSVRH-------LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK 304
Query: 79 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
++ L L+ L+LS+N L + ++ ++D+Q N ++ I K L
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 22/107 (20%), Positives = 36/107 (33%), Gaps = 11/107 (10%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+L+L I + +L +L +L L +++ PD+ L L L L F L
Sbjct: 52 LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 103 TI--PESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 147
+ N L LD+ N + + F L
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS--------FGKLNSL 150
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 19/74 (25%), Positives = 31/74 (41%), Gaps = 1/74 (1%)
Query: 63 LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI-PESLANNAELLFLDVQN 121
L + L L N + S L +L+ L+L TI E+ N L LD+ +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 122 NTLSGIVPSALKRL 135
+ + + P A + L
Sbjct: 83 SKIYFLHPDAFQGL 96
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 2/101 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L N++ L +L VL L +N L + L K+ +DL N +
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN 144
++ +L LD+++N L+ I + + F N
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALTTI--HFIPSIPDIFLSGNK 392
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 25/108 (23%), Positives = 40/108 (37%), Gaps = 7/108 (6%)
Query: 35 LKVILLCFVVLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKR 92
L I L ++ L N+L +I + + L +L L NR + D L++
Sbjct: 396 LPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ 455
Query: 93 LDLSFNSLFGTIPESLANNA-----ELLFLDVQNNTLSGIVPSALKRL 135
L L N L L + L L + +N L+ + P L
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 23/109 (21%), Positives = 34/109 (31%), Gaps = 9/109 (8%)
Query: 44 VLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--KLKRLDLSFNSL 100
L L NQ+ + G L SL + N++ L L L L+ NSL
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186
Query: 101 FGTIPESLAN------NAELLFLDVQNNTLSGIVPSALKRLNGGFQFQN 143
+ + N L LDV N + + Q +
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 67/291 (23%), Positives = 106/291 (36%), Gaps = 75/291 (25%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
LGKG FS V + G A IN + + + ++ + L+H NI+RL
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 375 CCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
G +LI+D G+L Y E +S+ I I + + +
Sbjct: 79 ISE--EGHHYLIFDLVTGGELFEDIVAREYY--SEADASH---------CIQQILEAVLH 125
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSA-AMG 483
H +VHRNL E +L+ + + +AD GL + + A G
Sbjct: 126 CHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPG 178
Query: 484 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN--- 538
YL+PE + + + D++A GVI IL L G + F D +
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYIL--LVG----------------YPPFWDEDQHR 220
Query: 539 -----LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
G + S + AK + KM L +P R T ++
Sbjct: 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKM-LTI---NPSKRITAAEALK 267
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 94/298 (31%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 370
LG+G+F V T + VA++ I+ ++++ + L LRH +II+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 371 LRGFCCSRGR---------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTRV 415
L + GE F D+ K +++ ++ Q
Sbjct: 74 LYDVITTPTDIVMVIEYAGGELF---DYIVEKKRMTEDEGRRFFQQ-------------- 116
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
I I Y H IVHR+L E +L+D N IAD GL ++ D +
Sbjct: 117 -----IICAIEYCHRH-----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NF 163
Query: 476 LKTSAAMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 530
LKTS G Y APE V G+ D+++ G+++ +L G L
Sbjct: 164 LKTSC--GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRL-------------- 206
Query: 531 FENFIDRNL--------KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVIE 574
F D + + A L +M + DP R T++ +
Sbjct: 207 --PFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA----DPMQRITIQEIRR 258
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 68/302 (22%), Positives = 111/302 (36%), Gaps = 88/302 (29%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTS----LR----HEN 367
+G+G S V + R G A++ + VT+ + + + LR H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGI 421
II L S FL++D KG+L L ++E SI+ +
Sbjct: 162 IITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSL 209
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--- 478
+ + +LH++ IVHR+L E +L+D ++D G L L+
Sbjct: 210 LEAVSFLHAN-----NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCG 261
Query: 479 SAAMGYLAPE------YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESAT 530
+ GYLAPE T + + D++A GVI L L G
Sbjct: 262 TP--GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL--LAG---------------- 301
Query: 531 FENFIDRN--------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAV 572
F R ++G++ S S K + ++ L DPE R T E
Sbjct: 302 SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRL-LQV---DPEARLTAEQA 357
Query: 573 IE 574
++
Sbjct: 358 LQ 359
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 42/204 (20%), Positives = 84/204 (41%), Gaps = 23/204 (11%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 374
LG+G F V++ + + K + VK + +L RH NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
S E +I++F + + ++ N + VS + + + + +LHS
Sbjct: 70 FESME--ELVMIFEFISGLDIFERINTSAFELNERE---IVSYVHQVCEALQFLHSHN-- 122
Query: 435 KPAIVHRNLSVEKVL-IDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 492
I H ++ E ++ ++ + + I + G + L F +L T+ Y APE
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP--EYYAPEVHQH 177
Query: 493 GRFTERSDIFAFGVI--ILQILTG 514
+ +D+++ G + +L L+G
Sbjct: 178 DVVSTATDMWSLGTLVYVL--LSG 199
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
S+ +LG G F V+K G +A + I K +E E + ++ L H N+I
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTR--VSIIIGIAKGI 425
+L S + + L+ ++ G+L D+ +E + + + + I +GI
Sbjct: 150 QLYDAFES--KNDIVLVMEYVDGGEL---FDRIIDESYN----LTELDTILFMKQICEGI 200
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG 483
++H I+H +L E +L +++ + I D GL + V +
Sbjct: 201 RHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP--E 253
Query: 484 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTG 514
+LAPE V + +D+++ GVI +L L+G
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYML--LSG 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 52/314 (16%), Positives = 98/314 (31%), Gaps = 73/314 (23%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIRL 371
+G+G++ V + AI+ +N + + V+ + L+ L H NI RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 372 RGF------------CCS----------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 409
C K ++ + E + N
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 410 DWSTRV------------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQFN 455
R +I+ I + YLH+ I HR++ E L ++ F
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFE 208
Query: 456 PLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTG--RFTERSDIFAFGVIILQ 510
+ D GL K + G ++APE + T + + D ++ GV++
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 511 ILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTH 560
+L G++ ++ T L K S A+ L + L
Sbjct: 269 LLMGAVPFPGV----NDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNL-LNR-- 317
Query: 561 EDPENRPTMEAVIE 574
+ + R ++
Sbjct: 318 -NVDERFDAMRALQ 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 43/327 (13%), Positives = 92/327 (28%), Gaps = 72/327 (22%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
F + +G+G F V++ D AI+ I + + + + ++ + L L H I+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 370 RLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
R + + + + K + + + + R +G L
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 429 HSSEVN---------------KPAIVHRNLSVEK-------------------------- 447
S K + R ++
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 448 -------VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-----------YLAPEY 489
+ + D GL + D + T Y++PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SE 547
+ ++ + DIF+ G+I+ ++L T R + + F++ +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--FSTQMER----VRIITDVRNLKFPLLFTQKYPQ 301
Query: 548 AAKLGKMALVCTHEDPENRPTMEAVIE 574
+ + P RP +IE
Sbjct: 302 EHMMVQD---MLSPSPTERPEATDIIE 325
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 66/282 (23%), Positives = 107/282 (37%), Gaps = 53/282 (18%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 370
LG G F+ V K + G A + I S + L +RH NII
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYL 428
L + + + LI + G+L D E+ S + + + I G+ YL
Sbjct: 73 LHDIFEN--KTDVVLILELVSGGEL---FDFLAEKESLTEDEAT---QFLKQILDGVHYL 124
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGY 484
HS I H +L E +++ + P + D G+ + F + + +
Sbjct: 125 HSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--EF 177
Query: 485 LAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542
+APE V +D+++ GVI IL L+G S + T N I
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGETKQETLTN-I---SAVN 227
Query: 543 F---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+ E SE AK + ++ LV +DP+ R T+ +E
Sbjct: 228 YDFDEEYFSNTSELAKDFIRRL-LV---KDPKRRMTIAQSLE 265
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 65/289 (22%), Positives = 109/289 (37%), Gaps = 72/289 (24%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
+G G++S + + A++ I+ + E + LL +H NII L+
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI----LLRYGQHPNIITLKDVY 85
Query: 376 CSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+++ + G+L K+ + E S+ ++ I K + YLH
Sbjct: 86 DDGKY--VYVVTELMKGGELLDKILRQKFFSEREASA----------VLFTITKTVEYLH 133
Query: 430 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL---IADCGLHKLLADDIVFSVLKT---SAAM 482
+ +VHR+L +L +D+ NP I D G K L + +L T +A
Sbjct: 134 AQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTA-- 184
Query: 483 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-------AAESATFENFI 535
++APE + + DI++ GV +L + L T E +
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGV-LLYTM-----------LTGYTPFANGPDDTPEEIL 232
Query: 536 DRNLKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
R GKF S+ AK + KM L DP R T V+
Sbjct: 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKM-LHV---DPHQRLTAALVLR 277
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 22/93 (23%), Positives = 41/93 (44%), Gaps = 2/93 (2%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L++ +T + + L SL++L + H+ + I + L K+ +DLS+N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 105 PESLANNAELLFLDVQNNTLSGIVP-SALKRLN 136
L EL L++Q + + +LN
Sbjct: 153 -MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLN 184
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 22/98 (22%), Positives = 39/98 (39%), Gaps = 7/98 (7%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + T N I L +L L + + +L L L LD+S ++ +
Sbjct: 70 DLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 104 IPESLANNAELLFLDVQ-NNTLSGIVP----SALKRLN 136
I + ++ +D+ N ++ I+P LK LN
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLN 165
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 17/83 (20%), Positives = 36/83 (43%), Gaps = 3/83 (3%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L + + +I +I +L ++ + L +N I L L +LK L++ F+ +
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV--HD 173
Query: 105 PESLANNAELLFLDVQNNTLSGI 127
+ + +L L + T+ G
Sbjct: 174 YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 49/307 (15%), Positives = 101/307 (32%), Gaps = 82/307 (26%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSIN---------------------VTSCKSEEAEF 353
+GKG++ V D T A++ ++ +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 354 VKGLY----LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 409
++ +Y +L L H N+++L +++++ +G + + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPL 134
Query: 410 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469
+ KGI YLH K I+HR++ +L+ + + IAD G+
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY---QK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 470 DIVFSVLKTSAAMG---YLAPEYVTTGRFT---ERSDIFAFGVIILQILTGSLVLTSSMR 523
L + G ++APE ++ R + D++A GV + + G
Sbjct: 190 SDAL--LSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC------- 238
Query: 524 LAAESATFENFIDRNL--------KGKFS------ESEAAK--LGKMALVCTHEDPENRP 567
F+D + +E K + +M +PE+R
Sbjct: 239 ---------PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK----NPESRI 285
Query: 568 TMEAVIE 574
+ +
Sbjct: 286 VVPEIKL 292
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 67/313 (21%), Positives = 117/313 (37%), Gaps = 64/313 (20%)
Query: 305 ESATQCFSEV-----NLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF--VKG 356
+S + F +V ++LG+G + V A++ I F V+
Sbjct: 4 DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63
Query: 357 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR 414
LY H N++ L F R +L+++ G + L + N L+ S
Sbjct: 64 LYQCQG--HRNVLELIEFFEEEDR--FYLVFEKMRGGSI---LSHIHKRRHFNELEAS-- 114
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDI 471
++ +A + +LH+ I HR+L E +L + P+ I D L + +
Sbjct: 115 -VVVQDVASALDFLHN-----KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 472 VFSVLKTSAAM------GYLAPE-----YVTTGRFTERSDIFAFGVI--ILQILTG---- 514
S + T + Y+APE + +R D+++ GVI IL L+G
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL--LSGYPPF 226
Query: 515 ---SLVLTSSMRLAAESATFENFIDRNLKGKF---SE-----SEAAK--LGKMALVCTHE 561
R A A + +GK+ + S AAK + K+ LV
Sbjct: 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL-LVR--- 282
Query: 562 DPENRPTMEAVIE 574
D + R + V++
Sbjct: 283 DAKQRLSAAQVLQ 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 53/282 (18%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 370
LG G F+ V K + G A + I KS + L ++H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYL 428
L ++ + LI + G+L D E+ S + + + I G+ YL
Sbjct: 79 LHEVYENKT--DVILILELVAGGEL---FDFLAEKESLTEEEAT---EFLKQILNGVYYL 130
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGY 484
HS + I H +L E +++ + P I D GL + F + + +
Sbjct: 131 HSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP--EF 183
Query: 485 LAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542
+APE V +D+++ GVI IL L+G S + T N +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-V---SAVN 233
Query: 543 --FSE------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
F + S AK + ++ LV +DP+ R T++ ++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRL-LV---KDPKKRMTIQDSLQ 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 61/287 (21%), Positives = 108/287 (37%), Gaps = 63/287 (21%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
V +G GNF LVA++ I + E + + + SLRH NI+R +
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFK 82
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS----------IIIGIA 422
+ +I ++A G+L + + + R S ++ G++
Sbjct: 83 EVILTPT--HLAIIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVS 130
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--IADCGLHKLLADDIVFSVLKTSA 480
Y HS ++ HR+L +E L+D P I D G K S K++
Sbjct: 131 ----YCHSMQI-----CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTV 178
Query: 481 AMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535
G Y+APE V + + +D+++ GV + +L G+ E + I
Sbjct: 179 --GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPRDYRKTI 231
Query: 536 DRNLKGKFSE------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
R L K+S S + ++ + DP R ++ +
Sbjct: 232 QRILSVKYSIPDDIRISPECCHLISRIFVA----DPATRISIPEIKT 274
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 21/94 (22%), Positives = 42/94 (44%), Gaps = 3/94 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ ++ + L + + S ++ L L N L+ L KL+ L+LS N L
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--Y 71
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP-SALKRLN 136
L + + L LD+ NN + ++ +++ L+
Sbjct: 72 ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLH 105
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N + ++ Q+ L L L N+L + + + + L N L
Sbjct: 173 HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VL 228
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
I ++L + L D++ N N
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 17/81 (20%), Positives = 31/81 (38%), Gaps = 4/81 (4%)
Query: 60 IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119
+ + + + L + + +K LDLS N L LA +L L++
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 120 QNNTLSGIVP----SALKRLN 136
+N L + S L+ L+
Sbjct: 66 SSNVLYETLDLESLSTLRTLD 86
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 8/98 (8%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG- 102
L N ++ + + + L +N++ G +++ LDL N +
Sbjct: 103 TLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSA----LKRLN 136
E A++ L L++Q N + + LK L+
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD 197
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 14/81 (17%), Positives = 32/81 (39%), Gaps = 3/81 (3%)
Query: 52 LTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN 111
L N ++ S+ L +N ++ + S G K + L+ N +
Sbjct: 87 LNNNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCR 143
Query: 112 AELLFLDVQNNTLSGIVPSAL 132
+ + +LD++ N + + + L
Sbjct: 144 SRVQYLDLKLNEIDTVNFAEL 164
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 12/57 (21%), Positives = 22/57 (38%)
Query: 79 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
I + N + K ++ +SL + + + LD+ N LS I + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF 57
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 13/91 (14%), Positives = 30/91 (32%), Gaps = 3/91 (3%)
Query: 47 LCCNQLTGNIPAQIGSLKS--LSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
CC L ++ +LK ++L+ Q + + N + + +D I
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVI 352
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + L+ + L V + +
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 18/142 (12%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
NQ+T P + ++ L+ L + +N++ L NL +L L++ N + +
Sbjct: 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI--S 256
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP----SALKRLNGGFQFQNNP--GLCGDGIASLRA 157
++ + +L L+V +N +S I S L L NN + I L
Sbjct: 257 DINAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLF----LNNNQLGNEDMEVIGGLTN 312
Query: 158 -CTVY-DNTQINPVKPFGSHSN 177
T++ I ++P S S
Sbjct: 313 LTTLFLSQNHITDIRPLASLSK 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 6e-11
Identities = 26/105 (24%), Positives = 45/105 (42%), Gaps = 12/105 (11%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L++ NQ++ +I A + L L +L + N+++ L NL +L L L+ N L
Sbjct: 248 LEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 105 PESLANNAELLFLDVQNNTLSGIVP----SALKRLNGGFQFQNNP 145
E + L L + N ++ I P S + + F N
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSAD----FANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + N++T +I A + +L +L L L + ++ L NL K+ L+L N +
Sbjct: 92 NLYIGTNKIT-DISA-LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN-LS 146
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
L+N L +L V + + + P + L L+
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLS 183
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 5e-10
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 14/117 (11%)
Query: 24 NKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS 83
+ ++ Q +L+ I L + ++ +I I L +L L L N++
Sbjct: 32 ASVTDVVTQEELESI----TKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITD--ISP 83
Query: 84 LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
L NL KL L + N + T +L N L L + + +S I P + + LN
Sbjct: 84 LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLANLTKMYSLN 138
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 22/82 (26%), Positives = 40/82 (48%), Gaps = 4/82 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+L + NQ++ +I + +L L+ L L +N+L + +G L L L LS N + T
Sbjct: 269 MLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI--T 324
Query: 104 IPESLANNAELLFLDVQNNTLS 125
LA+ +++ D N +
Sbjct: 325 DIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 10/97 (10%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + +++ P I +L L L+L +N++ P L +L L N + T
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI--T 212
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
+AN L L + NN ++ + P S L L
Sbjct: 213 DITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLE 249
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 20/142 (14%), Positives = 44/142 (30%), Gaps = 22/142 (15%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L + P L LQ + + L + +L ++ +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--AS 58
Query: 105 PESLANNAELLFLDVQNNTLSGIVP----SALKRLNGGFQFQNN-----PGLCGDGIASL 155
+ + L +L++ N ++ I P L L N L + +L
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLY----IGTNKITDISAL--QNLTNL 112
Query: 156 RACTVYDNTQINPVKPFGSHSN 177
R + ++ I+ + P + +
Sbjct: 113 RELYLNED-NISDISPLANLTK 133
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 47/278 (16%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH-ENIIRLRG 373
LG+G F+ V + + G A + + + + + +L + +I L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR--VSIIIGIAKGIGYLHSS 431
+ E LI ++A G++ E S + +I I +G+ YLH +
Sbjct: 97 VYENTS--EIILILEYAAGGEIFSLCLPELAEM----VSENDVIRLIKQILEGVYYLHQN 150
Query: 432 EVNKPAIVHRNLSVEKVLIDQQF--NPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 488
IVH +L + +L+ + + I D G+ + + + + YLAPE
Sbjct: 151 N-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP--EYLAPE 203
Query: 489 YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FS 544
+ T +D++ G+I +L LT TS T+ N I + +S
Sbjct: 204 ILNYDPITTATDMWNIGIIAYML--LTH----TSPFVGEDNQETYLN-I---SQVNVDYS 253
Query: 545 E------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
E S+ A + + LV ++PE RPT E +
Sbjct: 254 EETFSSVSQLATDFIQSL-LV---KNPEKRPTAEICLS 287
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 21/94 (22%), Positives = 42/94 (44%), Gaps = 3/94 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ ++ + L + + S ++ L L N L+ L KL+ L+LS N L
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--Y 71
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP-SALKRLN 136
L + + L LD+ NN + ++ +++ L+
Sbjct: 72 ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLH 105
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 7/92 (7%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N L+ A + L +L L N L D L +L L+ LDL+ N +
Sbjct: 38 ELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYV--- 92
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ L + L NN +S + S +
Sbjct: 93 --QELLVGPSIETLHAANNNISRVSCSRGQGK 122
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N + ++ Q+ L L L N+L + + + + L N L
Sbjct: 173 HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VL 228
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
I ++L + L D++ N N
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 23/129 (17%), Positives = 47/129 (36%), Gaps = 9/129 (6%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD 82
N I+ + Q+ + L L N+L + + S ++ ++L++N+L I
Sbjct: 178 YNFIYDVKGQVVFAKL----KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEK 231
Query: 83 SLGNLGKLKRLDLSFNSL-FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQF 141
+L L+ DL N GT+ + + N + + T+ + +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLG 289
Query: 142 QNNPGLCGD 150
C D
Sbjct: 290 HYGAYCCED 298
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 56 IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115
I + + + + L + + +K LDLS N L LA +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 116 FLDVQNNTLSGIVP----SALKRLN 136
L++ +N L + S L+ L+
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLD 86
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 8/98 (8%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG- 102
L N ++ + + + L +N++ G +++ LDL N +
Sbjct: 103 TLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSA----LKRLN 136
E A++ L L++Q N + + LK L+
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD 197
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 13/83 (15%), Positives = 32/83 (38%), Gaps = 8/83 (9%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N + ++ S+ L +N ++ + S G K + L+ N +
Sbjct: 90 NYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEG 141
Query: 110 NNAELLFLDVQNNTLSGIVPSAL 132
+ + +LD++ N + + + L
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAEL 164
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 12/57 (21%), Positives = 22/57 (38%)
Query: 79 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
I + N + K ++ +SL + + + LD+ N LS I + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF 57
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 56/283 (19%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG G V + + A++ + E E + + +I+R+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVY 124
Query: 376 --CSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYLH 429
GR ++ + G+L Q+ G ++ R I+ I + I YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQA---FTEREASEIMKSIGEAIQYLH 178
Query: 430 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKT---SAAMG 483
S I HR++ E +L ++ N + + D G K + L T +
Sbjct: 179 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTP--Y 228
Query: 484 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541
Y+APE + ++ + D+++ GVI IL L G S+ LA R G
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGYPPFYSNHGLAISPGMKT----RIRMG 282
Query: 542 KF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
++ + SE K + + L +P R T+ +
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNL-LKT---EPTQRMTITEFMN 321
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 21/159 (13%)
Query: 317 LGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
+G+G + VYK +D A++ I T + + LL L+H N+I L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 85
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN-----VLDWSTRVSIIIGIAKGIGYL 428
S + +L++D+A L + S L S++ I GI YL
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGL 463
H+ N ++HR+L +L+ + IAD G
Sbjct: 145 HA---NW--VLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 57/329 (17%), Positives = 112/329 (34%), Gaps = 92/329 (27%)
Query: 279 PLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVA 337
G TG+ ++ + ++E + +G G V+K + G ++A
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLE-------NLGEMGSGTCGQVWKMRFRKTGHVIA 54
Query: 338 IRSINVTSCKSEEAEFVKGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLS 396
++ + + K E + L +L S I++ + F +
Sbjct: 55 VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---CFGT-----------FITNTDVF 100
Query: 397 ---KYLDQEEGSSNVLDWSTRVSI---IIG-----IAKGIGYLHSSEVNKPAIVHRNLSV 445
+ + + L + I I+G I K + YL K ++HR++
Sbjct: 101 IAMELMG---TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE----KHGVIHRDVKP 153
Query: 446 EKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE-----YVTTGRFTE 497
+L+D++ + D G+ L D K +A G Y+APE T +
Sbjct: 154 SNILLDERGQIKLCDFGISGRLVD----DKAKDRSA-GCAAYMAPERIDPPDPTKPDYDI 208
Query: 498 RSDIFAFGVIILQILTG--------------SLVLTSSM-RLAAE---SATFENFIDRNL 539
R+D+++ G+ ++++ TG + VL L S F++F+
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD-- 266
Query: 540 KGKFSESEAAKLGKMALVCTHEDPENRPT 568
C +D RP
Sbjct: 267 ------------------CLTKDHRKRPK 277
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 18/92 (19%), Positives = 29/92 (31%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N L S L VL L + + +L L L L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + + L L L+ + + L
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 23/95 (24%), Positives = 33/95 (34%), Gaps = 1/95 (1%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI-PDSLGNLGKLKRLDLSFNSLF 101
+ L + L SL VL + N PD L L LDLS L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
P + + + L L++ +N L + RL
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 1/94 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L ++ SL LS L L N + + L L++L +L
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 104 IPESLANNAELLFLDVQNNTLSGI-VPSALKRLN 136
+ + L L+V +N + +P L
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 21/95 (22%), Positives = 33/95 (34%), Gaps = 4/95 (4%)
Query: 44 VLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
L + L + SL++L L + H L L+ L ++ NS
Sbjct: 400 HLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 102 GTI-PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
P+ L FLD+ L + P+A L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 1/80 (1%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
VL++ N N I L++L+ L L +L P + +L L+ L+++ N L
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508
Query: 103 TIPESLANNAELLFLDVQNN 122
L + + N
Sbjct: 509 VPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 4/96 (4%)
Query: 44 VLQLCCNQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
L L N L+ G SL L L N + + + L +L+ LD ++L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 102 GTIPES-LANNAELLFLDVQNNTLSGIVPSALKRLN 136
S + L++LD+ + L+
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 3/86 (3%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
IP + S L L N L S + +L+ LDLS + +
Sbjct: 17 LNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
+ + L L + N + + A L
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGL 99
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 6/92 (6%)
Query: 44 VLQLCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK----RLDLSFN 98
L + N + +P +L +L L L N++ L L ++ LDLS N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 99 SLFGTIPESLANNAELLFLDVQNNTLSGIVPS 130
+ I L L ++NN S V
Sbjct: 188 PM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/136 (22%), Positives = 50/136 (36%), Gaps = 15/136 (11%)
Query: 18 VFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNR 75
+F +N + + ++ + +L Q LKSL LT N+
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 76 LNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNNTLSGIVP---- 129
S +L L+ LDLS N L G +S L +LD+ N + +
Sbjct: 337 GGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG 394
Query: 130 -SALKRLNGGFQFQNN 144
L+ L+ FQ++
Sbjct: 395 LEQLEHLD----FQHS 406
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 18/62 (29%), Positives = 24/62 (38%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L QL P SL SL VL + N+L L L+++ L N +
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 104 IP 105
P
Sbjct: 534 CP 535
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 49/214 (22%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTS-CKSEEAEFVKG-LYLLTSLRH 365
+ F +LG+G+FS+V AI+ + K + +V +++ L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAK 423
++L + + +A G+L KY+ ++ GS + + I
Sbjct: 90 PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYI-RKIGS-----FDETCTRFYTAEIVS 141
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 483
+ YLH I+HR+L E +L+++ + I D G K+L+ + + + ++ +G
Sbjct: 142 ALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA--RANSFVG 194
Query: 484 ---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
Y++PE +T + SD++A G II Q++ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 52/282 (18%), Positives = 114/282 (40%), Gaps = 58/282 (20%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 366
+ F + LG+G++ SVYK G +VAI+ + V +S+ E +K + ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSP 84
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
++++ G + + +++ ++ G +S D + L +I+ KG+
Sbjct: 85 HVVKYYG-SYFKN-TDLWIVMEYCGAGSVS---DIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
YLH +HR++ +L++ + + +AD G+ L D ++ K + +G
Sbjct: 140 YLHFMR-----KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD----TMAKRNTVIGTPF 190
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 527
++APE + + +DI++ G+ +++ G + + +
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250
Query: 528 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
S F +F+ + C + PE R T
Sbjct: 251 WSDNFTDFVKQ--------------------CLVKSPEQRAT 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 58/299 (19%), Positives = 112/299 (37%), Gaps = 65/299 (21%)
Query: 296 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFV 354
S + +++E + LG+G + V K G ++A++ I T E+ +
Sbjct: 1 SMEVKADDLE-------PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL 53
Query: 355 KGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 413
L + ++ + G G+ ++ + L K+ Q +
Sbjct: 54 MDLDISMRTVDCPFTVTFYG--ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDI 110
Query: 414 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473
I + I K + +LHS K +++HR++ VLI+ + D G+ L D
Sbjct: 111 LGKIAVSIVKALEHLHS----KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---- 162
Query: 474 SVLKTSAAMG---YLAPE----YVTTGRFTERSDIFAFGVIILQILTGS----------- 515
V K A G Y+APE + ++ +SDI++ G+ ++++
Sbjct: 163 DVAKDIDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 516 ----LVLTSSMRLAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
+V S +L A+ SA F +F + C ++ + RPT
Sbjct: 222 QLKQVVEEPSPQLPADKFSAEFVDFTSQ--------------------CLKKNSKERPT 260
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 43/237 (18%), Positives = 88/237 (37%), Gaps = 21/237 (8%)
Query: 290 SREHLNSFRLNLEEVESATQCFSEVNLLGKG--NFSSVYKGT-LRDGTLVAIRSINVTSC 346
N + + C+ + ++GKG + +V G V +R IN+ +C
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 347 KSEEAEFVKG-LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS 405
+E F++G L++ H NI+ E +++ F G +
Sbjct: 66 SNEMVTFLQGELHVSKLFNHPNIVPY--RATFIADNELWVVTSFMAYGSAKDLI--CTHF 121
Query: 406 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465
+ ++ I+ G+ K + Y+H VHR++ +LI ++ +
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGY-----VHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 466 LLADDI-----VFSVLKTSAAMGY-LAPEYVTTGR--FTERSDIFAFGVIILQILTG 514
+ V K S + L+PE + + +SDI++ G+ ++ G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 46/278 (16%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGF 374
LG+G+FS K + A++ I+ K EA K + L H NI++L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 375 CCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
+ FL+ + G+L + +++ + + S I+ + + ++H
Sbjct: 75 FHDQLH--TFLVMELLNGGEL---FERIKKKKHFSETEAS---YIMRKLVSAVSHMHDVG 126
Query: 433 VNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKT---SAAMGYLA 486
+VHR+L E +L D+ N I D G +L D LKT + Y A
Sbjct: 127 -----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTL--HYAA 177
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--- 543
PE + + E D+++ GVI+ +L+G + S R ++ E + KG F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFSFE 236
Query: 544 SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
E S+ AK + + L DP R M +
Sbjct: 237 GEAWKNVSQEAKDLIQGL-LTV---DPNKRLKMSGLRY 270
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 32/164 (19%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHENI 368
++ ++G G+F V++ L + VAI+ + ++ F K L ++ ++H N+
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV------LQDKRF-KNRELQIMRIVKHPNV 94
Query: 369 IRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
+ L+ F S G + L+ ++ P+ + + + + + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLL 467
+ Y+HS I HR++ + +L+D L + D G K+L
Sbjct: 154 LAYIHSI-----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 63/303 (20%)
Query: 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG 356
++L + F V L+G G + VYKG ++ G L AI+ ++VT EE E +
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQE 70
Query: 357 LYLLTSL-RHENIIRLRG----FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 411
+ +L H NI G + +L+ +F G ++ + +G N L
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKE 128
Query: 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 471
I I +G+ +LH +V +HR++ + VL+ + + D G+ L
Sbjct: 129 EWIAYICREILRGLSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-- 181
Query: 472 VFSVLKTSAAMG---YLAPEYVTTGRFTE-----RSDIFAFGVIILQILTGS--LVLTSS 521
+V + + +G ++APE + + +SD+++ G+ +++ G+ L
Sbjct: 182 --TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
Query: 522 MR------------LAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 567
MR L ++ S F++FI+ C ++ RP
Sbjct: 240 MRALFLIPRNPAPRLKSKKWSKKFQSFIES--------------------CLVKNHSQRP 279
Query: 568 TME 570
E
Sbjct: 280 ATE 282
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 4/93 (4%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ L N+L I ++ L L + +NRL + + LK LDLS N L
Sbjct: 258 EVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL-L 314
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + L L + +N++ + S L
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL 347
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L + N + +P + ++ L+VL L+ N L+ N KL L +S N+L
Sbjct: 103 KLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-E 160
Query: 103 TIPES-LANNAELLFLDVQNNTLSGIVPSALKRL 135
I + L L + +N L+ + S + L
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 194
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 4/94 (4%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+L L Q+ I ++ L + N + P N+ L L L N L
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-S 136
Query: 103 TIPESL-ANNAELLFLDVQNNTLSGIVPSALKRL 135
++P + N +L L + NN L I +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 170
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 43 VVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
L + N L I + SL L L NRL + L + L ++S+N L
Sbjct: 150 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL- 204
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+LA + LD +N+++ + L
Sbjct: 205 ----STLAIPIAVEELDASHNSINVVRGPVNVEL 234
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 10/75 (13%), Positives = 32/75 (42%), Gaps = 2/75 (2%)
Query: 62 SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQ 120
+L + ++T +++ + L + +++ L+L+ + I + A + L +
Sbjct: 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMG 107
Query: 121 NNTLSGIVPSALKRL 135
N + + P + +
Sbjct: 108 FNAIRYLPPHVFQNV 122
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 19/92 (20%), Positives = 35/92 (38%), Gaps = 10/92 (10%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
+ N L+ + ++ L HN +N + + +L L L N+L T
Sbjct: 197 ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TD 246
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
L N L+ +D+ N L I+ ++
Sbjct: 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 58/302 (19%), Positives = 115/302 (38%), Gaps = 67/302 (22%)
Query: 296 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFV 354
+ E+++ ++ +G+G + SV K G ++A++ I T + E+ + +
Sbjct: 16 HWDFTAEDLK-------DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 355 KGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 413
L ++ S I++ G R G+C++ + Y +V+
Sbjct: 69 MDLDVVMRSSDCPYIVQFYG-ALFRE-GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 414 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 473
I + K + +L I+HR++ +L+D+ N + D G+ L D
Sbjct: 127 LGKITLATVKALNHLKE----NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---- 178
Query: 474 SVLKTSAAMG---YLAPE----YVTTGRFTERSDIFAFGVIILQILTG------------ 514
S+ KT A G Y+APE + + RSD+++ G+ + ++ TG
Sbjct: 179 SIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
Query: 515 --SLVLTSSM-RLAAE-----SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR 566
+ V+ +L+ S +F NF++ C +D R
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNL--------------------CLTKDESKR 277
Query: 567 PT 568
P
Sbjct: 278 PK 279
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTS 362
+ + + L+G+G++ V K +D G +VAI+ S++ + VK + LL
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE----SDDDKMVKKIAMREIKLLKQ 80
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
LRHEN++ L C + + +L+++F + L+ N LD+ + I
Sbjct: 81 LRHENLVNLLEVC--KKKKRWYLVFEFVDH-TILDDLEL---FPNGLDYQVVQKYLFQII 134
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
GIG+ HS + I+HR++ E +L+ Q + D G
Sbjct: 135 NGIGFCHS---HN--IIHRDIKPENILVSQSGVVKLCDFGF 170
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 33/188 (17%)
Query: 290 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS 348
+ S ++ ++ + + LG+G + VYK VAI+ I +
Sbjct: 15 QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL----E 70
Query: 349 EEAEFVKGL--------YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 400
E E G+ LL L+H NII L+ R LI+++A L KY+D
Sbjct: 71 HEEE---GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR--LHLIFEYAEN-DLKKYMD 124
Query: 401 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--- 457
+ + S + + G+ + HS + +HR+L + +L+
Sbjct: 125 ----KNPDVSMRVIKSFLYQLINGVNFCHS---RR--CLHRDLKPQNLLLSVSDASETPV 175
Query: 458 --IADCGL 463
I D GL
Sbjct: 176 LKIGDFGL 183
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 21/97 (21%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR----LDLSFNS 99
VL + NQLT +P SL++L + N L +P + N
Sbjct: 164 VLSVRNNQLTF-LPELPESLEALD---VSTNLLES-LPAVPVRNHHSEETEIFFRCRENR 218
Query: 100 LFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ IPE++ + + +++N LS + +L +
Sbjct: 219 I-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 18/123 (14%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
LQL L+ ++P + ++VL + N L +P+ +L + LD N L T
Sbjct: 63 ELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASL---EYLDACDNRL-ST 114
Query: 104 IPESLANNAELLFLDVQNNTLSGI--VPSALKRLNGGF-QFQNNPGLCGDGIASLRACTV 160
+PE A+ L LDV NN L+ + +P+ L+ +N Q P + SL +V
Sbjct: 115 LPELPAS---LKHLDVDNNQLTMLPELPALLEYINADNNQLTMLP----ELPTSLEVLSV 167
Query: 161 YDN 163
+N
Sbjct: 168 RNN 170
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 13/91 (14%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L + NQLT +P L+ ++ +N+L +P+ +L + L + N L +
Sbjct: 125 LDVDNNQLT-MLPELPALLEYIN---ADNNQLTM-LPELPTSL---EVLSVRNNQL-TFL 175
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
PE + L LDV N L + P+ R
Sbjct: 176 PELPES---LEALDVSTNLLESL-PAVPVRN 202
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 21/120 (17%), Positives = 51/120 (42%), Gaps = 15/120 (12%)
Query: 50 NQLTG---NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 106
N ++G + + + ++ N + + L + + L L+ +L ++P+
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL-SSLPD 76
Query: 107 SLANNAELLFLDVQNNTLSGI--VPSALKRLNGGF-QFQNNPGLCGDGIASLRACTVYDN 163
+L + L++ N L + +P++L+ L+ + P + ASL+ V +N
Sbjct: 77 NLPPQ--ITVLEITQNALISLPELPASLEYLDACDNRLSTLP----ELPASLKHLDVDNN 130
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 16/102 (15%), Positives = 32/102 (31%), Gaps = 3/102 (2%)
Query: 34 QLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRL 93
+ + + N++T +IP I SL + L+ N L+ I +SL
Sbjct: 201 RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
Query: 94 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
++ + N D S + ++
Sbjct: 260 HGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 303 EVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL---- 357
+V+S + + +++ LG+G F++VYK +VAI+ I + +E G+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH----RSEAKDGINRTA 59
Query: 358 ----YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 413
LL L H NII L + L++DF L + +S VL S
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETD-LEVIIKD---NSLVLTPSH 113
Query: 414 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ ++ +G+ YLH + I+HR+L +L+D+ +AD GL
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HW--ILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 4/115 (3%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L + ++P + L L L + N P S L LK+L + + +
Sbjct: 201 LNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRA 157
+ A L+ L++ +N LS + L +NP C I L
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAW 313
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 22/93 (23%), Positives = 33/93 (35%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L N + L L VL L N + + L L L+L N L
Sbjct: 78 RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV 137
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ ++L L ++NN + I A R+
Sbjct: 138 IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 5/93 (5%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQH-NRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L N + +IP+ + SL L L +L + L LK L+L ++
Sbjct: 152 LWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI-- 208
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+L L L++ N I P + L
Sbjct: 209 KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 22/87 (25%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SL 108
L+ +P I + L L N + D+ +L L+ L L NS+ I +
Sbjct: 64 RGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAF 119
Query: 109 ANNAELLFLDVQNNTLSGIVPSALKRL 135
A L L++ +N L+ I A + L
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYL 146
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 21/168 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHEN 367
+++ ++G G+F VY+ L D G LVAI+ + ++ F K L ++ L H N
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRF-KNRELQIMRKLDHCN 108
Query: 368 IIRLRGFCCSRG--RGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 423
I+RLR F S G + E +L + D+ P+ + + + L + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 424 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADD 470
+ Y+HS I HR++ + +L+D L + D G K L
Sbjct: 168 SLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 21/104 (20%), Positives = 39/104 (37%), Gaps = 6/104 (5%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N ++ P + SL L L +N+++ SL NL + L N + +
Sbjct: 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI--S 366
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 147
LAN + L + + + + ++ +N G
Sbjct: 367 DLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 14/133 (10%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
NQ+T P + +L +L L + N+++ L L L+ L + N + + L
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI--SDITPLG 218
Query: 110 NNAELLFLDVQNNTLSGIVP----SALKRLNGGF-QFQNNPGLCGDGIASLRACTVYDNT 164
L L + N L I + L L+ Q N L G+ L + N
Sbjct: 219 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGAN- 275
Query: 165 QINPVKPFGSHSN 177
QI+ + P +
Sbjct: 276 QISNISPLAGLTA 288
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 10/96 (10%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L NQ++ P + L L+ L L N+++ L L L L+L+ N L
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQL--ED 301
Query: 105 PESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
++N L +L + N +S I P + L+RL
Sbjct: 302 ISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLF 337
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 10/98 (10%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ L +T + L ++ L + D + L L +++ S N L
Sbjct: 27 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL-- 80
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
T L N +L+ + + NN ++ I P + L L
Sbjct: 81 TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLT 118
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 35/139 (25%), Positives = 66/139 (47%), Gaps = 15/139 (10%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ + NQ+ P + +L +L+ LTL +N++ D L NL L RL+LS N++ +
Sbjct: 94 DILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTI--S 147
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP----SALKRLN-GGFQFQNNPGLCGDGIASLRAC 158
+L+ L L N ++ + P + L+RL+ + + L + +L +
Sbjct: 148 DISALSGLTSLQQLSFGNQ-VTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESL 204
Query: 159 TVYDNTQINPVKPFGSHSN 177
+N QI+ + P G +N
Sbjct: 205 IATNN-QISDITPLGILTN 222
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 15/82 (18%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L N+++ ++ + + +L +++ L+ HN+++ P L NL ++ +L L+ +
Sbjct: 335 RLFFYNNKVS-DVSS-LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390
Query: 104 IPESLANNAELLFLDVQNNTLS 125
AN + + L
Sbjct: 391 PVNYKANVSIPNTVKNVTGALI 412
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 12/77 (15%), Positives = 25/77 (32%), Gaps = 5/77 (6%)
Query: 60 IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119
+L L + + +L ++ L + + + L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 120 QNNTLSGIVP-SALKRL 135
NN L+ I P L +L
Sbjct: 76 SNNQLTDITPLKNLTKL 92
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI-PDSLGNLGKLKRLDLSFNSLFGT 103
L L T ++S+ N I P ++ + G D+++N
Sbjct: 380 LGLNDQAWTNAPV---NYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP-SY 435
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALK 133
E ++ + + T SG V LK
Sbjct: 436 TNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 32/161 (19%), Positives = 68/161 (42%), Gaps = 21/161 (13%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTS 362
+ + ++ +G+G++ V+K RD G +VAI+ SE+ +K + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE----SEDDPVIKKIALREIRMLKQ 58
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
L+H N++ L R + L++++ + LD+ + SI
Sbjct: 59 LKHPNLVNLLEVF--RRKRRLHLVFEYCDH-TVLHELDR---YQRGVPEHLVKSITWQTL 112
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ + + H + +HR++ E +LI + + D G
Sbjct: 113 QAVNFCHK---HN--CIHRDVKPENILITKHSVIKLCDFGF 148
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 19/169 (11%)
Query: 306 SATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEF-------VKGL 357
AT + V +G G + +VYK G VA++S+ V + V L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 358 YLLTSLRHENIIRLRGFCCSRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 414
L + H N++RL C + L+++ + L YLD+ L T
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETI 122
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
++ +G+ +LH+ N IVHR+L E +L+ +AD GL
Sbjct: 123 KDLMRQFLRGLDFLHA---NC--IVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 27/246 (10%)
Query: 278 DPLGDYLNGTGFSREHLNSFRLNLEEVESAT-QCFSEVNLLGKGNFSSVYKGTLRD-GTL 335
D ++ F+R N+E T FS ++G+G F VY D G +
Sbjct: 160 DVFQKFIESDKFTRFC---QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216
Query: 336 VAIRSINVTSCKS-EEAEFVKG----LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390
A++ ++ K + L L+++ I+ + + I D
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS--YAFHTPDKLSFILDLM 274
Query: 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVL 449
G L +L Q S + I G+ ++H+ +V+R+L +L
Sbjct: 275 NGGDLHYHLSQHGVFSE-----ADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANIL 324
Query: 450 IDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVII 508
+D+ + I+D GL + + + T GY+APE + G + +D F+ G ++
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGT---HGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 509 LQILTG 514
++L G
Sbjct: 382 FKLLRG 387
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 33/109 (30%), Positives = 45/109 (41%), Gaps = 16/109 (14%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L LT + + L ++ L L HNRL +P +L L L+ L S N+L
Sbjct: 445 VLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-N 500
Query: 104 IPESLANNAELLFLDVQNN---TLSGIVP----SALKRLNGGFQFQNNP 145
+ +AN L L + NN + I P L LN Q N
Sbjct: 501 VDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN----LQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 26/108 (24%), Positives = 38/108 (35%), Gaps = 8/108 (7%)
Query: 31 FQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 90
F V + L ++ + VL L H L + L L +
Sbjct: 408 FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLV 465
Query: 91 KRLDLSFNSLFGTIPESLANNAELLFLDVQNN---TLSGIVPSALKRL 135
LDLS N L +P +LA L L +N + G+ + L RL
Sbjct: 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGV--ANLPRL 510
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 1e-04
Identities = 22/64 (34%), Positives = 29/64 (45%), Gaps = 5/64 (7%)
Query: 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD--SLGNLGKLKRLDLS 96
L C VLQ N L N+ + +L L L L +NRL L + +L L+L
Sbjct: 485 LRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQ 541
Query: 97 FNSL 100
NSL
Sbjct: 542 GNSL 545
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 48/282 (17%), Positives = 112/282 (39%), Gaps = 58/282 (20%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 366
+ ++ +G+G +VY + G VAIR +N+ + ++ + + ++ ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNP 77
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
NI+ E +++ ++ G L+ + + +D ++ + +
Sbjct: 78 NIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 130
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
+LHS++ ++HR++ + +L+ + + D G + K S +G
Sbjct: 131 FLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----EQSKRSTMVGTPY 181
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 527
++APE VT + + DI++ G++ ++++ G L L ++ L
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 528 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
SA F +F++R C D E R +
Sbjct: 242 LSAIFRDFLNR--------------------CLEMDVEKRGS 263
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 2e-09
Identities = 33/198 (16%), Positives = 56/198 (28%), Gaps = 44/198 (22%)
Query: 307 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF------------- 353
T+ +G+G F V++ D T VAI+ I +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 354 ---VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI--YDFAPKGKLSKY---------- 398
+ L R E I L C +G L+ +D K S
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 399 -----------LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 447
+D E+ + + +T SI+ + + HR+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE----ASLRFEHRDLHWGN 192
Query: 448 VLIDQQFNPLIADCGLHK 465
VL+ + + K
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 305 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL------- 357
+ + + ++ +G+G + VYK G +VA++ I + + E E G+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA----EDE---GIPSTAIRE 69
Query: 358 -YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 416
LL L H NI+ L S L+++F K L K LD+ + L S
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKD-LKKVLDE---NKTGLQDSQIKI 123
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ + +G+ + H ++ I+HR+L + +LI+ +AD GL
Sbjct: 124 YLYQLLRGVAHCHQ---HR--ILHRDLKPQNLLINSDGALKLADFGL 165
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 3/104 (2%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N++ I + L L L HN++ SL L L+ L L N L
Sbjct: 198 LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SR 255
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 147
+P L + L + + N ++ + + + G + G+
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-FG 102
L + N L IP SL L + NR+ L + +++ N L
Sbjct: 106 KLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ +L +L + L+GI + L
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL 195
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 8/94 (8%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFG 102
L++ +LT IP ++L+ L L HN++ I L KL RL L N +
Sbjct: 176 YLRISEAKLT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQI-R 230
Query: 103 TIPE-SLANNAELLFLDVQNNTLSGIVPSALKRL 135
I SL+ L L + NN LS + P+ L L
Sbjct: 231 MIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDL 263
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 3/93 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+L L N ++ L+ L L L +N+++ + L KL++L +S N L
Sbjct: 58 LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL-VE 116
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
IP +L ++ L+ L + +N + + L
Sbjct: 117 IPPNLPSS--LVELRIHDNRIRKVPKGVFSGLR 147
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 21/102 (20%), Positives = 40/102 (39%), Gaps = 13/102 (12%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L NQ+ I L +L L L +N+L+ +P L +L L+ + L N++
Sbjct: 221 RLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNI-T 277
Query: 103 TIPES-------LANNAELLFLDVQNN--TLSGIVPSALKRL 135
+ + A + + NN + P+ + +
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 44 VLQLCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+++ N L L+ L + +L GIP L L L L N +
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI-Q 206
Query: 103 TIPE-SLANNAELLFLDVQNNTLSGIVPSALKRL 135
I L ++L L + +N + I +L L
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 30/115 (26%), Positives = 45/115 (39%), Gaps = 4/115 (3%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N L +P L +L+ L L NR++ + L L RL L N +
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLR 156
P + + L+ L + N LS + AL L + +NP +C L
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 1/93 (1%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ L N+++ A + ++L++L L N L + L L++LDLS N+ +
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 104 IP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + L L + L + P + L
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 21/88 (23%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 50 NQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-S 107
QL ++ L L L L L P L L+ L L N+L +P+ +
Sbjct: 91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDT 148
Query: 108 LANNAELLFLDVQNNTLSGIVPSALKRL 135
+ L L + N +S + A + L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGL 176
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 6/88 (6%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SL 108
L +P I + + L NR++ S L L L N L I +
Sbjct: 21 QGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAF 76
Query: 109 ANNAELLFLDVQNNT-LSGIVPSALKRL 135
A L LD+ +N L + P+ L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGL 104
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 41/164 (25%), Positives = 79/164 (48%), Gaps = 28/164 (17%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL--------YL 359
+ + +++ LG+G +++VYKG + LVA++ I + + EE G L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL---EHEE-----GAPCTAIREVSL 53
Query: 360 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 419
L L+H NI+ L + L++++ K L +YLD N+++ +
Sbjct: 54 LKDLKHANIVTLHDIIHTEKS--LTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLF 107
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ +G+ Y H K ++HR+L + +LI+++ +AD GL
Sbjct: 108 QLLRGLAYCHR---QK--VLHRDLKPQNLLINERGELKLADFGL 146
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 4/94 (4%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L + N + +P + ++ L+VL L+ N L+ N KL L +S N+L
Sbjct: 97 KLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-E 154
Query: 103 TIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 135
I ++ L L + +N L+ + S + L
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 188
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + N+L + + +L VL L HN L + + +L+ L L NS+ T
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI-VT 332
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLC 148
+ S + L L + +N AL R + C
Sbjct: 333 LKLSTHHT--LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 22/93 (23%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L+L N LT + + + L + L +N L + + +L+RL +S N L +
Sbjct: 231 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VAL 287
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSA--LKRL 135
L LD+ +N L + + RL
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRL 320
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 43 VVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
L + N L I + SL L L NRL + L + L ++S+N L
Sbjct: 144 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL- 198
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+LA + LD +N+++ + L
Sbjct: 199 ----STLAIPIAVEELDASHNSINVVRGPVNVEL 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 10/97 (10%), Positives = 35/97 (36%)
Query: 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98
F + + + +L + ++T +++ + L + +++ L+L+
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 79
Query: 99 SLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + A + L + N + + P + +
Sbjct: 80 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 116
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 24/105 (22%), Positives = 37/105 (35%), Gaps = 12/105 (11%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD 82
N + + I ++ L N + + L++L LQHN L
Sbjct: 195 YNLLSTLAIPIAVEE-------LDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TA 242
Query: 83 SLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 127
L N L +DLS+N L + L L + NN L +
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 287
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 22/93 (23%), Positives = 36/93 (38%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+L L NQ+ L+ L +L L N + + L L L+L N L
Sbjct: 67 RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT 126
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ ++L L ++NN + I A R+
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 26/89 (29%), Positives = 34/89 (38%), Gaps = 4/89 (4%)
Query: 49 CNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES 107
+L+ I L +L L L L IP+ L L KL LDLS N L P S
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGS 226
Query: 108 LANNAELLFLDVQNNTLSGIVPSALKRLN 136
L L + + + I +A L
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 30/116 (25%), Positives = 43/116 (37%), Gaps = 25/116 (21%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L+L N+LT IP L L L L++N + + + L+RLDL
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 103 TIPE------------SLANN-----------AELLFLDVQNNTLSGIVPSALKRL 135
I E +LA +L LD+ N LS I P + + L
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGL 230
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 17/81 (20%), Positives = 32/81 (39%), Gaps = 4/81 (4%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L N L+ I L L L + +++ ++ NL L ++L+ N+L
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-T 268
Query: 103 TIPES-LANNAELLFLDVQNN 122
+P L + + +N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 5/87 (5%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SL 108
L +P I + + +L L N++ +S +L L+ L LS N + TI +
Sbjct: 53 KNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAF 108
Query: 109 ANNAELLFLDVQNNTLSGIVPSALKRL 135
A L L++ +N L+ I A L
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYL 135
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 4e-09
Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL--------YLL 360
+ + + +G+G + VYK G A++ I + +E E G+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL----EKEDE---GIPSTTIREISIL 54
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
L+H NI++L ++ R L+++ + L K LD L+ T S ++
Sbjct: 55 KELKHSNIVKLYDVIHTKKR--LVLVFEHLDQD-LKKLLDV---CEGGLESVTAKSFLLQ 108
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ GI Y H + ++HR+L + +LI+++ IAD GL
Sbjct: 109 LLNGIAYCHD---RR--VLHRDLKPQNLLINREGELKIADFGL 146
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 67/278 (24%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375
LG G V + + A++ + E E + + +I+R+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVY 80
Query: 376 --CSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYLH 429
GR ++ + G+L Q+ G ++ R I+ I + I YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQA---FTEREASEIMKSIGEAIQYLH 134
Query: 430 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKTSAAMGYLA 486
S I HR++ E +L ++ N + + D G A
Sbjct: 135 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FA 167
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--- 543
E T ++ + D+++ GVI+ +L G S+ LA R G++
Sbjct: 168 KE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYEFP 222
Query: 544 SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 574
+ SE K + + +P R T+ +
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMN 256
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 48 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFGTIPE 106
C + + ++L+ L +++ + + L LG+L+ L + + L P+
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 107 SLANNAELLFLDVQNNTLSGIVPSALKRLN-GGFQFQNNPGLC 148
+ L L++ N L + ++ L+ NP C
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 21/81 (25%), Positives = 35/81 (43%), Gaps = 2/81 (2%)
Query: 45 LQLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + Q ++ + + L L LT+ + L PD+ +L RL+LSFN+L +
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL-ES 94
Query: 104 IPESLANNAELLFLDVQNNTL 124
+ L L + N L
Sbjct: 95 LSWKTVQGLSLQELVLSGNPL 115
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 33/161 (20%), Positives = 56/161 (34%), Gaps = 31/161 (19%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L N++ ++ SL+ L+ + +N+L +P L +RL SFN L
Sbjct: 301 YLNASSNEIR-SLCDLPPSLEELN---VSNNKLIE-LPALPPRL---ERLIASFNHL-AE 351
Query: 104 IPESLANNAELLFLDVQNNTLSGI--VPSALKRLNGGFQFQNNPGLCG------------ 149
+PE N L L V+ N L +P +++ L P L
Sbjct: 352 VPELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408
Query: 150 ----DGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISE 186
D S+ + ++ F + D D+ E
Sbjct: 409 REFPDIPESVEDLRMNSE-RVVDPYEFAHETTDKLEDDVFE 448
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ N L +P SL+S+ +N L L NL L + N L T
Sbjct: 199 AIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNNLL-KT 251
Query: 104 IPESLANNAELLFLDVQNNTLSGI--VPSALKRLN 136
+P+ + L L+V++N L+ + +P +L L+
Sbjct: 252 LPDLPPS---LEALNVRDNYLTDLPELPQSLTFLD 283
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 14/97 (14%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
++ + N L +P SL+ + +N+L +P+ L NL L + NSL
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLEE-LPE-LQNLPFLTAIYADNNSL-KK 209
Query: 104 IPESLANNAELLFLDVQNNTLSGI----VPSALKRLN 136
+P+ + L + NN L + L +
Sbjct: 210 LPDLPLS---LESIVAGNNILEELPELQNLPFLTTIY 243
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 22/105 (20%), Positives = 36/105 (34%), Gaps = 19/105 (18%)
Query: 45 LQLCCNQLTGNIPAQIGSL-------------KSLSVLTLQHNRLNGGIPDSLGNLGKLK 91
++ N P G + L L + L+ +P+ + L+
Sbjct: 39 YYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LE 94
Query: 92 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
L S NSL +PE + LL + LS + P L+ L
Sbjct: 95 SLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDL-PPLLEYLG 137
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 14/95 (14%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ N L +P SL++L ++ N L +P+ +L L + F+ L
Sbjct: 241 TIYADNNLLK-TLPDLPPSLEAL---NVRDNYLTD-LPELPQSLTFLDVSENIFSGL--- 292
Query: 104 IPESLANNAELLFLDVQNNTLSGI--VPSALKRLN 136
E N L +L+ +N + + +P +L+ LN
Sbjct: 293 -SELPPN---LYYLNASSNEIRSLCDLPPSLEELN 323
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 23/108 (21%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--- 100
L+L L+ ++P L+SL N L +P+ +L L + + +L
Sbjct: 75 ELELNNLGLS-SLPELPPHLESLV---ASCNSLTE-LPELPQSLKSLLVDNNNLKALSDL 129
Query: 101 -------------FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+PE L N++ L +DV NN+L + P L
Sbjct: 130 PPLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKL-PDLPPSL 175
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 14/93 (15%), Positives = 25/93 (26%), Gaps = 15/93 (16%)
Query: 56 IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115
I + S L + L +P N+ +++ P E+
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 116 F-------------LDVQNNTLSGIVPSALKRL 135
L++ N LS + P L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSL-PELPPHL 93
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 16/99 (16%), Positives = 32/99 (32%), Gaps = 23/99 (23%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSV----------------LTLQHNRLNGGIPDSLGNL 87
L + N L P S++ L + L ++ N L PD ++
Sbjct: 361 QLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESV 418
Query: 88 GKLKRLDLSFNSLFGTIPESLANNAELLFLDV-QNNTLS 125
+ L ++ + E + L DV +++
Sbjct: 419 ---EDLRMNSERV-VDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 61/284 (21%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ V LG G F VYK G L A + I S + E +++ + +L + H I+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIV 79
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+L G G+ +++ +F P G + L + + + + +LH
Sbjct: 80 KLLG--AYYHDGKLWIMIEFCPGGAVD---AIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 486
S + +HR+L VL+ + + +AD G+ ++ K + +G ++A
Sbjct: 135 SKRI-----IHRDLKAGNVLMTLEGDIRLADFGVSAKNLK----TLQKRDSFIGTPYWMA 185
Query: 487 PEYVTTGRFTE-----RSDIFAFGVIILQILTGS--LVLTSSMR------------LAAE 527
PE V + ++DI++ G+ ++++ + MR L
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245
Query: 528 ---SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
S F +F+ ++PE RP+
Sbjct: 246 SKWSVEFRDFLKI--------------------ALDKNPETRPS 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 41/282 (14%), Positives = 103/282 (36%), Gaps = 58/282 (20%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 366
+G+G+ V G VA++ +++ + + ++ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF 102
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
N++ + E +++ +F G L+ + Q L+ ++ + + +
Sbjct: 103 NVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALA 155
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
YLH+ ++HR++ + +L+ ++D G ++ D V K + +G
Sbjct: 156 YLHAQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----VPKRKSLVGTPY 206
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 527
++APE ++ + DI++ G+++++++ G + +L
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK 266
Query: 528 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
S +F++R DP+ R T
Sbjct: 267 VSPVLRDFLER--------------------MLVRDPQERAT 288
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 2/93 (2%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L LT +IP + L L VL L+H +N S L +LK L++S
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
T+ + L L + + L+ + A++ L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL 247
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 2/94 (2%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L+L N ++ + +L +L L L+ NRL L L +LD+S N +
Sbjct: 60 ELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI 118
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ + L L+V +N L I A LN
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+L L N++ + S L L L N ++ P + NL L+ L L N L
Sbjct: 35 RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL-K 93
Query: 103 TIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP + L LD+ N + ++ + L
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL 127
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + N++ + + L +L L + N L + L L++L L +L +
Sbjct: 109 LDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL-TS 166
Query: 104 IP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP E+L++ L+ L +++ ++ I + KRL
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 18/87 (20%), Positives = 32/87 (36%), Gaps = 5/87 (5%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SL 108
+ +P I +L L NR+ D + L+ L+L+ N + + +
Sbjct: 21 KRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAF 76
Query: 109 ANNAELLFLDVQNNTLSGIVPSALKRL 135
N L L +++N L I L
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGL 103
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 4/107 (3%)
Query: 45 LQLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + LT +P + L L L L +N ++ L L +L+ + L L
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN--GGFQFQNNPGLC 148
P + L L+V N L+ + S + +NP C
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 27/169 (15%)
Query: 306 SATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL------- 357
S++ F ++ LG G +++VYKG G VA++ + + SEE G
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL---DSEE-----GTPSTAIRE 53
Query: 358 -YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV- 415
L+ L+HENI+RL + + L+++F L KY+D + +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENK--LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 416 -SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ +G+ + H NK I+HR+L + +LI+++ + D GL
Sbjct: 111 KYFQWQLLQGLAFCHE---NK--ILHRDLKPQNLLINKRGQLKLGDFGL 154
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 23/125 (18%), Positives = 39/125 (31%), Gaps = 13/125 (10%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIP----AQIGSLKSLSVLTLQHNRLN- 77
+ + L L N G +L VL L++ +
Sbjct: 158 QAHSLNFSCE--QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 78 --GGIPDSLGNLGKLKRLDLSFNSLFGTIPESL-ANNAELLFLDVQNNTLSGI---VPSA 131
G +L+ LDLS NSL ++L L++ L + +P+
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK 275
Query: 132 LKRLN 136
L L+
Sbjct: 276 LSVLD 280
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 24/107 (22%), Positives = 33/107 (30%), Gaps = 14/107 (13%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI-------PDSLGNLGKLKRLDLS 96
VL + Q+ +LS L L N G P L L +
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 97 FNSLFGTIPESLANNAELLFLDVQNNTLSGIV-------PSALKRLN 136
+ G A +L LD+ +N+L PS L LN
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 25/101 (24%), Positives = 34/101 (33%), Gaps = 11/101 (10%)
Query: 44 VLQLCCNQLT---GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKRLDLSFNS 99
VL L + G A + L L L HN L +L L+LSF
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 100 LFGTIPESLANNAELLFLDVQNNTLSGIVPSA----LKRLN 136
L +P+ L L LD+ N L + L+
Sbjct: 265 L-KQVPKGLPAK--LSVLDLSYNRLDRNPSPDELPQVGNLS 302
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 17/82 (20%), Positives = 27/82 (32%), Gaps = 7/82 (8%)
Query: 62 SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG--TIPESLANNA--ELLFL 117
L VL++ + + L LDLS N G + +L L L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 118 DVQNN---TLSGIVPSALKRLN 136
++N T SG+ +
Sbjct: 207 ALRNAGMETPSGVCSALAAARV 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 78/290 (26%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 367
FS++ +G G+F +VY +R+ +VAI+ ++ + +S E + +K + L LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I+ RG C +L+ ++ D E L ++ G +G+ Y
Sbjct: 116 TIQYRG--CYLREHTAWLVMEYCLGS----ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---- 483
LHS ++HR++ +L+ + GL K L D F ++ M
Sbjct: 170 LHSHN-----MIHRDVKAGNILLSEP--------GLVK-LGD---FGS---ASIMAPANS 209
Query: 484 ------YLAPEYVTT---GRFTERSDIFAFGVIILQILTGS--LVLTSSMR--------- 523
++APE + G++ + D+++ G+ +++ L ++M
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 524 ---LAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 568
L + S F NF+D C + P++RPT
Sbjct: 270 SPALQSGHWSEYFRNFVDS--------------------CLQKIPQDRPT 299
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 17/190 (8%)
Query: 290 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI--NVTSC 346
S LN+ E F + G+G F +V G + G VAI+ + +
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR 63
Query: 347 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE-----CFLIYDFAPKGKLSKYLDQ 401
E + L L H NI++L+ + + G + ++ ++ P L +
Sbjct: 64 NRELQI----MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN 118
Query: 402 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IAD 460
+ + + IG LH VN + HR++ VL+++ L + D
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCD 175
Query: 461 CGLHKLLADD 470
G K L+
Sbjct: 176 FGSAKKLSPS 185
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + N ++ + KSL L + N L I L ++K LDL N + +
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP+ + L L+V +N L + RL
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 26/123 (21%), Positives = 41/123 (33%), Gaps = 22/123 (17%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--- 100
+L + N ++ + I SL L +L + HNR+ +L+ LDLS N L
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI 84
Query: 101 -----------------FGTIPES--LANNAELLFLDVQNNTLSGIVPSALKRLNGGFQF 141
F +P N ++L FL + L + LN
Sbjct: 85 SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL 144
Query: 142 QNN 144
Sbjct: 145 LVL 147
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG---NLGKLKRLD 94
+ F+ L N LT + G L L L LQ N+L + + L++LD
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380
Query: 95 LSFNSL-FGTIPESLANNAELLFLDVQNNTLSGIVPSAL 132
+S NS+ + + LL L++ +N L+ + L
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 23/93 (24%), Positives = 35/93 (37%), Gaps = 7/93 (7%)
Query: 45 LQLCCNQLTGNIPAQIG---SLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKRLDLSFNSL 100
L L NQL + +KSL L + N ++ L L++S N L
Sbjct: 353 LILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
Query: 101 FGTIPESLANNAELLFLDVQNNTLSGIVPSALK 133
TI L + LD+ +N + I +K
Sbjct: 412 TDTIFRCLPPR--IKVLDLHSNKIKSIPKQVVK 442
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 19/80 (23%), Positives = 34/80 (42%), Gaps = 5/80 (6%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + N LT I + + VL L N++ IP + L L+ L+++ N L +
Sbjct: 403 SLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQL-KS 458
Query: 104 IPE-SLANNAELLFLDVQNN 122
+P+ L + + N
Sbjct: 459 VPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
N L ++P + ++L + N ++ + +L KL+ L +S N +
Sbjct: 10 NGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
N EL +LD+ +N L I L
Sbjct: 67 FNQELEYLDLSHNKLVKISCHPTVNL 92
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 3/58 (5%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSL 100
VL L N++ +IP Q+ L++L L + N+L +PD L L+++ L N
Sbjct: 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 19/120 (15%), Positives = 38/120 (31%), Gaps = 8/120 (6%)
Query: 21 EFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIG-----SLKSLSVLTLQHNR 75
E + F+ I Q+ + + +L G + + SLK+LS+ + +
Sbjct: 231 ETTWNSFIRILQLVWHTTVWY---FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 76 LNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + + + + + L LD NN L+ V L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 26/164 (15%)
Query: 309 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL--------YL 359
+ F +V +G+G + VYK G +VA++ I + E E G+ L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL----DTETE---GVPSTAIREISL 55
Query: 360 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 419
L L H NI++L + + +L+++F + L K++D + + S +
Sbjct: 56 LKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLF 110
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ +G+ + HS ++ ++HR+L + +LI+ + +AD GL
Sbjct: 111 QLLQGLAFCHS---HR--VLHRDLKPQNLLINTEGAIKLADFGL 149
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.8 bits (133), Expect = 2e-08
Identities = 40/164 (24%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL--------YL 359
Q + ++ +G+G + +V+K +VA++ + + ++ E G+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL----DDDDE---GVPSSALREICL 54
Query: 360 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 419
L L+H+NI+RL S + L+++F + L KY D + LD S +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKK--LTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLF 108
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ KG+G+ HS ++HR+L + +LI++ +A+ GL
Sbjct: 109 QLLKGLGFCHS---RN--VLHRDLKPQNLLINRNGELKLANFGL 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 26/117 (22%), Positives = 40/117 (34%), Gaps = 4/117 (3%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
VL++ N N I L++L+ L L +L P + +L L+ L++S N+ F
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQF---QNNPGLCGDGIASLR 156
L LD N + L+ F N C S
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 270
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 6/96 (6%)
Query: 44 VLQLCCNQLT-GNIPAQIGS-LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
L L N L+ +Q SL L L N + + + L +L+ LD ++L
Sbjct: 56 KLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL- 113
Query: 102 GTIPES--LANNAELLFLDVQNNTLSGIVPSALKRL 135
+ E + L++LD+ + L
Sbjct: 114 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 20/93 (21%), Positives = 31/93 (33%), Gaps = 2/93 (2%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + L + SL++L L + H L L+ L ++ NS
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
Query: 104 IPE-SLANNAELLFLDVQNNTLSGIVPSALKRL 135
L FLD+ L + P+A L
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN--GGIPDSLGNLGKLKRLDLSFNSLF 101
L+L N+L L L+ L+L N L+ G S LK LDLSFN +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV- 90
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSAL 132
T+ + +L LD Q++ L + ++
Sbjct: 91 ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 121
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 6/88 (6%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPES 107
LT ++P I S + L L+ N+L L +L +L LS N L G +S
Sbjct: 17 KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS 73
Query: 108 LANNAELLFLDVQNNTLSGIVPSALKRL 135
L +LD+ N + + S L
Sbjct: 74 DFGTTSLKYLDLSFNGVITM-SSNFLGL 100
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 32/216 (14%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 364
+ + +G G V VAI+ + N T K E V L+ +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 82
Query: 365 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
H+NII L + E F ++ + L + + E LD ++
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME------LDHERMSYLLYQ 135
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS- 479
+ GI +LHS+ + +HR+L +++ I D G LA S + T
Sbjct: 136 MLCGIKHLHSAGI-----IHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPY 186
Query: 480 -AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
Y APE + + E DI++ G I+ +++ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 4/95 (4%)
Query: 44 VLQLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFNSLF 101
L L N L+ ++ + G L SL L L N G+ NL L+ L + F
Sbjct: 78 HLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 102 GTIPE-SLANNAELLFLDVQNNTLSGIVPSALKRL 135
I A L L+++ +L +LK +
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 24/89 (26%), Positives = 42/89 (47%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N++T + + +L VL L+ +R+N D+ +LG L+ LDLS N L
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSL 89
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSAL 132
+ L +L++ N + ++L
Sbjct: 90 SSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 22/110 (20%), Positives = 38/110 (34%), Gaps = 20/110 (18%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN---GGIPDSL--------------GN 86
L + N +P + + L L + IP +L
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLF 449
Query: 87 LGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
L +L+ L +S N L T+P++ + LL + + N L + RL
Sbjct: 450 LPRLQELYISRNKL-KTLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 15/94 (15%), Positives = 34/94 (36%), Gaps = 1/94 (1%)
Query: 44 VLQLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L++ + I L SL+ L ++ L SL ++ + L L +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ + + +L++++ L+ S L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 26/94 (27%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 44 VLQLCCNQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
L L N L + +LK+L+ L + N + +PDS K++ L+LS +
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGI- 422
Query: 102 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + L LDV NN L L RL
Sbjct: 423 RVVKTCIPQT--LEVLDVSNNNLDSF-SLFLPRL 453
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109
T +IP+ + ++ L L N++ L L+ L L + + ++
Sbjct: 15 RSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFY 71
Query: 110 NNAELLFLDVQNNTLSGIVPSALKRL 135
+ L LD+ +N LS + S L
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPL 97
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 25/104 (24%), Positives = 38/104 (36%), Gaps = 12/104 (11%)
Query: 44 VLQLCCNQLTGNIPAQIGS-LKSLSVLTLQHNRLNGGIPDS---LGNLGKLKRLDLSFNS 99
+ + +++ +P LKSL L L N + + G L+ L LS N
Sbjct: 314 RITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
Query: 100 L--FGTIPESLANNAELLFLDVQNNTLSGI-----VPSALKRLN 136
L E L L LD+ NT + P ++ LN
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLN 416
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 13/92 (14%), Positives = 29/92 (31%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L++ L + S++ + LTL + + L ++ L+L +L
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
L + + S + + L
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/124 (16%), Positives = 43/124 (34%), Gaps = 10/124 (8%)
Query: 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLK--------SL 66
+ V + S + + + L++ + F L N L P++ + ++
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTL--NGLGDFNPSESDVVSELGKVETVTI 288
Query: 67 SVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG 126
L + L + L K+KR+ + + +F + L FLD+ N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 127 IVPS 130
Sbjct: 349 EYLK 352
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 3/74 (4%)
Query: 62 SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQN 121
S + V + IP L +K LDLSFN + L A L L +++
Sbjct: 3 SCDASGVCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 122 NTLSGIVPSALKRL 135
+ ++ I A L
Sbjct: 60 SRINTIEGDAFYSL 73
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 32/219 (14%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 361
+ + + +G G V VAI+ + N T K E V L+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 362 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 417
+ H+NII L + E F L+ + L + + E LD +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME------LDHERMSYL 169
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--V 475
+ + GI +LHS+ + +HR+L +++ I D GL + + + V
Sbjct: 170 LYQMLCGIKHLHSAGI-----IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 476 LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
Y APE + + E DI++ G I+ +++
Sbjct: 225 ----VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 309 QCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSI---------NVTSCKSEEAEFVK 355
F+ + +LGKG+F V KGT L A++ + +V E+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR---- 393
Query: 356 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 415
L + + +L C + + + ++ G L ++ Q
Sbjct: 394 --VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHA 444
Query: 416 SIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
IA G+ +L S I++R+L ++ V++D + + IAD G+ K ++I
Sbjct: 445 VFYAAEIAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 496
Query: 475 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
V T G Y+APE + + + D +AFGV++ ++L G
Sbjct: 497 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 49/254 (19%), Positives = 92/254 (36%), Gaps = 42/254 (16%)
Query: 278 DPLGDYLNGTGFSR----EHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD- 332
P ++L+ F R + L + + + F + +LG+G F V+ ++
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDW-------FLDFRVLGRGGFGEVFACQMKAT 209
Query: 333 GTLVAIRSIN---------VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383
G L A + +N E+ +L + I+ L + +
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKK-------ILAKVHSRFIVSL--AYAFETKTDL 260
Query: 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 443
L+ G + ++ + + + I G+ +LH I++R+L
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDL 315
Query: 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSD 500
E VL+D N I+D GL L KT G ++APE + + D
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQT----KTKGYAGTPGFMAPELLLGEEYDFSVD 371
Query: 501 IFAFGVIILQILTG 514
FA GV + +++
Sbjct: 372 YFALGVTLYEMIAA 385
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 31/218 (14%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 361
+ + +G G + SV R G VAI+ + + K E L LL
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLK 78
Query: 362 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 417
++HEN+I L F L+ F L K + + +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK------FSEEKIQYL 131
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
+ + KG+ Y+HS+ V VHR+L + +++ I D GL + ++ V
Sbjct: 132 VYQMLKGLKYIHSAGV-----VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV-- 184
Query: 478 TSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 514
Y APE + + + + DI++ G I+ ++LTG
Sbjct: 185 --VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 38/170 (22%), Positives = 72/170 (42%), Gaps = 33/170 (19%)
Query: 310 CFSEVNLLGKGNFSSVYKGT-LRDGTLVA---IR------SINVTSCKSEEAEFVKGLYL 359
+ ++ +G+G F V+K + G VA + +T+ ++ + +
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--------LREIKI 69
Query: 360 LTSLRHENIIRLRGFCCSRG------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 413
L L+HEN++ L C ++ +G +L++DF L+ L S
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSE 125
Query: 414 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
++ + G+ Y+H NK I+HR++ VLI + +AD GL
Sbjct: 126 IKRVMQMLLNGLYYIHR---NK--ILHRDMKAANVLITRDGVLKLADFGL 170
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 36/222 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 358
F + LLGKG F V + G A++ + V +E
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR------- 200
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
+L + RH + L + + ++A G+L +L +E S R
Sbjct: 201 VLQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE-----DRARFY 253
Query: 419 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
I + YLHS + +V+R+L +E +++D+ + I D GL K + I
Sbjct: 254 GAEIVSALDYLHS----EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGA-T 305
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
G YLAPE + + D + GV++ +++ G L
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 23/170 (13%)
Query: 306 SATQCFSEVNLLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKSEEAEF-------VKG 356
A Q + V +G+G + V+K G VA++ + V ++ E V
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAV 64
Query: 357 LYLLTSLRHENIIRLRGFCCSRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSNVLDWST 413
L L + H N++RL C L+++ + L+ YLD+ + T
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG--VPTET 121
Query: 414 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
++ + +G+ +LHS ++ +VHR+L + +L+ +AD GL
Sbjct: 122 IKDMMFQLLRGLDFLHS---HR--VVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 42/303 (13%)
Query: 228 IFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSL--EYCHGWDPLGDYLN 285
+ + H + L + ++ L L EY P DYL+
Sbjct: 105 LTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSV-APFADYLD 163
Query: 286 GTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN-- 342
F+R L L + V F + +LGKG F V +R G + A + +
Sbjct: 164 SIYFNR-FLQWKWLERQPV--TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 343 -------VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL 395
+E+ +L + ++ L + L+ G L
Sbjct: 221 RIKKRKGEAMALNEKQ-------ILEKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDL 271
Query: 396 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455
++ + V I G+ LH IV+R+L E +L+D +
Sbjct: 272 KFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLKPENILLDDHGH 324
Query: 456 PLIADCGLHKLLADDIVFSVLKTSAAM----GYLAPEYVTTGRFTERSDIFAFGVIILQI 511
I+D GL + + +T GY+APE V R+T D +A G ++ ++
Sbjct: 325 IRISDLGLAVHVPEG------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 512 LTG 514
+ G
Sbjct: 379 IAG 381
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 31/92 (33%), Positives = 41/92 (44%), Gaps = 4/92 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+++ +T IP G SL+ L L N++ SL L L +L LSFNS+
Sbjct: 175 YIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
SLAN L L + NN L VP L
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 5/94 (5%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-FG 102
L L NQL +P K+L L + N + L ++ ++L N L
Sbjct: 104 RLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 103 TIPE-SLANNAELLFLDVQNNTLSGIVPSALKRL 135
I + +L ++ + + ++ I L
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL 194
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 3/93 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+L L N++T +LK+L L L +N+++ P + L KL+RL LS N L
Sbjct: 56 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KE 114
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+PE + L L V N ++ + S LN
Sbjct: 115 LPEKMPKT--LQELRVHENEITKVRKSVFNGLN 145
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 13/102 (12%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L N ++ + + L L L +N+L +P L + ++ + L N++
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI-S 276
Query: 103 TIPES-------LANNAELLFLDVQNN--TLSGIVPSALKRL 135
I + A + + +N I PS + +
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 45/212 (21%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 367
F + +GKG+F V D + A++ +N C + E V L ++ L H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 426
++ L + + F++ D G L +L Q V + I + +
Sbjct: 77 LVNLW--YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE-----ETVKLFICELVMALD 129
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYL 485
YL + I+HR++ + +L+D+ + I D + +L + + + T + Y+
Sbjct: 130 YLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYM 181
Query: 486 APEYVTTGRFTERS---DIFAFGVIILQILTG 514
APE ++ + S D ++ GV ++L G
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 26/98 (26%), Positives = 38/98 (38%), Gaps = 5/98 (5%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGI--PDSLGNLGKLKRLDLSFNSL 100
+L+L NQ + L +L VLTL L+G + + L L+ L L N++
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 101 FGTIPESL-ANNAELLFLDVQNNTLSGIVPSALKRLNG 137
P S N LD+ N + I L G
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 26/94 (27%), Positives = 35/94 (37%), Gaps = 4/94 (4%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L L N++ I L L L L N L NL KL+ LDLS+N +
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-R 360
Query: 103 TIPE-SLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ + S L L + N L + RL
Sbjct: 361 ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 17/87 (19%), Positives = 27/87 (31%), Gaps = 3/87 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP-DSLGNLGKLKRLDLSFNSLFG 102
+ L N + L+ L L ++ I ++ L L L L +N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-L 92
Query: 103 TIPES-LANNAELLFLDVQNNTLSGIV 128
+ A L L + L G V
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 14/82 (17%), Positives = 27/82 (32%), Gaps = 7/82 (8%)
Query: 55 NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SLANNAE 113
+PA ++ + L N + S L L+ L + + I + +
Sbjct: 27 ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 114 LLFLDVQNNTLSGIVPSALKRL 135
L+ L + N + A L
Sbjct: 81 LIILKLDYNQFLQLETGAFNGL 102
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 6/92 (6%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + Q++ ++ + +L L+ L N+++ I L +L L + L N + +
Sbjct: 155 YLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQI--S 208
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
LAN + L + + N T++ L
Sbjct: 209 DVSPLANTSNLFIVTLTNQTITNQPVFYNNNL 240
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 10/96 (10%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L+L NQ+T ++ + +L ++ L L N L ++ L +K LDL+ + T
Sbjct: 68 LELKDNQIT-DLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI--TD 121
Query: 105 PESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
LA + L L + N ++ I P + L+ L+
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLS 157
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 17/98 (17%), Positives = 37/98 (37%), Gaps = 10/98 (10%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ + + +T + L ++ L+ + I + L L L+L N +
Sbjct: 22 IKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQI-- 75
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
T L N ++ L++ N L + ++K L+
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLD 113
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 18/89 (20%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L+ N+++ +I + SL +L + L++N+++ L N L + L+ ++ T
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTI--T 230
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSAL 132
NN ++ V+ + + I P+ +
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPIAPATI 259
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 28/92 (30%), Positives = 37/92 (40%), Gaps = 3/92 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+L L N L A + L+ L L L + G L L LDLS N L +
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQL-QS 91
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+P L LDV N L+ + AL+ L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 3/92 (3%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L NQL ++P +L +L+VL + NRL +L LG+L+ L L N L T+
Sbjct: 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL-KTL 139
Query: 105 PESL-ANNAELLFLDVQNNTLSGIVPSALKRL 135
P L +L L + NN L+ + L L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 25/80 (31%), Positives = 34/80 (42%), Gaps = 5/80 (6%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKRLDLSFNSLFG 102
L L N+L +P + L L+L +N L +P L L L L L NSL
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSL-Y 185
Query: 103 TIPESLANNAELLFLDVQNN 122
TIP+ + L F + N
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 364
+ ++ +G G + +V R G VAI+ + + K E L LL +R
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMR 82
Query: 365 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
HEN+I L + F L+ F L K + L ++
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-----KHEKLGEDRIQFLVYQ 136
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+ KG+ Y+H++ + +HR+L + +++ I D GL + ++ V
Sbjct: 137 MLKGLRYIHAAGI-----IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----V 187
Query: 481 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 514
Y APE + R+T+ DI++ G I+ +++TG
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 8/104 (7%)
Query: 44 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
VL+L N++ ++ + + L L + HNRL I + L+ LDLSFN
Sbjct: 80 VLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDF-D 134
Query: 103 TIPES--LANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN 144
+P N +L FL + + + L+ +
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDL 178
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 23/123 (18%), Positives = 44/123 (35%), Gaps = 13/123 (10%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLT---------GNIPAQIGSLKSLSVLTLQH 73
K V F + L+ + + ++P + L+L
Sbjct: 4 DRKPIVGSFHFVCALALIVGSMTPFSNELESMVDYSNRNLTHVPKDL--PPRTKALSLSQ 61
Query: 74 NRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL-ANNAELLFLDVQNNTLSGIVPSAL 132
N ++ + L +L+ L LS N + ++ + N +L +LDV +N L I +
Sbjct: 62 NSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQNISCCPM 120
Query: 133 KRL 135
L
Sbjct: 121 ASL 123
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 4/92 (4%)
Query: 45 LQLCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + N L +S+ VL L N L G + L K+K LDL N + +
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI-MS 464
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
IP+ + + L L+V +N L + RL
Sbjct: 465 IPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
VL L N LTG++ + + VL L +NR+ IP + +L L+ L+++ N L +
Sbjct: 432 VLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL-KS 487
Query: 104 IPE-SLANNAELLFLDVQNN 122
+P+ L ++ + +N
Sbjct: 488 VPDGVFDRLTSLQYIWLHDN 507
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 8/91 (8%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L + +T ++ I L L+ L N + + L L L N L +
Sbjct: 47 LDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKL-TNL 100
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ +L +L+ N L+ + S L
Sbjct: 101 D--VTPLTKLTYLNCDTNKLTKLDVSQNPLL 129
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 9/92 (9%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L N +T + + +L+ L N+L + + L KL L+ N L +
Sbjct: 69 LICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKL-TKL 121
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
S N L +L+ NTL+ I S +L
Sbjct: 122 DVS--QNPLLTYLNCARNTLTEIDVSHNTQLT 151
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 9/92 (9%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L N +T + + L+ L N+L I + L +L D S N L +
Sbjct: 196 LNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPL-TEL 248
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
S ++L L L I + +L
Sbjct: 249 DVS--TLSKLTTLHCIQTDLLEIDLTHNTQLI 278
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L N++T + + K L+ L N + + L +L LD S N L
Sbjct: 174 TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNKL-TE 226
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
I + +L + D N L+ + S L +L
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLT 257
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/93 (21%), Positives = 32/93 (34%), Gaps = 8/93 (8%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L N+LT + + L+ L N L + + +L LD N
Sbjct: 110 YLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK--I 161
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+ +L LD N ++ + S K LN
Sbjct: 162 TKLDVTPQTQLTTLDCSFNKITELDVSQNKLLN 194
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 19/92 (20%), Positives = 35/92 (38%), Gaps = 8/92 (8%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L N LT I + L+ L N+ + + +L LD SFN +
Sbjct: 131 YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI-TE 184
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ ++ N L L+ N ++ + + +L
Sbjct: 185 LD--VSQNKLLNRLNCDTNNITKLDLNQNIQL 214
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 16/101 (15%), Positives = 31/101 (30%), Gaps = 5/101 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L +LT + + L L+ + + S+G + L +
Sbjct: 322 YLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITM 376
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN 144
E+L NN+ + + G + G + N
Sbjct: 377 PKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 44 VLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
+L L N L+ + A+ L +L L L HN LN ++ + L+ LDLS N L
Sbjct: 43 LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL- 100
Query: 102 GTIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 135
T+ ++ L L + NN + + +A + +
Sbjct: 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 361
+ + ++ +G G + SV + G VA++ + ++ K E L LL
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLK 83
Query: 362 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 417
++HEN+I L E F L+ L+ + L +
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-----KCQKLTDDHVQFL 137
Query: 418 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
I I +G+ Y+HS+++ +HR+L + +++ I D GL + AD++ V
Sbjct: 138 IYQILRGLKYIHSADI-----IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-- 190
Query: 478 TSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 514
A Y APE + + + DI++ G I+ ++LTG
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 22/143 (15%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N+LT +I + +LK+L L L N++ + SL +L KLK L L N + +
Sbjct: 69 KLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGI--S 122
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP----SALKRLNGGFQFQNN-----PGLCGDGIAS 154
L + +L L + NN ++ I + L L+ ++N L G+
Sbjct: 123 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPL--AGLTK 176
Query: 155 LRACTVYDNTQINPVKPFGSHSN 177
L+ + N I+ ++ N
Sbjct: 177 LQNLYLSKN-HISDLRALAGLKN 198
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 7/94 (7%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N ++ +I + L L L L +N++ L L KL L L N + +
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI--S 166
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP-SALKRLN 136
LA +L L + N +S + + LK L+
Sbjct: 167 DIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLD 200
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 7/94 (7%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ L +T + L S+ + ++ + + L + +L L+ N L
Sbjct: 24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLFLNGNKL-- 77
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVP-SALKRL 135
T + L N L +L + N + + LK+L
Sbjct: 78 TDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKL 111
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 24/203 (11%), Positives = 47/203 (23%), Gaps = 10/203 (4%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L NQ++ +I + L L L L N ++ +L L L L+L
Sbjct: 157 TLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNK 212
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP-SALKRLNGGFQFQNNPGLCGDGIASLRACTVYD 162
+N + + +L S + P + + Y
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNE-----VSFIFYQ 267
Query: 163 NTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILA 222
I K ++ S + +
Sbjct: 268 PVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGW 327
Query: 223 GTGILIFFRYRRHKQKIGNTSES 245
T + + + +
Sbjct: 328 YTEKNGGHEWNFNTDYMSGNDFT 350
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 31/277 (11%), Positives = 74/277 (26%), Gaps = 51/277 (18%)
Query: 316 LLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEE--AEFVKGLYLLTSLRHENIIR 370
G ++ D L VA+ ++ ++ E + L+ + + R
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
+ R ++ ++ G L + D + + +A H
Sbjct: 96 V--LDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR 147
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
+ + +V + D V VL A +
Sbjct: 148 A-----GVALSIDHPSRVRVS----------------IDGDV--VL---AYPATMPDA-- 179
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-GKFSESEAA 549
+ DI G + +L L + + + + + ++
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 550 KLGKMALVCTHEDPENRP--TMEAVIEELTVAAPVMA 584
++ +A D R T+ ++++ T A
Sbjct: 235 QISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTE 271
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 43/211 (20%), Positives = 85/211 (40%), Gaps = 26/211 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 367
F + LG G+F V ++ G A++ ++ K ++ E +L ++
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 426
+++L +++ ++ G++ +L + S I
Sbjct: 103 LVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSE-----PHARFYAAQIVLTFE 155
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
YLHS + +++R+L E +LIDQQ + D G K + +T G
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------RTWTLCGTPE 203
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
LAPE + + + + D +A GV+I ++ G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI----NVTSCKSEEAEFVKGLYLLTSLRH 365
++ ++ +G+G + V + VAI+ I + T C+ E + +L RH
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRH 84
Query: 366 ENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
ENII + + + +++ D L K L + L + I
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-----KTQHLSNDHICYFLYQIL 138
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--A 480
+G+ Y+HS+ V +HR+L +L++ + I D GL ++ D + T A
Sbjct: 139 RGLKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 481 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 514
Y APE + + +T+ DI++ G I+ ++L+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 56/298 (18%), Positives = 111/298 (37%), Gaps = 47/298 (15%)
Query: 292 EHLNSFRLNLEEVESAT---QCFSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSIN-V 343
E+L + +V+ + F + ++G+G F V K + A++ +N
Sbjct: 54 EYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKW 110
Query: 344 TSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 402
K E + +L + + I L + +L+ D+ G L L +
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168
Query: 403 EGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461
E L + + I +H VHR++ + +L+D + +AD
Sbjct: 169 ED---RLP-EEMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADF 219
Query: 462 GLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERS-----DIFAFGVIILQILT 513
G L +D +++S A+G Y++PE + + D ++ GV + ++L
Sbjct: 220 GSCLKLMED---GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 514 GSLVLTSSMRLAAESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENR 566
G + + T+ ++ + +F SE AK L+C E+R
Sbjct: 277 GETPFYAE----SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC---SREHR 327
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 27/98 (27%), Positives = 34/98 (34%), Gaps = 9/98 (9%)
Query: 29 IIFQIQLKVILLCFVVLQLCCNQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN 86
L L LT N+P L L L L NR++GG+
Sbjct: 31 EGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEK 86
Query: 87 LGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNN 122
L L+LS N + TI E L L LD+ N
Sbjct: 87 CPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 3/93 (3%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-FG 102
L L N + ++ L SL L L +G+L LK L+++ N +
Sbjct: 81 LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+PE +N L LD+ +N + I + L+ L
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 21/96 (21%), Positives = 32/96 (33%), Gaps = 6/96 (6%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRL---NGGIPDSLGNLGKLK-RLDLSFNS 99
L + N + + +L +L L L N++ L + L LDLS N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 100 LFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ I L L + N L + RL
Sbjct: 189 M-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRL 223
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 2/90 (2%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N++T + + +L L L N +N DS +LG L+ LDLS+N L
Sbjct: 56 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL-SN 114
Query: 104 IPESL-ANNAELLFLDVQNNTLSGIVPSAL 132
+ S + L FL++ N + ++L
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 5/87 (5%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SL 108
L +IP+ + ++ L L +NR+ L L+ L L+ N + TI E S
Sbjct: 41 GSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSF 96
Query: 109 ANNAELLFLDVQNNTLSGIVPSALKRL 135
++ L LD+ N LS + S K L
Sbjct: 97 SSLGSLEHLDLSYNYLSNLSSSWFKPL 123
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 16/88 (18%), Positives = 31/88 (35%), Gaps = 4/88 (4%)
Query: 47 LCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 105
+ T I + L L L + + L P SL ++ + L L +
Sbjct: 157 GNMDTFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLL 214
Query: 106 E-SLANNAELLFLDVQNNTLSGIVPSAL 132
E + + + L++++ L S L
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSEL 242
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 18/114 (15%), Positives = 40/114 (35%), Gaps = 19/114 (16%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS------- 96
L++ + L + + S++++S L L + + + ++ L+L
Sbjct: 179 LEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF 237
Query: 97 -FNSLFGTIPESLANNAELLFLDVQNNTLSGIVP-----SALKRLNGGFQFQNN 144
F+ L SL + + + +L ++ S L L F N
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE----FSRN 287
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 45/220 (20%), Positives = 85/220 (38%), Gaps = 27/220 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI---NVTSCKSEEAEFVKGLYLLTSLRHE 366
+ ++ LG G V+ VAI+ I + S K E + ++ L H+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHD 68
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--EG------SSNVLDWSTRVSII 418
NI+++ G + + Y+ QE E L +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSV--YIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLK 477
+ +G+ Y+HS+ V +HR+L + I+ + L I D GL +++
Sbjct: 127 YQLLRGLKYIHSANV-----LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 478 TS--AAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 514
+ Y +P ++ +T+ D++A G I ++LTG
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 51/222 (22%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 309 QCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSIN---------VTSCKSEEAEFVK 355
+ F +LGKG+F V +K T AI+++ V E+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKR---- 69
Query: 356 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 415
L + H + + FC + + F + ++ G L ++ D S
Sbjct: 70 --VLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRAT 121
Query: 416 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
I G+ +LHS IV+R+L ++ +L+D+ + IAD G+ K ++++
Sbjct: 122 FYAAEIILGLQFLHSK-----GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDA 173
Query: 476 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
KT+ G Y+APE + ++ D ++FGV++ ++L G
Sbjct: 174 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/220 (18%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 358
Q F + ++G+G+++ V L+ + A+R + ++ ++E+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH------V 105
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
+ H ++ L C + F + ++ G L ++ ++
Sbjct: 106 FEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFY 158
Query: 419 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
I+ + YLH I++R+L ++ VL+D + + + D G+ K + +
Sbjct: 159 SAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD-T 209
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
TS G Y+APE + + D +A GV++ +++ G
Sbjct: 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 358
F + LLGKG F V + G A++ + V +E
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR------- 57
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
+L + RH + L + + ++A G+L +L +E + R
Sbjct: 58 VLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFY 110
Query: 419 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
I + YLHS + +V+R++ +E +++D+ + I D GL K + I
Sbjct: 111 GAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGA-T 161
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
G YLAPE + + D + GV++ +++ G
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 34/135 (25%), Positives = 51/135 (37%), Gaps = 25/135 (18%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLN---GGIPDSLGNLGKLKRLDLSFNSL 100
L + N+L +P + L +L+ L L N+L + DSL L L L +N L
Sbjct: 90 LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKL---TYLSLGYNEL 145
Query: 101 FGTIPESLANNA-----ELLFLDVQNNTLSGIVPSA------LKRLN-GGFQFQNNPGLC 148
+SL L L + NN L + A LK L Q + P
Sbjct: 146 -----QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 149 GDGIASLRACTVYDN 163
D + L+ + +N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 309 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSIN--VTSCKSEEAEFVKG-LYLLT 361
+CF + +LGKG + V+ K T + G + A++ + + +++ K +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 362 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG- 420
++H I+ L + G+ +LI ++ G+L L++E +
Sbjct: 77 EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-----EDTACFYLAE 129
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
I+ +G+LH I++R+L E ++++ Q + + D GL K D T
Sbjct: 130 ISMALGHLHQK-----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHT 180
Query: 481 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
G Y+APE + D ++ G ++ +LTG+
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 358
F+ + +LGKG+F V + L A++ + +V E+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR------V 73
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
L + + +L C + + + ++ G L ++ Q
Sbjct: 74 LALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHAVFY 126
Query: 419 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
IA G+ +L S I++R+L ++ V++D + + IAD G+ K ++I V
Sbjct: 127 AAEIAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV-T 177
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
T G Y+APE + + + D +AFGV++ ++L G
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 43/272 (15%), Positives = 102/272 (37%), Gaps = 56/272 (20%)
Query: 268 LVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVY- 326
L +L Y + L N F + + ++ + + V ++G+G F V
Sbjct: 29 LDALVYDLDFPALRKNKNIDNFLSRY-KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87
Query: 327 ---KGTLRDGTLVAIRSINVTSCKSE-----EAEFVKG-LYLLTSLRHENIIRLRGFCCS 377
K T + A++ ++ K E ++ F ++ +++L F
Sbjct: 88 VRHKST---RKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAF 138
Query: 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK--------GIGYLH 429
+ +++ ++ P G L + + A+ + +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-------------ARFYTAEVVLALDAIH 185
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 486
S +HR++ + +L+D+ + +AD G + + +++ A+G Y++
Sbjct: 186 SMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE---GMVRCDTAVGTPDYIS 237
Query: 487 PEYVTT----GRFTERSDIFAFGVIILQILTG 514
PE + + G + D ++ GV + ++L G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 30/162 (18%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 364
+ +L+G G++ V + + +VAI+ I ++ CK E + +L L
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILNRLN 110
Query: 365 HENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 421
H++++++ + E +++ + A K + L +++ +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPVYLTELHIKTLLYNL 165
Query: 422 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
G+ Y+HS+ + +HR+L L++Q + + D GL
Sbjct: 166 LVGVKYVHSAGI-----LHRDLKPANCLVNQDCSVKVCDFGL 202
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 28/119 (23%), Positives = 44/119 (36%), Gaps = 15/119 (12%)
Query: 24 NKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP-- 81
+ I + + + V L + + A + +LK+ L L N I
Sbjct: 9 DAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN----IEKI 63
Query: 82 DSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL-FLDVQNN---TLSGIVPSALKRLN 136
SL + L+ L L N + E+L A+ L L + N +LSGI L L
Sbjct: 64 SSLSGMENLRILSLGRNLI--KKIENLDAVADTLEELWISYNQIASLSGI--EKLVNLR 118
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 28/98 (28%), Positives = 35/98 (35%), Gaps = 9/98 (9%)
Query: 29 IIFQIQLKVILLCFVVLQLCCNQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN 86
L + L L L N+P L L L L NR+ GG+
Sbjct: 38 DGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEK 93
Query: 87 LGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNN 122
L L L+LS N L T+ E L L LD+ N
Sbjct: 94 LPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 39/220 (17%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 358
Q F + ++G+G+++ V L+ + A++ + ++ ++E+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH------V 62
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
+ H ++ L C + F + ++ G L ++ ++
Sbjct: 63 FEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFY 115
Query: 419 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
I+ + YLH I++R+L ++ VL+D + + + D G+ K + +
Sbjct: 116 SAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD-T 166
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
TS G Y+APE + + D +A GV++ +++ G
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 4e-05
Identities = 59/387 (15%), Positives = 108/387 (27%), Gaps = 89/387 (22%)
Query: 247 DWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGF-----SR-EHLNSFRLN 300
+ L + + K R + D L Y + F SR + R
Sbjct: 92 KF-LMSPI---KTEQRQPSMMTRMYIEQR--DRL--YNDNQVFAKYNVSRLQPYLKLRQA 143
Query: 301 LEEVESATQCFSEVNLLGKGNF--SSVYKGTLRDGTLVAIRS-----INVTSCKSEEA-- 351
L E+ A V + G + V + +N+ +C S E
Sbjct: 144 LLELRPA----KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 352 EFVKGLYL-----LTSL--RHENII--------RLRGFCCSRGRGECFLIYDFAPKGKLS 396
E ++ L TS NI LR S+ C L+ K
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 397 KYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE---KVL-IDQ 452
+ S +L +TR + H S + + + K L
Sbjct: 260 NAFN---LSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 453 Q--------FNPL-IADCGLHKLLADDI-------------VFSVLKTSAAMGYLAPEYV 490
Q NP ++ + + D + + +++++S + L P
Sbjct: 316 QDLPREVLTTNPRRLSIIA--ESIRDGLATWDNWKHVNCDKLTTIIESS--LNVLEPAEY 371
Query: 491 TTGRFTERSDIFAFGVII----LQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546
F S +F I L ++ ++ + M + + +L K +
Sbjct: 372 RK-MFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNK------LHKYSLVEKQPKE 423
Query: 547 EAAKLGKMALVCTHEDPENRPTMEAVI 573
+ + L EN + I
Sbjct: 424 STISIPSIYLE-LKVKLENEYALHRSI 449
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 4e-04
Identities = 71/575 (12%), Positives = 148/575 (25%), Gaps = 192/575 (33%)
Query: 72 QHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA 131
Q +RL F + + +L ++ A
Sbjct: 115 QRDRLYNDNQ--------------VFAKYNVSRLQ--------PYLKLRQ---------A 143
Query: 132 LKRLNGGFQFQNNP-----GLCGDGIASLRACTVYDNTQINPVKPFGSH----SNDTTPI 182
L L + G+ G G + A V + ++ F N +P
Sbjct: 144 LLEL------RPAKNVLIDGVLGSGKTWV-ALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 183 DISEP-SGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGN 241
+ E + + S S I + + + + + ++
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNI-------KLRIHSIQAELRRLLKSKPYEN---- 245
Query: 242 TSESS----D--WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLN 295
+ FN L++ + + D+L+ + L+
Sbjct: 246 ----CLLVLLNVQ----NAKAWNAFN-LSCKILLTTRF----KQVTDFLSAATTTHISLD 292
Query: 296 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA 351
+ L E +LL K + L + I A
Sbjct: 293 HHSMTLTPDEV-------KSLLLK--YLDCRPQDLPREVLTTNPRRLSII---------A 334
Query: 352 EFVK-GLYLLTSLRHENIIRLRGFCCSRGRGECF----------LIYDFA--------PK 392
E ++ GL + +H N +L + + + P
Sbjct: 335 ESIRDGLATWDNWKHVNCDKL-----TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389
Query: 393 GKLSKY---LDQEEGSSNVLDWSTRVSIIIGIAK-GIGYLHS------SEVNKPAIVHRN 442
LS + + + V++ + S++ K + S ++ +HR+
Sbjct: 390 ILLSLIWFDVIKSD-VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448
Query: 443 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIF 502
+ V+ I + F+ L D +S + G+ ++ ER +F
Sbjct: 449 I-VDHYNIPKTFDSD----DLIPPYLDQYFYSHI------GH----HLKNIEHPERMTLF 493
Query: 503 AFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHED 562
F +F R L+ K A +++ T +
Sbjct: 494 -------------------------RMVFLDF--RFLEQKIRHDSTAWNASGSILNTLQQ 526
Query: 563 --------PENRPTMEAVIEELTVAAPVMATFLFS 589
+N P E ++ + FL
Sbjct: 527 LKFYKPYICDNDPKYERLVNAIL-------DFLPK 554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 34/129 (26%), Positives = 43/129 (33%), Gaps = 29/129 (22%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN---GGIPDSLGNLG------------ 88
+L L NQ+T P SL +L L L N+L G+ DSL L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 89 ---------KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA---LKRLN 136
LK L + N L +P + L L + N L I A L L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 137 GGFQFQNNP 145
NP
Sbjct: 163 -HAYLFGNP 170
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 49 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-S 107
C + IP S L L L + NL + R+ +S + + S
Sbjct: 20 CKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS 75
Query: 108 LANNAELLFLDVQNN-TLSGIVPSALKRL 135
N +++ ++++N L+ I P ALK L
Sbjct: 76 FYNLSKVTHIEIRNTRNLTYIDPDALKEL 104
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 17/92 (18%), Positives = 37/92 (40%), Gaps = 7/92 (7%)
Query: 50 NQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIP-DSLGNLGKLKRLDLSFNSLFGTIPE- 106
L + + +L ++ + +++ R I D+L L LK L + L P+
Sbjct: 66 VTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDL 123
Query: 107 -SLANNAELLFLDVQ-NNTLSGIVPSALKRLN 136
+ + L++ N ++ I +A + L
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 34/156 (21%), Positives = 60/156 (38%), Gaps = 19/156 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI 368
+ V LG+G +S V++ + + V ++ + K + E +K +L +LR NI
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-IK---ILENLRGGPNI 93
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
I L L+++ + L + I K + Y
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC 146
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGL 463
HS I+HR++ V+ID + L + D GL
Sbjct: 147 HSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N+LT +I + +LK+L L L N++ SL +L KLK L L N + +
Sbjct: 72 KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGI--S 125
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 136
L + +L L + NN ++ I + L L+
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS 162
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 25/93 (26%), Positives = 39/93 (41%), Gaps = 7/93 (7%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N ++ +I + L L L L +N++ L L KL L L N + +
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI--S 169
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP-SALKRL 135
LA +L L + N +S + + LK L
Sbjct: 170 DIVPLAGLTKLQNLYLSKNHISDLRALAGLKNL 202
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 19/94 (20%), Positives = 38/94 (40%), Gaps = 7/94 (7%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ L +T + L S+ + ++ + + + L + +L L+ N L
Sbjct: 27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKL-- 80
Query: 103 TIPESLANNAELLFLDVQNNTLSGIVP-SALKRL 135
T + LAN L +L + N + + LK+L
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKL 114
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 9e-05
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 358
F + +LGKG+F V +++ G L A++ + +V +E+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR------I 76
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
L + H + +L FCC + F + +F G L ++ + R
Sbjct: 77 LSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFY 129
Query: 419 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
I + +LH I++R+L ++ VL+D + + +AD G+ K + I V
Sbjct: 130 AAEIISALMFLHDK-----GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGV-T 180
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
T+ G Y+APE + + D +A GV++ ++L G
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 54/282 (19%), Positives = 99/282 (35%), Gaps = 54/282 (19%)
Query: 311 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSE-----EAEFVKG-LYLL 360
F + ++G+G FS V K T G + A++ +N K + E + +L
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMN----KWDMLKRGEVSCFREERDVL 115
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
+ I +L + +L+ ++ G L L + +
Sbjct: 116 VNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA----EMARFYLA 169
Query: 421 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 479
I I +H VHR++ + +L+D+ + +AD G L D +++
Sbjct: 170 EIVMAIDSVHRL-----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD---GTVRSL 221
Query: 480 AAMG---YLAPE-------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529
A+G YL+PE TG + D +A GV ++ G + + +
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAE 277
Query: 530 TFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENR 566
T+ + E A+ L+C PE R
Sbjct: 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC---PPETR 316
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 23/116 (19%), Positives = 41/116 (35%), Gaps = 6/116 (5%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+ N++T +I ++ + L NRL L LK L L N +
Sbjct: 62 INFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI-TC 119
Query: 104 IPESLANN-AELLFLDVQNNTLSGIVPSALKRLN--GGFQFQNNPGLCGDGIASLR 156
+ + + L + +N ++ + P A L+ NP C +A L
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLG 175
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 20/79 (25%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L L N++T +P + L SL +L L N++N D+ +L L L L N L
Sbjct: 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI 143
Query: 104 IPESLANNAELLFLDVQNN 122
+ + + + + N
Sbjct: 144 AKGTFSPLRAIQTMHLAQN 162
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 53/256 (20%), Positives = 104/256 (40%), Gaps = 29/256 (11%)
Query: 309 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSIN--VTSCKSEEAEFVKG--LYLL 360
+ F + +LG G + V+ K + D G L A++ + K++ E + L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
+ ++ L + + LI D+ G+L +L Q E + V I +G
Sbjct: 114 HIRQSPFLVTLH--YAFQTETKLHLILDYINGGELFTHLSQRERFTE-----HEVQIYVG 166
Query: 421 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 479
I + +LH I++R++ +E +L+D + ++ D GL K + + +
Sbjct: 167 EIVLALEHLHKL-----GIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAY 218
Query: 480 AAMG---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534
G Y+AP+ V G + D ++ GV++ ++LTG+ T +++
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278
Query: 535 IDRNLKGKFSESEAAK 550
+ S AK
Sbjct: 279 LKSEPPYPQEMSALAK 294
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 367
F + LG G+F V+ R G A++ + + ++ E +L+ + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 426
IIR+ G + F+I D+ G+L L + + N + +
Sbjct: 68 IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPN-----PVAKFYAAEVCLALE 120
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 483
YLHS + I++R+L E +L+D+ + I D G K + D T G
Sbjct: 121 YLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------VTYTLCGTPD 168
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
Y+APE V+T + + D ++FG++I ++L G
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 18/88 (20%), Positives = 39/88 (44%), Gaps = 5/88 (5%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES-L 108
+++T IP+ + ++ L +L + G L+++++S N + I
Sbjct: 19 SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75
Query: 109 ANNAELLFLDVQN-NTLSGIVPSALKRL 135
+N +L + ++ N L I P A + L
Sbjct: 76 SNLPKLHEIRIEKANNLLYINPEAFQNL 103
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 44/231 (19%), Positives = 83/231 (35%), Gaps = 51/231 (22%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINV----TSCKSEEAEFVKGLYLLTSLRH 365
F +LLG+G + V T G +VAI+ I E + +L +H
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKHFKH 68
Query: 366 ENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
ENII + E ++I + L + + S+ +L I
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQMLSDDHIQYFIYQTL 122
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-------ADDIVFSV 475
+ + LH S V +HR+L +LI+ ++C L K+ D+
Sbjct: 123 RAVKVLHGSNV-----IHRDLKPSNLLIN-------SNCDL-KVCDFGLARIIDESAADN 169
Query: 476 LKTSAAMGYLAPEYVTT------------GRFTERSDIFAFGVIILQILTG 514
+ + + E+V T +++ D+++ G I+ ++
Sbjct: 170 SEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 42/230 (18%), Positives = 75/230 (32%), Gaps = 49/230 (21%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLY---------LL 360
++ + G++ +V G +G VAI+ + T LL
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 361 TSLRHENIIRLRGFCCSRGRG---ECFLIYDF----------APKGKLSKYLDQEEGSSN 407
H NI+ LR + +L+ + + +S Q
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ------ 137
Query: 408 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467
+ I G+ LH + V VHR+L +L+ + I D L +
Sbjct: 138 --------YFMYHILLGLHVLHEAGV-----VHRDLHPGNILLADNNDITICDFNLARED 184
Query: 468 ADDIVFS--VLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 514
D + V Y APE V FT+ D+++ G ++ ++
Sbjct: 185 TADANKTHYV----THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 27/104 (25%), Positives = 40/104 (38%), Gaps = 12/104 (11%)
Query: 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGI 80
KI VI L L F + N++ P L+ L L + +NR+
Sbjct: 28 GYKIPVIE---NLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIG 80
Query: 81 PDSLGNLGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNN 122
L L L L+ NSL G + + LA+ L +L + N
Sbjct: 81 EGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 12/86 (13%), Positives = 31/86 (36%), Gaps = 8/86 (9%)
Query: 44 VLQLCCNQLTGNIPAQIGS---LKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLS 96
L + + + L L + + L + D + + LK +++
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 97 FNSLFGTIPESLANNAELLFLDVQNN 122
+N L + + L + + +DV ++
Sbjct: 316 YNYLSDEMKKELQKSLPMK-IDVSDS 340
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 34/145 (23%), Positives = 52/145 (35%), Gaps = 19/145 (13%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
L + N+L N+ LS L L +N L DSL +L L+ L + N L
Sbjct: 89 ELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKL--K 141
Query: 104 IPESLANNAELLFLDVQNNTLSGIVP-SALKRLNGGFQFQNNPGLCGDGIASLRACTVYD 162
L ++L LD+ N ++ + LK++N + +
Sbjct: 142 SIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVN-WIDLTGQK------CVNEPVKYQPE 194
Query: 163 NTQINPVK-PFGSHSNDTTPIDISE 186
N VK P G +P IS
Sbjct: 195 LYITNTVKDPDG---RWISPYYISN 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 309 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSI--------NVTSCKSEEAEFVKG 356
F + +LG+G+F V+ K + D L A++ + + K E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER------ 77
Query: 357 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 416
+L + H I++L + G+ +LI DF G L L +E + V
Sbjct: 78 -DILVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVK 129
Query: 417 IIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 475
+ +A + +LHS I++R+L E +L+D++ + + D GL K D
Sbjct: 130 FYLAELALALDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 181
Query: 476 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
K + G Y+APE V T+ +D ++FGV++ ++LTG+L
Sbjct: 182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 309 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 358
F + ++GKG+F V + A++ + SE
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN------V 91
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
LL +++H ++ L + + + + D+ G+L +L Q E R
Sbjct: 92 LLKNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLE----PRARFY 144
Query: 419 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 477
IA +GYLHS IV+R+L E +L+D Q + ++ D GL K ++I +
Sbjct: 145 AAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNS-T 195
Query: 478 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 514
TS G YLAPE + + D + G ++ ++L G
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 34/204 (16%), Positives = 71/204 (34%), Gaps = 49/204 (24%)
Query: 305 ESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTS 362
E++++ +S LG G+F V + + G A++ + K+ E L ++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE------LDIMKV 56
Query: 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR-------- 414
L H NII+L + + G E KL + + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 415 -------VSIIIG--------------------IAKGIGYLHSSEVNKPAIVHRNLSVEK 447
+ ++ + + +G++HS + HR++ +
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI-----CHRDIKPQN 171
Query: 448 VLIDQQFNPL-IADCGLHKLLADD 470
+L++ + N L + D G K L
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPS 195
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 589 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.7 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.64 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.64 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.62 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.61 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.61 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.6 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.58 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.58 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.57 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.57 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.56 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.56 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.53 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.52 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.52 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.52 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.52 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.49 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.49 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.49 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.46 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.45 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.45 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.45 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.45 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.44 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.43 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.43 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.42 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.42 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.42 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.42 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.41 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.41 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.41 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.4 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.39 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.39 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.38 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.38 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.38 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.38 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.38 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.37 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.36 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.36 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.34 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.34 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.33 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.33 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.32 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.32 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.32 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.31 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.3 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.29 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.28 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.27 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.27 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.27 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.25 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.22 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.21 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.19 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.18 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.18 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.17 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.16 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.15 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.14 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.13 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.13 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.08 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.07 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.06 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.06 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.06 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.06 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.05 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.03 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.02 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.98 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.96 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.94 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.89 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.79 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.74 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.72 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.68 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.65 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.64 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.23 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.1 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.08 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.76 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.75 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.14 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.13 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.13 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.09 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.95 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.79 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.73 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.26 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.13 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.07 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.17 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.61 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 93.9 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.4 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 93.09 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.98 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.31 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 90.93 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 90.83 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.17 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.51 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.85 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.26 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.11 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=448.39 Aligned_cols=262 Identities=23% Similarity=0.396 Sum_probs=215.4
Q ss_pred ccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|...+.||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++++|||||+++|+|.+ .+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 46777889999999999999864 47889999998654 4556789999999999999999999999954 478
Q ss_pred EEEEEEeCCCCChHHHhhhhc---------CCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC
Q 007788 383 CFLIYDFAPKGKLSKYLDQEE---------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 453 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~ 453 (589)
.++|||||++|+|.++|+... .....++|..+++|+.|||.||+|||+.+ |+||||||+|||++++
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGEN 164 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGG
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccCHhhEEECCC
Confidence 999999999999999997642 22346999999999999999999999987 9999999999999999
Q ss_pred CceEEccccccccccCCceeee-ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhH
Q 007788 454 FNPLIADCGLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF 531 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 531 (589)
+.+||+|||+|+.......... ....+|++|||||++.++.|+.++|||||||+||||+| |+.||........
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~----- 239 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----- 239 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999987654433222 23357889999999999999999999999999999999 8999976433211
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
...+........+..++..+.+++..||+.||++||||+||++.|+.+.+..
T Consensus 240 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 240 IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1122222233445667788999999999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=451.13 Aligned_cols=264 Identities=22% Similarity=0.382 Sum_probs=211.0
Q ss_pred ccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|...+.||+|+||+||+|+++ +++.||||+++... ....++|.+|+++|++++|||||+++|+|.+ .+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTE--GRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 45666788999999999999874 47899999998654 4556789999999999999999999999954 478
Q ss_pred EEEEEEeCCCCChHHHhhhhcC-----------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEG-----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 451 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~ 451 (589)
.++|||||++|+|.++++.... ...+++|.++++|+.|||+||+|||+.+ ||||||||+||||+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVG 192 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHhhEEEC
Confidence 9999999999999999976432 1246999999999999999999999987 99999999999999
Q ss_pred CCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhh
Q 007788 452 QQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA 529 (589)
Q Consensus 452 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 529 (589)
+++.+||+|||+++....... .......+|+.|||||++.+..|+.++|||||||+||||+| |+.||........
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--- 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--- 269 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---
Confidence 999999999999987654332 22334568899999999999999999999999999999999 8999976433211
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccccc
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT 585 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~ 585 (589)
...+....+...+..++..+.+++.+||+.||++||||+||+++|+.+.+....
T Consensus 270 --~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~ 323 (329)
T 4aoj_A 270 --IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323 (329)
T ss_dssp --HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred --HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence 112222233345566778899999999999999999999999999998776543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=448.49 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=213.4
Q ss_pred cCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
+++..+.||+|+||+||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|.+ .+..
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--DQPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--CCEE
Confidence 3455678999999999999973 4689999999876555566789999999999999999999999954 4678
Q ss_pred EEEEEeCCCCChHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 451 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~ 451 (589)
++|||||++|+|.++|...... ...++|..+++|+.|||+||+|||+.+ ||||||||+||||+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVY 179 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEC
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCccccceEEC
Confidence 9999999999999999754311 235999999999999999999999988 99999999999999
Q ss_pred CCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhh
Q 007788 452 QQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA 529 (589)
Q Consensus 452 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 529 (589)
+++.+||+|||+++........ ......+|++|||||++.++.|+.++|||||||+||||+| |+.||.+.....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---- 255 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---- 255 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH----
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 9999999999999876543322 2234568899999999999999999999999999999999 889997643321
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+...+......+.+..++..+.+++..||+.||++||||+||+++|+..
T Consensus 256 -~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 -VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1222223333445667788899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=444.57 Aligned_cols=261 Identities=19% Similarity=0.364 Sum_probs=206.1
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.+++...+.||+|+||+||+|++++ .||||+++.... ....+.|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEE
Confidence 4566778899999999999999763 599999975442 3445789999999999999999999999843 468999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||||++|+|.++|+.... .++|..+++|+.|||.||+|||+.+ ||||||||+||||++++.+||+|||+|+.
T Consensus 110 mEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~-----IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAKN-----IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 999999999999986543 4999999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCc-eeeeecCCccccccCcccccC---CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH-hhccccCC
Q 007788 467 LADDI-VFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-FIDRNLKG 541 (589)
Q Consensus 467 ~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 541 (589)
..... ........||+.|||||++.+ +.|+.++|||||||+||||+||+.||............... ...+. ..
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~ 260 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-LS 260 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-ST
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-cc
Confidence 65422 222334568999999999864 46899999999999999999999999754321111111111 11111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..+..++..+.+++.+||+.||++||||.||+++|+.+...
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 23455677899999999999999999999999999887644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=444.62 Aligned_cols=275 Identities=22% Similarity=0.375 Sum_probs=227.0
Q ss_pred ccCHHHHHHhhccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCC-CCccc
Q 007788 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIR 370 (589)
Q Consensus 298 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H-~niv~ 370 (589)
..+..+|+...++|+..+.||+|+||+||+|.+.. ++.||||++.........++|.+|+++|.+++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 44556778888999999999999999999998642 468999999877656667789999999999965 89999
Q ss_pred eeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCe
Q 007788 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI 438 (589)
Q Consensus 371 l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~i 438 (589)
++|+|... .+..++|||||++|+|.++|+.... ....++|..++.|+.|||+||+|||+.+ |
T Consensus 133 l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-----i 206 (353)
T 4ase_A 133 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----C 206 (353)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-----C
T ss_pred EEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-----e
Confidence 99998543 3568999999999999999976432 1245899999999999999999999988 9
Q ss_pred EecCCCCCCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCC
Q 007788 439 VHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSL 516 (589)
Q Consensus 439 vH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~ 516 (589)
|||||||+|||+++++.+||+|||+|+.+..+.. .......+|+.|||||++.+..|+.++|||||||+||||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 9999999999999999999999999997654332 23334557889999999999999999999999999999998 899
Q ss_pred CcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 517 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 517 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
||.+.... ..+...+....+...+..++.++.+++..||+.||++||||.|++++|+.+-+.
T Consensus 287 Pf~~~~~~----~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 287 PYPGVKID----EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SSTTCCCS----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHH----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 99754211 112233333344445566677899999999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=416.96 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=201.8
Q ss_pred ccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC--CCCeEEEEE
Q 007788 312 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECFLIY 387 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~lv~ 387 (589)
...+.||+|+||.||+|... ++..||||++..... ......|.+|++++++++|||||++++++.+. ..+..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34467999999999999976 689999999975532 34456799999999999999999999988542 234689999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGla~~ 466 (589)
|||++|+|.+++.... .+++..+..|+.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~---~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999998654 4899999999999999999999875 56999999999999984 79999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... ....||+.|||||++.+ +|+.++|||||||+||||+||+.||......... ...+.........+..
T Consensus 182 ~~~~~~---~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 182 KRASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKV 254 (290)
T ss_dssp CCTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGC
T ss_pred CCCCcc---CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH---HHHHHcCCCCCCCCcc
Confidence 654432 23568999999998864 6999999999999999999999999653221111 1111111111111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+.++.+++.+||+.||++|||++|+++|-+.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 34568899999999999999999999988664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=423.19 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=202.3
Q ss_pred cCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC--CeEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECFLIY 387 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~~~~lv~ 387 (589)
+|...+.||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||+++|+|.+.+. ...++||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 466678999999999999998 58999999997542 222233456666778999999999999976432 3679999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC---CCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---NKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~---~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
|||++|+|.++|+.. .++|..+++|+.|+|+||+|||+... ..++|+||||||+||||++++++||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999754 38999999999999999999998621 1346999999999999999999999999999
Q ss_pred ccccCCcee---eeecCCccccccCcccccCC------CCCCcchhhhHHHHHHHHHhCCCCcchhHHH----------H
Q 007788 465 KLLADDIVF---SVLKTSAAMGYLAPEYVTTG------RFTERSDIFAFGVIILQILTGSLVLTSSMRL----------A 525 (589)
Q Consensus 465 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~----------~ 525 (589)
+........ ......||+.|||||++.+. .++.++|||||||+||||+||+.|+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543221 12234689999999998764 3678999999999999999998776422110 0
Q ss_pred -HhhhhHHHhhccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 526 -AESATFENFIDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 526 -~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
........+....+++..+ .+....+.+++.+||+.||++||||.||++.|+.+.+..
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 0001112222333333332 346678999999999999999999999999999887643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=429.01 Aligned_cols=256 Identities=18% Similarity=0.362 Sum_probs=207.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ......|.+|++++++++|||||++++++.+ .+..|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEE
Confidence 57899999999999999999975 799999999976543 3445789999999999999999999999854 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++..... ..+++...+.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 102 mEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp EECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----CEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred EeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCCEEEccccccee
Confidence 999999999999976542 34789999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... ......||+.|||||++.+..|+.++|||||||+||||+||+.||.+...... +..+..... ...+..
T Consensus 175 ~~~~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~-~~~~~~ 248 (350)
T 4b9d_A 175 LNSTVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL----VLKIISGSF-PPVSLH 248 (350)
T ss_dssp CCHHHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHTCC-CCCCTT
T ss_pred ecCCcc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHHcCCC-CCCCcc
Confidence 754321 11234589999999999999999999999999999999999999976543222 122222221 123344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+..+.+++.+||+.||++|||++|++++-+..
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 567799999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=427.22 Aligned_cols=255 Identities=16% Similarity=0.309 Sum_probs=211.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.|+..+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+ .+..||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 56888899999999999999976 799999999976542 234568899999999999999999999954 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++... .+++..+..|+.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 151 Ey~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 151 EFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp CCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 999999999999753 3899999999999999999999998 999999999999999999999999999877
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc-cCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 546 (589)
..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.+....... ..+.+.. ........
T Consensus 221 ~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~----~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 221 SKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM----KMIRDNLPPRLKNLHK 295 (346)
T ss_dssp CSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSSCCCCSCGGG
T ss_pred CCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHcCCCCCCCcccc
Confidence 54322 223456899999999999999999999999999999999999999765432221 1111111 11122334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+..+.+++.+||+.||++|||++|++++-+....
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 56788999999999999999999999998776543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=422.82 Aligned_cols=253 Identities=17% Similarity=0.204 Sum_probs=205.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.|...+.||+|+||.||+|+.+ +|+.||||+++.... +.+|+.++++++|||||++++++.+ .+..||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~--~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE--GPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 45777889999999999999975 699999999976532 2469999999999999999999854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEcccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL 466 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGla~~ 466 (589)
||+++|+|.+++.... .+++..+..|+.||+.||+|||+.+ ||||||||+|||++.++ .+||+|||+|+.
T Consensus 130 Ey~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR-----ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 9999999999998654 3999999999999999999999998 99999999999999987 699999999987
Q ss_pred ccCCceee----eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc-CC
Q 007788 467 LADDIVFS----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KG 541 (589)
Q Consensus 467 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 541 (589)
+..+.... .....||+.|||||++.+..|+.++|||||||++|||+||+.||........ ...+..... ..
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~~~~~~ 276 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CLKIASEPPPIR 276 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HHHHHHSCCGGG
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHcCCCCch
Confidence 75432211 1224589999999999999999999999999999999999999976432211 111111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..++..+..+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 23445567889999999999999999999999998876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=427.11 Aligned_cols=257 Identities=15% Similarity=0.306 Sum_probs=212.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.+.|+..+.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+ .+..|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEE
Confidence 356889999999999999999976 699999999976542 334568899999999999999999999955 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
||||++|+|.+++... .+++..+..|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.
T Consensus 227 mEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~-----IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEecCccceE
Confidence 9999999999999653 3899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
+..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.......... .....+. ......
T Consensus 297 ~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-~~~~~~~--~~~~~~ 372 (423)
T 4fie_A 297 VSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPR--LKNLHK 372 (423)
T ss_dssp CCSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCC--CSCTTS
T ss_pred CCCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-HcCCCCC--Cccccc
Confidence 754322 223456899999999999999999999999999999999999999765432221111 1111111 122234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+..+.+++.+||+.||++|||+.|+++|-+....
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 56678999999999999999999999998765443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=403.37 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=195.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||+||+|... +|+.||||++..... ......+.+|++++++++|||||++++++. +.+..++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK--SKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEEEE
Confidence 57899999999999999999975 799999999976532 233467999999999999999999999984 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+ +|+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 91 vmEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSN 160 (275)
T ss_dssp EEECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred EEeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCChHHeEECCCCCEEEeecCCCe
Confidence 99999 689999997653 4999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
....... .....||+.|||||++.+..+ +.++||||+||++|||+||+.||.+...... +..+..... ..+
T Consensus 161 ~~~~~~~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~----~~~i~~~~~--~~p 232 (275)
T 3hyh_A 161 IMTDGNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----FKNISNGVY--TLP 232 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCC--CCC
T ss_pred ecCCCCc--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCC--CCC
Confidence 7654322 223568999999999998876 5799999999999999999999976433211 112222111 233
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+..+.+++.+|++.||++|||++|++++-|.-
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 44566789999999999999999999999998763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=413.98 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=207.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ......+.+|++++++++|||||++++++. +.+..|+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence 46899999999999999999975 799999999975421 233467899999999999999999999984 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 110 vmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 999999999999998654 3999999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCc-eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
.+.... ........||+.|||||++.+..|+.++||||+||++|||+||+.||.+...... +..+..... .++
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~--~~p 254 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI----FAKIIKLEY--DFP 254 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCC--CCC
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCC--CCC
Confidence 775432 1223345699999999999999999999999999999999999999976543222 222222221 233
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 574 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~ 574 (589)
...+.++.+++.+|++.||++|||++|++.
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 445667899999999999999999998643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=403.89 Aligned_cols=257 Identities=19% Similarity=0.315 Sum_probs=195.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC-------
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR------- 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------- 380 (589)
++|+..+.||+|+||+||+|+.+ +|+.||||+++........+.+.+|++++++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888999999999999999975 7999999999876655556789999999999999999999998865432
Q ss_pred ---CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 381 ---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 381 ---~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
...|+||||+++|+|.+++..... ....++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~-----IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc-----CccccCcHHHeEECCCCcEE
Confidence 246899999999999999986542 234677888999999999999999998 99999999999999999999
Q ss_pred EccccccccccCCcee-----------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH
Q 007788 458 IADCGLHKLLADDIVF-----------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 526 (589)
Q Consensus 458 l~DfGla~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~ 526 (589)
|+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||++ ||........
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 9999999877543211 1123458999999999999999999999999999999996 7754432211
Q ss_pred hhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 527 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+..+..... +...........+++.+||+.||++|||+.|++++-+.
T Consensus 236 ---~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 236 ---TLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp ---HHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ---HHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 1111111111 11112334456789999999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=410.18 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=200.9
Q ss_pred ccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||+||+|+.. .++.||||+++.... ......+.+|++++++++|||||++++++.+ .+..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 46889999999999999999863 478999999975432 2223468899999999999999999999854 4789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
|+||||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred EEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHeEEcCCCCEEeccccc
Confidence 99999999999999998764 3999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
|+....... ......||+.|||||++.+..|+.++||||+||++|||+||+.||.+...... +..+.... ...
T Consensus 173 a~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~--~~~ 245 (304)
T 3ubd_A 173 SKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET----MTMILKAK--LGM 245 (304)
T ss_dssp EEC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCC--CCC
T ss_pred ceeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH----HHHHHcCC--CCC
Confidence 986543221 22345689999999999999999999999999999999999999976543222 12222222 123
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
+...+.++.+++.+||+.||++||| ++|+++|-+.
T Consensus 246 p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 4445677899999999999999998 5788877554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=393.59 Aligned_cols=261 Identities=17% Similarity=0.293 Sum_probs=204.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC----CCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----~~~~ 382 (589)
++|+..+.||+|+||+||+|... +|+.||||+++.... ......+.+|+++|++++|||||++++++... +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999975 799999999976543 33446788999999999999999999987432 3367
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSAQ-----VIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc-----CcCCCcCccccccCCCCCEEEeecc
Confidence 899999995 78999997543 4999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCce---eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc-
Q 007788 463 LHKLLADDIV---FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR- 537 (589)
Q Consensus 463 la~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~- 537 (589)
+|+.+..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+................+
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987643321 122345689999999998875 46999999999999999999999997643322111111100000
Q ss_pred -----------------ccC--CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 538 -----------------NLK--GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 538 -----------------~~~--~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+. ...+ +.....+.+++.+|++.||++|||++|+++|-+..
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 000 0001 11245688999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=385.77 Aligned_cols=281 Identities=33% Similarity=0.667 Sum_probs=234.0
Q ss_pred ccCHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeec
Q 007788 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 377 (589)
Q Consensus 298 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 377 (589)
.+++.++..+.++|...+.||+|+||.||+|..++|+.||||++...........|.+|++++++++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 57889999999999999999999999999999888999999999865543334478999999999999999999999943
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
.+..++||||+++|+|.+++.........++|..+..|+.|++.||+|||+.. .++|+||||||+|||++.++.+|
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 99 --PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS--SSCEECCCCSGGGEEECTTCCEE
T ss_pred --CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCchhhEEECCCCCEE
Confidence 46789999999999999999877655567999999999999999999999981 12399999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH-----------
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------- 526 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~----------- 526 (589)
|+|||+++..............+|+.|+|||.+.+..++.++||||||+++|||+||+.||........
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999987754443344445689999999999988999999999999999999999999964321111
Q ss_pred --hhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 527 --ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 527 --~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.........+..............+.+++..||+.||++|||++|++++|+.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 01122334444555566788899999999999999999999999999999875443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=380.63 Aligned_cols=280 Identities=33% Similarity=0.588 Sum_probs=230.6
Q ss_pred ccCHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeec
Q 007788 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 377 (589)
Q Consensus 298 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 377 (589)
.+++.++..++++|+..+.||+|+||.||+|.+++++.||||++.... ......|.+|++++++++||||+++++++.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 105 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCD- 105 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECC-
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-
Confidence 445556677889999999999999999999999889999999987654 345678999999999999999999999984
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
..+..++||||+++|+|.+++.........++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 106 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 106 -ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-----IIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp -CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCSTTEEECTTCCEE
T ss_pred -CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC-----eecCCCCHHHEEECCCCCEE
Confidence 457789999999999999999766544456999999999999999999999988 99999999999999999999
Q ss_pred EccccccccccCCc-eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH-----------
Q 007788 458 IADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA----------- 525 (589)
Q Consensus 458 l~DfGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~----------- 525 (589)
|+|||+++...... ........++..|+|||.+.+..++.++||||||+++|||+||+.||.......
T Consensus 180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 99999997654321 111223346888999999998999999999999999999999999986432110
Q ss_pred HhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccccc
Q 007788 526 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT 585 (589)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~ 585 (589)
.....+...+++.............+.+++.+||+.||++|||+.|++++|+.+......
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 011122333444455566788899999999999999999999999999999988765543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=382.19 Aligned_cols=258 Identities=19% Similarity=0.259 Sum_probs=198.6
Q ss_pred HHHhhccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
+....++|++.+.||+|+||+||+|+.+ .++.||||++.... ....+.+|++++.++ +|||||++++++.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~- 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRK- 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-
Confidence 3445688999999999999999999853 47899999987543 234678999999998 69999999998854
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceE
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL 457 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~k 457 (589)
.+..++||||+++|+|.+++. .+++.....++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 92 -~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g-----IiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 92 -NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG-----IVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp -TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEE
T ss_pred -CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCcCCHHHeEEeCCCCeEE
Confidence 578999999999999999984 2889999999999999999999998 9999999999999877 7999
Q ss_pred EccccccccccCCce---------------------------eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHH
Q 007788 458 IADCGLHKLLADDIV---------------------------FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIIL 509 (589)
Q Consensus 458 l~DfGla~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~ 509 (589)
|+|||+|+...+... .......||+.|+|||++.+. .|+.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 999999976543210 011234589999999999875 4899999999999999
Q ss_pred HHHhCCCCcchhHHHHHh-hh------------------------------hHHHhhc---------ccc---------C
Q 007788 510 QILTGSLVLTSSMRLAAE-SA------------------------------TFENFID---------RNL---------K 540 (589)
Q Consensus 510 elltg~~p~~~~~~~~~~-~~------------------------------~~~~~~~---------~~~---------~ 540 (589)
||+||+.||......... .. ....... +.. .
T Consensus 239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 318 (361)
T 4f9c_A 239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN 318 (361)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence 999999999543211000 00 0000000 000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.......+.++.+++.+|++.||++|||++|+++|-+.
T Consensus 319 ~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp ---CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 00011224567899999999999999999999988664
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=396.98 Aligned_cols=254 Identities=19% Similarity=0.233 Sum_probs=204.4
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHH---HHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEF---VKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~---~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
.++|+..+.||+|+||.||+|+.+ +|+.||||++..... ......+ ..++.+++.++|||||++++++. +.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~--~~~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPD 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSS
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE--ECC
Confidence 367999999999999999999976 699999999964321 1112223 34467778889999999999884 457
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..|+||||++||+|.++|.... .+++.....++.||+.||+|||+.+ ||||||||+||||+.+|.+||+||
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g-----IiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHeEEeCCCCEEeccc
Confidence 8999999999999999998764 3999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
|+|+.+..... ....||+.|||||++.. ..|+.++||||+||+||||++|+.||.+...... ...........
T Consensus 337 GlA~~~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~~~~-- 410 (689)
T 3v5w_A 337 GLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMA-- 410 (689)
T ss_dssp TTCEECSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHHHCC--
T ss_pred ceeeecCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCCC--
Confidence 99987765432 34569999999999975 5799999999999999999999999976432111 01111222211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
...+...+..+.+++..|++.||++|++ ++|+++|-+.
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 2234455677899999999999999998 7899887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=400.11 Aligned_cols=253 Identities=19% Similarity=0.270 Sum_probs=210.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|+++|++++|||||++++++. +.+..++||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEEE
Confidence 57899999999999999999976 79999999997654 344567889999999999999999999984 457899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC--CceEEccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ--FNPLIADCGLHK 465 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfGla~ 465 (589)
|||++|+|.+++....+ .+++.....++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 234 E~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~-----iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 234 EFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp ECCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred eecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhccccCCCCCCEEEeecccee
Confidence 99999999999965432 4899999999999999999999998 9999999999999854 899999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc--CCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KGKF 543 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 543 (589)
.+...... ....||+.|||||++.+..|+.++||||+||++|||++|+.||.+...... +..+..... ....
T Consensus 306 ~~~~~~~~--~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~ 379 (573)
T 3uto_A 306 HLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----LRNVKSCDWNMDDSA 379 (573)
T ss_dssp ECCTTSEE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCSGG
T ss_pred EccCCCce--eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHHhCCCCCCccc
Confidence 87655432 234689999999999999999999999999999999999999976543221 111211111 1111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
....+..+.+++.+||+.||++|||+.|+++|-+.
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 12345678899999999999999999999998664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=372.63 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=214.6
Q ss_pred hccCccccccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
.++|...+.||+|+||.||+|... ++..||||+++..........+.+|+++++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 467888899999999999999862 45689999998765555667899999999999 8999999999984
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
..+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~ 232 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAAR 232 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGG
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchh
Confidence 35678999999999999999986542 1235899999999999999999999988 999999999
Q ss_pred CeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986643221 11223345678999999999999999999999999999999 99998653221
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.....+........+..++..+.+++..||+.||++||++.|++++|+.+..
T Consensus 313 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 -----ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -----GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222223334455567789999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=377.86 Aligned_cols=260 Identities=24% Similarity=0.430 Sum_probs=214.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..++|...+.||+|+||.||+|.+. +++.||||+++.........+|.+|++++++++||||++++++|.. .+..++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEE
Confidence 3457788899999999999999986 7899999999865544455679999999999999999999999943 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 190 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKC-----CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999986542 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeee-cCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 466 LLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 466 ~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
........... ...+++.|+|||.+.++.++.++|||||||++|||+| |+.||...... ...+.+........
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----QTREFVEKGGRLPC 336 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----HHHHHHHTTCCCCC
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCC
Confidence 75543322111 1224567999999998899999999999999999999 89998754322 11222333333344
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+..++..+.+++..||+.||++|||++++++.|+.+..
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 45566789999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=366.23 Aligned_cols=261 Identities=22% Similarity=0.417 Sum_probs=213.2
Q ss_pred hccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|...+.||+|+||.||+|.+. .+..||||+++..........|.+|++++++++||||+++++++.. .+..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCcc
Confidence 357888899999999999999974 4557999999876555666789999999999999999999999844 4678
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... .+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEECCCCCEEECCCCc
Confidence 999999999999999975532 4999999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+.....
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----~~~~~~~~~ 272 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----ISSVEEGYR 272 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----HHHHHTTCC
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-----HHHHHcCCC
Confidence 987654321 12223345678999999998899999999999999999999 9999965432211 111222223
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
...+...+..+.+++..||+.||++|||+.|+++.|+.+....
T Consensus 273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 3344556678999999999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=364.56 Aligned_cols=269 Identities=22% Similarity=0.388 Sum_probs=207.8
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
.++....++|+..+.||+|+||.||+|+. +|+.||||++..... .....+|.+|++++++++||||+++++++. ..
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--ST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--EC
Confidence 33444567888999999999999999987 588999999976543 334467999999999999999999999984 44
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN---PPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS---SCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC---CCEECCCCChhhEEEeCCCcEEECC
Confidence 678999999999999999975421 123899999999999999999999875 5699999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
||+++....... ......+|+.|+|||.+.+..++.++||||||+++|||+||+.||........ ..........
T Consensus 183 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~----~~~~~~~~~~ 257 (309)
T 3p86_A 183 FGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV----VAAVGFKCKR 257 (309)
T ss_dssp CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHHSCCC
T ss_pred CCCCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCC
Confidence 999986543321 22344578899999999999999999999999999999999999975432211 1111111222
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+...+..+.+++..||+.||++|||++++++.|+.+...
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 234455667899999999999999999999999999877654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=373.77 Aligned_cols=260 Identities=23% Similarity=0.432 Sum_probs=203.6
Q ss_pred hccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|+..+.||+|+||.||+|+.. ++..||||+++.........+|.+|+.++++++||||+++++++.. .+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCce
Confidence 357888999999999999999875 5778999999876545566789999999999999999999999943 4678
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999997653 24899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~~~~~i~~~~~ 268 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----DVIKAVDEGYR 268 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----HHHHHHHTTEE
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCC
Confidence 987654321 11222334678999999999999999999999999999998 99999654321 11222223333
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+...+..+.+++..||+.||++||++.++++.|+.+...
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 333445667899999999999999999999999999987544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=355.78 Aligned_cols=257 Identities=23% Similarity=0.461 Sum_probs=213.5
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||+|...+++.||||++..... ..+++.+|++++++++||||+++++++.+ .+..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEEEEE
Confidence 56888899999999999999998899999999986542 34579999999999999999999999843 467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999999976543 4899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ... +........+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~ 232 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VED-ISTGFRLYKPRLA 232 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHH-HHTTCCCCCCTTS
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH----HHH-HhcCccCCCCCcC
Confidence 443333334456678999999998999999999999999999999 8999865432211 111 1112222333445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
+..+.+++..||+.||++||++.|++++|+.+.+.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 67799999999999999999999999999988653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=353.29 Aligned_cols=258 Identities=21% Similarity=0.405 Sum_probs=215.6
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|+..+.||+|+||.||+|..+++..||||++..... ...++.+|++++.+++||||+++++++. ..+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceEEEE
Confidence 467888899999999999999999888999999976542 3457999999999999999999999984 457789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 83 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp ECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999999987542 3899999999999999999999988 999999999999999999999999999877
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
............++..|+|||.+.+..++.++||||||+++|||+| |+.||......... .. +........+..
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~-~~~~~~~~~~~~ 229 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV----LK-VSQGHRLYRPHL 229 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----HH-HHTTCCCCCCTT
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH----HH-HHcCCCCCCCCc
Confidence 6655444555566778999999998899999999999999999999 99998654322111 11 111112222333
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+..+.+++..||+.||++|||+.|++++|+.+.+.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 456799999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=361.31 Aligned_cols=266 Identities=24% Similarity=0.412 Sum_probs=212.4
Q ss_pred ccCccccccccCCCccEEEEEe-----cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|++ .+++.||||++.... ....+.|.+|++++++++||||+++++++...+....
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5788889999999999999984 268999999997654 4455789999999999999999999999865545568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 999999999999999976542 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-----------hhh
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----------SAT 530 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-----------~~~ 530 (589)
++....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+......... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987654321 1122334566799999999999999999999999999999999988654321100 001
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
....+........+...+..+.+++..||+.||++|||++|+++.|+.+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 22222233333445566778999999999999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=362.00 Aligned_cols=260 Identities=23% Similarity=0.429 Sum_probs=211.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.|.+|++++++++||||+++++++.+ .+..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEE
Confidence 56788899999999999999975 68999999986543 4556789999999999999999999999965 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++..... .++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSMN-----IIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp ECCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 99999999999986432 4999999999999999999999988 999999999999999999999999999876
Q ss_pred cCCceee-------------eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-hhhHHH
Q 007788 468 ADDIVFS-------------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-SATFEN 533 (589)
Q Consensus 468 ~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~ 533 (589)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++|..|+......... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 5432211 11345788999999999999999999999999999999999988653221110 111122
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+... +...+..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 239 ~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 239 FLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 222221 2233456889999999999999999999999999887654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=373.33 Aligned_cols=277 Identities=22% Similarity=0.382 Sum_probs=223.7
Q ss_pred cccCHHHHHHhhccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCcc
Q 007788 297 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 369 (589)
Q Consensus 297 ~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv 369 (589)
..+...+++...++|...+.||+|+||.||+|.+ .+++.||||++.........+.|.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3456677888889999999999999999999984 246899999998765555667899999999999 799999
Q ss_pred ceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCC--------------------------------------------
Q 007788 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------------------------------------------- 405 (589)
Q Consensus 370 ~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~-------------------------------------------- 405 (589)
+++++|... ....++||||+++|+|.+++......
T Consensus 90 ~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 90 NLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CEEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999998543 34589999999999999999865321
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 406 ------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 406 ------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 122889999999999999999999988 999999999999999999999999999866
Q ss_pred cCCc-eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 468 ADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 468 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
.... ........+|..|+|||++.+..++.++||||||+++|||+| |+.||....... .....+........+.
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 319 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTRMRAPD 319 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHHHHHHTCCCCCCT
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----HHHHHHHcCCCCCCCC
Confidence 4332 222334456788999999999999999999999999999999 999996543211 1112222222233344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.....+.+++..||+.||++|||+.|++++|+.+.+..
T Consensus 320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 45667999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=363.81 Aligned_cols=262 Identities=22% Similarity=0.365 Sum_probs=206.9
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC--CCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG--RGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~~~l 385 (589)
.++|+..+.||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.... ....++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 467888999999999999999986 7999999997542 33445677999999999999999999986543 235799
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC----------CCCCCCeEecCCCCCCeeecCCCc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS----------EVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
||||+++|+|.+++... .++|..++.++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-----ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-----ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-----EECSCCSGGGEEECTTCC
T ss_pred EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-----EEeCCCChHhEEECCCCe
Confidence 99999999999999754 389999999999999999999987 6 999999999999999999
Q ss_pred eEEccccccccccCCcee-eeecCCccccccCcccccCC-----CCCCcchhhhHHHHHHHHHhCCCCcchhHHHH----
Q 007788 456 PLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTG-----RFTERSDIFAFGVIILQILTGSLVLTSSMRLA---- 525 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~---- 525 (589)
+||+|||+++........ ......+|+.|+|||++.+. .++.++|||||||++|||+||+.||.+.....
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999999876543221 12234578899999999863 45678899999999999999999986432100
Q ss_pred -H------hhhhHHH-hhccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 526 -A------ESATFEN-FIDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 526 -~------~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
. ....... .......... .......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0001111 1111112111 234567799999999999999999999999999988753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=357.74 Aligned_cols=255 Identities=16% Similarity=0.309 Sum_probs=210.2
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.. .+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEEE
Confidence 46788999999999999999996 478999999997654 2335678999999999999999999999854 4689999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 9999999999999764 3899999999999999999999988 99999999999999999999999999887
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... ......+|+.|+|||.+.+..++.++|||||||++|||+||+.||............. .........+..
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~ 241 (297)
T 3fxz_A 166 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEK 241 (297)
T ss_dssp CCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSCGGG
T ss_pred cCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCCCccc
Confidence 654332 2233468889999999999999999999999999999999999997543321111111 111111223345
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+..+.+++.+||+.||++|||++|++++-+..
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 567789999999999999999999999886654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=356.61 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=215.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|... +++.||||++.........+.+.+|++++++++||||+++++++........++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888899999999999999986 58999999998655444567788999999999999999999998766566889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee----cCCCceEEccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGL 463 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfGl 463 (589)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999986543 234899999999999999999999988 9999999999999 8888899999999
Q ss_pred cccccCCceeeeecCCccccccCccccc--------CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVT--------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 535 (589)
++....... .....+|..|+|||++. +..++.++|||||||++|||+||+.||............+..++
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 987654432 22345788999999886 56789999999999999999999999964321111111111111
Q ss_pred ccc-----------------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 536 DRN-----------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 536 ~~~-----------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
... ............+.+++..|++.||++|||++|++++..+.+-.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 110 11134577888999999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=359.69 Aligned_cols=268 Identities=16% Similarity=0.301 Sum_probs=217.4
Q ss_pred ccCHHHHHHhhcc----------CccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCC
Q 007788 298 RLNLEEVESATQC----------FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 366 (589)
Q Consensus 298 ~~~~~~l~~~~~~----------f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ 366 (589)
.++.+++..+++. |+..+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCC
Confidence 5677888877764 677789999999999999986 79999999997654 34456789999999999999
Q ss_pred CccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 367 niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
||+++++++.. .+..++||||+++|+|.+++... .++|..+..++.|++.||+|||+.+ |+||||||+
T Consensus 103 niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~ 170 (321)
T 2c30_A 103 NVVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG-----VIHRDIKSD 170 (321)
T ss_dssp TBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGG
T ss_pred CcceEEEEEEE--CCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHH
Confidence 99999999865 46899999999999999998643 3899999999999999999999988 999999999
Q ss_pred CeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 526 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~ 526 (589)
||+++.++.+||+|||++........ ......+|+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999887654322 12344688899999999999999999999999999999999999975433211
Q ss_pred hhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 527 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
. ..+.....+.. ......+..+.+++.+||+.||++|||+.|++++.+.....
T Consensus 250 ~-~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 250 M-KRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp H-HHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred H-HHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 1 11111111111 11223456789999999999999999999999987765443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=383.80 Aligned_cols=261 Identities=23% Similarity=0.431 Sum_probs=216.0
Q ss_pred HHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++...++|...+.||+|+||.||+|.++++..||||+++... ...+.|.+|++++++++|||||++++++. .+..
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~ 257 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPI 257 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSC
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCcc
Confidence 344556788889999999999999999889999999998653 34568999999999999999999999984 3568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999985432 13889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
++..............+++.|+|||.+....++.++|||||||++|||+| |+.||........ ...+.......
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~-----~~~i~~~~~~~ 405 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----IRALERGYRMP 405 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----HHHHHHTCCCC
T ss_pred ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCCCCC
Confidence 98765433222233445678999999998999999999999999999999 9999975432211 11222223333
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+..++..+.+++..||+.||++|||++++++.|+.+..
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 455567789999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=354.05 Aligned_cols=257 Identities=24% Similarity=0.426 Sum_probs=210.7
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|+..+.||+|+||.||+|...++..||||++..... ..+++.+|++++.+++||||+++++++. +.+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEe--cCCCeEEEE
Confidence 457888899999999999999999899999999986542 3467999999999999999999999984 457789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999976432 3899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
............+++.|+|||.+.+..++.++||||||+++|||+| |+.||........ ...+........+..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 245 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYRPHL 245 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHHTTCCCCCCTT
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-----HHHHhcccCCCCCCc
Confidence 5443323334456678999999998899999999999999999998 9999975433211 111112222233344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+..+.+++..||+.||++|||++|++++|+.+..
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 45679999999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.60 Aligned_cols=274 Identities=28% Similarity=0.530 Sum_probs=224.4
Q ss_pred cccCHHHHHHhhccCccc------cccccCCCccEEEEEecCCcEEEEEEeccCC---CchHHHHHHHHHHHHhccCCCC
Q 007788 297 FRLNLEEVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSLRHEN 367 (589)
Q Consensus 297 ~~~~~~~l~~~~~~f~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l~H~n 367 (589)
..|+++++..++++|... +.||+|+||.||+|.. +++.||||++.... .....+.|.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 368889999999999887 8899999999999997 58899999987542 2344578999999999999999
Q ss_pred ccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCC
Q 007788 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 447 (589)
Q Consensus 368 iv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~N 447 (589)
|+++++++.. .+..++||||+++|+|.+++..... ...++|..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 92 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~N 163 (307)
T 2nru_A 92 LVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH-----HIHRDIKSAN 163 (307)
T ss_dssp BCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGG
T ss_pred eEEEEEEEec--CCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHH
Confidence 9999999844 4678999999999999999975432 245999999999999999999999988 9999999999
Q ss_pred eeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH-
Q 007788 448 VLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA- 525 (589)
Q Consensus 448 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~- 525 (589)
|++++++.+||+|||+++....... .......++..|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999999999999999886654221 12223457889999998765 58999999999999999999999997532110
Q ss_pred ---------HhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 526 ---------AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 526 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.....+.+.++... ...+......+.+++..||+.||++|||+++++++|+.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 01112333444333 24567788899999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=363.31 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=205.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|.+. +++ .||+|.+..........+|.+|+.++++++||||++++++|.. +..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 91 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---SSE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---CCe
Confidence 56888899999999999999964 344 4688888765544556789999999999999999999999964 347
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++|+||+++|+|.+++..... .+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred EEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCChheEEECCCCCEEEccCcc
Confidence 899999999999999987543 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... .......+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+......
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~~~~~ 238 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERL 238 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTTCCC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----HHHHHHHcCCCC
Confidence 987654322 22233456778999999999999999999999999999999 99999654321 222333333333
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..+......+.+++.+||+.||++||+++|++++|+.+...
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 44555677899999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.47 Aligned_cols=264 Identities=19% Similarity=0.366 Sum_probs=213.3
Q ss_pred hccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
.++|...+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.. .+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--CC
Confidence 357888899999999999999953 4678999999766555666789999999999999999999999843 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC---c
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---N 455 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~---~ 455 (589)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEEecCCCCce
Confidence 77999999999999999987642 2245999999999999999999999998 99999999999999554 5
Q ss_pred eEEccccccccccCCc-eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHH
Q 007788 456 PLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 533 (589)
+||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....... ...
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----~~~ 297 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLE 297 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH
Confidence 9999999997543211 111223346788999999999999999999999999999998 999997543221 112
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.+........+...+..+.+++..||+.||++||++.+++++|+.+.+..
T Consensus 298 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 22222222334455677999999999999999999999999999887653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.95 Aligned_cols=270 Identities=21% Similarity=0.353 Sum_probs=217.8
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
.++....++|...+.||+|+||.||+|... +++.||||+++..........|.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556788999999999999999999975 34899999998765555567899999999999999999999998
Q ss_pred ecCCCCeEEEEEEeCCCCChHHHhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCC
Q 007788 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGS--------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435 (589)
Q Consensus 376 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 435 (589)
.. .+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+
T Consensus 120 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--- 194 (343)
T 1luf_A 120 AV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 194 (343)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 44 56789999999999999999864311 145999999999999999999999988
Q ss_pred CCeEecCCCCCCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-
Q 007788 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT- 513 (589)
Q Consensus 436 ~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt- 513 (589)
|+||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+|
T Consensus 195 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 195 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 99999999999999999999999999976543321 12233456788999999998899999999999999999999
Q ss_pred CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 514 GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 514 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
|+.||........ ...+.+. .....+...+..+.+++..||+.||++||++.+++++|+.+.+..
T Consensus 273 g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 273 GLQPYYGMAHEEV----IYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TCCTTTTSCHHHH----HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCcCCCCChHHH----HHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9999975432211 1111111 112234455678999999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=381.21 Aligned_cols=259 Identities=22% Similarity=0.420 Sum_probs=217.2
Q ss_pred hhccCccccccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..++|...+.||+|+||.||+|.++. +..||||+++... ....+|.+|+.++++++|||||+++++|.. .+..++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEE
Confidence 34668888999999999999999874 8899999997653 245689999999999999999999999944 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++..... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 294 v~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN-----FIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999986432 34899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
..............+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... ...+.+........+
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~ 441 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYRMERP 441 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHTTCCCCCC
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCC
Confidence 876544333334455678999999998899999999999999999999 88888654321 122333334444455
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..++..+.+++..||+.||++|||+.++++.|+.+.+
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 5667789999999999999999999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.21 Aligned_cols=259 Identities=21% Similarity=0.383 Sum_probs=201.7
Q ss_pred hccCccccccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|+..+.||+|+||.||+|.... +..||+|++...........|.+|+.++++++||||+++++++. .+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cCcc
Confidence 4678888999999999999998742 56799999887655555678999999999999999999999973 2567
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHEEECCCCCEEECcccc
Confidence 89999999999999997653 24899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
++..............+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ....+ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~~i-~~~~~~~ 237 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI-ENGERLP 237 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHH-HTTCCCC
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHHHH-HcCCCCC
Confidence 98776543333334456678999999998899999999999999999997 888986543211 11111 1112223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+...+..+.+++..||+.||++|||+.|++++|+.+.+.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 3445567899999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=353.73 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=200.9
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhc--cCCCCccceeeeeecC--CCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS--LRHENIIRLRGFCCSR--GRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~--~~~~~ 383 (589)
.++|...+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... .....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788899999999999999998 6899999998643 34456667666665 7999999999987543 23468
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhc--------CCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH--------SSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
++||||+++|+|.++++.. .+++..+++++.|++.||+||| +.+ |+||||||+|||++.++.
T Consensus 82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-----IAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-----EECSCCCGGGEEECTTSC
T ss_pred EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-----eecCCCChHhEEEcCCCC
Confidence 9999999999999999543 4899999999999999999999 665 999999999999999999
Q ss_pred eEEccccccccccCCceee---eecCCccccccCcccccCC------CCCCcchhhhHHHHHHHHHhC----------CC
Q 007788 456 PLIADCGLHKLLADDIVFS---VLKTSAAMGYLAPEYVTTG------RFTERSDIFAFGVIILQILTG----------SL 516 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~s~Gvvl~elltg----------~~ 516 (589)
+||+|||+++......... .....+|+.|+|||.+.+. .++.++|||||||++|||+|| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999997665433221 1223688899999999876 455799999999999999999 77
Q ss_pred CcchhHHHHHhhhhHHHhh-ccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 517 VLTSSMRLAAESATFENFI-DRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 517 p~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
||................. ........ .......+.+++..||+.||++|||+.|+++.|+.+
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 7754321111111111111 11111111 235678899999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=365.80 Aligned_cols=264 Identities=24% Similarity=0.392 Sum_probs=216.4
Q ss_pred hhccCccccccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeec
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS 377 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 377 (589)
..++|...+.||+|+||.||+|... .+..||||++...........+.+|+++++++ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence 3467888999999999999999862 34689999998776556667899999999999 8999999999994
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCC
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV 445 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~ 445 (589)
..+..++||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+.+ |+||||||
T Consensus 146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp 219 (382)
T 3tt0_A 146 -QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAA 219 (382)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCG
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCc
Confidence 356789999999999999999875421 235999999999999999999999988 99999999
Q ss_pred CCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHH
Q 007788 446 EKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMR 523 (589)
Q Consensus 446 ~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~ 523 (589)
+|||+++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654221 12233446778999999999999999999999999999999 9999865432
Q ss_pred HHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
. .....+........+......+.+++..||+.||++|||++|++++|+.+...
T Consensus 300 ~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 300 E-----ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp H-----HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-----HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 11222222223333445567899999999999999999999999999987644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=352.86 Aligned_cols=261 Identities=21% Similarity=0.347 Sum_probs=205.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|... +++.||+|++..... ......|.+|+.++.+++||||+++++++. ..+..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDCYYL 88 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCeEEE
Confidence 57888899999999999999975 689999999865432 333467999999999999999999999984 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 89 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred EEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 999999999999998654 4899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..............+|+.|+|||.+.+..++.++||||||+++|||+||+.||.................. ........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP-NVTTDVRK 238 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-CHHHHSCT
T ss_pred ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-Ccchhccc
Confidence 77554333333455888999999999999999999999999999999999999765432211111110000 00001122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhc
Q 007788 546 SEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAAP 581 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~~~ 581 (589)
..+..+.+++.+|++.||++|| +++++.+.|+.+..
T Consensus 239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 3456799999999999999998 99999999987643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=358.02 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=209.4
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ......+.+|++++++++||||+++++++. ..+..++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE--TEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEE
Confidence 45788899999999999999997 4799999999976542 344567889999999999999999999984 3578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 92 v~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR-----IVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp EECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 999999999999997664 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCC-CcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
...... ......+|+.|+|||.+.+..+. .++|||||||++|||++|+.||.+....... ..+..... ..+
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~--~~p 234 (328)
T 3fe3_A 163 EFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR----ERVLRGKY--RIP 234 (328)
T ss_dssp GGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCC--CCC
T ss_pred ecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCC--CCC
Confidence 665432 12345688899999999988875 7999999999999999999999765332111 11222111 223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+..+.+++.+|++.||.+|||++|++++-+..
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 34456788999999999999999999999986653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=355.23 Aligned_cols=264 Identities=22% Similarity=0.394 Sum_probs=215.7
Q ss_pred hhccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
..++|...+.||+|+||.||+|.. .+++.||||++.........+.+.+|++++++++||||+++++++.. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--D 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--C
Confidence 356788889999999999999986 24589999999876555566789999999999999999999999843 5
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcC--------------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEe
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 440 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH 440 (589)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH 173 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVH 173 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-----EEC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-----Ccc
Confidence 678999999999999999986542 1234889999999999999999999988 999
Q ss_pred cCCCCCCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCc
Q 007788 441 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVL 518 (589)
Q Consensus 441 ~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~ 518 (589)
|||||+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654322 12233446678999999998889999999999999999999 99998
Q ss_pred chhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...... .....+........+...+..+.+++..||+.||++||++.|++++|+.+...
T Consensus 254 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPPE-----RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCGG-----GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHH-----HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 654321 11222222223334445567899999999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.89 Aligned_cols=263 Identities=23% Similarity=0.400 Sum_probs=217.5
Q ss_pred CccccccccCCCccEEEEEec-----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
|+..+.||+|+||.||++.+. +++.||||++...........|.+|++++++++||||+++++++.+......++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377899999999999998753 688999999987655556678999999999999999999999997766678899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... +++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEEcCCCCEEECCccccc
Confidence 999999999999997542 899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCcee--eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH----------HhhhhHHH
Q 007788 466 LLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA----------AESATFEN 533 (589)
Q Consensus 466 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~----------~~~~~~~~ 533 (589)
........ ......++..|+|||.+.+..++.++||||||+++|||+||+.||....... .......+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 77543321 2233456778999999998899999999999999999999999997543211 11112333
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.+........+...+..+.+++..||+.||++|||++|+++.|+.+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 34444444455566788999999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.61 Aligned_cols=260 Identities=24% Similarity=0.429 Sum_probs=209.2
Q ss_pred HhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
...++|...+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 3456788889999999999999999888899999998654 234679999999999999999999999843 56899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++....+ ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 256 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp EECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred EehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEECCCCCEEECCCccce
Confidence 9999999999999976432 24899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
..............+++.|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+....+...+
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~~~~~~~~~ 403 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYRMPCP 403 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCC
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCCCCCC
Confidence 765443323334456778999999999999999999999999999999 899986543211 11112222333445
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..++..+.+++..||+.||++|||++++++.|+.+...
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 56677899999999999999999999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=351.94 Aligned_cols=264 Identities=26% Similarity=0.426 Sum_probs=211.2
Q ss_pred ccCccccccccCCCccEEEEEe-----cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|++ .+++.||||++...........+.+|++++.+++||||+++++++.....+..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577789999999999999984 36899999999866545556789999999999999999999999976655778
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcCC-----cccCCCchheEEEcCCCCEEECcccc
Confidence 999999999999999976543 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH----------hhhhH
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATF 531 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~----------~~~~~ 531 (589)
+........ .......++..|+|||.+.+..++.++||||||+++|||+||+.|+........ .....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987654432 122234567779999999998999999999999999999999998754322110 11112
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+........+...+..+.+++..||+.||++|||+.|+++.|+.+-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222223333344556678999999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.87 Aligned_cols=257 Identities=20% Similarity=0.354 Sum_probs=211.5
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|+.+ ++.||||++..... ....+.|.+|+.++++++||||+++++++.....+..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999985 88999999986543 34456799999999999999999999999665557889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLE---PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSS---SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCC---CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999986432 35899999999999999999999865 56999999999999999999999998887654
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCC---cchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTE---RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
... ...+|+.|+|||.+.+..++. ++||||||+++|||+||+.||........ .............+
T Consensus 164 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 164 QSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----GMKVALEGLRPTIP 233 (271)
T ss_dssp SCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----HHHHHHSCCCCCCC
T ss_pred ccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----HHHHHhcCCCCCCC
Confidence 322 235678899999998765544 79999999999999999999975433221 12222223333444
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
...+..+.+++..||+.||++|||++|+++.|+.+..
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 5566789999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.41 Aligned_cols=255 Identities=18% Similarity=0.272 Sum_probs=201.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-------------------------hHHHHHHHHHHHHhc
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------------------------SEEAEFVKGLYLLTS 362 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------------------------~~~~~~~~e~~~l~~ 362 (589)
++|...+.||+|+||.||+|... +++.||||++...... .....+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888899999999999999975 6899999999754311 112468899999999
Q ss_pred cCCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecC
Q 007788 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 442 (589)
Q Consensus 363 l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~d 442 (589)
++||||+++++++.....+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~D 162 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK-----IIHRD 162 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccC
Confidence 999999999999976556789999999999999887543 24999999999999999999999988 99999
Q ss_pred CCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccCCC---CCCcchhhhHHHHHHHHHhCCCCcc
Q 007788 443 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLT 519 (589)
Q Consensus 443 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltg~~p~~ 519 (589)
|||+||+++.++.+||+|||+++....... ......+|+.|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999987654322 223456889999999998765 3778999999999999999999997
Q ss_pred hhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 520 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
........ ..+.............+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 242 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 242 DERIMCLH----SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp CSSHHHHH----HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred CccHHHHH----HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 54322111 11111111111122345678999999999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=361.39 Aligned_cols=270 Identities=24% Similarity=0.383 Sum_probs=212.4
Q ss_pred HHhhccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeec
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS 377 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 377 (589)
+...++|...+.||+|+||.||+|.. .++..||||++...........+.+|+.++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34557889999999999999999996 246789999998654444557899999999999 89999999999854
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCC-------------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCe
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGS-------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI 438 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~i 438 (589)
.+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ |
T Consensus 121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----i 193 (344)
T 1rjb_A 121 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----C 193 (344)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----E
T ss_pred --CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----c
Confidence 46789999999999999999765321 134899999999999999999999988 9
Q ss_pred EecCCCCCCeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCC
Q 007788 439 VHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSL 516 (589)
Q Consensus 439 vH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~ 516 (589)
+||||||+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |..
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999876543221 2223345778999999999999999999999999999998 999
Q ss_pred CcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccccc
Q 007788 517 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT 585 (589)
Q Consensus 517 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~~ 585 (589)
||...... ......+........+...+..+.+++..||+.||++|||+.|++++|+.+......
T Consensus 274 p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 274 PYPGIPVD----ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp SSTTCCCS----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred CcccCCcH----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 99654221 112222333333334445567899999999999999999999999999987665443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=370.04 Aligned_cols=255 Identities=23% Similarity=0.421 Sum_probs=211.1
Q ss_pred hhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
..++|...+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|++++++++||||+++++++... .+..++|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv 265 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 265 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEE
Confidence 4567888899999999999999986 7899999997653 346799999999999999999999998653 3468999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 999999999999987642 24789999999999999999999988 99999999999999999999999999985
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+....+...+.
T Consensus 339 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~~~~~p~ 409 (450)
T 1k9a_A 339 ASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYKMDAPD 409 (450)
T ss_dssp CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----THHHHHHTTCCCCCCT
T ss_pred ccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCCC
Confidence 43321 12345778999999999999999999999999999999 99999654221 1112222233334455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.++..+.+++..||+.||++|||+.++++.|+.+...
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 6678899999999999999999999999999987643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.80 Aligned_cols=257 Identities=18% Similarity=0.305 Sum_probs=205.4
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC------
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR------ 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------ 380 (589)
.++|+..+.||+|+||.||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357888999999999999999986 7999999999866555566789999999999999999999998865422
Q ss_pred -------------------------------------------------CeEEEEEEeCCCCChHHHhhhhcCCCCCCCH
Q 007788 381 -------------------------------------------------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 411 (589)
Q Consensus 381 -------------------------------------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~ 411 (589)
...++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 137999999999999999986543 234678
Q ss_pred HHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce-----------eeeecCCc
Q 007788 412 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-----------FSVLKTSA 480 (589)
Q Consensus 412 ~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~~ 480 (589)
..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .......+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred HHHHHHHHHHHHHHHHHHhCC-----eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 889999999999999999988 99999999999999999999999999987754321 11223457
Q ss_pred cccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcc
Q 007788 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH 560 (589)
Q Consensus 481 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~ 560 (589)
|+.|+|||.+.+..++.++||||||+++|||++|..|+........ ..... ............+.+++..||+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~------~~~~~-~~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIIT------DVRNL-KFPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHH------HHHTT-CCCHHHHHHCHHHHHHHHHHHC
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHH------Hhhcc-CCCcccccCChhHHHHHHHHcc
Confidence 8899999999999999999999999999999999877643322111 11111 1111123445677899999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 007788 561 EDPENRPTMEAVIEELT 577 (589)
Q Consensus 561 ~dp~~RPs~~evl~~L~ 577 (589)
.||++|||++|++++-+
T Consensus 312 ~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 312 PSPTERPEATDIIENAI 328 (332)
T ss_dssp SSGGGSCCHHHHHHSTT
T ss_pred CCCCcCCCHHHHhhchh
Confidence 99999999999998644
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.18 Aligned_cols=260 Identities=22% Similarity=0.386 Sum_probs=209.1
Q ss_pred hccCccccccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|...+.||+|+||.||+|...+ +..||||.+...........|.+|+.++++++||||+++++++.+ +..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCC
Confidence 4678888999999999999998643 346999999876555566789999999999999999999999743 456
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EEEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEECCCCcEEeCccCC
Confidence 899999999999999976542 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
+...............++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~~~~~~~~~~~ 234 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVLEKGDRLP 234 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HHHHHHHTCCCC
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HHHHHhcCCCCC
Confidence 98776544333344556778999999998899999999999999999998 999996432211 111111112222
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.+...+..+.+++..||+.||++||++.|++++|+.+.+..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 33445667999999999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.58 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=207.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|+.+ +|+.||+|+++... .......+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~l 82 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEEE
Confidence 57888999999999999999976 68999999997542 12344678899999999999999999999854 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCCHHHEEECCCCCEEEeeccchh
Confidence 999999999999998654 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..+.
T Consensus 154 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~--~~p~ 226 (337)
T 1o6l_A 154 EGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEI--RFPR 226 (337)
T ss_dssp CSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCC--CCCT
T ss_pred hcccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH----HHHHHcCCC--CCCC
Confidence 6432211 12234578899999999999999999999999999999999999976433211 112222221 2334
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
..+..+.+++..|++.||++|| +++|++++-+.
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 4566789999999999999999 99999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=345.82 Aligned_cols=256 Identities=22% Similarity=0.451 Sum_probs=211.7
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|...+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.. .+..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEEEEe
Confidence 56788899999999999999998899999999986542 34679999999999999999999999844 467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp CCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999999976532 4899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+ ........+...
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~i-~~~~~~~~~~~~ 230 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDI-STGFRLYKPRLA 230 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHH-HTTCCCCCCTTS
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----HHHH-hcCCcCCCCccC
Confidence 432222233445678999999998899999999999999999999 8999865432111 1111 111222233344
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+..+.+++..||+.||++||++++++++|+.+.+
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6678999999999999999999999999998865
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.47 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=217.3
Q ss_pred ccCccccccccCCCccEEEEEe-----cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++...+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5788889999999999999984 368899999997654 4455679999999999999999999999876666789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRR-----CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChhhEEECCCCCEEEccccc
Confidence 999999999999999986543 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCcee--eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh----------hhhH
Q 007788 464 HKLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE----------SATF 531 (589)
Q Consensus 464 a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~----------~~~~ 531 (589)
+......... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9876543321 222344677799999999888999999999999999999999999754332110 1122
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
...+........+...+..+.+++..||+.||++|||++|++++|+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 23333334444555667889999999999999999999999999987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.26 Aligned_cols=265 Identities=23% Similarity=0.395 Sum_probs=216.0
Q ss_pred hhccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG 379 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 379 (589)
..++|...+.||+|+||.||+|.. .+++.||||++.........+.+.+|++++.++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 446788899999999999999985 257899999998765455567899999999999 99999999999844
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCC
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGS--------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV 445 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~ 445 (589)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp 173 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAA 173 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCcc
Confidence 46789999999999999999865421 224899999999999999999999988 99999999
Q ss_pred CCeeecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHH
Q 007788 446 EKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMR 523 (589)
Q Consensus 446 ~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~ 523 (589)
+||+++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999999998775443222 223345678999999999999999999999999999999 9999865422
Q ss_pred HHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.. .....+........+...+..+.+++..||+.||++|||+.|++++|+.+...
T Consensus 254 ~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DS----KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SH----HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hh----HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 11222222233333445567899999999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=350.03 Aligned_cols=261 Identities=21% Similarity=0.403 Sum_probs=217.6
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
...++|+..+.||+|+||.||+|... ++..||||++... ....+.+.+|++++++++||||+++++++. ..+..+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 85 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFY 85 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCEE
Confidence 34567888999999999999999986 4889999999764 345568999999999999999999999984 457789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT-----CCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred EEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC-----ccCCCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999976432 35899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYRMER 233 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHTTCCCCC
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhccCCCCC
Confidence 8876554444444556778999999999999999999999999999999 88888654321 11222223333344
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
+...+..+.+++..|++.||++|||+.|+++.|+.+.+.
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 455567899999999999999999999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=356.82 Aligned_cols=258 Identities=19% Similarity=0.306 Sum_probs=205.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEE
Confidence 57888999999999999999976 7899999999765544445678899999999999999999999854 57889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccchHHEEEeCCCCEEEEEeecccee
Confidence 9999999999997543 4899999999999999999999988 999999999999999999999999999866
Q ss_pred cCCce-eeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 468 ADDIV-FSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 468 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..... .......+|+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ................
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKEKKTYLNPWK 232 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHHHTTCTTSTTGG
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhcccccCCccc
Confidence 43321 12234568889999999987775 7799999999999999999999975432111 1111111111111123
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.....+.+++.+|++.||++|||+.|++++.+...
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 44567889999999999999999999999877643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=343.39 Aligned_cols=255 Identities=26% Similarity=0.489 Sum_probs=205.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHH------HHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~------~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
++|+..+.||+|+||.||+|... +++.||||++......... +.|.+|++++++++||||+++++++.. .
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~- 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--P- 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--T-
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--C-
Confidence 56788899999999999999975 7899999998754432111 578999999999999999999999833 2
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc-----e
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-----P 456 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~-----~ 456 (589)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++. +
T Consensus 96 -~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 -PRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQN---PPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -TEEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSS---SCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -CeEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCC---CCeecCCCCcceEEEeccCCCCceeE
Confidence 279999999999999887543 24999999999999999999999875 46999999999999988776 9
Q ss_pred EEccccccccccCCceeeeecCCccccccCccccc--CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 457 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT--TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 457 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
||+|||+++..... .....++..|+|||.+. ...++.++||||||+++|||++|+.||........ ......
T Consensus 169 kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMI 242 (287)
T ss_dssp EECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHH
T ss_pred EeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHH
Confidence 99999999865442 23456788999999984 45578999999999999999999999965322111 111222
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.........+...+..+.+++..||+.||++|||++|+++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 223333444556677899999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=347.85 Aligned_cols=259 Identities=24% Similarity=0.433 Sum_probs=213.2
Q ss_pred HhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
...++|+..+.||+|+||.||+|...++..||||++.... ...+.|.+|++++++++||||+++++++.. +..++
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 3456788899999999999999999888899999997653 235679999999999999999999998842 45899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 9999999999999975431 13899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
..............++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~ 232 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMVRP 232 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHTTCCCCCC
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-----HHHHhcccCCCCc
Confidence 776544333334456678999999988889999999999999999999 8999865432211 1111122222334
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
...+..+.+++..|++.||++|||++++++.|+.+..
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 4556789999999999999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=349.28 Aligned_cols=270 Identities=17% Similarity=0.299 Sum_probs=213.9
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++.....+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999976 789999999976543 344567999999999999999999999887655678999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.........+++..++.++.|++.||+|||+.+....+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999876544456999999999999999999999865223459999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......++..|+|||.+.+..++.++||||||+++|||+||+.||......... ..+.. ......+.
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~ 238 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----GKIRE-GKFRRIPY 238 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHH-TCCCCCCT
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH----HHHhh-cccccCCc
Confidence 6643221 111234678899999999989999999999999999999999999764322111 11111 11122334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+..+.+++..||+.||++||++.|++++++..++..
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 45678999999999999999999999999998876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=352.67 Aligned_cols=263 Identities=24% Similarity=0.419 Sum_probs=213.4
Q ss_pred hccCccccccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
.++|...+.||+|+||.||+|... ++..||||++...........+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 467888999999999999999863 46789999998765555667899999999999 89999999999844
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
.+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 113 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~ 186 (334)
T 2pvf_A 113 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAAR 186 (334)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGG
T ss_pred -CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCccc
Confidence 46789999999999999999865421 234899999999999999999999988 999999999
Q ss_pred CeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 999999999999999999876543321 2233446778999999988889999999999999999999 99998654321
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
. ....+........+...+..+.+++..||+.||++||++.|++++|+.+...
T Consensus 267 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 267 E-----LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H-----HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-----HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1111112222233445567899999999999999999999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=351.00 Aligned_cols=259 Identities=23% Similarity=0.471 Sum_probs=205.1
Q ss_pred ccCccccccccCCCccEEEEEecC-----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|...+.||+|+||.||+|.... +..||||++...........|.+|++++++++||||+++++++. ..+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe--cCCCc
Confidence 467778899999999999998753 34699999987654555678999999999999999999999984 45789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999976532 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~~~~~~~ 268 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAINDGFR 268 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTTCC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHHCCCc
Confidence 987654321 11223345678999999999999999999999999999999 999996543211 1111222222
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+...+..+.+++..||+.||++||++.+++++|+.+...
T Consensus 269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 233445567899999999999999999999999999876544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=357.49 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=207.9
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch-----HHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-----EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
.++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++.+++||||+++++++.. .+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 357888999999999999999976 68999999997654321 34678999999999999999999999843 57
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC----ceE
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPL 457 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~----~~k 457 (589)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEeCCCCCccCEE
Confidence 8999999999999999997543 4899999999999999999999988 99999999999998877 799
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+...... +..+...
T Consensus 160 l~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~ 233 (361)
T 2yab_A 160 LIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----LANITAV 233 (361)
T ss_dssp ECCCSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTT
T ss_pred EEecCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhc
Confidence 999999987654321 2334588999999999999999999999999999999999999976433211 1111111
Q ss_pred ccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 538 NLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 538 ~~~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.. ..+. ..+..+.+++..|+..||++|||+.|++++-+..
T Consensus 234 ~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 234 SY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp CC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 11 1121 2356788999999999999999999999876643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.43 Aligned_cols=275 Identities=22% Similarity=0.383 Sum_probs=220.7
Q ss_pred ccCHHHHHHhhccCccccccccCCCccEEEEEe------cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccc
Q 007788 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 370 (589)
Q Consensus 298 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~ 370 (589)
.+...++....++|...+.||+|+||.||+|.. .+++.||||++...........+.+|++++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 455566777788999999999999999999984 356899999998766555567899999999999 7999999
Q ss_pred eeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCe
Q 007788 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI 438 (589)
Q Consensus 371 l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~i 438 (589)
+++++... ....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |
T Consensus 96 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i 169 (316)
T 2xir_A 96 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----C 169 (316)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-----C
T ss_pred EEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-----c
Confidence 99998543 34689999999999999999865421 123889999999999999999999988 9
Q ss_pred EecCCCCCCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCC
Q 007788 439 VHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSL 516 (589)
Q Consensus 439 vH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~ 516 (589)
+||||||+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987644322 22233446778999999999999999999999999999998 999
Q ss_pred CcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 517 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 517 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
||....... .....+........+......+.+++..||+.||++|||+.|++++|+.+.+.
T Consensus 250 p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 250 PYPGVKIDE----EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp SSTTCCCSH----HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccchhH----HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 986532111 11111111222223334556789999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.24 Aligned_cols=258 Identities=19% Similarity=0.259 Sum_probs=199.9
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+++.. +++.||||++..... ....+.+|+.++++++||||+++++++.. .+..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEEE
Confidence 357888899999999999999986 789999999976532 23468899999999999999999999954 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc--eEEcccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PLIADCGLH 464 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfGla 464 (589)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 95 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~-----ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 95 MEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 99999999999997654 3899999999999999999999988 999999999999987766 999999998
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCc-chhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTER-SDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
+...... ......+|+.|+|||++.+..++.+ +|||||||++|||++|+.||...............+.........
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 166 KSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT
T ss_pred ccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC
Confidence 7543221 1223457889999999988887666 899999999999999999997654322222223333332222222
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
....+..+.+++.+||+.||++|||+.|++++-+...
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 2234567899999999999999999999999977643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.84 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=197.8
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCc---hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|+..+.||+|+||.||+|... ++.||||++...... ...+.+.+|++++++++||||+++++++.. .+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceE
Confidence 357888899999999999999985 889999998754322 224678999999999999999999999843 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC--------CCce
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--------QFNP 456 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~--------~~~~ 456 (589)
+||||+++++|.+++... .+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++. ++.+
T Consensus 83 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~--~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEA--IVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEEECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSS--SSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCchHHEEEecccccccccCcce
Confidence 999999999999998633 4899999999999999999999876 234899999999999986 7789
Q ss_pred EEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 457 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 457 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
||+|||++........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 156 kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~ 228 (271)
T 3dtc_A 156 KITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----AYGVAM 228 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHT
T ss_pred EEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHhhhc
Confidence 9999999986654322 234578899999999998999999999999999999999999976433211 112222
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.......+...+..+.+++..||+.||++|||+.|++++|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 2233334455567899999999999999999999999999853
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=353.40 Aligned_cols=253 Identities=17% Similarity=0.237 Sum_probs=209.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|... +++.||+|.+... ......+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEE
Confidence 367888999999999999999976 6899999998754 3445678899999999999999999999854 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC--CCceEEcccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLH 464 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGla 464 (589)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g-----ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 80 FEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp ECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 99999999999997543 24899999999999999999999988 999999999999987 789999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+....... .....+++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...... .+
T Consensus 152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~--~~ 223 (321)
T 1tki_A 152 RQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYT--FD 223 (321)
T ss_dssp EECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCC--CC
T ss_pred eECCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHHcCCCC--CC
Confidence 87755432 223457889999999998889999999999999999999999997643321 11222222111 11
Q ss_pred H----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 545 E----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 545 ~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
. ..+..+.+++.+|++.||++|||+.|++++-+...
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 1 23567899999999999999999999999887543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=346.68 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=197.6
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||+|+..+ .||||+++.... ....+.|.+|++++++++||||+++++++. .+..++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEE
Confidence 4578888999999999999998753 599999976543 344577999999999999999999999763 3467999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS-----IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCccceEEECCCCCEEEccceeccc
Confidence 99999999999997543 34899999999999999999999988 99999999999999999999999999976
Q ss_pred ccCCc-eeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 467 LADDI-VFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 467 ~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
..... ........++..|+|||.+. +..++.++||||||+++|||++|+.||........................
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 54321 11223345788999999986 566888999999999999999999999754321111111111000001112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
....++..+.+++..||+.||++|||+.++++.|+.+.+
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 233456789999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=356.97 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=206.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|...+.||+|+||.||+|... +++ .||+|.+...........+.+|+.++++++||||+++++++. .+..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcc
Confidence 46778899999999999999965 444 388888865543344456788999999999999999999984 2568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++....+ .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHHTT-----CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred EEEEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCccchheEEECCCCeEEECCCCc
Confidence 999999999999999976532 4889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+......
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~ 236 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----EVPDLLEKGERL 236 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----HHHHHHHTTCBC
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----HHHHHHHcCCCC
Confidence 987654321 12233456678999999999999999999999999999999 99999754321 112222222222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+...+..+.+++..||+.||++||+++|++++|+.+....
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 333445567889999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.16 Aligned_cols=269 Identities=23% Similarity=0.381 Sum_probs=204.5
Q ss_pred HhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc--CCCCccceeeeeecCCC--C
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL--RHENIIRLRGFCCSRGR--G 381 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l--~H~niv~l~g~~~~~~~--~ 381 (589)
...++|...+.||+|+||.||+|+.. ++.||||++... ....+..|.+++... +||||+++++++..... .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34578999999999999999999986 899999998643 233455566665554 89999999999865433 5
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCC---CCCCCeEecCCCCCCeeecCCCceEE
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE---VNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
..++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. ..++.|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999654 3899999999999999999999871 00123999999999999999999999
Q ss_pred ccccccccccCCceee---eecCCccccccCcccccCCCCCCc------chhhhHHHHHHHHHhC----------CCCcc
Q 007788 459 ADCGLHKLLADDIVFS---VLKTSAAMGYLAPEYVTTGRFTER------SDIFAFGVIILQILTG----------SLVLT 519 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~Dv~s~Gvvl~elltg----------~~p~~ 519 (589)
+|||+++......... .....+|+.|+|||.+.+..+..+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997664432211 123468889999999988776665 9999999999999999 55554
Q ss_pred hhHHHHHhhhhHHHhh-ccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 520 SSMRLAAESATFENFI-DRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 520 ~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
...............+ ........+ ..+...+.+++..||+.||++|||+.|++++|+.+.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 3211111111111111 112222222 3678889999999999999999999999999999887654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=359.88 Aligned_cols=259 Identities=23% Similarity=0.439 Sum_probs=198.4
Q ss_pred cCccccccccCCCccEEEEEec--CC--cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR--DG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.|...+.||+|+||.||+|.+. ++ ..||||.++.........+|.+|+.++++++||||++++++|... .+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCeEE
Confidence 4566789999999999999864 22 468999997665556678899999999999999999999987543 356789
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 169 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCccchheEEECCCCCEEEeeccccc
Confidence 9999999999999975432 4889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCcee---eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 466 LLADDIVF---SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 466 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||....... ....+......
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~~~~~~~~ 315 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLLQGRRL 315 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHHHHTTCCC
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHHHHcCCCC
Confidence 66443211 1223446678999999999999999999999999999999 556664432111 11111111122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..+...+..+.+++..||+.||++||++.|++++|+.+...
T Consensus 316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 23344567899999999999999999999999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=366.78 Aligned_cols=263 Identities=13% Similarity=0.224 Sum_probs=213.7
Q ss_pred HHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeec
Q 007788 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 377 (589)
Q Consensus 301 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 377 (589)
+.++....++|...+.||+|+||.||+|+.+ +++.||+|++..... ......+.+|+.+++.++|||||++++++.
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~- 139 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ- 139 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 4556667789999999999999999999986 589999999965221 112235789999999999999999999985
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
+.+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 140 -~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 140 -DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp -CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEE
T ss_pred -ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeeECCCCCEE
Confidence 457899999999999999999753 2889999999999999999999988 99999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCC----CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 533 (589)
|+|||+++..............||+.|+|||++.+.. ++.++|||||||++|||+||+.||......... ..
T Consensus 209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~ 284 (410)
T 3v8s_A 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SK 284 (410)
T ss_dssp ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HH
T ss_pred EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH----HH
Confidence 9999999877655444444567899999999998765 789999999999999999999999765432222 22
Q ss_pred hhccc--cCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhh
Q 007788 534 FIDRN--LKGKFSESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTVA 579 (589)
Q Consensus 534 ~~~~~--~~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~~ 579 (589)
+.... +........+..+.+++..|++.+|.+ ||+++|+++|-+..
T Consensus 285 i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 285 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 334 (410)
T ss_dssp HHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred HHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence 22111 111111234567889999999999988 99999999987764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=347.45 Aligned_cols=259 Identities=20% Similarity=0.326 Sum_probs=201.0
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||+|...+|+.||||++..... ......+.+|++++++++||||+++++++. +.+..++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH--SERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC--CSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc--cCCEEEEE
Confidence 367888999999999999999998899999999975532 233467889999999999999999999984 45789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR-----ILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EcCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCchHhEEECCCCCEEEccCcCcee
Confidence 999974 8888887543 24899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH-------------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE------------- 532 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~------------- 532 (589)
...... ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus 169 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 169 FGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp TTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred cCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 653321 2233457889999999876 5689999999999999999999999965432111111000
Q ss_pred ----HhhccccC--CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 533 ----NFIDRNLK--GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 533 ----~~~~~~~~--~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+.... ... .+....++.+++..|++.||++|||++|++++-+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 00000000 000 11224578899999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=355.28 Aligned_cols=256 Identities=19% Similarity=0.312 Sum_probs=207.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC----CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|..+ +|+.||||++.... .......+.+|+.++++++||||+++++++.+ .+..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 57888999999999999999975 68999999986432 11235679999999999999999999999854 4789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc---eEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~D 460 (589)
++||||+++|+|.+++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECSSSTTCCEEECC
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChHHeEEecCCCCCcEEEec
Confidence 9999999999999988765433445899999999999999999999988 999999999999987654 99999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+......
T Consensus 177 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~i~~~~~~ 250 (351)
T 3c0i_A 177 FGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGKYK 250 (351)
T ss_dssp CTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-----HHHHHHHTCCC
T ss_pred CcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-----HHHHHHcCCCC
Confidence 999987654322 122345889999999999999999999999999999999999999764321 11122221111
Q ss_pred CCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 541 GKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 541 ~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
... ..+..+.+++.+||+.||++|||+.|++++-+..
T Consensus 251 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 251 --MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp --CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 111 2356789999999999999999999999876643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=369.12 Aligned_cols=270 Identities=16% Similarity=0.217 Sum_probs=215.0
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
..+.++...+++|+..+.||+|+||.||+|+.+ +++.||||++..... ......+.+|+.++.+++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445667777899999999999999999999987 588999999975321 11223488999999999999999999998
Q ss_pred ecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 376 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
.+ .+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 144 ~~--~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 144 QD--DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp EC--SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSC
T ss_pred ee--CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeeEcCCCC
Confidence 54 578999999999999999998643 24999999999999999999999988 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 530 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 530 (589)
+||+|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 214 vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 999999999876554443444457899999999987 567899999999999999999999999765432222111
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhh
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTVA 579 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~--RPs~~evl~~L~~~ 579 (589)
......... .......+..+.+++.+|+..+|++ ||+++|++++-+..
T Consensus 294 ~~~~~~~~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 294 MNHKERFQF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp HTHHHHCCC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred hhccccccC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 111000011 1111224567889999999888888 99999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=353.00 Aligned_cols=260 Identities=24% Similarity=0.419 Sum_probs=207.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||.||+|... +++ .||+|.+...........+.+|+.++++++||||+++++++.. +..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~ 91 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 91 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES---SSE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec---CCc
Confidence 57888899999999999999964 444 4688888765555566789999999999999999999999864 347
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++|+||+++|+|.+++..... .+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred eEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC-----CcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 899999999999999987543 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+......
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~~~~~~ 238 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERL 238 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTTCCC
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCC
Confidence 987644321 12233445778999999999999999999999999999999 99999654321 122233333333
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
..+...+..+.+++..||+.||++||++.|+++.|+.+.....
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 3445566789999999999999999999999999998876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=349.94 Aligned_cols=249 Identities=18% Similarity=0.254 Sum_probs=197.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||+||+|... +|+.||||++..... ......+..|+..+.++ +||||++++++|.+ .+..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 57889999999999999999986 799999999865432 23334566666666655 89999999999954 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+ +++|.+++..... .++|..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 135 v~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQG-----LVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEccceeee
Confidence 99999 7799999877643 4999999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... ......+|++|+|||++.+ .++.++|||||||++|||++|..|+........ +...........
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------~~~~~~~~~~~~ 275 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-------LRQGYLPPEFTA 275 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-------HTTTCCCHHHHT
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-------HhccCCCccccc
Confidence 765432 2233457899999998876 799999999999999999999777655432211 111111101111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+..+.+++..|++.||++|||++|++++-+.
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 235678999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=381.33 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=215.0
Q ss_pred HHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++...++|...+.||+|+||.||+|.+.++..||||+++.... ..++|.+|++++++++||||+++++++.+ +..
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~ 336 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 336 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccc
Confidence 3344567888899999999999999998888999999986542 34679999999999999999999999843 568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred eEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEEcCCCcEEEccccc
Confidence 999999999999999976432 24899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
++..............++..|+|||.+.+..++.++|||||||+||||+| |+.||....... ....+....+..
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----~~~~i~~~~~~~ 484 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYRMP 484 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----HHHHHHTTCCCC
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCCCC
Confidence 98765432222223445678999999999999999999999999999999 899986543211 111222223333
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+..++..+.+++..||+.||++|||++++++.|+.+..
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 445567789999999999999999999999999997654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=351.13 Aligned_cols=269 Identities=22% Similarity=0.374 Sum_probs=216.5
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
+++....++|...+.||+|+||.||+|... +++.||||++...........|.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 445556788999999999999999999864 36889999998665555567899999999999999999999998
Q ss_pred ecCCCCeEEEEEEeCCCCChHHHhhhhcC------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCee
Q 007788 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEG------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL 449 (589)
Q Consensus 376 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nil 449 (589)
. ..+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 98 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~NIl 170 (322)
T 1p4o_A 98 S--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCM 170 (322)
T ss_dssp C--SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEE
T ss_pred c--cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCccceEE
Confidence 4 34678999999999999999976421 1234789999999999999999999988 999999999999
Q ss_pred ecCCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHh
Q 007788 450 IDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAE 527 (589)
Q Consensus 450 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~ 527 (589)
++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~- 249 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV- 249 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-
Confidence 9999999999999998665433221 122345678999999999899999999999999999999 7888865432111
Q ss_pred hhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 528 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+... .....+...+..+.+++..||+.||++|||+.|++++|+.....
T Consensus 250 ---~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 250 ---LRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ---HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---HHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1111111 11223345567799999999999999999999999999986543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=343.92 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=210.5
Q ss_pred ccCcccc-ccccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVN-LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|...+ .||+|+||.||+|... ++..||||+++..........+.+|++++++++||||+++++++. .+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCCcE
Confidence 4455555 8999999999999864 678899999987655556678999999999999999999999983 24689
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCchheEEEcCCCCEEECcccce
Confidence 9999999999999997543 34899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 465 KLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 465 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
.......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~i~~~~~~ 232 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQGKRM 232 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHHTTCCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHhcCCcC
Confidence 8765432211 222345788999999988889999999999999999999 999996543211 11222222223
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..+...+..+.+++..||+.||++||++.+++++|+.+-.
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 3445567789999999999999999999999999997643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=352.56 Aligned_cols=271 Identities=23% Similarity=0.355 Sum_probs=201.0
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEecCC----cEEEEEEeccCC-CchHHHHHHHHHHHHhccCCCCccceeeeee
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 376 (589)
+++....++|...+.||+|+||.||+|..... ..||||++.... .....+.|.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34445567899999999999999999997643 279999997653 2345678999999999999999999999986
Q ss_pred cCCCC----eEEEEEEeCCCCChHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee
Q 007788 377 SRGRG----ECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450 (589)
Q Consensus 377 ~~~~~----~~~lv~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill 450 (589)
..... ..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dikp~NIli 170 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCML 170 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEE
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-----cccCCCCcceEEE
Confidence 54221 23899999999999999976542 2235899999999999999999999988 9999999999999
Q ss_pred cCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhh
Q 007788 451 DQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAES 528 (589)
Q Consensus 451 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 528 (589)
++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-- 248 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-- 248 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--
Confidence 9999999999999987644322 12223445678999999999999999999999999999999 8999865432211
Q ss_pred hhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+. .......+...+..+.+++..||+.||++|||+.++++.|+.+...
T Consensus 249 --~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 --YNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp --HHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --HHHHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111 1222233445567899999999999999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=350.40 Aligned_cols=267 Identities=24% Similarity=0.416 Sum_probs=214.6
Q ss_pred hccCccccccccCCCccEEEEEe-----cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
.++|+..+.||+|+||.||+|.+ .+++.||||++.... ......|.+|++++++++||||+++++++.......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 35678889999999999999984 368999999997654 455678999999999999999999999986655557
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCT
T ss_pred eEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEEcCCCcEEEecCc
Confidence 8999999999999999986532 4899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH-----------hhh
Q 007788 463 LHKLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-----------ESA 529 (589)
Q Consensus 463 la~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~-----------~~~ 529 (589)
++.......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+........ ...
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 998775443221 1223456679999999988899999999999999999999998864321110 001
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.+.+.+........+...+..+.+++..||+.||++|||+.|+++.|+.+...+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 122233333233344556778999999999999999999999999999887643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=346.32 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=199.0
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||+|... ++.||||++... .....|.+|++++++++||||+++++++. +..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL----NPVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcEEEEE
Confidence 46778899999999999999985 788999998643 34568999999999999999999999884 34789999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc-eEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-PLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~-~kl~DfGla~~~ 467 (589)
|+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ ...|+||||||+||+++.++. +||+|||++...
T Consensus 80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQ--PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCS--SSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred cCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCC--CCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999976532 224789999999999999999999831 112999999999999998886 799999999765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
... .....++..|+|||.+.+..++.++||||||+++|||+||+.||........ ..................
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHHHHTTCCCCCBTTC
T ss_pred ccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHHHhcCCCCCccccc
Confidence 432 1234578899999999999999999999999999999999999964321110 000111111122233345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
+..+.+++.+||+.||++|||+++++++|+.+.+.
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 56789999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=378.64 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=204.6
Q ss_pred ccccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 316 LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
.||+|+||.||+|.++ ++..||||+++.........+|.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCCC
Confidence 7999999999999874 5678999999876555567789999999999999999999999853 458999999999
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 472 (589)
|+|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 420 g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 420 GPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp CBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred CcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999997543 34999999999999999999999988 99999999999999999999999999987654321
Q ss_pred e--eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHH
Q 007788 473 F--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549 (589)
Q Consensus 473 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (589)
. ......+++.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+........+..++.
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~~~~~~~~p~~~~~ 566 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIEQGKRMECPPECPP 566 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----HHHHHHHTTCCCCCCTTCCH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCCCCCCcCCH
Confidence 1 1122334578999999999999999999999999999998 99999754321 12222333333344556678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 550 KLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 550 ~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
.+.+++..||+.||++||++.++++.|+.+-.
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=349.14 Aligned_cols=263 Identities=21% Similarity=0.380 Sum_probs=192.9
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++. ..+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH--TENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC--CTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE--ECCeEEEE
Confidence 457888899999999999999975 689999999976654444467889999999999999999999984 45789999
Q ss_pred EEeCCCCChHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 387 YDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
|||++ |+|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 99998 699999876532 2235899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc-------
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------- 536 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------- 536 (589)
+....... ......+|..|+|||.+.+. .++.++|||||||++|||+||+.||................-.
T Consensus 156 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 156 RAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp EETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred eecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 87643221 12234578899999998764 6899999999999999999999999754332111111100000
Q ss_pred ---------cccC------------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 537 ---------RNLK------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 537 ---------~~~~------------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+... ..........+.+++..|++.||++|||++|++++-+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence 0000 000112345789999999999999999999999886643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=359.34 Aligned_cols=264 Identities=15% Similarity=0.209 Sum_probs=205.3
Q ss_pred hhccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchH----------HHHHHHHHHHHhccCCCCccc
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSE----------EAEFVKGLYLLTSLRHENIIR 370 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~----------~~~~~~e~~~l~~l~H~niv~ 370 (589)
..++|...+.||+|+||.||+|.+.+ ++.||||++........ ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34678889999999999999999864 47899999876531100 123445666778889999999
Q ss_pred eeeeeecCCC--CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCe
Q 007788 371 LRGFCCSRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV 448 (589)
Q Consensus 371 l~g~~~~~~~--~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Ni 448 (589)
+++++..... ...++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDlkp~Ni 183 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE-----YVHGDIKASNL 183 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEEecCCHHHE
Confidence 9999865422 4579999999 999999998653 24999999999999999999999988 99999999999
Q ss_pred eec--CCCceEEccccccccccCCceeee------ecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcch
Q 007788 449 LID--QQFNPLIADCGLHKLLADDIVFSV------LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS 520 (589)
Q Consensus 449 ll~--~~~~~kl~DfGla~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~ 520 (589)
|++ .++.+||+|||+++.+........ ....+|+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999 889999999999987654322111 223488899999999999999999999999999999999999975
Q ss_pred hHHHHH--------hhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 521 SMRLAA--------ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 521 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...... ....+..+++..+.. ...+..+.+++..||+.||++||+++++++.|+.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp GTTCHHHHHHHHHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 322111 111223333333221 12346789999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=350.86 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=206.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++.. .+.
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 56888899999999999999976 6899999999765322 135679999999999999999999999854 578
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC----ceEE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLI 458 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl 458 (589)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHCC-----eEcCCCCHHHEEEecCCCCCCCEEE
Confidence 999999999999999997543 4899999999999999999999988 99999999999999887 7999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+....
T Consensus 160 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~~~~~~ 233 (326)
T 2y0a_A 160 IDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVN 233 (326)
T ss_dssp CCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHTC
T ss_pred EECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHHhcC
Confidence 99999987654321 22345888999999999999999999999999999999999999754322111 1111111
Q ss_pred cCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 539 LKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 539 ~~~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+ ...+..+.+++..|++.||++|||+.|++++-+..
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 234 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred --CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 1111 12346788999999999999999999999886643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=343.96 Aligned_cols=260 Identities=23% Similarity=0.427 Sum_probs=206.5
Q ss_pred ccCccccccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.+|...+.||+|+||.||+|...+ ...||||.+...........|.+|+.++++++||||++++++|... .+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCceE
Confidence 467778999999999999998642 3368999998765555667899999999999999999999987543 45788
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEECCCCCEEECccccc
Confidence 9999999999999997543 24899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCce---eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCC-CcchhHHHHHhhhhHHHhhccccC
Q 007788 465 KLLADDIV---FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-VLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 465 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
+....... .......+++.|+|||.+.+..++.++||||||+++|||++|.. ||....... ....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~ 250 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLLQGRR 250 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHHHHHTTCC
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHhcCCC
Confidence 87654322 12233456678999999999999999999999999999999555 443322111 1111111112
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+...+..+.+++..||+.||++|||++|+++.|+.+...
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 222334456799999999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=361.51 Aligned_cols=255 Identities=21% Similarity=0.276 Sum_probs=207.2
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++++++||||+++++++. +.+..++
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEEEE
Confidence 467889999999999999999865 789999999976543 234467899999999999999999999985 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec---CCCceEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG 462 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||
T Consensus 88 v~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g-----ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 999999999999997653 3899999999999999999999998 99999999999998 56789999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC--
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-- 540 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 540 (589)
++........ ......+|+.|+|||++.+..++.++||||+||++|||++|+.||......... ..+......
T Consensus 159 ~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~ 233 (444)
T 3soa_A 159 LAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY----QQIKAGAYDFP 233 (444)
T ss_dssp SCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCC
T ss_pred eeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhCCCCCC
Confidence 9987654322 223456889999999999999999999999999999999999999765332211 111111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.......+..+.+++..|++.||++|||+.|++++-+.
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 11112345678999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=347.01 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=207.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ......+.+|+.+++.++||||+++++++.+ .+..++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l 83 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFM 83 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEEE
Confidence 57888999999999999999976 799999999975421 1234568899999999999999999999844 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp EECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChheEEEcCCCCEEEeecCcce
Confidence 999999999999998653 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..+.
T Consensus 155 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~--~~p~ 224 (318)
T 1fot_A 155 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILNAEL--RFPP 224 (318)
T ss_dssp ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHCCC--CCCT
T ss_pred ecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCC--CCCC
Confidence 76542 2234688999999999999999999999999999999999999976533221 222222222 2334
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
.....+.+++.+|++.||++|| +++|++++-+.
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 4556789999999999999999 89999987664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=354.62 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=208.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|...+.||+|+||.||+|..+ +|+.||||++..... ......+.+|++++++++||||+++++++.+ .+..++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 467899999999999999999976 689999999976543 3344678999999999999999999999854 478899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC---CceEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG 462 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEeecC
Confidence 999999999999987543 4899999999999999999999988 9999999999999865 459999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC-
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG- 541 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 541 (589)
++........ .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.......
T Consensus 177 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~ 250 (362)
T 2bdw_A 177 LAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY----AQIKAGAYDYP 250 (362)
T ss_dssp TCBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCC
T ss_pred cceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCC
Confidence 9987654321 22356889999999999999999999999999999999999999764332111 1111111111
Q ss_pred -CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 -KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 -~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+..+.+++..||+.||++||++.|++++-+..
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 11123456789999999999999999999999886643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=346.92 Aligned_cols=268 Identities=20% Similarity=0.353 Sum_probs=211.7
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC--CCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~ 384 (589)
.++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++... .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 46788999999999999999997 478999999987643 44567899999999999999999999998632 235789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-----YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999875444456999999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCcee--------eeecCCccccccCcccccCCC---CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH
Q 007788 465 KLLADDIVF--------SVLKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 465 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 533 (589)
......... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~ 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVAL 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhH
Confidence 765321100 001223578899999987654 6899999999999999999999996532211 11111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
.+............+..+.+++..||+.||.+||++.+++++|+.+.+...
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 111122222233456689999999999999999999999999998877643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.07 Aligned_cols=267 Identities=21% Similarity=0.366 Sum_probs=214.6
Q ss_pred HHhhccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeec
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS 377 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 377 (589)
+...++|...+.||+|+||.||+|.... ...||||.+...........+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345788889999999999999999642 2489999998765555667899999999999 89999999999843
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcC----------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCC
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEG----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 447 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~N 447 (589)
.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~N 194 (333)
T 2i1m_A 122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARN 194 (333)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGG
T ss_pred --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCcccce
Confidence 4678999999999999999976431 1235899999999999999999999988 9999999999
Q ss_pred eeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHH
Q 007788 448 VLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA 525 (589)
Q Consensus 448 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~ 525 (589)
|+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||.......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999999866443221 2223345678999999999899999999999999999999 888886532211
Q ss_pred HhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 526 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.....+........+...+..+.+++..||+.||++|||+.|+++.|+.+...
T Consensus 275 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 ----KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11222222222233344466889999999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.16 Aligned_cols=265 Identities=19% Similarity=0.242 Sum_probs=213.0
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
+.++++....++|+..+.||+|+||.||+|+.+ +|+.||||++..... ......+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445666677899999999999999999999986 799999999975321 12224588999999999999999999998
Q ss_pred ecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 376 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
.+ .+..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 131 ~~--~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 131 QD--ENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRLG-----YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EC--SSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSC
T ss_pred ee--CCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccCHHHeeecCCCC
Confidence 44 5789999999999999999986532 4899999999999999999999988 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCccccc-------CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~ 528 (589)
+||+|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~- 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY- 279 (412)
T ss_dssp EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-
T ss_pred EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-
Confidence 999999999877654433333456899999999987 456899999999999999999999999765432221
Q ss_pred hhHHHhhccc--cC-CCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHh
Q 007788 529 ATFENFIDRN--LK-GKFSESEAAKLGKMALVCTHEDPENR---PTMEAVIEELTV 578 (589)
Q Consensus 529 ~~~~~~~~~~--~~-~~~~~~~~~~l~~l~~~C~~~dp~~R---Ps~~evl~~L~~ 578 (589)
..++... .. .......+..+.+++.+|++ +|++| |+++|+++|-+.
T Consensus 280 ---~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 280 ---GKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp ---HHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred ---HHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 1111111 11 11123346678999999999 99998 699999988664
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=355.35 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=204.2
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|+..+.||+|+||.||+|+.+ +|+.||||++..... ......+..|.+++..+ +||||+++++++.. .+..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 467889999999999999999976 689999999975421 22345678899999988 69999999999844 5789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCHHHEEECCCCCEEEccccc
Confidence 99999999999999998764 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..
T Consensus 171 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~--~~ 243 (353)
T 3txo_A 171 CKEGICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEV--VY 243 (353)
T ss_dssp CBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCC--CC
T ss_pred eeecccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCC--CC
Confidence 986433221 22334588999999999988999999999999999999999999976543222 222222222 23
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHHHh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTM------EAVIEELTV 578 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~------~evl~~L~~ 578 (589)
+......+.+++..|++.||++||++ .|++++-+.
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 33455678999999999999999998 888877654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=359.46 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=215.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++........++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57888899999999999999986 58999999998655444567788999999999999999999998766556789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee----cCCCceEEccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGL 463 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfGl 463 (589)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999986542 223899999999999999999999988 9999999999999 7888899999999
Q ss_pred cccccCCceeeeecCCccccccCcccccC--------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTT--------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 535 (589)
++....... .....+|..|+|||++.+ ..++.++|||||||++|||+||+.||............+..++
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp CEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred ceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 987654332 123457889999999865 5678899999999999999999999964321111111111111
Q ss_pred ccc-----------------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 536 DRN-----------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 536 ~~~-----------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
... .....+......+.+++..|++.||++||+++|+++.++.+-..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 110 11133477888999999999999999999999999999877554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=343.65 Aligned_cols=258 Identities=21% Similarity=0.365 Sum_probs=200.4
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|...+|+.||||++...... .....+.+|++++++++||||+++++++.. .+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEEE
Confidence 468888999999999999999988999999999765422 223678899999999999999999999854 46899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++ +|.+++....+ .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 80 e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp ECCSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EecCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 99975 99999876432 4899999999999999999999988 999999999999999999999999999865
Q ss_pred cCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh-----------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI----------- 535 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------- 535 (589)
..... ......+|..|+|||.+.+. .++.++|||||||++|||+||+.||................-
T Consensus 151 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred Ccccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 43221 22234578889999998764 589999999999999999999999975432211111111000
Q ss_pred -----ccccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 536 -----DRNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 536 -----~~~~~~-------~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
++.... ......+..+.+++.+|++.||++|||++|++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 000000 0112245678899999999999999999999987654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=346.55 Aligned_cols=273 Identities=24% Similarity=0.398 Sum_probs=206.7
Q ss_pred HHHHHHhhccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 301 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
++++....++|...+.||+|+||.||+|... .+..||||++..... ......|.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445556678899999999999999999864 345899999976543 33456799999999999999999999998
Q ss_pred ecCCCC---eEEEEEEeCCCCChHHHhhhhc--CCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee
Q 007788 376 CSRGRG---ECFLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 450 (589)
Q Consensus 376 ~~~~~~---~~~lv~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill 450 (589)
...... ..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIli 180 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCML 180 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCSGGGEEE
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEE
Confidence 654322 4599999999999999995432 22345999999999999999999999988 9999999999999
Q ss_pred cCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhh
Q 007788 451 DQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAES 528 (589)
Q Consensus 451 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 528 (589)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 258 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-- 258 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--
Confidence 99999999999999876443211 2223345678999999999999999999999999999999 8888865432111
Q ss_pred hhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
...+........+...+..+.+++..||+.||++||++.+++++|+.+.+..
T Consensus 259 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 259 ---YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ---HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111112222334455678999999999999999999999999999886544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=351.23 Aligned_cols=256 Identities=21% Similarity=0.378 Sum_probs=207.3
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.+.|...+.||+|+||.||+|.. .+++.||||++...... .....|.+|++++++++||||+++++++.. .+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEE
Confidence 35688889999999999999996 47999999999765322 233678999999999999999999999865 46899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||++ |+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 131 lv~e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred EEEecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 9999997 688888865432 4899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
+..... ....+|+.|+|||++. .+.++.++|||||||++|||++|+.||........ ...+.......
T Consensus 202 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----~~~~~~~~~~~ 272 (348)
T 1u5q_A 202 SIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPA 272 (348)
T ss_dssp BSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCC
T ss_pred eecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhcCCCC
Confidence 876542 2345788999999984 56789999999999999999999999965432211 11111111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
......+..+.+++..||+.||++|||+++++++.+......
T Consensus 273 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 222344567889999999999999999999999887665443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.03 Aligned_cols=259 Identities=19% Similarity=0.339 Sum_probs=202.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+ .+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 46888899999999999999976 689999999976543 3344678899999999999999999999854 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++ ++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~-----ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999975 6666665433 24999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc-------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN------- 538 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 538 (589)
...... ......+|..|+|||.+.+.. ++.++|||||||++|||++|+.|+............+.......
T Consensus 151 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 643321 223345788899999998766 79999999999999999999988643322111111111100000
Q ss_pred -----------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 539 -----------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 539 -----------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
............+.+++..|++.||++|||++|++++-+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 287 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence 00011123456788999999999999999999999886654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.52 Aligned_cols=257 Identities=17% Similarity=0.267 Sum_probs=204.8
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|+..+.||+|+||.||+|+.+ +++.||||+++.... ......+..|..++.++ +|||||++++++. +.+..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--ECCEE
Confidence 457888999999999999999976 688999999976532 22234578899999887 8999999999884 45789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ikL~DFGl 199 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGM 199 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEECCCCCEEEeecce
Confidence 99999999999999998654 3899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH-----HhhhhHHHhhccc
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRN 538 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~ 538 (589)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+....
T Consensus 200 a~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 200 CKEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CBCCCCTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred eeecccCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 986322211 2234568899999999999999999999999999999999999996421110 0011112222222
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHHHh
Q 007788 539 LKGKFSESEAAKLGKMALVCTHEDPENRPTM------EAVIEELTV 578 (589)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~------~evl~~L~~ 578 (589)
. ..+...+..+.+++..|++.||++||++ .|++++-+.
T Consensus 279 ~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 279 I--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp C--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred c--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 2 2344456778999999999999999984 788877554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.02 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=208.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++.+++||||+++++++.+ .+..++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEEE
Confidence 357889999999999999999976 68999999997654 3345678999999999999999999999854 5789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC--CCceEEcccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLH 464 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGla 464 (589)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 127 ~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp EECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccchHHeEEecCCCCceEEEecccc
Confidence 99999999999997543 24899999999999999999999988 999999999999974 577999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc--cCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKGK 542 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 542 (589)
+........ ....+|+.|+|||++.+..++.++|||||||++|||+||+.||......... ..+.... ....
T Consensus 199 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~ 272 (387)
T 1kob_A 199 TKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDED 272 (387)
T ss_dssp EECCTTSCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSS
T ss_pred eecCCCcce--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCcc
Confidence 877654322 2235788999999999999999999999999999999999999764332111 1111111 1111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.....+..+.+++..||+.||++|||+.|++++-+.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 223446678999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=354.16 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=199.2
Q ss_pred cccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 313 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
..+.||+|+||.||+|... +|+.||+|++.... ......|.+|++++++++||||+++++++.. .+..++||||++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~ 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVD 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCCC
Confidence 3578999999999999975 68999999998654 3455689999999999999999999999954 478999999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee--cCCCceEEccccccccccC
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill--~~~~~~kl~DfGla~~~~~ 469 (589)
+|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 170 ~~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 170 GGELFDRIIDESY---NLTELDTILFMKQICEGIRHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp TCEEHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999875432 4899999999999999999999988 9999999999999 5678999999999987654
Q ss_pred CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC--CCCHHH
Q 007788 470 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSESE 547 (589)
Q Consensus 470 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 547 (589)
... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ +..+....... ......
T Consensus 242 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 242 REK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET----LNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp TCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCSCSGGGTTS
T ss_pred ccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCCCChhhhccC
Confidence 332 2234588899999999998999999999999999999999999976543221 12222211111 111234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+..+.+++..|++.||++|||+.|++++-+..
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 56789999999999999999999999976643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=350.73 Aligned_cols=249 Identities=17% Similarity=0.270 Sum_probs=208.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++.+ .+..++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 118 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEE
Confidence 57888899999999999999976 689999999965421 2234678899999999999999999999854 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 119 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCccceEEECCCCCEEEcccccce
Confidence 999999999999998654 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..+.
T Consensus 190 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~--~~p~ 259 (350)
T 1rdq_E 190 RVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVSGKV--RFPS 259 (350)
T ss_dssp ECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCC--CCCT
T ss_pred eccCCc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH----HHHHHcCCC--CCCC
Confidence 765432 234578899999999999999999999999999999999999976533221 122222221 2334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
..+..+.+++..|++.||++||+ ++|++++-+.
T Consensus 260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 45677899999999999999998 9999987664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=351.35 Aligned_cols=256 Identities=18% Similarity=0.328 Sum_probs=204.5
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCC--CCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~~~ 384 (589)
.++|+..+.||+|+||.||+|...+++.||||++..... ......|.+|+.++.+++| |||+++++++.. .+..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEEE
Confidence 456888999999999999999998999999999976543 3344679999999999986 999999999854 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||| +.+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 86 lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEE-CCcEEEeecccc
Confidence 9999 46889999998653 4899999999999999999999988 99999999999997 578999999999
Q ss_pred ccccCCcee-eeecCCccccccCcccccC-----------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH
Q 007788 465 KLLADDIVF-SVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 465 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 532 (589)
+........ ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~ 231 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLH 231 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HHHHH
Confidence 877543221 1224468899999999865 67899999999999999999999999653221 12233
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..++.......+......+.+++..||+.||.+|||+.|++++.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 232 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 44444444444444456789999999999999999999999987764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.80 Aligned_cols=257 Identities=22% Similarity=0.318 Sum_probs=201.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|... ++..||+|++...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEEEE
Confidence 46888899999999999999975 6899999999876555556789999999999999999999999853 57899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee---cCCCceEEcccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLH 464 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGla 464 (589)
||+++|+|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999999999765333345999999999999999999999988 9999999999999 45688999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
....... ......++..|+|||.+. +.++.++||||||+++|||++|+.||............ ......... ..
T Consensus 175 ~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~~-~~ 248 (285)
T 3is5_A 175 ELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAV-EC 248 (285)
T ss_dssp CC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCC---
T ss_pred eecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh--ccCCccccc-cc
Confidence 8765432 123445788999999875 57899999999999999999999999754322111110 011111110 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+.+++..|++.||++|||+.|++++-+.
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 1134578899999999999999999999987553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.34 Aligned_cols=265 Identities=19% Similarity=0.326 Sum_probs=201.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++.. .+..++
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 109 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 109 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEEE
Confidence 56888899999999999999974 78999999997533 23445679999999999999999999999865 468999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 99999999999999764433446899999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .....+...........
T Consensus 185 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 261 (310)
T 2wqm_A 185 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQCDYPPLPSD 261 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HHHHHHHTTCSCCCCTT
T ss_pred eecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HHHHHhhcccCCCCccc
Confidence 6644321 12234577889999999999999999999999999999999999965421110 01111111111111123
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+..+.+++..||+.||++|||++++++.|+.+++..
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 44567999999999999999999999999999887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=352.69 Aligned_cols=254 Identities=18% Similarity=0.263 Sum_probs=205.8
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCC
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 381 (589)
...++|...+.||+|+||.||+|+.+ +|+.||||+++.... ......+..|..++..+ +||||+++++++.+ .+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CC
Confidence 34578999999999999999999986 689999999975421 22345678899999877 89999999999844 57
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCChhhEEECCCCCEEEeEC
Confidence 8999999999999999998654 3899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.... .
T Consensus 163 G~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~--~ 235 (345)
T 1xjd_A 163 GMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRMDN--P 235 (345)
T ss_dssp TTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCC--C
T ss_pred hhhhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHhCC--C
Confidence 99986432211 223456889999999999999999999999999999999999999765332211 1121111 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHH
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTME-AVIEELT 577 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~-evl~~L~ 577 (589)
..+...+..+.+++..|++.||++||++. |++++-+
T Consensus 236 ~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 236 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 23334566789999999999999999998 7776544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.34 Aligned_cols=258 Identities=17% Similarity=0.179 Sum_probs=204.8
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++++ +||||+++++++.. .+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEE
Confidence 5688889999999999999996 4789999999875532 23588999999999 99999999999855 4688999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc-----eEEccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-----PLIADC 461 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Df 461 (589)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 84 ~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSKN-----LIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred EEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9999 999999998653 24999999999999999999999988 999999999999999887 999999
Q ss_pred cccccccCCcee------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh
Q 007788 462 GLHKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 462 Gla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 535 (589)
|+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..+.
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~ 233 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIG 233 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHH
Confidence 999876443211 12345688999999999999999999999999999999999999975321100 00011111
Q ss_pred ccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 536 DRNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 536 ~~~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
....... .....+ .+.+++..||+.||.+||+++++++.|+.+...
T Consensus 234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 1000000 001123 899999999999999999999999999876544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.48 Aligned_cols=261 Identities=23% Similarity=0.389 Sum_probs=208.2
Q ss_pred cCccccccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.|...+.||+|+||.||+|...+ +..||+|++.........+.|.+|+.++++++||||+++++++... ....++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCCcEE
Confidence 34556889999999999998642 3379999998765555667899999999999999999999998543 234589
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 101 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp EECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred EEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 999999999999997643 34899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCce---eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 466 LLADDIV---FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 466 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~ 248 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----DLTHFLAQGRRLP 248 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG----GHHHHHHTTCCCC
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH----HHHHHhhcCCCCC
Confidence 6644321 11223446778999999999999999999999999999999776664332211 1122222222223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.+...+..+.+++..||+.||++|||++++++.|+.+....
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 34445678999999999999999999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=344.45 Aligned_cols=254 Identities=19% Similarity=0.392 Sum_probs=202.5
Q ss_pred hccCccccccccCCCccEEEEEecC-C-------cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD-G-------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG 379 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 379 (589)
.++|...+.||+|+||.||+|.... + ..||+|++.... ....+.|.+|++++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC-- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence 3578888999999999999998652 3 579999997654 3455789999999999999999999999954
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc----
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---- 455 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~---- 455 (589)
.+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEEECCBGGGT
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhCC-----eECCCcCcceEEEecCCccccc
Confidence 4678999999999999999986542 3899999999999999999999988 999999999999998887
Q ss_pred ----eEEccccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh
Q 007788 456 ----PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 530 (589)
Q Consensus 456 ----~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 530 (589)
+||+|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||++|..|+............
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp BCCEEEECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred ccceeeeccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 9999999987654322 2346778999999987 67999999999999999999976665443221111111
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
... ....+...+..+.+++..||+.||++|||++|++++|+.+-...
T Consensus 231 ----~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 231 ----YED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ----HHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ----hhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 111 11112223456889999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.28 Aligned_cols=253 Identities=20% Similarity=0.329 Sum_probs=198.4
Q ss_pred hccCccccccccCCCccEEEEEe----cCCcEEEEEEeccCCC---chHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
.++|+..+.||+|+||.||+|+. .+++.||+|+++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--G 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--C
Confidence 35788899999999999999997 4789999999976532 2234567889999999999999999999854 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG-----IIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EEcccCCHHHeEECCCCcEEEEe
Confidence 78999999999999999998654 3889999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
||+++....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.....
T Consensus 165 fg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~- 238 (327)
T 3a62_A 165 FGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT----IDKILKCKL- 238 (327)
T ss_dssp CSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHTCC-
T ss_pred CCcccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCC-
Confidence 999876433221 12334578899999999999999999999999999999999999976533221 122222211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
..+......+.+++..||+.||++|| ++.|++++-+.
T Consensus 239 -~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 239 -NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred -CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 23344566789999999999999999 88899987664
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.51 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=205.9
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
+.++|...+.||+|+||.||+|... ++..||||++..... ......+.+|+.++++++||||+++++++.. .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence 3467888999999999999999876 578999999865321 1224578899999999999999999999854 4789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT-----CEECCCCGGGEEECTTSCEEECSCCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHhEEEcCCCCEEEEeccc
Confidence 99999999999999998654 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
+....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.. .....
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~--~~~~~ 226 (279)
T 3fdn_A 156 SVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----KRISR--VEFTF 226 (279)
T ss_dssp ESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHH--TCCCC
T ss_pred cccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH----HHHHh--CCCCC
Confidence 86654332 22345788899999999999999999999999999999999999754322111 11111 11223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
+......+.+++..|++.||++|||++|++++-+...
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 3345567889999999999999999999999987544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.84 Aligned_cols=261 Identities=23% Similarity=0.418 Sum_probs=207.2
Q ss_pred ccCccccccccCCCccEEEEEec-CCcE--EEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|...+.||+|+||.||+|... ++.. ||||.+...........+.+|++++.++ +||||+++++++.. .+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCceE
Confidence 56888899999999999999975 5654 4999987654445556799999999999 89999999999854 47899
Q ss_pred EEEEeCCCCChHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 385 LIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+||||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE 177 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCccceEEEcC
Confidence 9999999999999997653 22345999999999999999999999988 999999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF 531 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 531 (589)
++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~----- 250 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 250 (327)
T ss_dssp GGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-----
Confidence 9999999999987443211 1222345678999999988889999999999999999998 9999965432211
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
...+........+...+..+.+++.+||+.||++|||++|++++|+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 251 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1112222222334455678999999999999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.66 Aligned_cols=256 Identities=16% Similarity=0.271 Sum_probs=205.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|+.+ +++.||+|++..... ......+.+|..++.++ +||||+++++++.. .+..+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLF 86 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEEE
Confidence 56888899999999999999986 689999999976532 23446688999999988 89999999999844 57899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 87 lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp EEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999998653 3899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHH-----HHhhhhHHHhhcccc
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-----AAESATFENFIDRNL 539 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 539 (589)
+....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+.....
T Consensus 158 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 158 KEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp BCSCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred ccccCCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 86432211 223446889999999999999999999999999999999999999642110 000111122222221
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHHHh
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTM------EAVIEELTV 578 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~------~evl~~L~~ 578 (589)
..+...+..+.+++..|++.||++||++ .|++++-+.
T Consensus 237 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 237 --RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 2344456778999999999999999985 788877554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.39 Aligned_cols=252 Identities=23% Similarity=0.433 Sum_probs=207.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeec---------
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS--------- 377 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--------- 377 (589)
.++|+..+.||+|+||.||+|... +++.||||++.... ..+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 357888999999999999999986 79999999997543 246789999999999999999998743
Q ss_pred -----CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 378 -----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 378 -----~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
......++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK-----LINRDLKPSNIFLVD 157 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHEEEcC
Confidence 113457999999999999999976532 34899999999999999999999988 999999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 532 (589)
++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+...... ..
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------~~ 229 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------FT 229 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH------HH
T ss_pred CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH------HH
Confidence 99999999999887654321 22345788999999999999999999999999999999999988643221 11
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 533 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
......+ +...+..+.+++..||+.||++||++.|++++|+.+....
T Consensus 230 ~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 DLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred Hhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1112222 2233456889999999999999999999999999887654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.53 Aligned_cols=264 Identities=19% Similarity=0.370 Sum_probs=208.9
Q ss_pred hccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
.++|...+.||+|+||.||+|.+. ++..||||++..........+|.+|+.++++++||||+++++++.. .+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--CC
Confidence 467888999999999999999842 5778999999765555566789999999999999999999999854 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCC---CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGS---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFN 455 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~ 455 (589)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++. +..
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eecCcCCHhHEEEecCCCcce
Confidence 789999999999999999875422 235899999999999999999999988 999999999999984 456
Q ss_pred eEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHH
Q 007788 456 PLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 533 (589)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... ...
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~ 256 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLE 256 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-----HHH
Confidence 99999999876543221 12223446778999999998899999999999999999998 888986543211 111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.+........+...+..+.+++..||+.||++||++.+++++|+.+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 12222222334445678999999999999999999999999999877653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.13 Aligned_cols=260 Identities=15% Similarity=0.169 Sum_probs=206.1
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|++.+.++ +|+|++++++++.. ....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEE
Confidence 35688889999999999999996 5799999999875432 23578899999999 79999999998844 478899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc-----eEEcc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN-----PLIAD 460 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~-----~kl~D 460 (589)
||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|
T Consensus 84 v~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 99999 9999999986532 4899999999999999999999988 999999999999987776 99999
Q ss_pred ccccccccCCcee------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHh
Q 007788 461 CGLHKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534 (589)
Q Consensus 461 fGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 534 (589)
||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ ......+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~ 233 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERI 233 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHHHHH
Confidence 9999876543211 12344578899999999999999999999999999999999999975321000 0000111
Q ss_pred hccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 535 IDRNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 535 ~~~~~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
....... ......+..+.+++..||+.||++||+++++++.|+.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000000 00112356799999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.87 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=207.3
Q ss_pred HhhccCcccc-ccccCCCccEEEEEec---CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 306 SATQCFSEVN-LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 306 ~~~~~f~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
...++|...+ .||+|+||.||+|.+. +++.||||++..... ....++|.+|++++++++||||+++++++. .
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~ 89 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---A 89 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---S
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---C
Confidence 3446677777 9999999999999653 478899999976543 333578999999999999999999999983 3
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEcCCCCcceEEEeCCCcEEEcc
Confidence 56899999999999999997643 3899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcc
Q 007788 461 CGLHKLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 461 fGla~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
||++.......... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+..
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~ 235 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEK 235 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHT
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHc
Confidence 99998765433221 222345678999999988889999999999999999999 999997543221 1122222
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
......+...+..+.+++..||+.||++||++.++++.|+.+-.
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 236 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22233344566789999999999999999999999999987643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.97 Aligned_cols=255 Identities=19% Similarity=0.331 Sum_probs=203.8
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccC--CCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~~~l 385 (589)
.+|...+.||+|+||.||+|...+++.||||++..... ......|.+|+.++.+++ ||||+++++++.. .+..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEE
Confidence 46888999999999999999988899999999976543 344578999999999996 5999999999854 467999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||| +.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++
T Consensus 134 v~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred EEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 999 56889999998653 4889999999999999999999988 99999999999996 5899999999998
Q ss_pred cccCCcee-eeecCCccccccCcccccC-----------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH
Q 007788 466 LLADDIVF-SVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 466 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 533 (589)
........ ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~~ 279 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHA 279 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHH
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHHHHH
Confidence 77543221 1234568899999999865 46899999999999999999999999653221 122334
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+++.......+......+.+++..||+.||++|||+.|++++.+..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 4444433333333456789999999999999999999999887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=341.60 Aligned_cols=260 Identities=17% Similarity=0.254 Sum_probs=200.7
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.++.+++||||+++++++.. .+..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 467888999999999999999976 789999999976532 2234678999999999999999999999855 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 111 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred EEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc-----CCcCCCChHHEEEcCCCCEEEecCccC
Confidence 9999999999999998653 4899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC--CC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GK 542 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 542 (589)
...............++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+..... ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~ 256 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-----GAHINQAIPRPST 256 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-----HHHHHSCCCCGGG
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-----HHHhccCCCCccc
Confidence 87655433233345578889999999999999999999999999999999999976543211 111111110 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhccc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAAPVM 583 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~~~~~ 583 (589)
.....+..+.+++.+||+.||++|| +++++++.|+.+....
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 2233456789999999999999999 9999999999765543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.18 Aligned_cols=266 Identities=16% Similarity=0.223 Sum_probs=204.8
Q ss_pred HHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC----CchHHHHHHHHHHHHhccCCCCccceeeeeecC
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR 378 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 378 (589)
+....++|...+.||+|+||.||+|... ++..||+|++.... .......+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 3445678999999999999999999975 68899999986532 23445789999999999999999999999954
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCC------------------------------------CCCCCHHHHHHHHHHHH
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGS------------------------------------SNVLDWSTRVSIIIGIA 422 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia 422 (589)
.+..++||||+++|+|.+++...... ...+++..++.|+.|++
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 57899999999999999998521100 11235677889999999
Q ss_pred HHhHHhcCCCCCCCCeEecCCCCCCeeecCCC--ceEEccccccccccC---CceeeeecCCccccccCcccccC--CCC
Q 007788 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF--NPLIADCGLHKLLAD---DIVFSVLKTSAAMGYLAPEYVTT--GRF 495 (589)
Q Consensus 423 ~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~--~~kl~DfGla~~~~~---~~~~~~~~~~~~~~y~aPE~~~~--~~~ 495 (589)
.||+|||+.+ |+||||||+||+++.++ .+||+|||+++.... ..........+|+.|+|||.+.+ ..+
T Consensus 179 ~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 179 SALHYLHNQG-----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHHTT-----EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHHCC-----ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 9999999988 99999999999998776 899999999986533 11222334568889999999875 678
Q ss_pred CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007788 496 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--SESEAAKLGKMALVCTHEDPENRPTMEAVI 573 (589)
Q Consensus 496 ~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl 573 (589)
+.++||||||+++|||++|+.||........ ...+......... .......+.+++..|++.||++||++.|++
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADT----ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHH----HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9999999999999999999999975433211 1222222221111 122456789999999999999999999999
Q ss_pred HHHHhhh
Q 007788 574 EELTVAA 580 (589)
Q Consensus 574 ~~L~~~~ 580 (589)
++-+...
T Consensus 330 ~hp~~~~ 336 (345)
T 3hko_A 330 QHPWISQ 336 (345)
T ss_dssp HSHHHHT
T ss_pred cChhhcc
Confidence 9876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=350.35 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=204.5
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.+++.++||||+++++++.. .+..++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 5788889999999999999997 4789999999864321 1123568899999999999999999999854 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+ +|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 87 v~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK-----IVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp EECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT-----CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCchhhEEEcCCCCEEEEEeccce
Confidence 99999 789999987654 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
....... .....+|+.|+|||.+.+..+ +.++|||||||++|||++|+.||......... ..+ .. .....+
T Consensus 157 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i-~~-~~~~~p 228 (336)
T 3h4j_B 157 IMTDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKV-NS-CVYVMP 228 (336)
T ss_dssp TTTTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCC-CS-SCCCCC
T ss_pred eccCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHH-Hc-CCCCCc
Confidence 7654332 223457889999999988776 78999999999999999999999754221100 000 00 011223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+..+.+++.+|++.||.+|||++|++++-+..
T Consensus 229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 34556789999999999999999999999988754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.69 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=192.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..++|...+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++.+++||||+++++++.. .+..++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 3467888999999999999999986 58899999997543 34568899999999999999999999954 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCceEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG 462 (589)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 126 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EECCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCcccEEEecCCCCCCEEEccCc
Confidence 999999999999997543 4899999999999999999999988 999999999999975 8899999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC--
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-- 540 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 540 (589)
+++....... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+......
T Consensus 197 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~i~~~~~~~~ 271 (349)
T 2w4o_A 197 LSKIVEHQVL--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFI 271 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHHHHHTTCCCCC
T ss_pred cccccCcccc--cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HHHHHHhCCCccC
Confidence 9987654321 2234578899999999999999999999999999999999999965432111 11222221111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.......+..+.+++.+|++.||++|||+.|++++-+..
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 111234566789999999999999999999999886643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.18 Aligned_cols=265 Identities=16% Similarity=0.185 Sum_probs=200.2
Q ss_pred ccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCch----------HHHHHHHHHHHHhccCCCCccceeee
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKS----------EEAEFVKGLYLLTSLRHENIIRLRGF 374 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~----------~~~~~~~e~~~l~~l~H~niv~l~g~ 374 (589)
++|...+.||+|+||.||+|... ++..||||++....... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888899999999999999985 57889999987653211 11346778889999999999999999
Q ss_pred eecC--CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 375 CCSR--GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 375 ~~~~--~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+... +....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE-----YVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEES
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCcCHHHEEEcc
Confidence 8652 246789999999 999999998654 4999999999999999999999988 999999999999998
Q ss_pred CC--ceEEccccccccccCCceee------eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHH
Q 007788 453 QF--NPLIADCGLHKLLADDIVFS------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 524 (589)
Q Consensus 453 ~~--~~kl~DfGla~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~ 524 (589)
++ .+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 99999999998764332111 12345788999999999999999999999999999999999999643211
Q ss_pred HHhhhhHHHhhccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 525 AAESATFENFIDRNLKG-----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
................. ......+..+.+++..||+.||++||+++++++.|+......
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 11111111111100000 000133457999999999999999999999999999876443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.84 Aligned_cols=253 Identities=18% Similarity=0.312 Sum_probs=203.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++|||||++++++.. .+..++
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMFM 92 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEE
Confidence 56888899999999999999976 688999999865321 2334678899999999999999999999854 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp EECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999997643 4899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccC---CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......+.. ....
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~--~~~~ 238 (384)
T 4fr4_A 164 MLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFET--TVVT 238 (384)
T ss_dssp ECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHHH--CCCC
T ss_pred eccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhh--cccC
Confidence 765432 2234568899999999874 4589999999999999999999999964321110 011111111 1122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHH
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPT-MEAVIEELT 577 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L~ 577 (589)
.+...+..+.+++..||+.||++||+ ++++.++-+
T Consensus 239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 34445678999999999999999998 787776544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=339.78 Aligned_cols=255 Identities=20% Similarity=0.380 Sum_probs=211.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.|...+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.. .+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 56888899999999999999865 6899999999876555566789999999999999999999999865 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 100 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp ECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChheEEECCCCCEEEeecccceec
Confidence 999999999998642 4899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+............
T Consensus 170 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~ 243 (303)
T 3a7i_A 170 TDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-----FLIPKNNPPTLEGNY 243 (303)
T ss_dssp BTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCCSSC
T ss_pred Ccccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-----HHhhcCCCCCCcccc
Confidence 54322 223345788899999999999999999999999999999999999754322111 111111122223344
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+..+.+++..||+.||++|||+.|++++.+....
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 5678999999999999999999999998776543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.41 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=206.8
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|...+.||+|+||.||+|+.+ +++.||||+++.... ......+..|..++..+ +||||+++++++. +.+..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CSSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cCCEE
Confidence 467888999999999999999986 488999999975421 23345688899999988 7999999999884 35789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 99999999999999998654 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... ...+..... ..
T Consensus 168 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~--~~ 240 (353)
T 2i0e_A 168 CKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNV--AY 240 (353)
T ss_dssp CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCC--CC
T ss_pred ccccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCC--CC
Confidence 986432211 22344688999999999999999999999999999999999999976533221 222222222 23
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
+...+..+.+++..|++.||++||+ ++|++++-+.
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 4455678999999999999999995 6888877543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=344.38 Aligned_cols=264 Identities=20% Similarity=0.319 Sum_probs=208.1
Q ss_pred HHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhc--cCCCCccceeeeeecCCC--
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS--LRHENIIRLRGFCCSRGR-- 380 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~~~-- 380 (589)
....++|...+.||+|+||.||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++.....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 34457899999999999999999998 4899999998643 34567888888887 789999999999865432
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhc--------CCCCCCCCeEecCCCCCCeeecC
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH--------SSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
...++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+||+++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-----IAHRDLKSKNILVKK 182 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-----EECSCCSGGGEEECT
T ss_pred ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-----eeeCCCCHHHEEECC
Confidence 2789999999999999999753 3899999999999999999999 555 999999999999999
Q ss_pred CCceEEccccccccccCCcee---eeecCCccccccCcccccCCC------CCCcchhhhHHHHHHHHHhC---------
Q 007788 453 QFNPLIADCGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTG--------- 514 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~elltg--------- 514 (589)
++.+||+|||++......... ......++..|+|||.+.+.. ++.++||||||+++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999766543321 123345788999999987753 33689999999999999999
Q ss_pred -CCCcchhHHHHHhhhhH-HHhhccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 515 -SLVLTSSMRLAAESATF-ENFIDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 515 -~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..||............+ ..+.........+ ......+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 67775432111001111 1122222222222 366788999999999999999999999999999887653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=334.88 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=208.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 467888999999999999999976 689999999976542 3344678899999999999999999999843 577899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc---eEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG 462 (589)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 83 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 999999999999987654 3899999999999999999999988 999999999999987655 9999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc--C
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--K 540 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 540 (589)
++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .+..... .
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~ 227 (284)
T 3kk8_A 154 LAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYP 227 (284)
T ss_dssp TCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCC
T ss_pred eeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH----HHHhccccCC
Confidence 9977654332 223467889999999999999999999999999999999999997643322111 1111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.......+..+.+++..|++.||++|||+.|++++-+...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 1111234567899999999999999999999999876544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=346.16 Aligned_cols=256 Identities=18% Similarity=0.273 Sum_probs=197.1
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCC--eE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG--EC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~--~~ 383 (589)
++|+..+.||+|+||.||+|.. .+++.||||++..... ......|.+|++++.+++||||+++++++...... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788889999999999999997 4789999999976542 23346789999999999999999999988654322 35
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred EEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999998654 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... .......+++.|+|||.+.+..++.++||||||+++|||+||+.||........... ........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~ 238 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVREDPIP 238 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHCCCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HhcCCCCC
Confidence 987654321 122234578899999999999999999999999999999999999976433221111 11111000
Q ss_pred --CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 542 --KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 542 --~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
......+..+.+++.+||+.||++||+..+++++-.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 001123567899999999999999998777765543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=339.80 Aligned_cols=263 Identities=21% Similarity=0.344 Sum_probs=201.1
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC----chHHHHHHHHHHHHhcc---CCCCccceeeeeecCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRG 379 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~ 379 (589)
.++|+..+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.+++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999996 4789999999974331 11123566777766666 5999999999986543
Q ss_pred CC---eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCce
Q 007788 380 RG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP 456 (589)
Q Consensus 380 ~~---~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~ 456 (589)
.+ ..++||||+. |+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCTTTEEECTTSCE
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCE
Confidence 22 5789999997 599999976543 24899999999999999999999998 9999999999999999999
Q ss_pred EEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 457 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 457 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
||+|||+++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||................-.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998765432 223345788999999999999999999999999999999999999764432221111111000
Q ss_pred c--------------ccC--CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 537 R--------------NLK--GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 537 ~--------------~~~--~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
+ ... ... .+.....+.+++.+|++.||++|||+.|++++-+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 0 000 000 0123567889999999999999999999998866543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=363.02 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=199.4
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|++++++++||||+++++++.. .+..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence 467889999999999999999975 68999999997542 23344578899999999999999999999954 46899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+
T Consensus 225 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g-----iiHrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC-----CCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred EEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC-----EEECCCCHHHEEECCCCCEEEccCCC
Confidence 9999999999999997654 38999999999999999999997 77 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
++....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... ..
T Consensus 296 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~--~~ 368 (446)
T 4ejn_A 296 CKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEI--RF 368 (446)
T ss_dssp CCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCC--CC
T ss_pred ceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHHhCCC--CC
Confidence 986433221 22345688999999999999999999999999999999999999976433211 111222211 23
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA 579 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~ 579 (589)
+...+..+.+++..||+.||++|| +++|++++-+..
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 334556789999999999999999 999999876653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.60 Aligned_cols=262 Identities=16% Similarity=0.305 Sum_probs=203.3
Q ss_pred hccCccccccccC--CCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|+..+.||+| +||.||+|+.. +|+.||||++..... ......+.+|++++++++|||||++++++.. .+..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEE
Confidence 3578889999999 99999999986 799999999976543 2334678889999999999999999999964 4789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999999986532 24899999999999999999999988 99999999999999999999999998
Q ss_pred cccccCCcee------eeecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh----H
Q 007788 464 HKLLADDIVF------SVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----F 531 (589)
Q Consensus 464 a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~----~ 531 (589)
+......... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.......... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 8654322111 1112357788999999987 57899999999999999999999999653211110000 0
Q ss_pred HHhhccc------------------------------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 532 ENFIDRN------------------------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 532 ~~~~~~~------------------------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
....+.. ............+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000 0001123345678999999999999999999999988
Q ss_pred HHh
Q 007788 576 LTV 578 (589)
Q Consensus 576 L~~ 578 (589)
-+.
T Consensus 335 p~f 337 (389)
T 3gni_B 335 SFF 337 (389)
T ss_dssp GGG
T ss_pred HHH
Confidence 543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.16 Aligned_cols=254 Identities=22% Similarity=0.419 Sum_probs=202.1
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|+..+.||+|+||.||+|... |+.||||++.... ..+.|.+|++++++++||||+++++++... .+..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEEEE
Confidence 357888899999999999999885 8899999997543 456799999999999999999999987543 34689999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 99999999999976532 23789999999999999999999988 999999999999999999999999998765
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
.... ....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+........+..
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~ 238 (278)
T 1byg_A 168 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYKMDAPDG 238 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHTTTCCCCCCTT
T ss_pred cccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhcCCCCCCccc
Confidence 4321 12345778999999998899999999999999999998 99998654221 11111222222334445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+..+.+++..||+.||++||++.|+++.|+.+...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 567899999999999999999999999999988654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=335.30 Aligned_cols=259 Identities=19% Similarity=0.304 Sum_probs=208.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 357888999999999999999976 7899999999765545556789999999999999999999999854 4788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 99999999999986542 4899999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCcee-eeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 467 LADDIVF-SVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 467 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
....... ......++..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 231 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKEKKTYLNPW 231 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---HHHHHHTTCTTSTTG
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHhhhcccccCch
Confidence 6432211 1233457888999999987765 7799999999999999999999965432111 111111111111112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+..+.+++..|++.||++|||++|++++.+...
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 334567889999999999999999999998866543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=351.82 Aligned_cols=258 Identities=21% Similarity=0.349 Sum_probs=194.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++.++. ||||+++++++...+....+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 468999999999999999999975 789999999865432 344567889999999997 99999999999766556799
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 9999997 6999998753 3899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCc--------------------eeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHH
Q 007788 465 KLLADDI--------------------VFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMR 523 (589)
Q Consensus 465 ~~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~ 523 (589)
+...... ........+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8653210 111223468889999999886 6789999999999999999999999975432
Q ss_pred HHHhhhhHHHhhc-----------------------------cccCCCC-------------CHHHHHHHHHHHHHhccc
Q 007788 524 LAAESATFENFID-----------------------------RNLKGKF-------------SESEAAKLGKMALVCTHE 561 (589)
Q Consensus 524 ~~~~~~~~~~~~~-----------------------------~~~~~~~-------------~~~~~~~l~~l~~~C~~~ 561 (589)
......... .+. ....... .......+.+++.+|++.
T Consensus 237 ~~~~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 221111110 000 0000000 002245788999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 007788 562 DPENRPTMEAVIEELT 577 (589)
Q Consensus 562 dp~~RPs~~evl~~L~ 577 (589)
||++|||++|++++-+
T Consensus 316 dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 316 NPNKRISANDALKHPF 331 (388)
T ss_dssp SGGGSCCHHHHTTSTT
T ss_pred CcccCCCHHHHhCCHH
Confidence 9999999999999855
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.08 Aligned_cols=259 Identities=18% Similarity=0.314 Sum_probs=208.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|... +++.||+|++...........+.+|+.++++++||||+++++++.. .+..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEE
Confidence 367888999999999999999986 7899999999876555556789999999999999999999999865 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
|||+++|+|.+++.... .+++..+..++.+++.||+|||+. + |+||||||+||+++.++.+||+|||++.
T Consensus 110 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSG 180 (360)
T ss_dssp ECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC-----EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence 99999999999998754 389999999999999999999985 6 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh-----------------
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES----------------- 528 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~----------------- 528 (589)
...... .....++..|+|||++.+..++.++||||||+++|||+||+.||..........
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 181 QLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 553321 123457889999999999999999999999999999999999996432111000
Q ss_pred ---------------------hhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 529 ---------------------ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 529 ---------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...................+..+.+++..||+.||++|||++|++++-+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0000111111111111223567899999999999999999999999877543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=373.08 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=203.3
Q ss_pred cccccCCCccEEEEEec---CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||.||+|.+. .++.||||+++.... ....++|.+|++++.+++|||||+++++|.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 47999999999999753 468899999976532 3345789999999999999999999999843 4588999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 452 ~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 452 ELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp TTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999997543 4899999999999999999999988 999999999999999999999999999876543
Q ss_pred ce--eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 471 IV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 471 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
.. .......+++.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+........+..+
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~~~~~~~~p~~~ 597 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEKGERMGCPAGC 597 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCCTTC
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCCCCC
Confidence 21 12223345678999999999999999999999999999999 99999764332 122223333333445566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+..+.+++..||+.||++||++.++++.|+.+-.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 7889999999999999999999999999987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=345.04 Aligned_cols=265 Identities=25% Similarity=0.439 Sum_probs=197.3
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHH--HhccCCCCccceeeeee---cCCCCe
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYL--LTSLRHENIIRLRGFCC---SRGRGE 382 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~g~~~---~~~~~~ 382 (589)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++. ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 35788889999999999999987 68999999997432 3344444444 55689999999998553 223346
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC----CCCCeEecCCCCCCeeecCCCceEE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV----NKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
.++||||+++|+|.+++.... .+|..++.++.||+.||+|||+... ..+.|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 789999999999999997543 6899999999999999999998800 0112999999999999999999999
Q ss_pred ccccccccccCCce-------eeeecCCccccccCcccccC-------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHH
Q 007788 459 ADCGLHKLLADDIV-------FSVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILTGSLVLTSSMRL 524 (589)
Q Consensus 459 ~DfGla~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~ 524 (589)
+|||+++.+..... .......+|..|+|||++.+ ..++.++|||||||++|||+||+.|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221 11223458889999999987 45677999999999999999998877532211
Q ss_pred HHh-------------hhhHHHhh-ccccCCCC------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 525 AAE-------------SATFENFI-DRNLKGKF------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 525 ~~~-------------~~~~~~~~-~~~~~~~~------~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
... .......+ ........ ....+..+.+++..||+.||++|||++|+++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 000 00011111 11111111 234677899999999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.25 Aligned_cols=257 Identities=17% Similarity=0.225 Sum_probs=195.3
Q ss_pred ccCccc-cccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhc-cCCCCccceeeeeec--CCCCeE
Q 007788 309 QCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTS-LRHENIIRLRGFCCS--RGRGEC 383 (589)
Q Consensus 309 ~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~--~~~~~~ 383 (589)
++|... +.||+|+||.||+|... +|+.||||++... ..+.+|++++.+ .+||||+++++++.. .+.+..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 345554 68999999999999976 6899999998632 246678887744 589999999998743 224568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCceEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 460 (589)
++||||+++|+|.+++..... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCcceEEEecCCCCccEEEEe
Confidence 999999999999999976432 34999999999999999999999988 999999999999998 78999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...............+......
T Consensus 208 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 208 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp CTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 99998665332 1223457889999999999999999999999999999999999997543221111111111111111
Q ss_pred --CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 --GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 --~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.......+..+.+++..||+.||++|||+.|++++.+...
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 1111334567899999999999999999999999977643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=364.34 Aligned_cols=261 Identities=17% Similarity=0.269 Sum_probs=210.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|...+.||+|+||.||+|+.+ +|+.||||++..... ......+..|++++++++||||+++++++.. .+..+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEEE
Confidence 467888999999999999999986 699999999975421 1234678899999999999999999998843 57899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-----IvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC-----CcccCCChHHEEEeCCCCEEEeeccee
Confidence 999999999999999865543456999999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...............+.... ...+
T Consensus 337 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p 413 (543)
T 3c4z_A 337 VELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYP 413 (543)
T ss_dssp EECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCC
T ss_pred eeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCC
Confidence 87654322 12234688999999999999999999999999999999999999976432111111112222221 1234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTM-----EAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~L~~ 578 (589)
...+..+.+++..|++.||++||++ ++++++-+.
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 4556788999999999999999965 778766443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.07 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=182.4
Q ss_pred ccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEEeCC
Q 007788 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFAP 391 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~Ey~~ 391 (589)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.++.++. ||||+++++++.+ .+..++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEccC
Confidence 478999999999999986 6899999999643 3456789999999997 9999999999954 578999999999
Q ss_pred CCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC---ceEEcccccccccc
Q 007788 392 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---NPLIADCGLHKLLA 468 (589)
Q Consensus 392 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfGla~~~~ 468 (589)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++...
T Consensus 90 ~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 90 GGELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG-----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp SCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999998653 4899999999999999999999988 99999999999998765 89999999998664
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh---hhhHHHhhccccCCCC--
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---SATFENFIDRNLKGKF-- 543 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~-- 543 (589)
.... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||......... ......+.........
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 161 PDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp C-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 4322 222345688899999999999999999999999999999999999764321110 1111122211111110
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
....+..+.+++..|++.||++|||++|++++-+..
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 123467899999999999999999999999887653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=343.00 Aligned_cols=261 Identities=19% Similarity=0.346 Sum_probs=192.8
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeec------CC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCS------RG 379 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~------~~ 379 (589)
..+|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.++. ||||+++++++.. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 457888999999999999999975 78999999986553 445567899999999996 9999999998842 23
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEc
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 459 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~ 459 (589)
....++||||+. |+|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK---PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS---SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEEccCCcccEEECCCCCEEEe
Confidence 346899999995 799999876432 235999999999999999999999875 459999999999999999999999
Q ss_pred cccccccccCCceee-----------eecCCccccccCcccc---cCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH
Q 007788 460 DCGLHKLLADDIVFS-----------VLKTSAAMGYLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 525 (589)
Q Consensus 460 DfGla~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~ 525 (589)
|||+++......... .....+++.|+|||.+ .+..++.++||||||+++|||+||+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432211 1133477889999998 56678999999999999999999999996543211
Q ss_pred HhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 526 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.................+.+++..||+.||++||++.|++++|+.+...
T Consensus 261 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 --------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111112222334588999999999999999999999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=337.60 Aligned_cols=259 Identities=17% Similarity=0.296 Sum_probs=192.7
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHH-HHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~-~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|+..+.||+|+||.||+|... +|+.||||++..........+ +.++...++.++||||+++++++.. .+..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEEE
Confidence 467888999999999999999974 789999999976644333333 4445556888899999999999954 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
||||++ |+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-----VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC-----CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 999997 599888876433345699999999999999999999987 7 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccc----cCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYV----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
+....... .....+++.|+|||.+ .+..++.++||||||+++|||+||+.||....... ............
T Consensus 158 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~ 232 (290)
T 3fme_A 158 GYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF---QQLKQVVEEPSP 232 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---HHHHHHHHSCCC
T ss_pred cccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH---HHHHHHhccCCC
Confidence 87654322 2233578889999996 55678999999999999999999999997532211 111222222222
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.......+..+.+++..|++.||++|||+.|++++-+..
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 222234466789999999999999999999999976654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.03 Aligned_cols=251 Identities=18% Similarity=0.275 Sum_probs=205.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEE
Confidence 457888999999999999999976 57899999997654 2345679999999999999999999999854 5789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee---cCCCceEEccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl 463 (589)
|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 85 MELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 99999999999997654 3899999999999999999999988 9999999999999 8889999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
+........ .....+++.|+|||.+.+ .++.++||||||+++|||++|+.||......... ..+..... ..
T Consensus 156 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~--~~ 226 (277)
T 3f3z_A 156 AARFKPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM----LKIREGTF--TF 226 (277)
T ss_dssp CEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCC--CC
T ss_pred ceeccCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCC--CC
Confidence 987654332 223457889999998865 4899999999999999999999999764332111 11111111 11
Q ss_pred CH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 544 SE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 544 ~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+. ..+..+.+++..|++.||++|||+.|++++-+..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 22 2356789999999999999999999999876643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.42 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=191.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHH-HhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYL-LTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|+.+ +++.||||++..... ......+..|..+ ++.++||||+++++++.. .+..+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~~ 115 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLY 115 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEEE
Confidence 57888999999999999999986 588999999976542 2233456677766 577899999999999854 57899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 116 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEeeCccc
Confidence 9999999999999998654 3889999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...++.... ..+
T Consensus 187 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~--~~~ 259 (373)
T 2r5t_A 187 KENIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----YDNILNKPL--QLK 259 (373)
T ss_dssp GGGBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH----HHHHHHSCC--CCC
T ss_pred cccccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHhccc--CCC
Confidence 86432211 22344688999999999999999999999999999999999999976543222 222222222 123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTME 570 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~ 570 (589)
......+.+++..|++.||++||++.
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 34456789999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=336.38 Aligned_cols=252 Identities=18% Similarity=0.337 Sum_probs=204.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|...+.||+|+||.||+|... +++.||||++..... .....++.+|+..+.++ +||||+++++++.+ .+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 467889999999999999999986 799999999986532 34557788999999999 89999999999854 46899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC------------
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ------------ 452 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~------------ 452 (589)
+||||+++|+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-----LVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEC-------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecCCCHHHEEEcCCCCCcccccccc
Confidence 999999999999999875433345899999999999999999999988 999999999999984
Q ss_pred -------CCceEEccccccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHH
Q 007788 453 -------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRL 524 (589)
Q Consensus 453 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~ 524 (589)
...+||+|||.+....... ...++..|+|||.+.+. .++.++||||||+++|||++|..++......
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp -------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred cccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 4479999999998765432 23478889999999876 5668999999999999999999876543221
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+.. ......+...+..+.+++..||+.||++|||+.|++++-+..
T Consensus 238 -------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 -------HEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp -------HHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred -------HHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 11111 111223334456799999999999999999999999876643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=342.42 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=206.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch-----HHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-----EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
.++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++.+++||||+++++++.. .+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 356888999999999999999976 68999999997654221 35679999999999999999999999854 47
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC----ceE
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPL 457 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~----~~k 457 (589)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~-----ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChHHEEEecCCCCcCCEE
Confidence 8999999999999999997543 4899999999999999999999988 99999999999999888 799
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+...
T Consensus 160 l~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~ 233 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----ANITSV 233 (321)
T ss_dssp ECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTT
T ss_pred EccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhc
Confidence 999999987654321 22345788999999999999999999999999999999999999754322111 111111
Q ss_pred ccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 538 NLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 538 ~~~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.. ..+. ..+..+.+++..|++.||++|||+.|++++-+.
T Consensus 234 ~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 234 SY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp CC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred cc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 11 1111 234578999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=345.12 Aligned_cols=260 Identities=18% Similarity=0.351 Sum_probs=196.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|...+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEEe
Confidence 46888899999999999999986 7899999999765433323356679999999999999999999854 47789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||++ |+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 80 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQK-----VLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp ECCS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred cccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 9997 599999876542 4899999999999999999999988 999999999999999999999999999865
Q ss_pred cCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh-----------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI----------- 535 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------- 535 (589)
..... ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||................-
T Consensus 151 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 151 SIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 43221 2223456888999999876 5689999999999999999999999976432211111100000
Q ss_pred ------c---cccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 536 ------D---RNLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 536 ------~---~~~~~~----~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
. +..... ........+.+++..|++.||++|||++|++++-+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0 000000 01123457889999999999999999999999877543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=345.90 Aligned_cols=262 Identities=18% Similarity=0.259 Sum_probs=205.6
Q ss_pred cCHHHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-----CCCcccee
Q 007788 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----HENIIRLR 372 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~ 372 (589)
+++.+.....++|...+.||+|+||.||+|+.. +++.||||++... ......+..|++++.++. ||||++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344444455688999999999999999999974 7899999999743 344567788999999986 99999999
Q ss_pred eeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 373 g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+++.. .+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 103 ~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 103 GKFMY--YDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS-----LTHTDLKPENILLDD 172 (360)
T ss_dssp EEEEE--TTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESC
T ss_pred ceeeE--CCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCcccEEEcc
Confidence 99855 46899999999 9999999986542 24899999999999999999999988 999999999999975
Q ss_pred -------------------------CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHH
Q 007788 453 -------------------------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVI 507 (589)
Q Consensus 453 -------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvv 507 (589)
++.+||+|||+++...... ....+|+.|+|||++.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 7899999999998654422 23457889999999999999999999999999
Q ss_pred HHHHHhCCCCcchhHHHHHhhhhHHHhh--------------------ccc-----cCCCC-C---------------HH
Q 007788 508 ILQILTGSLVLTSSMRLAAESATFENFI--------------------DRN-----LKGKF-S---------------ES 546 (589)
Q Consensus 508 l~elltg~~p~~~~~~~~~~~~~~~~~~--------------------~~~-----~~~~~-~---------------~~ 546 (589)
+|||+||+.||........... +.... +.. ..... . ..
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHHCCCCCCCCcHHHHHHH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 9999999999965322111000 00000 000 00000 0 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+.+++..||+.||++|||++|++++-+
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 1256789999999999999999999997644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=346.08 Aligned_cols=249 Identities=19% Similarity=0.314 Sum_probs=205.1
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhccCCCCccceeeeeecC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSR 378 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 378 (589)
..++|...+.||+|+||.||+|... +++.||||++...... .....+.+|++++++++||||+++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3568999999999999999999964 7899999999765321 123457789999999999999999999843
Q ss_pred CCCeEEEEEEeCCCC-ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 379 GRGECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
.+..++||||+..| +|.+++.... .+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~k 170 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIK 170 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEE
T ss_pred -CCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEEeccCHHHEEEcCCCcEE
Confidence 57899999999877 9999997543 3899999999999999999999988 99999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
|+|||+++....... .....+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ..
T Consensus 171 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~ 238 (335)
T 3dls_A 171 LIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VE 238 (335)
T ss_dssp ECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TT
T ss_pred EeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------Hh
Confidence 999999987654432 122457889999999988776 78999999999999999999999653221 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
... ..+...+..+.+++..||+.||++|||++|++++-+...
T Consensus 239 ~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 AAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp TCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred hcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 111 112223557899999999999999999999999877543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=357.42 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=206.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++.. .+..++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~l 93 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIFM 93 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 56788899999999999999976 799999999975421 1234578899999999999999999999854 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 94 v~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp EEECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCcccccHHHEEEecCCCeEEEeccchh
Confidence 999999999999997543 4899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
....... .....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ...+.+... ..+
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~--~~p 236 (476)
T 2y94_A 165 MMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL----FKKICDGIF--YTP 236 (476)
T ss_dssp ECCTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH----HHHHHTTCC--CCC
T ss_pred hcccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCc--CCC
Confidence 7654322 223457889999999988765 6899999999999999999999975432211 122222211 123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+.+++..|++.||++|||++|++++-+..
T Consensus 237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 33456789999999999999999999999986654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=352.83 Aligned_cols=258 Identities=17% Similarity=0.279 Sum_probs=198.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~ 381 (589)
.++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999865 689999999975432 344567889999999999999999999985432 24
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChHhEEEeCCCCEEEEEE
Confidence 67999999976 46666642 2889999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------- 531 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~---------- 531 (589)
|+++....... .....+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+...........
T Consensus 209 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 209 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CCC-----CCC--C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EeeeecCCCcc--cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99987654321 233467889999999999999999999999999999999999997643221111111
Q ss_pred --------HHhhccc---------------cCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 532 --------ENFIDRN---------------LKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 532 --------~~~~~~~---------------~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+... ..... .......+.+++.+|++.||++|||++|++++-+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0111100 00000 012256789999999999999999999999987653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=332.88 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=201.8
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC--CCCeEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECFL 385 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~l 385 (589)
.|...+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+.++++++||||+++++++... .....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3566778999999999999875 688999999976542 34457799999999999999999999987542 2456899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-CCCceEEcccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLH 464 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGla 464 (589)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||||+||+++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCC---CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999998653 3899999999999999999999875 4599999999999998 7899999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
........ ....+++.|+|||.+. +.++.++||||||+++|||++|+.||.......... ..+.........+
T Consensus 180 ~~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 180 TLKRASFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFD 252 (290)
T ss_dssp GGCCTTSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGG
T ss_pred cccccccc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH---HHHhccCCccccC
Confidence 76554322 2345788999999876 469999999999999999999999996532211111 1111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+.+++..||+.||++|||++|++++-+.
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 2223568999999999999999999999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.88 Aligned_cols=259 Identities=19% Similarity=0.295 Sum_probs=205.0
Q ss_pred ccCccccccccCCCccEEEEEe----cCCcEEEEEEeccCCC---chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~ 380 (589)
++|...+.||+|+||.||+|+. .+++.||||+++.... ......+.+|++++.++ +||||+++++++.. .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--C
Confidence 5788899999999999999997 3789999999875321 12234577899999999 69999999998854 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESC
T ss_pred ceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCcEEEee
Confidence 68899999999999999998654 3899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCC--CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
||+++..............+|+.|+|||++.+. .++.++|||||||++|||+||+.||...............+...
T Consensus 203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~- 281 (355)
T 1vzo_A 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS- 281 (355)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-
Confidence 999986643322222334588999999999863 47899999999999999999999996432111111111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhh
Q 007788 539 LKGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVAA 580 (589)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~~ 580 (589)
....+......+.+++.+||+.||++|| +++|++++.+...
T Consensus 282 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 282 -EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 1233445566789999999999999999 9999999877643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=364.21 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=211.0
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
..++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|++++.+++|||||++++++.+ .+..
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEE
Confidence 3567899999999999999999986 799999999965321 2234568899999999999999999998844 5789
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g-----IvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCchheEEEeCCCCeEEEeccc
Confidence 999999999999999976432 24899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+...+. .....+
T Consensus 333 a~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-~i~~~i~-~~~~~~ 408 (576)
T 2acx_A 333 AVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVK-EVPEEY 408 (576)
T ss_dssp CEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-HHHHHHH-HCCCCC
T ss_pred ceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-HHHHHhh-cccccC
Confidence 987754432 233468999999999999899999999999999999999999997642211101 1111111 112223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA 579 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~~ 579 (589)
+...+..+.+++..|++.||++|| +++|+++|-+..
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 444567899999999999999999 789999886643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=370.59 Aligned_cols=261 Identities=21% Similarity=0.378 Sum_probs=210.6
Q ss_pred HhhccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
...++|...+.||+|+||.||+|.+. .+..||||++...........|.+|+.++++++||||+++++++.+ +
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---C
Confidence 34577888999999999999999874 2568999998766545556789999999999999999999999832 4
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCC
T ss_pred ceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchHhEEEeCCCCEEEEec
Confidence 6899999999999999997653 24899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
|+++..............+++.|+|||.+.+..++.++||||||+++|||++ |..||.+...... ... +.....
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----~~~-i~~~~~ 610 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----IGR-IENGER 610 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHH-HHHTCC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHH-HHcCCC
Confidence 9998876544333334456778999999998899999999999999999997 8899875432211 111 111222
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...+...+..+.+++..||+.||++|||+.|+++.|+.+...
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 233445567899999999999999999999999999987543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=335.64 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=199.6
Q ss_pred ccCccccccccCCCccEEEEEec--CCc--EEEEEEeccCC--CchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR--DGT--LVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|+..+.||+|+||.||+|.+. +++ .||||+++... .....+.|.+|++++.+++||||+++++++.. +.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 94 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 94 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc---CC
Confidence 57888899999999999999864 333 68999987543 23455789999999999999999999999854 34
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEEcCCCCEEEcccc
Confidence 7899999999999999986542 3899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCcee--eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 463 LHKLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 463 la~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~ 242 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGE 242 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCC
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHccCC
Confidence 99876543221 1223346678999999998889999999999999999999 999997543221 1122222222
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
....+...+..+.+++..||+.||++|||+.++++.|+.+.+.
T Consensus 243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 2233445567899999999999999999999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.59 Aligned_cols=259 Identities=17% Similarity=0.272 Sum_probs=199.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|++++++++||||+++++++.. .+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence 57888999999999999999986 5899999998765432 334678899999999999999999999954 4788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN-----CIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp EECCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 99999999999886543 3899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH----------Hhh
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----------NFI 535 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~----------~~~ 535 (589)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ...
T Consensus 152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 152 LTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp CC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 653322 1223457888999999876 5689999999999999999999999975432211110000 000
Q ss_pred c-c------ccC---CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 536 D-R------NLK---GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 536 ~-~------~~~---~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
. . ... ... .+..+..+.+++..||+.||++|||++|++++-+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 0 0 000 000 012355688999999999999999999999886543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.19 Aligned_cols=256 Identities=16% Similarity=0.300 Sum_probs=209.7
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEEE
Confidence 357888899999999999999986 588999999875432 3345678999999999999999999999854 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp EEEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEcCCCCEEEEeccCc
Confidence 9999999999999987653 3899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.... ...+
T Consensus 163 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~--~~~~ 235 (294)
T 2rku_A 163 TKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNE--YSIP 235 (294)
T ss_dssp EECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTC--CCCC
T ss_pred eecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhcc--CCCc
Confidence 87643221 12234578889999999998899999999999999999999999976432211 11111111 1223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
......+.+++..||+.||++|||++|++++.+....
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 3445678999999999999999999999998776443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.37 Aligned_cols=251 Identities=22% Similarity=0.364 Sum_probs=207.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++.. .+..++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 91 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIYL 91 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEEE
Confidence 56888899999999999999976 688999999865321 1224678999999999999999999999854 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK-----VIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEEcCCCCEEEecccccc
Confidence 999999999999998654 3899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.... ...+.
T Consensus 163 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~--~~~~~ 233 (284)
T 2vgo_A 163 HAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----HRRIVNVD--LKFPP 233 (284)
T ss_dssp ECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTC--CCCCT
T ss_pred cCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----HHHHhccc--cCCCC
Confidence 654322 1234578889999999999999999999999999999999999975432211 11122211 12334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+..+.+++..|++.||++||+++|++++-+..
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 4556789999999999999999999999886654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.95 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=203.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++.. .+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 56888999999999999999986 6899999998765321 135689999999999999999999999854 478
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC----ceEE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLI 458 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl 458 (589)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChHHEEEecCCCCCCceEE
Confidence 999999999999999997653 3899999999999999999999988 99999999999999877 8999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
+|||++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+....
T Consensus 154 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~ 227 (283)
T 3bhy_A 154 IDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET----LTNISAVN 227 (283)
T ss_dssp CCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTC
T ss_pred EecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH----HHHhHhcc
Confidence 99999987654321 2234578889999999999999999999999999999999999975432211 11111111
Q ss_pred cCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 539 LKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 539 ~~~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+ ...+..+.+++.+|++.||++||++.|++++-+.
T Consensus 228 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 228 --YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp --CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred --cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 1111 1234578999999999999999999999987553
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=334.17 Aligned_cols=255 Identities=21% Similarity=0.367 Sum_probs=186.4
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+.++.+++||||+++++++.. .+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEE
Confidence 35788889999999999999997 4789999999965321 1223678999999999999999999999854 57899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG-----ILHRDLTLSNLLLTRNMNIKIADFGLA 159 (278)
T ss_dssp EEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEEeecce
Confidence 9999999999999997643 34899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......... ...+
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~--~~~~ 232 (278)
T 3cok_A 160 TQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----TLNKVVLAD--YEMP 232 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSC--CCCC
T ss_pred eeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----HHHHHhhcc--cCCc
Confidence 87643221 1223457888999999999899999999999999999999999996532111 111111111 1123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...+..+.+++.+|++.||++|||+++++++-+..
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 267 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence 33456789999999999999999999999876644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=335.26 Aligned_cols=263 Identities=14% Similarity=0.201 Sum_probs=204.0
Q ss_pred hhccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|++++.+++|++++..++++... .+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 347899999999999999999996 5789999998765432 23578899999999999999888877543 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee---cCCCceEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG 462 (589)
||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||
T Consensus 83 v~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 99999 9999999975432 4999999999999999999999988 9999999999999 789999999999
Q ss_pred ccccccCCcee------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 463 LHKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 463 la~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
+++........ ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ......+..
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 232 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISE 232 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-hhhhhhhhc
Confidence 99876543221 12234578899999999999999999999999999999999999975321100 000111111
Q ss_pred cccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 537 RNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 537 ~~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
...... .....+..+.+++..||+.||++|||++++++.|+.+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 111000 01122467999999999999999999999999999876643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=346.08 Aligned_cols=260 Identities=15% Similarity=0.192 Sum_probs=203.7
Q ss_pred ccCccccccccCCCccEEEEEecC---------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccc---------
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRD---------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR--------- 370 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~--------- 370 (589)
++|...+.||+|+||.||+|.... ++.||||++... ..+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 578888999999999999999763 789999998754 25789999999999999998
Q ss_pred ------eeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCC
Q 007788 371 ------LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 444 (589)
Q Consensus 371 ------l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk 444 (589)
+++++.. ..+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 116 ~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dik 186 (352)
T 2jii_A 116 LLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE-----YVHGNVT 186 (352)
T ss_dssp TCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCC
T ss_pred ccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCC
Confidence 5666644 246889999999 999999998652 124999999999999999999999988 9999999
Q ss_pred CCCeeecCCC--ceEEccccccccccCCceee------eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCC
Q 007788 445 VEKVLIDQQF--NPLIADCGLHKLLADDIVFS------VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516 (589)
Q Consensus 445 ~~Nill~~~~--~~kl~DfGla~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~ 516 (589)
|+||+++.++ .+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 89999999998765432111 122357889999999999999999999999999999999999
Q ss_pred CcchhHHHHHhhh-hHHHhhccc--cCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 517 VLTSSMRLAAESA-TFENFIDRN--LKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 517 p~~~~~~~~~~~~-~~~~~~~~~--~~~--~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
||........... ....+.... +.. ......+..+.+++..||+.||++||+++++++.|+.+....
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 9976531111111 111111110 000 000123567999999999999999999999999999876553
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=356.43 Aligned_cols=250 Identities=14% Similarity=0.181 Sum_probs=192.9
Q ss_pred hhccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCC--CchHHHHHHHHH---HHHhccCCCCcccee-------e
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS--CKSEEAEFVKGL---YLLTSLRHENIIRLR-------G 373 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~---~~l~~l~H~niv~l~-------g 373 (589)
..++|...+.||+|+||.||+|.. .+|+.||||++.... .....+.|.+|+ +.+++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788889999999999999996 469999999997532 234557889999 556666899999998 4
Q ss_pred eeecCCC----------C-----eEEEEEEeCCCCChHHHhhhhcCC---CCCCCHHHHHHHHHHHHHHhHHhcCCCCCC
Q 007788 374 FCCSRGR----------G-----ECFLIYDFAPKGKLSKYLDQEEGS---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435 (589)
Q Consensus 374 ~~~~~~~----------~-----~~~lv~Ey~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 435 (589)
++..... + ..++||||+ +|+|.+++...... ...++|..++.|+.||+.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4432210 1 378999999 68999999864321 123556888999999999999999988
Q ss_pred CCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccCC-----------CCCCcchhhhH
Q 007788 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-----------RFTERSDIFAF 504 (589)
Q Consensus 436 ~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~s~ 504 (589)
|+||||||+|||++.++.+||+|||+++.... ......+ +.|+|||++.+. .++.++|||||
T Consensus 227 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 227 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred --eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 99999999999999999999999999986443 2223445 889999999887 89999999999
Q ss_pred HHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 505 GVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 505 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
||++|||+||+.||........ ...+.. . ....+..+.+++..||+.||++|||+.|++++-+
T Consensus 300 G~il~elltg~~Pf~~~~~~~~----~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGG----SEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHHHHSSCCC------CC----SGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHHHHCCCCCcccccccc----hhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 9999999999999965432211 111111 0 1123457889999999999999999999998644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=341.62 Aligned_cols=260 Identities=20% Similarity=0.333 Sum_probs=195.6
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
..++|...+.||+|+||.||+|... +++.||||++...... .....+.+|++++++++||||+++++++.. .+..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence 4568999999999999999999865 7899999999765432 234568899999999999999999999854 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-----CCCceEEc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-----QQFNPLIA 459 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-----~~~~~kl~ 459 (589)
+||||++ |+|.+++.... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 110 lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR-----CLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EECCCCCHHHEEEecCCCCccceEEEC
Confidence 9999997 59999997653 3899999999999999999999988 99999999999994 55569999
Q ss_pred cccccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc-
Q 007788 460 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR- 537 (589)
Q Consensus 460 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~- 537 (589)
|||+++....... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||................-.+
T Consensus 180 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 180 DFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp CTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence 9999987643221 22234568889999999875 48999999999999999999999997643322111111110000
Q ss_pred ------------------ccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 538 ------------------NLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 538 ------------------~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...... .......+.+++..|++.||++|||++|++++-+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 323 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence 000000 011346788999999999999999999999886654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.38 Aligned_cols=262 Identities=15% Similarity=0.201 Sum_probs=206.7
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|+. .+++.||||++..... ..++.+|+.++.+++|++++..++++... .+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCC-CCceEEE
Confidence 46788899999999999999997 5799999999876542 23588999999999999988888777543 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee---cCCCceEEccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl 463 (589)
|||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 9999 9999999975432 4999999999999999999999988 9999999999999 5889999999999
Q ss_pred cccccCCcee------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 464 HKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 464 a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
++........ ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 233 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEK 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhccc
Confidence 9876543221 12334578899999999999999999999999999999999999975321000 0001111111
Q ss_pred ccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 538 NLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 538 ~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..... .....+..+.+++..||+.||++|||+.++++.|+.+....
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 10000 01123467999999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.27 Aligned_cols=255 Identities=16% Similarity=0.299 Sum_probs=209.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.++++++||||+++++++.+ .+..+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 467888899999999999999976 588999999875432 3445678999999999999999999999954 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 118 lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp EEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CEecCCCchhEEEcCCCCEEEeeccCc
Confidence 9999999999999987653 3899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+..... ..+
T Consensus 189 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~--~~~ 261 (335)
T 2owb_A 189 TKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEY--SIP 261 (335)
T ss_dssp EECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCC--CCC
T ss_pred eecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHhcCCC--CCC
Confidence 87643221 122345788899999999988999999999999999999999999754322111 11111111 123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
......+.+++.+||+.||++||+++|++++-+...
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 344567889999999999999999999999876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=331.30 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=201.9
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
+|....+||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEE
Confidence 3455568999999999999974 68899999997654 3445679999999999999999999999954 468899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfGla~~~ 467 (589)
|+++++|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 100 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 100 QVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp CCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred eCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC-----EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999986532 234778999999999999999999988 999999999999998 899999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCCC--CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||......... .............+.
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 174 AGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMFKVHPEIPE 249 (295)
T ss_dssp CC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHHCCCCCCCT
T ss_pred CCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhccccccccccc
Confidence 53221 122345788999999987654 889999999999999999999999653221111 011111122223344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+..+.+++..||+.||++||++.|++++-+.
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 556788999999999999999999999987554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.24 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=204.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++.. .+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEE
Confidence 357888999999999999999976 78999999998653 2334578899999999999999999999854 5789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee---cCCCceEEccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl 463 (589)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 85 MQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp ECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred EEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 99999999999997654 3899999999999999999999988 9999999999999 7889999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc--CC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KG 541 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 541 (589)
+....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+..... ..
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~ 228 (304)
T 2jam_A 156 SKMEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL----FEKIKEGYYEFES 228 (304)
T ss_dssp TCCCCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHCCCCCCT
T ss_pred ceecCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCCCCc
Confidence 87654321 1123477889999999999999999999999999999999999975433211 111111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+..+.+++..|++.||++||++.|++++.+..
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 22234457799999999999999999999999886653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.64 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=197.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC----C
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----~ 381 (589)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|++++++++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888999999999999999975 799999999965432 3345678999999999999999999999854321 3
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCHHHEEEcCCCCEEEEee
Confidence 569999999 88999999753 3899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH--------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-------- 532 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~-------- 532 (589)
|+++..... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+............
T Consensus 173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999876542 223457888999999887 6799999999999999999999999975432211111000
Q ss_pred -----------Hhhcc--ccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 533 -----------NFIDR--NLK----GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 533 -----------~~~~~--~~~----~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+.. ... ..........+.+++.+|++.||++|||++|++++-+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 00000 000 01112335678999999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.76 Aligned_cols=258 Identities=21% Similarity=0.284 Sum_probs=197.1
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-------chHHHHHHHHHHHHhccCCCCccceeeeeecC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-------KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR 378 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 378 (589)
..++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4578999999999999999999875 689999999975421 1122358899999999999999999999743
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC---Cc
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FN 455 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~---~~ 455 (589)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSSSCC
T ss_pred --CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCCCcce
Confidence 46899999999999999987543 4899999999999999999999988 9999999999999754 45
Q ss_pred eEEccccccccccCCceeeeecCCccccccCcccccC---CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 532 (589)
+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ...
T Consensus 281 ~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~ 354 (419)
T 3i6u_A 281 IKITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLK 354 (419)
T ss_dssp EEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHH
T ss_pred EEEeecccceecCCCcc--ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHH
Confidence 99999999987754322 223457889999999864 568889999999999999999999996532110 111
Q ss_pred HhhccccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 533 NFIDRNLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 533 ~~~~~~~~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..+........+ ...+..+.+++.+|++.||++|||++|++++-+...+.
T Consensus 355 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 355 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred HHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 111111111111 12356789999999999999999999999987765443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.66 Aligned_cols=262 Identities=22% Similarity=0.300 Sum_probs=199.1
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch----HHHHHHHHHHHHhccCCCCccceeeeeecCCCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS----EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 381 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 381 (589)
..++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|++++++++||||+++++++. ..+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--eCC
Confidence 4568999999999999999999976 68999999997543211 1246889999999999999999999984 456
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCHHHEEEcCCCCEEEEec
Confidence 78999999986 8988887543 24888899999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc-
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL- 539 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 539 (589)
|+++....... ......+|+.|+|||.+.+. .++.++|||||||++|||++|..||............+.....+..
T Consensus 157 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 157 GLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp GGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 99987654321 22334578899999998764 4899999999999999999999998765432221111111100000
Q ss_pred ----------------CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 540 ----------------KGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 540 ----------------~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
....+ ......+.+++..|++.||++|||+.|++++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 00001 223467999999999999999999999999877643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=339.53 Aligned_cols=262 Identities=19% Similarity=0.315 Sum_probs=202.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC------C
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~ 380 (589)
++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|++++++++||||+++++++.... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999984 789999999865543 223457889999999999999999999986543 3
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++ +|.+.+..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCCEEEcc
Confidence 568999999975 78777765432 4899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCc---eeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 461 CGLHKLLADDI---VFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 461 fGla~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
||+++...... ........+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||............ .....
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~ 246 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI-SQLCG 246 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhC
Confidence 99998664221 112233457888999998876 45899999999999999999999999764332111110 00000
Q ss_pred ---cccC----------------C-CCC-HH------HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 537 ---RNLK----------------G-KFS-ES------EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 537 ---~~~~----------------~-~~~-~~------~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
+... . ... .. ....+.+++.+|++.||++|||++|++++-+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 0000 0 000 00 1345889999999999999999999999877644
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=348.61 Aligned_cols=261 Identities=18% Similarity=0.277 Sum_probs=199.4
Q ss_pred HHhhccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC----
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---- 379 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---- 379 (589)
+...++|...+.||+|+||.||+|.. .+|+.||||++..... ...+|++++++++||||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34567899999999999999999987 4799999999875432 2336899999999999999999885432
Q ss_pred --------------------------------CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHH
Q 007788 380 --------------------------------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427 (589)
Q Consensus 380 --------------------------------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~ 427 (589)
....++||||++ |+|.+.+.........+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 234789999998 58888887543334569999999999999999999
Q ss_pred hcCCCCCCCCeEecCCCCCCeeec-CCCceEEccccccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHH
Q 007788 428 LHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFG 505 (589)
Q Consensus 428 LH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G 505 (589)
||+.+ |+||||||+||+++ .++.+||+|||+++...... ......++..|+|||.+.+. .++.++||||+|
T Consensus 157 LH~~g-----i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 157 IHSLG-----ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHTTT-----EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHCc-----CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 99988 99999999999998 68899999999998764432 22234568889999998775 489999999999
Q ss_pred HHHHHHHhCCCCcchhHHHHHhhhhHH--------Hh--hccc--------cCC-----CCCHHHHHHHHHHHHHhcccC
Q 007788 506 VIILQILTGSLVLTSSMRLAAESATFE--------NF--IDRN--------LKG-----KFSESEAAKLGKMALVCTHED 562 (589)
Q Consensus 506 vvl~elltg~~p~~~~~~~~~~~~~~~--------~~--~~~~--------~~~-----~~~~~~~~~l~~l~~~C~~~d 562 (589)
|++|||++|+.||.+............ .+ .++. ... ..+...+..+.+++.+|++.|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999999976433221111110 00 0000 000 012234567899999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 007788 563 PENRPTMEAVIEELTV 578 (589)
Q Consensus 563 p~~RPs~~evl~~L~~ 578 (589)
|++|||+.|++++-+.
T Consensus 310 P~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFF 325 (383)
T ss_dssp GGGSCCHHHHHTSGGG
T ss_pred hhhCCCHHHHhcCHHH
Confidence 9999999999987553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.35 Aligned_cols=271 Identities=17% Similarity=0.260 Sum_probs=205.9
Q ss_pred ccCHHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCc----------hHHHHHHHHHHHHhccCCCC
Q 007788 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK----------SEEAEFVKGLYLLTSLRHEN 367 (589)
Q Consensus 298 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~~~~~e~~~l~~l~H~n 367 (589)
+..++++....++|...+.||+|+||.||+|...+|+.||||++...... ...+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 34567888899999999999999999999999888999999998654321 12367999999999999999
Q ss_pred ccceeeeeecC---CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCC
Q 007788 368 IIRLRGFCCSR---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 444 (589)
Q Consensus 368 iv~l~g~~~~~---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk 444 (589)
|+++++++... .....++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlk 161 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG-----VVHRDLH 161 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCC
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc-----CEecCCC
Confidence 99999998643 2346899999997 68888887543 24899999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHH
Q 007788 445 VEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMR 523 (589)
Q Consensus 445 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~ 523 (589)
|+||+++.++.+||+|||+++...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp GGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999997554332 2223457788999999877 6789999999999999999999999975432
Q ss_pred HHHhhhh-------------------HHHhhccccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 524 LAAESAT-------------------FENFIDRNLKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 524 ~~~~~~~-------------------~~~~~~~~~~~~-------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....... ..+.+....... ........+.+++..|++.||++|||+.|++++-+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 2111110 011111111100 01122456889999999999999999999999866
Q ss_pred hh
Q 007788 578 VA 579 (589)
Q Consensus 578 ~~ 579 (589)
..
T Consensus 320 f~ 321 (362)
T 3pg1_A 320 FE 321 (362)
T ss_dssp GT
T ss_pred hh
Confidence 43
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.20 Aligned_cols=254 Identities=13% Similarity=0.196 Sum_probs=202.1
Q ss_pred hhccCccccccccCCCccEEEEE------ecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC---CCCccceeeeeec
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGT------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCS 377 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~ 377 (589)
..++|...+.||+|+||.||+|. ..+++.||||++... ...++..|++++.+++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45778889999999999999994 446889999999754 2446778888888886 9999999999854
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcC-CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC----
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---- 452 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---- 452 (589)
.+..++||||+++|+|.+++..... ....++|..++.|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-----ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECGGGTC
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEecccccC
Confidence 4678999999999999999986432 2345999999999999999999999988 999999999999998
Q ss_pred -------CCceEEccccccccccC-CceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHH
Q 007788 453 -------QFNPLIADCGLHKLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 524 (589)
Q Consensus 453 -------~~~~kl~DfGla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~ 524 (589)
++.+||+|||+++.+.. ..........+|.+|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999975532 1112334556899999999999999999999999999999999999999654221
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhc
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR-PTMEAVIEELTVAAP 581 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~R-Ps~~evl~~L~~~~~ 581 (589)
. .. +....... ...+.+.+++..|++.+|.+| |+++++.+.|+..-+
T Consensus 292 ~---~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 292 E---CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp E---EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred c---ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0 00 11111111 124567789999999999999 678888877776543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=350.33 Aligned_cols=257 Identities=13% Similarity=0.064 Sum_probs=186.2
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHH---HHHhccCCCCcccee-------ee
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGL---YLLTSLRHENIIRLR-------GF 374 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~---~~l~~l~H~niv~l~-------g~ 374 (589)
...|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+ ..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345778899999999999999975 789999999987653 23345677774 55555 799988754 33
Q ss_pred eecCCC---------------CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHH------HHHHHHHHHHhHHhcCCCC
Q 007788 375 CCSRGR---------------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR------VSIIIGIAKGIGYLHSSEV 433 (589)
Q Consensus 375 ~~~~~~---------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~ 433 (589)
+..... ...++||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 322211 34799999998 899999987532 2455566 788899999999999988
Q ss_pred CCCCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccC--CCCCCcchhhhHHHHHHHH
Q 007788 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQI 511 (589)
Q Consensus 434 ~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~el 511 (589)
|+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 215 ----ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 215 ----LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp ----EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred ----CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 999999999999999999999999999876532 224456688999999987 6799999999999999999
Q ss_pred HhCCCCcchhHHHHHhhhh---HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 512 LTGSLVLTSSMRLAAESAT---FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 512 ltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+||+.||............ .................+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 9999999765321110000 000001111111123446789999999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=343.39 Aligned_cols=254 Identities=19% Similarity=0.308 Sum_probs=201.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|+..+.||+|+||.||+|..+ +|+.||||++..... .+.+|++++.++ +||||+++++++. +.+..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYD--DGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEEEE
Confidence 467889999999999999999976 689999999976542 234678888888 7999999999984 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC----CceEEccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLIADC 461 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~----~~~kl~Df 461 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+||
T Consensus 94 v~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g-----ivHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 999999999999997543 4899999999999999999999998 9999999999998543 35999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc--
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-- 539 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 539 (589)
|+++....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.....
T Consensus 165 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 165 GFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-PEEILARIGSGKFSL 242 (342)
T ss_dssp TTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-HHHHHHHHHHCCCCC
T ss_pred CCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-HHHHHHHHccCCccc
Confidence 99987654321 1223457889999999988889999999999999999999999997531100 0111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
........+..+.+++..|++.||++||++.|++++-+..
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 1112234567789999999999999999999999987763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=336.78 Aligned_cols=257 Identities=18% Similarity=0.299 Sum_probs=197.8
Q ss_pred ccCccc-cccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l 385 (589)
+.|... +.||+|+||.||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.. .+..++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEE
Confidence 456663 78999999999999965 78999999997654 34456789999999985 79999999999854 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc---eEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG 462 (589)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG-----IAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 999999999999998754 3899999999999999999999988 999999999999998776 9999999
Q ss_pred ccccccCCce------eeeecCCccccccCcccccC-----CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHH------
Q 007788 463 LHKLLADDIV------FSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLA------ 525 (589)
Q Consensus 463 la~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~------ 525 (589)
++........ .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 9876542211 11123347889999999875 558899999999999999999999996532100
Q ss_pred ----H-hhhhHHHhhccccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 526 ----A-ESATFENFIDRNLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 526 ----~-~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
. .......+..... ..+. ..+..+.+++.+|++.||++|||+.|++++-+..
T Consensus 240 ~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred ccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 0 0001111111111 1222 2356789999999999999999999999986653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.30 Aligned_cols=264 Identities=21% Similarity=0.368 Sum_probs=203.8
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCC
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG 379 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 379 (589)
.++....++|...+.||+|+||.||+|... +++.||||++.... .....+.+|+.++.++ +||||+++++++....
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 344456788999999999999999999974 78999999997553 2345788999999999 7999999999986542
Q ss_pred ----CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 380 ----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 380 ----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
.+..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTCC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCcHHHEEEcCCCC
Confidence 4678999999999999999986532 24899999999999999999999988 999999999999999999
Q ss_pred eEEccccccccccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh
Q 007788 456 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 530 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 530 (589)
+||+|||++........ ......++..|+|||.+. +..++.++||||||+++|||++|+.||.........
T Consensus 168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--- 243 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--- 243 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---
T ss_pred EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---
Confidence 99999999887643221 122345788899999987 567899999999999999999999999654322111
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 531 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+.............+..+.+++..||+.||++||++++++++-+..
T Consensus 244 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 244 -FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp -HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred -HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 111111111111223456789999999999999999999999876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=327.44 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=198.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.. .+..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 88 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFFM 88 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEEE
Confidence 57888899999999999999986 799999999865321 2234578899999999999999999999854 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC-----SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChhhEEECCCCCEEEeeccccc
Confidence 999999999999997653 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
....... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ...+.... ...+
T Consensus 160 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~--~~~~ 231 (276)
T 2h6d_A 160 MMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL----FKKIRGGV--FYIP 231 (276)
T ss_dssp CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCC--CCCC
T ss_pred ccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCc--ccCc
Confidence 7654321 123457788999999988765 6899999999999999999999975432211 11111111 1123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+.+++..|++.||++|||++|++++-+.
T Consensus 232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 3345678999999999999999999999998665
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=335.19 Aligned_cols=253 Identities=16% Similarity=0.241 Sum_probs=201.6
Q ss_pred ccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|.. .+++.||||++... ....+.+|++++.+++ ||||+++++++........++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 6788899999999999999986 47899999998743 2457899999999997 9999999999976556788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHK 465 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGla~ 465 (589)
|||+++++|.+++.. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999999852 788999999999999999999988 99999999999999776 89999999998
Q ss_pred cccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh---------hhhHHHhh
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---------SATFENFI 535 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~ 535 (589)
....... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .....+.+
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 7654322 223457788999999887 66899999999999999999999999532111000 00111111
Q ss_pred ccc-----------------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 536 DRN-----------------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 536 ~~~-----------------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+.. ............+.+++..|++.||++|||++|++++-+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 100 00111122467789999999999999999999999886653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=349.68 Aligned_cols=261 Identities=16% Similarity=0.276 Sum_probs=187.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC---CCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~ 383 (589)
++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++|||||++++++.... ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57889999999999999999876 789999999975432 334567899999999999999999999985432 2568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+ +|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~-----iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cCCCCCChhhEEECCCCCEeeccccc
Confidence 9999998 579999987543 4999999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce--------------------------eeeecCCccccccCcccc-cCCCCCCcchhhhHHHHHHHHHh---
Q 007788 464 HKLLADDIV--------------------------FSVLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILT--- 513 (589)
Q Consensus 464 a~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvvl~ellt--- 513 (589)
++....... .......+|..|+|||++ ....++.++|||||||++|||+|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 987642210 112334568889999976 45679999999999999999999
Q ss_pred --------CCCCcchhHHHH----------------HhhhhHHHhh-----------------------cc---ccC---
Q 007788 514 --------GSLVLTSSMRLA----------------AESATFENFI-----------------------DR---NLK--- 540 (589)
Q Consensus 514 --------g~~p~~~~~~~~----------------~~~~~~~~~~-----------------------~~---~~~--- 540 (589)
|+.+|.+..... .....+..++ .. ...
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 555554321100 0000000000 00 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
....+.....+.+|+.+||+.||++|||++|++++-+..
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 000112356788999999999999999999999987653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=337.15 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=200.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|++++++++||||+++++++.. .+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 102 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYLV 102 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEEE
Confidence 57888899999999999999986 5899999998765433 334668899999999999999999999954 4788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp EECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 99999999988865443 3899999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------HH--
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------EN-- 533 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~----------~~-- 533 (589)
...... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||............. ..
T Consensus 174 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 174 LAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 643321 22234578889999999875 68999999999999999999999997543221111000 00
Q ss_pred --------hhccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 534 --------FIDRNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 534 --------~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+......+ +..+..+.+++.+||+.||++|||++|++++-+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00000111111 123567999999999999999999999998876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=330.55 Aligned_cols=258 Identities=21% Similarity=0.380 Sum_probs=199.2
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC--------
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR-------- 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-------- 378 (589)
.++|+..+.||+|+||.||+|... +++.||||++... ......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467889999999999999999975 7899999999653 34456789999999999999999999988643
Q ss_pred ---CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc
Q 007788 379 ---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 379 ---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
..+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG-----IIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHhEEEcCCCC
Confidence 2357899999999999999998643 24788999999999999999999988 999999999999999999
Q ss_pred eEEccccccccccCCc-------------eeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 456 PLIADCGLHKLLADDI-------------VFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
+||+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++ |+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999998764321 1112234577889999999764 68999999999999999998 44332
Q ss_pred HHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 522 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.........+.. .........+...+..+.+++..||+.||++|||++|++++-+..
T Consensus 232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (303)
T 1zy4_A 232 MERVNILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288 (303)
T ss_dssp HHHHHHHHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred hhHHHHHHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence 221111111111 111222233445566789999999999999999999999986654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.52 Aligned_cols=259 Identities=18% Similarity=0.239 Sum_probs=205.1
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC---chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++...+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367899999999999999999975 689999999975421 2345679999999999999999999999876656788
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||++++ |.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEcCCCcEEeecccc
Confidence 9999999876 777776543 235899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCc-eeeeecCCccccccCcccccCCC--CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 464 HKLLADDI-VFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 464 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
+....... ........++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~-- 229 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL----FENIGKGS-- 229 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHCC--
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HHHHhcCC--
Confidence 98764321 11223445788999999987644 37799999999999999999999976432211 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+......+.+++.+||+.||++|||++|++++.+...
T Consensus 230 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 1223345567889999999999999999999999876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=331.82 Aligned_cols=257 Identities=19% Similarity=0.356 Sum_probs=203.0
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+|+.++.+++||||+++++++.. .+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 3567889999999999999999976 58999999997643 23568899999999999999999999865 467899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 102 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR-----KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 999999999999997543 24899999999999999999999988 9999999999999999999999999997
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ........+.
T Consensus 174 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~ 249 (314)
T 3com_A 174 QLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPT--NPPPTFRKPE 249 (314)
T ss_dssp ECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHH--SCCCCCSSGG
T ss_pred hhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhc--CCCcccCCcc
Confidence 6654322 2233457888999999999999999999999999999999999997543221110 0000 0111111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
..+..+.+++..||+.||.+|||+.+++++-+...
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 34567899999999999999999999998766543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=354.49 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=205.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++.. .+..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 357889999999999999999976 789999999864321 2345678999999999999999999999854 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec---CCCceEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG 462 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 99 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEEECC
Confidence 999999999999987654 3899999999999999999999988 99999999999995 56679999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC-
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG- 541 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 541 (589)
+++...... ......+|+.|+|||++.+ .++.++||||+||++|||++|+.||......... ..+.......
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~ 242 (486)
T 3mwu_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVETGKYAFD 242 (486)
T ss_dssp CTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCSC
T ss_pred cCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC
Confidence 998765432 2234568899999999875 5999999999999999999999999765432211 1111111111
Q ss_pred -CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 -KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 -~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+..+.+++..||+.||++|||+.|++++-+..
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~ 281 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence 11123456789999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.28 Aligned_cols=261 Identities=20% Similarity=0.323 Sum_probs=204.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC---CCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~ 383 (589)
.++|+..+.||+|+||.||+|... +++.||||++...........+.+|++++.+++||||+++++++.... ....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888999999999999999975 688999999986554555578999999999999999999999985432 2468
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+. |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChHhEEECCCCCEEEEeCcc
Confidence 99999997 5999998653 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceee--eecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH--------
Q 007788 464 HKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-------- 532 (589)
Q Consensus 464 a~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~-------- 532 (589)
++......... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 98765432211 123467889999998765 4589999999999999999999999965432211111000
Q ss_pred -----------Hhhccc-cCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 533 -----------NFIDRN-LKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 533 -----------~~~~~~-~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
...... .....+ ......+.+++.+|++.||++|||+.|++++-+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 318 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 000000 000011 12346788999999999999999999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.22 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=206.3
Q ss_pred HHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-------hHHHHHHHHHHHHhcc-CCCCccceeee
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSL-RHENIIRLRGF 374 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~~e~~~l~~l-~H~niv~l~g~ 374 (589)
.....++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999986 7999999998765321 1235678999999999 79999999999
Q ss_pred eecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC
Q 007788 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~ 454 (589)
+.. .+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 169 ~~~--~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g-----i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 169 YES--SSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN-----IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEB--SSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTC
T ss_pred Eee--CCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCC
Confidence 854 478999999999999999998653 3899999999999999999999988 99999999999999999
Q ss_pred ceEEccccccccccCCceeeeecCCccccccCcccccC------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh
Q 007788 455 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528 (589)
Q Consensus 455 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~ 528 (589)
.+||+|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 238 ~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 314 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML- 314 (365)
T ss_dssp CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-
T ss_pred CEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 999999999887654321 233567889999998863 35888999999999999999999999754322111
Q ss_pred hhHHHhhccccCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 529 ATFENFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 529 ~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+.........+ ...+..+.+++..|++.||++|||+.|++++-+.
T Consensus 315 ---~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 315 ---RMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp ---HHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred ---HHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 1111111111000 1224568999999999999999999999987553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.08 Aligned_cols=261 Identities=20% Similarity=0.288 Sum_probs=205.4
Q ss_pred HHhhccCccc-cccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccC-CCCccceeeeeecCCC
Q 007788 305 ESATQCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGR 380 (589)
Q Consensus 305 ~~~~~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~ 380 (589)
+...++|... +.||+|+||.||+|... +++.||||++..... ......+.+|+.++.+++ ||||+++++++. ..
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--~~ 101 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--NT 101 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE--eC
Confidence 3344567766 88999999999999976 689999999976432 334568899999999995 699999999984 45
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCceE
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPL 457 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~k 457 (589)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g-----ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN-----IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESCBTTBCCEE
T ss_pred CeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCChHHEEEecCCCCCcEE
Confidence 78999999999999999986532 235899999999999999999999988 999999999999998 78999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||............ .. ...
T Consensus 175 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~~-~~~ 250 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-SQ-VNV 250 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HH-TCC
T ss_pred EeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH-Hh-ccc
Confidence 999999987654321 22345788999999999999999999999999999999999999764332211111 11 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.............+.+++..|++.||++|||++|++++-+.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 11122223456678999999999999999999999988664
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.77 Aligned_cols=255 Identities=19% Similarity=0.327 Sum_probs=200.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|+..+.||+|+||.||+|... +++.||+|++.... ......|.+|++++++++||||+++++++.. .+..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEEE
Confidence 467888999999999999999986 58999999987654 3445689999999999999999999999854 4678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 95 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp EECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred EEeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 999999999999876432 3899999999999999999999988 99999999999999999999999998754
Q ss_pred ccCCceeeeecCCccccccCcccc-----cCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc-C
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYV-----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-K 540 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 540 (589)
...... ......++..|+|||.+ .+..++.++||||||+++|||++|+.||......... ........ .
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~ 241 (302)
T 2j7t_A 167 NLKTLQ-KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LKIAKSDPPT 241 (302)
T ss_dssp HHHHHH-C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSCCCC
T ss_pred cccccc-ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH----HHHhccCCcc
Confidence 322111 11233578889999998 4667899999999999999999999999754322111 11111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+...+..+.+++..||+.||++|||+.|++++-+.
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 279 (302)
T 2j7t_A 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279 (302)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence 11233445678999999999999999999999986543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.64 Aligned_cols=269 Identities=18% Similarity=0.236 Sum_probs=195.3
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
++.....++|...+.||+|+||.||+|... +|+.||||++..... ....+.++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 455667789999999999999999999985 689999999865432 22356778888999999999999999864321
Q ss_pred -----CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhc--CCCCCCCCeEecCCCCCCeeecC-
Q 007788 381 -----GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH--SSEVNKPAIVHRNLSVEKVLIDQ- 452 (589)
Q Consensus 381 -----~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~~~ivH~dlk~~Nill~~- 452 (589)
...++||||+++ +|.+.+.........+++..+..++.|++.||+||| +.+ |+||||||+|||++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-----ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-----VCHRDIKPHNVLVNEA 167 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-----CBCSCCCGGGEEEETT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-----eecCcCCHHHEEEeCC
Confidence 237899999976 666555443333445899999999999999999999 777 999999999999997
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
++.+||+|||+++....... .....+|..|+|||++.+.. ++.++|||||||++|||+||+.||.............
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 89999999999987654332 22345788899999987654 8999999999999999999999997543221111111
Q ss_pred H----------Hhhccc----------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 532 E----------NFIDRN----------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 532 ~----------~~~~~~----------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
. ..+++. ............+.+++..|++.||++|||+.|++++-+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 0 000000 000111224678999999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=365.01 Aligned_cols=253 Identities=19% Similarity=0.278 Sum_probs=207.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCe
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 382 (589)
..++|...+.||+|+||.||+|+.. +++.||||+++... .......+..|..++..+ +||||+++++++ .+.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BCSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE--EeCCE
Confidence 4567999999999999999999976 68899999997532 123345678899999988 799999999988 44578
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----IiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS-----EECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeccCChhhEEEcCCCcEEEeecc
Confidence 999999999999999998764 3899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+..+..... .
T Consensus 488 la~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~--~ 560 (674)
T 3pfq_A 488 MCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNV--A 560 (674)
T ss_dssp TCEECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHSSCC--C
T ss_pred eeeccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCC--C
Confidence 9986432221 2234568999999999999999999999999999999999999997654322 2223333222 2
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHH
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTM-----EAVIEELT 577 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~-----~evl~~L~ 577 (589)
++...+..+.+++..|++.||++||++ +||+++-+
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 344566789999999999999999997 78876644
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=339.32 Aligned_cols=257 Identities=17% Similarity=0.273 Sum_probs=195.4
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~ 381 (589)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357888999999999999999875 689999999976432 334567889999999999999999999985432 13
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+++ +|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEEEe
Confidence 78999999974 78888752 2889999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------- 531 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~---------- 531 (589)
|+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.+...........
T Consensus 172 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 172 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp CC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred eccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998765432 1223457888999999999999999999999999999999999997543321111100
Q ss_pred --------HHhhc---------------cccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 --------ENFID---------------RNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 --------~~~~~---------------~~~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..... ....... .......+.+++.+|++.||++|||++|++++-+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 00000 0000000 12236788999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=337.79 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=187.1
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
...++|...+.||+|+||.||+|... +++.||||++..........++.+|+.++.+++||||+++++++.. .+..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES--SSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcE
Confidence 34578889999999999999999864 6899999998765544455678999999999999999999999854 46789
Q ss_pred EEEEeCCCCChHHHhhhhc----CCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 385 LIYDFAPKGKLSKYLDQEE----GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-----QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTCCEEECC
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCCChhhEEEcCCCCEEEEe
Confidence 9999999999999997521 12345899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCcee----eeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhh
Q 007788 461 CGLHKLLADDIVF----SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 461 fGla~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 535 (589)
||++......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 243 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-
Confidence 9998765432111 1123357888999999876 568999999999999999999999997543211110000000
Q ss_pred cccc-----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 536 DRNL-----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 536 ~~~~-----~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+.. ........+..+.+++..||+.||++||++.|++++-+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 0000 001112234578899999999999999999999987554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=354.76 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=203.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc------------hHHHHHHHHHHHHhccCCCCccceeee
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK------------SEEAEFVKGLYLLTSLRHENIIRLRGF 374 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------------~~~~~~~~e~~~l~~l~H~niv~l~g~ 374 (589)
.++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467899999999999999999976 6889999999764321 234678999999999999999999999
Q ss_pred eecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC
Q 007788 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~ 454 (589)
+. +.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 115 ~~--~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 115 FE--DKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN-----IVHRDIKPENILLENKN 183 (504)
T ss_dssp EE--CSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESSTT
T ss_pred EE--cCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCcHHHEEEecCC
Confidence 94 4578999999999999999997654 3899999999999999999999988 99999999999998776
Q ss_pred ---ceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 455 ---NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 455 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
.+||+|||+++...... ......+|+.|+|||++. +.++.++||||+||++|||++|+.||........ .
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~ 256 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI----I 256 (504)
T ss_dssp CCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----H
T ss_pred CCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence 69999999998765442 223445889999999987 4699999999999999999999999976533211 1
Q ss_pred HHhhccccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 532 ENFIDRNLKGKF--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 532 ~~~~~~~~~~~~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+......... ....+..+.+++..|++.||.+|||++|++++-+..
T Consensus 257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 111111111100 012356789999999999999999999999987753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=353.48 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=200.7
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|...+.||+|+||.||+|... ++..||||++..... ......+.+|+.++++++||||+++++++.. .+..++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 357888999999999999999976 689999999976532 2334678999999999999999999999954 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC---CceEEcccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCG 462 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG 462 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||
T Consensus 114 v~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN-----IVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 999999999999987654 3899999999999999999999988 9999999999999764 559999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC-
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG- 541 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 541 (589)
+++...... ......+|+.|+|||++. +.++.++||||+||++|||++|+.||......... ..+.......
T Consensus 185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~ 257 (494)
T 3lij_A 185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL----RKVEKGKYTFD 257 (494)
T ss_dssp TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCC
T ss_pred CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC
Confidence 998765432 223346889999999886 56999999999999999999999999765432211 1111111111
Q ss_pred -CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 -KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 -~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
......+..+.+++..|++.||++|||+.|++++-+..
T Consensus 258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 11123456788999999999999999999999886643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=337.78 Aligned_cols=262 Identities=18% Similarity=0.341 Sum_probs=184.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHH-HHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|...+.||+|+||.||+|... +|+.||||++..........++..|+. +++.++||||+++++++.. .+..++|
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~lv 99 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCWIC 99 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceEEE
Confidence 57788899999999999999985 789999999987654445556666666 6777899999999999854 4788999
Q ss_pred EEeCCCCChHHHhhhhc-CCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 387 YDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
|||+++ +|.+++.... .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-----IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-----CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-----EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 999975 8888876421 1234589999999999999999999997 7 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccc----cCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYV----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
+....... .....++..|+|||.+ .+..++.++||||||+++|||++|+.||..................+.+.
T Consensus 174 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 174 GQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred eecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 87654321 2233578889999998 45678999999999999999999999997543211100000000001111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
..........+.+++..||+.||++||++.|++++.+...
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1111234567999999999999999999999998766543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.20 Aligned_cols=254 Identities=21% Similarity=0.338 Sum_probs=207.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.. .+..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 357888999999999999999986 789999999965432 3345679999999999999999999999854 57899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee---cCCCceEEccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADC 461 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~Df 461 (589)
+||||+.+|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 103 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK-----IVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EEECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 9999999999999997543 4899999999999999999999988 9999999999999 56789999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
|+++...... ......+|+.|+|||++.+ .++.++||||+||++|||++|+.||........ ...+.......
T Consensus 174 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~ 246 (484)
T 3nyv_A 174 GLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI----LKKVEKGKYTF 246 (484)
T ss_dssp THHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCC
T ss_pred eeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCCC
Confidence 9998765432 1223457889999999876 699999999999999999999999976543221 11121111111
Q ss_pred C--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 K--FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 ~--~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
. .....+..+.+++..|++.||++|||+.|++++-+..
T Consensus 247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 1 1123456789999999999999999999999987754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.51 Aligned_cols=261 Identities=19% Similarity=0.281 Sum_probs=202.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC---CCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~---~~~~~ 383 (589)
.++|...+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++... .....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357888899999999999999976 68999999997655455567789999999999999999999987542 13578
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+. |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEcCCCcEEEEeccc
Confidence 99999997 6999998753 3899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCcee---------eeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh---
Q 007788 464 HKLLADDIVF---------SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT--- 530 (589)
Q Consensus 464 a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~--- 530 (589)
++........ ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 9876532211 1122357888999998764 67899999999999999999999999754321111000
Q ss_pred -----------------HHHhhccccC-CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 531 -----------------FENFIDRNLK-GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 531 -----------------~~~~~~~~~~-~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+.+..... ... ....+..+.+++.+|++.||++|||++|++++-+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 0011100000 000 112356788999999999999999999999986643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=346.90 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=196.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCC----CCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~ 383 (589)
.+|...+.||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++|||||++++++.... ....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35778899999999999999986 689999999865431 2346999999999999999999885421 1236
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-CceEEcccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCG 462 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG 462 (589)
++||||+++ +|.+.+.........+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChhhEEEeCCCCeEEeccch
Confidence 789999976 677766543323346999999999999999999999988 9999999999999965 568999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH--------H
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--------N 533 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------~ 533 (589)
+++...... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||.+..........+. .
T Consensus 203 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 203 SAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998764432 12234578889999998765 799999999999999999999999975432211111110 0
Q ss_pred h--hccccCC-C------------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 534 F--IDRNLKG-K------------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 534 ~--~~~~~~~-~------------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+ ..+.... . +....+..+.+++.+|++.||++||++.|++++-+.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 0 0111000 0 112235678999999999999999999999988665
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.15 Aligned_cols=258 Identities=18% Similarity=0.231 Sum_probs=201.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc------CCCCccceeeeeecCCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL------RHENIIRLRGFCCSRGR 380 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~g~~~~~~~ 380 (589)
..+|+..+.||+|+||.||+|... +++.||||++... .....++.+|++++..+ .|+||+++++++.. .
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--R 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--T
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--C
Confidence 356888999999999999999875 5899999999754 33446778888888777 57799999999854 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc--eEE
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PLI 458 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~--~kl 458 (589)
+..++||||+. ++|.+++..... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR-----IIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT-----EECSCCSGGGEEESSTTSCCEEE
T ss_pred CeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEccCCCcceEE
Confidence 78999999996 699999976542 24899999999999999999999988 999999999999999887 999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhh--------
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-------- 530 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~-------- 530 (589)
+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||............
T Consensus 244 ~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 244 IDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999765432 22346788899999999999999999999999999999999999754322111100
Q ss_pred ---------HHHhhccccCC------------------------------C------CCHHHHHHHHHHHHHhcccCCCC
Q 007788 531 ---------FENFIDRNLKG------------------------------K------FSESEAAKLGKMALVCTHEDPEN 565 (589)
Q Consensus 531 ---------~~~~~~~~~~~------------------------------~------~~~~~~~~l~~l~~~C~~~dp~~ 565 (589)
...+++..-.. . ........+.+++.+||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 01111100000 0 00011456889999999999999
Q ss_pred CCCHHHHHHHHHhhhc
Q 007788 566 RPTMEAVIEELTVAAP 581 (589)
Q Consensus 566 RPs~~evl~~L~~~~~ 581 (589)
|||++|++++-+....
T Consensus 400 Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRR 415 (429)
T ss_dssp SCCHHHHHTSTTTC--
T ss_pred CCCHHHHhCChhhccC
Confidence 9999999998775443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=338.51 Aligned_cols=257 Identities=16% Similarity=0.355 Sum_probs=205.4
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCch----------------HHHHHHHHHHHHhccCCCCccce
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS----------------EEAEFVKGLYLLTSLRHENIIRL 371 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------~~~~~~~e~~~l~~l~H~niv~l 371 (589)
.++|...+.||+|+||.||+|.. +++.||||++....... ....|.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788899999999999999999 89999999997542111 11689999999999999999999
Q ss_pred eeeeecCCCCeEEEEEEeCCCCChHHH------hhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCC
Q 007788 372 RGFCCSRGRGECFLIYDFAPKGKLSKY------LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLS 444 (589)
Q Consensus 372 ~g~~~~~~~~~~~lv~Ey~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk 444 (589)
++++.. .+..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ .+ |+|||||
T Consensus 109 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dl~ 179 (348)
T 2pml_X 109 EGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKN-----ICHRDVK 179 (348)
T ss_dssp SEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSC-----EECCCCC
T ss_pred EEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCC-----EeecCCC
Confidence 999854 4789999999999999999 54321 3459999999999999999999998 77 9999999
Q ss_pred CCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccCC-CCCC-cchhhhHHHHHHHHHhCCCCcchhH
Q 007788 445 VEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTE-RSDIFAFGVIILQILTGSLVLTSSM 522 (589)
Q Consensus 445 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~s~Gvvl~elltg~~p~~~~~ 522 (589)
|+||+++.++.+||+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876544 23345678899999999887 5666 9999999999999999999997543
Q ss_pred HHHHhhhhHHHhhccccCCC-----------------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 523 RLAAESATFENFIDRNLKGK-----------------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.... ....+........ .....+..+.+++..||+.||++|||+.|++++-+...
T Consensus 257 ~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 257 SLVE---LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp CSHH---HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred cHHH---HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 2100 1111111111100 01345678899999999999999999999998766443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.17 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=205.7
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--------chHHHHHHHHHHHHhccC-CCCccceeeeeec
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--------KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCS 377 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~ 377 (589)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888899999999999999986 689999999975431 122356889999999996 9999999999843
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
.+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~k 164 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIK 164 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEcCCCcEE
Confidence 578999999999999999998653 3899999999999999999999988 99999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCccccc------CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
|+|||++....... ......++..|+|||.+. ...++.++||||||+++|||++|+.||.........
T Consensus 165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---- 238 (298)
T 1phk_A 165 LTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---- 238 (298)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----
T ss_pred EecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH----
Confidence 99999998765432 122345788899999885 456889999999999999999999999654322111
Q ss_pred HHhhccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 532 ENFIDRNLKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 532 ~~~~~~~~~~--~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+....... ......+..+.+++..|++.||++|||+.|++++-+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 1111111111 11134567899999999999999999999999876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.88 Aligned_cols=262 Identities=19% Similarity=0.280 Sum_probs=197.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC---Ce
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GE 382 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---~~ 382 (589)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357888999999999999999975 688999999976432 3345678999999999999999999999864422 56
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+. |+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHeEECCCCCEEEccCC
Confidence 899999986 59999997542 4899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcee---------------------eeecCCccccccCcccc-cCCCCCCcchhhhHHHHHHHHHhCCCCcc-
Q 007788 463 LHKLLADDIVF---------------------SVLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVLT- 519 (589)
Q Consensus 463 la~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvvl~elltg~~p~~- 519 (589)
+++........ ......+|..|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 99876543211 12345678899999986 55669999999999999999998544432
Q ss_pred ----------hhHH-------------HHHhhhh-----------------------HHHhhccc-cCCCCC-----HHH
Q 007788 520 ----------SSMR-------------LAAESAT-----------------------FENFIDRN-LKGKFS-----ESE 547 (589)
Q Consensus 520 ----------~~~~-------------~~~~~~~-----------------------~~~~~~~~-~~~~~~-----~~~ 547 (589)
+... ....... ....+... ...... +..
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 1100 0000000 00000000 000000 123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+..+.+++.+||+.||++|||++|++++-+..
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 366 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLK 366 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence 56788999999999999999999999986643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.77 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=200.7
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 380 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 380 (589)
+++....++|+..+.||+|+||.||+|..++ .||+|++..... ......|.+|+.++++++||||+++++++.. .
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--P 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--S
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--C
Confidence 3444456788899999999999999999864 499999875432 2233467889999999999999999999954 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++ ++.+||+|
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG-----ILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCSTTEEEC---CCEECC
T ss_pred CceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChhhEEEe-CCCEEEee
Confidence 67899999999999999997643 24899999999999999999999988 99999999999998 67999999
Q ss_pred ccccccccCCce----eeeecCCccccccCcccccC---------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh
Q 007788 461 CGLHKLLADDIV----FSVLKTSAAMGYLAPEYVTT---------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 527 (589)
Q Consensus 461 fGla~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~ 527 (589)
||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999876532111 11223347788999999874 35788999999999999999999999754322111
Q ss_pred hhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 528 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+.............+..+.+++..||+.||++|||++++++.|+.+....
T Consensus 253 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 253 ----WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ----HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ----HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111111111233456899999999999999999999999999887653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.34 Aligned_cols=260 Identities=18% Similarity=0.320 Sum_probs=204.4
Q ss_pred HHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccC--CCCccceeeeeecCCCC
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGRG 381 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~ 381 (589)
....++|...+.||+|+||.||+|...+++.||||++..... ......+.+|++++.+++ ||||+++++++.. .+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CC
Confidence 344577899999999999999999998899999999976543 344578999999999997 5999999999854 46
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||| +.+++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++++ +.+||+||
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEET-TEEEECCC
T ss_pred EEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEEEC-CeEEEeec
Confidence 7999999 56889999998653 4899999999999999999999988 999999999999975 89999999
Q ss_pred cccccccCCcee-eeecCCccccccCcccccC-----------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh
Q 007788 462 GLHKLLADDIVF-SVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 529 (589)
Q Consensus 462 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~ 529 (589)
|+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~ 247 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---S 247 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---H
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---H
Confidence 999876543221 1223457889999999875 468889999999999999999999996542211 1
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.....++.......+......+.+++..||+.||++||++.|++++.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 223334433333333344567899999999999999999999999877544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.80 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=185.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC----CCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----~~~ 381 (589)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|++++++++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367889999999999999999864 789999999975432 33456788999999999999999999998542 124
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++|+||+ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHhhEEECCCCCEEEeec
Confidence 679999999 78999988642 4899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH---------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF--------- 531 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------- 531 (589)
|+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...........
T Consensus 177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999875432 223457888999999887 678999999999999999999999997543221111100
Q ss_pred ----------HHhhccccC-CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 ----------ENFIDRNLK-GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 ----------~~~~~~~~~-~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..++..... .... ......+.+++.+|++.||++|||+.|++++-+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 011110000 0000 1124568899999999999999999999988654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.85 Aligned_cols=260 Identities=16% Similarity=0.206 Sum_probs=201.7
Q ss_pred hccCccccccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|...+.||+|+||.||+|.. .+++.||||++...... .++..|++++..++|++.+..+.++.. ..+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGV-EGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEEEEE
Confidence 36788899999999999999996 47899999988765422 357889999999987555555444432 34678999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee---cCCCceEEccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfGl 463 (589)
|||+ +++|.+++..... .+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 me~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9999 9999999985432 4999999999999999999999988 9999999999999 6889999999999
Q ss_pred cccccCCcee------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 464 HKLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 464 a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
++.+...... ......+|..|+|||.+.+..++.++|||||||+||||++|+.||........ ...+..+...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~ 231 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEK 231 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHHHHHHhhc
Confidence 9876543221 11245688899999999999999999999999999999999999975321100 0001111111
Q ss_pred ccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 538 NLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 538 ~~~~~---~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..... .....+.++.+++..||+.||++||++.++++.|+.+..
T Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 232 KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 10000 001224678999999999999999999999999988754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.42 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=188.5
Q ss_pred ccCcc-ccccccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSE-VNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
+.|.. .++||+|+||.||+|..+ +++.||||++..... ...+.+|+.++++++||||+++++++........+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34554 458999999999999975 578999999975432 23688999999999999999999999776677899
Q ss_pred EEEEeCCCCChHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee----cCCCc
Q 007788 385 LIYDFAPKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFN 455 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill----~~~~~ 455 (589)
+||||+. |+|.+++..... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeCCCcCHHHeEEecCCCCCCc
Confidence 9999996 588888764321 1224899999999999999999999988 9999999999999 77899
Q ss_pred eEEccccccccccCCce--eeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHh-----
Q 007788 456 PLIADCGLHKLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE----- 527 (589)
Q Consensus 456 ~kl~DfGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~----- 527 (589)
+||+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999987654221 122335678899999999874 5899999999999999999999999643211000
Q ss_pred hhhHHHhhc---------------------------cccCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 007788 528 SATFENFID---------------------------RNLKGKFS---------ESEAAKLGKMALVCTHEDPENRPTMEA 571 (589)
Q Consensus 528 ~~~~~~~~~---------------------------~~~~~~~~---------~~~~~~l~~l~~~C~~~dp~~RPs~~e 571 (589)
...+..++. ........ ......+.+++..|++.||++|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 000000000 00000000 001456789999999999999999999
Q ss_pred HHHHHHhhhc
Q 007788 572 VIEELTVAAP 581 (589)
Q Consensus 572 vl~~L~~~~~ 581 (589)
++++-+....
T Consensus 331 ~L~hp~f~~~ 340 (405)
T 3rgf_A 331 AMQDPYFLED 340 (405)
T ss_dssp HHTSGGGTSS
T ss_pred HhcChhhccC
Confidence 9999887553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.14 Aligned_cols=255 Identities=19% Similarity=0.267 Sum_probs=200.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC--------CCCccceeeeeecC-
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR--------HENIIRLRGFCCSR- 378 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~g~~~~~- 378 (589)
++|...+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++ |+||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 67889999999999999999865 6899999999743 344567889999999985 78899999988532
Q ss_pred -CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCC--
Q 007788 379 -GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQF-- 454 (589)
Q Consensus 379 -~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~-- 454 (589)
.....++||||+ +++|.+++..... ..+++..++.|+.||+.||+|||+. + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g-----ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR-----IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECCCCSGGGEEECCCHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHeeEeccchh
Confidence 345789999999 6677776654431 3489999999999999999999997 7 99999999999999775
Q ss_pred -----------------------------------------------ceEEccccccccccCCceeeeecCCccccccCc
Q 007788 455 -----------------------------------------------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487 (589)
Q Consensus 455 -----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aP 487 (589)
.+||+|||++...... .....+|..|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aP 262 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCC
Confidence 7999999999876543 2234578899999
Q ss_pred ccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHH-----HHhhhhHHHhhc------------------cc------
Q 007788 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-----AAESATFENFID------------------RN------ 538 (589)
Q Consensus 488 E~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~------------------~~------ 538 (589)
|++.+..++.++|||||||++|||+||+.||...... ......+..... ..
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 9999999999999999999999999999999642110 000000000000 00
Q ss_pred -------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 539 -------------LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 539 -------------~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
-....+......+.+++.+||+.||++|||++|++++-+
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 001235677888999999999999999999999998755
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=341.87 Aligned_cols=257 Identities=17% Similarity=0.270 Sum_probs=194.8
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC----CeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----GECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----~~~~ 384 (589)
.+|...+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++..... ...+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46888899999999999999998777799998865432 12368999999999999999999864322 2378
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-CCCceEEccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGL 463 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGl 463 (589)
+||||++++.+ +.+.........+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 115 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 115 LVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-----ICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 99999987544 433322222345999999999999999999999988 99999999999999 799999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH----------
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------- 532 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~---------- 532 (589)
++...... ......+|..|+|||.+.+. .++.++|||||||++|||++|+.||.+............
T Consensus 189 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 189 AKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98764432 12344578889999998765 589999999999999999999999976432211111100
Q ss_pred HhhccccC--------C-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 533 NFIDRNLK--------G-----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 533 ~~~~~~~~--------~-----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...++... . ......+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 00011100 0 0111245679999999999999999999999988654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.30 Aligned_cols=262 Identities=19% Similarity=0.353 Sum_probs=202.1
Q ss_pred hhccCccccccccCCCccEEEEEe--cCCcEEEEEEeccCCCc-hHHHHHHHHHHHHhcc---CCCCccceeeeeec---
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTL--RDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCS--- 377 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~--- 377 (589)
+.++|...+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.+++++ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 36889999999754321 1123456677666655 89999999999852
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceE
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 457 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~k 457 (589)
......++||||++ |+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g-----i~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHHHeEEcCCCCEE
Confidence 13457899999997 699999976542 24899999999999999999999988 99999999999999999999
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
|+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..................+
T Consensus 161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999998765332 1223457888999999999999999999999999999999999997643322211111100000
Q ss_pred --------------cc-------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 538 --------------NL-------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 538 --------------~~-------~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.. ........+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 00 001112345678899999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.05 Aligned_cols=259 Identities=18% Similarity=0.307 Sum_probs=195.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC---------
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--------- 378 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------- 378 (589)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 57888899999999999999986 58999999997653 44557899999999999999999999987432
Q ss_pred ---CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-CCC
Q 007788 379 ---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQF 454 (589)
Q Consensus 379 ---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-~~~ 454 (589)
..+..++||||++ |+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++ +++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANLFINTEDL 158 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCC
Confidence 2367899999997 6999998642 4889999999999999999999988 99999999999997 567
Q ss_pred ceEEccccccccccCCcee--eeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 455 NPLIADCGLHKLLADDIVF--SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 455 ~~kl~DfGla~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||.............
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999876532211 1123345778999998865 678999999999999999999999997543221111100
Q ss_pred H-----------Hh-------hccccC-CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 532 E-----------NF-------IDRNLK-GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 532 ~-----------~~-------~~~~~~-~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
. ++ +..... ... ....+..+.+++.+|++.||++|||++|++++-+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 0 00 000000 000 112356789999999999999999999999986654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=329.34 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=196.4
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-------chHHHHHHHHHHHHhccCCCCccceeeeeecCC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-------KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG 379 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 379 (589)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 357889999999999999999975 689999999875421 1223458899999999999999999999843
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc---e
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---P 456 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~---~ 456 (589)
+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +
T Consensus 87 -~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 87 -EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp -SSEEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSSSCCE
T ss_pred -CceEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEecCCCCCeE
Confidence 34899999999999999987543 4899999999999999999999988 999999999999987664 9
Q ss_pred EEccccccccccCCceeeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH
Q 007788 457 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 533 (589)
Q Consensus 457 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 533 (589)
||+|||+++....... .....++..|+|||++. ...++.++||||||+++|||++|+.||....... ....
T Consensus 157 kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~ 230 (322)
T 2ycf_A 157 KITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKD 230 (322)
T ss_dssp EECCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHH
T ss_pred EEccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHH
Confidence 9999999987654321 11234788899999874 5678999999999999999999999996542211 1111
Q ss_pred hhccccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 534 FIDRNLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 534 ~~~~~~~~~~~---~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+........+ ...+..+.+++..||+.||++||++.|++++-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 11111110001 1235678999999999999999999999976543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=328.02 Aligned_cols=253 Identities=16% Similarity=0.240 Sum_probs=201.3
Q ss_pred ccCccccccccCCCccEEEEEe-c-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCC------ccceeeeeecCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTL-R-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN------IIRLRGFCCSRGR 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~g~~~~~~~ 380 (589)
++|+..+.||+|+||.||+|.. . +++.||||++... ......+.+|++++.+++|++ ++++++++.. .
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--H 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--T
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--C
Confidence 5788889999999999999987 3 6899999999753 334567889999998887654 9999999854 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC--------
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-------- 452 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-------- 452 (589)
+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK-----LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCCCEEEEEC
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHEEEeccccccccC
Confidence 6899999999 8899999976542 34889999999999999999999988 999999999999987
Q ss_pred -----------CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 453 -----------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 453 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
++.+||+|||+++..... .....+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999865432 22345788999999999999999999999999999999999999653
Q ss_pred HHHHHhhhhHHHhhc--------------------------------------c-ccCCCCCHHHHHHHHHHHHHhcccC
Q 007788 522 MRLAAESATFENFID--------------------------------------R-NLKGKFSESEAAKLGKMALVCTHED 562 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~--------------------------------------~-~~~~~~~~~~~~~l~~l~~~C~~~d 562 (589)
....... .+..... + .............+.+++..||+.|
T Consensus 238 ~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 238 DSKEHLA-MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp CHHHHHH-HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred ChHHHHH-HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 2211100 0000000 0 0001123355778999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 007788 563 PENRPTMEAVIEELTV 578 (589)
Q Consensus 563 p~~RPs~~evl~~L~~ 578 (589)
|++|||+.|++++-+.
T Consensus 317 P~~Rpt~~ell~hp~f 332 (339)
T 1z57_A 317 PAKRITLREALKHPFF 332 (339)
T ss_dssp TTTSCCHHHHTTSGGG
T ss_pred cccccCHHHHhcCHHH
Confidence 9999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.06 Aligned_cols=255 Identities=19% Similarity=0.308 Sum_probs=197.3
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCC----
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG---- 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~---- 381 (589)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999975 689999999976543 33356788999999999999999999998543221
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+. ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCcCHHHeEECCCCCEEEEec
Confidence 2399999997 688888742 3899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH---------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF--------- 531 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------- 531 (589)
|+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 999865432 234457889999999887 678999999999999999999999997543221111100
Q ss_pred ----------HHhhccccCCC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 ----------ENFIDRNLKGK------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 ----------~~~~~~~~~~~------~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
........... ........+.+++..|++.||++|||++|++++-+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 00000000000 011235678999999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=322.81 Aligned_cols=255 Identities=21% Similarity=0.323 Sum_probs=204.2
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
..++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++.. .+..+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEE
Confidence 3468999999999999999999986 789999999975432 3345679999999999999999999999854 47899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC---CceEEccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADC 461 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~---~~~kl~Df 461 (589)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+||
T Consensus 98 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999987654 3899999999999999999999988 9999999999999764 46999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
|++........ .....++..|+|||.+.+ .++.++||||||+++|||++|+.||......... ..+.......
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~ 241 (287)
T 2wei_A 169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVETGKYAF 241 (287)
T ss_dssp TGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCC
T ss_pred CcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCC
Confidence 99987654321 112236778999998875 5899999999999999999999999764332111 1111111111
Q ss_pred CC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 542 KF--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 542 ~~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.. ....+..+.+++..|++.||++|||+.|++++-+..
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 11 123456789999999999999999999999876543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=341.08 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=188.4
Q ss_pred CccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEEEEe
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++. +.+..++||||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~lv~E~ 90 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYIALEL 90 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEEEECC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEEEEec
Confidence 4446789999999998777778999999998653 234678899999886 8999999999884 45789999999
Q ss_pred CCCCChHHHhhhhcCCCCC---CCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCC-------------
Q 007788 390 APKGKLSKYLDQEEGSSNV---LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ------------- 453 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~------------- 453 (589)
+. |+|.+++......... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-----IIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCcccccccccCCCc
Confidence 95 6999999865432211 133456789999999999999988 9999999999999754
Q ss_pred CceEEccccccccccCCcee---eeecCCccccccCcccccC-------CCCCCcchhhhHHHHHHHHHh-CCCCcchhH
Q 007788 454 FNPLIADCGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILT-GSLVLTSSM 522 (589)
Q Consensus 454 ~~~kl~DfGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~ 522 (589)
+.+||+|||+++........ ......+|++|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999877543211 1223468899999999875 568999999999999999999 899986543
Q ss_pred HHHHhhhhHHHhhc-cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 523 RLAAESATFENFID-RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 523 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
... ......... +..........+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 211 111111111 111122245677889999999999999999999999986543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.98 Aligned_cols=254 Identities=19% Similarity=0.320 Sum_probs=197.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCC----Ce
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----GE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----~~ 382 (589)
++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999975 689999999976542 3335678999999999999999999999854321 13
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||++ ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEeECCCCcEEEeecc
Confidence 599999997 688887742 3899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------- 531 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~---------- 531 (589)
+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+...........
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 223457888999999887 678999999999999999999999997543221111000
Q ss_pred ---------HHhhc---cccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 ---------ENFID---RNLK---GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 ---------~~~~~---~~~~---~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...+. .... .......+..+.+++.+|++.||++|||++|++++-+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00000 0000 01123446789999999999999999999999988664
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=329.28 Aligned_cols=258 Identities=17% Similarity=0.215 Sum_probs=177.3
Q ss_pred hccCccc-cccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC--CCCeE
Q 007788 308 TQCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGEC 383 (589)
Q Consensus 308 ~~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~ 383 (589)
.++|... ++||+|+||.||+|... +|+.||||++.... .. ..+....+..++||||+++++++... .....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 3567774 46999999999999986 68999999986531 11 12223345667999999999988542 23457
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCceEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 460 (589)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEEecCCCceEEEec
Confidence 999999999999999986532 35999999999999999999999988 999999999999986 45599999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc--c
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--N 538 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~ 538 (589)
||+++...... .....+++.|+|||++.+..++.++||||||+++|||++|+.||...............+... .
T Consensus 175 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 175 FGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 99998665332 223456888999999988889999999999999999999999997654322111111111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 539 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.........+..+.+++..|++.||++|||++|++++.+...
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 111112344667899999999999999999999999877543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=333.42 Aligned_cols=258 Identities=19% Similarity=0.294 Sum_probs=202.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-----------CCCccceeeeee
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----------HENIIRLRGFCC 376 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~ 376 (589)
++|...+.||+|+||.||+|... +++.||||++... ......+.+|++++.+++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 57888899999999999999974 7899999999753 334567889999998886 899999999986
Q ss_pred cCC--CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeec--
Q 007788 377 SRG--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLID-- 451 (589)
Q Consensus 377 ~~~--~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~-- 451 (589)
... ....++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~-----ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCChHHeEEecc
Confidence 532 22689999999 8999999986432 2489999999999999999999997 7 99999999999994
Q ss_pred ----CCCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH-
Q 007788 452 ----QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA- 526 (589)
Q Consensus 452 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~- 526 (589)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999876543 2234678899999999999999999999999999999999999974321100
Q ss_pred -hhhhHHHhhc---------------------c-------------------ccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 007788 527 -ESATFENFID---------------------R-------------------NLKGKFSESEAAKLGKMALVCTHEDPEN 565 (589)
Q Consensus 527 -~~~~~~~~~~---------------------~-------------------~~~~~~~~~~~~~l~~l~~~C~~~dp~~ 565 (589)
....+..++. . ......+......+.+++..||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 0000000000 0 0011345677889999999999999999
Q ss_pred CCCHHHHHHHHHhhh
Q 007788 566 RPTMEAVIEELTVAA 580 (589)
Q Consensus 566 RPs~~evl~~L~~~~ 580 (589)
|||++|++++-+...
T Consensus 325 Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 325 RADAGGLVNHPWLKD 339 (373)
T ss_dssp CBCHHHHHTCGGGTT
T ss_pred cCCHHHHhhChhhhc
Confidence 999999999876543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.86 Aligned_cols=258 Identities=18% Similarity=0.255 Sum_probs=200.2
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CC-----CccceeeeeecCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HE-----NIIRLRGFCCSRG 379 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~g~~~~~~ 379 (589)
..++|...+.||+|+||.||+|... +++.||||+++.. .....++..|++++..++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 3568889999999999999999976 6889999999743 334567788888888885 55 49999998854
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec--CCCceE
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPL 457 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~--~~~~~k 457 (589)
.+..++||||++ |+|.+++..... ..+++..+..++.|++.||+|||+.. .+|+||||||+|||++ .++.+|
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE---LSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT---TCEECCCCSGGGEEESSTTSCCEE
T ss_pred CCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC---CCEEcCCCCcccEEEecCCCCcEE
Confidence 478999999996 599999986542 24899999999999999999999521 2399999999999994 578899
Q ss_pred EccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH------
Q 007788 458 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF------ 531 (589)
Q Consensus 458 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~------ 531 (589)
|+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||.............
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999876542 223567888999999999999999999999999999999999997543221111100
Q ss_pred -----------HHhhccccC-----------------------------------------CCCCHHHHHHHHHHHHHhc
Q 007788 532 -----------ENFIDRNLK-----------------------------------------GKFSESEAAKLGKMALVCT 559 (589)
Q Consensus 532 -----------~~~~~~~~~-----------------------------------------~~~~~~~~~~l~~l~~~C~ 559 (589)
..+++.... ......+...+.+++.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 001100000 0012234568899999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 007788 560 HEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 560 ~~dp~~RPs~~evl~~L~~ 578 (589)
+.||++|||++|++++-+.
T Consensus 358 ~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGG
T ss_pred CCChhhCCCHHHHhcCccc
Confidence 9999999999999988664
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.46 Aligned_cols=251 Identities=20% Similarity=0.349 Sum_probs=202.3
Q ss_pred HHHHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCch-----HHHHHHHHHHHHhccC--CCCccceeee
Q 007788 303 EVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-----EEAEFVKGLYLLTSLR--HENIIRLRGF 374 (589)
Q Consensus 303 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~~e~~~l~~l~--H~niv~l~g~ 374 (589)
+.....++|...+.||+|+||.||+|... +++.||||++....... ....+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999864 78999999997653221 2245678999999996 5999999999
Q ss_pred eecCCCCeEEEEEEeCCC-CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-C
Q 007788 375 CCSRGRGECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-Q 452 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-~ 452 (589)
+.. .+..++||||+.+ ++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++ +
T Consensus 117 ~~~--~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 117 FER--PDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLN 185 (320)
T ss_dssp EEC--SSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETT
T ss_pred Eec--CCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEeCCCCHHHEEEeCC
Confidence 954 4789999999986 89999998653 3899999999999999999999988 99999999999999 7
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
++.+||+|||+++...... .....++..|+|||++.+..+ +.++||||||+++|||++|+.||........
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----- 257 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----- 257 (320)
T ss_dssp TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-----
T ss_pred CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc-----
Confidence 8999999999998765432 223457888999999887665 6789999999999999999999976432111
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
... ......+..+.+++.+||+.||++|||++|++++-+..
T Consensus 258 -----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~ 298 (320)
T 3a99_A 258 -----GQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298 (320)
T ss_dssp -----CCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred -----ccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence 111 11223345788999999999999999999999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=325.23 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=196.8
Q ss_pred HHhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhcc----CCCCccceeee
Q 007788 305 ESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSL----RHENIIRLRGF 374 (589)
Q Consensus 305 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l----~H~niv~l~g~ 374 (589)
....++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 334578999999999999999999874 7899999999755321 1223456788888888 89999999999
Q ss_pred eecCCCCeEEEEEEe-CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-C
Q 007788 375 CCSRGRGECFLIYDF-APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-Q 452 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-~ 452 (589)
+.. .+..++|||| +.+++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++ .
T Consensus 107 ~~~--~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 107 FET--QEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG-----VVHRDIKDENILIDLR 175 (312)
T ss_dssp C-------CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT-----EECCCCSGGGEEEETT
T ss_pred Eec--CCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChhhEEEeCC
Confidence 844 4678999999 78999999998754 3899999999999999999999988 99999999999999 8
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCC-CcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 531 (589)
++.+||+|||++....... .....++..|+|||++.+..+. .++||||||+++|||++|+.||.......
T Consensus 176 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------ 246 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------ 246 (312)
T ss_dssp TTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------
T ss_pred CCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh------
Confidence 8999999999998765532 2234578889999998876664 58999999999999999999997543211
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
... ...+......+.+++.+||+.||++|||++|++++-+...
T Consensus 247 ----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 247 ----EAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp ----HTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred ----hhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 111 1123334567899999999999999999999998766543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.32 Aligned_cols=254 Identities=15% Similarity=0.229 Sum_probs=199.8
Q ss_pred ccCccccccccCCCccEEEEEec-CC-cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCC------ccceeeeeecCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN------IIRLRGFCCSRGR 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~g~~~~~~~ 380 (589)
++|...+.||+|+||.||+|... ++ +.||||+++.. ......+.+|+.++++++|++ ++.+++++.. .
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--H 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--T
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--C
Confidence 57888999999999999999975 34 78999999753 344567888999999997766 8888888854 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeee----------
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---------- 450 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill---------- 450 (589)
+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ-----LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEESCCCEEEEEC
T ss_pred CeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEeccccccccc
Confidence 6899999999 6677777765432 34899999999999999999999988 9999999999999
Q ss_pred ---------cCCCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 451 ---------DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 451 ---------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
+.++.+||+|||+++...... ....+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 678899999999998654422 2346788999999999999999999999999999999999999754
Q ss_pred HHHHHhhhhHHHhhc----------------------------------c-----ccCCCCCHHHHHHHHHHHHHhcccC
Q 007788 522 MRLAAESATFENFID----------------------------------R-----NLKGKFSESEAAKLGKMALVCTHED 562 (589)
Q Consensus 522 ~~~~~~~~~~~~~~~----------------------------------~-----~~~~~~~~~~~~~l~~l~~~C~~~d 562 (589)
........ +..... . .............+.+++.+||+.|
T Consensus 243 ~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 243 ENREHLVM-MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SHHHHHHH-HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CHHHHHHH-HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 32111000 000000 0 0000112344668999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 007788 563 PENRPTMEAVIEELTVA 579 (589)
Q Consensus 563 p~~RPs~~evl~~L~~~ 579 (589)
|++|||++|++++-+..
T Consensus 322 P~~Rpt~~e~l~hp~f~ 338 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFA 338 (355)
T ss_dssp TTTSCCHHHHTTSGGGG
T ss_pred hhhCcCHHHHhcChhhc
Confidence 99999999999886644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.66 Aligned_cols=255 Identities=16% Similarity=0.305 Sum_probs=181.7
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHH-HHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~-~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
.++|+..+.||+|+||.||+|... +|+.||||++..........+ +.++..+++.++||||+++++++.. .+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Confidence 357888899999999999999986 789999999987654333333 4445567888899999999999854 468999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
||||+ ++.+..+..... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++
T Consensus 102 v~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG-----VIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC-----EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999 555555554332 2489999999999999999999985 7 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
........ .....++..|+|||.+. ...++.++||||||+++|||++|+.||........ ..........
T Consensus 173 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~ 247 (318)
T 2dyl_A 173 GRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VLTKVLQEEP 247 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHHSCC
T ss_pred hhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---HHHHHhccCC
Confidence 76644321 22345788899999984 45688999999999999999999999965321111 1111111111
Q ss_pred C-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 540 K-GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 540 ~-~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
. .......+..+.+++..||+.||.+||+++|++++-+.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 0 11112245678999999999999999999999987553
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=332.91 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=187.2
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lv 386 (589)
..+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++++ +|||||++++++.+ .+..++|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEE
Confidence 4567888999999999976665668999999999754322 356799999999 79999999998854 4788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-----CCceEEccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-----QFNPLIADC 461 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Df 461 (589)
|||++ |+|.+++...... +.+..++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+||
T Consensus 97 ~E~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSLN-----IVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EECCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHTT-----CCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred EECCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHCc-----CEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 99996 6999999865432 444456789999999999999988 999999999999943 346789999
Q ss_pred cccccccCCce--eeeecCCccccccCccccc---CCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhh
Q 007788 462 GLHKLLADDIV--FSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFI 535 (589)
Q Consensus 462 Gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 535 (589)
|+++....... .......+|++|+|||++. ...++.++|||||||++|||+| |..||........ ....
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-----~~~~ 242 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-----NILL 242 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-----HHHT
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-----HHHh
Confidence 99987653321 1223456899999999997 4567889999999999999999 8888864422111 1111
Q ss_pred cc-ccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 536 DR-NLK-GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 536 ~~-~~~-~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.. ... ..........+.+++..||+.||++|||+.|++++-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 11 011 1112345666889999999999999999999997644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=343.11 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=201.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeec----CCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS----RGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~~ 383 (589)
++|...+.||+|+||.||+|... +|+.||||++...........|.+|++++++++||||+++++++.. ...+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67889999999999999999975 6899999999876555566789999999999999999999998743 124677
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCc---eEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~---~kl~D 460 (589)
++||||+++|+|.+++..... ...+++..++.|+.|++.||+|||+.+ |+||||||+||+++.++. +||+|
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g-----IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR-----IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT-----BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEeecCCCceeEEEcc
Confidence 999999999999999986542 234888999999999999999999988 999999999999997765 89999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH------HHh
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF------ENF 534 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~------~~~ 534 (589)
||++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||........+.... ...
T Consensus 168 FG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 168 LGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 999987754432 223467889999999999999999999999999999999999996542222111100 000
Q ss_pred hcccc------------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007788 535 IDRNL------------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 573 (589)
Q Consensus 535 ~~~~~------------~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl 573 (589)
..... ........+..+.+++..|++.||++|||+.|++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00000 1123445678899999999999999999998854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.98 Aligned_cols=232 Identities=11% Similarity=0.090 Sum_probs=182.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|...+.||+|+||.||+|... +++.||||++..... ......|.+|+..+.+++||||+++++++.. .+..++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence 56888899999999999999986 589999999986543 2334789999999999999999999999854 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++... ....+..+|+.|++.||+|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g-----ivH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG-----VALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC-----CccCCCCcccEEEcCCCCEEEEecc---
Confidence 99999999999999532 345568899999999999999998 9999999999999999999998543
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC--CC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KF 543 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 543 (589)
|++ .++.++|||||||++|||+||+.||............ ...+...... ..
T Consensus 175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-ERDTAGQPIEPADI 228 (286)
T ss_dssp ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-CBCTTSCBCCHHHH
T ss_pred ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-HHHhccCCCChhhc
Confidence 443 3688999999999999999999999754321100000 0000000000 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
....+..+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 12235678999999999999999 9999999999877553
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=346.02 Aligned_cols=240 Identities=18% Similarity=0.244 Sum_probs=192.0
Q ss_pred ccCccccccccCCCccEEEEEec--CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCC---eE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG---EC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~---~~ 383 (589)
++|.+.+.||+|+||.||+|.+. +|+.||||++...........|.+|++++.+++||||+++++++...... ..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67888999999999999999975 68999999997655445567899999999999999999999998654321 26
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++++|.+++.. .++|..++.|+.||+.||+|||+.+ |+||||||+|||++.+ .+||+|||+
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g-----iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG-----LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC-----CeecccChHHeEEeCC-cEEEEeccc
Confidence 999999999999987753 3899999999999999999999988 9999999999999986 899999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (589)
++..... ....+|++|+|||++.++ ++.++|||||||++|||++|..|+...... .......
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~~~~~~~ 289 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------GLPEDDP 289 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------SCCTTCH
T ss_pred chhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------------ccccccc
Confidence 9876543 234588999999998765 488999999999999999998887542110 0000001
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHh
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPT-MEAVIEELTV 578 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs-~~evl~~L~~ 578 (589)
.......+.+++.+||+.||++||+ ++++...|..
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 1223467889999999999999995 5555555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=307.28 Aligned_cols=234 Identities=17% Similarity=0.245 Sum_probs=181.2
Q ss_pred ccCccc-cccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHH-hccCCCCccceeeeeec--CCCCeE
Q 007788 309 QCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLL-TSLRHENIIRLRGFCCS--RGRGEC 383 (589)
Q Consensus 309 ~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~--~~~~~~ 383 (589)
++|... +.||+|+||.||+|... +++.||||++... ..+.+|+.++ +..+||||+++++++.. ......
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 445555 78999999999999974 7899999998642 3567788887 55689999999998854 224578
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCceEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 460 (589)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEecCCCCCcEEEec
Confidence 999999999999999987532 35999999999999999999999988 999999999999998 78999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
||++.... +..++.++|||||||++|||+||+.||....................
T Consensus 164 fg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-- 218 (299)
T 3m2w_A 164 FGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-- 218 (299)
T ss_dssp CTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC--
T ss_pred cccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc--
Confidence 99886432 23467899999999999999999999975433211110000000000
Q ss_pred CCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 541 GKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+ ...+..+.+++..||+.||++|||+.|++++.+...
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 0111 123567999999999999999999999999877543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.16 Aligned_cols=248 Identities=15% Similarity=0.137 Sum_probs=183.8
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCC-CCccceeee--------
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRH-ENIIRLRGF-------- 374 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H-~niv~l~g~-------- 374 (589)
.+..|...+.||+|+||.||+|.+. +|+.||||++...... ...+.|.+|+.++..++| +|...+..+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3445777789999999999999964 7999999998844322 224679999999999987 322221111
Q ss_pred -------------eecCC---CCeEEEEEEeCCCCChHHHhhhh---cCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCC
Q 007788 375 -------------CCSRG---RGECFLIYDFAPKGKLSKYLDQE---EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435 (589)
Q Consensus 375 -------------~~~~~---~~~~~lv~Ey~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 435 (589)
+.... ....+++|+++ +++|.+++... ......++|..++.|+.||+.||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11100 12356677765 68999988532 122335888999999999999999999988
Q ss_pred CCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccc----------cCCCCCCcchhhhHH
Q 007788 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV----------TTGRFTERSDIFAFG 505 (589)
Q Consensus 436 ~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv~s~G 505 (589)
|+||||||+|||++.++.+||+|||+++..... .....+ +.|+|||++ .+..++.++||||||
T Consensus 232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred --cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999998865543 233445 889999999 556688999999999
Q ss_pred HHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 506 VIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 506 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
|++|||+||+.||........ ....+.. .. ..+..+.+++..||+.||++||++.|++++
T Consensus 305 vil~elltg~~Pf~~~~~~~~----~~~~~~~--~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGG----SEWIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSC----SGGGGSS--CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHCCCCCCCcchhhh----HHHHHhh--cc----cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999976533211 1111111 01 224679999999999999999998888765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.43 Aligned_cols=244 Identities=16% Similarity=0.203 Sum_probs=186.3
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-------chHHHHHHHHHHHHhccC---------CCCccce
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-------KSEEAEFVKGLYLLTSLR---------HENIIRL 371 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~e~~~l~~l~---------H~niv~l 371 (589)
.++|...+.||+|+||.||+|+. +|+.||||++..... ......+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45678889999999999999998 689999999986532 223367889999988886 6666666
Q ss_pred eeeeecC----------------------------CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHH
Q 007788 372 RGFCCSR----------------------------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 423 (589)
Q Consensus 372 ~g~~~~~----------------------------~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 423 (589)
.+.+... +.+..++||||+++|++.+.+.. ..+++..+..|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 6553211 25689999999999977766643 23899999999999999
Q ss_pred HhHHhc-CCCCCCCCeEecCCCCCCeeecCCC--------------------ceEEccccccccccCCceeeeecCCccc
Q 007788 424 GIGYLH-SSEVNKPAIVHRNLSVEKVLIDQQF--------------------NPLIADCGLHKLLADDIVFSVLKTSAAM 482 (589)
Q Consensus 424 ~L~~LH-~~~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~ 482 (589)
||+||| +.+ |+||||||+|||++.++ .+||+|||+++...... ..+|.
T Consensus 173 aL~~lH~~~~-----ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~------~~gt~ 241 (336)
T 2vuw_A 173 SLAVAEASLR-----FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI------VVFCD 241 (336)
T ss_dssp HHHHHHHHHC-----CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTE------EECCC
T ss_pred HHHHHHHhCC-----EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCc------EEEee
Confidence 999999 887 99999999999999887 89999999998765432 25788
Q ss_pred cccCcccccCCCCCCcchhhhHHHH-HHHHHhCCCCcchhHHHHHhhhhHHHhhcc-cc----CCCCCHHHHHHHHHHHH
Q 007788 483 GYLAPEYVTTGRFTERSDIFAFGVI-ILQILTGSLVLTSSMRLAAESATFENFIDR-NL----KGKFSESEAAKLGKMAL 556 (589)
Q Consensus 483 ~y~aPE~~~~~~~~~~~Dv~s~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~l~~l~~ 556 (589)
.|+|||++.+.. +.++||||+|++ .+++++|..||........ ....+... .. ........+..+.+++.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY---LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH---HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH---HHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence 899999998766 889999998777 7788999999864311000 11111111 01 11113457888999999
Q ss_pred HhcccCCCCCCCHHHHH-HHHH
Q 007788 557 VCTHEDPENRPTMEAVI-EELT 577 (589)
Q Consensus 557 ~C~~~dp~~RPs~~evl-~~L~ 577 (589)
+|++.| |++|++ ++-+
T Consensus 318 ~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 318 TMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HGGGSS-----SHHHHHHHCGG
T ss_pred HHhccC-----CHHHHHhcCCC
Confidence 999976 999998 6643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=275.68 Aligned_cols=187 Identities=12% Similarity=0.012 Sum_probs=128.0
Q ss_pred ccccCCCccEEEEE-ecCCcEEEEEEeccCCC---------chHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSC---------KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 316 ~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---------~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
..+.|+.|.++.++ .-.|+.++||++..... ....++|.+|+++|+++ .|+||+++++++. +.+..|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECCEEE
Confidence 35666666666554 23588999999975421 12235799999999999 6999999999984 457899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
|||||++|++|.++|.... +++.. +|+.||+.||+|+|+.+ ||||||||+|||+++++.+||+|||+|
T Consensus 319 LVMEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~G-----IIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQG-----FWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp EEEECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHTT-----CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred EEEecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHCC-----ceeccCchHhEEECCCCCEEEeecccC
Confidence 9999999999999997653 35543 58999999999999998 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCc
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL 518 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~ 518 (589)
+....... ......||++|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 387 r~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 387 VTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred eeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 87654322 1223458899999999875 5677899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=250.41 Aligned_cols=184 Identities=14% Similarity=0.148 Sum_probs=142.3
Q ss_pred cccccccCCCccEEEEEecCCcEEEEEEeccCCCc-h------HHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-S------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..+.||+|+||.||+|.. .++.+++|+....... . ..+.|.+|++++++++||||+++..++... +..++
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DNKRI 416 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TTTEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--CccEE
Confidence 357899999999999955 4778888886543321 1 134589999999999999999666666533 45699
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++++|.+++.. ++.++.|+++||+|||+.+ |+||||||+|||+++ .+||+|||+++
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g-----IiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND-----VIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT-----EECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc-----CccCCCCHHHEEECC--eEEEEECccCE
Confidence 9999999999999975 4579999999999999988 999999999999999 99999999999
Q ss_pred cccCCceee------eecCCccccccCcccccC--CCCCCcchhhhHHHHHHHHHhCCCCc
Q 007788 466 LLADDIVFS------VLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVL 518 (589)
Q Consensus 466 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltg~~p~ 518 (589)
......... .....+|+.|+|||++.. ..|+..+|+|+..+-.++-+.++.+|
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 875432111 123457889999999987 56888899999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=207.95 Aligned_cols=155 Identities=14% Similarity=0.075 Sum_probs=123.0
Q ss_pred HHHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCc-----------------hHHHHHHHHHHHHhcc
Q 007788 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-----------------SEEAEFVKGLYLLTSL 363 (589)
Q Consensus 301 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~~e~~~l~~l 363 (589)
+..+......|...+.||+|+||.||+|...+|+.||||.++..... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34455556677778999999999999999978999999999653211 1345789999999999
Q ss_pred CCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCC
Q 007788 364 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 443 (589)
Q Consensus 364 ~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dl 443 (589)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+.+ |+||||
T Consensus 162 ~--~-~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g-----iiHrDl 219 (282)
T 1zar_A 162 Q--G-LAVPKVYAW---EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG-----IVHGDL 219 (282)
T ss_dssp T--T-SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT-----EECSCC
T ss_pred c--C-CCcCeEEec---cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC-----CEeCCC
Confidence 9 5 666665532 45699999999999998 421 123469999999999999988 999999
Q ss_pred CCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccC
Q 007788 444 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 492 (589)
Q Consensus 444 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 492 (589)
||+|||++ ++.+||+|||+++.. ..|+|||++..
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~r 253 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVEV--------------GEEGWREILER 253 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEET--------------TSTTHHHHHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeEC--------------CCCCHHHHHHH
Confidence 99999999 999999999998643 23788998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.9e-19 Score=174.28 Aligned_cols=146 Identities=14% Similarity=0.146 Sum_probs=109.1
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEe-cCCcE--EEEEEeccCCCc-----------------------hHHHHHHH
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTL--VAIRSINVTSCK-----------------------SEEAEFVK 355 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~-----------------------~~~~~~~~ 355 (589)
..+.....-|...+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 33333333456778999999999999998 68989 999997643211 11236889
Q ss_pred HHHHHhccCCCCc--cceeeeeecCCCCeEEEEEEeCCC-C----ChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHh
Q 007788 356 GLYLLTSLRHENI--IRLRGFCCSRGRGECFLIYDFAPK-G----KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428 (589)
Q Consensus 356 e~~~l~~l~H~ni--v~l~g~~~~~~~~~~~lv~Ey~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 428 (589)
|++.+.++.|+++ ..++++ +..++||||+.+ | +|.++... .++.....++.|++.||+||
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHH
Confidence 9999999988864 333332 245899999942 4 66665432 12345678999999999999
Q ss_pred c-CCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 429 H-SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 429 H-~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
| +.+ |+||||||.|||+++ .++|+|||+|...
T Consensus 187 H~~~g-----ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEAE-----LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTSC-----EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHCC-----EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 887 999999999999998 9999999998754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=9.3e-19 Score=198.47 Aligned_cols=113 Identities=41% Similarity=0.672 Sum_probs=104.9
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|++|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|.+|++|++|+.|||++|+|+|.+|..+..+++|+.||
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 68899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcCcccCchh--HhhccCCccccCCCCCCCCCC
Q 007788 119 VQNNTLSGIVPSA--LKRLNGGFQFQNNPGLCGDGI 152 (589)
Q Consensus 119 l~~N~l~g~~p~~--~~~~~~~~~~~~n~~~c~~~~ 152 (589)
|++|+|+|.+|.. +..+. ...+.+||++||.++
T Consensus 711 ls~N~l~g~iP~~~~~~~~~-~~~~~gN~~Lcg~~l 745 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFP-PAKFLNNPGLCGYPL 745 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSC-GGGGCSCTEEESTTS
T ss_pred CcCCcccccCCCchhhccCC-HHHhcCCchhcCCCC
Confidence 9999999999975 33333 357889999999753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=159.89 Aligned_cols=141 Identities=18% Similarity=0.194 Sum_probs=118.8
Q ss_pred cccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeecc
Q 007788 17 IVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS 96 (589)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 96 (589)
..++...|.|...... ..+..+++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 35 ~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 35 AELRLNNNEFTVLEAT-GIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp SEEECCSSCCCEECCC-CCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CEEEcCCCcCCccCch-hhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 3445555555433211 234459999999999999998888899999999999999999998888889999999999999
Q ss_pred CccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCccc
Q 007788 97 FNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRAC 158 (589)
Q Consensus 97 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~ 158 (589)
+|+|++..|..|..+++|+.|+|++|+|++..|..+..+.. .+.+.+|++.|+|.+..+..+
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~ 177 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLGEW 177 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHHHHHH
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchHHHHHH
Confidence 99999988999999999999999999999998988887654 467899999999987765543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.3e-17 Score=157.55 Aligned_cols=142 Identities=21% Similarity=0.195 Sum_probs=117.0
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|...... .+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 110 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPG--AFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLL 110 (220)
T ss_dssp TCCEEECCSSCCCEECTT--SSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCcCCCcCHh--HhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEE
Confidence 444455555555432221 234489999999999999988899999999999999999999965555679999999999
Q ss_pred ccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCccc
Q 007788 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRAC 158 (589)
Q Consensus 95 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~ 158 (589)
|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+.. .+.+.+|++.|+|.+.++..+
T Consensus 111 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~~l~~~ 176 (220)
T 2v9t_B 111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLKWLADY 176 (220)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred CCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccHHHHHH
Confidence 9999999988999999999999999999999988877776653 567899999999988776544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.2e-17 Score=151.69 Aligned_cols=120 Identities=25% Similarity=0.328 Sum_probs=107.4
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
.++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|.+|.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 30 ~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 108 (193)
T 2wfh_A 30 PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108 (193)
T ss_dssp CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEE
Confidence 357999999999999 8899999999999999999999988888999999999999999999988888999999999999
Q ss_pred ccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCcccc
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRACT 159 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~~ 159 (589)
|++|+|++..+..+..+.. .+.+.+|+|.|+|.+.++..+.
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~ 151 (193)
T 2wfh_A 109 LHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWV 151 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred CCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHH
Confidence 9999999877777766643 5678999999999887766544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6e-17 Score=165.14 Aligned_cols=151 Identities=10% Similarity=0.069 Sum_probs=101.0
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-------------chHHHHHHHHHHHHhccCCCCc
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-------------KSEEAEFVKGLYLLTSLRHENI 368 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~~e~~~l~~l~H~ni 368 (589)
..+.....-|++.+.||+|++|.||+|...+|+.||||+++.... ......+..+.++.....|+|+
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 333333344888999999999999999999999999999864211 0011122233333333334444
Q ss_pred cceeeeeecCC----CCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCC
Q 007788 369 IRLRGFCCSRG----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 444 (589)
Q Consensus 369 v~l~g~~~~~~----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk 444 (589)
++++....... ....++||||+++++|.++... .....++.|++.+|.|||+.+ |||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g-----IVHrDLK 232 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG-----LIHGDFN 232 (397)
T ss_dssp HHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT-----EECSCCS
T ss_pred HHHHhcCCCCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC-----CcCCCCC
Confidence 44332111000 0123699999999888665421 123468899999999999988 9999999
Q ss_pred CCCeeecCCC----------ceEEccccccccc
Q 007788 445 VEKVLIDQQF----------NPLIADCGLHKLL 467 (589)
Q Consensus 445 ~~Nill~~~~----------~~kl~DfGla~~~ 467 (589)
|.|||+++++ .+.|+||+-+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998876 3899999976543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.5e-16 Score=148.97 Aligned_cols=134 Identities=25% Similarity=0.235 Sum_probs=108.3
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|...... .+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 41 ~L~~L~Ls~n~i~~~~~~--~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 118 (229)
T 3e6j_A 41 NAQILYLHDNQITKLEPG--VFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118 (229)
T ss_dssp TCSEEECCSSCCCCCCTT--TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEEcCCCccCccCHH--HhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence 344445555555433221 234489999999999999866556789999999999999999977677789999999999
Q ss_pred ccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCC
Q 007788 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG 151 (589)
Q Consensus 95 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~ 151 (589)
|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+.. .+.+.+|++.|+|.
T Consensus 119 Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999999 88999999999999999999999877776766543 46788999999985
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=148.25 Aligned_cols=117 Identities=24% Similarity=0.324 Sum_probs=104.3
Q ss_pred ccceEEEccCcccccCCCc-cccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 40 LCFVVLQLCCNQLTGNIPA-QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
.+|+.|+|++|+|++..|. .|+.+++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 3799999999999977664 489999999999999999998899999999999999999999988888899999999999
Q ss_pred ccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCc
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLR 156 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~ 156 (589)
|++|+|++.+|..+..+.. .+.+.+|++.|+|.+..+.
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~ 148 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH
Confidence 9999999999988877654 4678899999999876544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.3e-16 Score=149.87 Aligned_cols=121 Identities=26% Similarity=0.214 Sum_probs=95.5
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.
T Consensus 80 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 159 (251)
T 3m19_A 80 DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQT 159 (251)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCE
Confidence 34788888888888888766677888888888888888888666666788888999999999988666667888889999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCCCCC-CCCccCcc
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCG-DGIASLRA 157 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~-~~~~~l~~ 157 (589)
|+|++|+|++..|..+..+.. .+.+.+|++.|. |.+..+..
T Consensus 160 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~ 203 (251)
T 3m19_A 160 LSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQ 203 (251)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHH
T ss_pred EECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccHHHHH
Confidence 999999998877777766543 467889999998 66554443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.61 E-value=6.9e-16 Score=155.67 Aligned_cols=111 Identities=31% Similarity=0.445 Sum_probs=96.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+. |+.|+|++|++++.+|..|+.+++|+.|+|++|++++.+|. +..+++|++|+|++|+|+|.+|..+..+++|+.|+
T Consensus 197 l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 274 (313)
T 1ogq_A 197 LN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274 (313)
T ss_dssp CC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE
T ss_pred Cc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEE
Confidence 55 99999999999988899999999999999999999977665 88899999999999999999999999999999999
Q ss_pred ccCCcCcccCchhHhhcc--CCccccCCCCCCCCCC
Q 007788 119 VQNNTLSGIVPSALKRLN--GGFQFQNNPGLCGDGI 152 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~--~~~~~~~n~~~c~~~~ 152 (589)
|++|+++|.+|.. ..+. ..+.+.+|+++||.++
T Consensus 275 Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 275 VSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp CCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTTS
T ss_pred CcCCcccccCCCC-ccccccChHHhcCCCCccCCCC
Confidence 9999999999976 3333 2467889999998644
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1e-15 Score=152.60 Aligned_cols=121 Identities=27% Similarity=0.249 Sum_probs=96.7
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|
T Consensus 98 ~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 177 (290)
T 1p9a_G 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (290)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE
Confidence 47888999999999987767788889999999999999987666677888999999999999985555567788999999
Q ss_pred eccCCcCcccCchhHhhcc--CCccccCCCCCCCCCCccCcccc
Q 007788 118 DVQNNTLSGIVPSALKRLN--GGFQFQNNPGLCGDGIASLRACT 159 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~--~~~~~~~n~~~c~~~~~~l~~~~ 159 (589)
+|++|+|+ .+|..+.... ..+.+.+|||.|+|.+..+..+.
T Consensus 178 ~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~~~l~~wl 220 (290)
T 1p9a_G 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWL 220 (290)
T ss_dssp ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHH
T ss_pred ECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCccHHHHHHH
Confidence 99999998 5666655443 24578899999999876665443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=171.80 Aligned_cols=83 Identities=31% Similarity=0.507 Sum_probs=70.7
Q ss_pred CCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--Cc
Q 007788 62 SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GF 139 (589)
Q Consensus 62 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~ 139 (589)
.+++|+.|||++|+|+|.+|.+|++|++|+.|+|++|+|+|.+|..++++++|+.|||++|+|+|.+|..+..+.. .+
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 3567888999999999999999999999999999999999999999999999999999999999999988887754 34
Q ss_pred cccCC
Q 007788 140 QFQNN 144 (589)
Q Consensus 140 ~~~~n 144 (589)
.+.+|
T Consensus 710 ~ls~N 714 (768)
T 3rgz_A 710 DLSNN 714 (768)
T ss_dssp ECCSS
T ss_pred ECcCC
Confidence 55555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.6e-15 Score=140.21 Aligned_cols=135 Identities=21% Similarity=0.181 Sum_probs=107.7
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|...... .+..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|+++++|+.|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNG--VFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp TCSEEECCSSCCCCCCTT--TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcEEEcCCCccCcCChh--hhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 344455555555422221 234589999999999999976666789999999999999999976666789999999999
Q ss_pred ccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCC
Q 007788 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG 151 (589)
Q Consensus 95 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~ 151 (589)
|++|+|++..+..+..+++|+.|+|++|++++..+..+..+.. .+.+.+|++.|.++
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 9999999777777899999999999999999877766665543 46788999998874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.58 E-value=6.1e-15 Score=145.55 Aligned_cols=114 Identities=26% Similarity=0.281 Sum_probs=77.8
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|++|+|++|++++..|..|+.+++|+.|+|++|++++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 107 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 186 (272)
T 3rfs_A 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence 36777777777777776655666777777777777777776555556777777777777777776665566777777777
Q ss_pred eccCCcCcccCchhHhhccC--CccccCCCCCCCCC
Q 007788 118 DVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG 151 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~ 151 (589)
+|++|++++..|..+..+.. .+.+.+|++.|.|+
T Consensus 187 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 187 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 77777777766655554433 35566777777654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.58 E-value=2.1e-15 Score=140.65 Aligned_cols=115 Identities=23% Similarity=0.175 Sum_probs=98.5
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|...... ..+..+++|+.|+|++|+|++.+|..|+.+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 30 ~l~~L~l~~n~i~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSD-GLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TCSEEECCSCCCCSBCCS-CSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCEEECCCCcCCccCCc-cccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 444555555555433221 1244599999999999999999999999999999999999999998888899999999999
Q ss_pred ccCccccCCChhhhhcCCCCceeeccCCcCcccCch
Q 007788 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPS 130 (589)
Q Consensus 95 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 130 (589)
|++|+|++.+|..+..+++|+.|+|++|.+++..+-
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 999999999999999999999999999999987764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.7e-15 Score=167.73 Aligned_cols=123 Identities=20% Similarity=0.231 Sum_probs=110.2
Q ss_pred hhcccceEEEccCcccc-cCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 37 VILLCFVVLQLCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
..+++|+.|+|++|++. +.+|..|..+++|+.|+|++|+|++..|.+|++|++|+.|+|++|+|++..|..|..+++|+
T Consensus 466 ~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~ 545 (635)
T 4g8a_A 466 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 545 (635)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCC
T ss_pred ccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCC
Confidence 34899999999999854 46788999999999999999999999999999999999999999999988889999999999
Q ss_pred eeeccCCcCcccCchhHhhccC---CccccCCCCCCCCCCccCcccc
Q 007788 116 FLDVQNNTLSGIVPSALKRLNG---GFQFQNNPGLCGDGIASLRACT 159 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~~~~~~~---~~~~~~n~~~c~~~~~~l~~~~ 159 (589)
.|||++|+|++..|..+..+.. .+.+.+|||.|+|.+.++..+.
T Consensus 546 ~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl 592 (635)
T 4g8a_A 546 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 592 (635)
T ss_dssp EEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred EEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHH
Confidence 9999999999999998876632 4678999999999987776554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.57 E-value=2.7e-15 Score=151.31 Aligned_cols=121 Identities=27% Similarity=0.401 Sum_probs=98.5
Q ss_pred ccccccccccccchh--hhhhhhhHhhcccceEEEccC-cccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCC
Q 007788 14 GKIIVFKEFSNKIFV--IIFQIQLKVILLCFVVLQLCC-NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 90 (589)
Q Consensus 14 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~L~L~~-n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 90 (589)
+.|..++...+.|.. .++. .+..+++|++|+|++ |++++.+|..|+++++|++|+|++|+++|.+|..|+++++|
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~--~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 127 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPS--SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCG--GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred ceEEEEECCCCCccCCcccCh--hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCC
Confidence 445555444444332 2211 233489999999994 99999999999999999999999999999999999999999
Q ss_pred CeeeccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhcc
Q 007788 91 KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 91 ~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~ 136 (589)
++|+|++|+|+|.+|..+..+++|+.|+|++|+++|.+|..+..+.
T Consensus 128 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 173 (313)
T 1ogq_A 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC
T ss_pred CEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh
Confidence 9999999999999999999999999999999999999998887665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-14 Score=143.01 Aligned_cols=115 Identities=30% Similarity=0.289 Sum_probs=90.4
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++..|..|+.+++|+.|+|++|+|++..+..|+.+++|+.|+|++|++++..|..|..+++|+.
T Consensus 106 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 185 (270)
T 2o6q_A 106 DQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT 185 (270)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred ccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCE
Confidence 34788888888888888776777888888888888888888655556788888888888888888666667888888888
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCCCCCCC
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG 151 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~ 151 (589)
|+|++|++++..+..+..+.. .+.+.+|||.|+|.
T Consensus 186 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred EECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 888888888766666655543 46788899999885
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=8.2e-15 Score=134.67 Aligned_cols=113 Identities=22% Similarity=0.210 Sum_probs=97.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
.++|+.|+|++|++++..+..|+.+++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 46899999999999977777889999999999999999976666789999999999999999987777789999999999
Q ss_pred ccCCcCcccCchhHhhccC--CccccCCCCCCCCC
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG 151 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~ 151 (589)
|++|++++..+..+..+.. .+.+.+|++.|.++
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999999777666665543 46788999999875
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.8e-15 Score=151.46 Aligned_cols=117 Identities=25% Similarity=0.344 Sum_probs=93.6
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhh-h---hcCC
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES-L---ANNA 112 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~---~~l~ 112 (589)
..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++ +|.. | ..++
T Consensus 85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~ 163 (361)
T 2xot_A 85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLP 163 (361)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CT
T ss_pred cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCC
Confidence 347888888888888887767778888888888888888887778888888999999999999885 4544 4 5688
Q ss_pred CCceeeccCCcCcccCchhHhhcc----CCccccCCCCCCCCCCcc
Q 007788 113 ELLFLDVQNNTLSGIVPSALKRLN----GGFQFQNNPGLCGDGIAS 154 (589)
Q Consensus 113 ~L~~l~l~~N~l~g~~p~~~~~~~----~~~~~~~n~~~c~~~~~~ 154 (589)
+|+.|||++|+|++..+..+..+. ..+.+.+|||.|+|.+..
T Consensus 164 ~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~ 209 (361)
T 2xot_A 164 KLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQ 209 (361)
T ss_dssp TCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHHHH
T ss_pred cCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCcHH
Confidence 899999999999876666776664 347889999999997654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-14 Score=144.85 Aligned_cols=118 Identities=25% Similarity=0.257 Sum_probs=97.6
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++..+..|+.+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..+..+++|+.
T Consensus 126 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 205 (285)
T 1ozn_A 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205 (285)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred hCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccE
Confidence 34888889999998888666667888899999999999988655567888999999999999999888888999999999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCcc
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIAS 154 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~ 154 (589)
|+|++|++++..+..+..+.. .+.+.+|++.|+|.+..
T Consensus 206 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~ 245 (285)
T 1ozn_A 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245 (285)
T ss_dssp EECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHH
T ss_pred eeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHH
Confidence 999999999877777766653 46788999999987654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=1.6e-14 Score=131.89 Aligned_cols=89 Identities=26% Similarity=0.213 Sum_probs=55.6
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 45666666666666555666666666666666666666544445566666666666666666544445666666666666
Q ss_pred cCCcCcccC
Q 007788 120 QNNTLSGIV 128 (589)
Q Consensus 120 ~~N~l~g~~ 128 (589)
++|.+++..
T Consensus 110 ~~N~~~c~c 118 (170)
T 3g39_A 110 LNNPWDCAC 118 (170)
T ss_dssp CSSCBCTTB
T ss_pred CCCCCCCCc
Confidence 666666443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=153.54 Aligned_cols=121 Identities=22% Similarity=0.237 Sum_probs=107.2
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.
T Consensus 182 ~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 259 (440)
T 3zyj_A 182 EGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259 (440)
T ss_dssp TTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCE
T ss_pred hcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCE
Confidence 34899999999999999 666 4899999999999999999988999999999999999999999988999999999999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCcccc
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRACT 159 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~~ 159 (589)
|+|++|+|++..+..+..+.. .+.+.+|||.|+|.+.++..+.
T Consensus 260 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~ 304 (440)
T 3zyj_A 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWI 304 (440)
T ss_dssp EECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHHHHH
T ss_pred EECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHHHHH
Confidence 999999999887777766543 4678999999999987765443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=144.90 Aligned_cols=98 Identities=24% Similarity=0.240 Sum_probs=66.8
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|+++ .+|+.++.+++|+.|+|++|++.+.+|..++++++|+.|+|++|++.+.+|..+..+++|+.|+
T Consensus 205 l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~ 283 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283 (328)
T ss_dssp CTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEE
T ss_pred CCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEe
Confidence 666777777777766 3555666677777777777666666776677777777777777666666776666677777777
Q ss_pred ccCCcCcccCchhHhhccC
Q 007788 119 VQNNTLSGIVPSALKRLNG 137 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~ 137 (589)
|++|++.|.+|..+..+..
T Consensus 284 L~~n~~~~~iP~~l~~L~~ 302 (328)
T 4fcg_A 284 LRGCVNLSRLPSLIAQLPA 302 (328)
T ss_dssp CTTCTTCCCCCGGGGGSCT
T ss_pred CCCCCchhhccHHHhhccC
Confidence 7777776677766665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=8.3e-15 Score=147.14 Aligned_cols=120 Identities=21% Similarity=0.238 Sum_probs=102.3
Q ss_pred hhcccceEEEccCccccc-CCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 37 VILLCFVVLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
..+++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..+..+++|+
T Consensus 147 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 226 (306)
T 2z66_A 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226 (306)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCC
T ss_pred ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCC
Confidence 348889999999999987 5788899999999999999999988888999999999999999999977777888899999
Q ss_pred eeeccCCcCcccCchhHhhcc---CCccccCCCCCCCCCCccCc
Q 007788 116 FLDVQNNTLSGIVPSALKRLN---GGFQFQNNPGLCGDGIASLR 156 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~~~~~~---~~~~~~~n~~~c~~~~~~l~ 156 (589)
.|+|++|++++..|..+..+. ..+.+.+|++.|+|.+..+.
T Consensus 227 ~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~ 270 (306)
T 2z66_A 227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 270 (306)
T ss_dssp EEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHH
T ss_pred EeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHH
Confidence 999999999998888777653 24678899999998765443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=160.41 Aligned_cols=122 Identities=18% Similarity=0.177 Sum_probs=106.4
Q ss_pred hhcccceEEEccCccccc-CCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 37 VILLCFVVLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
..+++|+.|+|++|++++ .+|..|+.+++|+.|+|++|++++..|..|+++++|+.|+|++|++++.+|..+..+++|+
T Consensus 445 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 524 (606)
T 3vq2_A 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524 (606)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCC
T ss_pred cCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCC
Confidence 348999999999999998 4788999999999999999999998899999999999999999999998899999999999
Q ss_pred eeeccCCcCcccCchhHhhccC---CccccCCCCCCCCCCccCcccc
Q 007788 116 FLDVQNNTLSGIVPSALKRLNG---GFQFQNNPGLCGDGIASLRACT 159 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~~~~~~~---~~~~~~n~~~c~~~~~~l~~~~ 159 (589)
.|+|++|+|+ .+|..+..+.. .+.+.+||+.|+|.+.++..+.
T Consensus 525 ~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l 570 (606)
T 3vq2_A 525 TLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWV 570 (606)
T ss_dssp EEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTT
T ss_pred EEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHH
Confidence 9999999999 56766766642 4678999999999886655443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-14 Score=152.56 Aligned_cols=115 Identities=24% Similarity=0.231 Sum_probs=103.6
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..|..+++|+.
T Consensus 296 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 375 (455)
T 3v47_A 296 SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375 (455)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred ccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccE
Confidence 34899999999999999888999999999999999999999888899999999999999999999888999999999999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCCCCCCC
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG 151 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~ 151 (589)
|+|++|++++..+..+..+.. .+.+.+|++.|+|+
T Consensus 376 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999877766665543 46789999999987
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.3e-14 Score=130.26 Aligned_cols=87 Identities=25% Similarity=0.195 Sum_probs=52.8
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|+|++.+|..|+++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 45666666666666555666666666666666666666433334566666666666666666444344666666666666
Q ss_pred cCCcCcc
Q 007788 120 QNNTLSG 126 (589)
Q Consensus 120 ~~N~l~g 126 (589)
++|.++.
T Consensus 113 ~~N~~~c 119 (174)
T 2r9u_A 113 YNNPWDC 119 (174)
T ss_dssp CSSCBCT
T ss_pred CCCCccc
Confidence 6666653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.7e-15 Score=170.65 Aligned_cols=117 Identities=26% Similarity=0.261 Sum_probs=90.3
Q ss_pred cccceEEEccCcccc-----cCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCC
Q 007788 39 LLCFVVLQLCCNQLT-----GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 113 (589)
Q Consensus 39 l~~l~~L~L~~n~l~-----g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~ 113 (589)
+++|+.|+|++|.++ +..|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence 566666666666665 34445677888888888888888887788888888888888888888866555554 78
Q ss_pred CceeeccCCcCcccCchhHhhccCCccccCCCCCCCCCCccCccc
Q 007788 114 LLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRAC 158 (589)
Q Consensus 114 L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n~~~c~~~~~~l~~~ 158 (589)
|+.|||++|+|+|.+|..+..+. .+.+.+||+.|+|.+..+..+
T Consensus 528 L~~L~Ls~N~l~~~~~~~~~~L~-~l~l~~Np~~C~c~~~~f~~~ 571 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPDVFVSLS-VLDITHNKFICECELSTFINW 571 (844)
T ss_dssp CCEEEEEEECCCCCCSCCCSSCC-EEEEEEECCCCSSSCCSHHHH
T ss_pred ccEEECCCCcCCCCChhHhCCcC-EEEecCCCcccccccHHHHHH
Confidence 88888888888888888776543 467899999999988766544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=4.6e-14 Score=128.73 Aligned_cols=112 Identities=26% Similarity=0.304 Sum_probs=97.7
Q ss_pred ceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccC
Q 007788 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQN 121 (589)
Q Consensus 42 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~ 121 (589)
.+.|++++|.|+ .+|..+. ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 6887664 8999999999999988899999999999999999999977777789999999999999
Q ss_pred CcCcccCchhHhhccC--CccccCCCCCCCCC-CccCc
Q 007788 122 NTLSGIVPSALKRLNG--GFQFQNNPGLCGDG-IASLR 156 (589)
Q Consensus 122 N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~-~~~l~ 156 (589)
|+|++..|..+..+.. .+.+.+|++.|.|. +..+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l~~l~ 125 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDILYLS 125 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGGHHHH
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhHHHHH
Confidence 9999888877776654 56789999999985 54443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.4e-14 Score=134.05 Aligned_cols=123 Identities=20% Similarity=0.074 Sum_probs=101.0
Q ss_pred EEeeccccccccc-----------ccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccC
Q 007788 5 YFLDECGIHGKII-----------VFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQH 73 (589)
Q Consensus 5 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~ 73 (589)
..|..|.|+.... .++...|.|...... .+..+++|+.|+|++|+|++..|..|+.+++|+.|+|++
T Consensus 37 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 114 (220)
T 2v70_A 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG--AFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114 (220)
T ss_dssp EECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTT--TTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred EEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHH--HhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence 4566666665422 124444444432221 234599999999999999988888899999999999999
Q ss_pred CcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCcccCc
Q 007788 74 NRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 74 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p 129 (589)
|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999889999999999999999999998889999999999999999999998765
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.49 E-value=2.2e-14 Score=152.32 Aligned_cols=119 Identities=22% Similarity=0.237 Sum_probs=105.5
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++ +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.
T Consensus 193 ~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 270 (452)
T 3zyi_A 193 EGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270 (452)
T ss_dssp TTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCE
Confidence 348999999999999994 55 5899999999999999999988999999999999999999999988999999999999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCcc
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRA 157 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~ 157 (589)
|+|++|+|++..+..+..+.. .+.+.+|||.|+|.+..+..
T Consensus 271 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l~~ 313 (452)
T 3zyi_A 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAW 313 (452)
T ss_dssp EECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHHHH
T ss_pred EECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHHHH
Confidence 999999999877777666543 46789999999998876543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.49 E-value=6.1e-14 Score=136.58 Aligned_cols=97 Identities=26% Similarity=0.239 Sum_probs=56.7
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 55666666666666655555566666666666666666654445556666666666666666644444455566666666
Q ss_pred ccCCcCcccCchhHhhc
Q 007788 119 VQNNTLSGIVPSALKRL 135 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~ 135 (589)
|++|+|++..|..+..+
T Consensus 138 Ls~N~l~~~~~~~~~~l 154 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKL 154 (251)
T ss_dssp CCSSCCCCCCTTTTTTC
T ss_pred CcCCcCCccCHHHcCcC
Confidence 66666665554444433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.46 E-value=6.7e-14 Score=124.62 Aligned_cols=89 Identities=26% Similarity=0.247 Sum_probs=49.0
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCC-ChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT-IPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~l~~L~~l 117 (589)
+++|+.|+|++|++++. ..++.+++|+.|+|++|++++.+|..++++++|+.|+|++|++++. .|..+..+++|+.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 55555555555555533 4455555555555555555554555555555555555555555532 22455555555555
Q ss_pred eccCCcCcccCc
Q 007788 118 DVQNNTLSGIVP 129 (589)
Q Consensus 118 ~l~~N~l~g~~p 129 (589)
++++|++++..+
T Consensus 119 ~l~~N~l~~~~~ 130 (149)
T 2je0_A 119 DLFNCEVTNLND 130 (149)
T ss_dssp ECTTCGGGGSTT
T ss_pred eCcCCcccchHH
Confidence 555555554443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=5.7e-14 Score=154.88 Aligned_cols=121 Identities=23% Similarity=0.271 Sum_probs=104.6
Q ss_pred hhcccceEEEccCcccccC---CCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCC
Q 007788 37 VILLCFVVLQLCCNQLTGN---IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 113 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~---~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~ 113 (589)
..+++|+.|+|++|.+++. .+..+..+++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..+..+++
T Consensus 446 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 525 (606)
T 3t6q_A 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525 (606)
T ss_dssp TTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCS
T ss_pred hCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccc
Confidence 3488999999999999873 3367899999999999999999888999999999999999999999999999999999
Q ss_pred CceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCccc
Q 007788 114 LLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRAC 158 (589)
Q Consensus 114 L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~ 158 (589)
| .|+|++|++++.+|..+..+.. .+.+.+||+.|+|....+..+
T Consensus 526 L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w 571 (606)
T 3t6q_A 526 I-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEW 571 (606)
T ss_dssp C-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHH
T ss_pred c-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHH
Confidence 9 9999999999998888776643 578899999999986554433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=6.6e-14 Score=143.22 Aligned_cols=110 Identities=19% Similarity=0.266 Sum_probs=57.8
Q ss_pred EEccCc-ccccCCCccccCCCCCCeEeccC-CcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCC
Q 007788 45 LQLCCN-QLTGNIPAQIGSLKSLSVLTLQH-NRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 122 (589)
Q Consensus 45 L~L~~n-~l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N 122 (589)
+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 355554 555 3455 55555555555554 5555444455555555555555555555555555555555555555555
Q ss_pred cCcccCchhHhhcc-CCccccCCCCCCCCCCccCc
Q 007788 123 TLSGIVPSALKRLN-GGFQFQNNPGLCGDGIASLR 156 (589)
Q Consensus 123 ~l~g~~p~~~~~~~-~~~~~~~n~~~c~~~~~~l~ 156 (589)
+|++..|..+..+. ..+.+.+|++.|+|.+..+.
T Consensus 91 ~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~~~~ 125 (347)
T 2ifg_A 91 ALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125 (347)
T ss_dssp CCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHH
T ss_pred ccceeCHHHcccCCceEEEeeCCCccCCCccHHHH
Confidence 55544444333221 12345555556665544433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=127.31 Aligned_cols=110 Identities=17% Similarity=0.145 Sum_probs=91.7
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|.. ++ ..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 32 ~l~~L~L~~n~i~~-ip--~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 108 (193)
T 2wfh_A 32 DVTELYLDGNQFTL-VP--KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108 (193)
T ss_dssp TCCEEECCSSCCCS-CC--GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCcCch-hH--HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEE
Confidence 34444444444432 21 1334599999999999999988888999999999999999999988888999999999999
Q ss_pred ccCccccCCChhhhhcCCCCceeeccCCcCccc
Q 007788 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 95 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 109 LHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999999966666799999999999999999864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.7e-13 Score=124.56 Aligned_cols=89 Identities=27% Similarity=0.266 Sum_probs=69.7
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCC-hhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI-PESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~~L~~l 117 (589)
+++|+.|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|+.|+|++|+|++.. +..+..+++|+.|
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence 78888888888888854 67788888888888888888777777777888888888888888531 2677788888888
Q ss_pred eccCCcCcccCc
Q 007788 118 DVQNNTLSGIVP 129 (589)
Q Consensus 118 ~l~~N~l~g~~p 129 (589)
++++|++++..+
T Consensus 126 ~l~~N~l~~~~~ 137 (168)
T 2ell_A 126 DLFNCEVTNLND 137 (168)
T ss_dssp ECCSSGGGTSTT
T ss_pred EeeCCcCcchHH
Confidence 888888886655
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=131.09 Aligned_cols=105 Identities=27% Similarity=0.223 Sum_probs=90.7
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
.++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 39 ~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 118 (229)
T 3e6j_A 39 PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118 (229)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence 47899999999999998899999999999999999999865556789999999999999999977777789999999999
Q ss_pred ccCCcCcccCchhHhhccC--CccccCC
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNN 144 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n 144 (589)
|++|+|+ .+|..+..+.. .+.+.+|
T Consensus 119 Ls~N~l~-~lp~~~~~l~~L~~L~L~~N 145 (229)
T 3e6j_A 119 MCCNKLT-ELPRGIERLTHLTHLALDQN 145 (229)
T ss_dssp CCSSCCC-SCCTTGGGCTTCSEEECCSS
T ss_pred ccCCccc-ccCcccccCCCCCEEECCCC
Confidence 9999999 77877766543 2344444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.44 E-value=5.5e-14 Score=155.71 Aligned_cols=84 Identities=18% Similarity=0.261 Sum_probs=65.9
Q ss_pred ccccCCCccccCCCCCCeEeccCCcCCcc-----------------CCcccc--CCCCCCeeeccCccccCCChhhhhcC
Q 007788 51 QLTGNIPAQIGSLKSLSVLTLQHNRLNGG-----------------IPDSLG--NLGKLKRLDLSFNSLFGTIPESLANN 111 (589)
Q Consensus 51 ~l~g~~p~~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~ls~N~l~g~~p~~~~~l 111 (589)
+|+| ||..|+++++|++|+|++|+|+|. +|++++ +|++|++|+|++|++.|.+|+.++++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4445 777788888888888888888875 888877 88888888888888888888888888
Q ss_pred CCCceeeccCCc-Ccc-cCchhHhhc
Q 007788 112 AELLFLDVQNNT-LSG-IVPSALKRL 135 (589)
Q Consensus 112 ~~L~~l~l~~N~-l~g-~~p~~~~~~ 135 (589)
++|+.|+|++|+ ++| .+|..+..+
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L 298 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQAL 298 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred CCCCEEECcCCCCCccccchHHHHhh
Confidence 888888888887 887 777776654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-13 Score=125.15 Aligned_cols=112 Identities=25% Similarity=0.289 Sum_probs=96.3
Q ss_pred ceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccC
Q 007788 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQN 121 (589)
Q Consensus 42 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~ 121 (589)
-+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999997 8888775 8999999999999988899999999999999999999976666688999999999999
Q ss_pred CcCcccCchhHhhccC--CccccCCCCCCCCC-CccCc
Q 007788 122 NTLSGIVPSALKRLNG--GFQFQNNPGLCGDG-IASLR 156 (589)
Q Consensus 122 N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~-~~~l~ 156 (589)
|+|++..+..+..+.. .+.+.+|++.|.|. +..++
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l~ 128 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLR 128 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHHH
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccccHHHHH
Confidence 9999877766776654 46789999999985 44333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.44 E-value=2e-13 Score=125.39 Aligned_cols=113 Identities=21% Similarity=0.165 Sum_probs=91.8
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|...... .+..+++|++|+|++|+|++..+..|+.+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHG--VFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp TCSEEECCSSCCCCCCTT--TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcEEEeCCCcccEeCHH--HhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 344445444554422211 234489999999999999977667789999999999999999977777789999999999
Q ss_pred ccCccccCCChhhhhcCCCCceeeccCCcCcccCc
Q 007788 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 95 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p 129 (589)
|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999997666667889999999999999998776
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=139.03 Aligned_cols=96 Identities=22% Similarity=0.270 Sum_probs=65.5
Q ss_pred cccceEEEccCcccccCCCccccC---------CCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhh
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGS---------LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~---------l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 109 (589)
+++|++|+|++|++.+.+|..++. +++|+.|+|++|+|+ .+|..++++++|+.|+|++|++++ +|+.+.
T Consensus 149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~ 226 (328)
T 4fcg_A 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226 (328)
T ss_dssp CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGG
T ss_pred CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhc
Confidence 667777777776666677766544 677777777777776 667667777777777777777773 555666
Q ss_pred cCCCCceeeccCCcCcccCchhHhhcc
Q 007788 110 NNAELLFLDVQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 110 ~l~~L~~l~l~~N~l~g~~p~~~~~~~ 136 (589)
.+++|+.|+|++|++.+.+|..+..+.
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~ 253 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRA 253 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCC
Confidence 777777777777777777666655543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-13 Score=128.93 Aligned_cols=107 Identities=21% Similarity=0.120 Sum_probs=90.0
Q ss_pred cccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCc
Q 007788 19 FKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98 (589)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 98 (589)
++...|+|...... .+..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 61 L~Ls~N~i~~~~~~--~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 138 (220)
T 2v9t_B 61 IDLSNNQISELAPD--AFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138 (220)
T ss_dssp EECCSSCCCEECTT--TTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EECCCCcCCCcCHH--HhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCC
Confidence 34445555432221 2344999999999999999665567899999999999999999988999999999999999999
Q ss_pred cccCCChhhhhcCCCCceeeccCCcCccc
Q 007788 99 SLFGTIPESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 99 ~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
+|++..+..|..+++|+.|+|++|.+...
T Consensus 139 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 139 KLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99988778899999999999999999763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.42 E-value=9.7e-14 Score=155.58 Aligned_cols=102 Identities=35% Similarity=0.439 Sum_probs=87.2
Q ss_pred cchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCC
Q 007788 25 KIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104 (589)
Q Consensus 25 ~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 104 (589)
.||..++. |++|+.|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|.+|++|++|+.|+|++|.|+ .+
T Consensus 238 ~l~~~~~~------l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~l 308 (727)
T 4b8c_D 238 NISANIFK------YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TL 308 (727)
T ss_dssp CCCGGGGG------CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CC
T ss_pred CCChhhcC------CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-cc
Confidence 45555554 888999999999998 88888999999999999999998 78999999999999999999987 78
Q ss_pred hhhhhcCCCCceeeccCCcCcccCchhHhhc
Q 007788 105 PESLANNAELLFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 105 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~ 135 (589)
|..|+.+++|+.|+|++|+|+|.+|..+..+
T Consensus 309 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 339 (727)
T 4b8c_D 309 PWEFGNLCNLQFLGVEGNPLEKQFLKILTEK 339 (727)
T ss_dssp CSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred ChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence 8889999999999999999998888877543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=2.9e-13 Score=133.72 Aligned_cols=98 Identities=26% Similarity=0.305 Sum_probs=76.8
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccC-CChhhhhcCCCCce
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG-TIPESLANNAELLF 116 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~ 116 (589)
.+++|++|+|++|.+++..|..|+++++|+.|+|++|++++..+..++++++|+.|+|++|++++ .+|..+..+++|+.
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~ 153 (276)
T 2z62_A 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153 (276)
T ss_dssp TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCE
T ss_pred CCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCE
Confidence 37888888888888887777788888888888888888886666678888888888888888876 36788888888888
Q ss_pred eeccCCcCcccCchhHhhc
Q 007788 117 LDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~ 135 (589)
|+|++|++++..+..+..+
T Consensus 154 L~Ls~N~l~~~~~~~~~~l 172 (276)
T 2z62_A 154 LDLSSNKIQSIYCTDLRVL 172 (276)
T ss_dssp EECCSSCCCEECGGGGHHH
T ss_pred EECCCCCCCcCCHHHhhhh
Confidence 8888888887766655443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.2e-13 Score=148.86 Aligned_cols=118 Identities=23% Similarity=0.297 Sum_probs=107.0
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCC-ccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN-GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|+++ +.+|..++.+++|+.|+|++|++++..|..+..+++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 44899999999999999999999999999999999999998 68999999999999999999999988899999999999
Q ss_pred eeeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCcc
Q 007788 116 FLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIAS 154 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~ 154 (589)
.|+|++|++++.+|..+..+.. .+.+.+|++.|+|+...
T Consensus 498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 9999999999988887776654 46789999999987543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=2e-13 Score=150.91 Aligned_cols=123 Identities=17% Similarity=0.083 Sum_probs=81.3
Q ss_pred ccccccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCC
Q 007788 12 IHGKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 91 (589)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 91 (589)
|+..+..+|...|.|...... .+..|++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|.+|++|+
T Consensus 50 lp~~~~~LdLs~N~i~~l~~~--~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~ 127 (635)
T 4g8a_A 50 LPFSTKNLDLSFNPLRHLGSY--SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 127 (635)
T ss_dssp SCTTCCEEECTTSCCCEECTT--TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCC
T ss_pred CCcCCCEEEeeCCCCCCCCHH--HHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCC
Confidence 344555566666665533221 234477777777777777766666777777777777777777755555677777777
Q ss_pred eeeccCccccCCChhhhhcCCCCceeeccCCcCccc-CchhHhhcc
Q 007788 92 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI-VPSALKRLN 136 (589)
Q Consensus 92 ~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~~~~~~ 136 (589)
+|+|++|+|++..|..|+++++|+.|+|++|++++. +|..+..+.
T Consensus 128 ~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 128 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred EEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 777777777755555677777777777777777653 455555443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.3e-13 Score=147.40 Aligned_cols=127 Identities=19% Similarity=0.158 Sum_probs=107.9
Q ss_pred cccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccC
Q 007788 23 SNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102 (589)
Q Consensus 23 ~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 102 (589)
.+.+|..++. ..+|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++
T Consensus 213 ~~~~~~~~~~------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 286 (477)
T 2id5_A 213 LDTMTPNCLY------GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286 (477)
T ss_dssp CCEECTTTTT------TCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSE
T ss_pred ccccCccccc------CccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccce
Confidence 3445554444 5589999999999995444689999999999999999998888889999999999999999999
Q ss_pred CChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccC
Q 007788 103 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASL 155 (589)
Q Consensus 103 ~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l 155 (589)
..|..|..+++|+.|+|++|+|++..+..+..+.. .+.+.+|++.|+|.+.++
T Consensus 287 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~ 341 (477)
T 2id5_A 287 VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWV 341 (477)
T ss_dssp ECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHH
T ss_pred ECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhH
Confidence 99999999999999999999999877776655543 567899999999987654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.41 E-value=8.3e-14 Score=157.86 Aligned_cols=81 Identities=22% Similarity=0.289 Sum_probs=71.9
Q ss_pred CCccccCCCCCCeEeccCCcCCc-----------------cCCcccc--CCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 56 IPAQIGSLKSLSVLTLQHNRLNG-----------------GIPDSLG--NLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 56 ~p~~~~~l~~L~~L~L~~N~l~g-----------------~~p~~~~--~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
||..|++|++|+.|+|++|+|+| .+|++++ +|++|+.|+|++|++.|.+|..|+++++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 78889999999999999999998 4899988 9999999999999999999999999999999
Q ss_pred eeccCCc-Ccc-cCchhHhhcc
Q 007788 117 LDVQNNT-LSG-IVPSALKRLN 136 (589)
Q Consensus 117 l~l~~N~-l~g-~~p~~~~~~~ 136 (589)
|+|++|+ |+| .+|..+..+.
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~ 541 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLA 541 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHH
T ss_pred EECcCCCCcccccchHHHHhhh
Confidence 9999998 998 8888777654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=4.9e-13 Score=149.49 Aligned_cols=121 Identities=23% Similarity=0.250 Sum_probs=98.3
Q ss_pred hhcccceEEEccCcccccCCC--------ccccCCCCCCeEeccCCcCCccCCc-cccCCCCCCeeeccCccccCCChhh
Q 007788 37 VILLCFVVLQLCCNQLTGNIP--------AQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFGTIPES 107 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p--------~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~ 107 (589)
..+++|+.|+|++|++++..+ ..|+++++|+.|+|++|+|+ .+|. .|.++++|+.|+|++|+|++..|..
T Consensus 501 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~ 579 (680)
T 1ziw_A 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASV 579 (680)
T ss_dssp TTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred ccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhH
Confidence 348889999999998886422 24788899999999999999 5554 6899999999999999999766667
Q ss_pred hhcCCCCceeeccCCcCcccCchhHh-hcc--CCccccCCCCCCCCCC-ccCccc
Q 007788 108 LANNAELLFLDVQNNTLSGIVPSALK-RLN--GGFQFQNNPGLCGDGI-ASLRAC 158 (589)
Q Consensus 108 ~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~--~~~~~~~n~~~c~~~~-~~l~~~ 158 (589)
|..+++|+.|+|++|+|++..|..+. .+. ..+.+.+|||.|+|.. .++..+
T Consensus 580 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~ 634 (680)
T 1ziw_A 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634 (680)
T ss_dssp TTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECC
T ss_pred hCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHH
Confidence 88999999999999999998888765 343 2567899999999985 665544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.41 E-value=7.6e-13 Score=130.45 Aligned_cols=94 Identities=24% Similarity=0.236 Sum_probs=48.3
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 45555555555555544444455555555555555555544444455555555555555555544444445555555555
Q ss_pred ccCCcCcccCchhH
Q 007788 119 VQNNTLSGIVPSAL 132 (589)
Q Consensus 119 l~~N~l~g~~p~~~ 132 (589)
|++|++++..|..+
T Consensus 164 l~~n~l~~~~~~~~ 177 (272)
T 3rfs_A 164 LSYNQLQSLPEGVF 177 (272)
T ss_dssp CCSSCCCCCCTTTT
T ss_pred CCCCCcCccCHHHh
Confidence 55555554444333
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=5e-13 Score=145.29 Aligned_cols=91 Identities=31% Similarity=0.292 Sum_probs=53.0
Q ss_pred cceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeecc
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQ 120 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~ 120 (589)
.|+.|+|++|+|++ +|. |+.|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 35556666666653 444 566666666666666666 556666666666666666666664 45 55556666666666
Q ss_pred CCcCcccC-chhHhhcc
Q 007788 121 NNTLSGIV-PSALKRLN 136 (589)
Q Consensus 121 ~N~l~g~~-p~~~~~~~ 136 (589)
+|+|++.+ |..+..+.
T Consensus 517 ~N~l~~~~~p~~l~~l~ 533 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCP 533 (567)
T ss_dssp SSCCCSSSTTGGGGGCT
T ss_pred CCCCCCCCCcHHHhcCC
Confidence 66666554 55555443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.39 E-value=6.1e-13 Score=118.34 Aligned_cols=96 Identities=23% Similarity=0.268 Sum_probs=87.0
Q ss_pred cccceEEEccCcccc-cCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.++|+.|+|++|.++ +.+|..++.+++|+.|+|++|++++. ..++++++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 578999999999999 89999999999999999999999965 789999999999999999998899999999999999
Q ss_pred eccCCcCccc-CchhHhhcc
Q 007788 118 DVQNNTLSGI-VPSALKRLN 136 (589)
Q Consensus 118 ~l~~N~l~g~-~p~~~~~~~ 136 (589)
++++|++++. .|..+..+.
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~ 113 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLE 113 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCT
T ss_pred ECCCCcCCChHHHHHHhhCC
Confidence 9999999974 346666554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.39 E-value=4e-13 Score=138.16 Aligned_cols=93 Identities=22% Similarity=0.114 Sum_probs=63.0
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 36667777777777776555667777777777777777775555566777777777777777776666667777777777
Q ss_pred eccCCcCcccCch
Q 007788 118 DVQNNTLSGIVPS 130 (589)
Q Consensus 118 ~l~~N~l~g~~p~ 130 (589)
+|++|+|++..+.
T Consensus 142 ~L~~N~l~~l~~~ 154 (361)
T 2xot_A 142 YLSQNQISRFPVE 154 (361)
T ss_dssp ECCSSCCCSCCGG
T ss_pred ECCCCcCCeeCHH
Confidence 7777777654433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=123.41 Aligned_cols=94 Identities=23% Similarity=0.237 Sum_probs=85.0
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|++|+|++|++++..+..|+.+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.
T Consensus 73 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 152 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY 152 (208)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred CCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccE
Confidence 44899999999999999776677899999999999999999777777899999999999999999777667899999999
Q ss_pred eeccCCcCcccCch
Q 007788 117 LDVQNNTLSGIVPS 130 (589)
Q Consensus 117 l~l~~N~l~g~~p~ 130 (589)
|+|++|.+.+..|.
T Consensus 153 L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 153 IWLHDNPWDCTCPG 166 (208)
T ss_dssp EECCSCCBCCCTTT
T ss_pred EEecCCCeecCCCC
Confidence 99999999987763
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=128.81 Aligned_cols=100 Identities=23% Similarity=0.235 Sum_probs=76.6
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|++|+|++|+++...+..|..+++|++|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.
T Consensus 58 ~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 137 (270)
T 2o6q_A 58 HRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137 (270)
T ss_dssp SSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE
Confidence 34788888888888888555556678888888888888888666666788888888888888888777777788888888
Q ss_pred eeccCCcCcccCchhHhhcc
Q 007788 117 LDVQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~ 136 (589)
|+|++|++++..+..+..+.
T Consensus 138 L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 138 LSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCT
T ss_pred EECCCCcCCccCHhHccCCc
Confidence 88888888876665555443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.9e-13 Score=149.91 Aligned_cols=117 Identities=12% Similarity=0.218 Sum_probs=100.5
Q ss_pred ccccccchhhhhhhhhHhhcccceEEEccCcccccC-----------------CCcccc--CCCCCCeEeccCCcCCccC
Q 007788 20 KEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGN-----------------IPAQIG--SLKSLSVLTLQHNRLNGGI 80 (589)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~-----------------~p~~~~--~l~~L~~L~L~~N~l~g~~ 80 (589)
|.+++ ||..+.. +++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.+
T Consensus 193 n~l~~-ip~~l~~------l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 193 NNITF-VSKAVMR------LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp CEEEE-ECGGGGG------CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred CCCcc-CCHHHhc------ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 35555 7766655 99999999999999986 999999 9999999999999999999
Q ss_pred CccccCCCCCCeeeccCcc-ccC-CChhhhhcC------CCCceeeccCCcCcccCch--hHhhccC--CccccCC
Q 007788 81 PDSLGNLGKLKRLDLSFNS-LFG-TIPESLANN------AELLFLDVQNNTLSGIVPS--ALKRLNG--GFQFQNN 144 (589)
Q Consensus 81 p~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l------~~L~~l~l~~N~l~g~~p~--~~~~~~~--~~~~~~n 144 (589)
|.+|+++++|+.|+|++|+ |+| .+|..++.+ ++|+.|+|++|+++ .+|. .+..+.. .+.+.+|
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 9999999999999999998 999 899998887 89999999999999 7887 7776653 2344444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.38 E-value=9.6e-13 Score=130.97 Aligned_cols=95 Identities=31% Similarity=0.316 Sum_probs=59.5
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|+.|+|++|+|++. |.. +.+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 53 ~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L 129 (290)
T 1p9a_G 53 PYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (290)
T ss_dssp TCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence 366677777777766643 322 56666666666666666 566666666666666666666665555566666666666
Q ss_pred eccCCcCcccCchhHhhc
Q 007788 118 DVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~ 135 (589)
+|++|+|++..+..+..+
T Consensus 130 ~L~~N~l~~~~~~~~~~l 147 (290)
T 1p9a_G 130 YLKGNELKTLPPGLLTPT 147 (290)
T ss_dssp ECTTSCCCCCCTTTTTTC
T ss_pred ECCCCCCCccChhhcccc
Confidence 666666665555444433
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.2e-13 Score=145.84 Aligned_cols=115 Identities=27% Similarity=0.335 Sum_probs=95.2
Q ss_pred hhcccceEEEccCcccccCCCc-cccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 37 VILLCFVVLQLCCNQLTGNIPA-QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
..+++|+.|+|++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|+
T Consensus 400 ~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~ 476 (562)
T 3a79_B 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQ 476 (562)
T ss_dssp TTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCS
T ss_pred cCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCC
Confidence 4488888999999988875665 578888899999999998887777665 78999999999999 7898888999999
Q ss_pred eeeccCCcCcccCchh-HhhccC--CccccCCCCCCCCCCccC
Q 007788 116 FLDVQNNTLSGIVPSA-LKRLNG--GFQFQNNPGLCGDGIASL 155 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~-~~~~~~--~~~~~~n~~~c~~~~~~l 155 (589)
.|+|++|+|++ +|.. +..+.. .+.+.+|++.|+|++.++
T Consensus 477 ~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 477 ELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp EEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred EEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 99999999995 5554 665543 467899999999987655
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=144.21 Aligned_cols=116 Identities=25% Similarity=0.300 Sum_probs=97.9
Q ss_pred HhhcccceEEEccCcccccCCCc-cccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCC
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPA-QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAEL 114 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 114 (589)
+..+++|+.|+|++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|
T Consensus 370 ~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L 446 (520)
T 2z7x_B 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEAL 446 (520)
T ss_dssp HTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTC
T ss_pred HhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCC
Confidence 34588999999999999986776 488899999999999999988887765 79999999999999 889988899999
Q ss_pred ceeeccCCcCcccCchh-HhhccC--CccccCCCCCCCCCCccC
Q 007788 115 LFLDVQNNTLSGIVPSA-LKRLNG--GFQFQNNPGLCGDGIASL 155 (589)
Q Consensus 115 ~~l~l~~N~l~g~~p~~-~~~~~~--~~~~~~n~~~c~~~~~~l 155 (589)
+.|+|++|+|++ +|.. +..+.. .+.+.+|++.|+|.+.++
T Consensus 447 ~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 489 (520)
T 2z7x_B 447 QELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 489 (520)
T ss_dssp CEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHHHHHH
T ss_pred CEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCCchHH
Confidence 999999999995 5554 655543 467899999999987666
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.5e-13 Score=144.22 Aligned_cols=107 Identities=27% Similarity=0.264 Sum_probs=64.3
Q ss_pred cccceEEEccCcccccCCCcccc-CCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIG-SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
+++|+.|+|++|.|++.+|..+. .+++|+.|+|++|+|++. | .+..+++|+.|+|++|+|++ +|+.+..+++|+.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L 219 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEE
Confidence 66666666666666666666554 566666666666666644 2 23346667777777777664 33446666677777
Q ss_pred eccCCcCcccCchhHhhccC--CccccCCCCCCC
Q 007788 118 DVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCG 149 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~ 149 (589)
+|++|+|++ +|..+..+.. .+.+.+|++.|+
T Consensus 220 ~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 220 SLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp ECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred EecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 777777765 4444433322 345566666654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=129.13 Aligned_cols=98 Identities=26% Similarity=0.260 Sum_probs=74.0
Q ss_pred cccceEEEccCcc-cccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQ-LTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~-l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
+++|+.|+|++|. ++...|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..+..+++|+.|
T Consensus 79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence 7778888888886 665556778888888888888888887667777888888888888888886655667778888888
Q ss_pred eccCCcCcccCchhHhhcc
Q 007788 118 DVQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~ 136 (589)
+|++|++++..+..+..+.
T Consensus 159 ~l~~n~l~~~~~~~~~~l~ 177 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGLH 177 (285)
T ss_dssp ECCSSCCCEECTTTTTTCT
T ss_pred ECCCCcccccCHHHhcCcc
Confidence 8888888766665555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-12 Score=128.19 Aligned_cols=131 Identities=17% Similarity=0.101 Sum_probs=105.8
Q ss_pred ccccccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCC
Q 007788 12 IHGKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 91 (589)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 91 (589)
++..+..++...|.|...... .+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|+
T Consensus 26 l~~~l~~L~ls~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (276)
T 2z62_A 26 LPFSTKNLDLSFNPLRHLGSY--SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103 (276)
T ss_dssp SCTTCCEEECTTCCCCEECTT--TTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCCccEEECCCCcccccCHh--HhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCcccc
Confidence 444555566665555433221 234489999999999999987778999999999999999999988888999999999
Q ss_pred eeeccCccccCCChhhhhcCCCCceeeccCCcCccc-CchhHhhccC--CccccCC
Q 007788 92 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI-VPSALKRLNG--GFQFQNN 144 (589)
Q Consensus 92 ~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~~~~~~~--~~~~~~n 144 (589)
.|+|++|++++..+..+..+++|+.|+|++|++++. +|..+..+.. .+.+.+|
T Consensus 104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N 159 (276)
T 2z62_A 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (276)
T ss_dssp EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred EEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence 999999999977666899999999999999999874 6888877654 3445555
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-12 Score=121.38 Aligned_cols=95 Identities=20% Similarity=0.154 Sum_probs=72.1
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|.++ . ++.++.+++|+.|+|++|++++..|..|+.|++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 65 l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 778888888888655 3 34678888888888888888877788888888888888888888877788888888888888
Q ss_pred ccCCcCcccCchhHhhcc
Q 007788 119 VQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~ 136 (589)
|++|++-+.+| .+..+.
T Consensus 143 L~~n~~i~~~~-~l~~l~ 159 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLP 159 (197)
T ss_dssp CCSCTBCCCCG-GGGGCS
T ss_pred ccCCCCccccH-hhcCCC
Confidence 88887333455 344443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=9.9e-13 Score=134.42 Aligned_cols=95 Identities=22% Similarity=0.161 Sum_probs=83.9
Q ss_pred cchhhhhhhhhHhhcccceEEEccC-cccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCC
Q 007788 25 KIFVIIFQIQLKVILLCFVVLQLCC-NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103 (589)
Q Consensus 25 ~~~~~~~~~~~~~~l~~l~~L~L~~-n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 103 (589)
.||. +.. +++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|++|+|++.
T Consensus 23 ~ip~-l~~------~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 95 (347)
T 2ifg_A 23 SLHH-LPG------AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESL 95 (347)
T ss_dssp TTTT-SCS------CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCC
T ss_pred ccCC-CCC------CCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCcccee
Confidence 4666 544 89999999996 999988888999999999999999999999999999999999999999999966
Q ss_pred ChhhhhcCCCCceeeccCCcCccc
Q 007788 104 IPESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 104 ~p~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
.|..+..++ |+.|+|++|+|...
T Consensus 96 ~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 96 SWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp CSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CHHHcccCC-ceEEEeeCCCccCC
Confidence 555565555 99999999999854
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.34 E-value=5.5e-13 Score=151.13 Aligned_cols=117 Identities=18% Similarity=0.231 Sum_probs=100.3
Q ss_pred ccccccchhhhhhhhhHhhcccceEEEccCccccc-----------------CCCcccc--CCCCCCeEeccCCcCCccC
Q 007788 20 KEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTG-----------------NIPAQIG--SLKSLSVLTLQHNRLNGGI 80 (589)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g-----------------~~p~~~~--~l~~L~~L~L~~N~l~g~~ 80 (589)
|.+.+ ||..+.. |++|+.|+|++|+|+| .+|+.++ +|++|+.|+|++|++.|.+
T Consensus 435 N~L~~-IP~~l~~------L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~i 507 (876)
T 4ecn_A 435 NRITF-ISKAIQR------LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507 (876)
T ss_dssp CEEEE-ECGGGGG------CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSC
T ss_pred Ccccc-hhHHHhc------CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccC
Confidence 34444 7766555 9999999999999998 4999988 9999999999999999999
Q ss_pred CccccCCCCCCeeeccCcc-ccC-CChhhhhcCC-------CCceeeccCCcCcccCch--hHhhccC--CccccCC
Q 007788 81 PDSLGNLGKLKRLDLSFNS-LFG-TIPESLANNA-------ELLFLDVQNNTLSGIVPS--ALKRLNG--GFQFQNN 144 (589)
Q Consensus 81 p~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l~-------~L~~l~l~~N~l~g~~p~--~~~~~~~--~~~~~~n 144 (589)
|..|++|++|+.|+|++|+ |+| .+|..++.++ +|+.|+|++|+|+ .+|. .+..+.. .+.+.+|
T Consensus 508 P~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N 583 (876)
T 4ecn_A 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHN 583 (876)
T ss_dssp CGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTS
T ss_pred hHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCC
Confidence 9999999999999999998 999 8999888776 9999999999999 7888 7776654 3445555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.3e-12 Score=138.93 Aligned_cols=112 Identities=21% Similarity=0.287 Sum_probs=92.9
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccc------------------cCCCCCCeeeccC
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL------------------GNLGKLKRLDLSF 97 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~------------------~~l~~L~~L~ls~ 97 (589)
...+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+++ .+|..+ +++++|+.|+|++
T Consensus 383 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~ 460 (549)
T 2z81_A 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISR 460 (549)
T ss_dssp GGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCS
T ss_pred hhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCC
Confidence 445889999999999998 78888888888888888888887 344332 2688999999999
Q ss_pred ccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCC
Q 007788 98 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG 151 (589)
Q Consensus 98 N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~ 151 (589)
|+|+ .+|+ ...+++|+.|+|++|+|++.+|..+..+.. .+.+.+|++.|+|+
T Consensus 461 N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 461 NKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9998 7886 567999999999999999999888877654 56789999999986
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.4e-12 Score=139.93 Aligned_cols=92 Identities=28% Similarity=0.381 Sum_probs=86.1
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCC-hhhhhcCCCC
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI-PESLANNAEL 114 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~~L 114 (589)
+..|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++.+ |..++.+++|
T Consensus 459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L 535 (567)
T 1dce_A 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535 (567)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence 344999999999999999 899999999999999999999996 78 8999999999999999999887 9999999999
Q ss_pred ceeeccCCcCcccCch
Q 007788 115 LFLDVQNNTLSGIVPS 130 (589)
Q Consensus 115 ~~l~l~~N~l~g~~p~ 130 (589)
+.|+|++|+|++.+|.
T Consensus 536 ~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 536 VLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CEEECTTSGGGGSSSC
T ss_pred CEEEecCCcCCCCccH
Confidence 9999999999987764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-12 Score=118.33 Aligned_cols=96 Identities=28% Similarity=0.326 Sum_probs=86.0
Q ss_pred cccceEEEccCcccc-cCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++. ..++.+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 578999999999999 89999999999999999999999965 789999999999999999998899999999999999
Q ss_pred eccCCcCcccCc-hhHhhcc
Q 007788 118 DVQNNTLSGIVP-SALKRLN 136 (589)
Q Consensus 118 ~l~~N~l~g~~p-~~~~~~~ 136 (589)
+|++|++++..+ ..+..+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~ 120 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLE 120 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCS
T ss_pred eccCCccCcchhHHHHhcCC
Confidence 999999997532 5555443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.33 E-value=1e-12 Score=147.36 Aligned_cols=106 Identities=28% Similarity=0.344 Sum_probs=94.6
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+..|+.|+|++|.+. .+|..+.+|++|+.|+|++|+|+ .+|.+|++|++|+.|+|++|+|+ .+|..|+.|++|+.
T Consensus 221 ~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~ 297 (727)
T 4b8c_D 221 YDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKY 297 (727)
T ss_dssp -CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSE
T ss_pred ccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCE
Confidence 34899999999999999 88988889999999999999999 89999999999999999999999 88999999999999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCC
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPG 146 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~ 146 (589)
|+|++|.|+ .+|..+..+.. .+.+.+|+.
T Consensus 298 L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 298 FYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp EECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred EECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence 999999998 77877776654 455666653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.5e-12 Score=128.95 Aligned_cols=97 Identities=23% Similarity=0.299 Sum_probs=56.0
Q ss_pred cccceEEEccCcccccCCC-ccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccC-CChhhhhcCCCCce
Q 007788 39 LLCFVVLQLCCNQLTGNIP-AQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG-TIPESLANNAELLF 116 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~ 116 (589)
+++|+.|+|++|++++..+ ..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++ .+|..+..+++|+.
T Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 5556666666666654433 355556666666666666665555555666666666666666654 35555555666666
Q ss_pred eeccCCcCcccCchhHhhc
Q 007788 117 LDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~ 135 (589)
|+|++|++++..|..+..+
T Consensus 180 L~Ls~n~l~~~~~~~~~~l 198 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSL 198 (306)
T ss_dssp EECTTSCCCEECTTTTTTC
T ss_pred EECCCCCcCCcCHHHhcCC
Confidence 6666666665555554443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.2e-12 Score=142.16 Aligned_cols=121 Identities=17% Similarity=0.079 Sum_probs=78.0
Q ss_pred ccccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCee
Q 007788 14 GKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRL 93 (589)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 93 (589)
..+..++...|.|...... .+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|.+|++|++|++|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 109 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSY--SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109 (606)
T ss_dssp TTCCEEECTTSCCCEECTT--TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEE
T ss_pred CCcCEEECCCCCcCEeChh--hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEE
Confidence 3444445555544432221 23346777777777777776666677777777777777777776667777777777777
Q ss_pred eccCccccCCChhhhhcCCCCceeeccCCcCcc-cCchhHhhcc
Q 007788 94 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSG-IVPSALKRLN 136 (589)
Q Consensus 94 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~ 136 (589)
+|++|++++..|..++++++|+.|+|++|++++ .+|..+..+.
T Consensus 110 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~ 153 (606)
T 3vq2_A 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153 (606)
T ss_dssp ECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCT
T ss_pred EccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcC
Confidence 777777775555667777777777777777765 4566665554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.9e-12 Score=135.98 Aligned_cols=94 Identities=23% Similarity=0.150 Sum_probs=88.0
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|.+|+++++|++|+|++|+|++..+..+..+++|+.
T Consensus 320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (455)
T 3v47_A 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK 399 (455)
T ss_dssp TTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccE
Confidence 34899999999999999888999999999999999999999988999999999999999999999766667899999999
Q ss_pred eeccCCcCcccCch
Q 007788 117 LDVQNNTLSGIVPS 130 (589)
Q Consensus 117 l~l~~N~l~g~~p~ 130 (589)
|+|++|++++..|.
T Consensus 400 L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 400 IWLHTNPWDCSCPR 413 (455)
T ss_dssp EECCSSCBCCCTTT
T ss_pred EEccCCCcccCCCc
Confidence 99999999999883
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.2e-12 Score=140.54 Aligned_cols=116 Identities=19% Similarity=0.160 Sum_probs=96.0
Q ss_pred ccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCC
Q 007788 24 NKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103 (589)
Q Consensus 24 ~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 103 (589)
..+|..++. .+++|++|+|++|.+++..|..|+.+++|+.|+|++|.|++..|..|+++++|++|+|++|+|++.
T Consensus 64 ~~lp~~~~~-----~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l 138 (597)
T 3oja_B 64 RKLPAALLD-----SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 138 (597)
T ss_dssp SEECTHHHH-----HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcCHHHHc-----cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCC
Confidence 355555443 489999999999999988888999999999999999999988888889999999999999999965
Q ss_pred ChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCC
Q 007788 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNN 144 (589)
Q Consensus 104 ~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n 144 (589)
.|..|..+++|+.|+|++|++++..|..+..+.. .+.+.+|
T Consensus 139 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 181 (597)
T 3oja_B 139 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181 (597)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTS
T ss_pred CHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCC
Confidence 5556789999999999999999988887776654 3344444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.9e-12 Score=130.04 Aligned_cols=93 Identities=22% Similarity=0.195 Sum_probs=69.3
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|..++.+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 56777777777777666677777777777777777777666667777777777777777777 67777777777777777
Q ss_pred cCCcCcccCchhHh
Q 007788 120 QNNTLSGIVPSALK 133 (589)
Q Consensus 120 ~~N~l~g~~p~~~~ 133 (589)
++|++++..+..+.
T Consensus 272 ~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 272 HTNNITKVGVNDFC 285 (332)
T ss_dssp CSSCCCBCCTTSSS
T ss_pred CCCCCCccChhHcc
Confidence 77777766555543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.7e-12 Score=137.13 Aligned_cols=120 Identities=23% Similarity=0.182 Sum_probs=76.9
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|...... .+..+++|+.|+|++|.+++..|..|+++++|+.|+|++|+|++..+..|+++++|+.|+
T Consensus 33 ~l~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQD--EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp TCSEEECCSSCCCEECTT--TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred CCcEEECCCCccceECHh--HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence 344444444444432211 233467777777777777766677777777777777777777754444567777777777
Q ss_pred ccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhcc
Q 007788 95 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 95 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~ 136 (589)
|++|++++..|..|..+++|+.|+|++|++++..|..+..+.
T Consensus 111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 152 (477)
T 2id5_A 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152 (477)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCT
T ss_pred CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCC
Confidence 777777766666777777777777777777766665555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.29 E-value=8.5e-12 Score=114.27 Aligned_cols=88 Identities=23% Similarity=0.218 Sum_probs=71.3
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChh--hhhcCCCCce
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE--SLANNAELLF 116 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~--~~~~l~~L~~ 116 (589)
.++|+.|+|++|+|++. ..|+.+++|+.|+|++|+|++..|..++.+++|+.|+|++|+|+ .+|. .+..+++|+.
T Consensus 41 ~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 41 LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 117 (176)
T ss_dssp TTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred CCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence 34899999999999865 57888999999999999998543344588899999999999986 6776 7888889999
Q ss_pred eeccCCcCcccCch
Q 007788 117 LDVQNNTLSGIVPS 130 (589)
Q Consensus 117 l~l~~N~l~g~~p~ 130 (589)
|+|++|.++. +|.
T Consensus 118 L~l~~N~i~~-~~~ 130 (176)
T 1a9n_A 118 LCILRNPVTN-KKH 130 (176)
T ss_dssp EECCSSGGGG-STT
T ss_pred EEecCCCCCC-cHh
Confidence 9999999884 454
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.28 E-value=7.3e-12 Score=130.10 Aligned_cols=115 Identities=19% Similarity=0.150 Sum_probs=93.8
Q ss_pred cchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCC
Q 007788 25 KIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104 (589)
Q Consensus 25 ~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 104 (589)
.+|..++ ..+++|++|+|++|.+++..|..|+.+++|+.|+|++|++++..|..|+++++|+.|+|++|+++...
T Consensus 59 ~l~~~~~-----~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~ 133 (390)
T 3o6n_A 59 KLPAALL-----DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 133 (390)
T ss_dssp EECTHHH-----HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred hCChhHh-----cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCC
Confidence 4555443 34899999999999999877789999999999999999999888888999999999999999999444
Q ss_pred hhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCC
Q 007788 105 PESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNN 144 (589)
Q Consensus 105 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n 144 (589)
+..|..+++|+.|+|++|++++..|..+..+.. .+.+.+|
T Consensus 134 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 175 (390)
T 3o6n_A 134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175 (390)
T ss_dssp TTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSS
T ss_pred HHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCC
Confidence 444688999999999999999888877765543 2344444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.7e-12 Score=130.55 Aligned_cols=88 Identities=22% Similarity=0.203 Sum_probs=70.3
Q ss_pred cccceEEEccCcccccCCCccc--cCCCCCCeEeccCCcCCccCCccccCC-----CCCCeeeccCccccCCChhhhhcC
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLNGGIPDSLGNL-----GKLKRLDLSFNSLFGTIPESLANN 111 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~--~~l~~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~ls~N~l~g~~p~~~~~l 111 (589)
+++|+.|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..++.+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 7788888888888888888765 7788888888888888865 7777776 788888888888887777788888
Q ss_pred CCCceeeccCCcCccc
Q 007788 112 AELLFLDVQNNTLSGI 127 (589)
Q Consensus 112 ~~L~~l~l~~N~l~g~ 127 (589)
++|+.|+|++|++.|.
T Consensus 173 ~~L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 173 PALSTLDLSDNPELGE 188 (312)
T ss_dssp SSCCEEECCSCTTCHH
T ss_pred CCCCEEECCCCCcCcc
Confidence 8888888888887765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.1e-12 Score=130.04 Aligned_cols=86 Identities=21% Similarity=0.181 Sum_probs=45.4
Q ss_pred cccceEEEccCcccccCCCccccCC-----CCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCC--Chhhh--h
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSL-----KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT--IPESL--A 109 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~--~p~~~--~ 109 (589)
+++|+.|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|+.|+|++|++.|. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 55555555555555544 4444444 5555555555555554445555555555555555555543 22333 4
Q ss_pred cCCCCceeeccCCcCc
Q 007788 110 NNAELLFLDVQNNTLS 125 (589)
Q Consensus 110 ~l~~L~~l~l~~N~l~ 125 (589)
.+++|+.|+|++|+++
T Consensus 199 ~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 199 KFPTLQVLALRNAGME 214 (312)
T ss_dssp SCTTCCEEECTTSCCC
T ss_pred cCCCCCEEECCCCcCc
Confidence 5555555555555555
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=8.5e-12 Score=137.15 Aligned_cols=116 Identities=21% Similarity=0.133 Sum_probs=95.2
Q ss_pred ccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccC
Q 007788 18 VFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSF 97 (589)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~ 97 (589)
.++...|.|...... .+..+++|++|+|++|.|++..|..|+++++|+.|+|++|+|++..|..|+++++|+.|+|++
T Consensus 79 ~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~ 156 (597)
T 3oja_B 79 LLNLNDLQIEEIDTY--AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN 156 (597)
T ss_dssp EEECTTSCCCEECTT--TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EEECCCCCCCCCChH--HhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC
Confidence 345555554433221 234599999999999999998888999999999999999999965555579999999999999
Q ss_pred ccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhc
Q 007788 98 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 98 N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~ 135 (589)
|.|++..|..|..+++|+.|+|++|++++..+..+..+
T Consensus 157 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L 194 (597)
T 3oja_B 157 NNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 194 (597)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTC
T ss_pred CcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhh
Confidence 99999988899999999999999999998765555444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=8.8e-12 Score=126.37 Aligned_cols=92 Identities=33% Similarity=0.408 Sum_probs=51.0
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|.++ .+|..+. ++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 170 l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 246 (330)
T 1xku_A 170 MKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246 (330)
T ss_dssp CTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred CCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEE
Confidence 566666666666665 3444332 4555555555555555555555555555555555555554444555555555555
Q ss_pred ccCCcCcccCchhHhh
Q 007788 119 VQNNTLSGIVPSALKR 134 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~ 134 (589)
|++|+++ .+|..+..
T Consensus 247 L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 247 LNNNKLV-KVPGGLAD 261 (330)
T ss_dssp CCSSCCS-SCCTTTTT
T ss_pred CCCCcCc-cCChhhcc
Confidence 5555555 44444433
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.7e-11 Score=114.52 Aligned_cols=103 Identities=15% Similarity=0.219 Sum_probs=70.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|.++ .+| .+..+++|+.|+|++|+++ .++.+..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 667777777777777 555 5777777777777777655 334677777777777777777766677777777777777
Q ss_pred ccCCcCcccCchhHhhccC--CccccCCC
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNNP 145 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n~ 145 (589)
|++|++++..|..+..+.. .+.+.+|.
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 7777777766666665543 23444443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=7.6e-12 Score=139.81 Aligned_cols=96 Identities=24% Similarity=0.229 Sum_probs=54.1
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|++|+|++|++++..|..|+++++|++|+|++|++++..+.+|+++++|++|+|++|++++..|..|.++++|+.|
T Consensus 47 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 126 (680)
T 1ziw_A 47 RYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL 126 (680)
T ss_dssp GGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEE
T ss_pred CCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEE
Confidence 35556666666666665555555556666666666666653333345556666666666665554444555555556666
Q ss_pred eccCCcCcccCchhHh
Q 007788 118 DVQNNTLSGIVPSALK 133 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~ 133 (589)
+|++|++++..|..+.
T Consensus 127 ~Ls~n~l~~~~~~~~~ 142 (680)
T 1ziw_A 127 DLSHNGLSSTKLGTQV 142 (680)
T ss_dssp ECCSSCCSCCCCCSSS
T ss_pred ECCCCcccccCchhhc
Confidence 6666555555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.24 E-value=5.3e-12 Score=127.29 Aligned_cols=109 Identities=27% Similarity=0.256 Sum_probs=76.2
Q ss_pred hcccceEEEccCcccccCCCccc-cCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~-~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
.+++|+.|+|++|.+++..|..+ ..+++|+.|+|++|++++. | ....+++|+.|+|++|+|++ +|+.+..+++|+.
T Consensus 142 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~ 218 (317)
T 3o53_A 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW 218 (317)
T ss_dssp GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE
T ss_pred ccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccE
Confidence 37778888888888877666665 3677888888888887743 3 33457888888888888884 4555778888888
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCCCCCCC
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGD 150 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~ 150 (589)
|+|++|++++ +|..+..+.. .+.+.+|++.|++
T Consensus 219 L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp EECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred EECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcC
Confidence 8888888874 5555544432 3566777777654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=7.1e-12 Score=138.04 Aligned_cols=112 Identities=21% Similarity=0.045 Sum_probs=69.2
Q ss_pred ccccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCee
Q 007788 14 GKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRL 93 (589)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 93 (589)
..+..+|...|.|...... .+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|.+|+++++|++|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~--~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 110 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNT--TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110 (606)
T ss_dssp TTCCEEECTTCCCSEECTT--TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEE
T ss_pred CcCcEEEccCCccCcCChh--HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEe
Confidence 3444444444444432211 22346667777777777766666667777777777777777766666666677777777
Q ss_pred eccCccccCCChhhhhcCCCCceeeccCCcCccc
Q 007788 94 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 94 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
+|++|++++..|..+.++++|+.|+|++|++++.
T Consensus 111 ~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~ 144 (606)
T 3t6q_A 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144 (606)
T ss_dssp ECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCC
T ss_pred eccccCcccCCcchhccCCcccEEECCCCccccc
Confidence 7777766654455666666666666666666653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.4e-11 Score=118.91 Aligned_cols=147 Identities=14% Similarity=0.057 Sum_probs=109.5
Q ss_pred HhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 384 (589)
.....|.....++.|+.+.||++... +..+++|+...... .....+.+|.++++.+. |..+.++++++.. .+..+
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~ 86 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSN 86 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceE
Confidence 34456777778888888999999865 67899999865321 11235788999998884 6778889888754 46789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC-------------------------------
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV------------------------------- 433 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~------------------------------- 433 (589)
+||||++|.+|.+.+.. ......++.+++++|+.||+...
T Consensus 87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 99999999999876321 11234688999999999997210
Q ss_pred -----------------------CCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 434 -----------------------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 434 -----------------------~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
..+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876566799998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=140.34 Aligned_cols=98 Identities=24% Similarity=0.223 Sum_probs=76.2
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCcc--ccCCCCCCeeeccCccccCCCh-hhhhcCCCC
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS--LGNLGKLKRLDLSFNSLFGTIP-ESLANNAEL 114 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~--~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L 114 (589)
.|++|++|+|++|++++..|..|+++++|++|+|++|++++.+|.. |++|++|+.|+|++|++++..| ..|+++++|
T Consensus 71 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L 150 (844)
T 3j0a_A 71 NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL 150 (844)
T ss_dssp SCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSC
T ss_pred CCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCC
Confidence 3778888888888888777888888888888888888888766665 7788888888888888876644 567888888
Q ss_pred ceeeccCCcCcccCchhHhhc
Q 007788 115 LFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 115 ~~l~l~~N~l~g~~p~~~~~~ 135 (589)
+.|+|++|++++..|..+..+
T Consensus 151 ~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 151 KSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp CEEEEESSCCCCCCSGGGHHH
T ss_pred CEEECCCCcCCeeCHHHcccc
Confidence 888888888887777766554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=134.19 Aligned_cols=95 Identities=20% Similarity=0.248 Sum_probs=89.3
Q ss_pred hhcccceEEEccCcccc-cCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 37 VILLCFVVLQLCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
..+++|+.|+|++|.++ +.+|..++.+++|+.|+|++|++++..|..|+++++|+.|+|++|+|++..|..+..+++|+
T Consensus 442 ~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 521 (570)
T 2z63_A 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQ 521 (570)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCc
Confidence 34899999999999998 68999999999999999999999998899999999999999999999988888899999999
Q ss_pred eeeccCCcCcccCchh
Q 007788 116 FLDVQNNTLSGIVPSA 131 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~ 131 (589)
.|++++|.+++..|..
T Consensus 522 ~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 522 KIWLHTNPWDCSCPRI 537 (570)
T ss_dssp EEECCSSCBCCCTTTT
T ss_pred EEEecCCcccCCCcch
Confidence 9999999999988853
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.21 E-value=9.4e-12 Score=133.12 Aligned_cols=125 Identities=18% Similarity=0.147 Sum_probs=95.9
Q ss_pred Eeeccccccccc----------ccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCc
Q 007788 6 FLDECGIHGKII----------VFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNR 75 (589)
Q Consensus 6 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~ 75 (589)
.|.+|.|++... .++...|.|...++. .+...+++|+.|+|++|.|++. | .+..+++|+.|+|++|+
T Consensus 126 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~ 202 (487)
T 3oja_A 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA-ELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNK 202 (487)
T ss_dssp ECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGG-GGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSC
T ss_pred ECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChH-HHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCC
Confidence 456666665432 124444444433322 1223489999999999999976 3 34569999999999999
Q ss_pred CCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCc-ccCchhHhhc
Q 007788 76 LNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS-GIVPSALKRL 135 (589)
Q Consensus 76 l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-g~~p~~~~~~ 135 (589)
|++ +|+.++.+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.+. +.+|..+..+
T Consensus 203 l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l 261 (487)
T 3oja_A 203 LAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261 (487)
T ss_dssp CCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTC
T ss_pred CCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhC
Confidence 996 66679999999999999999995 7888999999999999999998 6677666544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=130.09 Aligned_cols=98 Identities=22% Similarity=0.161 Sum_probs=80.3
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|++++..|..|+++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 56888888888888877888888888888888888888877788888888888888888888666666888888888888
Q ss_pred cCCcCcccCchhHhhccC
Q 007788 120 QNNTLSGIVPSALKRLNG 137 (589)
Q Consensus 120 ~~N~l~g~~p~~~~~~~~ 137 (589)
++|++++..+..+..+..
T Consensus 155 ~~N~l~~~~~~~~~~l~~ 172 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPS 172 (452)
T ss_dssp CSCCCCEECTTTTTTCTT
T ss_pred CCCCcceeCHhHHhcCCc
Confidence 888888766666655543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.4e-11 Score=125.02 Aligned_cols=99 Identities=23% Similarity=0.252 Sum_probs=87.1
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCcc-ccCCCCCCeeeccCccccCCChhhhhcCCCC
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS-LGNLGKLKRLDLSFNSLFGTIPESLANNAEL 114 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 114 (589)
+..+++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. |+++++|++|+|++|++++..|..+..+++|
T Consensus 89 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 167 (390)
T 3o6n_A 89 FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSL 167 (390)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTC
T ss_pred ccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCC
Confidence 344999999999999999888888999999999999999999 56655 6999999999999999998888889999999
Q ss_pred ceeeccCCcCcccCchhHhhc
Q 007788 115 LFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 115 ~~l~l~~N~l~g~~p~~~~~~ 135 (589)
+.|++++|++++.....+..+
T Consensus 168 ~~L~l~~n~l~~~~~~~l~~L 188 (390)
T 3o6n_A 168 QNLQLSSNRLTHVDLSLIPSL 188 (390)
T ss_dssp CEEECCSSCCSBCCGGGCTTC
T ss_pred CEEECCCCcCCcccccccccc
Confidence 999999999997654444433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.3e-11 Score=132.28 Aligned_cols=96 Identities=27% Similarity=0.306 Sum_probs=73.0
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|++++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|+.|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 56788888888888777777888888888888888888777777888888888888888888776667888888888888
Q ss_pred cCCcCccc-CchhHhhc
Q 007788 120 QNNTLSGI-VPSALKRL 135 (589)
Q Consensus 120 ~~N~l~g~-~p~~~~~~ 135 (589)
++|++++. +|..+..+
T Consensus 106 s~n~l~~~~~~~~~~~l 122 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNL 122 (549)
T ss_dssp TTCCCSSSCSSCSCTTC
T ss_pred CCCcccccchhhhhhcc
Confidence 88888753 45444444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-11 Score=126.94 Aligned_cols=106 Identities=25% Similarity=0.268 Sum_probs=82.0
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
.++|+.|+|++|++++..+..|+++++|+.|+|++|++++..|..|+++++|++|+|++|+|++..+..+..+++|+.|+
T Consensus 51 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 51 TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence 35788999999999876666888899999999999999887788888999999999999999865555588889999999
Q ss_pred ccCCcCcccCc-hhHhhccC--CccccCC
Q 007788 119 VQNNTLSGIVP-SALKRLNG--GFQFQNN 144 (589)
Q Consensus 119 l~~N~l~g~~p-~~~~~~~~--~~~~~~n 144 (589)
|++|++++..+ ..+..+.. .+.+.+|
T Consensus 131 L~~n~l~~l~~~~~~~~l~~L~~L~l~~n 159 (353)
T 2z80_A 131 LLGNPYKTLGETSLFSHLTKLQILRVGNM 159 (353)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEES
T ss_pred CCCCCCcccCchhhhccCCCCcEEECCCC
Confidence 99999885444 34544432 2344454
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.2e-11 Score=119.32 Aligned_cols=86 Identities=21% Similarity=0.194 Sum_probs=49.3
Q ss_pred cceEEEccCcccccCCCccccCCCCCCeEeccCCc-CCccCCccccCCCCCCeeeccC-ccccCCChhhhhcCCCCceee
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNR-LNGGIPDSLGNLGKLKRLDLSF-NSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+|+.|+|++|++++..+..|+++++|+.|+|++|+ +++..|.+|.++++|+.|+|++ |+|++..|..|..+++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45566666666664444455666666666666664 5543344555666666666665 666544444555566666666
Q ss_pred ccCCcCcc
Q 007788 119 VQNNTLSG 126 (589)
Q Consensus 119 l~~N~l~g 126 (589)
+++|++++
T Consensus 112 l~~n~l~~ 119 (239)
T 2xwt_C 112 IFNTGLKM 119 (239)
T ss_dssp EEEECCCS
T ss_pred CCCCCCcc
Confidence 66666654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.3e-11 Score=110.36 Aligned_cols=103 Identities=19% Similarity=0.151 Sum_probs=82.2
Q ss_pred hcccceEEEccCcccccCCCccccCCC-CCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLK-SLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
.+.+|+.|+|++|+++ .+|. +..+. +|+.|+|++|+|++. +.|+++++|+.|+|++|+|++..|..+..+++|+.
T Consensus 17 ~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp CTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 3788999999999999 5665 55554 999999999999964 68999999999999999999655556699999999
Q ss_pred eeccCCcCcccCch--hHhhccC--CccccCCC
Q 007788 117 LDVQNNTLSGIVPS--ALKRLNG--GFQFQNNP 145 (589)
Q Consensus 117 l~l~~N~l~g~~p~--~~~~~~~--~~~~~~n~ 145 (589)
|+|++|+++ .+|. .+..+.. .+.+.+|+
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~ 124 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNP 124 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSG
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCC
Confidence 999999996 4555 5555433 23444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.6e-11 Score=123.30 Aligned_cols=97 Identities=19% Similarity=0.144 Sum_probs=78.6
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCcc--CC--ccccCCCCCCeeeccCccccCCChh----hhh
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG--IP--DSLGNLGKLKRLDLSFNSLFGTIPE----SLA 109 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~--~p--~~~~~l~~L~~L~ls~N~l~g~~p~----~~~ 109 (589)
.+++|++|+|++|++++..|..|+.+++|++|+|++|++.+. +| ..++++++|++|+|++|+|+ .+|. .+.
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~ 221 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA 221 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence 488899999999999888888899999999999999998763 32 23478899999999999997 4454 257
Q ss_pred cCCCCceeeccCCcCcccCchhHhhc
Q 007788 110 NNAELLFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 110 ~l~~L~~l~l~~N~l~g~~p~~~~~~ 135 (589)
.+++|+.|||++|++++..|..+..+
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhc
Confidence 78999999999999998877666544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.3e-11 Score=131.32 Aligned_cols=85 Identities=28% Similarity=0.305 Sum_probs=51.5
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccC-CChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG-TIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~l 117 (589)
+++|++|+|++|++++..|..|+++++|++|+|++|+|+ .+|.. .+++|++|+|++|++++ .+|..++++++|+.|
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 120 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence 566666666666666555556666666666666666666 45544 56666666666666655 355666666666666
Q ss_pred eccCCcCcc
Q 007788 118 DVQNNTLSG 126 (589)
Q Consensus 118 ~l~~N~l~g 126 (589)
+|++|++++
T Consensus 121 ~L~~n~l~~ 129 (520)
T 2z7x_B 121 GLSTTHLEK 129 (520)
T ss_dssp EEEESSCCG
T ss_pred EecCcccch
Confidence 666666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3e-11 Score=127.57 Aligned_cols=97 Identities=23% Similarity=0.199 Sum_probs=71.6
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..|.+|.++++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 45777788888877776677777888888888888877666677777788888888888877555556777777888888
Q ss_pred cCCcCcccCchhHhhcc
Q 007788 120 QNNTLSGIVPSALKRLN 136 (589)
Q Consensus 120 ~~N~l~g~~p~~~~~~~ 136 (589)
++|++++..+..+..+.
T Consensus 144 ~~N~i~~~~~~~~~~l~ 160 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIP 160 (440)
T ss_dssp CSCCCCEECTTTTTTCT
T ss_pred CCCcccccCHHHhhhCc
Confidence 88877766665555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.17 E-value=9.2e-13 Score=123.29 Aligned_cols=103 Identities=21% Similarity=0.323 Sum_probs=84.3
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|+.|+|++|++++ +| .++.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|
T Consensus 46 ~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L 120 (198)
T 1ds9_A 46 TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL 120 (198)
T ss_dssp HTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE
T ss_pred cCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEE
Confidence 38999999999999996 77 8999999999999999999 789888889999999999999995 56 68889999999
Q ss_pred eccCCcCcccCc-hhHhhccC--CccccCCC
Q 007788 118 DVQNNTLSGIVP-SALKRLNG--GFQFQNNP 145 (589)
Q Consensus 118 ~l~~N~l~g~~p-~~~~~~~~--~~~~~~n~ 145 (589)
+|++|++++..+ ..+..+.. .+.+.+|+
T Consensus 121 ~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp EESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred ECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 999999986433 34544432 23445554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.7e-11 Score=122.97 Aligned_cols=119 Identities=24% Similarity=0.152 Sum_probs=92.1
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeee
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 94 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 94 (589)
.+..++...|.|..... ..+..+++|+.|+|++|++++..|..|+++++|++|+|++|++++..+..|+++++|++|+
T Consensus 53 ~L~~L~l~~n~i~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 53 AVKSLDLSNNRITYISN--SDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp TCCEEECTTSCCCEECT--TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred cCcEEECCCCcCcccCH--HHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence 44455555555543222 1234589999999999999988888899999999999999999954444489999999999
Q ss_pred ccCccccCCChh--hhhcCCCCceeeccCC-cCcccCchhHhhcc
Q 007788 95 LSFNSLFGTIPE--SLANNAELLFLDVQNN-TLSGIVPSALKRLN 136 (589)
Q Consensus 95 ls~N~l~g~~p~--~~~~l~~L~~l~l~~N-~l~g~~p~~~~~~~ 136 (589)
|++|+++ .+|. .+..+++|+.|++++| .+++..|..+..+.
T Consensus 131 L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 174 (353)
T 2z80_A 131 LLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174 (353)
T ss_dssp CTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred CCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCC
Confidence 9999999 5565 7889999999999999 47766666665543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.16 E-value=4.9e-11 Score=130.11 Aligned_cols=95 Identities=27% Similarity=0.189 Sum_probs=71.5
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|++++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|+|+ .+|.. .+++|+.|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 56778888888888666677888888888888888888777777888888888888888877 56665 6778888888
Q ss_pred cCCcCcc-cCchhHhhccC
Q 007788 120 QNNTLSG-IVPSALKRLNG 137 (589)
Q Consensus 120 ~~N~l~g-~~p~~~~~~~~ 137 (589)
++|++++ .+|..+..+..
T Consensus 129 s~N~l~~l~~p~~~~~l~~ 147 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTK 147 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTT
T ss_pred CCCCccccCchHhhcccCc
Confidence 8888876 34566665543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=9.7e-11 Score=118.63 Aligned_cols=94 Identities=31% Similarity=0.368 Sum_probs=61.4
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|++|+|++|++++..+..|+++++|++|+|++|++++..|.+|+++++|++|+|++|+|+ .+|..+. ++|+.|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 45667777777777555556777777777777777777666667777777777777777766 5555443 56666666
Q ss_pred cCCcCcccCchhHhhcc
Q 007788 120 QNNTLSGIVPSALKRLN 136 (589)
Q Consensus 120 ~~N~l~g~~p~~~~~~~ 136 (589)
++|++++..+..+..+.
T Consensus 129 ~~n~l~~~~~~~~~~l~ 145 (330)
T 1xku_A 129 HENEITKVRKSVFNGLN 145 (330)
T ss_dssp CSSCCCBBCHHHHTTCT
T ss_pred CCCcccccCHhHhcCCc
Confidence 66666665555554443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.7e-12 Score=121.46 Aligned_cols=91 Identities=20% Similarity=0.139 Sum_probs=81.9
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCCh--hhhhcCCC
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP--ESLANNAE 113 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~ 113 (589)
+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .++++++|+.|+|++|++++ +| +.+..+++
T Consensus 66 ~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~ 141 (198)
T 1ds9_A 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDK 141 (198)
T ss_dssp HHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTT
T ss_pred cccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCC
Confidence 345999999999999999 789888889999999999999996 66 79999999999999999994 44 47999999
Q ss_pred CceeeccCCcCcccCch
Q 007788 114 LLFLDVQNNTLSGIVPS 130 (589)
Q Consensus 114 L~~l~l~~N~l~g~~p~ 130 (589)
|+.|++++|++++.+|.
T Consensus 142 L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 142 LEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp CSEEEECSCHHHHHHHT
T ss_pred CCEEEecCCcccccccc
Confidence 99999999999988765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.3e-10 Score=115.60 Aligned_cols=84 Identities=33% Similarity=0.402 Sum_probs=60.5
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|+.|+|++|++++. +. ++.+++|+.|+|++|++++ +| .++.+++|+.|+|++|++++ + +.+..+++|+.|
T Consensus 66 ~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L 139 (291)
T 1h6t_A 66 YLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESL 139 (291)
T ss_dssp GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEE
T ss_pred cCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEE
Confidence 377777888888877754 33 7777777777777777774 43 37777777777777777774 3 457777777777
Q ss_pred eccCCcCccc
Q 007788 118 DVQNNTLSGI 127 (589)
Q Consensus 118 ~l~~N~l~g~ 127 (589)
++++|++++.
T Consensus 140 ~l~~n~l~~~ 149 (291)
T 1h6t_A 140 YLGNNKITDI 149 (291)
T ss_dssp ECCSSCCCCC
T ss_pred EccCCcCCcc
Confidence 7777777754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.6e-11 Score=123.28 Aligned_cols=123 Identities=19% Similarity=0.122 Sum_probs=87.8
Q ss_pred ccccccccchhhhhhhhhHhhcccceEEEccCcccccC--CC--ccccCCCCCCeEeccCCcCCccCCc----cccCCCC
Q 007788 18 VFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGN--IP--AQIGSLKSLSVLTLQHNRLNGGIPD----SLGNLGK 89 (589)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~--~p--~~~~~l~~L~~L~L~~N~l~g~~p~----~~~~l~~ 89 (589)
.++...|.|...... .+..+++|++|+|++|++.+. ++ ..++.+++|++|+|++|+|+ .+|. .++++++
T Consensus 149 ~L~Ls~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~ 225 (310)
T 4glp_A 149 VLSIAQAHSPAFSCE--QVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQ 225 (310)
T ss_dssp EEEEECCSSCCCCTT--SCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCC
T ss_pred EEEeeCCCcchhhHH--HhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCC
Confidence 345555555333221 233489999999999998763 22 23478999999999999998 3444 2578899
Q ss_pred CCeeeccCccccCCChhhhhcC---CCCceeeccCCcCcccCchhHhhccCCccccCC
Q 007788 90 LKRLDLSFNSLFGTIPESLANN---AELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN 144 (589)
Q Consensus 90 L~~L~ls~N~l~g~~p~~~~~l---~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n 144 (589)
|++|+|++|+|++.+|+.+..+ ++|+.|+|++|+|+ .+|..+..--..+.+.+|
T Consensus 226 L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N 282 (310)
T 4glp_A 226 PHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSN 282 (310)
T ss_dssp CSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSC
T ss_pred CCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCC
Confidence 9999999999998888888777 69999999999999 566654321123444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.13 E-value=4.7e-11 Score=129.30 Aligned_cols=88 Identities=24% Similarity=0.283 Sum_probs=45.1
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCC-------CeeeccCccccCCChhhhhcC
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL-------KRLDLSFNSLFGTIPESLANN 111 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L-------~~L~ls~N~l~g~~p~~~~~l 111 (589)
+++|+.|+|++|+|++ +|. |+ ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+
T Consensus 159 l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l 229 (571)
T 3cvr_A 159 PTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSL 229 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGS
T ss_pred CCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcC
Confidence 3445555555555543 444 33 45555555555555 4444 333 44 55555555555 455555555
Q ss_pred CCCceeeccCCcCcccCchhHhhc
Q 007788 112 AELLFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 112 ~~L~~l~l~~N~l~g~~p~~~~~~ 135 (589)
++|+.|+|++|+|++.+|..+..+
T Consensus 230 ~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 230 DPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CTTEEEECCSSSCCHHHHHHHHHH
T ss_pred CCCCEEEeeCCcCCCcCHHHHHHh
Confidence 566666666666665555555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.13 E-value=6.5e-11 Score=119.29 Aligned_cols=112 Identities=19% Similarity=0.181 Sum_probs=90.0
Q ss_pred ccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCcc
Q 007788 20 KEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 99 (589)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 99 (589)
+...|.|....+. .+...+++|+.|+|++|++++. |. ...+++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|+
T Consensus 150 ~Ls~N~l~~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~ 225 (317)
T 3o53_A 150 DLKLNEIDTVNFA-ELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225 (317)
T ss_dssp ECTTSCCCEEEGG-GGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSC
T ss_pred ECCCCCCCcccHH-HHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCc
Confidence 4445555433222 1223489999999999999965 43 446999999999999999 577779999999999999999
Q ss_pred ccCCChhhhhcCCCCceeeccCCcCc-ccCchhHhhcc
Q 007788 100 LFGTIPESLANNAELLFLDVQNNTLS-GIVPSALKRLN 136 (589)
Q Consensus 100 l~g~~p~~~~~l~~L~~l~l~~N~l~-g~~p~~~~~~~ 136 (589)
|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+.
T Consensus 226 l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~ 262 (317)
T 3o53_A 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262 (317)
T ss_dssp CC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCH
T ss_pred cc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccc
Confidence 99 68999999999999999999999 77777766543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.4e-10 Score=117.60 Aligned_cols=94 Identities=23% Similarity=0.315 Sum_probs=65.2
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|.+|+++++|++|+|++|+++ .+|..+. ++|+.|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 45777777777777666667777777777777777777666777777777777777777777 5665554 66777777
Q ss_pred cCCcCcccCchhHhhcc
Q 007788 120 QNNTLSGIVPSALKRLN 136 (589)
Q Consensus 120 ~~N~l~g~~p~~~~~~~ 136 (589)
++|++++..+..+..+.
T Consensus 131 ~~n~i~~~~~~~~~~l~ 147 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLR 147 (332)
T ss_dssp CSSCCCCCCSGGGSSCS
T ss_pred CCCccCccCHhHhCCCc
Confidence 77777765555554443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-10 Score=113.55 Aligned_cols=130 Identities=12% Similarity=0.150 Sum_probs=94.4
Q ss_pred ccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCC--ccceeeeeecCCCCeEEEEEEeCCCCCh
Q 007788 318 GKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN--IIRLRGFCCSRGRGECFLIYDFAPKGKL 395 (589)
Q Consensus 318 g~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~~~lv~Ey~~~gsL 395 (589)
+.|..+.||++...+|..+++|...... ...+..|+.+++.+.+.+ +.+++++... .+..++||||++|.+|
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEecCCccc
Confidence 4556699999988778889999976431 235678888888886444 4557776643 3568999999999888
Q ss_pred HHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC------------------------------------------
Q 007788 396 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV------------------------------------------ 433 (589)
Q Consensus 396 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~------------------------------------------ 433 (589)
. ... .+ ...++.++++.|+.||+...
T Consensus 103 ~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 4 211 11 23577888888888886430
Q ss_pred -----------CCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 434 -----------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 434 -----------~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
..+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 01239999999999999887667799999865
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.5e-10 Score=116.20 Aligned_cols=87 Identities=29% Similarity=0.414 Sum_probs=66.2
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++ +|. ++.+++|+.|+|++|++++ +|. ++++++|+.|+|++|++++ +|. +..+++|+.
T Consensus 104 ~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~ 177 (308)
T 1h6u_A 104 AGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTT 177 (308)
T ss_dssp TTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCE
T ss_pred cCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCE
Confidence 347888888888888885 443 7888888888888888885 333 7788888888888888885 444 778888888
Q ss_pred eeccCCcCcccCc
Q 007788 117 LDVQNNTLSGIVP 129 (589)
Q Consensus 117 l~l~~N~l~g~~p 129 (589)
|+|++|++++..+
T Consensus 178 L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 178 LKADDNKISDISP 190 (308)
T ss_dssp EECCSSCCCCCGG
T ss_pred EECCCCccCcChh
Confidence 8888888876544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.07 E-value=8.4e-11 Score=113.27 Aligned_cols=119 Identities=18% Similarity=0.141 Sum_probs=89.4
Q ss_pred ccccccccccccchhhhhhhhhHhhcccceEEEccCcc-cccCCCccccCCCCCCeEeccC-CcCCccCCccccCCCCCC
Q 007788 14 GKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQ-LTGNIPAQIGSLKSLSVLTLQH-NRLNGGIPDSLGNLGKLK 91 (589)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~-l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~ 91 (589)
..+..++...|.|...... .+..+++|+.|+|++|. +++..+..|.++++|++|+|++ |+|++..|..|.++++|+
T Consensus 31 ~~l~~L~l~~n~l~~i~~~--~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSH--AFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp TTCCEEEEESCCCSEECTT--TTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred CcccEEEEeCCcceEECHH--HccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 3444444444444322211 23348899999999996 8866666899999999999998 999976667889999999
Q ss_pred eeeccCccccCCChhhhhcCCCCc---eeeccCC-cCcccCchhHhhcc
Q 007788 92 RLDLSFNSLFGTIPESLANNAELL---FLDVQNN-TLSGIVPSALKRLN 136 (589)
Q Consensus 92 ~L~ls~N~l~g~~p~~~~~l~~L~---~l~l~~N-~l~g~~p~~~~~~~ 136 (589)
.|+|++|++++ +|+ +..+++|+ .|++++| ++++..+..+..+.
T Consensus 109 ~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~ 155 (239)
T 2xwt_C 109 FLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155 (239)
T ss_dssp EEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTB
T ss_pred EEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchh
Confidence 99999999995 776 88888888 9999999 88877776666554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.6e-10 Score=114.39 Aligned_cols=103 Identities=23% Similarity=0.280 Sum_probs=71.0
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|+.|+|++|.+++. |. +..+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++ + +.+..+++|+.|
T Consensus 219 ~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L 292 (347)
T 4fmz_A 219 NMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSL 292 (347)
T ss_dssp GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred cCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEE
Confidence 377777777777777743 33 7777777777777777774 3 457777777777777777774 3 356777777777
Q ss_pred eccCCcCcccCchhHhhccC--CccccCCCC
Q 007788 118 DVQNNTLSGIVPSALKRLNG--GFQFQNNPG 146 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~ 146 (589)
++++|++++..|..+..+.. .+.+.+|+.
T Consensus 293 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp ECCSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred ECcCCcCCCcChhHhhccccCCEEEccCCcc
Confidence 77777777777776665543 344555543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.5e-10 Score=111.64 Aligned_cols=99 Identities=27% Similarity=0.321 Sum_probs=73.6
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+++|+.|+|++|++++. |. ++.+++|+.|+|++|++++ +|... . ++|+.|+|++|+|++ +| .+..+++|+.|
T Consensus 61 ~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L 133 (263)
T 1xeu_A 61 FFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEIL 133 (263)
T ss_dssp GCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEE
T ss_pred hCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEE
Confidence 388899999999999854 44 8889999999999999985 55433 3 888888888888885 44 58888888888
Q ss_pred eccCCcCcccCchhHhhccC--CccccCCC
Q 007788 118 DVQNNTLSGIVPSALKRLNG--GFQFQNNP 145 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~~--~~~~~~n~ 145 (589)
+|++|++++. | .+..+.. .+.+.+|.
T Consensus 134 ~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 134 SIRNNKLKSI-V-MLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp ECTTSCCCBC-G-GGGGCTTCCEEECTTSC
T ss_pred ECCCCcCCCC-h-HHccCCCCCEEECCCCc
Confidence 8888888865 3 3444432 23445553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.7e-10 Score=115.81 Aligned_cols=147 Identities=14% Similarity=0.218 Sum_probs=105.2
Q ss_pred cccccccCCCccEEEEEecCCcEEEEEEec--cCCCchHHHHHHHHHHHHhccC--CCCccceeeeeecCCC-CeEEEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGR-GECFLIY 387 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~-~~~~lv~ 387 (589)
..+.|+.|.++.||+....+ ..+++|+.. ..........+.+|.++++.+. +..+.++++++.+... +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998765 577888775 3321122346788999998886 4568888888743311 4578999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC----------------------------------
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---------------------------------- 433 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~---------------------------------- 433 (589)
||+++..+.+... ..++...+..++.++++.|+.||+...
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987743211 136788889999999999999997311
Q ss_pred -------------------CCCCeEecCCCCCCeeecCCCc--eEEcccccccc
Q 007788 434 -------------------NKPAIVHRNLSVEKVLIDQQFN--PLIADCGLHKL 466 (589)
Q Consensus 434 -------------------~~~~ivH~dlk~~Nill~~~~~--~kl~DfGla~~ 466 (589)
..+.++|||+++.||++++++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 0256999999999999997753 58999998764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.3e-10 Score=123.86 Aligned_cols=73 Identities=32% Similarity=0.354 Sum_probs=40.8
Q ss_pred cceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeecc
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQ 120 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~ 120 (589)
+|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|+
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls 188 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVS 188 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECC
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECc
Confidence 55666666666654 444 45556666666666653 554 34555566666666554 444 33 555555555
Q ss_pred CCcCc
Q 007788 121 NNTLS 125 (589)
Q Consensus 121 ~N~l~ 125 (589)
+|+|+
T Consensus 189 ~N~L~ 193 (571)
T 3cvr_A 189 TNLLE 193 (571)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 55555
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.06 E-value=3.1e-10 Score=112.79 Aligned_cols=100 Identities=29% Similarity=0.375 Sum_probs=74.2
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++ +| .++.+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++. +.+..+++|+.
T Consensus 87 ~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 160 (291)
T 1h6t_A 87 ANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT 160 (291)
T ss_dssp TTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred ccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCE
Confidence 348888888888888885 34 48888888888888888885 3 4688888888888888888854 57888888888
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCC
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNN 144 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n 144 (589)
|+|++|++++..| +..+.. .+.+.+|
T Consensus 161 L~L~~N~l~~~~~--l~~l~~L~~L~L~~N 188 (291)
T 1h6t_A 161 LSLEDNQISDIVP--LAGLTKLQNLYLSKN 188 (291)
T ss_dssp EECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEccCCccccchh--hcCCCccCEEECCCC
Confidence 8888888887655 444432 2344444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.06 E-value=5.1e-10 Score=112.20 Aligned_cols=85 Identities=27% Similarity=0.413 Sum_probs=61.3
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++ +|. +..+++|+.|+
T Consensus 62 l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 7777888888887774 344 7777778888888887774 33 57777777777777777774 443 77777777777
Q ss_pred ccCCcCcccCc
Q 007788 119 VQNNTLSGIVP 129 (589)
Q Consensus 119 l~~N~l~g~~p 129 (589)
|++|++++..+
T Consensus 136 l~~n~l~~~~~ 146 (308)
T 1h6u_A 136 LDLNQITNISP 146 (308)
T ss_dssp CCSSCCCCCGG
T ss_pred CCCCccCcCcc
Confidence 77777776544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.06 E-value=4.8e-10 Score=122.59 Aligned_cols=86 Identities=30% Similarity=0.387 Sum_probs=50.4
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.|++|+.|+|++|+|++ +| .++.|++|+.|+|++|+|++ + +.+..|++|+.|+|++|+|++. +.+..+++|+.|
T Consensus 85 ~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp GCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred cCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 35666666666666653 23 45666666666666666663 2 3456666666666666666643 455566666666
Q ss_pred eccCCcCcccCc
Q 007788 118 DVQNNTLSGIVP 129 (589)
Q Consensus 118 ~l~~N~l~g~~p 129 (589)
+|++|+|++..|
T Consensus 159 ~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 159 SLEDNQISDIVP 170 (605)
T ss_dssp ECCSSCCCCCGG
T ss_pred ECcCCcCCCchh
Confidence 666666665544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.6e-10 Score=124.93 Aligned_cols=89 Identities=27% Similarity=0.289 Sum_probs=65.2
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+
T Consensus 220 ~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 220 PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 3567777777777774 55 44567777777777777 5665 5677788888888887 6777788888888888
Q ss_pred ccCCcCcccCchhHhhcc
Q 007788 119 VQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~ 136 (589)
|++|++++.+|..+..+.
T Consensus 291 L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 291 LEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCSCCCCHHHHHHHHHHH
T ss_pred ecCCCCCCcCHHHHHhcc
Confidence 888888877777776654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.05 E-value=5.3e-10 Score=109.33 Aligned_cols=99 Identities=23% Similarity=0.245 Sum_probs=73.6
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|.++ .+| .++.+++|+.|+|++|+|++ +|+ ++++++|+.|+|++|+|++ +|... . ++|+.
T Consensus 38 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~ 110 (263)
T 1xeu_A 38 KELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSR 110 (263)
T ss_dssp HHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCE
T ss_pred hhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCccc-c-CcccE
Confidence 34888999999999888 566 68888999999999999985 444 8888999999999999885 55433 3 88999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCC
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNN 144 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n 144 (589)
|+|++|++++. | .+..+.. .+.+.+|
T Consensus 111 L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N 138 (263)
T 1xeu_A 111 LFLDNNELRDT-D-SLIHLKNLEILSIRNN 138 (263)
T ss_dssp EECCSSCCSBS-G-GGTTCTTCCEEECTTS
T ss_pred EEccCCccCCC-h-hhcCcccccEEECCCC
Confidence 99999998864 3 3444432 2344444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.2e-10 Score=120.65 Aligned_cols=88 Identities=22% Similarity=0.232 Sum_probs=42.8
Q ss_pred ccceEEEccCcccc-cCCC---ccccCCCCCCeEeccCCcCC--c---cCCccccCCCCCCeeeccCcccc----CCChh
Q 007788 40 LCFVVLQLCCNQLT-GNIP---AQIGSLKSLSVLTLQHNRLN--G---GIPDSLGNLGKLKRLDLSFNSLF----GTIPE 106 (589)
Q Consensus 40 ~~l~~L~L~~n~l~-g~~p---~~~~~l~~L~~L~L~~N~l~--g---~~p~~~~~l~~L~~L~ls~N~l~----g~~p~ 106 (589)
++|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+++ | .+|..+..+++|+.|+|++|.|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 45555555555554 2333 23444555555555555554 2 23334445555555555555553 34445
Q ss_pred hhhcCCCCceeeccCCcCccc
Q 007788 107 SLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 107 ~~~~l~~L~~l~l~~N~l~g~ 127 (589)
.+..+++|+.|+|++|++++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHH
T ss_pred HHccCCCcCEEECCCCCCchh
Confidence 555555555555555555443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.02 E-value=5e-10 Score=122.45 Aligned_cols=101 Identities=27% Similarity=0.285 Sum_probs=81.5
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
+..|++|+.|+|++|+|++ + +.+..|++|+.|+|++|+|++. +.|+.|++|+.|+|++|+|++..| +..+++|+
T Consensus 105 l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~ 178 (605)
T 1m9s_A 105 LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 178 (605)
T ss_dssp STTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCC
Confidence 3448999999999999995 4 4689999999999999999964 679999999999999999997665 89999999
Q ss_pred eeeccCCcCcccCchhHhhccC--CccccCC
Q 007788 116 FLDVQNNTLSGIVPSALKRLNG--GFQFQNN 144 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n 144 (589)
.|+|++|+|++. | .+..+.. .+.+.+|
T Consensus 179 ~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N 207 (605)
T 1m9s_A 179 NLYLSKNHISDL-R-ALAGLKNLDVLELFSQ 207 (605)
T ss_dssp EEECCSSCCCBC-G-GGTTCTTCSEEECCSE
T ss_pred EEECcCCCCCCC-h-HHccCCCCCEEEccCC
Confidence 999999999974 3 3444433 2344444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.00 E-value=8.8e-11 Score=119.14 Aligned_cols=99 Identities=16% Similarity=0.193 Sum_probs=61.3
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCC-cCCc-cCCccccCCCCCCeeeccCc-cccCC-ChhhhhcCC
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHN-RLNG-GIPDSLGNLGKLKRLDLSFN-SLFGT-IPESLANNA 112 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N-~l~g-~~p~~~~~l~~L~~L~ls~N-~l~g~-~p~~~~~l~ 112 (589)
..+++|+.|+|++|.+++..|..++.+++|+.|+|++| .+++ .+|..+.++++|+.|+|++| ++++. +|..+..++
T Consensus 115 ~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~ 194 (336)
T 2ast_B 115 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 194 (336)
T ss_dssp TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC
T ss_pred hhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcc
Confidence 33666667777766666666666666666777777666 5664 25555666666777777666 66643 556666666
Q ss_pred -CCceeeccCC--cCc-ccCchhHhhc
Q 007788 113 -ELLFLDVQNN--TLS-GIVPSALKRL 135 (589)
Q Consensus 113 -~L~~l~l~~N--~l~-g~~p~~~~~~ 135 (589)
+|+.|+|++| .++ +.+|..+..+
T Consensus 195 ~~L~~L~l~~~~~~~~~~~l~~~~~~~ 221 (336)
T 2ast_B 195 ETITQLNLSGYRKNLQKSDLSTLVRRC 221 (336)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHC
T ss_pred cCCCEEEeCCCcccCCHHHHHHHHhhC
Confidence 6777777666 344 3444444443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.00 E-value=5e-10 Score=119.16 Aligned_cols=83 Identities=31% Similarity=0.426 Sum_probs=54.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|.+++..| +..+++|+.|+|++|++++..| ++.+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 337 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeE
Confidence 6667777777777774333 6667777777777777765333 6667777777777777775544 56666777777
Q ss_pred ccCCcCccc
Q 007788 119 VQNNTLSGI 127 (589)
Q Consensus 119 l~~N~l~g~ 127 (589)
+++|++++.
T Consensus 338 l~~n~l~~~ 346 (466)
T 1o6v_A 338 FYNNKVSDV 346 (466)
T ss_dssp CCSSCCCCC
T ss_pred CCCCccCCc
Confidence 777766654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.2e-09 Score=109.36 Aligned_cols=82 Identities=24% Similarity=0.438 Sum_probs=45.2
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|++++|.+++..+ +..+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++ + +.+..+++|+.|+
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~ 271 (347)
T 4fmz_A 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLN 271 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEE
T ss_pred CCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEE
Confidence 5555666666665553322 5555566666666666553 332 5555566666666665553 2 3455555666666
Q ss_pred ccCCcCcc
Q 007788 119 VQNNTLSG 126 (589)
Q Consensus 119 l~~N~l~g 126 (589)
+++|++++
T Consensus 272 l~~n~l~~ 279 (347)
T 4fmz_A 272 VGSNQISD 279 (347)
T ss_dssp CCSSCCCC
T ss_pred ccCCccCC
Confidence 66665554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1.7e-10 Score=117.06 Aligned_cols=124 Identities=15% Similarity=0.124 Sum_probs=95.8
Q ss_pred ccccccchhhhhhhhhHhhcccceEEEccCc-cccc-CCCccccCCCCCCeEeccCC-cCCcc-CCccccCCC-CCCeee
Q 007788 20 KEFSNKIFVIIFQIQLKVILLCFVVLQLCCN-QLTG-NIPAQIGSLKSLSVLTLQHN-RLNGG-IPDSLGNLG-KLKRLD 94 (589)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n-~l~g-~~p~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~~l~-~L~~L~ 94 (589)
+...+.+...... .+..+++|+.|+|++| .+++ .+|..+.++++|+.|+|++| ++++. +|..+.+++ +|+.|+
T Consensus 124 ~L~~~~l~~~~~~--~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~ 201 (336)
T 2ast_B 124 SLEGLRLSDPIVN--TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLN 201 (336)
T ss_dssp ECTTCBCCHHHHH--HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEE
T ss_pred eCcCcccCHHHHH--HHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEE
Confidence 4444444433322 2344899999999999 7886 37778899999999999999 99965 788889999 999999
Q ss_pred ccCc--ccc-CCChhhhhcCCCCceeeccCCc-CcccCchhHhhccC--CccccCCC
Q 007788 95 LSFN--SLF-GTIPESLANNAELLFLDVQNNT-LSGIVPSALKRLNG--GFQFQNNP 145 (589)
Q Consensus 95 ls~N--~l~-g~~p~~~~~l~~L~~l~l~~N~-l~g~~p~~~~~~~~--~~~~~~n~ 145 (589)
|++| .++ +.+|..+..+++|+.|+|++|. +++..+..+..+.. .+.+.+|.
T Consensus 202 l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 202 LSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred eCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 9999 565 5688889999999999999999 77777777766643 23445554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.7e-09 Score=114.63 Aligned_cols=87 Identities=24% Similarity=0.256 Sum_probs=53.7
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|++++ +| ++.+++|+.|+|++|++++. .++.+++|+.|+|++|+|++ +| +..+++|+.|+
T Consensus 169 l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~ 239 (457)
T 3bz5_A 169 QTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239 (457)
T ss_dssp CTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred CCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence 5566666666666664 34 56666666666666666643 26666666666666666665 45 56666666666
Q ss_pred ccCCcCcccCchhHhh
Q 007788 119 VQNNTLSGIVPSALKR 134 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~ 134 (589)
+++|++++..+..+..
T Consensus 240 l~~N~l~~~~~~~l~~ 255 (457)
T 3bz5_A 240 CSVNPLTELDVSTLSK 255 (457)
T ss_dssp CCSSCCSCCCCTTCTT
T ss_pred eeCCcCCCcCHHHCCC
Confidence 6666666655444433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.95 E-value=4.1e-10 Score=115.67 Aligned_cols=95 Identities=24% Similarity=0.201 Sum_probs=69.6
Q ss_pred cccceEEEccCcccccCCC----ccccCCC-CCCeEeccCCcCCccCCccccCC-----CCCCeeeccCccccCCChhhh
Q 007788 39 LLCFVVLQLCCNQLTGNIP----AQIGSLK-SLSVLTLQHNRLNGGIPDSLGNL-----GKLKRLDLSFNSLFGTIPESL 108 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p----~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~ls~N~l~g~~p~~~ 108 (589)
..+|+.|+|++|.+++..+ ..+..++ +|+.|+|++|++++..+..++.+ ++|+.|+|++|+|++..+..+
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 4558888888888886655 6677777 78888888888887667766665 788888888888887766654
Q ss_pred hcC-----CCCceeeccCCcCcccCchhHh
Q 007788 109 ANN-----AELLFLDVQNNTLSGIVPSALK 133 (589)
Q Consensus 109 ~~l-----~~L~~l~l~~N~l~g~~p~~~~ 133 (589)
... ++|+.|+|++|++++..+..+.
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 130 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFK 130 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHH
Confidence 443 7788888888888776665554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.94 E-value=6.6e-10 Score=117.61 Aligned_cols=80 Identities=30% Similarity=0.416 Sum_probs=39.8
Q ss_pred cceEEEccCcccccCCCccccCC-CCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 41 CFVVLQLCCNQLTGNIPAQIGSL-KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 41 ~l~~L~L~~n~l~g~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
+|+.|+|++|++++ +| .+ ++|+.|+|++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|+.|++
T Consensus 298 ~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L 364 (454)
T 1jl5_A 298 NLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHV 364 (454)
T ss_dssp TCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEEC
T ss_pred cCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEEC
Confidence 44445555554443 11 12 355555555555553 4433 355555555555555 3444 2455555555
Q ss_pred cCCcCcc--cCchhHh
Q 007788 120 QNNTLSG--IVPSALK 133 (589)
Q Consensus 120 ~~N~l~g--~~p~~~~ 133 (589)
++|++++ .+|..+.
T Consensus 365 ~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 365 EYNPLREFPDIPESVE 380 (454)
T ss_dssp CSSCCSSCCCCCTTCC
T ss_pred CCCCCCcCCCChHHHH
Confidence 5555555 4454443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.94 E-value=3.6e-10 Score=117.10 Aligned_cols=133 Identities=15% Similarity=0.145 Sum_probs=101.6
Q ss_pred ccccccccccccch-hhhhhh-hhHhhcccceEEEccCcccc--c---CCCccccCCCCCCeEeccCCcCC----ccCCc
Q 007788 14 GKIIVFKEFSNKIF-VIIFQI-QLKVILLCFVVLQLCCNQLT--G---NIPAQIGSLKSLSVLTLQHNRLN----GGIPD 82 (589)
Q Consensus 14 ~~~~~~~~~~~~~~-~~~~~~-~~~~~l~~l~~L~L~~n~l~--g---~~p~~~~~l~~L~~L~L~~N~l~----g~~p~ 82 (589)
..+..++...|.|. ..+... ..+..+++|+.|+|++|+++ | .+|..+..+++|+.|+|++|+++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 55556666666664 222211 13445889999999999998 4 45558899999999999999997 68999
Q ss_pred cccCCCCCCeeeccCccccCC----Chhhhhc--CCCCceeeccCCcCcc----cCchhH-hhccC--CccccCCCC
Q 007788 83 SLGNLGKLKRLDLSFNSLFGT----IPESLAN--NAELLFLDVQNNTLSG----IVPSAL-KRLNG--GFQFQNNPG 146 (589)
Q Consensus 83 ~~~~l~~L~~L~ls~N~l~g~----~p~~~~~--l~~L~~l~l~~N~l~g----~~p~~~-~~~~~--~~~~~~n~~ 146 (589)
.+..+++|+.|+|++|+|++. +|..+.. +++|+.|+|++|++++ .+|..+ ..+.. .+.+.+|+.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 999999999999999999976 6777744 9999999999999998 477776 33433 345556543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.8e-09 Score=114.18 Aligned_cols=77 Identities=29% Similarity=0.349 Sum_probs=37.7
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
++|+.|+|++|++++ +|.. .++|++|+|++|++++ +| +|+++++|++|++++|++++ +|..+ ++|+.|++
T Consensus 111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 455555555555553 2221 1455555555555553 44 35555555555555555553 34322 34555555
Q ss_pred cCCcCcc
Q 007788 120 QNNTLSG 126 (589)
Q Consensus 120 ~~N~l~g 126 (589)
++|++++
T Consensus 181 ~~n~l~~ 187 (454)
T 1jl5_A 181 GNNQLEE 187 (454)
T ss_dssp CSSCCSS
T ss_pred cCCcCCc
Confidence 5555554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.91 E-value=3.6e-09 Score=112.44 Aligned_cols=101 Identities=30% Similarity=0.403 Sum_probs=83.2
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|.+++..| ++.+++|+.|+|++|++++. |. +..+++|+.|+|++|++++..| +..+++|+.
T Consensus 240 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 313 (466)
T 1o6v_A 240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTY 313 (466)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSE
T ss_pred hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCE
Confidence 448999999999999997655 89999999999999999964 43 8999999999999999997544 889999999
Q ss_pred eeccCCcCcccCchhHhhccC--CccccCCC
Q 007788 117 LDVQNNTLSGIVPSALKRLNG--GFQFQNNP 145 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~ 145 (589)
|+|++|++++..| +..+.. .+.+.+|.
T Consensus 314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNK 342 (466)
T ss_dssp EECCSSCCSCCGG--GGGCTTCCEEECCSSC
T ss_pred EECcCCcCCCchh--hccCccCCEeECCCCc
Confidence 9999999998876 444332 34555553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.89 E-value=4e-09 Score=115.54 Aligned_cols=73 Identities=33% Similarity=0.434 Sum_probs=43.5
Q ss_pred CCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--Cccc
Q 007788 64 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQF 141 (589)
Q Consensus 64 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~ 141 (589)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+.. .+.+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 456666666666663 55 34466666666666666 4554 4566777777777777 55666655543 2344
Q ss_pred cCCC
Q 007788 142 QNNP 145 (589)
Q Consensus 142 ~~n~ 145 (589)
.+|+
T Consensus 292 ~~N~ 295 (622)
T 3g06_A 292 EGNP 295 (622)
T ss_dssp CSCC
T ss_pred cCCC
Confidence 5554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.89 E-value=8.9e-10 Score=112.55 Aligned_cols=94 Identities=18% Similarity=0.166 Sum_probs=80.5
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCc-cccCCCCCCe-eeccCccccCCChhhhhcCCCCce
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKR-LDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~-L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
.++|+.|+|++|+|+...+..|++|++|+.|+|++|++.+.+|. +|.+|++|.. +++++|+|++..|..|..+++|+.
T Consensus 29 ~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~ 108 (350)
T 4ay9_X 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 108 (350)
T ss_dssp CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCE
T ss_pred CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccc
Confidence 35799999999999955456899999999999999999877775 6789998875 677789999777889999999999
Q ss_pred eeccCCcCcccCchhH
Q 007788 117 LDVQNNTLSGIVPSAL 132 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~ 132 (589)
|++++|++++..+..+
T Consensus 109 L~l~~n~l~~~~~~~~ 124 (350)
T 4ay9_X 109 LLISNTGIKHLPDVHK 124 (350)
T ss_dssp EEEEEECCSSCCCCTT
T ss_pred ccccccccccCCchhh
Confidence 9999999997666544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.87 E-value=3.4e-09 Score=112.20 Aligned_cols=86 Identities=23% Similarity=0.186 Sum_probs=69.2
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCC-----
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNA----- 112 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~----- 112 (589)
.+++|+.|+|++|++++. .++.+++|+.|+|++|+|++ +| ++.+++|+.|+|++|+|++..+..+.++.
T Consensus 189 ~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~ 262 (457)
T 3bz5_A 189 QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCI 262 (457)
T ss_dssp TCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECT
T ss_pred cCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEecc
Confidence 488999999999999965 38899999999999999997 77 88999999999999999986555554444
Q ss_pred --CCceeeccCCcCcccCc
Q 007788 113 --ELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 113 --~L~~l~l~~N~l~g~~p 129 (589)
+|+.|++++|++.|.+|
T Consensus 263 ~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 263 QTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp TCCCSCCCCTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCccc
Confidence 45666666666666666
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.6e-09 Score=108.25 Aligned_cols=192 Identities=16% Similarity=0.158 Sum_probs=119.9
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCC--ccceeeeeecCC-CCeEEEEEEe
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HEN--IIRLRGFCCSRG-RGECFLIYDF 389 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~g~~~~~~-~~~~~lv~Ey 389 (589)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++.+..... ....|+||||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568899999999864 45888875432 33467889999998873 332 334444332111 1234889999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCC-------------------------------------
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE------------------------------------- 432 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 432 (589)
++|.+|.+.... .++..++..++.++++.|+.||+..
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888654321 2566777788888888888888521
Q ss_pred ----------------CCCCCeEecCCCCCCeeecC--CCceEEccccccccccCCceeeeecC----Ccc-------cc
Q 007788 433 ----------------VNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLHKLLADDIVFSVLKT----SAA-------MG 483 (589)
Q Consensus 433 ----------------~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~----~~~-------~~ 483 (589)
...+.++|+|+++.||++++ +..+.|.||+.+.............. .+. .+
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 11345899999999999998 45678999998765332110000000 000 00
Q ss_pred c--cC-cccccCCCCCCcchhhhHHHHHHHHHhCCCCcch
Q 007788 484 Y--LA-PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS 520 (589)
Q Consensus 484 y--~a-PE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~ 520 (589)
| .. |+... ......+.|++|.++|++.+|..++..
T Consensus 252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 1 11 11111 011235899999999999999877643
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.79 E-value=3.1e-09 Score=109.03 Aligned_cols=129 Identities=19% Similarity=0.129 Sum_probs=97.0
Q ss_pred eEEeecccccccccc----------cccccccchhhhhhh--hhHhhcc-cceEEEccCcccccCCCccccCC-----CC
Q 007788 4 FYFLDECGIHGKIIV----------FKEFSNKIFVIIFQI--QLKVILL-CFVVLQLCCNQLTGNIPAQIGSL-----KS 65 (589)
Q Consensus 4 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~--~~~~~l~-~l~~L~L~~n~l~g~~p~~~~~l-----~~ 65 (589)
|+.|..|++++.+.. +|...|.|....... ..+..++ +|+.|+|++|++++..+..++.+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 566777777765433 355555554332210 1334467 89999999999998888888775 99
Q ss_pred CCeEeccCCcCCccCCccccC----C-CCCCeeeccCccccCCChhhhhc-----CCCCceeeccCCcCcccCchhH
Q 007788 66 LSVLTLQHNRLNGGIPDSLGN----L-GKLKRLDLSFNSLFGTIPESLAN-----NAELLFLDVQNNTLSGIVPSAL 132 (589)
Q Consensus 66 L~~L~L~~N~l~g~~p~~~~~----l-~~L~~L~ls~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~g~~p~~~ 132 (589)
|+.|+|++|++++..+..++. + ++|+.|+|++|+|++..+..+.. .++|+.|+|++|+++...+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 999999999999877775554 4 89999999999999877766554 3699999999999997555444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.74 E-value=6.8e-09 Score=100.66 Aligned_cols=83 Identities=23% Similarity=0.235 Sum_probs=56.4
Q ss_pred EEccCcccc---cCCCccccCCCCCCeEeccCCcCCc--cCCccccCCCCCCeeeccCccccCCChhhhhcCC--CCcee
Q 007788 45 LQLCCNQLT---GNIPAQIGSLKSLSVLTLQHNRLNG--GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNA--ELLFL 117 (589)
Q Consensus 45 L~L~~n~l~---g~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~--~L~~l 117 (589)
++++.|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 566777333 2222233567788888888888887 5666777788888888888888754 3344444 78888
Q ss_pred eccCCcCcccCc
Q 007788 118 DVQNNTLSGIVP 129 (589)
Q Consensus 118 ~l~~N~l~g~~p 129 (589)
+|++|.+++.+|
T Consensus 226 ~L~~Npl~~~~~ 237 (267)
T 3rw6_A 226 WLDGNSLCDTFR 237 (267)
T ss_dssp ECTTSTTGGGCS
T ss_pred EccCCcCccccC
Confidence 888888877666
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.72 E-value=6.7e-09 Score=105.99 Aligned_cols=119 Identities=18% Similarity=0.093 Sum_probs=88.0
Q ss_pred ccccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCc-cccCCCCCCe-EeccCCcCCccCCccccCCCCCC
Q 007788 14 GKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPA-QIGSLKSLSV-LTLQHNRLNGGIPDSLGNLGKLK 91 (589)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~-L~L~~N~l~g~~p~~~~~l~~L~ 91 (589)
..+..++...|+|..... ..+..|++|+.|+|++|++.+.+|. .|.++++|+. +++++|+|++..|..|.++++|+
T Consensus 30 ~~l~~L~Ls~N~i~~i~~--~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~ 107 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQK--GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ 107 (350)
T ss_dssp TTCSEEEEESCCCSEECT--TSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCC
T ss_pred CCCCEEEccCCcCCCcCH--HHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccc
Confidence 345556666666542221 1234599999999999999877775 7899999875 67788999987788999999999
Q ss_pred eeeccCccccCCChhhhhcCCCCceeeccC-CcCcccCchhHhh
Q 007788 92 RLDLSFNSLFGTIPESLANNAELLFLDVQN-NTLSGIVPSALKR 134 (589)
Q Consensus 92 ~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~ 134 (589)
.|++++|+|++..+..+....++..|++.+ |++....+..+..
T Consensus 108 ~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 108 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp EEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred cccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence 999999999976666666677777888754 5666444444443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.68 E-value=3.7e-09 Score=102.50 Aligned_cols=80 Identities=28% Similarity=0.309 Sum_probs=65.8
Q ss_pred hhcccceEEEccCccccc--CCCccccCCCCCCeEeccCCcCCccCCccccCCC--CCCeeeccCccccCCChh------
Q 007788 37 VILLCFVVLQLCCNQLTG--NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--KLKRLDLSFNSLFGTIPE------ 106 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~--~L~~L~ls~N~l~g~~p~------ 106 (589)
..+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 458899999999999997 5667788899999999999999964 4455555 899999999999987763
Q ss_pred -hhhcCCCCceee
Q 007788 107 -SLANNAELLFLD 118 (589)
Q Consensus 107 -~~~~l~~L~~l~ 118 (589)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 467788888887
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.65 E-value=8.9e-09 Score=109.06 Aligned_cols=88 Identities=26% Similarity=0.232 Sum_probs=41.5
Q ss_pred cccceEEEccCcccccCCCccc-cCCC----CCCeEeccCCcCCc----cCCccccCCCCCCeeeccCccccCCChhhhh
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQI-GSLK----SLSVLTLQHNRLNG----GIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 109 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~-~~l~----~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 109 (589)
+++|+.|+|++|.++...+..+ ..++ +|+.|+|++|+++. .+|..+.++++|+.|+|++|.+++..+..+.
T Consensus 55 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 134 (461)
T 1z7x_W 55 NPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC 134 (461)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHH
Confidence 4555555555555543322222 2233 45555555555552 3455555555555555555555433333222
Q ss_pred c-----CCCCceeeccCCcCcc
Q 007788 110 N-----NAELLFLDVQNNTLSG 126 (589)
Q Consensus 110 ~-----l~~L~~l~l~~N~l~g 126 (589)
. +++|+.|+|++|++++
T Consensus 135 ~~l~~~~~~L~~L~L~~n~l~~ 156 (461)
T 1z7x_W 135 EGLLDPQCRLEKLQLEYCSLSA 156 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBG
T ss_pred HHHhcCCCcceEEECCCCCCCH
Confidence 2 2345555555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.64 E-value=4.1e-09 Score=111.71 Aligned_cols=94 Identities=23% Similarity=0.150 Sum_probs=54.2
Q ss_pred cccceEEEccCcccccC----CCccccCCCCCCeEeccCCcCCccCCccccC-----CCCCCeeeccCccccCC----Ch
Q 007788 39 LLCFVVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN-----LGKLKRLDLSFNSLFGT----IP 105 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~-----l~~L~~L~ls~N~l~g~----~p 105 (589)
+++|+.|+|++|+++.. ++..+..+++|+.|+|++|++++..+..+.. .++|+.|+|++|.+++. +|
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 55666666666666643 4555566666666666666665433333332 24666666666666644 44
Q ss_pred hhhhcCCCCceeeccCCcCcccCchhH
Q 007788 106 ESLANNAELLFLDVQNNTLSGIVPSAL 132 (589)
Q Consensus 106 ~~~~~l~~L~~l~l~~N~l~g~~p~~~ 132 (589)
..+..+++|+.|+|++|++++..+..+
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l 361 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVREL 361 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHH
T ss_pred HHHhhCCCccEEEccCCccccccHHHH
Confidence 555556666666666666655444433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.60 E-value=1.3e-08 Score=104.55 Aligned_cols=112 Identities=19% Similarity=0.135 Sum_probs=77.5
Q ss_pred cccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccc-----cCCCCCCeEeccCCcCCc----cCCcccc
Q 007788 15 KIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQI-----GSLKSLSVLTLQHNRLNG----GIPDSLG 85 (589)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~-----~~l~~L~~L~L~~N~l~g----~~p~~~~ 85 (589)
.+..+|...|.|...-.. .+...+.+|+.|+|++|+|+..-...+ ...++|+.|+|++|+|+. .++..+.
T Consensus 102 ~L~~L~Ls~n~l~~~~~~-~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLR-TLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp CEEEEECTTCCCCHHHHH-HTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CceEEEecCCCCCHHHHH-HHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 444556666666433222 234447788888888888875433333 346788888999888874 3555667
Q ss_pred CCCCCCeeeccCccccCC----ChhhhhcCCCCceeeccCCcCccc
Q 007788 86 NLGKLKRLDLSFNSLFGT----IPESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 86 ~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
.+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~ 226 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence 788888999998888742 355677778888899998888754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=9.5e-07 Score=88.11 Aligned_cols=139 Identities=22% Similarity=0.144 Sum_probs=92.4
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCC---CccceeeeeecCCCCeEEEEEEeC
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE---NIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
.+.++.|....||+. |..+++|+-.. ......+..|.+++..+.+. .+.+++.++.. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEecc
Confidence 355788888899987 46678887421 23446788999999998753 35566666532 245678999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC-------------------------------------
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV------------------------------------- 433 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~------------------------------------- 433 (589)
+|..+.+.... .++...+..++.++++.|+.||+...
T Consensus 96 ~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 96 QGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 99888663211 13344445555555555555553210
Q ss_pred ------------------CCCCeEecCCCCCCeeecC---CCce-EEcccccccc
Q 007788 434 ------------------NKPAIVHRNLSVEKVLIDQ---QFNP-LIADCGLHKL 466 (589)
Q Consensus 434 ------------------~~~~ivH~dlk~~Nill~~---~~~~-kl~DfGla~~ 466 (589)
..+.++|+|+++.||+++. ++.+ .|.||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999997 4554 7999997653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.45 E-value=4.7e-08 Score=100.37 Aligned_cols=116 Identities=20% Similarity=0.188 Sum_probs=86.2
Q ss_pred ccccccccchhhhhhhhhH----hhcccceEEEccCccccc----CCCccccCCCCCCeEeccCCcCCc----cCCcccc
Q 007788 18 VFKEFSNKIFVIIFQIQLK----VILLCFVVLQLCCNQLTG----NIPAQIGSLKSLSVLTLQHNRLNG----GIPDSLG 85 (589)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~----~~l~~l~~L~L~~n~l~g----~~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~ 85 (589)
.+|...|.|...-.. .+. ...++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+. .++..+.
T Consensus 130 ~L~Ls~n~l~~~~~~-~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~ 208 (372)
T 3un9_A 130 KLGLQLNSLGPEACK-DLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLD 208 (372)
T ss_dssp EEECCSSCCCHHHHH-HHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGG
T ss_pred HhhcCCCCCCHHHHH-HHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHh
Confidence 346666666433221 111 125789999999999975 255566889999999999999985 3466778
Q ss_pred CCCCCCeeeccCccccCC----ChhhhhcCCCCceeeccCCcCcccCchhHhh
Q 007788 86 NLGKLKRLDLSFNSLFGT----IPESLANNAELLFLDVQNNTLSGIVPSALKR 134 (589)
Q Consensus 86 ~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~ 134 (589)
.+++|+.|+|++|+|+.. ++..+..+++|+.|||++|.|+..-...+..
T Consensus 209 ~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 209 RNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp GCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred cCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 889999999999999853 4556667899999999999998655445544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.7e-06 Score=84.38 Aligned_cols=136 Identities=15% Similarity=0.168 Sum_probs=93.5
Q ss_pred ccccCCCc-cEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEEEEeCCC
Q 007788 316 LLGKGNFS-SVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 316 ~lg~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
.+..|..| .||+.... ++..+++|+-.. ....++..|...|+.+. +--+.++++++.+ .+..++|||++++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCC
Confidence 35556555 58988765 467788898653 23456788988888774 3346677887744 3678999999999
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC---------------------------------------
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV--------------------------------------- 433 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~--------------------------------------- 433 (589)
.++.+...... ..+..++.+++..|+.||+...
T Consensus 105 ~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 105 KTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred ccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 88876653211 1223455666666666664210
Q ss_pred --------------CCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 434 --------------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 434 --------------~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
..+.++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 12347999999999999987777799999765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.23 E-value=2.2e-06 Score=86.43 Aligned_cols=95 Identities=17% Similarity=0.153 Sum_probs=80.7
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCC-eeeccCccccCCChhhhhcCCCCce
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK-RLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
.+++|+.|+|++|+++...+..|.+|++|+.|+|.+| ++..-+.+|.+|++|+ .|+|++ +++..-+.+|.++++|+.
T Consensus 224 ~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 224 YMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp HCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred hcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 4899999999999999554568999999999999999 8855566899999999 999999 777455688999999999
Q ss_pred eeccCCcCcccCchhHhh
Q 007788 117 LDVQNNTLSGIVPSALKR 134 (589)
Q Consensus 117 l~l~~N~l~g~~p~~~~~ 134 (589)
|++++|+++...+.+|..
T Consensus 302 l~l~~n~i~~I~~~aF~~ 319 (329)
T 3sb4_A 302 VLATGDKITTLGDELFGN 319 (329)
T ss_dssp EEECSSCCCEECTTTTCT
T ss_pred EEeCCCccCccchhhhcC
Confidence 999999999665555543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.10 E-value=5.9e-07 Score=98.18 Aligned_cols=89 Identities=13% Similarity=0.082 Sum_probs=53.2
Q ss_pred cccceEEEcc----CcccccC-----CCccccCCCCCCeEeccC--CcCCccCCccccC-CCCCCeeeccCccccC-CCh
Q 007788 39 LLCFVVLQLC----CNQLTGN-----IPAQIGSLKSLSVLTLQH--NRLNGGIPDSLGN-LGKLKRLDLSFNSLFG-TIP 105 (589)
Q Consensus 39 l~~l~~L~L~----~n~l~g~-----~p~~~~~l~~L~~L~L~~--N~l~g~~p~~~~~-l~~L~~L~ls~N~l~g-~~p 105 (589)
+++|+.|+|+ +|++++. ++..+.++++|+.|+|++ |.+++..+..++. +++|+.|+|++|++++ .++
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 6666666664 5666643 333355566666666653 2355554444443 6677777777777765 344
Q ss_pred hhhhcCCCCceeeccCCcCccc
Q 007788 106 ESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 106 ~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
..+..+++|+.|+|++|++++.
T Consensus 482 ~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 482 EFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHhcCcccCeeeccCCCCcHH
Confidence 4556667777777777776543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=1e-06 Score=80.84 Aligned_cols=93 Identities=17% Similarity=0.178 Sum_probs=69.2
Q ss_pred hHhhcccceEEEccCc-ccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCccccCC--
Q 007788 35 LKVILLCFVVLQLCCN-QLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGT-- 103 (589)
Q Consensus 35 ~~~~l~~l~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~-- 103 (589)
.....++|+.|+|++| .++.. +...+...++|++|+|++|+|+.. +...+...+.|++|+|++|+|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3344778999999998 87632 345567778899999999988742 444555668899999999988753
Q ss_pred --ChhhhhcCCCCceeec--cCCcCccc
Q 007788 104 --IPESLANNAELLFLDV--QNNTLSGI 127 (589)
Q Consensus 104 --~p~~~~~l~~L~~l~l--~~N~l~g~ 127 (589)
+...+...++|+.|+| ++|.+...
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 4566777788999999 78888754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=4.5e-06 Score=85.02 Aligned_cols=83 Identities=12% Similarity=0.025 Sum_probs=53.4
Q ss_pred ccc-ccCCCccEEEEEec-------CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccC-C--CCccceeeeeecCC-C
Q 007788 315 NLL-GKGNFSSVYKGTLR-------DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLR-H--ENIIRLRGFCCSRG-R 380 (589)
Q Consensus 315 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~-H--~niv~l~g~~~~~~-~ 380 (589)
+.| +.|....+|+.... ++..+++|+...... ......+..|..+++.+. + -.+.++++++.+.. .
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999998765 267788887654320 001134667777777764 2 35667777763321 1
Q ss_pred CeEEEEEEeCCCCChHH
Q 007788 381 GECFLIYDFAPKGKLSK 397 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~ 397 (589)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=1.2e-06 Score=80.50 Aligned_cols=87 Identities=15% Similarity=0.180 Sum_probs=64.5
Q ss_pred cccceEEEccCcccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeec--cCccccCC----C
Q 007788 39 LLCFVVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDL--SFNSLFGT----I 104 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l--s~N~l~g~----~ 104 (589)
.++|+.|+|++|.|+.. +...+...++|+.|+|++|+|+.. +..++...++|+.|+| ++|.|+.. +
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 57788888888888632 334455667888888888888743 5566777788888888 77888743 3
Q ss_pred hhhhhcCCCCceeeccCCcCc
Q 007788 105 PESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 105 p~~~~~l~~L~~l~l~~N~l~ 125 (589)
...+...++|+.|+|++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 445666788888888888875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.07 E-value=8.5e-07 Score=96.93 Aligned_cols=92 Identities=15% Similarity=0.057 Sum_probs=75.7
Q ss_pred HhhcccceEEEccC--cccccCCCccccC-CCCCCeEeccCCcCCc-cCCccccCCCCCCeeeccCccccCC-Chhhhhc
Q 007788 36 KVILLCFVVLQLCC--NQLTGNIPAQIGS-LKSLSVLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFNSLFGT-IPESLAN 110 (589)
Q Consensus 36 ~~~l~~l~~L~L~~--n~l~g~~p~~~~~-l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~ 110 (589)
...+++|+.|+|++ |.+++..+..++. +++|+.|+|++|++++ .+|..+.++++|+.|+|++|.|++. ++..+..
T Consensus 432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 511 (592)
T 3ogk_B 432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTK 511 (592)
T ss_dssp HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHH
T ss_pred HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHh
Confidence 44599999999985 3477666665554 8999999999999997 4566678899999999999999865 4555677
Q ss_pred CCCCceeeccCCcCccc
Q 007788 111 NAELLFLDVQNNTLSGI 127 (589)
Q Consensus 111 l~~L~~l~l~~N~l~g~ 127 (589)
+++|+.|+|++|+++..
T Consensus 512 l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 512 LPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CSSCCEEEEESCBCCTT
T ss_pred cCccCeeECcCCcCCHH
Confidence 99999999999999864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=4.6e-06 Score=84.94 Aligned_cols=64 Identities=19% Similarity=0.248 Sum_probs=36.1
Q ss_pred CCCCCCeEeccCCcCCccCCcccc---CCCCCCeeeccCccccCC----ChhhhhcCCCCceeeccCCcCc
Q 007788 62 SLKSLSVLTLQHNRLNGGIPDSLG---NLGKLKRLDLSFNSLFGT----IPESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 62 ~l~~L~~L~L~~N~l~g~~p~~~~---~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 125 (589)
.+++|+.|+|++|++++..+..+. .+++|+.|+|+.|+|++. ++..+..+++|+.|+|++|.++
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 356666666666666543333332 356666666666666542 3333445566666666666655
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=5.1e-05 Score=78.42 Aligned_cols=76 Identities=9% Similarity=-0.049 Sum_probs=47.8
Q ss_pred ccccccCCCccEEEEEec-CCcEEEEEEeccCCC------chHHHHHHHHHHHHhccCC--CCc-cceeeeeecCCCCeE
Q 007788 314 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC------KSEEAEFVKGLYLLTSLRH--ENI-IRLRGFCCSRGRGEC 383 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~~e~~~l~~l~H--~ni-v~l~g~~~~~~~~~~ 383 (589)
.+.||.|.++.||++... +++.++||....... ......+..|.+++..+.. +.. .+++.+. . +..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence 457899999999999764 467899998653211 0112346678888877632 333 3555432 2 345
Q ss_pred EEEEEeCCCC
Q 007788 384 FLIYDFAPKG 393 (589)
Q Consensus 384 ~lv~Ey~~~g 393 (589)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00017 Score=72.60 Aligned_cols=144 Identities=13% Similarity=0.240 Sum_probs=77.2
Q ss_pred cccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-----CCCCcccee-e-eeecCCCCeEEEEE
Q 007788 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-----RHENIIRLR-G-FCCSRGRGECFLIY 387 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~-g-~~~~~~~~~~~lv~ 387 (589)
+.|+.|..+.||+....+|. +++|+.... . .+...|..++..+ ..|.++... | ++. ...+..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~-~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS-KHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE-EETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE-EECCEEEEEE
Confidence 44666778999999876554 888988642 1 2223344444333 234444311 1 111 1235678999
Q ss_pred EeCCCCChH--------------HHhhhhcCC---C-------CCCCHHHHH----------------------------
Q 007788 388 DFAPKGKLS--------------KYLDQEEGS---S-------NVLDWSTRV---------------------------- 415 (589)
Q Consensus 388 Ey~~~gsL~--------------~~l~~~~~~---~-------~~l~~~~~~---------------------------- 415 (589)
||++|..+. ..+|..... . ..-.|....
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 112221110 0 112343211
Q ss_pred ---HHHHHHHHHhHHhcCC-------C-CCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 416 ---SIIIGIAKGIGYLHSS-------E-VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 416 ---~i~~~ia~~L~~LH~~-------~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
.+...+..++++|+.. . ...+.++|||+++.||+++.++.+.|.||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111233456666530 0 012449999999999999888889999999764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.76 E-value=3.7e-06 Score=91.83 Aligned_cols=92 Identities=17% Similarity=0.170 Sum_probs=65.1
Q ss_pred hhcccceEEEcc--C----cccccC-----CCccccCCCCCCeEeccCCcCCccCCccccC-CCCCCeeeccCccccCCC
Q 007788 37 VILLCFVVLQLC--C----NQLTGN-----IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN-LGKLKRLDLSFNSLFGTI 104 (589)
Q Consensus 37 ~~l~~l~~L~L~--~----n~l~g~-----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~-l~~L~~L~ls~N~l~g~~ 104 (589)
..+++|+.|+|+ + |+++.. ++..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..
T Consensus 394 ~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~ 472 (594)
T 2p1m_B 394 RNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472 (594)
T ss_dssp HHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred hhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence 347888888888 4 566632 122366778888888876 666666666665 788888888888887655
Q ss_pred hhhh-hcCCCCceeeccCCcCcccCc
Q 007788 105 PESL-ANNAELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 105 p~~~-~~l~~L~~l~l~~N~l~g~~p 129 (589)
+..+ ..+++|+.|+|++|.+++..+
T Consensus 473 ~~~l~~~~~~L~~L~L~~n~~~~~~~ 498 (594)
T 2p1m_B 473 MHHVLSGCDSLRKLEIRDCPFGDKAL 498 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCSCCHHHH
T ss_pred HHHHHhcCCCcCEEECcCCCCcHHHH
Confidence 5555 568888888888888854433
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.75 E-value=3e-05 Score=77.93 Aligned_cols=88 Identities=13% Similarity=0.005 Sum_probs=73.9
Q ss_pred cchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCC-eEeccCCcCCccCCccccCCCCCCeeeccCccccCC
Q 007788 25 KIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLS-VLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103 (589)
Q Consensus 25 ~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~-~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 103 (589)
.||...|. .|.+|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+.+|.+|++|+.|+|+.|+++..
T Consensus 240 ~I~~~aF~-----~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I 312 (329)
T 3sb4_A 240 TIPDFTFA-----QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL 312 (329)
T ss_dssp EECTTTTT-----TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred eecHhhhh-----CCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence 55555554 4999999999998 8755556999999999 999999 78755568999999999999999999965
Q ss_pred ChhhhhcCCCCceeec
Q 007788 104 IPESLANNAELLFLDV 119 (589)
Q Consensus 104 ~p~~~~~l~~L~~l~l 119 (589)
-+..|.++++|+.++.
T Consensus 313 ~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 313 GDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTTTTCTTCCCCEEEC
T ss_pred chhhhcCCcchhhhcc
Confidence 5668999999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00018 Score=71.44 Aligned_cols=140 Identities=20% Similarity=0.205 Sum_probs=90.6
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC---CCCccceeeeeecCCCCeEEEEEEeC
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
.+.|+.|....+|+.... +..+++|+.... ....|..|.+.|+.+. ...+.++++++.. .+..++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEec
Confidence 456899999999999864 667888987532 3456888888888773 3667888887743 36789999999
Q ss_pred CCCChHH-----------HhhhhcC-C-----------------CCCCCHHHHH---HHH--HH--------------HH
Q 007788 391 PKGKLSK-----------YLDQEEG-S-----------------SNVLDWSTRV---SII--IG--------------IA 422 (589)
Q Consensus 391 ~~gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~--~~--------------ia 422 (589)
++..+.. .||.... . ...-+|.... ++. .+ +.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9876521 2333221 0 0012565321 111 11 11
Q ss_pred -HHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 423 -KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 423 -~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.....|... ...|.++|+|+.+.||+++.++ +.|.||.
T Consensus 194 ~~l~~~L~~~-~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKH-NPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTC-CCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccC-CCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 112334322 1357799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00018 Score=70.69 Aligned_cols=78 Identities=15% Similarity=0.199 Sum_probs=55.0
Q ss_pred CccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC---CCccceeeeeecCCCCeEEEEE
Q 007788 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH---ENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 311 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~g~~~~~~~~~~~lv~ 387 (589)
....+.+|.|..+.||+.++.||+.|+||+..... ......|..|.+.|+.+.- -.+.+++++. .-++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEEEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceEEE
Confidence 34456789999999999999999999999875443 2223457789888887742 2344555432 237899
Q ss_pred EeCCCCCh
Q 007788 388 DFAPKGKL 395 (589)
Q Consensus 388 Ey~~~gsL 395 (589)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.59 E-value=1.7e-05 Score=86.59 Aligned_cols=86 Identities=19% Similarity=0.164 Sum_probs=51.3
Q ss_pred hcccceEEEccCcccccCCCcccc-CCCCCCeEeccCC-cCCcc-CCccccCCCCCCeeeccCccccCCChhhhh----c
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIG-SLKSLSVLTLQHN-RLNGG-IPDSLGNLGKLKRLDLSFNSLFGTIPESLA----N 110 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~ 110 (589)
.+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 466677777777766665555554 4667777777666 44422 333344566677777776666654444433 3
Q ss_pred CCCCceeeccCCc
Q 007788 111 NAELLFLDVQNNT 123 (589)
Q Consensus 111 l~~L~~l~l~~N~ 123 (589)
+++|+.|+|++|.
T Consensus 183 ~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 183 YTSLVSLNISCLA 195 (594)
T ss_dssp CCCCCEEECTTCC
T ss_pred CCcCcEEEecccC
Confidence 4466666666665
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00034 Score=72.79 Aligned_cols=78 Identities=13% Similarity=0.101 Sum_probs=46.3
Q ss_pred CCeEecCCCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccCC---CCCCcchhhhHHHHHHHHH
Q 007788 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQIL 512 (589)
Q Consensus 436 ~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~ell 512 (589)
+.++|||+++.|||++.++ ++|.||+.+..-.........-..-...|.+|+..... ......++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3499999999999999876 99999998765432110000000001235666554311 1112345567888888877
Q ss_pred hC
Q 007788 513 TG 514 (589)
Q Consensus 513 tg 514 (589)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00058 Score=58.28 Aligned_cols=36 Identities=22% Similarity=0.114 Sum_probs=17.8
Q ss_pred CCCeeeccCccccCCChhhhhcCCCCceeeccCCcC
Q 007788 89 KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTL 124 (589)
Q Consensus 89 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l 124 (589)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 345555555555533333344455555555555555
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00067 Score=67.01 Aligned_cols=71 Identities=4% Similarity=-0.070 Sum_probs=41.3
Q ss_pred ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCc-cceeeeeecCCCCeEEEEEEeC-C
Q 007788 314 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-IRLRGFCCSRGRGECFLIYDFA-P 391 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~~~lv~Ey~-~ 391 (589)
.+.|+.|....+|+. ..+++|+....... ......|..++..+....+ .++++++ . +.-++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~--~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--P--ATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T--TTCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--C--CCCEEEEeecCC
Confidence 467888999999998 45788887643211 0112356666655532222 4555543 2 2236899999 5
Q ss_pred CCCh
Q 007788 392 KGKL 395 (589)
Q Consensus 392 ~gsL 395 (589)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.13 E-value=6.4e-05 Score=76.42 Aligned_cols=83 Identities=14% Similarity=0.227 Sum_probs=62.2
Q ss_pred cccceEEEccCcccccCCCccc---cCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCccccCCChhhhhc-
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQI---GSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGTIPESLAN- 110 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~---~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~- 110 (589)
+++|++|+|++|.++...+..+ ..+++|+.|+|+.|+|++. ++..+.++++|+.|+|++|.++...-..+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 6789999998888875444333 3588999999999999863 5556677899999999999988443333443
Q ss_pred CCCCceeeccCCc
Q 007788 111 NAELLFLDVQNNT 123 (589)
Q Consensus 111 l~~L~~l~l~~N~ 123 (589)
+ ...++++.|+
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 2 3568888877
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00014 Score=65.20 Aligned_cols=84 Identities=10% Similarity=0.074 Sum_probs=63.0
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCc-CCccCCccccCC----CCCCeeeccCc-cccCCChhhhhcCCC
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNR-LNGGIPDSLGNL----GKLKRLDLSFN-SLFGTIPESLANNAE 113 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l----~~L~~L~ls~N-~l~g~~p~~~~~l~~ 113 (589)
-.|+.|||+++.++..=-..+..+++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++ +++..=-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 469999999998875433567899999999999985 764222234543 47999999986 476432345778999
Q ss_pred CceeeccCCc
Q 007788 114 LLFLDVQNNT 123 (589)
Q Consensus 114 L~~l~l~~N~ 123 (589)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0029 Score=62.96 Aligned_cols=163 Identities=13% Similarity=0.022 Sum_probs=84.9
Q ss_pred cCHHHHHHhhccCcc-----ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCC--ccce
Q 007788 299 LNLEEVESATQCFSE-----VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN--IIRL 371 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l 371 (589)
++.+++......|.. .+.|+.|....+|+....+| .+++|........ ..+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 455666655555654 23466788889999987766 5778887652111 23445666655553111 2333
Q ss_pred eeee----ecCCCCeEEEEEEeCCCCChHH--------------HhhhhcCC---C--CC---CCHHHHHHH--------
Q 007788 372 RGFC----CSRGRGECFLIYDFAPKGKLSK--------------YLDQEEGS---S--NV---LDWSTRVSI-------- 417 (589)
Q Consensus 372 ~g~~----~~~~~~~~~lv~Ey~~~gsL~~--------------~l~~~~~~---~--~~---l~~~~~~~i-------- 417 (589)
+... .....+..+++++|++|..+.. .+|..... . .. ..|.....-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3211 0001245689999999865321 12221100 0 00 124331110
Q ss_pred ----HHHHHHHhHHhcCCC--CCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 418 ----IIGIAKGIGYLHSSE--VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 418 ----~~~ia~~L~~LH~~~--~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
...+.+.+++++... .....++|+|+.+.|||++++..+.|.||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 111334445554210 123458999999999999987666899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0077 Score=59.94 Aligned_cols=162 Identities=9% Similarity=0.070 Sum_probs=86.8
Q ss_pred cCHHHHHHhhccCcc-----ccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC--CCccce
Q 007788 299 LNLEEVESATQCFSE-----VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRL 371 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l 371 (589)
++.+++....+.|.. ...++ |....||+....+|+.+++|....... ....+..|..++..+.. -.+.++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecce
Confidence 444555544444432 23466 788899998877787899999864321 23345567777666632 123444
Q ss_pred eee---eecCCCCeEEEEEEeCCCCChH-----HH---------hhhhcC-----CCCCCCHHHH---------------
Q 007788 372 RGF---CCSRGRGECFLIYDFAPKGKLS-----KY---------LDQEEG-----SSNVLDWSTR--------------- 414 (589)
Q Consensus 372 ~g~---~~~~~~~~~~lv~Ey~~~gsL~-----~~---------l~~~~~-----~~~~l~~~~~--------------- 414 (589)
+.. ......+..++||||++|..+. .+ +|.... ....+++...
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 432 0001134568899999885432 11 121111 0112333211
Q ss_pred -------HHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 415 -------VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 415 -------~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
...+..++..++-+-.. .....++|||+++.||+++ + .+.|.||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWRE-DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCS-CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhh-cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111222222222111 1234589999999999999 4 889999987653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00089 Score=57.11 Aligned_cols=65 Identities=23% Similarity=0.343 Sum_probs=37.7
Q ss_pred eeeccCcccc-CCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCccc
Q 007788 92 RLDLSFNSLF-GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRAC 158 (589)
Q Consensus 92 ~L~ls~N~l~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~ 158 (589)
.++.+++.|+ ..+|..+ -++|+.|+|++|+|+...+..|..+.. .+.+.+|||.|+|.+..+..+
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~w 79 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAW 79 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHH
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHH
Confidence 5566666665 2344332 135777777777777555555555432 355667777777766554443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0032 Score=57.92 Aligned_cols=103 Identities=15% Similarity=0.088 Sum_probs=67.3
Q ss_pred CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCCce
Q 007788 393 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472 (589)
Q Consensus 393 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 472 (589)
-+|.+.|...+. ++++.++|.++.|.+++|.-+-... .+ ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~--~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR--QP--RHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CC--CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc--cC--CceecCCcceEEecCCceeccc-cccc-------
Confidence 489999987764 5999999999999999988762111 00 1222346889999999998874 2111
Q ss_pred eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCC
Q 007788 473 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 517 (589)
Q Consensus 473 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p 517 (589)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0111267888764 3457888999999999988765443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00094 Score=68.89 Aligned_cols=90 Identities=21% Similarity=0.135 Sum_probs=54.5
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCC-----ccCCccccCCCCCCeeeccCccccCCChhhhhcCCCC
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN-----GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAEL 114 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~-----g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 114 (589)
.+|+.+.|. |+++..-+..|.+|++|+.++|.+|.+. -.-+.+|.+|++|+.++|. |+++-.-...|.++.+|
T Consensus 248 ~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L 325 (401)
T 4fdw_A 248 SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKV 325 (401)
T ss_dssp CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSC
T ss_pred CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCc
Confidence 567777773 4455333457777777777777777664 2334567777777777777 34553333456667777
Q ss_pred ceeeccCCcCcccCchhH
Q 007788 115 LFLDVQNNTLSGIVPSAL 132 (589)
Q Consensus 115 ~~l~l~~N~l~g~~p~~~ 132 (589)
+.++|.+| ++..-+.+|
T Consensus 326 ~~l~lp~~-l~~I~~~aF 342 (401)
T 4fdw_A 326 TQLTIPAN-VTQINFSAF 342 (401)
T ss_dssp CEEEECTT-CCEECTTSS
T ss_pred cEEEECcc-ccEEcHHhC
Confidence 77777544 443333333
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0073 Score=60.35 Aligned_cols=31 Identities=23% Similarity=0.220 Sum_probs=26.7
Q ss_pred CCeEecCCCCCCeeecCC----CceEEcccccccc
Q 007788 436 PAIVHRNLSVEKVLIDQQ----FNPLIADCGLHKL 466 (589)
Q Consensus 436 ~~ivH~dlk~~Nill~~~----~~~kl~DfGla~~ 466 (589)
+.++|||+.+.|||++.+ ..+.|.||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 459999999999999875 6789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0027 Score=66.01 Aligned_cols=73 Identities=18% Similarity=0.264 Sum_probs=48.6
Q ss_pred ccccccCCCccEEEEEecC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCc-cceeeeeecCCCCeEE
Q 007788 314 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-IRLRGFCCSRGRGECF 384 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~~~ 384 (589)
.+.|+.|....+|+....+ +..+++|+..... ....+..|..++..+...++ .++++.+ . + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~--~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIF--S--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEE--T--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEe--C--C--C
Confidence 3567888889999998753 5789999884321 11345678888887743333 5666655 2 1 3
Q ss_pred EEEEeCCCCCh
Q 007788 385 LIYDFAPKGKL 395 (589)
Q Consensus 385 lv~Ey~~~gsL 395 (589)
+|+||+++.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0033 Score=64.02 Aligned_cols=142 Identities=13% Similarity=0.137 Sum_probs=80.4
Q ss_pred cccccCCCccEEEEEec--------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEE
Q 007788 315 NLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l 385 (589)
+.|..|-...+|+.... +++.+++|+..... .....+.+|.++++.+. +.-..++++++ .+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----cc
Confidence 45777888899999875 24789999864321 22345668888887774 32235666655 32 28
Q ss_pred EEEeCCCCChHHH-----------------hhhhcC-CCCCCC--HHHHHHHHHHHHH-------------------HhH
Q 007788 386 IYDFAPKGKLSKY-----------------LDQEEG-SSNVLD--WSTRVSIIIGIAK-------------------GIG 426 (589)
Q Consensus 386 v~Ey~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia~-------------------~L~ 426 (589)
||||++|.+|..- ||.... ...... |.+..++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998655311 111111 011222 3333334433211 122
Q ss_pred ----HhcCCCCCCCCeEecCCCCCCeeecCC----CceEEccccccc
Q 007788 427 ----YLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLIADCGLHK 465 (589)
Q Consensus 427 ----~LH~~~~~~~~ivH~dlk~~Nill~~~----~~~kl~DfGla~ 465 (589)
+|.... ....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 208 ~L~~~L~~~~-~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTP-SPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSC-CCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcC-CCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 232222 23468999999999999876 789999998765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.00059 Score=62.38 Aligned_cols=87 Identities=9% Similarity=0.078 Sum_probs=63.3
Q ss_pred hcccceEEEccCc-cccc----CCCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCccccCC----C
Q 007788 38 ILLCFVVLQLCCN-QLTG----NIPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGT----I 104 (589)
Q Consensus 38 ~l~~l~~L~L~~n-~l~g----~~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~----~ 104 (589)
.-+.|+.|+|++| ++.. .+-..+..-+.|+.|+|++|+|... |-..+..-+.|+.|+|++|+|+.. +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3567999999986 7652 1345567778999999999999842 333344457899999999999843 2
Q ss_pred hhhhhcCCCCceeeccCCcC
Q 007788 105 PESLANNAELLFLDVQNNTL 124 (589)
Q Consensus 105 p~~~~~l~~L~~l~l~~N~l 124 (589)
-..+...+.|+.|+|++|..
T Consensus 119 a~aL~~N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQ 138 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSS
T ss_pred HHHHhhCCceeEEECCCCcC
Confidence 33466677899999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.018 Score=57.71 Aligned_cols=32 Identities=22% Similarity=0.281 Sum_probs=27.7
Q ss_pred CCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 435 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 435 ~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45699999999999999888899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0059 Score=62.04 Aligned_cols=73 Identities=14% Similarity=0.086 Sum_probs=42.1
Q ss_pred cccccCCCccEEEEEecC---------CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCC-ccceeeeeecCCCCeEE
Q 007788 315 NLLGKGNFSSVYKGTLRD---------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRGRGECF 384 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~~~ 384 (589)
..|+.|....+|+....+ +..+++|+...... ...+...|.+++..+...+ ..++++.. . + +
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~--~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G--G 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--E
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--C--C--c
Confidence 457788888999998754 26788888754321 1112346677776664323 34565543 2 2 6
Q ss_pred EEEEeCCCCCh
Q 007788 385 LIYDFAPKGKL 395 (589)
Q Consensus 385 lv~Ey~~~gsL 395 (589)
+||||+++..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0046 Score=63.64 Aligned_cols=95 Identities=11% Similarity=0.029 Sum_probs=75.2
Q ss_pred hhcccceEEEccCcccc-----cCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcC
Q 007788 37 VILLCFVVLQLCCNQLT-----GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN 111 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~-----g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l 111 (589)
..|++|+.|+|.+|.+. ..-+..|.+|++|+.++|. |.++-.-..+|.+|++|+.++|.+| ++..-+.+|.++
T Consensus 268 ~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~ 345 (401)
T 4fdw_A 268 YYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT 345 (401)
T ss_dssp TTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred hCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence 34999999999998775 2345689999999999999 4587455668999999999999765 664445678889
Q ss_pred CCCceeeccCCcCcccCchhHhh
Q 007788 112 AELLFLDVQNNTLSGIVPSALKR 134 (589)
Q Consensus 112 ~~L~~l~l~~N~l~g~~p~~~~~ 134 (589)
+|+.|++++|.+....+..+..
T Consensus 346 -~L~~l~l~~n~~~~l~~~~F~~ 367 (401)
T 4fdw_A 346 -GIKEVKVEGTTPPQVFEKVWYG 367 (401)
T ss_dssp -CCCEEEECCSSCCBCCCSSCCC
T ss_pred -CCCEEEEcCCCCcccccccccC
Confidence 9999999999887555444443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.025 Score=59.11 Aligned_cols=73 Identities=15% Similarity=0.038 Sum_probs=46.0
Q ss_pred cccccCCCccEEEEEecC-CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCc-cceeeeeecCCCCeEEEEEEeCCC
Q 007788 315 NLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-IRLRGFCCSRGRGECFLIYDFAPK 392 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~~~lv~Ey~~~ 392 (589)
+.|+.|-...+|+....+ +..+++|+....... . .+-..|..++..+...++ .++++++ . + ..||||+++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~-idR~~E~~vl~~L~~~gl~P~ll~~~--~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-I-INREREKKISCILYNKNIAKKIYVFF--T--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-C-SCHHHHHHHHHHHTTSSSBCCEEEEE--T--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-h-cCHHHHHHHHHHHHhcCCCCCEEEEe--C--C--eEEEEeeCC
Confidence 567888889999999875 578889987543211 1 112467778887764444 4666665 2 2 259999987
Q ss_pred CCh
Q 007788 393 GKL 395 (589)
Q Consensus 393 gsL 395 (589)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0016 Score=59.46 Aligned_cols=87 Identities=15% Similarity=0.126 Sum_probs=64.6
Q ss_pred cccceEEEccCcccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCc---cccC----C
Q 007788 39 LLCFVVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFN---SLFG----T 103 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N---~l~g----~ 103 (589)
-+.|+.|+|++|+|... +-+.+..-+.|+.|+|++|+|+.. |-.++..-+.|+.|+|++| .+.. .
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ 148 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 148 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence 46799999999999832 333455668999999999999842 3334555577999999875 3332 2
Q ss_pred ChhhhhcCCCCceeeccCCcCc
Q 007788 104 IPESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 104 ~p~~~~~l~~L~~l~l~~N~l~ 125 (589)
+...+...+.|+.|+++.|...
T Consensus 149 ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 149 MMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhCCCcCeEeccCCCcc
Confidence 4566778899999999988764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.61 E-value=0.039 Score=56.43 Aligned_cols=79 Identities=11% Similarity=0.025 Sum_probs=42.9
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++-.=..+|.+|++|+.+.+..| ++-.-..+|.++.+|+.++
T Consensus 296 ~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp CTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred cccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 556666666544 44222345666666666666533 44222345666666666666555 4422234566666666666
Q ss_pred cc
Q 007788 119 VQ 120 (589)
Q Consensus 119 l~ 120 (589)
+.
T Consensus 373 lp 374 (394)
T 4fs7_A 373 LP 374 (394)
T ss_dssp EE
T ss_pred EC
Confidence 54
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=93.90 E-value=0.027 Score=50.33 Aligned_cols=62 Identities=10% Similarity=0.089 Sum_probs=46.5
Q ss_pred CCCCeEeccCCcCCccCCccccCCCCCCeeeccCcc-ccCCChhhhhcC----CCCceeeccCCc-Cc
Q 007788 64 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS-LFGTIPESLANN----AELLFLDVQNNT-LS 125 (589)
Q Consensus 64 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~ 125 (589)
.+|+.|||+++.++..==..+.+|++|+.|+|+++. ++..==..+..+ ++|+.|+|+++. ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 579999999999875433457889999999999985 664322345554 379999999974 65
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.15 Score=52.04 Aligned_cols=79 Identities=9% Similarity=0.092 Sum_probs=36.1
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+..|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-..+|.+|.+|+.++|..| ++-.-..+|.++.+|+.+.
T Consensus 264 c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 264 CAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA 340 (394)
T ss_dssp CSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred cccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence 555555555544322 223345555555555553 3333222234555555555555433 3311123455555555555
Q ss_pred cc
Q 007788 119 VQ 120 (589)
Q Consensus 119 l~ 120 (589)
+.
T Consensus 341 ip 342 (394)
T 4gt6_A 341 IP 342 (394)
T ss_dssp EC
T ss_pred EC
Confidence 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.40 E-value=0.18 Score=51.89 Aligned_cols=74 Identities=12% Similarity=-0.015 Sum_probs=46.1
Q ss_pred ccccccCCCccEEEEEecC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEE
Q 007788 314 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 384 (589)
.+.+..|-...+|+....+ +..+++|+....... ..+-.+|.++++.+. +.-..++++.+ . + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADF--P--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--C--C
Confidence 3457778888999998763 578999987543211 112245666666663 22244555543 2 2 6
Q ss_pred EEEEeCCCCCh
Q 007788 385 LIYDFAPKGKL 395 (589)
Q Consensus 385 lv~Ey~~~gsL 395 (589)
.||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=93.09 E-value=0.14 Score=51.82 Aligned_cols=83 Identities=8% Similarity=0.011 Sum_probs=51.0
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+..|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++-.-..+|.+|++|+.+.+.+|.++-.-...|.++.+|+.+
T Consensus 238 ~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i 315 (379)
T 4h09_A 238 GMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSV 315 (379)
T ss_dssp TCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEE
T ss_pred CCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEE
Confidence 3667777777655 54233446677777777777543 442333456777777777777776663333466677777777
Q ss_pred eccCC
Q 007788 118 DVQNN 122 (589)
Q Consensus 118 ~l~~N 122 (589)
+|.+|
T Consensus 316 ~lp~~ 320 (379)
T 4h09_A 316 TLPTA 320 (379)
T ss_dssp ECCTT
T ss_pred EcCcc
Confidence 77543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.98 E-value=0.099 Score=53.37 Aligned_cols=86 Identities=9% Similarity=0.137 Sum_probs=66.5
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+.+|+.+.+. +.++..-...|.++++|+.++|..| ++-.-..+|.+|.+|+.+.|..+ ++-.-..+|.++.+|+.
T Consensus 285 ~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~ 361 (394)
T 4gt6_A 285 MNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNN 361 (394)
T ss_dssp TTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCE
T ss_pred ccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCE
Confidence 348899999996 4566343458999999999999865 66344568999999999999765 66233467999999999
Q ss_pred eeccCCcCc
Q 007788 117 LDVQNNTLS 125 (589)
Q Consensus 117 l~l~~N~l~ 125 (589)
+++.+|...
T Consensus 362 i~~~~~~~~ 370 (394)
T 4gt6_A 362 IEYSGSRSQ 370 (394)
T ss_dssp EEESSCHHH
T ss_pred EEECCceee
Confidence 999887643
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.31 E-value=0.35 Score=31.85 Aligned_cols=12 Identities=8% Similarity=0.346 Sum_probs=4.9
Q ss_pred chhhHHHHHHHH
Q 007788 210 VLAAVTSVTVIL 221 (589)
Q Consensus 210 iia~v~~~~v~l 221 (589)
+.+++++.++++
T Consensus 13 IA~gVVgGv~~~ 24 (44)
T 2ks1_B 13 IATGMVGALLLL 24 (44)
T ss_dssp STHHHHHHHHHH
T ss_pred EEeehhHHHHHH
Confidence 344444433333
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=90.93 E-value=0.2 Score=51.06 Aligned_cols=78 Identities=13% Similarity=0.073 Sum_probs=60.1
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
+..+.+|+.++|.++ ++-.-...|.++++|+.++|..| ++-.-..+|.+|++|+.+++..| ++ .+...|.++++|+
T Consensus 316 F~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~ 391 (394)
T 4fs7_A 316 FESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFK 391 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEE
T ss_pred hcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCc
Confidence 345899999999755 77333568999999999999877 77444568999999999999865 44 4556788887776
Q ss_pred ee
Q 007788 116 FL 117 (589)
Q Consensus 116 ~l 117 (589)
.+
T Consensus 392 ~I 393 (394)
T 4fs7_A 392 WI 393 (394)
T ss_dssp EE
T ss_pred EE
Confidence 54
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=90.83 E-value=0.34 Score=48.89 Aligned_cols=93 Identities=13% Similarity=0.058 Sum_probs=62.3
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++..-...|..+.+|+.++
T Consensus 216 ~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~ 292 (379)
T 4h09_A 216 GKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVV 292 (379)
T ss_dssp CSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEE
T ss_pred ccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccc
Confidence 667777777655 44244457788888888888765 55334556778888888888654 4423334677788888888
Q ss_pred ccCCcCcccCchhHhh
Q 007788 119 VQNNTLSGIVPSALKR 134 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~ 134 (589)
+.+|.++..-..+|..
T Consensus 293 l~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 293 MDNSAIETLEPRVFMD 308 (379)
T ss_dssp ECCTTCCEECTTTTTT
T ss_pred ccccccceehhhhhcC
Confidence 8888777444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.17 E-value=0.34 Score=31.85 Aligned_cols=12 Identities=33% Similarity=0.321 Sum_probs=4.8
Q ss_pred chhhHHHHHHHH
Q 007788 210 VLAAVTSVTVIL 221 (589)
Q Consensus 210 iia~v~~~~v~l 221 (589)
+.+++++.++++
T Consensus 12 IA~gVVgGv~~v 23 (44)
T 2l2t_A 12 IAAGVIGGLFIL 23 (44)
T ss_dssp HHHHHHHHHHHH
T ss_pred EEEeehHHHHHH
Confidence 334444433333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.67 E-value=0.5 Score=30.96 Aligned_cols=7 Identities=29% Similarity=0.434 Sum_probs=2.6
Q ss_pred hhhhhhh
Q 007788 229 FFRYRRH 235 (589)
Q Consensus 229 ~~~~rr~ 235 (589)
++.+||+
T Consensus 33 ~~~RRR~ 39 (44)
T 2jwa_A 33 ILIKRRQ 39 (44)
T ss_dssp HHHHHHC
T ss_pred hheehhh
Confidence 3333333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.51 E-value=0.089 Score=53.95 Aligned_cols=29 Identities=10% Similarity=0.273 Sum_probs=24.4
Q ss_pred eEecCCCCCCeee------cCCCceEEcccccccc
Q 007788 438 IVHRNLSVEKVLI------DQQFNPLIADCGLHKL 466 (589)
Q Consensus 438 ivH~dlk~~Nill------~~~~~~kl~DfGla~~ 466 (589)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999987754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.85 E-value=4.1 Score=37.22 Aligned_cols=119 Identities=9% Similarity=0.152 Sum_probs=78.8
Q ss_pred cCCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecC
Q 007788 363 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 442 (589)
Q Consensus 363 l~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~d 442 (589)
..||+.+.. .+- .+.+.+.+.|+.- .+...|-.-. .++...+++++..|+..-+++++. +|--
T Consensus 42 ~~~~~Fl~~-~I~--e~eD~v~~~y~~~--~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~r-------~tf~ 104 (215)
T 4ann_A 42 QHSPYFIDA-ELT--ELRDSFQIHYDIN--DNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRTR-------YTFV 104 (215)
T ss_dssp SCCTTBCCE-EEE--ECSSEEEEEECCC--TTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGSS-------EECC
T ss_pred ccCCcccce-EEE--EcccEEEEEEEcC--cccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcCc-------eEEE
Confidence 368888865 233 2334555545443 3333332211 277889999999999988777653 7888
Q ss_pred CCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 443 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 443 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
|.|+|++++.++.+++.-.|+...+ +|. ..++..=.-.+=+++..+++++..|...
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred EecceEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999999999887764322 222 1222333445788899999998888543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.26 E-value=0.14 Score=53.46 Aligned_cols=60 Identities=10% Similarity=0.120 Sum_probs=16.9
Q ss_pred ccccccCCCccEEEEEecC-CcEEEE------EEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeee
Q 007788 314 VNLLGKGNFSSVYKGTLRD-GTLVAI------RSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~-~~~vav------K~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 376 (589)
.+.|| ||.||+|.+.. ...||| |..+.... ......|.+|..++.+.+|||+++.++|..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34565 99999999864 467888 76654322 233356888999999999999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.11 E-value=4.9 Score=36.85 Aligned_cols=117 Identities=9% Similarity=0.109 Sum_probs=77.4
Q ss_pred CCCCccceeeeeecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhH-HhcCCCCCCCCeEecC
Q 007788 364 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG-YLHSSEVNKPAIVHRN 442 (589)
Q Consensus 364 ~H~niv~l~g~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~~~ivH~d 442 (589)
.||+. .. .+- .+.+.+.+.|+.-+++.=...+. .++...|++++..|+.... +++. -+|--
T Consensus 48 ~~~~f-~~-~I~--~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-------r~tf~ 109 (219)
T 4ano_A 48 VDPCI-VR-DID--VSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-------RLIFI 109 (219)
T ss_dssp SCSSS-EE-EEE--ECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-------SEECC
T ss_pred cCCCC-Ce-EEE--EeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-------ceeEE
Confidence 67777 22 222 33466666666554432233332 2778899999999998877 6665 37888
Q ss_pred CCCCCeeecCCCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchh
Q 007788 443 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 521 (589)
Q Consensus 443 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~ 521 (589)
|.|+|+++|.++.+++.-.|+-.. ++|.- .++.-=.-.+=+++..++.++..|...
T Consensus 110 l~P~NL~f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 110 VCPENLMFNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp CCGGGEEECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred EeCceEEEeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 999999999999999998876432 23321 122222445778888889888877544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 589 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.002 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-53
Identities = 62/266 (23%), Positives = 120/266 (45%), Gaps = 16/266 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
V LG G F V+ G T VA++S+ S + F+ L+ L+H+ ++R
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVR 72
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L ++I ++ G L +L G L + + + IA+G+ ++
Sbjct: 73 LYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE 127
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
+HR+L +L+ + IAD GL +L+ D+ + + + APE +
Sbjct: 128 -----RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
G FT +SD+++FG+++ +I+T + M +N ++R + ++ +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRMVRPDNCPEE 238
Query: 551 LGKMALVCTHEDPENRPTMEAVIEEL 576
L ++ +C E PE+RPT + + L
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 51/271 (18%), Positives = 112/271 (41%), Gaps = 18/271 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENII 369
+ +G G+F +VYKG VA++ +NVT+ ++ F + +L RH NI+
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
G+ + + ++ + L +L E + + I A+G+ YLH
Sbjct: 68 LFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH 121
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPE 488
+I+HR+L + + + I D GL + + + + ++ ++APE
Sbjct: 122 -----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 489 YVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545
+ ++ +SD++AFG+++ +++TG L ++ K
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + ++ C + + RP ++ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-51
Identities = 56/266 (21%), Positives = 121/266 (45%), Gaps = 16/266 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
+ V +G G F V+ G + VAI++I E +F++ ++ L H +++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L G C + L+++F G LS YL + + T + + + + +G+ YL
Sbjct: 65 LYGVCLEQA--PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE- 118
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
+ ++HR+L+ L+ + ++D G+ + + DD S T + + +PE
Sbjct: 119 ----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
+ R++ +SD+++FGV++ ++ + + + S E+ I + +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVED-ISTGFRLYKPRLASTH 230
Query: 551 LGKMALVCTHEDPENRPTMEAVIEEL 576
+ ++ C E PE+RP ++ +L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-50
Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 16/278 (5%)
Query: 299 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLY 358
L + E + LG+G F V+ GT T VAI+++ + E F++
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQ 64
Query: 359 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 418
++ LRHE +++L +++ ++ KG L +L E G V +
Sbjct: 65 VMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMA 119
Query: 419 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 478
IA G+ Y+ + VHR+L +L+ + +AD GL +L+ D+ +
Sbjct: 120 AQIASGMAYVE-----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
Query: 479 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538
+ + APE GRFT +SD+++FG+++ ++ T V M + + ++R
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERG 230
Query: 539 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ L + C ++PE RPT E + L
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 6e-50
Identities = 58/280 (20%), Positives = 125/280 (44%), Gaps = 16/280 (5%)
Query: 298 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG 356
N ++ E + + LG G + VY+G + VA++++ + + EE F+K
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKE 63
Query: 357 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 416
++ ++H N+++L G C ++I +F G L YL E + + +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLY 119
Query: 417 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 476
+ I+ + YL +HR+L+ L+ + +AD GL +L+ D +
Sbjct: 120 MATQISSAMEYLEK-----KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 477 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536
+ + APE + +F+ +SD++AFGV++ +I T + + L + ++
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLE 230
Query: 537 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
++ + + E K+ ++ C +P +RP+ + +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 8e-50
Identities = 60/266 (22%), Positives = 116/266 (43%), Gaps = 16/266 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
+ + LG G F V G R VAI+ I S E EF++ ++ +L HE +++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L G C + F+I ++ G L YL + + + + + + YL
Sbjct: 64 LYGVCTKQR--PIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE- 117
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
+HR+L+ L++ Q ++D GL + + DD S + + + + PE +
Sbjct: 118 ----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
+F+ +SDI+AFGV++ +I + + ++ I + L+ + K
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAEHIAQGLRLYRPHLASEK 229
Query: 551 LGKMALVCTHEDPENRPTMEAVIEEL 576
+ + C HE + RPT + ++ +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-49
Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 21/279 (7%)
Query: 305 ESATQCFSEVNLLGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYL 359
E C + ++G G F VYKG L+ + VAI+++ + + +F+ +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 360 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 419
+ H NIIRL G +I ++ G L K+L +++G V ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLR 117
Query: 420 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 479
GIA G+ YL + VHR+L+ +L++ ++D GL ++L DD + +
Sbjct: 118 GIAAGMKYLAN-----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 480 AA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537
+ + APE ++ +FT SD+++FG+++ +++T + I+
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG----ERPYWELSNHEVMKAIND 228
Query: 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + ++ + C ++ RP ++ L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-48
Identities = 50/273 (18%), Positives = 115/273 (42%), Gaps = 22/273 (8%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 368
+ + +G G++ K + DG ++ + ++ S ++E+ V + LL L+H NI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+R R +++ ++ G L+ + + LD + ++ + +
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLA 486
H ++HR+L V +D + N + D GL ++L D F + + T Y++
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT---PYYMS 182
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE- 545
PE + + E+SDI++ G ++ ++ + + + + +GKF
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCAL--------MPPFTAFSQKELAGKIREGKFRRI 234
Query: 546 ----SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
S+ ++ + +RP++E ++E
Sbjct: 235 PYRYSDELN--EIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-48
Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 317 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 373
LG GNF SV +G R VAI+ + + K++ E ++ ++ L + I+RL G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 433
C + L+ + A G L K+L + + S ++ ++ G+ YL
Sbjct: 77 VCQAEAL---MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLE---- 126
Query: 434 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYVT 491
+ VHR+L+ VL+ + I+D GL K L D + +++ + + APE +
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 492 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551
+F+ RSD++++GV + + L+ M + FI++ + + +L
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIEQGKRMECPPECPPEL 241
Query: 552 GKMALVCTHEDPENRPTMEAVIEEL 576
+ C E+RP V + +
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (424), Expect = 4e-48
Identities = 61/293 (20%), Positives = 121/293 (41%), Gaps = 31/293 (10%)
Query: 301 LEEVESATQCFSE---------VNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCK 347
E+ A + F++ ++G G F V G L+ VAI+++ +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 348 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 407
+ +F+ ++ H N+I L G +I +F G L +L Q +G
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 408 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467
V ++ GIA G+ YL VHR+L+ +L++ ++D GL + L
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA-----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 468 ADDIVFSVLKTSAAM----GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523
DD ++ + APE + +FT SD++++G+++ ++++ M
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM- 237
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ N I+++ + + L ++ L C +D +RP ++ L
Sbjct: 238 ---TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 6e-47
Identities = 66/302 (21%), Positives = 136/302 (45%), Gaps = 22/302 (7%)
Query: 283 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAI 338
+++ + + E + + + + S F+EV +G+G+F VY GTL D A+
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 339 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 398
+S+N + E ++F+ ++ H N++ L G C R G ++ + G L +
Sbjct: 61 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 399 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458
+ E + + + +AKG+ +L VHR+L+ ++D++F +
Sbjct: 120 IRNETHN---PTVKDLIGFGLQVAKGMKFLA-----SKKFVHRDLAARNCMLDEKFTVKV 171
Query: 459 ADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGS 515
AD GL + + D SV + A ++A E + T +FT +SD+++FGV++ +++T
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 516 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575
+ ++ + + E L ++ L C H E RP+ ++
Sbjct: 232 APPYPDVNTFD----ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 576 LT 577
++
Sbjct: 288 IS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-46
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 33/290 (11%)
Query: 293 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSE 349
+L+ L LE+ LG GNF +V KG + VA++ + +
Sbjct: 2 YLDRKLLTLED-----------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 50
Query: 350 -EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV 408
+ E + ++ L + I+R+ G C L+ + A G L+KYL Q
Sbjct: 51 LKDELLAEANVMQQLDNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRH---- 103
Query: 409 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468
+ + ++ ++ G+ YL S VHR+L+ VL+ Q I+D GL K L
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 469 DDIVFSVLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 526
D + +T + + APE + +F+ +SD+++FGV++ + + M
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---- 214
Query: 527 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + +++ + ++ + +C D ENRP AV L
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-46
Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 20/266 (7%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 370
+ +GKG F V G R G VA++ I + F+ ++T LRH N+++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 371 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 430
L G +G +++ ++ KG L YL S VL + + + + + YL
Sbjct: 65 LLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEG 121
Query: 431 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
VHR+L+ VL+ + ++D GL K + + + APE +
Sbjct: 122 -----NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEAL 172
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
+F+ +SD+++FG+++ +I + V + L +++ K +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA 228
Query: 551 LGKMALVCTHEDPENRPTMEAVIEEL 576
+ ++ C H D RP+ + E+L
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-46
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 37/293 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL- 363
+LG G F V T VA++ + + SE + L ++T L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 364 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-------------------DQEEG 404
HENI+ L G C G +LI+++ G L YL +EE
Sbjct: 99 SHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 405 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464
NVL + + +AKG+ +L + VHR+L+ VL+ I D GL
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-----KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 465 KLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523
+ + D + V + + ++APE + G +T +SD++++G+++ +I + + +
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
A F I K ++ + C D RP+ + L
Sbjct: 272 ---VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-45
Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 38/291 (13%)
Query: 317 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 376
+GKG F V++G R G VA++ + +S E +Y LRHENI+
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 67
Query: 377 SRGRG--ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 434
+ +L+ D+ G L YL++ + + + + A G+ +LH V
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 435 ---KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 488
KPAI HR+L + +L+ + IAD GL + + +G Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 489 YVTT------GRFTERSDIFAFGVIILQILTGS---------------LVLTSSMRLAAE 527
+ +R+DI+A G++ +I LV +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 528 SATFENFIDRNLKGKFSESEAAK-LGKMALVCTHEDPENRPTMEAVIEELT 577
E + N+ ++ EA + + K+ C + + R T + + L+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 2e-45
Identities = 61/303 (20%), Positives = 120/303 (39%), Gaps = 38/303 (12%)
Query: 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFV 354
L +E V +G+G F V++ T+VA++ + + +A+F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 355 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN------- 407
+ L+ + NI++L G C L++++ G L+++L +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 408 -------------VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454
L + ++ I +A G+ YL VHR+L+ L+ +
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-----RKFVHRDLATRNCLVGENM 177
Query: 455 NPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 513
IAD GL + + + A + ++ PE + R+T SD++A+GV++ +I +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 514 GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 573
L M A D N+ E+ +L + +C + P +RP+ ++
Sbjct: 238 YGLQPYYGM---AHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 574 EEL 576
L
Sbjct: 294 RIL 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-45
Identities = 61/288 (21%), Positives = 116/288 (40%), Gaps = 32/288 (11%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL- 363
S LG G F V + T VA++ + ++ +E + L +L+ L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 364 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--------------EGSSNVL 409
H NI+ L G C G +I ++ G L +L ++ E L
Sbjct: 85 NHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 410 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469
D +S +AKG+ +L S +HR+L+ +L+ I D GL + + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-----KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 470 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528
D + V + + ++APE + +T SD++++G+ + ++ + M
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---VD 254
Query: 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ F I + E A++ + C DP RPT + +++ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
F +++ LG GN V+K + + G ++A + I++ + + ++ L +L I+
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
G S G E + + G L + L + + + I + KG+ YL
Sbjct: 68 GFYGAFYSDG--EISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLR 121
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
K I+HR++ +L++ + + D G+ L D + S + T Y++PE
Sbjct: 122 E----KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT---RSYMSPER 174
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSL 516
+ ++ +SDI++ G+ ++++ G
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-44
Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 19/263 (7%)
Query: 317 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+G+G+F +VYKG + VA + KSE F + +L L+H NI+R
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 375 C--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
+G+ L+ + G L YL + V+ S I KG+ +LH+
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT-- 130
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 491
P I+HR+L + + I + I D GL L +V+ T ++APE
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT---PEFMAPEMYE 186
Query: 492 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 551
++ E D++AFG+ +L++ T + + + F + ++
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 552 GKMALVCTHEDPENRPTMEAVIE 574
++ C ++ + R +++ ++
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-44
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 22/275 (8%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLR 364
+ LG G+F V +G VA++ + EA +F++ + + SL
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
H N+IRL G + ++ + AP G L L + +G T + +A+G
Sbjct: 70 HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEG 123
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--M 482
+GYL S +HR+L+ +L+ + I D GL + L + V++
Sbjct: 124 MGYLES-----KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 483 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542
+ APE + T F+ SD + FGV + ++ T + S +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLP 235
Query: 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577
E + + + C PE+RPT A+ + L
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-44
Identities = 60/282 (21%), Positives = 122/282 (43%), Gaps = 29/282 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 366
+++G+GNF V K ++ L AI+ + + K + +F L +L L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE------------EGSSNVLDWSTR 414
NII L G C RG +L ++AP G L +L + +++ L
Sbjct: 72 NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 415 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 474
+ +A+G+ YL +HR+L+ +L+ + + IAD GL + + +
Sbjct: 130 LHFAADVARGMDYLSQ-----KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 475 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534
+ + + ++A E + +T SD++++GV++ +I++ M A +E
Sbjct: 185 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK- 238
Query: 535 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + + + ++ + C E P RP+ ++ L
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 59/272 (21%), Positives = 114/272 (41%), Gaps = 21/272 (7%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 365
F ++ +LG G F +VYKG VAI+ + + E + Y++ S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
++ RL G C + LI P G L LD + + ++ + IAKG+
Sbjct: 71 PHVCRLLGICLT---STVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGY 484
YL +VHR+L+ VL+ + I D GL KLL + + + +
Sbjct: 125 NYLE-----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
+A E + +T +SD++++GV + +++T + + + +++ +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQP 235
Query: 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + C D ++RP +I E
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-42
Identities = 61/271 (22%), Positives = 114/271 (42%), Gaps = 31/271 (11%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHEN 367
F LGKG F +VY + ++A++ + + E + + + + LRH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
I+RL G+ R +LI ++AP G + + L + + D + I +A + Y
Sbjct: 68 ILRLYGYFHDATR--VYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSY 121
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
HS ++HR++ E +L+ IAD G ++ T + YL P
Sbjct: 122 CHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT---LDYLPP 173
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE-- 545
E + E+ D+++ GV+ + L G + E+ T++ R + +F+
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPD 225
Query: 546 --SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+E A+ + +P RP + V+E
Sbjct: 226 FVTEGAR--DLISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 4e-42
Identities = 55/273 (20%), Positives = 117/273 (42%), Gaps = 26/273 (9%)
Query: 308 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLR 364
+ FS++ +G G+F +VY +R+ +VAI+ ++ + +S E + +K + L LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
H N I+ RG +L+ ++ ++ L ++ G +G
Sbjct: 74 HPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQG 127
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 484
+ YLHS ++HR++ +L+ + + D G ++A F +
Sbjct: 128 LAYLHSH-----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYW 177
Query: 485 LAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541
+APE + G++ + D+++ G+ +++ L + ++A +N G
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+SE C + P++RPT E +++
Sbjct: 238 HWSE-YFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-41
Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 19/268 (7%)
Query: 314 VNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+G+G F V++G VAI++ + S +F++ + H +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+L G ++I + G+L +L + S LD ++ + ++ + YL
Sbjct: 72 KLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE 125
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
S VHR+++ VL+ + D GL + + D + K + ++APE
Sbjct: 126 S-----KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549
+ RFT SD++ FGV + +IL + ++ I+ + +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNCPP 236
Query: 550 KLGKMALVCTHEDPENRPTMEAVIEELT 577
L + C DP RP + +L+
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-40
Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 17/267 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ V LG+G + V R VA++ +++ K + + L HEN++
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+ G R +L ++ G+L ++ + G + + G+ YLH
Sbjct: 67 KFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLAPE 488
I HR++ E +L+D++ N I+D GL + + +L + Y+APE
Sbjct: 121 G-----IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 489 YVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
+ F E D+++ G+++ +L G L E + ++ K +S
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 548 AAKLGKMALVCTHEDPENRPTMEAVIE 574
L E+P R T+ + +
Sbjct: 236 PLALLHK---ILVENPSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 58/285 (20%), Positives = 116/285 (40%), Gaps = 27/285 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 364
LG+G F V + VA++ + + SE + L +L +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWS 412
H + C++ G +I +F G LS YL E+ + L
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 413 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 472
+ +AKG+ +L S + +HR+L+ +L+ ++ I D GL + + D
Sbjct: 135 HLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 473 FSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 531
+ + + ++APE + +T +SD+++FGV++ +I + +++ E F
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F 246
Query: 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + + ++ + L C H +P RPT ++E L
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-40
Identities = 60/291 (20%), Positives = 123/291 (42%), Gaps = 30/291 (10%)
Query: 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVK 355
+E E A + + LG+G+F VY+G + T VAI+++N + E EF+
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 356 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVL 409
++ +++RL G +I + +G L YL
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 410 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469
S + + IA G+ YL++++ VHR+L+ ++ + F I D G+ + + +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185
Query: 470 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528
+ + +++PE + G FT SD+++FGV++ +I T +
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL-------AEQPYQG 238
Query: 529 ATFENFIDRNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ E + ++G ++ L ++ +C +P+ RP+ +I +
Sbjct: 239 LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-38
Identities = 47/270 (17%), Positives = 102/270 (37%), Gaps = 27/270 (10%)
Query: 314 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+ LG G F VYK ++ L A + I+ S + E +++ + +L S H NI++L
Sbjct: 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLL 75
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
+++ +F G + + + E L S + + YLH +
Sbjct: 76 DAFYYENN--LWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDN- 129
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 489
I+HR+L +L + +AD G+ I + + +G ++APE
Sbjct: 130 ----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----RRDSFIGTPYWMAPEV 181
Query: 490 V-----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
V + ++D+++ G+ ++++ + ++ +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241
Query: 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
S K C ++ + R T +++
Sbjct: 242 SSNFKDFLKK---CLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 62/288 (21%), Positives = 117/288 (40%), Gaps = 33/288 (11%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 362
LG+G F V T VA++ + + + + ++ + + ++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 363 L-RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVL 409
+ +H+NII L G C G ++I ++A KG L +YL + L
Sbjct: 75 IGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 410 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469
VS +A+G+ YL S +HR+L+ VL+ + IAD GL + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS-----KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 470 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 528
+ + ++APE + +T +SD+++FGV++ +I T + +
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245
Query: 529 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
+ + + +L M C H P RPT + ++E+L
Sbjct: 246 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 41/265 (15%), Positives = 103/265 (38%), Gaps = 18/265 (6%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
++ +G+G +VY + G VAIR +N+ +E + + ++ ++ NI+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIV 80
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
E +++ ++ G L+ + + +D ++ + + +LH
Sbjct: 81 NYLDSYLVGD--ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH 133
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
S+ ++HR++ + +L+ + + D G + + ++APE
Sbjct: 134 SN-----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEV 187
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549
VT + + DI++ G++ ++++ G + L A N + +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 550 KLGKMALVCTHEDPENRPTMEAVIE 574
C D E R + + +++
Sbjct: 248 DFLNR---CLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (349), Expect = 6e-37
Identities = 52/268 (19%), Positives = 99/268 (36%), Gaps = 26/268 (9%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
LG G F V++ T G A + + +E K + ++ LRH ++ L
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLH 89
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
E +IY+F G+L + + E + V + + KG+ ++H +
Sbjct: 90 DAFEDDN--EMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENN 144
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
VH +L E ++ + + + D GL L SV T+ + APE
Sbjct: 145 -----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVA 197
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
+D+++ GV+ +L+G + T N ++ +S +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNV--KSCDWNMDDSAFSG 251
Query: 551 LGKMA--LV--CTHEDPENRPTMEAVIE 574
+ + + DP R T+ +E
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 21/264 (7%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 367
F +LG+G+FS+V L AI+ + E + +++ L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
++L + + + +A G+L KY+ + D + I + Y
Sbjct: 70 FVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEY 123
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GYLA 486
LH I+HR+L E +L+++ + I D G K+L+ + + + Y++
Sbjct: 124 LHG-----KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 487 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546
PE +T + SD++A G II Q++ G + E F+ I L+ F E
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKII--KLEYDFPEK 232
Query: 547 EAAKLGKMALVCTHEDPENRPTME 570
K + D R E
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCE 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (341), Expect = 8e-36
Identities = 50/269 (18%), Positives = 100/269 (37%), Gaps = 22/269 (8%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+ + LG G F V++ G + + IN ++ + ++ L H +I
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLI 89
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
L + LI +F G+L + E+ + + ++ + +G+ ++H
Sbjct: 90 NLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH 144
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
+IVH ++ E ++ + + + D GL L D + V +A + AP
Sbjct: 145 EH-----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAP 197
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
E V +D++A GV+ +L+G L + + S S
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 548 AAKLGKMALV--CTHEDPENRPTMEAVIE 574
AK + ++P R T+ +E
Sbjct: 258 EAK----DFIKNLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 133 bits (335), Expect = 8e-36
Identities = 48/276 (17%), Positives = 100/276 (36%), Gaps = 23/276 (8%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 367
+ +LG G S V+ LR VA++ + + F + +L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 368 IIRLRGFCCSRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
I+ + + +++ ++ L + E + + +I + +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQAL 124
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MG 483
+ H + I+HR++ ++I + D G+ + +AD +
Sbjct: 125 NFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENFIDRNLKG 541
YL+PE RSD+++ G ++ ++LTG T S + +A + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 542 KFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEEL 576
S L + L ++PENR T + +L
Sbjct: 240 GLSAD----LDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (331), Expect = 6e-35
Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 19/277 (6%)
Query: 302 EEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 360
++ E + ++LG G FS V R LVAI+ I + + +E + +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
++H NI+ L S G +LI G+L + ++ +I
Sbjct: 62 HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 115
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLK 477
+ + YLH IVHR+L E +L D+ +I+D GL K+ V S
Sbjct: 116 VLDAVKYLH-----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170
Query: 478 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537
+ GY+APE + +++ D ++ GVI +L G + +
Sbjct: 171 GTP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228
Query: 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ S++AK +DPE R T E ++
Sbjct: 229 DSPYWDDISDSAK--DFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-33
Identities = 49/268 (18%), Positives = 103/268 (38%), Gaps = 27/268 (10%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
LG+G F V++ + + V +++ K + +L RH NI+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLH 67
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
S E +I++F + + ++ L+ VS + + + + +LHS
Sbjct: 68 ESFESME--ELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHSHN 122
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPL--IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 490
I H ++ E ++ + + I + G + L F +L T+ Y APE
Sbjct: 123 -----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA--PEYYAPEVH 175
Query: 491 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 550
+ +D+++ G ++ +L+G + EN + N + F E +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIM--NAEYTFDEEAFKE 229
Query: 551 LGKMA--LV--CTHEDPENRPTMEAVIE 574
+ A V ++ ++R T ++
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 49/269 (18%), Positives = 96/269 (35%), Gaps = 26/269 (9%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 374
+LG G V + R A++ + E E + + +I+R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDV 73
Query: 375 C--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
GR ++ + G+L + ++ I+ I + I YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
I HR++ E +L + + D G K + + Y+APE
Sbjct: 132 -----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT--PYYVAPEV 184
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549
+ ++ + D+++ GVI+ +L G S+ LA R + +F E +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--RMGQYEFPNPEWS 242
Query: 550 KLGKMA--LV--CTHEDPENRPTMEAVIE 574
++ + L+ +P R T+ +
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (310), Expect = 1e-31
Identities = 50/274 (18%), Positives = 103/274 (37%), Gaps = 25/274 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE-----FVKGLYLLTSLR 364
FS ++G+G F VY D G + A++ ++ K ++ E L L+++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 365 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
I+ + + + I D G L +L Q + I G
Sbjct: 66 CPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 484
+ ++H+ +V+R+L +L+D+ + I+D GL + + + T GY
Sbjct: 120 LEHMHN-----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT---HGY 171
Query: 485 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 543
+APE + G + +D F+ G ++ ++L G + + + ++
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD 230
Query: 544 SESEAAKLGKMALVCTHEDPENRPT-MEAVIEEL 576
S S + + D R + +E+
Sbjct: 231 SFSPELR--SLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (303), Expect = 2e-31
Identities = 65/284 (22%), Positives = 107/284 (37%), Gaps = 39/284 (13%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY--------LLT 361
+ +LG+G S V + A++ I+VT S AE V+ L +L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 362 SLR-HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
+ H NII+L+ + FL++D KG+L YL ++ L I+
Sbjct: 65 KVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+ + I LH IVHR+L E +L+D N + D G L + +
Sbjct: 119 LLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT- 172
Query: 481 AMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 534
YLAPE + + + D+++ GVI+ +L GS +
Sbjct: 173 -PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQMLMLRMI 227
Query: 535 IDRNLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ N + E S+ K + P+ R T E +
Sbjct: 228 MSGNYQFGSPEWDDYSDTVK--DLVSRFLVVQPQKRYTAEEALA 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 54/294 (18%), Positives = 104/294 (35%), Gaps = 43/294 (14%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
+++ ++G G+F VY+ L D G LVAI+ + ++ + L ++ L H NI+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 370 RLRGFCCSRGRGE----CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
RLR F S G + L+ D+ P+ + + L + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGY 484
Y+HS I HR++ + +L+D L + D G K L + Y
Sbjct: 136 AYIHS-----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYY 188
Query: 485 LAP-EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS------MRLAAESATFENFIDR 537
AP +T D+++ G ++ ++L G + + + T R
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 538 NLKGKFSESEAAKLGKMALV-----------------CTHEDPENRPTMEAVIE 574
+ ++E + ++ P R T
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (295), Expect = 4e-30
Identities = 44/279 (15%), Positives = 87/279 (31%), Gaps = 33/279 (11%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+G G+F +Y GT + G VAI+ V K++ + + ++ I
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
+C + G ++ + D S T + + + I Y+HS
Sbjct: 69 RWCGAEG-DYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK- 122
Query: 433 VNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVL---KTSAAMG--- 483
+HR++ + L+ + I D GL K D + + G
Sbjct: 123 ----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 484 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL------TSSMRLAAESATFENFIDR 537
Y + + R D+ + G +++ GSL T + S +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576
L + C +++P + +
Sbjct: 239 VLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 44/295 (14%), Positives = 99/295 (33%), Gaps = 34/295 (11%)
Query: 307 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAE----FVKGLYLL 360
A Q + V +G+G + V+K G VA++ + V + + V L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 361 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 420
+ H N++RL C + ++ + T ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 421 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 480
+ +G+ +LHS +VHR+L + +L+ +AD GL ++ + + + + +
Sbjct: 125 LLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT- 178
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-----------------SLVLTSSMR 523
+ Y APE + + D+++ G I ++ ++
Sbjct: 179 -LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALV----CTHEDPENRPTMEAVIE 574
+ + E + ++ C +P R + + +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 51/269 (18%), Positives = 92/269 (34%), Gaps = 35/269 (13%)
Query: 316 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-----AEFVKGLYLLTSLR--HEN 367
LLG G F SVY G + D VAI+ + + LL +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
+IRL + LI + + E G+ L S + + + +
Sbjct: 71 VIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 125
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLA 486
H+ ++HR++ E +LID L + D G LL D + T Y
Sbjct: 126 CHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT---RVYSP 177
Query: 487 PEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545
PE++ R+ + +++ G+++ ++ G + + F + +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ----- 232
Query: 546 SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ C P +RPT E +
Sbjct: 233 -------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (289), Expect = 2e-29
Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 35/288 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENII 369
+ + +G+G + VYK G A++ I + + ++ + +L L+H NI+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
+L ++ R ++ L K LD EG L+ T S ++ + GI Y H
Sbjct: 64 KLYDVIHTKKR---LVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH 117
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
++HR+L + +LI+++ IAD GL + + +
Sbjct: 118 D-----RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 490 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 549
+ + +++ DI++ G I +++ G+ + F N K + +E
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 550 KLGKMALV-----------------------CTHEDPENRPTMEAVIE 574
K V DP R T + +E
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 3e-29
Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 26/269 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE---EAEFVKGLYLLTSLRHE 366
F +LGKG+F V+ + AI+++ + E V+ L + H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 367 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
+ + ++ F + ++ G L ++ D S I G+
Sbjct: 64 FLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAMGY 484
+LH IV+R+L ++ +L+D+ + IAD G+ K D + T Y
Sbjct: 118 FLH-----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT---PDY 169
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544
+APE + ++ D ++FGV++ ++L G E F + N
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMDNPFYPRW 225
Query: 545 ESEAAKLGKMALVCTHEDPENRPTMEAVI 573
+ AK + + +PE R + I
Sbjct: 226 LEKEAK--DLLVKLFVREPEKRLGVRGDI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 46/289 (15%), Positives = 103/289 (35%), Gaps = 35/289 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 368
F +V +G+G + VYK + G +VA++ I + + ++ + LL L H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
++L + + +L+++F + + S + + +G+ +
Sbjct: 64 VKLLDVIHTENK--LYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 488
HS ++HR+L + +LI+ + +AD GL + + +
Sbjct: 119 HS-----HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 489 YVTTGRFTERSDIFAFGVIILQILTGSL------------VLTSSMRLAAESATFENFID 536
+ ++ DI++ G I +++T + ++ E
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 537 RNLKGKFSESEAAKLGKMALVCTHE-----------DPENRPTMEAVIE 574
+ K F + K+ + DP R + +A +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 59/298 (19%), Positives = 111/298 (37%), Gaps = 38/298 (12%)
Query: 287 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTS 345
T F +E+++ + + LG G F+ V K G A + I
Sbjct: 1 TVFRQENVDDY-------------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRR 47
Query: 346 CKSEE-----AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 400
KS + + + +L ++H N+I L + + LI + G+L +L
Sbjct: 48 TKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLA 105
Query: 401 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--- 457
++E L + I G+ YLHS I H +L E +++ + P
Sbjct: 106 EKES----LTEEEATEFLKQILNGVYYLHS-----LQIAHFDLKPENIMLLDRNVPKPRI 156
Query: 458 -IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
I D GL + F + + ++APE V +D+++ GVI +L+G+
Sbjct: 157 KIIDFGLAHKIDFGNEFKNIFGT--PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214
Query: 517 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ + + + + S AK +DP+ R T++ ++
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 6e-28
Identities = 59/272 (21%), Positives = 106/272 (38%), Gaps = 29/272 (10%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 367
F + LG G+F V+ R +G A++ + + +L+ + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
IIR+ G + F+I D+ G+L L + S + + Y
Sbjct: 66 IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEY 119
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
LHS I++R+L E +L+D+ + I D G K + D Y+AP
Sbjct: 120 LHS-----KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAP 170
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
E V+T + + D ++FG++I ++L G S T+E ++ L+ +E
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRFPPFFNE 226
Query: 548 AAKLGKMALV--CTHEDPENRPT-MEAVIEEL 576
K L+ D R ++ E++
Sbjct: 227 DVK----DLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 44/210 (20%), Positives = 90/210 (42%), Gaps = 16/210 (7%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 369
++ ++ +G+G + V + VAI+ I+ ++ ++ + +L RHENII
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 370 RLRGFCCSRG--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
+ + + + + L K L + L + I +G+ Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKY 124
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYL 485
+HS+ ++HR+L +L++ + I D GL ++ D + T A Y
Sbjct: 125 IHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 486 APEYVTTGRFTERS-DIFAFGVIILQILTG 514
APE + + +S DI++ G I+ ++L+
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-26
Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 28/235 (11%)
Query: 287 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTS 345
+GF R+ + + V + ++ +G G + +V R G VAI+ +
Sbjct: 2 SGFYRQEVTKTAWEVRAV------YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF 55
Query: 346 CKSEEAE-FVKGLYLLTSLRHENIIRLRGFCCSRGR----GECFLIYDFAPKGKLSKYLD 400
A+ + L LL +RHEN+I L + +L+ F G L
Sbjct: 56 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM 113
Query: 401 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460
+ E L ++ + KG+ Y+H+ I+HR+L + +++ I D
Sbjct: 114 KHEK----LGEDRIQFLVYQMLKGLRYIHA-----AGIIHRDLKPGNLAVNEDCELKILD 164
Query: 461 CGLHKLLADDIVFSVLKTSAAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 514
GL + ++ V+ Y APE + R+T+ DI++ G I+ +++TG
Sbjct: 165 FGLARQADSEMTGYVVTR----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 64/291 (21%), Positives = 105/291 (36%), Gaps = 46/291 (15%)
Query: 315 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENII 369
+ LG+G F++VYK + +VAI+ I + + + LL L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 370 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 429
L + L++DF D S VL S + ++ +G+ YLH
Sbjct: 64 GLLDAFGHKS--NISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 430 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 489
I+HR+L +L+D+ +AD GL K + Y APE
Sbjct: 118 Q-----HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPEL 171
Query: 490 VTTGR-FTERSDIFAFGVIILQILTGSLVLTSS-----------------------MRLA 525
+ R + D++A G I+ ++L L M
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 526 AESATFENFIDRNLKGKFSE--SEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ TF++F L FS + L + + +P R T ++
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF---NPCARITATQALK 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (267), Expect = 2e-26
Identities = 41/278 (14%), Positives = 85/278 (30%), Gaps = 29/278 (10%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
+G+G+F +++GT L + VAI+ +S+ + L I
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 432
+ G L+ D D + T + + +H
Sbjct: 67 YYFGQEG-LHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 433 VNKPAIVHRNLSVEKVLIDQQFNPL-----IADCGLHKLLADDIVFSVLKTSAA------ 481
+V+R++ + LI + + + D G+ K D + +
Sbjct: 122 -----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 482 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541
Y++ + R D+ A G + + L GSL ++ A +E ++
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQST 235
Query: 542 KFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 576
E A + K + + P + +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 26/272 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 367
F + LLGKG F V G A++ + +++ A V +L + RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
+ L + + ++A G+L +L +E V I + Y
Sbjct: 67 LTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEY 120
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
LHS +V+R++ +E +++D+ + I D GL K D YLAP
Sbjct: 121 LHS-----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT-PEYLAP 174
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
E + + D + GV++ +++ G L + FE + ++ + S
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFELILMEEIRFPRTLSP 230
Query: 548 AAKLGKMALV--CTHEDPENRPTM-EAVIEEL 576
AK +L+ +DP+ R + +E+
Sbjct: 231 EAK----SLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-24
Identities = 51/302 (16%), Positives = 106/302 (35%), Gaps = 47/302 (15%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENI 368
+ ++ +G+G F V+K R G VA++ + + + K ++ + +L L+HEN+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 369 IRLRGFCCS------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 422
+ L C + R +G +L++DF + S ++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 127
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 482
G+ Y+H ++ I+HR++ VLI + +AD GL + + + + +
Sbjct: 128 NGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 483 G---YLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTS------------------ 520
Y PE + R + D++ G I+ ++ T S ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 521 -------SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV-CTHEDPENRPTMEAV 572
E R +K + + DP R +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 573 IE 574
+
Sbjct: 303 LN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 2e-23
Identities = 43/290 (14%), Positives = 100/290 (34%), Gaps = 37/290 (12%)
Query: 311 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 368
+ ++ +G+G + +V+K R +VA++ + + ++ + LL L+H+NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
+RL S + L+++F + + + LD S + + KG+G+
Sbjct: 64 VRLHDVLHSDK--KLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 488
H ++HR+L + +LI++ +A+ GL + + +
Sbjct: 118 H-----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 489 YVTTGRFTERSDIFAFGVIILQILTGSLVL------------------------TSSMRL 524
++ D+++ G I ++ L SM
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 574
+ + + A + +P R + E ++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.5 bits (247), Expect = 3e-23
Identities = 43/270 (15%), Positives = 93/270 (34%), Gaps = 25/270 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 367
F + LG G+F V G A++ ++ + + +L ++
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 368 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 427
+++L +++ ++ G++ +L + I Y
Sbjct: 103 LVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 428 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
LHS + +++R+L E +LIDQQ + D G A + LAP
Sbjct: 157 LHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGF----AKRVKGRTWTLCGTPEALAP 207
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547
E + + + + D +A GV+I ++ G + +E + ++ S
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSGKVRFPSHFSS 263
Query: 548 AAKLGKMALVCTHEDPENR-PTMEAVIEEL 576
K + D R ++ + ++
Sbjct: 264 DLK--DLLRNLLQVDLTKRFGNLKNGVNDI 291
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 1e-21
Identities = 53/294 (18%), Positives = 109/294 (37%), Gaps = 33/294 (11%)
Query: 295 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEE 350
++ ++ +E F + +LG G + V+ G L A++ + + +
Sbjct: 17 HAEKVGIEN-------FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69
Query: 351 ---AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 407
+L +R + + + + LI D+ G+L +L Q E
Sbjct: 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTETKLHLILDYINGGELFTHLSQRER--- 125
Query: 408 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467
+ I + +LH K I++R++ +E +L+D + ++ D GL K
Sbjct: 126 -FTEHEVQIYVGEIVLALEHLH-----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 468 ADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLA 525
D + Y+AP+ V G + D ++ GV++ ++LTG+ T
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
Query: 526 AESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTM-EAVIEEL 576
+++ + S AK L+ +DP+ R +E+
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAK----DLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 87.2 bits (215), Expect = 2e-19
Identities = 36/207 (17%), Positives = 76/207 (36%), Gaps = 20/207 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI 368
+ V LG+G +S V++ + + V ++ + ++ + + + +L +LR NI
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPNI 92
Query: 369 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 428
I L L+++ + L + I K + Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC 145
Query: 429 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAP 487
HS I+HR++ V+ID + L + D GL + ++V S
Sbjct: 146 HSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPE 199
Query: 488 EYVTTGRFTERSDIFAFGVIILQILTG 514
V + D+++ G ++ ++
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFR 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 5e-19
Identities = 39/210 (18%), Positives = 76/210 (36%), Gaps = 20/210 (9%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 368
+ + +G G V VAI+ ++ A+ + L L+ + H+NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 369 IRLRGFCCSRGRGE----CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 424
I L + E +L+ + + D ++ + G
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCG 131
Query: 425 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 484
I +LHS I+HR+L +++ I D GL + + + + Y
Sbjct: 132 IKHLHS-----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT--RYY 184
Query: 485 LAPEYVTTGRFTERSDIFAFGVIILQILTG 514
APE + + E DI++ G I+ +++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 6e-19
Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 18/209 (8%)
Query: 311 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 368
+ ++ +G G + SV + G VA++ ++ A+ + L LL ++HEN+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 369 IRLRGFCCSRG--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 426
I L + G + + + L +I I +G+
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLK 135
Query: 427 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 486
Y+HS I+HR+L + +++ I D GL A + A Y A
Sbjct: 136 YIHS-----ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATRWYRA 186
Query: 487 PE-YVTTGRFTERSDIFAFGVIILQILTG 514
PE + + + DI++ G I+ ++LTG
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.2 bits (204), Expect = 8e-18
Identities = 37/216 (17%), Positives = 77/216 (35%), Gaps = 19/216 (8%)
Query: 314 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 372
V LG G+FS+V+ + + T VA++ + +E AE + LL + + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE--DEIKLLQRVNDADNTKED 75
Query: 373 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL----------DWSTRVSIIIGIA 422
+ P G + + G + + I +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 423 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKL-LADDIVFSVLKTSA 480
G+ Y+H + I+H ++ E VL++ + + L A +
Sbjct: 136 LGLDYMH----RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 481 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 516
Y +PE + + +DI++ +I +++TG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 3e-13
Identities = 23/158 (14%), Positives = 50/158 (31%), Gaps = 24/158 (15%)
Query: 315 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE---------EAEFVKGLYLLTSLRH 365
L+G+G S+V+ ++ V + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 366 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 425
+ +L+G + +Y + L + +D +E ++ ++ I + +
Sbjct: 66 RALQKLQGLAVPK-------VYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEV 116
Query: 426 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463
+ IVH +LS VL+ + I D
Sbjct: 117 AKFYH-----RGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.2 bits (160), Expect = 3e-12
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 6/84 (7%)
Query: 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98
L L L N ++ P + SL L L +N+++ SL NL + L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 99 SLFGTIPESLANNAELLFLDVQNN 122
+ P LAN + L + +
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.9 bits (136), Expect = 3e-09
Identities = 23/78 (29%), Positives = 41/78 (52%), Gaps = 8/78 (10%)
Query: 63 LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 122
LK+L+ LTL N ++ P + +L KL+RL + N + + SLAN + +L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHN 361
Query: 123 TLSGIVP----SALKRLN 136
+S + P + + +L
Sbjct: 362 QISDLTPLANLTRITQLG 379
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 34/141 (24%), Positives = 55/141 (39%), Gaps = 8/141 (5%)
Query: 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98
L L NQ++ P I + +L L+L N+L +L +L L LDL+ N
Sbjct: 196 LTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 99 SLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRAC 158
+ P L+ +L L + N +S I P A + N I++L+
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 159 TVYD--NTQINPVKPFGSHSN 177
T I+ + P S +
Sbjct: 310 TYLTLYFNNISDISPVSSLTK 330
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 14/75 (18%), Positives = 27/75 (36%), Gaps = 6/75 (8%)
Query: 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
+ L +T + L ++ L + D + L L +++ S N L
Sbjct: 25 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTD 80
Query: 103 TIPESLANNAELLFL 117
P L N +L+ +
Sbjct: 81 ITP--LKNLTKLVDI 93
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.8 bits (151), Expect = 2e-11
Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 26/96 (27%)
Query: 64 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT 123
K+L+ L L++NR+ G +P L L L L++SFN+L G IP+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG---------------- 287
Query: 124 LSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACT 159
L+R + + NN LCG + L ACT
Sbjct: 288 ------GNLQRFD-VSAYANNKCLCG---SPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 4e-11
Identities = 18/60 (30%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 46 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 105
L N++ G +P + LK L L + N L G IP GNL + + N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 4e-04
Identities = 13/38 (34%), Positives = 18/38 (47%), Gaps = 1/38 (2%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP 81
L + N L G IP Q G+L+ V +N+ G P
Sbjct: 272 SLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.5 bits (142), Expect = 3e-10
Identities = 25/93 (26%), Positives = 38/93 (40%), Gaps = 10/93 (10%)
Query: 46 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 105
N + I + SL L + +N+L +P L +RL SFN L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHL-AEVP 320
Query: 106 ESLANNAELLFLDVQNNTLSGI--VPSALKRLN 136
E N L L V+ N L +P +++ L
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 18/64 (28%), Positives = 28/64 (43%), Gaps = 8/64 (12%)
Query: 64 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT 123
+ L L + L+ +P+ +L + L S NSL +PE + L L V NN
Sbjct: 38 RQAHELELNNLGLSS-LPELPPHL---ESLVASCNSL-TELPELPQS---LKSLLVDNNN 89
Query: 124 LSGI 127
L +
Sbjct: 90 LKAL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.004
Identities = 15/59 (25%), Positives = 25/59 (42%), Gaps = 8/59 (13%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 102
L+L L+ ++P L+SL N L +P+ + LK L + N+L
Sbjct: 42 ELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQS---LKSLLVDNNNLKA 92
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 3/93 (3%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103
+L L N++T +LK+L L L +N+++ P + L KL+RL LS N L
Sbjct: 35 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KE 93
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 136
+PE + + L V N ++ + S LN
Sbjct: 94 LPEKMPKTLQELR--VHENEITKVRKSVFNGLN 124
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.5 bits (127), Expect = 3e-08
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 48 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES 107
C + +P + ++L LQ+N++ NL L L L N + P +
Sbjct: 17 CSDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 108 LANNAELLFLDVQNNTLSGIVPS 130
A +L L + N L +
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEK 97
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 21/109 (19%), Positives = 37/109 (33%), Gaps = 3/109 (2%)
Query: 22 FSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP 81
N+I + + + + V L + +G +K LS + + + IP
Sbjct: 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IP 166
Query: 82 DSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPS 130
L L L L N + SL L L + N++S +
Sbjct: 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.5 bits (88), Expect = 0.002
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 1/88 (1%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 104
L L N++T A + L +L+ L L N ++ SL N L+ L L+ N L +
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 234
Query: 105 PESLANNAELLFLDVQNNTLSGIVPSAL 132
P LA++ + + + NN +S I +
Sbjct: 235 PGGLADHKYIQVVYLHNNNISAIGSNDF 262
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 36.9 bits (84), Expect = 0.004
Identities = 19/71 (26%), Positives = 24/71 (33%), Gaps = 3/71 (4%)
Query: 65 SLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTL 124
L V+ L +P L LDL N + N L L + NN +
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 125 SGIVPSALKRL 135
S I P A L
Sbjct: 68 SKISPGAFAPL 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 7e-08
Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 14/102 (13%)
Query: 55 NIPAQIGSLKSLSVLTLQHNRLNG----GIPDSLGNLGKLKRLDLSFNSLFGTIPESLA- 109
L VL L ++ + +L L+ LDLS N L L
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 110 ----NNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 147
L L + + S + L+ L ++ P L
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQAL-----EKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 5/87 (5%)
Query: 45 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNG----GIPDSLGNLGKLKRLDLSFNS 99
L + C +L+ A++ L+ V+ L L I +L L L+L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 100 LFGTIPESLANNAELLFLDVQNNTLSG 126
L + + +Q +L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 4e-07
Identities = 14/73 (19%), Positives = 28/73 (38%), Gaps = 5/73 (6%)
Query: 65 SLSVLTLQHNRLN-GGIPDSLGNLGKLKRLDLSFNSL----FGTIPESLANNAELLFLDV 119
+ L +Q L+ + L L + + + L L I +L N L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 120 QNNTLSGIVPSAL 132
++N L + +
Sbjct: 63 RSNELGDVGVHCV 75
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 29/118 (24%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 46 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 105
L N L L +L+ L L NR++ + L L RL L N + P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 106 ESLANNAELLFLDVQNNTLSGIVPS------ALKRLNGGFQFQNNPGLCGDGIASLRA 157
+ + L+ L + N LS + AL+ L +NP +C L A
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR----LNDNPWVCDCRARPLWA 248
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 8e-05
Identities = 25/107 (23%), Positives = 35/107 (32%)
Query: 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98
L L L L P L +L L LQ N L D+ +LG L L L N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 99 SLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNP 145
+ + L L + N ++ + P A + L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 1e-05
Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 26/107 (24%)
Query: 44 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL------------- 90
VL L LT + + L ++ L L HNRL P +L L L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 91 ---------KRLDLSFNSLFGT-IPESLANNAELLFLDVQNNTLSGI 127
+ L L N L + + L + L+ L++Q N+L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 8e-04
Identities = 26/92 (28%), Positives = 32/92 (34%), Gaps = 3/92 (3%)
Query: 68 VLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 127
VL L H L + L L + LDLS N L P +LA L L +N L +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 128 VPSALKRLNGGFQFQNNPGLCGDGIASLRACT 159
A NN I L +C
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCP 90
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 14/92 (15%), Positives = 39/92 (42%), Gaps = 3/92 (3%)
Query: 45 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-FGT 103
L L L ++ ++ S + + ++ + + +++ +DLS + + T
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 104 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 135
+ L+ ++L L ++ LS + + L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN 94
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 1e-04
Identities = 18/111 (16%), Positives = 41/111 (36%), Gaps = 2/111 (1%)
Query: 48 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP-DSLGNLGKLKRLDLSFNSLFGTIPE 106
C + + ++L+ L +++ + + L LG+L+ L + + L P+
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 107 SLANNAELLFLDVQNNTLSGIVPSALK-RLNGGFQFQNNPGLCGDGIASLR 156
+ L L++ N L + ++ NP C + L+
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 12/47 (25%), Positives = 20/47 (42%), Gaps = 3/47 (6%)
Query: 50 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS 96
LT +P + K ++L L N L +L +L +L+L
Sbjct: 20 RNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 22/75 (29%), Positives = 30/75 (40%), Gaps = 1/75 (1%)
Query: 48 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES 107
N+L P + L L+L +N L L L L L L NSL+ TIP+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 108 LANNAELLFLDVQNN 122
+ L F + N
Sbjct: 191 FFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 15/53 (28%), Positives = 18/53 (33%), Gaps = 1/53 (1%)
Query: 48 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100
N LT + L++L L LQ N L IP L L N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.003
Identities = 12/64 (18%), Positives = 21/64 (32%), Gaps = 3/64 (4%)
Query: 59 QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118
++ + S + L +P L L LS N L+ +L L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 119 VQNN 122
+
Sbjct: 62 LDRA 65
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 4/63 (6%)
Query: 59 QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118
+ +L L+ L N+++ P L +L L + L N + P LAN + L +
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 119 VQN 121
+ N
Sbjct: 224 LTN 226
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 9/50 (18%), Positives = 16/50 (32%), Gaps = 1/50 (2%)
Query: 48 CCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS 96
N +P + +L + R++ L NL KL+
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.004
Identities = 14/83 (16%), Positives = 22/83 (26%)
Query: 41 CFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 100
V+L L N + + + +N L D LD+S +
Sbjct: 154 ESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213
Query: 101 FGTIPESLANNAELLFLDVQNNT 123
L N +L N
Sbjct: 214 HSLPSYGLENLKKLRARSTYNLK 236
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 11/68 (16%), Positives = 26/68 (38%), Gaps = 5/68 (7%)
Query: 64 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL----FGTIPESLANNAELLFLDV 119
KSL + + + L +K + LS N++ + E++A+ +L +
Sbjct: 8 KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 120 QNNTLSGI 127
+ +
Sbjct: 67 SDIFTGRV 74
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 10/53 (18%), Positives = 18/53 (33%), Gaps = 4/53 (7%)
Query: 52 LTGNIPAQIGS---LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 101
LT + Q L L+ ++ I + L + +D S N +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR 54
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.003
Identities = 16/58 (27%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS 96
L L L NQ++ +P + L L L L N ++ +L L L L+L
Sbjct: 155 LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 589 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.62 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.53 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.5 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.49 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.4 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.22 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.19 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.15 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.11 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.01 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.97 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.82 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.62 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.56 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.51 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.35 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.27 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.18 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.12 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.02 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.71 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.64 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.62 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.36 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.75 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.71 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.51 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=423.64 Aligned_cols=257 Identities=21% Similarity=0.424 Sum_probs=203.0
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.. .+..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceecc--CCceEEEEE
Confidence 4677788999999999999999989999999997654 334679999999999999999999999954 467899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.+++.... ..++|..++.|+.|||.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp CCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred ecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc-----eeecccchhheeecCCCCeEecccchheecc
Confidence 999999999987653 34899999999999999999999988 9999999999999999999999999998876
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 548 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (589)
...........+|+.|+|||++.+..++.++|||||||++|||+|++.|+....... .+...+........+..++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~----~~~~~i~~~~~~~~p~~~~ 228 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRLYKPRLAS 228 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH----HHHHHHHHTCCCCCCTTSC
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH----HHHHHHHhcCCCCCccccC
Confidence 554444445568889999999999999999999999999999999655543322111 1111222233333445556
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 549 AKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 549 ~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..+.+++..||+.||++||||+|++++|+++++
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999999998865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=427.55 Aligned_cols=263 Identities=21% Similarity=0.388 Sum_probs=207.4
Q ss_pred hhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..++|...+.||+|+||+||+|++++ .||||+++.... ....+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 35678888999999999999998753 599999975542 4456789999999999999999999999843 46799
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.++++.... .++|..++.|+.|||+||+|||+.+ ||||||||+|||++.++.+||+|||+|+
T Consensus 81 v~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~-----ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKS-----IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcCC-----EeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999999976543 4999999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCce-eeeecCCccccccCcccccC---CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHH-hhccccC
Q 007788 466 LLADDIV-FSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-FIDRNLK 540 (589)
Q Consensus 466 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~ 540 (589)
....... .......+|+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+............. ...+..
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~- 231 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL- 231 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG-
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc-
Confidence 7654322 22334568999999999864 35899999999999999999999999754322111111111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
...+..++..+.+++.+||+.||++||||+|++++|+.+++.+
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1223445678999999999999999999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=425.15 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=214.6
Q ss_pred HhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
...++|+..+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|+|.+ +..++
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence 3456788889999999999999999989999999997654 334679999999999999999999998843 45789
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++..... ..++|..+++|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+
T Consensus 85 v~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccchhheeeecccceeeccccceE
Confidence 9999999999998865532 24899999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
..............+++.|+|||++.++.++.++|||||||++|||+||+.|+....... .....+....+...+.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~----~~~~~i~~~~~~~~p~ 233 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLERGYRMVRPD 233 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHHTTCCCCCCT
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH----HHHHHHHhcCCCCCcc
Confidence 887655444455668889999999999999999999999999999999776664432211 1112222233334455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+..+.+++.+||+.||++||||+||++.|+..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 5667899999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-54 Score=425.42 Aligned_cols=261 Identities=21% Similarity=0.420 Sum_probs=220.3
Q ss_pred HhhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
...++|+..+.||+|+||+||+|.++ +++.||||+++... ...++|.+|++++++++|||||+++|+|.+ .+..+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEee--CCeeE
Confidence 34567888899999999999999986 58899999997654 345679999999999999999999999943 47789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++..... ..++|..++.|+.|||.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 90 iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred EEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC-----cccCccccCeEEECCCCcEEEccccce
Confidence 99999999999999976532 35999999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+....+.........+++.|+|||++.++.|+.++|||||||++|||++|+.|+...... ..+.+.+........+
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~~~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLEKDYRMERP 238 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHTTCCCCCC
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----HHHHHHHhcCCCCCCC
Confidence 987765554555556788899999999999999999999999999999988777543322 1223334444455556
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
...+..+.+++..||+.||++||||+|+++.|+.+.+
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 6677889999999999999999999999999987644
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-53 Score=423.57 Aligned_cols=260 Identities=24% Similarity=0.469 Sum_probs=204.7
Q ss_pred ccCccccccccCCCccEEEEEec-CC---cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..++||+|+||+||+|.++ ++ ..||||++.........++|.+|++++++++|||||+++|+|.. .+..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCEEE
Confidence 44566789999999999999975 22 36899998876656666789999999999999999999999944 47789
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++....+ .++|.+++.|+.|||+||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMN-----YVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhCC-----CccCccccceEEECCCCcEEECCcccc
Confidence 99999999999999876543 4999999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCcee----eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 465 KLLADDIVF----SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 465 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
+........ ......+|+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+...+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~~~i~~~~ 250 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVINAIEQDY 250 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTC
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCC
Confidence 877543221 1223346788999999999999999999999999999998 89998754322 1122223333
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
+...+...+..+.+++.+||+.||++||||+||++.|+.+.+..
T Consensus 251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 44455566788999999999999999999999999998876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=408.71 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=215.8
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+ .+..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEE
Confidence 57888899999999999999999899999999986543 34689999999999999999999999943 578999999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.+++..... .++|..+++++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 y~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~~-----iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp CCTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTT-----BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred ccCCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhcC-----cccccccceeEEEcCCCcEEECcchhheecc
Confidence 9999999999876543 4899999999999999999999988 9999999999999999999999999998776
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
...........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||........ ...+....+...+...
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-----~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYRPHLA 226 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----HHHHHTTCCCCCCTTC
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-----HHHHHhCCCCCCcccc
Confidence 554444445668889999999999999999999999999999998 7889876533211 1122223334445566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
+..+.+++..||+.||++|||++|++++|.+
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 6789999999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=417.13 Aligned_cols=262 Identities=18% Similarity=0.317 Sum_probs=202.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||+||+|+.+ +|+.||||++..... +...+.|.+|++++++++|||||++++++.+...+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67889999999999999999975 789999999976643 3445679999999999999999999999876656778999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+++|+|.+++.........+++..++.++.||+.||+|||+.+....+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999997654334569999999999999999999998653334599999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
...... ......+|+.|+|||++.+..|+.++|||||||++|||+||+.||........ ...+..... ...+..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~----~~~i~~~~~-~~~~~~ 237 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL----AGKIREGKF-RRIPYR 237 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHTCC-CCCCTT
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCC-CCCCcc
Confidence 754332 22345688999999999999999999999999999999999999976433211 122222221 223445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
.+.++.+++.+||+.||++|||++|++++-
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 566899999999999999999999998763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=413.34 Aligned_cols=261 Identities=23% Similarity=0.455 Sum_probs=209.4
Q ss_pred ccCccccccccCCCccEEEEEecCC-----cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..++||+|+||.||+|.+++. ..||||++..........+|.+|++++++++|||||+++|+|.+ .+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CCce
Confidence 4677789999999999999997642 47999999876655666789999999999999999999999954 4778
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+.+|++.+++..... .++|..+++++.|||.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccccc-----cccCccccceEEECCCCeEEEcccch
Confidence 999999999999998876543 4999999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCc--eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++...... ........+|+.|+|||++.++.++.++|||||||++|||+||+.|+...... ..+...+....+.
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGFRL 232 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCCC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHHHHhccCCC
Confidence 98765432 22233445788999999999999999999999999999999987776543221 1122333344445
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
..+...+..+.+++.+||+.||++||||.||++.|+.+.+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 556667788999999999999999999999999998776543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=412.80 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=212.9
Q ss_pred ccCccccc-cccCCCccEEEEEec---CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNL-LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|...+. ||+|+||.||+|.++ ++..||||+++....+...++|.+|++++++++|||||+++|+|.. +..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEE
Confidence 44555564 999999999999864 4568999999876656667889999999999999999999999843 4589
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... ..++|..+++++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 85 lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCcCchhheeeccCCceeeccchhh
Confidence 9999999999999986543 24999999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 465 KLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 465 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
+.+....... .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~~~i~~~~~~ 231 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIEQGKRM 231 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHHHHHTTCCC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCC
Confidence 8775433222 223457889999999999999999999999999999998 89999754321 112222333334
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..+...+..+.+++..||+.||++||||.+|++.|+..-..
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 45566778899999999999999999999999999865443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=409.73 Aligned_cols=259 Identities=19% Similarity=0.313 Sum_probs=207.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||+||+|+.+ +|+.||||++.........+.|.+|++++++++|||||++++++.+ .+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEE
Confidence 56888999999999999999975 7999999999766544445679999999999999999999999955 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 83 Ey~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~~-----IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcC-----CccCcccHHHEEECCCCCEEEccchhheee
Confidence 9999999999997543 4999999999999999999999988 999999999999999999999999999877
Q ss_pred cCCcee-eeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 468 ADDIVF-SVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 468 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ ................
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKEKKTYLNPWK 230 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HHHHHHTTCTTSTTGG
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCCCCccc
Confidence 543322 2334568999999999988776 5789999999999999999999965432211 1111112111112223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..+..+.+++.+||+.||++|||++|++++-+.-++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 345678899999999999999999999988765443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=401.40 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=210.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||+||+|+.+ +++.||||++..... ......+.+|++++++++|||||++++++.+ .+..++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEEE
Confidence 46888999999999999999986 689999999864321 2334678999999999999999999999954 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 vmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred EEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeeeeccccceecCCCCEeecccceee
Confidence 999999999999998654 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||........ +..+.... ...+.
T Consensus 155 ~~~~~~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~--~~~p~ 225 (263)
T d2j4za1 155 HAPSSRR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVE--FTFPD 225 (263)
T ss_dssp CCCCCCC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTC--CCCCT
T ss_pred ecCCCcc---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCC--CCCCc
Confidence 7755432 345689999999999999999999999999999999999999976433211 12222211 22344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 546 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
..+..+.+++.+|++.||++|||++|++++-+..
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 4567889999999999999999999999876643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=405.35 Aligned_cols=252 Identities=16% Similarity=0.304 Sum_probs=210.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++|||||++++++.+ .+..++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEE
Confidence 46899999999999999999974 799999999976542 345679999999999999999999999854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 97 Ey~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 999999999988653 3899999999999999999999998 999999999999999999999999999877
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc-cccCCCCCHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-RNLKGKFSES 546 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 546 (589)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ..... .......+..
T Consensus 167 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNGTPELQNPEK 241 (293)
T ss_dssp CSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHHCSCCCSSGGG
T ss_pred ccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH----HHHHhCCCCCCCCccc
Confidence 54332 223456899999999999999999999999999999999999999754332211 11111 1112223445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+..+.+++.+||+.||++|||++|+++|-+.
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 56789999999999999999999999988654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=409.77 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=207.1
Q ss_pred hccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
.++|+..+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEEE
Confidence 35788899999999999999999988899999997654 334679999999999999999999999843 4579999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|..++..... ..++|..++.|+.|||.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 91 Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~-----ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhhh-----eecccccceEEEECCCCcEEEcccchhhhc
Confidence 99999999999876532 24999999999999999999999988 999999999999999999999999999887
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
............+|+.|+|||++.++.++.++|||||||++|||+||+.|+....... .....+........+...
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~----~~~~~i~~~~~~~~~~~~ 239 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPEC 239 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHHTTCCCCCCTTS
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH----HHHHHHHhcCCCCCCccc
Confidence 6554444445568899999999999999999999999999999999877765432211 111222223334455666
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
+.++.+++.+||+.||++||+|++|++.|+..-
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 778999999999999999999999999887643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=403.35 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=202.9
Q ss_pred cccccCCCccEEEEEec---CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEeC
Q 007788 315 NLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 390 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey~ 390 (589)
+.||+|+||+||+|.++ .++.||||+++.... ....++|.+|++++++++|||||+++|+|.. +..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 56999999999999875 356899999975432 3445789999999999999999999999843 4578999999
Q ss_pred CCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccCC
Q 007788 391 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 470 (589)
Q Consensus 391 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 470 (589)
++|+|.+++.... .++|..+++|+.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~-----iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 90 ELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp TTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC-----cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 9999999997653 4999999999999999999999988 999999999999999999999999999876543
Q ss_pred cee--eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 471 IVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 471 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.... .+...+....+...+..+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----~~~~~i~~~~~~~~p~~~ 235 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEKGERMGCPAGC 235 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCCTTC
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----HHHHHHHcCCCCCCCccc
Confidence 322 2233467889999999999999999999999999999998 89999754322 122233333344455666
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+..+.+++.+||+.||++||||++|++.|+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 78899999999999999999999999888754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=416.23 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=210.7
Q ss_pred hhccCccccccccCCCccEEEEEecC------CcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCC
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG 379 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 379 (589)
..++|+..+.||+|+||+||+|++.. ...||||++...........|.+|+.++.++ +|||||+++|+|. +
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~ 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--L 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--e
Confidence 44678889999999999999998752 2369999997665455557899999999998 8999999999994 4
Q ss_pred CCeEEEEEEeCCCCChHHHhhhhcCC-------------------CCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEe
Q 007788 380 RGECFLIYDFAPKGKLSKYLDQEEGS-------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 440 (589)
Q Consensus 380 ~~~~~lv~Ey~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH 440 (589)
.+..++||||+++|+|.++++..... ...++|..++.|+.||+.||+|||+.+ |+|
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-----IiH 187 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVH 187 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EEE
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eee
Confidence 57789999999999999999765321 235899999999999999999999988 999
Q ss_pred cCCCCCCeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCc
Q 007788 441 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVL 518 (589)
Q Consensus 441 ~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~ 518 (589)
|||||+|||++.++.+||+|||+|+........ ......+|+.|+|||++.++.++.++|||||||++|||+| |+.||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999999876543322 2233457889999999999999999999999999999998 89998
Q ss_pred chhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 519 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.+.... ..+..++....+...+...+..+.+++.+||+.||++||||+||+++|.
T Consensus 268 ~~~~~~----~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVD----ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCS----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHH----HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 653221 1223344444444555666788999999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-51 Score=407.35 Aligned_cols=267 Identities=21% Similarity=0.360 Sum_probs=217.1
Q ss_pred HHHHHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeee
Q 007788 302 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 375 (589)
Q Consensus 302 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 375 (589)
.+++...++|+..+.||+|+||+||+|+++ +++.||||+++.........+|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445566788999999999999999999864 45789999998766555667899999999999999999999999
Q ss_pred ecCCCCeEEEEEEeCCCCChHHHhhhhcC--------------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCC
Q 007788 376 CSRGRGECFLIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 435 (589)
Q Consensus 376 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 435 (589)
.. .+..++||||+++|+|.+++..... ....++|..+++|+.|+|.||+|||+.+
T Consensus 86 ~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--- 160 (301)
T d1lufa_ 86 AV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 160 (301)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence 44 5778999999999999999975321 1234899999999999999999999988
Q ss_pred CCeEecCCCCCCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhC
Q 007788 436 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 514 (589)
Q Consensus 436 ~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg 514 (589)
||||||||+|||+|.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|
T Consensus 161 --ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 161 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 99999999999999999999999999986644322 222344577889999999999999999999999999999999
Q ss_pred CC-CcchhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 515 SL-VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 515 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
.. ||........ ...+.+ ......+...+..+.+++.+||+.||++||||.||++.|+++.
T Consensus 239 ~~~p~~~~~~~e~----~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 239 GLQPYYGMAHEEV----IYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCCTTTTSCHHHH----HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCCHHHH----HHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 65 5654332211 122222 2223345556678999999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=395.92 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=200.1
Q ss_pred cccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC--CCCeEEEEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECFLIYD 388 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~lv~E 388 (589)
..+.||+|+||+||+|... +++.||+|++..... +...+.|.+|++++++++|||||++++++.+. .....++|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 3467999999999999976 688999999976542 34456799999999999999999999998542 2456899999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec-CCCceEEccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKLL 467 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfGla~~~ 467 (589)
|+++|+|.+++.... .+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++..
T Consensus 93 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~---~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC---CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999998654 3899999999999999999999875 5699999999999996 5789999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
..... ....||+.|+|||++.+ +++.++|||||||++|||+||+.||......... ...+.........+...
T Consensus 166 ~~~~~---~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 166 RASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKVA 238 (270)
T ss_dssp CTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGCC
T ss_pred cCCcc---CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH---HHHHHcCCCCcccCccC
Confidence 54432 23568999999998865 6999999999999999999999999643221111 11111111111112223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
..++.+++.+||+.||++|||++|+++|-+
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 456889999999999999999999998643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=402.71 Aligned_cols=259 Identities=21% Similarity=0.383 Sum_probs=203.7
Q ss_pred hccCccccccccCCCccEEEEEecC----CcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
.++|+..+.||+|+||.||+|.+.. +..||||.++..........|.+|++++++++|||||+++|++.+ +..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 4678888999999999999998752 457999998766656666789999999999999999999999842 568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++||||+++|+|.+++..... .+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcccC-----eeccccchhheeecCCCcEEEccchh
Confidence 999999999999998876543 4899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
++..............+|+.|+|||++.+..++.++|||||||++|||+| |..||........ ... +.......
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~----~~~-i~~~~~~~ 229 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----IGR-IENGERLP 229 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----HHH-HHTTCCCC
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH----HHH-HHcCCCCC
Confidence 98876544444445567889999999999999999999999999999998 7888865432211 111 12222334
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+...+..+.+++..||+.||++|||++||+++|+.+.+.
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 4556677899999999999999999999999999877543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=412.37 Aligned_cols=258 Identities=18% Similarity=0.316 Sum_probs=207.6
Q ss_pred hhccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 307 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 307 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
..++|+..+.||+|+||+||+|+.. +|+.||+|+++..........+.+|+.++++++|||||+++++|.+ .+..++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 3578999999999999999999975 7899999999876555566789999999999999999999999954 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCC-CCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++ + |+||||||+|||+++++.+||+|||+|
T Consensus 82 VmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC-----EEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999999999999998654 389999999999999999999975 6 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhh---h------------
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES---A------------ 529 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~---~------------ 529 (589)
+....... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+........ .
T Consensus 153 ~~~~~~~~---~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 153 GQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HHHHHHTC------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred cccCCCcc---ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 87654322 23468999999999999999999999999999999999999996432110000 0
Q ss_pred -----------------------hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 530 -----------------------TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 530 -----------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..................+.++.+++.+|++.||++|||++|+++|-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 0000000000000011124578899999999999999999999988543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=403.34 Aligned_cols=254 Identities=18% Similarity=0.279 Sum_probs=207.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
+.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.|.+|++++++++|||||++++++.+ .+..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEE
Confidence 46788899999999999999975 68999999997654 3445679999999999999999999999854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 89 Ey~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 89 EFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp ECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99999999999876543 4999999999999999999999998 999999999999999999999999999765
Q ss_pred cCCceeeeecCCccccccCccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc-cCC
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKG 541 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 541 (589)
..... ......||+.|+|||++. +..|+.++|||||||++|||+||+.||........ +..+.... ...
T Consensus 161 ~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~----~~~i~~~~~~~~ 235 (288)
T d2jfla1 161 TRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV----LLKIAKSEPPTL 235 (288)
T ss_dssp HHHHH-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHHHHHSCCCCC
T ss_pred CCCcc-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCC
Confidence 43211 122356889999999984 45689999999999999999999999976433211 12222111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
..+...+..+.+++.+||+.||++|||++|++++-+.
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 2234556789999999999999999999999987553
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=396.86 Aligned_cols=252 Identities=23% Similarity=0.426 Sum_probs=201.9
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD 388 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~E 388 (589)
++|+..+.||+|+||.||+|.++ |+.||||+++... ..++|.+|++++++++|||||+++|+|.+. .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEe
Confidence 45677889999999999999985 7899999997543 346799999999999999999999998643 345799999
Q ss_pred eCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccccc
Q 007788 389 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 468 (589)
Q Consensus 389 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~ 468 (589)
|+++|+|.+++..... ..++|..+++|+.|||.||+|||+.+ |+||||||+|||++.++.+|++|||+++...
T Consensus 82 y~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCc-----eeccccchHhheecCCCCEeecccccceecC
Confidence 9999999999976532 24899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCCCCCHHH
Q 007788 469 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 547 (589)
Q Consensus 469 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (589)
... ....++..|+|||++.+..++.++|||||||++|||+| |+.|+...... .+...+....+...+...
T Consensus 155 ~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~~~~~i~~~~~~~~~~~~ 225 (262)
T d1byga_ 155 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYKMDAPDGC 225 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHTTTCCCCCCTTC
T ss_pred CCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCCCCCccC
Confidence 432 23346778999999999999999999999999999999 57666543211 122223333444555666
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 548 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 548 ~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
+..+.+++.+||+.||++||||.|++++|+.++.
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 7789999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=405.03 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=208.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCc----EEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 383 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~ 383 (589)
++|+..+.||+|+||+||+|.+. +|+ .||||+++........++|.+|++++++++|||||+++|+|.+ +..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCe
Confidence 35888999999999999999875 443 6899998765555566789999999999999999999999964 357
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
++++||+.+|+|.+++..... .++|..+++++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~-----iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred eEEEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHcC-----cccCcchhhcceeCCCCCeEeecccc
Confidence 889999999999998876543 4999999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 464 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 464 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
++....... .......+|+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+....+.
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----~~~~~i~~~~~~ 232 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERL 232 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----GHHHHHHHTCCC
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCC
Confidence 987754332 22333457889999999999999999999999999999999 67777643221 223333334444
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
..+..++..+.+++.+||+.||++|||++|++++|+.+...
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 55566778899999999999999999999999999877543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-50 Score=401.46 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=193.9
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.+.|+..+.||+|+||+||+|+.+ +|+.||||++...........+.+|++++++++|||||++++++. +.+..++|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEE
Confidence 356888999999999999999976 689999999986654445567889999999999999999999984 45789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec---CCCceEEccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfGl 463 (589)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+
T Consensus 86 mE~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp ECCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EeccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhce-----eeeEEecccceeecccCCCceEEEeccce
Confidence 99999999999997543 4999999999999999999999988 99999999999994 578999999999
Q ss_pred cccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcccc--CC
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KG 541 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 541 (589)
++....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+....... ..+..... ..
T Consensus 157 a~~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~ 230 (307)
T d1a06a_ 157 SKMEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDS 230 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCT
T ss_pred eEEccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHhccCCCCCC
Confidence 987654332 22346899999999999999999999999999999999999999765332211 22222221 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
......+..+.+++.+|++.||++|||++|++++-+.
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 2233456778999999999999999999999998554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-50 Score=401.20 Aligned_cols=251 Identities=20% Similarity=0.357 Sum_probs=206.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
+.|+..+.||+|+||.||+|+.. +|+.||||++...... ...+.|.+|++++++++|||||++++++.+ .+..++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEE
Confidence 45888999999999999999965 7899999999765432 334679999999999999999999999855 478999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 v~E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp EEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEEecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEECCCCCEEEeeccccc
Confidence 999999999987765443 4999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccC---CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 542 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (589)
..... ....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||........ +..+........
T Consensus 164 ~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~----~~~i~~~~~~~~ 234 (309)
T d1u5ra_ 164 IMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPAL 234 (309)
T ss_dssp SSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCC
T ss_pred ccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCC
Confidence 76543 23568999999999864 4589999999999999999999999976433221 122222222222
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 543 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 543 ~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
.+...+..+.+++.+||+.||++|||++|+++|-+..
T Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 2334466899999999999999999999999875543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=402.50 Aligned_cols=271 Identities=22% Similarity=0.374 Sum_probs=208.7
Q ss_pred HHHHHHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceee
Q 007788 301 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRG 373 (589)
Q Consensus 301 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g 373 (589)
..+|+...++|+..+.||+|+||.||+|.+. +++.||||+++..........+.+|...+.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3455555678999999999999999999864 35789999998766556667888998888887 6899999999
Q ss_pred eeecCCCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEec
Q 007788 374 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR 441 (589)
Q Consensus 374 ~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~ 441 (589)
++... .+..++||||+++|+|.++++.... ....++|..++.++.|||+||+|||+.+ |+||
T Consensus 85 ~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-----ivHr 158 (299)
T d1ywna1 85 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHR 158 (299)
T ss_dssp EECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-----CCCS
T ss_pred eeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-----CcCC
Confidence 88543 4568999999999999999976432 1235899999999999999999999988 9999
Q ss_pred CCCCCCeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCC-Ccc
Q 007788 442 NLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-VLT 519 (589)
Q Consensus 442 dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~-p~~ 519 (589)
||||+|||+++++.+||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||+||.. ||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876443221 2223468899999999999999999999999999999999765 564
Q ss_pred hhHHHHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 520 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..... ..+...+........+...+..+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 239 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 239 GVKID----EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TCCCS----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHH----HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 33211 11222233333444455566789999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=397.62 Aligned_cols=250 Identities=21% Similarity=0.275 Sum_probs=205.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ......+.+|++++++++|||||++++++.+ .+..++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEEE
Confidence 56889999999999999999975 799999999974321 2334678999999999999999999999854 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 86 vmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc-----EEcCcCCccccccCCCceEEecccccce
Confidence 999999999999988664 3999999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 466 LLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 466 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
.+..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....... ..+.... ...+
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~--~~~p 230 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLE--YDFP 230 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTC--CCCC
T ss_pred ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH----HHHHcCC--CCCC
Confidence 7754322 1223456899999999999999999999999999999999999999765432221 2222211 1233
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...+..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 4456678999999999999999999987544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=396.95 Aligned_cols=256 Identities=23% Similarity=0.428 Sum_probs=207.8
Q ss_pred ccccccCCCccEEEEEecCC----cEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEEEe
Q 007788 314 VNLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF 389 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~Ey 389 (589)
.++||+|+||+||+|.+.++ ..||||+++.........+|.+|++++++++|||||+++|+|... .+..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEE
Confidence 36799999999999997532 368999998655566668899999999999999999999998653 3578999999
Q ss_pred CCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccccC
Q 007788 390 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 469 (589)
Q Consensus 390 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 469 (589)
+++|+|.+++..... .+++..+++++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 111 ~~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~~-----iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp CTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred eecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcccC-----cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999876543 4789999999999999999999987 99999999999999999999999999987654
Q ss_pred Ccee---eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCHH
Q 007788 470 DIVF---SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 546 (589)
Q Consensus 470 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (589)
.... ......+|+.|+|||.+.++.++.++||||||+++|||+||+.||........ +...+....+...+..
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i~~g~~~~~p~~ 258 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEY 258 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCCTT
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCCCCCccc
Confidence 3321 12234578889999999999999999999999999999998888865432211 1111112223334455
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 547 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 547 ~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+..+.+++.+||+.||++||+|.||+++|+.+...
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 667899999999999999999999999999987644
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=390.85 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=201.5
Q ss_pred ccCccccccccCCCccEEEEEec--C--CcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR--D--GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|+..+.||+|+||.||+|++. + ...||||+++.... ....++|.+|++++++++|||||+++|+|.+ +.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 56888899999999999999864 2 24789999875432 3445689999999999999999999999943 35
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+++|++.+++....+ .++|..++.++.|||+||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCT
T ss_pred hheeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhCC-----EeeeeecHHHhccccccceeeccch
Confidence 6899999999999999876643 4999999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCceee--eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHHHHhhhhHHHhhcccc
Q 007788 463 LHKLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL 539 (589)
Q Consensus 463 la~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 539 (589)
+++......... .....++..|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+.....
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~~i~~~~~ 232 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGE 232 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH----HHHHHHhCCC
Confidence 999875443222 223346778999999999999999999999999999998 899996543322 1223333333
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 540 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
+...+...+..+.+++..||+.||++||||.||++.|+++
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 4444556667899999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=396.67 Aligned_cols=261 Identities=22% Similarity=0.402 Sum_probs=207.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCc--EEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|+..+.||+|+||.||+|.++ +|. .||||+++....+...++|.+|+++++++ +|||||+++|+|.+ .+..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeE
Confidence 56777899999999999999976 444 57888887655455567899999999999 79999999999965 47899
Q ss_pred EEEEeCCCCChHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC
Q 007788 385 LIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 452 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~ 452 (589)
+||||+++|+|.++++... .....++|..+++++.|||+||.|||+.+ |+||||||+|||++.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-----iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE 162 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-----ccccccccceEEEcC
Confidence 9999999999999997542 22356999999999999999999999987 999999999999999
Q ss_pred CCceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCC-CcchhHHHHHhhhhH
Q 007788 453 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-VLTSSMRLAAESATF 531 (589)
Q Consensus 453 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~-p~~~~~~~~~~~~~~ 531 (589)
++.+||+|||+++...... ......+|..|+|||.+.++.++.++|||||||++|||++|.. ||...... .+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-----~~ 235 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----EL 235 (309)
T ss_dssp GGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred CCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-----HH
Confidence 9999999999998654322 1223457888999999999999999999999999999999875 45433221 11
Q ss_pred HHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 007788 532 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM 583 (589)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~ 583 (589)
.+.+....+...+...+..+.+++.+||+.||++||||+||+++|+.+.+..
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 2222223334455566778999999999999999999999999998876543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=395.27 Aligned_cols=267 Identities=22% Similarity=0.367 Sum_probs=216.4
Q ss_pred HHHhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeec
Q 007788 304 VESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 377 (589)
Q Consensus 304 l~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 377 (589)
|+...++|...+.||+|+||.||+|.++ +++.||||+++..........|.+|+.++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3444567888899999999999999874 3578999999876655666789999999999999999999999943
Q ss_pred CCCCeEEEEEEeCCCCChHHHhhhhc------CCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec
Q 007788 378 RGRGECFLIYDFAPKGKLSKYLDQEE------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 451 (589)
Q Consensus 378 ~~~~~~~lv~Ey~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~ 451 (589)
.+..++||||+++|+|.+++.... .....++|..+.+++.|+|+||+|||+.+ |+||||||+|||++
T Consensus 95 --~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-----ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 95 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVA 167 (308)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEEEC
T ss_pred --CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeeceEcCCceeec
Confidence 467899999999999999987542 12234799999999999999999999987 99999999999999
Q ss_pred CCCceEEccccccccccCCceee-eecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCC-CCcchhHHHHHhhh
Q 007788 452 QQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESA 529 (589)
Q Consensus 452 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~-~p~~~~~~~~~~~~ 529 (589)
+++++||+|||+++.+....... .....+++.|+|||.+.+..++.++||||||+++|||+||+ .|+...... .
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----~ 243 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----Q 243 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----H
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH----H
Confidence 99999999999998775443222 22335788999999999999999999999999999999996 555443221 1
Q ss_pred hHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 530 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
.+..+.+ ......+...+..+.+++.+||+.+|++||||+||+++|+...+.
T Consensus 244 ~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 244 VLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1222222 222334455667899999999999999999999999999987553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-49 Score=399.88 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=208.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 57889999999999999999975 79999999997654 3455678999999999999999999999854 47899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec--CCCceEEccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPLIADCGLHK 465 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfGla~ 465 (589)
||+++|+|.+++....+ .+++..+..|+.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 103 E~~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 103 EFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp CCCCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EcCCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcC-----CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 99999999999965432 4999999999999999999999998 99999999999996 46789999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC--CCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GKF 543 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 543 (589)
........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+...... +..+...... ...
T Consensus 175 ~~~~~~~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~ 248 (350)
T d1koaa2 175 HLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----LRNVKSCDWNMDDSA 248 (350)
T ss_dssp ECCTTSCE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCSCCGG
T ss_pred eccccccc--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCccc
Confidence 87654332 234678999999999999999999999999999999999999976433211 1122211111 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+..+.+++.+||+.||++|||++|++++-+
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1234567899999999999999999999998854
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=390.96 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=207.5
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-----chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.|.+|++++++++|||||++++++.+ .+.
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 57899999999999999999975 799999999975432 2235689999999999999999999999844 578
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC----ceEE
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLI 458 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl 458 (589)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~-----ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc-----eeecccccceEEEecCCCcccceEe
Confidence 999999999999999998654 3999999999999999999999988 99999999999998876 4999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+...... +..+....
T Consensus 159 ~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~ 232 (293)
T d1jksa_ 159 IDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----LANVSAVN 232 (293)
T ss_dssp CCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTC
T ss_pred cchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH----HHHHHhcC
Confidence 99999987754332 2344678899999999999999999999999999999999999976533221 11111111
Q ss_pred cCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 539 LKGK--FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 539 ~~~~--~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.... .....+..+.+++.+||+.||++|||++|++++-+.
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1100 011235678899999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-48 Score=396.50 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=208.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++|||||++++++.+ .+..++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 46888999999999999999975 79999999997654 3445678899999999999999999999854 57899999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec--CCCceEEccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPLIADCGLHK 465 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfGla~ 465 (589)
||+++|+|.+++.... ..+++...+.|+.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+|+
T Consensus 106 E~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 106 EFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp ECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccccccccccccCCCeEEEeecccce
Confidence 9999999998876543 24999999999999999999999988 99999999999998 67899999999999
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc--cCCCC
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKGKF 543 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 543 (589)
.+..... .....+|+.|+|||++.+..++.++||||+||++|||+||+.||.+...... +..+.... .....
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 178 KLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRCDWEFDEDA 251 (352)
T ss_dssp ECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHCCCCCCSST
T ss_pred ecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCccc
Confidence 8765432 2234578899999999999999999999999999999999999976533221 11121111 11222
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 544 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 544 ~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
....+..+.+++.+||+.||++|||++|++++-+
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 3345667899999999999999999999998744
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=393.03 Aligned_cols=264 Identities=22% Similarity=0.385 Sum_probs=217.2
Q ss_pred HhhccCccccccccCCCccEEEEEec------CCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 306 SATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 306 ~~~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
...++|+..+.||+|+||.||+|++. +++.||||+++.........+|.+|+.+++++ +|||||+++|+|.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~- 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-
Confidence 34567888899999999999999862 46789999998776666677899999999999 69999999999944
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC--------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG--------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 444 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk 444 (589)
.+..++||||+++|+|.++++.... ....+++..++.++.|||+||+|||+.+ |+|||||
T Consensus 99 -~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-----ivHrDLK 172 (311)
T d1t46a_ 99 -GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLA 172 (311)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCS
T ss_pred -CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccc
Confidence 4678999999999999999976432 1235899999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEccccccccccCCce-eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHH
Q 007788 445 VEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 523 (589)
Q Consensus 445 ~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~ 523 (589)
|+||+++.++.+|++|||+++....... .......+|+.|+|||.+.++.++.++|||||||++|||+|++.|+.....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999997764332 233345678899999999999999999999999999999996555443221
Q ss_pred HHHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 007788 524 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 579 (589)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~ 579 (589)
. ...+..++....+...+...+..+.+++.+||+.||++||||+|++++|+.+
T Consensus 253 ~---~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 253 V---DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp S---SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 1223344444555555556678899999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=389.05 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=210.6
Q ss_pred hccCccccccccCCCccEEEEEecC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeecC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 378 (589)
.++|...+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 4578888999999999999998632 3579999998776666668899999999988 79999999999954
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcC------------CCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCC
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 446 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~ 446 (589)
.+..++||||+++|+|.+++..... ....+++.++++++.|||.||+|||+.+ ||||||||+
T Consensus 91 -~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-----ivHrDiKp~ 164 (299)
T d1fgka_ 91 -DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAAR 164 (299)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGG
T ss_pred -CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-----EEeeeeccc
Confidence 4678999999999999999976532 1245899999999999999999999988 999999999
Q ss_pred CeeecCCCceEEccccccccccCCcee-eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHh-CCCCcchhHHH
Q 007788 447 KVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRL 524 (589)
Q Consensus 447 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~ 524 (589)
|||++.++.+||+|||+++........ ......+++.|+|||.+.++.|+.++|||||||++|||+| |..||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 999999999999999999877543321 2234457788999999999999999999999999999998 67777544322
Q ss_pred HHhhhhHHHhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 525 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
...+.+........+...+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 245 -----~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 -----ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -----HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 122233334444455556678999999999999999999999999998774
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-48 Score=387.29 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=207.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||+||+|+.+ +|+.||||+++.... ....+.+.+|+.++++++|||||++++++.+ .+..++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeeee
Confidence 46888999999999999999975 699999999975321 2334678999999999999999999999854 578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 82 vmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NILl~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAK 152 (316)
T ss_dssp EECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc-----EEccccCchheeEcCCCCEEEecCccce
Confidence 999999999999987654 3788899999999999999999998 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....... ..+..... ..+.
T Consensus 153 ~~~~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~--~~p~ 222 (316)
T d1fota_ 153 YVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAEL--RFPP 222 (316)
T ss_dssp ECSSCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCC--CCCT
T ss_pred Eecccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH----HHHHcCCC--CCCC
Confidence 876532 2456899999999999999999999999999999999999999765432221 22222221 2334
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
..+..+.+++.+|++.||.+|+ |++|+++|-+
T Consensus 223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 4556789999999999999996 8999998744
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=389.33 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=208.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|+.+ +|+.||||+++.... ......+.+|+.+|++++|||||++++++. +.+..++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~i 82 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec--ccccccc
Confidence 57889999999999999999975 799999999975421 234567899999999999999999999984 4578999
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 83 v~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred ceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC-----ccccccCHHHeEecCCCCEEEeeccccc
Confidence 999999999999998765 3889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
....... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....... ..+.... ...+.
T Consensus 154 ~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~----~~i~~~~--~~~p~ 226 (337)
T d1o6la_ 154 EGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEE--IRFPR 226 (337)
T ss_dssp CSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCC--CCCCT
T ss_pred ccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH----HHHhcCC--CCCCc
Confidence 7643321 223456899999999999999999999999999999999999999765432221 1122111 22344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 007788 546 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELT 577 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~ 577 (589)
..+.++.+++..|++.||++||+ +.|+++|-+
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 45667899999999999999994 889988754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=385.32 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=200.6
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC--CeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~~~~lv 386 (589)
++|...+.||+|+||.||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|..... ...++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 3566678899999999999997 58899999996542 222223345556678899999999999976543 367999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC---CCCCeEecCCCCCCeeecCCCceEEccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---NKPAIVHRNLSVEKVLIDQQFNPLIADCGL 463 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~---~~~~ivH~dlk~~Nill~~~~~~kl~DfGl 463 (589)
|||+++|+|.++++.. .++|..+++++.|+|.||+|||+... ..++|+||||||+||||++++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999764 38999999999999999999997421 124599999999999999999999999999
Q ss_pred cccccCCcee---eeecCCccccccCcccccCCC------CCCcchhhhHHHHHHHHHhCCCCcchhHHH----------
Q 007788 464 HKLLADDIVF---SVLKTSAAMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRL---------- 524 (589)
Q Consensus 464 a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~---------- 524 (589)
++........ ......||++|+|||++.+.. ++.++|||||||+||||+||..|+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876543211 223456899999999987643 577899999999999999998877431100
Q ss_pred -HHhhhhHHHhhccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 007788 525 -AAESATFENFIDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 582 (589)
Q Consensus 525 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~ 582 (589)
...........+...++.. +.+....+.+++.+||+.||++||||.||+++|+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0000111122222333222 234567799999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-47 Score=379.96 Aligned_cols=262 Identities=18% Similarity=0.251 Sum_probs=204.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCC--Ce
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GE 382 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~~ 382 (589)
.++|+..+.||+|+||.||+|... +|+.||||+++.... ......|.+|++++++++|||||++++++...+. ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367889999999999999999974 799999999976543 2334679999999999999999999998865432 34
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++..+++|||
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTSCEEECCCT
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCccccCcccccCccccceeehhh
Confidence 789999999999999987664 3999999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCc--eeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 463 LHKLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 463 la~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
.+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...............- +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~--~~~~ 234 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPP 234 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCG
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC--CCCC
Confidence 987654322 122334568899999999999999999999999999999999999997654322211111110 0000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhh
Q 007788 541 GKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAA 580 (589)
Q Consensus 541 ~~~~~~~~~~l~~l~~~C~~~dp~~RP-s~~evl~~L~~~~ 580 (589)
.......+..+.+++.+|++.||++|| |++++++.|..+.
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111223456789999999999999999 8999999887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-47 Score=376.82 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=208.1
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc--------hHHHHHHHHHHHHhccC-CCCccceeeeeecC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--------SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR 378 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~ 378 (589)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ...+.+.+|+.++++++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 57888999999999999999974 7999999999764321 12346889999999997 999999999984
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEE
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEE
T ss_pred cCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC-----CcccccccceEEEcCCCCeEE
Confidence 4578999999999999999998654 3999999999999999999999988 999999999999999999999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccC------CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 532 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 532 (589)
+|||+++....... .....||..|+|||.+.+ ..++.++||||+||++|||+||+.||......... .
T Consensus 152 ~DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~----~ 225 (277)
T d1phka_ 152 TDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----R 225 (277)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----H
T ss_pred ccchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH----H
Confidence 99999988765432 234568899999998863 34688999999999999999999999865433221 1
Q ss_pred Hhhcccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 533 NFIDRNL--KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 533 ~~~~~~~--~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.+..... ........+.++.+++.+|++.||++|||++|++++-+.
T Consensus 226 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 2222221 222233566789999999999999999999999987543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-47 Score=387.48 Aligned_cols=249 Identities=17% Similarity=0.259 Sum_probs=207.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL 385 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l 385 (589)
++|+..+.||+|+||.||+|+.+ +|+.||||++..... ......+.+|++++++++|||||++++++.. .+..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccccc
Confidence 47889999999999999999975 799999999864321 2334578999999999999999999999844 578899
Q ss_pred EEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 386 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 386 v~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
||||+.+|+|.+++.... .+++.....++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+
T Consensus 119 v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCcCCHHHcccCCCCCEEeeeceeee
Confidence 999999999999998764 3899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCCH
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 545 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (589)
...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+....... ..+..... ..+.
T Consensus 190 ~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~--~~p~ 259 (350)
T d1rdqe_ 190 RVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKV--RFPS 259 (350)
T ss_dssp ECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCC--CCCT
T ss_pred eccccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH----HHHhcCCC--CCCc
Confidence 775432 2346889999999999999999999999999999999999999765432221 22222211 2334
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 007788 546 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV 578 (589)
Q Consensus 546 ~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~~ 578 (589)
..+..+.+++..|++.||++|+ |++|+++|-+.
T Consensus 260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 4566789999999999999994 89999987553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=383.45 Aligned_cols=249 Identities=18% Similarity=0.277 Sum_probs=203.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCC--CchHHHHHHHHHHHHh-ccCCCCccceeeeeecCCCCeEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLT-SLRHENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~-~l~H~niv~l~g~~~~~~~~~~~ 384 (589)
++|...+.||+|+||+||+|+.. +|+.||||+++... .......+..|..++. .++|||||++++++.+ .+..|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 57888999999999999999976 79999999997532 1233455677777665 6899999999999854 57899
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 80 ivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~-----iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCcccceeecCCCceeccccchh
Confidence 9999999999999998664 3889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+........ .+... ....+
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~~~--~~~~p 223 (320)
T d1xjda_ 151 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH----SIRMD--NPFYP 223 (320)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHC--CCCCC
T ss_pred hhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH----HHHcC--CCCCC
Confidence 86654322 2234568899999999999999999999999999999999999997654322211 11111 12233
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 007788 545 ESEAAKLGKMALVCTHEDPENRPTME-AVIEE 575 (589)
Q Consensus 545 ~~~~~~l~~l~~~C~~~dp~~RPs~~-evl~~ 575 (589)
...+..+.+++.+||+.||++||++. |+++|
T Consensus 224 ~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 44566789999999999999999995 77654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=381.43 Aligned_cols=251 Identities=18% Similarity=0.242 Sum_probs=207.0
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
.++|.+.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++|++++|||||++++++.+ .+..|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEE
Confidence 367888999999999999999975 68999999997653 344568899999999999999999999854 4789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC--CCceEEcccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLH 464 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfGla 464 (589)
|||+++|+|.+++.... ..+++.....|+.||+.||+|||+.+ |+||||||+|||++. ...+||+|||++
T Consensus 80 mE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~-----iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp ECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC-----CCcccccccceeecCCCceEEEEcccchh
Confidence 99999999999997643 24899999999999999999999988 999999999999985 458999999999
Q ss_pred ccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCCCCC
Q 007788 465 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 544 (589)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (589)
+....... .....+++.|+|||.+.+..++.++||||+||++|||++|+.||........ +..+...... .+
T Consensus 152 ~~~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----~~~i~~~~~~--~~ 223 (321)
T d1tkia_ 152 RQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----IENIMNAEYT--FD 223 (321)
T ss_dssp EECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCC--CC
T ss_pred hccccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCC--CC
Confidence 87755432 2234567889999999999999999999999999999999999976543222 1222221111 12
Q ss_pred H----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 545 E----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 545 ~----~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
. ..+..+.+++..|++.||++|||++|++++-+.
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 2 235568899999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-46 Score=384.72 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=200.9
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC--chHHHHHH---HHHHHHhccCCCCccceeeeeecCCCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFV---KGLYLLTSLRHENIIRLRGFCCSRGRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~---~e~~~l~~l~H~niv~l~g~~~~~~~~~ 382 (589)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ......+. .|+++++.++|||||++++++.+ .+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CCE
Confidence 57888999999999999999975 699999999864321 11122333 44777888899999999999844 578
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~-----iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSSSCEEECCCT
T ss_pred EEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC-----ccceeeccceeEEcCCCcEEEeeec
Confidence 999999999999999998664 3889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccCC
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 541 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 541 (589)
+|+...... .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||......... ....... ....
T Consensus 153 la~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~--~~~~ 226 (364)
T d1omwa3 153 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL--TMAV 226 (364)
T ss_dssp TCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSS--SCCC
T ss_pred eeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcc--cCCC
Confidence 998776542 234568999999999875 46899999999999999999999999753211100 0011111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 007788 542 KFSESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV 578 (589)
Q Consensus 542 ~~~~~~~~~l~~l~~~C~~~dp~~RPs-----~~evl~~L~~ 578 (589)
..+...+..+.+++.+||+.||++||| ++|+++|-+.
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 223345667899999999999999999 6899877543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=381.77 Aligned_cols=255 Identities=18% Similarity=0.226 Sum_probs=200.1
Q ss_pred ccCccc-cccccCCCccEEEEEe-cCCcEEEEEEeccCCCchHHHHHHHHHHHHhcc-CCCCccceeeeeec--CCCCeE
Q 007788 309 QCFSEV-NLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS--RGRGEC 383 (589)
Q Consensus 309 ~~f~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~--~~~~~~ 383 (589)
++|.+. +.||+|+||.||+|.. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ......
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 567765 4699999999999997 47899999998642 3567899887655 89999999998753 234568
Q ss_pred EEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC---CCceEEcc
Q 007788 384 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD 460 (589)
Q Consensus 384 ~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 460 (589)
|+||||+++|+|.+++..... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~-----iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC-----Cccccccccccccccccccccccccc
Confidence 999999999999999976432 35999999999999999999999988 999999999999986 56799999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccccC
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 540 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 540 (589)
||+++...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.............+......
T Consensus 158 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 158 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred cceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 99998765433 2234568999999999999999999999999999999999999997653221111111111111111
Q ss_pred CCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 541 GKF--SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 541 ~~~--~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
... ....+.++.+++.+|++.||++|||+.|++++-+.
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 111 13456789999999999999999999999987554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=373.67 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=194.5
Q ss_pred cccccccCCCccEEEEEec-CCcEEEEEEeccCCCchH----HHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 313 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE----EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 313 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~----~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
..++||+|+||+||+|+.+ +|+.||||+++....... ...+.+|+.++++++|||||++++++. ..+..++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~--~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec--cCCceeehh
Confidence 3578999999999999975 699999999975432211 246889999999999999999999994 457799999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+.++++..+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 E~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp ECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc-----eecccCCcceEEecCCCccccccCcccccc
Confidence 999988777665433 24888899999999999999999998 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc--------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-------- 538 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 538 (589)
..... ......+|+.|+|||++... .|+.++|||||||++|||+||+.||..................+.
T Consensus 151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 151 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred CCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 55432 22334678899999998754 579999999999999999999999975433222111111000000
Q ss_pred ---------cCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 539 ---------LKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 539 ---------~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.....+ ......+.+++.+|++.||++|||++|+++|-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 000001 1234678999999999999999999999988554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=371.14 Aligned_cols=256 Identities=20% Similarity=0.384 Sum_probs=196.8
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-hHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|++++++++|||||++++++.+ .+..++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 57889999999999999999974 7999999999755322 234678999999999999999999999954 5789999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
|||+.+ ++.+++.... ...+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~e~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~-----IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp EECCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred EeecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC-----EEccccCchheeecccCcceeccCCccee
Confidence 999975 4555554332 234999999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc---------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--------- 536 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 536 (589)
...... ......+|+.|+|||.+.... ++.++||||+||++|||++|+.||..................
T Consensus 152 ~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 152 FGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp HCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 654322 223346788999999877665 578999999999999999999999754332211111110000
Q ss_pred ---cccCCC------C-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007788 537 ---RNLKGK------F-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 575 (589)
Q Consensus 537 ---~~~~~~------~-----~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~ 575 (589)
...... . ....+..+.+++.+|++.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0 01224678899999999999999999999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=368.41 Aligned_cols=244 Identities=20% Similarity=0.349 Sum_probs=198.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCc-----hHHHHHHHHHHHHhccC--CCCccceeeeeecCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGR 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~ 380 (589)
++|++.+.||+|+||.||+|+.. +|+.||||++...... .....+.+|+.++++++ |||||++++++. +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--eC
Confidence 57888999999999999999975 7899999999754211 11234678999999986 999999999984 45
Q ss_pred CeEEEEEEeCCC-CChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-CCceEE
Q 007788 381 GECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLI 458 (589)
Q Consensus 381 ~~~~lv~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl 458 (589)
+..++||||+.+ +++.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEE
T ss_pred CeEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CccccCcccceEEecCCCeEEE
Confidence 789999999976 68888887653 3899999999999999999999988 999999999999985 479999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCC-CCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 537 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 537 (589)
+|||+++...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....... ..
T Consensus 153 ~DFG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~----------~~ 219 (273)
T d1xwsa_ 153 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----------RG 219 (273)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----------HC
T ss_pred Cccccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh----------hc
Confidence 9999998765432 224568999999999987765 567999999999999999999997653211 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 538 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.. ..+...+.++.+++.+|++.||++|||++|++++-+.
T Consensus 220 ~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 220 QV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp CC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred cc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 11 1222345678999999999999999999999987553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-45 Score=365.88 Aligned_cols=257 Identities=19% Similarity=0.321 Sum_probs=199.3
Q ss_pred ccCccccccccCCCccEEEEEecCCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||+||+|+.++|+.||||+++.... ......|.+|+.++++++|||||++++++.. .+..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEEE
Confidence 57888999999999999999999999999999976543 2234679999999999999999999999854 47889999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 467 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~~ 467 (589)
||+.++.+..+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+...
T Consensus 80 e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~-----IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp ECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc-----EEecCCCCceeeEcCCCCEEecccccceec
Confidence 999887776665533 24999999999999999999999988 999999999999999999999999999876
Q ss_pred cCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc----------
Q 007788 468 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---------- 536 (589)
Q Consensus 468 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 536 (589)
..... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+..............-.
T Consensus 151 ~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 54322 22334577889999998765 4689999999999999999999999754322111111000000
Q ss_pred ------cccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 537 ------RNLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 537 ------~~~~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.... .......+..+.+++.+|++.||++|||++|++++-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0000 0011223467889999999999999999999997744
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=366.99 Aligned_cols=260 Identities=18% Similarity=0.327 Sum_probs=197.6
Q ss_pred hccCccccccccCCCccEEEEEec-C-CcEEEEEEeccCCCc-hHHHHHHHHHHHHhcc---CCCCccceeeeeecC---
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-D-GTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSR--- 378 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~--- 378 (589)
.++|++.+.||+|+||+||+|+.. + ++.||||+++..... .....+.+|+.+++.+ +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 678999999754322 1223455677666555 899999999988532
Q ss_pred CCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEE
Q 007788 379 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 458 (589)
Q Consensus 379 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl 458 (589)
.....+++|||++++++........ ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~-----ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----EEecCCCccEEEEcCCCCeee
Confidence 2346899999998877765544332 34899999999999999999999988 999999999999999999999
Q ss_pred ccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc--
Q 007788 459 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-- 536 (589)
Q Consensus 459 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-- 536 (589)
+|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+................
T Consensus 158 ~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 158 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cchhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 9999988664432 223456899999999999999999999999999999999999999765332211111110000
Q ss_pred ------------cccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 537 ------------RNLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 537 ------------~~~~-------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.... .......+..+.+++.+|++.||++|||++|+++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0000 0011223457889999999999999999999998844
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=364.07 Aligned_cols=259 Identities=20% Similarity=0.293 Sum_probs=197.2
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCC--CeEE
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECF 384 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~~~~ 384 (589)
+++|+..+.||+|+||+||+|... +|+.||||++.........+.+.+|+++|++++||||+++++++..... ...+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357889999999999999999864 8999999999866545556789999999999999999999999854321 1234
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 464 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla 464 (589)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~-----iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCcceEEECCCCCEEEcccCce
Confidence 556677799999999653 3899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCcee--eeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH----------
Q 007788 465 KLLADDIVF--SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------- 531 (589)
Q Consensus 465 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~---------- 531 (589)
+........ ......+++.|+|||.+.. ..++.++||||+||++|||++|+.||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 876543221 1233457888999999855 457899999999999999999999996543211111000
Q ss_pred ---------HHhhcc-ccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007788 532 ---------ENFIDR-NLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 576 (589)
Q Consensus 532 ---------~~~~~~-~~~~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L 576 (589)
...... ......+ ......+.+++..|++.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 000000 0000111 11234688999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=358.57 Aligned_cols=267 Identities=18% Similarity=0.265 Sum_probs=199.6
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC------C
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~ 380 (589)
++|+..+.||+|+||+||+|+.. +|+.||||++..... +.....+.+|+++|++++||||+++++++.... .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67889999999999999999975 799999999865533 233467899999999999999999999885432 3
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
+..++||||+.++++....... ..++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~-----ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccCC-----EEecCcCchheeecCCCcEEeee
Confidence 4689999999887776554433 24888999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCcee---eeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhc
Q 007788 461 CGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 536 (589)
Q Consensus 461 fGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 536 (589)
||+++........ ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+................
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999766543211 12234578999999998765 6899999999999999999999999754332211111000000
Q ss_pred --cc-----------------cCCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccc
Q 007788 537 --RN-----------------LKGKFSE-------SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 584 (589)
Q Consensus 537 --~~-----------------~~~~~~~-------~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~~~~ 584 (589)
+. ....... .....+.+++.+|++.||++|||++|+++|-+.....+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence 00 0000000 113456789999999999999999999999876554443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=359.82 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=194.6
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCC----CC
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG 381 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~ 381 (589)
.++|+..+.||+|+||+||+|... +|+.||||+++.... +...+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367899999999999999999975 699999999975432 334567899999999999999999999986432 23
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccc
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 461 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 461 (589)
..++||||+ +.+|..+.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~-----IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCcchhhcccccccccccc
Confidence 579999999 56777776543 3999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCceeeeecCCccccccCcccccCC-CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH---------
Q 007788 462 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF--------- 531 (589)
Q Consensus 462 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------- 531 (589)
|+++...... ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.............
T Consensus 166 g~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 166 GLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TTCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 9998765532 345678899999998764 56899999999999999999999996543221110000
Q ss_pred ----------HHhh--ccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 532 ----------ENFI--DRNLKG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 532 ----------~~~~--~~~~~~----~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
.... .+.... .........+.+++.+|++.||++|||++|+++|-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0000 000000 011223456789999999999999999999999844
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-43 Score=351.97 Aligned_cols=258 Identities=15% Similarity=0.209 Sum_probs=196.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 387 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv~ 387 (589)
++|+..+.||+|+||.||+|+.. +|+.||||++..... ..++..|++++++++|+|++..++.|... .+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEEE
Confidence 46888999999999999999974 689999999876532 23578899999999988877777666443 46789999
Q ss_pred EeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeec---CCCceEEcccccc
Q 007788 388 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH 464 (589)
Q Consensus 388 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfGla 464 (589)
||+ +++|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+|
T Consensus 83 e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 999 557766665443 24999999999999999999999998 99999999999875 4567999999999
Q ss_pred ccccCCcee------eeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 465 KLLADDIVF------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 465 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
+.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~~ 232 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKK 232 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhccc
Confidence 877543211 12334689999999999999999999999999999999999999965322111000 00000000
Q ss_pred cCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 007788 539 LKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 580 (589)
Q Consensus 539 ~~~---~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~ 580 (589)
... ......+.++.+++..||+.+|++||+++++.+.|+.+.
T Consensus 233 ~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 000 011223467899999999999999999999988887653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=361.04 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=193.5
Q ss_pred cCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCccceeeeeecC----CCCeEE
Q 007788 310 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGECF 384 (589)
Q Consensus 310 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----~~~~~~ 384 (589)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|++++++++|||||++++++... +....+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 4777889999999999999985 699999999976532 234799999999999999999988543 233578
Q ss_pred EEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEccccc
Q 007788 385 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGL 463 (589)
Q Consensus 385 lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGl 463 (589)
+||||++++.+..+.+.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 96 lv~Ey~~~~~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~-----IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEECCSEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEeccCCccHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CcccCCCcceEEEecCCCceeEecccc
Confidence 999999876444443322 22345999999999999999999999988 99999999999999775 899999999
Q ss_pred cccccCCceeeeecCCccccccCcccccC-CCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH-----------
Q 007788 464 HKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------- 531 (589)
Q Consensus 464 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~----------- 531 (589)
++....... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.............
T Consensus 170 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 170 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 987654332 223467888999998765 468999999999999999999999996543221111100
Q ss_pred HHh----hccccC--------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 007788 532 ENF----IDRNLK--------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 577 (589)
Q Consensus 532 ~~~----~~~~~~--------~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~ 577 (589)
... .+.... ..........+.+++.+|++.||++|||++|++++-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 000 000000 0011234557889999999999999999999998743
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=349.53 Aligned_cols=258 Identities=17% Similarity=0.305 Sum_probs=203.0
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|+.++++++||||+++++++.. ....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 57889999999999999999975 789999999976543 3445789999999999999999999999954 5788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 466 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~~ 466 (589)
+||+.+++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++.
T Consensus 80 ~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~-----IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EECCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eeecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcCC-----EeeecccCcccccccCCceeeeecchhhc
Confidence 99999999988876543 3889999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhcc--------
Q 007788 467 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-------- 537 (589)
Q Consensus 467 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 537 (589)
...... ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||............+......
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 654332 222334567799999987765 6899999999999999999999975322111110111000000
Q ss_pred ----------------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 538 ----------------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 538 ----------------~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
.............+.+++.+|++.||.+|||++|++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 00001122335678899999999999999999999987543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.5e-43 Score=353.63 Aligned_cols=252 Identities=16% Similarity=0.228 Sum_probs=198.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lv 386 (589)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|+++|.+++ ||||+++++++........++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999999999999974 7999999999743 2457889999999995 9999999999876556679999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC-ceEEccccccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHK 465 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfGla~ 465 (589)
|||+++++|..+.+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g-----IvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc-----cccccccccceEEcCCCCeeeecccccce
Confidence 99999999977642 3899999999999999999999998 99999999999998655 68999999998
Q ss_pred cccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhH-------------
Q 007788 466 LLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF------------- 531 (589)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~------------- 531 (589)
....... .....+|..|+|||.+.+.. ++.++||||+||++|||++|+.||............+
T Consensus 179 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 179 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred eccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 7654432 23345788899999987754 7999999999999999999999986432110000000
Q ss_pred -----------HHhhcc--------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 532 -----------ENFIDR--------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 532 -----------~~~~~~--------~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
...... ............++.+++.+|++.||++|||++|+++|-+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000000 00001112234678899999999999999999999987654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-44 Score=359.47 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=203.1
Q ss_pred ccCccccccccCCCccEEEEEec----CCcEEEEEEeccCCC---chHHHHHHHHHHHHhccCC-CCccceeeeeecCCC
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGR 380 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~ 380 (589)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ....+.+.+|++++++++| |||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--C
Confidence 56889999999999999999852 588999999865321 2233568899999999976 899999998844 4
Q ss_pred CeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcc
Q 007788 381 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 460 (589)
Q Consensus 381 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D 460 (589)
...++||||+.+|+|.+++..... +.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESC
T ss_pred CceeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcCC-----EEeccCCccceeecCCCCEEEee
Confidence 789999999999999999987653 677888999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCceeeeecCCccccccCcccccCC--CCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHHHhhccc
Q 007788 461 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 538 (589)
Q Consensus 461 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 538 (589)
||+++.+............+++.|+|||.+.+. .++.++|||||||+||||+||+.||...................
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~- 251 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS- 251 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-
Confidence 999987654433333345678889999998764 46889999999999999999999997653221111111221111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 007788 539 LKGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT 577 (589)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~C~~~dp~~RP-----s~~evl~~L~ 577 (589)
....+...+..+.+++.+||+.||++|| |++|+++|-+
T Consensus 252 -~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 252 -EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 2233445677899999999999999999 5899988654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-42 Score=344.59 Aligned_cols=259 Identities=15% Similarity=0.146 Sum_probs=200.3
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccCC-CCccceeeeeecCCCCeEEEE
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGRGECFLI 386 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~lv 386 (589)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+|++.+..+.| +|++.+++++.. ....++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEE
Confidence 57888999999999999999975 689999999865432 2346778888888865 899999988854 4788999
Q ss_pred EEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecC-----CCceEEccc
Q 007788 387 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-----QFNPLIADC 461 (589)
Q Consensus 387 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Df 461 (589)
|||+ +++|.+++..... .+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 80 me~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~g-----iiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHCC-----ceeccCCccceeecCcccccCCceEEccc
Confidence 9999 7899999876543 4899999999999999999999998 999999999999974 578999999
Q ss_pred cccccccCCce------eeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH--hhhhHHH
Q 007788 462 GLHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA--ESATFEN 533 (589)
Q Consensus 462 Gla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~ 533 (589)
|+|+.+..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ....+..
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 99987653221 112234689999999999999999999999999999999999999964321100 0000100
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 007788 534 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 581 (589)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~~~~ 581 (589)
..............+.++.+++..|++.+|++||+++.+.+.|+++.+
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 000000000011234578899999999999999999999888887644
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=349.45 Aligned_cols=256 Identities=18% Similarity=0.282 Sum_probs=192.4
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC----CCCe
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGE 382 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----~~~~ 382 (589)
++|++.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++|||||++++++... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999976 699999999976543 33445788999999999999999999998543 2368
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++||||+.++ +.+.+.. .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~g-----iiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhcc-----cccccCCccccccccccceeeechh
Confidence 89999999765 4444432 3899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhh-------------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA------------- 529 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~------------- 529 (589)
+++...... ......+|..|+|||++.+..++.++||||+||++|||++|+.||.+.........
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 988665432 22334578889999999999999999999999999999999999964322111000
Q ss_pred -----hHHHhhcc---------------ccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 530 -----TFENFIDR---------------NLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 530 -----~~~~~~~~---------------~~~~~~---~~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
........ ...... .......+.+++.+|++.||++|||++|+++|-+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 00111111 011111 12346778999999999999999999999988654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=352.10 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=196.5
Q ss_pred hccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCC-chHHHHHHHHHHHHhccCCCCccceeeeeecC---CCCe
Q 007788 308 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGE 382 (589)
Q Consensus 308 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~---~~~~ 382 (589)
.++|+..+.||+|+||+||+|+.. +|+.||||++..... ....+.+.+|++++++++|||||++++++... +...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999964 799999999976543 23446788999999999999999999987532 1234
Q ss_pred EEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEcccc
Q 007788 383 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 462 (589)
Q Consensus 383 ~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 462 (589)
.++++||+.+|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g-----iiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCccccccccccccccccc
Confidence 46677888899999999643 3999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCceeeeecCCccccccCcccccCCC-CCCcchhhhHHHHHHHHHhCCCCcchhHHHHHhhhhHH---------
Q 007788 463 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--------- 532 (589)
Q Consensus 463 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------- 532 (589)
++....... ....++..|+|||...+.. ++.++||||+||++|||++|+.||.+............
T Consensus 167 ~a~~~~~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 167 LARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp ---CCTGGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhcccCccc----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 997664422 2345778899999877654 68899999999999999999999965432211111100
Q ss_pred ----------HhhccccC-CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 007788 533 ----------NFIDRNLK-GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 578 (589)
Q Consensus 533 ----------~~~~~~~~-~~~~-----~~~~~~l~~l~~~C~~~dp~~RPs~~evl~~L~~ 578 (589)
........ .... ......+.+++.+|++.||++|||++|+++|-+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 00000000 0000 1224567899999999999999999999998554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-37 Score=320.30 Aligned_cols=258 Identities=19% Similarity=0.261 Sum_probs=194.7
Q ss_pred ccCccccccccCCCccEEEEEec-CCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-----------CCCccceeeeee
Q 007788 309 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----------HENIIRLRGFCC 376 (589)
Q Consensus 309 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~ 376 (589)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 35888999999999999999974 7999999999754 233456788888888775 578999999886
Q ss_pred cCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcC-CCCCCCCeEecCCCCCCeeecCCCc
Q 007788 377 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFN 455 (589)
Q Consensus 377 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~ 455 (589)
.......+++++++..+.......... ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~-----IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEEET
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC-----cccccCChhHeeeeccCc
Confidence 655667778888877665444333222 23458899999999999999999997 66 999999999999986653
Q ss_pred ------eEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHHHHHHHhCCCCcchhHHHHH---
Q 007788 456 ------PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA--- 526 (589)
Q Consensus 456 ------~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~--- 526 (589)
++++|||.+...... .....+|+.|+|||.+....++.++||||+||+++||++|+.||........
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred ccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 899999998765432 2345688899999999999999999999999999999999999863211000
Q ss_pred ---hh-----------------hhHHHhhcc-------------------ccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 007788 527 ---ES-----------------ATFENFIDR-------------------NLKGKFSESEAAKLGKMALVCTHEDPENRP 567 (589)
Q Consensus 527 ---~~-----------------~~~~~~~~~-------------------~~~~~~~~~~~~~l~~l~~~C~~~dp~~RP 567 (589)
.. .......+. .............+.+++.+|++.||++||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 00 000000000 001223466788899999999999999999
Q ss_pred CHHHHHHHHHh
Q 007788 568 TMEAVIEELTV 578 (589)
Q Consensus 568 s~~evl~~L~~ 578 (589)
|++|+++|-+.
T Consensus 321 ta~e~L~Hp~f 331 (362)
T d1q8ya_ 321 DAGGLVNHPWL 331 (362)
T ss_dssp CHHHHHTCGGG
T ss_pred CHHHHhcCccc
Confidence 99999988554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.2e-23 Score=192.66 Aligned_cols=169 Identities=14% Similarity=0.109 Sum_probs=118.8
Q ss_pred ccccccccCCCccEEEEEecCCcEEEEEEeccCCCc-----------------hHHHHHHHHHHHHhccCCCCccceeee
Q 007788 312 SEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-----------------SEEAEFVKGLYLLTSLRHENIIRLRGF 374 (589)
Q Consensus 312 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~~e~~~l~~l~H~niv~l~g~ 374 (589)
...+.||+|+||.||+|...+|+.||||+++..... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346789999999999999989999999987532110 012345568889999999999998765
Q ss_pred eecCCCCeEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCC
Q 007788 375 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 454 (589)
Q Consensus 375 ~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~ 454 (589)
. . .+++|||++++.+.+ +++.....++.|++++|+|||+.+ |+||||||+|||++++
T Consensus 83 ~--~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g-----iiHrDiKP~NILv~~~- 139 (191)
T d1zara2 83 E--G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp E--T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEEETT-
T ss_pred c--C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC-----EEEccCChhheeeeCC-
Confidence 3 1 269999998865432 233345679999999999999988 9999999999999965
Q ss_pred ceEEccccccccccCCceeeeecCCccccccCcccccCCCCCCcchhhhHHHH
Q 007788 455 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVI 507 (589)
Q Consensus 455 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvv 507 (589)
.++|+|||.|............. ..... -.|. ....|..++|+||..--
T Consensus 140 ~~~liDFG~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 140 GIWIIDFPQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp EEEECCCTTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred CEEEEECCCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHHH
Confidence 58999999987654321100000 00000 0111 13567889999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.62 E-value=1.8e-16 Score=145.75 Aligned_cols=117 Identities=24% Similarity=0.324 Sum_probs=104.1
Q ss_pred ccceEEEccCcccccCC-CccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 40 LCFVVLQLCCNQLTGNI-PAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
++++.|+|++|+|++.+ +..|+++++|+.|+|++|++.+..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 57999999999998755 45789999999999999999999999999999999999999999987788899999999999
Q ss_pred ccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCc
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLR 156 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~ 156 (589)
|++|+|++..|+.|..+.. .+.+.+|++.|+|.+..+.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~ 148 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchHHHh
Confidence 9999999988888876654 4678899999998776544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=7.4e-15 Score=142.07 Aligned_cols=120 Identities=28% Similarity=0.245 Sum_probs=92.2
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|++|+|++|.+.+..+..+..+.+|+.|++++|.+++..|..+..+++|+.|++++|+|++..|..|..+++|+.|+
T Consensus 99 l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~ 178 (266)
T d1p9ag_ 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (266)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee
Confidence 55566666666665554555556666666666677777755556677899999999999999988888899999999999
Q ss_pred ccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCcccc
Q 007788 119 VQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRACT 159 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~~ 159 (589)
|++|+|+ .+|+.+..+.. .+.+.+|||.|+|.+.++..+.
T Consensus 179 Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~l~~wl 220 (266)
T d1p9ag_ 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWL 220 (266)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHH
T ss_pred cccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchHHHHHHH
Confidence 9999999 78877766543 5678999999999887766543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.50 E-value=1.1e-14 Score=144.35 Aligned_cols=109 Identities=31% Similarity=0.474 Sum_probs=95.1
Q ss_pred ceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccC
Q 007788 42 FVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQN 121 (589)
Q Consensus 42 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~ 121 (589)
+..+++++|.+.|.+|..++.+++|+.|++++|+++|.+| .++.+++|+.|+|++|+|+|.+|+.|+++++|+.|||++
T Consensus 199 ~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 4468888888888888889999999999999999998765 699999999999999999999999999999999999999
Q ss_pred CcCcccCchh--HhhccCCccccCCCCCCCCCC
Q 007788 122 NTLSGIVPSA--LKRLNGGFQFQNNPGLCGDGI 152 (589)
Q Consensus 122 N~l~g~~p~~--~~~~~~~~~~~~n~~~c~~~~ 152 (589)
|+|+|.+|.. +..+ ..+.+.+|+.+||.++
T Consensus 278 N~l~g~iP~~~~L~~L-~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRF-DVSAYANNKCLCGSPL 309 (313)
T ss_dssp SEEEEECCCSTTGGGS-CGGGTCSSSEEESTTS
T ss_pred CcccccCCCcccCCCC-CHHHhCCCccccCCCC
Confidence 9999999963 3333 2467889999998653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1e-14 Score=142.46 Aligned_cols=120 Identities=26% Similarity=0.271 Sum_probs=107.3
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|.+|.++++|+.|++++|++++..|..|..+++|+.|
T Consensus 127 ~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 37889999999999997667789999999999999999998888899999999999999999999899999999999999
Q ss_pred eccCCcCcccCchhHhhccC--CccccCCCCCCCCCCccCcc
Q 007788 118 DVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRA 157 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~~ 157 (589)
|+++|++++..|..+..+.. .+.+.+|||.|+|.+..+..
T Consensus 207 ~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~ 248 (284)
T d1ozna_ 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248 (284)
T ss_dssp ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred cccccccccccccccccccccCEEEecCCCCCCCccchHHHH
Confidence 99999999988888877653 46788999999998765443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.49 E-value=1.6e-14 Score=132.42 Aligned_cols=117 Identities=24% Similarity=0.174 Sum_probs=99.4
Q ss_pred ccccccccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCC
Q 007788 12 IHGKIIVFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 91 (589)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 91 (589)
|+..+..++...|.|...+.. ..+..+++|+.|+|++|++.+.++..|..+++|+.|+|++|+|++..|.+|.++++|+
T Consensus 27 lp~~l~~L~Ls~N~i~~~~~~-~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~ 105 (192)
T d1w8aa_ 27 IPLHTTELLLNDNELGRISSD-GLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLK 105 (192)
T ss_dssp CCTTCSEEECCSCCCCSBCCS-CSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCC
T ss_pred CCCCCCEEEeCCCCCcccccc-cccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccc
Confidence 344555667777766543322 2445699999999999999999999999999999999999999987788899999999
Q ss_pred eeeccCccccCCChhhhhcCCCCceeeccCCcCcccCc
Q 007788 92 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 92 ~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p 129 (589)
.|+|++|+|++..|..|..+++|+.|+|++|.+.+..+
T Consensus 106 ~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 106 TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99999999998888889999999999999999986544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.48 E-value=1.8e-14 Score=142.77 Aligned_cols=117 Identities=28% Similarity=0.449 Sum_probs=102.0
Q ss_pred cccccccccc------cchhhhhhhhhHhhcccceEEEccC-cccccCCCccccCCCCCCeEeccCCcCCccCCccccCC
Q 007788 15 KIIVFKEFSN------KIFVIIFQIQLKVILLCFVVLQLCC-NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL 87 (589)
Q Consensus 15 ~~~~~~~~~~------~~~~~~~~~~~~~~l~~l~~L~L~~-n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 87 (589)
.|+.+|...+ .||..+.. |++|++|+|++ |+|+|.+|.+|++|++|++|+|++|+++|..|..+..+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~------L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~ 124 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLAN------LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGG------CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGC
T ss_pred EEEEEECCCCCCCCCCCCChHHhc------Cccccccccccccccccccccccccccccchhhhccccccccccccccch
Confidence 3555544433 35666655 99999999986 89999999999999999999999999999999999999
Q ss_pred CCCCeeeccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC
Q 007788 88 GKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 137 (589)
Q Consensus 88 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~ 137 (589)
..|+.+++++|++.+.+|..+.+++.|+.+++++|.++|.+|..+..+..
T Consensus 125 ~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~ 174 (313)
T d1ogqa_ 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCT
T ss_pred hhhcccccccccccccCchhhccCcccceeeccccccccccccccccccc
Confidence 99999999999999999999999999999999999999999988776643
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=2e-13 Score=115.22 Aligned_cols=85 Identities=31% Similarity=0.466 Sum_probs=63.3
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCC-hhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI-PESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~~L~~l 117 (589)
+++|+.|+|++|+|+ .+|+.|+.+++|+.|+|++|+|+ .+| .++++++|+.|++++|+|+... +..+..+++|+.|
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEE
Confidence 777888888888887 56777777888888888888887 454 4777888888888888877332 1457777788888
Q ss_pred eccCCcCcc
Q 007788 118 DVQNNTLSG 126 (589)
Q Consensus 118 ~l~~N~l~g 126 (589)
++++|+++.
T Consensus 96 ~l~~N~i~~ 104 (124)
T d1dcea3 96 NLQGNSLCQ 104 (124)
T ss_dssp ECTTSGGGG
T ss_pred ECCCCcCCc
Confidence 888888764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.7e-13 Score=120.68 Aligned_cols=119 Identities=17% Similarity=0.175 Sum_probs=92.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCC-cCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHN-RLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
+...+.++++++++. .+|..+..+++|+.|+|++| .|+..-+.+|.++++|+.|+|++|+|+...|.+|..+++|+.|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 445667888888888 67888888899999999766 4885555678899999999999999997667888899999999
Q ss_pred eccCCcCcccCchhHhhcc-CCccccCCCCCCCCCCccCccc
Q 007788 118 DVQNNTLSGIVPSALKRLN-GGFQFQNNPGLCGDGIASLRAC 158 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~-~~~~~~~n~~~c~~~~~~l~~~ 158 (589)
+|++|+|+...+..+..+. ..+.+.+||+.|+|.+.++..+
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~ 127 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHH
T ss_pred eccCCCCcccChhhhccccccccccCCCcccCCchHHHHHHH
Confidence 9999999855555554332 2467889999999987766544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.40 E-value=5e-13 Score=112.69 Aligned_cols=98 Identities=31% Similarity=0.325 Sum_probs=82.8
Q ss_pred eEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeeccCC
Q 007788 43 VVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 122 (589)
Q Consensus 43 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l~~N 122 (589)
++|+|++|+++ .+| .++.+++|++|+|++|+|+ .+|++|+.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 57999999999 666 4899999999999999999 78999999999999999999999 566 5999999999999999
Q ss_pred cCcccCc-hhHhhccC--CccccCCC
Q 007788 123 TLSGIVP-SALKRLNG--GFQFQNNP 145 (589)
Q Consensus 123 ~l~g~~p-~~~~~~~~--~~~~~~n~ 145 (589)
+++.... ..+..+.. .+.+.+|+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCc
Confidence 9986542 45555543 35566775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=2.3e-12 Score=114.08 Aligned_cols=85 Identities=18% Similarity=0.117 Sum_probs=66.3
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+..|+.|+|++|+|+ .+|..+..+++|+.|||++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence 567888888888888 66776777888888888888888 564 578888888888888888854444566788888888
Q ss_pred ccCCcCcc
Q 007788 119 VQNNTLSG 126 (589)
Q Consensus 119 l~~N~l~g 126 (589)
|++|+++.
T Consensus 94 L~~N~i~~ 101 (162)
T d1a9na_ 94 LTNNSLVE 101 (162)
T ss_dssp CCSCCCCC
T ss_pred eccccccc
Confidence 88888874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=4.8e-12 Score=111.19 Aligned_cols=94 Identities=22% Similarity=0.176 Sum_probs=80.1
Q ss_pred cchhhhhhhhhHhhcccceEEEccCc-ccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCC
Q 007788 25 KIFVIIFQIQLKVILLCFVVLQLCCN-QLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 103 (589)
Q Consensus 25 ~~~~~~~~~~~~~~l~~l~~L~L~~n-~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 103 (589)
.+|..++. +++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+...|.+|.++++|+.|+|++|+|+ .
T Consensus 22 ~~p~~l~~------l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~ 94 (156)
T d2ifga3 22 DSLHHLPG------AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-S 94 (156)
T ss_dssp TTTTTSCS------CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-C
T ss_pred cCcccccC------ccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-c
Confidence 44555544 889999999876 588665678999999999999999999777888999999999999999999 6
Q ss_pred ChhhhhcCCCCceeeccCCcCc
Q 007788 104 IPESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 104 ~p~~~~~l~~L~~l~l~~N~l~ 125 (589)
+|.......+|+.|+|++|.+.
T Consensus 95 l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 95 LSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSTTTCSCCCCEEECCSSCCC
T ss_pred cChhhhccccccccccCCCccc
Confidence 6666555668999999999995
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.2e-11 Score=109.35 Aligned_cols=103 Identities=24% Similarity=0.229 Sum_probs=83.1
Q ss_pred cccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCc
Q 007788 19 FKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98 (589)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 98 (589)
+|...|+|... + ++...+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+++...+..+..+++|+.|+|++|
T Consensus 23 L~L~~n~I~~i-~--~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N 97 (162)
T d1a9na_ 23 LDLRGYKIPVI-E--NLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 97 (162)
T ss_dssp EECTTSCCCSC-C--CGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSC
T ss_pred EECCCCCCCcc-C--ccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccc
Confidence 45555555533 2 23455899999999999999 554 5899999999999999999544445678999999999999
Q ss_pred cccCCChh--hhhcCCCCceeeccCCcCccc
Q 007788 99 SLFGTIPE--SLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 99 ~l~g~~p~--~~~~l~~L~~l~l~~N~l~g~ 127 (589)
+|+ .+++ .+..+++|+.|++++|.++..
T Consensus 98 ~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 98 SLV-ELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CCC-CGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred ccc-ccccccccccccccchhhcCCCccccc
Confidence 998 5554 688999999999999999743
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=1.8e-11 Score=118.98 Aligned_cols=93 Identities=27% Similarity=0.248 Sum_probs=87.3
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|++|++++|++++..|..|..+++|+.
T Consensus 150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~ 229 (284)
T d1ozna_ 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence 34889999999999999888889999999999999999999999999999999999999999999998899999999999
Q ss_pred eeccCCcCcccCc
Q 007788 117 LDVQNNTLSGIVP 129 (589)
Q Consensus 117 l~l~~N~l~g~~p 129 (589)
|+|++|.+.+.-+
T Consensus 230 L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 230 LRLNDNPWVCDCR 242 (284)
T ss_dssp EECCSSCEECSGG
T ss_pred EEecCCCCCCCcc
Confidence 9999999997544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.15 E-value=2.9e-11 Score=118.71 Aligned_cols=110 Identities=25% Similarity=0.289 Sum_probs=89.8
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|+.|+|++|..++.++..|..+++++.|++++|++++..|..+.++++|++|+|++|+|+ .+|+.|..+++|+.|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 677889999999999888889999999999999999999888888899999999999999998 7888999999999999
Q ss_pred ccCCcCcccCchhHhh------cc--CCccccCCCCCCC
Q 007788 119 VQNNTLSGIVPSALKR------LN--GGFQFQNNPGLCG 149 (589)
Q Consensus 119 l~~N~l~g~~p~~~~~------~~--~~~~~~~n~~~c~ 149 (589)
|++|+|+......|.. .. ..+.+.+|||.+.
T Consensus 249 Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred CCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 9999998554333321 11 1345677777653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=8.4e-11 Score=112.93 Aligned_cols=89 Identities=28% Similarity=0.223 Sum_probs=82.8
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+.+|+.|++++|.++...+..+..+++|+.|++++|+|++..|..|..+++|++|+|++|+|+ .+|+.+..+++|+.
T Consensus 121 ~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~ 199 (266)
T d1p9ag_ 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199 (266)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSE
T ss_pred ccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCE
Confidence 44899999999999999777778899999999999999999888888999999999999999999 89999999999999
Q ss_pred eeccCCcCcc
Q 007788 117 LDVQNNTLSG 126 (589)
Q Consensus 117 l~l~~N~l~g 126 (589)
|+|++|.+..
T Consensus 200 L~L~~Np~~C 209 (266)
T d1p9ag_ 200 AFLHGNPWLC 209 (266)
T ss_dssp EECCSCCBCC
T ss_pred EEecCCCCCC
Confidence 9999999864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.01 E-value=7.3e-12 Score=114.71 Aligned_cols=105 Identities=21% Similarity=0.316 Sum_probs=83.2
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
+..|++|+.|+|++|+|+ .++ .+..|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+ .+ +.+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l-~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CH-HHHHHHHHSS
T ss_pred HhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cc-cccccccccc
Confidence 344999999999999999 665 5899999999999999998 78877777789999999999999 45 4588899999
Q ss_pred eeeccCCcCcccCc-hhHhhccC--CccccCCC
Q 007788 116 FLDVQNNTLSGIVP-SALKRLNG--GFQFQNNP 145 (589)
Q Consensus 116 ~l~l~~N~l~g~~p-~~~~~~~~--~~~~~~n~ 145 (589)
.|+|++|+++.... ..+..+.. .+.+.+|+
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~ 151 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred ccccccchhccccccccccCCCccceeecCCCc
Confidence 99999999985422 23444432 23445553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.97 E-value=6.4e-10 Score=108.80 Aligned_cols=87 Identities=18% Similarity=0.190 Sum_probs=77.8
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChh-h------hh
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-S------LA 109 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~------~~ 109 (589)
..++.+++|++++|.+++..|..|.++++|++|+|++|+|+ .+|++|.++++|+.|+|++|+|+ .++. . +.
T Consensus 192 ~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~ 269 (305)
T d1xkua_ 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNT 269 (305)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCT
T ss_pred hccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhc
Confidence 34889999999999999888899999999999999999999 78999999999999999999999 5543 2 34
Q ss_pred cCCCCceeeccCCcCc
Q 007788 110 NNAELLFLDVQNNTLS 125 (589)
Q Consensus 110 ~l~~L~~l~l~~N~l~ 125 (589)
.+.+|+.|+|++|.++
T Consensus 270 ~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 270 KKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TSCCCSEEECCSSSSC
T ss_pred ccCCCCEEECCCCcCc
Confidence 5788999999999986
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.95 E-value=2.3e-11 Score=111.30 Aligned_cols=91 Identities=20% Similarity=0.139 Sum_probs=78.5
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCCh--hhhhcCCC
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP--ESLANNAE 113 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~ 113 (589)
+..|++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ .++ .+.++++|+.|+|++|+|+ .++ ..+..+++
T Consensus 66 l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~ 141 (198)
T d1m9la_ 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDK 141 (198)
T ss_dssp HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTT
T ss_pred ccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhc-cccccccccCCCc
Confidence 345999999999999998 77877777789999999999999 454 5889999999999999998 555 46899999
Q ss_pred CceeeccCCcCcccCch
Q 007788 114 LLFLDVQNNTLSGIVPS 130 (589)
Q Consensus 114 L~~l~l~~N~l~g~~p~ 130 (589)
|+.|+|++|++....+.
T Consensus 142 L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 142 LEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp CSEEEECSSHHHHHHCT
T ss_pred cceeecCCCccccCccc
Confidence 99999999999765443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.82 E-value=1.9e-09 Score=108.68 Aligned_cols=91 Identities=34% Similarity=0.447 Sum_probs=73.4
Q ss_pred hcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCcee
Q 007788 38 ILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 117 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l 117 (589)
.+..++.++++.|++++ + ..+..+++|+.|+|++|++++. + .+..+++|+.|+|++|+|++ +| .+.++++|+.|
T Consensus 283 ~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L 356 (384)
T d2omza2 283 GLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWL 356 (384)
T ss_dssp TCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred ccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEE
Confidence 47888899999999885 3 3578889999999999999864 3 38889999999999999984 55 68889999999
Q ss_pred eccCCcCcccCchhHhhcc
Q 007788 118 DVQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 118 ~l~~N~l~g~~p~~~~~~~ 136 (589)
+|++|+|++.+| +..+.
T Consensus 357 ~l~~N~l~~l~~--l~~l~ 373 (384)
T d2omza2 357 SAGHNQISDLTP--LANLT 373 (384)
T ss_dssp ECCSSCCCBCGG--GTTCT
T ss_pred ECCCCcCCCChh--hccCC
Confidence 999999997665 44443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=5.7e-09 Score=105.01 Aligned_cols=101 Identities=27% Similarity=0.329 Sum_probs=70.6
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccC--------------------CccccCCCCCCeeeccCc
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI--------------------PDSLGNLGKLKRLDLSFN 98 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~--------------------p~~~~~l~~L~~L~ls~N 98 (589)
+++|+.|++++|.+++..| ++.+++|+.|++++|++++.. +..+..+++++.|+|++|
T Consensus 240 l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n 317 (384)
T d2omza2 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSS
T ss_pred ccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCC
Confidence 6667777777777764332 566667777777766666422 224667789999999999
Q ss_pred cccCCChhhhhcCCCCceeeccCCcCcccCchhHhhccC--CccccCCC
Q 007788 99 SLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNP 145 (589)
Q Consensus 99 ~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~--~~~~~~n~ 145 (589)
+|++. + .+..+++|+.|++++|+|++ +| .+..+.. .+.+.+|.
T Consensus 318 ~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 318 NISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQ 362 (384)
T ss_dssp CCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSC
T ss_pred CCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCc
Confidence 99965 3 38889999999999999985 44 4665543 34555553
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.73 E-value=1.2e-08 Score=92.82 Aligned_cols=81 Identities=30% Similarity=0.385 Sum_probs=42.1
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|++|+|++|++++. ++ ++++++|+.|++++|.+. .+| .+++++.|+.|++++|.+.. + +.+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhh
Confidence 55555555555555532 22 555555555555555554 233 25555555555555555542 2 2344555555555
Q ss_pred ccCCcCc
Q 007788 119 VQNNTLS 125 (589)
Q Consensus 119 l~~N~l~ 125 (589)
+++|++.
T Consensus 135 l~~n~l~ 141 (199)
T d2omxa2 135 LSSNTIS 141 (199)
T ss_dssp CCSSCCC
T ss_pred hhhhhhc
Confidence 5555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.71 E-value=3e-08 Score=90.22 Aligned_cols=100 Identities=29% Similarity=0.370 Sum_probs=79.0
Q ss_pred cccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCc
Q 007788 19 FKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 98 (589)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 98 (589)
++...|+|... .+ +..+++|+.|++++|.+. .+| .++++++|+.|++++|++.. + +.+..+++|+.|++++|
T Consensus 67 L~Ls~N~l~~~-~~---l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 67 INFSNNQLTDI-TP---LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSN 138 (199)
T ss_dssp EECCSSCCCCC-GG---GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSS
T ss_pred CccccccccCc-cc---ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhhhhh
Confidence 45555555432 12 345899999999999988 555 48899999999999999884 3 35888999999999999
Q ss_pred cccCCChhhhhcCCCCceeeccCCcCcccC
Q 007788 99 SLFGTIPESLANNAELLFLDVQNNTLSGIV 128 (589)
Q Consensus 99 ~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~ 128 (589)
++. .+| .+..+++|+.|++++|++++..
T Consensus 139 ~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~ 166 (199)
T d2omxa2 139 TIS-DIS-ALSGLTSLQQLNFSSNQVTDLK 166 (199)
T ss_dssp CCC-CCG-GGTTCTTCSEEECCSSCCCCCG
T ss_pred hhc-ccc-cccccccccccccccccccCCc
Confidence 998 454 6888999999999999998643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.70 E-value=1e-08 Score=95.52 Aligned_cols=87 Identities=29% Similarity=0.355 Sum_probs=70.0
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
...+.+..+.++++.+.... .+..+++|+.|++++|++++. + .++++++|+.|+|++|++++ +|+ +..+++|+.
T Consensus 126 ~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~ 199 (227)
T d1h6ua2 126 AGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIE 199 (227)
T ss_dssp TTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCE
T ss_pred ccccchhhhhchhhhhchhh--hhccccccccccccccccccc-h-hhcccccceecccCCCccCC-Chh-hcCCCCCCE
Confidence 34778889999998887443 377888999999999998843 2 48889999999999999984 554 888999999
Q ss_pred eeccCCcCcccCc
Q 007788 117 LDVQNNTLSGIVP 129 (589)
Q Consensus 117 l~l~~N~l~g~~p 129 (589)
|+|++|++++..|
T Consensus 200 L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 200 VHLKNNQISDVSP 212 (227)
T ss_dssp EECTTSCCCBCGG
T ss_pred EECcCCcCCCCcc
Confidence 9999999986543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.69 E-value=2.1e-08 Score=92.09 Aligned_cols=81 Identities=26% Similarity=0.284 Sum_probs=53.5
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
|.+|+.|++++|.++. ++ .+..+++|+.|+|++|++++ +| .+++|++|+.|++++|+|+ .+| .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccc
Confidence 5667777777777763 33 26667777777777777774 33 3566777777777777776 344 466677777777
Q ss_pred ccCCcCc
Q 007788 119 VQNNTLS 125 (589)
Q Consensus 119 l~~N~l~ 125 (589)
+++|.+.
T Consensus 119 l~~~~~~ 125 (210)
T d1h6ta2 119 LEHNGIS 125 (210)
T ss_dssp CTTSCCC
T ss_pred ccccccc
Confidence 7777665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.62 E-value=2.9e-08 Score=91.12 Aligned_cols=85 Identities=34% Similarity=0.416 Sum_probs=72.3
Q ss_pred hhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCce
Q 007788 37 VILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 116 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 116 (589)
..+++|+.|+|++|++++ ++ .++.|++|+.|+|++|+|+ .+| .+.++++|+.|++++|.+. .+ +.+..+++|+.
T Consensus 65 ~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~ 138 (210)
T d1h6ta2 65 QYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLES 138 (210)
T ss_dssp GGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCE
T ss_pred hhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccc
Confidence 348999999999999995 44 3788999999999999998 466 5889999999999999987 44 46888999999
Q ss_pred eeccCCcCccc
Q 007788 117 LDVQNNTLSGI 127 (589)
Q Consensus 117 l~l~~N~l~g~ 127 (589)
+++++|.+++.
T Consensus 139 l~~~~n~l~~~ 149 (210)
T d1h6ta2 139 LYLGNNKITDI 149 (210)
T ss_dssp EECCSSCCCCC
T ss_pred ccccccccccc
Confidence 99999999853
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=2.3e-08 Score=93.78 Aligned_cols=97 Identities=19% Similarity=0.216 Sum_probs=81.3
Q ss_pred cchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCc-cccCCCCCCeeecc-CccccC
Q 007788 25 KIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLS-FNSLFG 102 (589)
Q Consensus 25 ~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~ls-~N~l~g 102 (589)
.+|..++ +++++|+|++|+|+...+..|.++++|++|+|++|.+...+|. +|.+++.++.|++. .|++..
T Consensus 22 ~iP~~l~--------~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~ 93 (242)
T d1xwdc1 22 EIPSDLP--------RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 93 (242)
T ss_dssp SCCSCSC--------SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCE
T ss_pred CcCCCCC--------CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccc
Confidence 6665543 4799999999999955556899999999999999999876654 68899999999986 578887
Q ss_pred CChhhhhcCCCCceeeccCCcCcccCc
Q 007788 103 TIPESLANNAELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 103 ~~p~~~~~l~~L~~l~l~~N~l~g~~p 129 (589)
..|..|..+++|+.|++++|++....+
T Consensus 94 ~~~~~~~~l~~L~~l~l~~~~l~~~~~ 120 (242)
T d1xwdc1 94 INPEAFQNLPNLQYLLISNTGIKHLPD 120 (242)
T ss_dssp ECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred cccccccccccccccccchhhhccccc
Confidence 888889999999999999999975433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.51 E-value=9e-08 Score=88.81 Aligned_cols=93 Identities=27% Similarity=0.318 Sum_probs=73.2
Q ss_pred HhhcccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCc
Q 007788 36 KVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 115 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 115 (589)
+..+++|+.|+++++...+. ..+...+.+..++++++.+.... .+.++++|+.|++++|.+++. + .+.++++|+
T Consensus 103 l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~ 176 (227)
T d1h6ua2 103 IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLT 176 (227)
T ss_dssp GTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCC
T ss_pred cccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccc-h-hhcccccce
Confidence 34589999999999988754 34677889999999999988533 478889999999999998853 3 388899999
Q ss_pred eeeccCCcCcccCchhHhhcc
Q 007788 116 FLDVQNNTLSGIVPSALKRLN 136 (589)
Q Consensus 116 ~l~l~~N~l~g~~p~~~~~~~ 136 (589)
.|+|++|++++. |. +..+.
T Consensus 177 ~L~Ls~n~l~~l-~~-l~~l~ 195 (227)
T d1h6ua2 177 TLKADDNKISDI-SP-LASLP 195 (227)
T ss_dssp EEECCSSCCCCC-GG-GGGCT
T ss_pred ecccCCCccCCC-hh-hcCCC
Confidence 999999999864 32 44444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=1.8e-08 Score=88.39 Aligned_cols=74 Identities=26% Similarity=0.198 Sum_probs=47.9
Q ss_pred CCCccccCCCCCCeEeccCCcCCcc--CCccccCCCCCCeeeccCccccCCChh-hhhcCCCCceeeccCCcCcccCc
Q 007788 55 NIPAQIGSLKSLSVLTLQHNRLNGG--IPDSLGNLGKLKRLDLSFNSLFGTIPE-SLANNAELLFLDVQNNTLSGIVP 129 (589)
Q Consensus 55 ~~p~~~~~l~~L~~L~L~~N~l~g~--~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p 129 (589)
.++..+..+++|++|+|++|+|+.. ++..+..|++|+.|+|++|+++ .+++ .+....+|+.|+|++|.++....
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 3444445677777788888877742 2344566777888888888777 4443 33344567777788887775544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=4.1e-08 Score=86.02 Aligned_cols=82 Identities=26% Similarity=0.194 Sum_probs=65.5
Q ss_pred HhhcccceEEEccCcccccC--CCccccCCCCCCeEeccCCcCCccCCc-cccCCCCCCeeeccCccccCCChh------
Q 007788 36 KVILLCFVVLQLCCNQLTGN--IPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFGTIPE------ 106 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~--~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~------ 106 (589)
...+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+++ .+++ .+.....|+.|+|++|.++.....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 34599999999999999953 2355778999999999999999 4554 444556799999999999876543
Q ss_pred -hhhcCCCCceee
Q 007788 107 -SLANNAELLFLD 118 (589)
Q Consensus 107 -~~~~l~~L~~l~ 118 (589)
.+..+|+|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 366789999887
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=1.2e-06 Score=82.84 Aligned_cols=150 Identities=15% Similarity=0.079 Sum_probs=93.6
Q ss_pred HHHHhhccCccccccccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCC
Q 007788 303 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRG 381 (589)
Q Consensus 303 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~ 381 (589)
++...-+.|...+..+-++...||+...+ +..+++|+...... .....+.+|...+..+. +--+.+++.+.. ..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~ 83 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDG 83 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETT
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCC
Confidence 44554556655544333445689998754 55667787754431 12224567777766653 433556666653 346
Q ss_pred eEEEEEEeCCCCChHHHhhhhcCCCCCCCHHHHHHHHHHHHHHhHHhcCCCC----------------------------
Q 007788 382 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---------------------------- 433 (589)
Q Consensus 382 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~---------------------------- 433 (589)
..++|||++++.++.+..... .. ...++.++++.++.||+...
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred ceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 789999999998876554211 11 23355666666666664211
Q ss_pred --------------------------CCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 434 --------------------------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 434 --------------------------~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
..+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12237999999999999987767799998765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.27 E-value=4.9e-07 Score=89.07 Aligned_cols=74 Identities=27% Similarity=0.280 Sum_probs=43.7
Q ss_pred ccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceeec
Q 007788 40 LCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 119 (589)
Q Consensus 40 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~l 119 (589)
.+|+.|+|++|.|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .+++. .+.|+.|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 45666777777666 45642 356666677777776 566543 35566666666665 44321 134666666
Q ss_pred cCCcCc
Q 007788 120 QNNTLS 125 (589)
Q Consensus 120 ~~N~l~ 125 (589)
++|.++
T Consensus 106 ~~n~l~ 111 (353)
T d1jl5a_ 106 SNNQLE 111 (353)
T ss_dssp CSSCCS
T ss_pred cccccc
Confidence 666665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.18 E-value=1.2e-06 Score=86.19 Aligned_cols=80 Identities=34% Similarity=0.444 Sum_probs=67.3
Q ss_pred cccceEEEccCcccccCCCccccCCCCCCeEeccCCcCCccCCccccCCCCCCeeeccCccccCCChhhhhcCCCCceee
Q 007788 39 LLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 118 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~l~ 118 (589)
+++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.- .+.|++|+|++|.++ .+|. ++.+++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeec
Confidence 678999999999999 888764 57899999999998 55532 246999999999999 6775 68899999999
Q ss_pred ccCCcCcccC
Q 007788 119 VQNNTLSGIV 128 (589)
Q Consensus 119 l~~N~l~g~~ 128 (589)
+++|.++...
T Consensus 127 l~~~~~~~~~ 136 (353)
T d1jl5a_ 127 VDNNSLKKLP 136 (353)
T ss_dssp CCSSCCSCCC
T ss_pred cccccccccc
Confidence 9999998543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=3.3e-07 Score=93.70 Aligned_cols=91 Identities=24% Similarity=0.268 Sum_probs=71.7
Q ss_pred hhcccceEEEccCccccc----CCCccccCCCCCCeEeccCCcCCcc----CCcccc-CCCCCCeeeccCccccCC----
Q 007788 37 VILLCFVVLQLCCNQLTG----NIPAQIGSLKSLSVLTLQHNRLNGG----IPDSLG-NLGKLKRLDLSFNSLFGT---- 103 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g----~~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~-~l~~L~~L~ls~N~l~g~---- 103 (589)
..+++|+.|+|++|.++- .+...+..+++|+.|||++|+|+.. +...+. ...+|++|+|++|+++..
T Consensus 24 ~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~ 103 (460)
T d1z7xw1 24 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103 (460)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred HhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccc
Confidence 348999999999999882 3455678999999999999998631 222332 235799999999999754
Q ss_pred ChhhhhcCCCCceeeccCCcCccc
Q 007788 104 IPESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 104 ~p~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
++..+..+++|+.|+|++|.++..
T Consensus 104 l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 104 LSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp HHHHTTSCTTCCEEECCSSBCHHH
T ss_pred ccchhhccccccccccccccchhh
Confidence 566788899999999999999753
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.02 E-value=4.6e-06 Score=77.51 Aligned_cols=70 Identities=19% Similarity=0.185 Sum_probs=42.2
Q ss_pred CCCeEeccCCcCCccCCccccCCCCCCee-eccCccccCCChhhhhcCCCCceeeccCCcCcccCchhHhhc
Q 007788 65 SLSVLTLQHNRLNGGIPDSLGNLGKLKRL-DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 135 (589)
Q Consensus 65 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L-~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~ 135 (589)
.++.|++++|+++ .++..+.+..+++.+ ++++|+|+...+..|.++++|+.|+|++|+|+...+..+..+
T Consensus 154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred cceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 5566777777777 344444444444444 567777773333457777888888888888875444444433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=6.5e-06 Score=77.08 Aligned_cols=74 Identities=12% Similarity=0.090 Sum_probs=48.8
Q ss_pred cccCCC-ccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC--CCCccceeeeeecCCCCeEEEEEEeCCCC
Q 007788 317 LGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 317 lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
+..|.. +.||+...+++..+++|.-..... ..+..|...++.+. .-.+.++++++. +.+..++||||+++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEeeecc
Confidence 444543 578999988888889998654432 23556666666553 333566676653 346789999999886
Q ss_pred ChH
Q 007788 394 KLS 396 (589)
Q Consensus 394 sL~ 396 (589)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.82 E-value=8e-06 Score=78.01 Aligned_cols=118 Identities=17% Similarity=0.159 Sum_probs=74.2
Q ss_pred ccccccccchhhhhhhhhHhhcccceEEEccCcccccCCCccccCCCCCCeEeccC-CcCCcc-CCccccCCCCCCeeec
Q 007788 18 VFKEFSNKIFVIIFQIQLKVILLCFVVLQLCCNQLTGNIPAQIGSLKSLSVLTLQH-NRLNGG-IPDSLGNLGKLKRLDL 95 (589)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~l~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~-N~l~g~-~p~~~~~l~~L~~L~l 95 (589)
.+|...+.+...... .+...+++|+.|+|+++.++...+..++.+++|+.|+|++ +.++.. +..-+.++++|+.|+|
T Consensus 50 ~LdLs~~~i~~~~l~-~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l 128 (284)
T d2astb2 50 HMDLSNSVIEVSTLH-GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 128 (284)
T ss_dssp EEECTTCEECHHHHH-HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC
T ss_pred EEECCCCccCHHHHH-HHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccc
Confidence 345544455433322 2455689999999999998888788888899999999988 456521 2222344566666666
Q ss_pred cCc-ccc----------------------------CC-ChhhhhcCCCCceeeccCC-cCcccCchhHhhcc
Q 007788 96 SFN-SLF----------------------------GT-IPESLANNAELLFLDVQNN-TLSGIVPSALKRLN 136 (589)
Q Consensus 96 s~N-~l~----------------------------g~-~p~~~~~l~~L~~l~l~~N-~l~g~~p~~~~~~~ 136 (589)
++. +++ .. +...+..+++|+.|++++| .+++.....+.+++
T Consensus 129 s~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred ccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 652 221 10 1112345789999999885 57766666666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.71 E-value=5.8e-06 Score=84.07 Aligned_cols=89 Identities=22% Similarity=0.191 Sum_probs=61.7
Q ss_pred cccceEEEccCcccccCCCc----cccCCCCCCeEeccCCcCCcc----CCcccc-CCCCCCeeeccCccccCC----Ch
Q 007788 39 LLCFVVLQLCCNQLTGNIPA----QIGSLKSLSVLTLQHNRLNGG----IPDSLG-NLGKLKRLDLSFNSLFGT----IP 105 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~~p~----~~~~l~~L~~L~L~~N~l~g~----~p~~~~-~l~~L~~L~ls~N~l~g~----~p 105 (589)
...|+.+++++|.++..-.. .+...++|++|+|++|+++.. ++..+. ..+.|+.|+|++|+|+.. ++
T Consensus 311 ~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~ 390 (460)
T d1z7xw1 311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 390 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred ccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHH
Confidence 45688888888887744222 234456788888888888642 444443 356788888888888742 45
Q ss_pred hhhhcCCCCceeeccCCcCccc
Q 007788 106 ESLANNAELLFLDVQNNTLSGI 127 (589)
Q Consensus 106 ~~~~~l~~L~~l~l~~N~l~g~ 127 (589)
..+..+++|+.|||++|+++..
T Consensus 391 ~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 391 ATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HHHHHCCCCCEEECCSSSCCHH
T ss_pred HHHhcCCCCCEEECCCCcCCHH
Confidence 5667778888888888888754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.64 E-value=1.5e-05 Score=78.33 Aligned_cols=63 Identities=19% Similarity=0.184 Sum_probs=29.6
Q ss_pred cccceEEEccCcccccC-----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCcccc
Q 007788 39 LLCFVVLQLCCNQLTGN-----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLF 101 (589)
Q Consensus 39 l~~l~~L~L~~n~l~g~-----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 101 (589)
+..|+.|+|++|+++.. +...+..+++|+.|+|++|+++.. +...+..+++|+.|+|++|.|+
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 44555555555554421 122344445555555555554321 2333444555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.62 E-value=1.2e-05 Score=79.03 Aligned_cols=91 Identities=22% Similarity=0.232 Sum_probs=70.1
Q ss_pred HhhcccceEEEccCcccccC----CCccccCCCCCCeEeccCCcCCccCCc----cccC--CCCCCeeeccCccccCC--
Q 007788 36 KVILLCFVVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGGIPD----SLGN--LGKLKRLDLSFNSLFGT-- 103 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~----~~~~--l~~L~~L~ls~N~l~g~-- 103 (589)
...+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-.. .+.. .+.|+.|+|++|+++..
T Consensus 211 l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~ 290 (344)
T d2ca6a1 211 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290 (344)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred hcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHH
Confidence 44588999999999998743 445678899999999999999864222 3333 36799999999998743
Q ss_pred --Chhhhh-cCCCCceeeccCCcCcc
Q 007788 104 --IPESLA-NNAELLFLDVQNNTLSG 126 (589)
Q Consensus 104 --~p~~~~-~l~~L~~l~l~~N~l~g 126 (589)
+...+. ++++|+.|+|++|++..
T Consensus 291 ~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 291 RTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHHccCCCCCEEECCCCcCCC
Confidence 334443 57899999999999974
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.56 E-value=4.1e-05 Score=72.91 Aligned_cols=84 Identities=19% Similarity=0.129 Sum_probs=68.9
Q ss_pred cccceEEEccCc--ccccC-CCccccCCCCCCeEeccCC-cCCccCCccccCCCCCCeeeccC-ccccCCChhhhhcCCC
Q 007788 39 LLCFVVLQLCCN--QLTGN-IPAQIGSLKSLSVLTLQHN-RLNGGIPDSLGNLGKLKRLDLSF-NSLFGTIPESLANNAE 113 (589)
Q Consensus 39 l~~l~~L~L~~n--~l~g~-~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~ 113 (589)
.++|+.|+|++. .++.. +...+.++++|+.|+|++| .+++..+..++++++|++|+|++ +++++.-...++++++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 578999999864 44422 3334467899999999985 58888888999999999999998 6788777778899999
Q ss_pred CceeeccCC
Q 007788 114 LLFLDVQNN 122 (589)
Q Consensus 114 L~~l~l~~N 122 (589)
|+.|+++++
T Consensus 227 L~~L~l~~~ 235 (284)
T d2astb2 227 LKTLQVFGI 235 (284)
T ss_dssp CCEEECTTS
T ss_pred CCEEeeeCC
Confidence 999999887
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00023 Score=70.82 Aligned_cols=76 Identities=13% Similarity=-0.001 Sum_probs=45.5
Q ss_pred cccccCCCccEEEEEecC-CcEEEEEEeccC------CCchHHHHHHHHHHHHhccC-C--CCccceeeeeecCCCCeEE
Q 007788 315 NLLGKGNFSSVYKGTLRD-GTLVAIRSINVT------SCKSEEAEFVKGLYLLTSLR-H--ENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 315 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~------~~~~~~~~~~~e~~~l~~l~-H--~niv~l~g~~~~~~~~~~~ 384 (589)
+.||.|....||+....+ ++.|+||.-... ...........|.+.+..+. + ..+.+++.+. . +..+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTTE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCCE
Confidence 468999999999998764 678889964321 11111123345666666552 2 3455666543 3 3457
Q ss_pred EEEEeCCCCC
Q 007788 385 LIYDFAPKGK 394 (589)
Q Consensus 385 lv~Ey~~~gs 394 (589)
+||||+++..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.36 E-value=4.6e-05 Score=66.23 Aligned_cols=91 Identities=10% Similarity=0.074 Sum_probs=67.1
Q ss_pred HhhcccceEEEccCc-ccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCccccCC---
Q 007788 36 KVILLCFVVLQLCCN-QLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGT--- 103 (589)
Q Consensus 36 ~~~l~~l~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~--- 103 (589)
....++|+.|+|+++ .++.. +-..+...++|+.|+|++|.++.. +-..+...+.|+.|+|++|.|+..
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 334688999999974 56532 223567788999999999999742 223445568999999999998843
Q ss_pred -ChhhhhcCCCCceeeccCCcCcc
Q 007788 104 -IPESLANNAELLFLDVQNNTLSG 126 (589)
Q Consensus 104 -~p~~~~~l~~L~~l~l~~N~l~g 126 (589)
+-..+...++|+.|+|++|++..
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHHhCCcCCEEECCCCcCCC
Confidence 22346667889999999998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.01 E-value=0.00018 Score=62.35 Aligned_cols=89 Identities=13% Similarity=0.085 Sum_probs=66.8
Q ss_pred hhcccceEEEccCcccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCccccCC-----
Q 007788 37 VILLCFVVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGT----- 103 (589)
Q Consensus 37 ~~l~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~----- 103 (589)
...+.|+.|+|++|.++.. +...+...+.|+.|+|++|.++.. +-.++...++|+.|+|++|.+...
T Consensus 41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~ 120 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 120 (167)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence 3467799999999999732 223455678999999999999852 233466678899999999976522
Q ss_pred --ChhhhhcCCCCceeeccCCcCc
Q 007788 104 --IPESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 104 --~p~~~~~l~~L~~l~l~~N~l~ 125 (589)
+...+...++|+.|+++.+...
T Consensus 121 ~~l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 121 MDMMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHhCCCccEeeCcCCCch
Confidence 4456667899999999877553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.74 E-value=0.0035 Score=60.21 Aligned_cols=69 Identities=10% Similarity=0.148 Sum_probs=43.2
Q ss_pred ccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccCCCCc-----cceeeeeecCCCCeEEEEEEeCCCC
Q 007788 323 SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-----IRLRGFCCSRGRGECFLIYDFAPKG 393 (589)
Q Consensus 323 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-----v~l~g~~~~~~~~~~~lv~Ey~~~g 393 (589)
-.||++..++|..|++|+.+.... ...++..|...+..+....+ +..-+-......+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 479999999999999999875432 23456678777766642221 1211111111235678899999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.75 E-value=0.023 Score=53.70 Aligned_cols=162 Identities=11% Similarity=-0.008 Sum_probs=83.1
Q ss_pred cCHHHHHHhhccCcccccc-----ccCCCccEEEEEecCCcEEEEEEeccCCCchHHHHHHHHHHHHhccC-----CCCc
Q 007788 299 LNLEEVESATQCFSEVNLL-----GKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----HENI 368 (589)
Q Consensus 299 ~~~~~l~~~~~~f~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----H~ni 368 (589)
++.+|++....+|...++. ..|.--+.|+.+..+|+ +++|+........ +...|++++..+. -|..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccccc
Confidence 5667888877888765443 34555778999887665 7889886542222 2233444544442 2222
Q ss_pred ccee-eeeecCCCCeEEEEEEeCCCCChHH--------------HhhhhcC------CCCCCCH----------------
Q 007788 369 IRLR-GFCCSRGRGECFLIYDFAPKGKLSK--------------YLDQEEG------SSNVLDW---------------- 411 (589)
Q Consensus 369 v~l~-g~~~~~~~~~~~lv~Ey~~~gsL~~--------------~l~~~~~------~~~~l~~---------------- 411 (589)
+... |.....-......++.++.+..... .++.... ......+
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2211 1111111245667777777643321 0110000 0000000
Q ss_pred -HHHHHHHHHHHHHhHHhcCCCCCCCCeEecCCCCCCeeecCCCceEEccccccc
Q 007788 412 -STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 465 (589)
Q Consensus 412 -~~~~~i~~~ia~~L~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~DfGla~ 465 (589)
......+..+...+.-.+... .+-.+||+|+.+.||+++++...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~-L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKD-LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCS-SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccc-cccccccCCcchhhhhcccccceeEecccccc
Confidence 011122333333444444332 23458999999999999998777899999764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.71 E-value=0.0018 Score=55.59 Aligned_cols=88 Identities=18% Similarity=0.191 Sum_probs=60.9
Q ss_pred hcccceEEEccC-cccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeeccCccccCC----C
Q 007788 38 ILLCFVVLQLCC-NQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGT----I 104 (589)
Q Consensus 38 ~l~~l~~L~L~~-n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~----~ 104 (589)
..++|+.|+|++ |.++.. +-..+...++|+.|+|++|+++.. +-..+...++|+.|++++|.++.. +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 468899999997 556522 223456788999999999988743 222345578899999999988633 2
Q ss_pred hhhhhcCCCCceeec--cCCcCc
Q 007788 105 PESLANNAELLFLDV--QNNTLS 125 (589)
Q Consensus 105 p~~~~~l~~L~~l~l--~~N~l~ 125 (589)
-..+...++|+.++| ++|.+.
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHhCccccEEeeccCCCcCc
Confidence 245667788886555 566664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.52 E-value=0.0019 Score=55.46 Aligned_cols=88 Identities=15% Similarity=0.174 Sum_probs=66.4
Q ss_pred hcccceEEEccCcccccC----CCccccCCCCCCeEeccCCcCCcc----CCccccCCCCCCeeec--cCccccC----C
Q 007788 38 ILLCFVVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDL--SFNSLFG----T 103 (589)
Q Consensus 38 ~l~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l--s~N~l~g----~ 103 (589)
..+.|+.|+|++|.++.. +-..+...++|+.|++++|.++.. +-..+...++|+.++| +.|.+.. .
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 478899999999998743 223456679999999999998743 3346677888987555 5777753 3
Q ss_pred ChhhhhcCCCCceeeccCCcCc
Q 007788 104 IPESLANNAELLFLDVQNNTLS 125 (589)
Q Consensus 104 ~p~~~~~l~~L~~l~l~~N~l~ 125 (589)
+...+...++|+.|+++.|...
T Consensus 124 La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCcCEEeCcCCCCc
Confidence 5566778999999999887664
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.51 E-value=0.027 Score=55.19 Aligned_cols=73 Identities=18% Similarity=0.225 Sum_probs=47.6
Q ss_pred ccccccCCCccEEEEEecC--------CcEEEEEEeccCCCchHHHHHHHHHHHHhccC-CCCccceeeeeecCCCCeEE
Q 007788 314 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF 384 (589)
Q Consensus 314 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 384 (589)
.+.|+.|-.-.+|+....+ .+.|.+++.-.. .. .....+|..+++.+. +.-..++++++ . + .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~-~idr~~E~~i~~~ls~~gl~Pkll~~~--~--~--g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-ESHLVAESVIFTLLSERHLGPKLYGIF--S--G--G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-HHHHHHHHHHHHHHHHTTSSSCEEEEE--T--T--E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch-hhHHHHHHHHHHHHHhCCCCCeEEEEc--C--C--c
Confidence 3567888888999998754 346777776532 22 234557887877774 43344777766 2 2 5
Q ss_pred EEEEeCCCCCh
Q 007788 385 LIYDFAPKGKL 395 (589)
Q Consensus 385 lv~Ey~~~gsL 395 (589)
.|+||+++..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987544
|